data_6h8c_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6h8c _Structure_validation_residue.Date_analyzed 2019-04-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 121.894 0.854 . . . . 72.54 109.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tpt -55.97 -46.74 78.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 113.941 -1.481 . . . . 75.24 109.35 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -59.01 -50.32 74.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.046 0.938 . . . . 75.31 111.747 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -65.05 -27.31 68.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.549 1.539 . . . . 75.12 111.672 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.67 -47.94 28.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.536 -0.913 . . . . 74.41 108.536 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -74.95 0.15 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.58 1.152 . . . . 72.55 113.086 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -158.98 122.26 3.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 105.815 -1.92 . . . . 72.44 105.815 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -130.73 -65.14 0.8 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.66 -1.162 . . . . 74.12 112.686 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.5 mt -39.85 -57.12 1.64 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.562 1.689 . . . . 74.44 115.562 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.38 -52.71 51.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.254 -0.904 . . . . 72.12 110.073 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' HH21 ' A' ' 14' ' ' ARG . 6.6 t60 -54.37 -55.22 30.8 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.315 1.446 . . . . 75.51 111.39 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.543 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.0 mmp_? -58.53 -39.88 81.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 116.495 -1.717 . . . . 71.31 109.031 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -60.64 -55.38 33.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.246 1.384 . . . . 71.34 111.26 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.67 -47.88 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 117.974 0.352 . . . . 74.53 111.267 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -62.08 -39.88 93.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.626 -0.702 . . . . 72.21 110.805 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 t -59.73 -46.78 88.09 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.56 -1.274 . . . . 74.24 107.56 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.63 86.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.487 1.039 . . . . 72.02 112.251 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.23 -47.71 83.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.321 0.51 . . . . 73.24 110.747 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.13 -42.36 96.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 C-N-CA 123.923 0.889 . . . . 74.43 110.322 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -67.6 -40.26 84.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.955 1.252 . . . . 75.42 109.29 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.07 68.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.771 -0.58 . . . . 62.34 111.053 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -77.55 -46.72 21.44 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.599 0.963 . . . . 74.14 113.599 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -119.94 71.95 16.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.305 1.842 . . . . 75.33 111.024 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.28 -25.4 49.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.139 1.893 . . . . 75.32 112.644 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.21 11.92 21.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.488 0.715 . . . . 61.24 111.265 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -115.92 158.76 22.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.318 1.417 . . . . 74.14 109.539 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 m -119.68 129.92 25.11 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.621 1.568 . . . . 72.41 108.171 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.76 111.66 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.18 3.92 . . . . 74.32 112.694 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.12 151.45 20.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.306 1.442 . . . . 75.3 111.206 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.58 133.39 68.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 103.166 -2.901 . . . . 74.13 103.166 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.31 121.77 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.362 -0.828 . . . . 74.25 110.516 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.6 151.09 46.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.191 0.905 . . . . 73.34 111.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 123.46 31.75 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.764 1.626 . . . . 73.54 108.931 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.58 128.55 33.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.81 -1.552 . . . . 71.12 106.81 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 p -61.95 147.63 46.32 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.905 0.859 . . . . 73.14 112.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.91 -20.68 45.93 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 116.375 -2.347 . . . . 74.32 116.415 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 160.9 25.06 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 122.041 2.921 . . . . 75.53 110.668 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -72.86 -13.0 61.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.953 2.205 . . . . 71.25 116.953 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.07 162.59 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 120.595 1.543 . . . . 74.11 114.548 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.2 152.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.173 1.389 . . . . 73.33 109.578 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -81.1 169.15 17.79 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.016 0.526 . . . . 74.42 111.417 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -125.61 142.0 43.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.961 1.305 . . . . 75.45 111.485 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.12 161.49 30.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.889 2.076 . . . . 71.44 107.986 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -84.2 98.26 9.84 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.768 -2.308 . . . . 75.31 104.768 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -136.02 159.13 42.64 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.763 0.71 . . . . 73.23 111.459 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -106.25 99.01 8.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.583 1.553 . . . . 72.44 107.064 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.43 120.76 26.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.922 0.889 . . . . 70.44 110.337 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.79 105.46 14.69 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.972 1.309 . . . . 73.43 108.021 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.51 143.16 27.23 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-O 118.227 -0.892 . . . . 72.53 112.143 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.16 138.82 57.92 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.369 2.046 . . . . 73.44 110.329 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.0 p -63.61 -15.75 59.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.803 1.641 . . . . 62.1 112.431 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -75.07 -35.59 61.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.027 1.731 . . . . 74.11 113.712 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.06 165.54 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.866 0.841 . . . . 73.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -99.87 165.35 11.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.783 0.833 . . . . 75.41 110.905 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.25 -35.6 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.676 1.19 . . . . 75.23 108.143 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.77 88.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.966 1.306 . . . . 74.34 110.447 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.97 -45.63 66.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.373 -0.822 . . . . 64.43 110.006 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -59.07 -48.54 81.21 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.858 0.754 . . . . 73.45 109.483 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.2 ttp -55.19 -51.37 66.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.766 0.826 . . . . 75.02 109.949 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.96 -38.94 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.432 -0.318 . . . . 75.54 110.436 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.0 mt -66.38 -43.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 116.997 -1.477 . . . . 74.4 110.367 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.86 -50.81 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.636 1.562 . . . . 74.41 108.417 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -61.93 -39.62 92.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.91 -0.716 . . . . 75.13 112.616 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -66.93 -40.39 87.58 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.246 0.93 . . . . 74.14 110.392 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.43 -47.24 86.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 121.348 -0.845 . . . . 71.42 110.054 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -81.48 -1.24 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.837 0.68 . . . . 74.51 112.837 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 57.5 58.04 4.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.346 2.258 . . . . 74.55 112.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.27 108.13 2.55 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.073 0.949 . . . . 75.23 111.644 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.08 156.67 64.4 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 62.4 111.296 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.1 m -63.29 -13.97 44.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.696 -0.668 . . . . 74.44 112.463 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -37.37 76.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.863 1.21 . . . . 71.55 109.686 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -103.25 164.25 11.75 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.508 1.049 . . . . 73.41 111.059 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.18 170.79 7.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.044 1.738 . . . . 64.41 106.843 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 tt -151.62 129.78 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.915 -1.143 . . . . 75.22 107.915 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.26 147.76 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.889 1.275 . . . . 75.44 109.145 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.9 mt -114.16 154.59 27.57 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.152 1.381 . . . . 71.13 109.435 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -145.15 139.83 27.54 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.797 1.239 . . . . 72.44 108.533 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.37 128.81 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 106.035 -1.839 . . . . 74.13 106.035 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 45.96 37.13 3.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.447 1.022 . . . . 75.22 112.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.0 tptt 68.02 22.1 8.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.571 0.952 . . . . 74.21 113.571 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 p -127.28 162.16 26.89 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.985 1.714 . . . . 63.24 111.191 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.56 108.01 53.78 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 104.096 -2.557 . . . . 73.3 104.096 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.09 148.72 51.08 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.877 1.718 . . . . 74.4 111.881 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.41 117.97 16.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.94 1.296 . . . . 73.11 108.329 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 p -51.28 -38.79 54.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.134 1.373 . . . . 70.12 112.953 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -74.36 -12.36 60.5 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.755 1.02 . . . . 72.1 113.755 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.61 150.62 47.77 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.552 -1.343 . . . . 73.12 109.631 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.92 26.57 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.162 0.985 . . . . 60.43 110.798 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.8 mmt -57.2 -47.33 81.55 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.841 0.856 . . . . 74.33 111.063 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.58 96.59 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.526 -0.597 . . . . 71.41 113.138 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -67.76 -51.0 54.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.948 0.874 . . . . 75.31 110.508 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.47 -35.84 80.61 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.068 -0.716 . . . . 74.44 109.068 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -66.26 -57.19 8.09 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.428 -0.796 . . . . 72.53 108.906 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.7 -41.97 87.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.43 1.013 . . . . 74.32 112.734 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -32.9 65.48 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 118.398 -0.811 . . . . 73.03 111.73 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.59 7.09 44.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.071 0.85 . . . . 73.41 112.584 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.29 119.54 3.04 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 126.783 2.033 . . . . 74.43 109.13 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.54 175.69 9.59 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.725 0.639 . . . . 72.13 112.725 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.15 -25.41 61.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.172 1.389 . . . . 75.34 110.498 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.42 4.98 39.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.215 1.806 . . . . 73.23 111.248 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.23 28.93 69.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.511 -1.16 . . . . 72.41 114.78 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -123.78 168.62 12.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.352 1.576 . . . . 72.04 109.125 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tp -122.02 139.97 53.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.511 1.124 . . . . 75.31 110.58 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -113.84 115.72 28.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.305 1.442 . . . . 74.34 109.489 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.54 131.53 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 O-C-N 120.746 -1.221 . . . . 72.45 108.592 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.59 151.83 31.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.983 -1.117 . . . . 74.34 107.983 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -131.04 154.42 48.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.607 0.363 . . . . 74.55 110.588 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.8 m -140.39 155.1 46.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.489 -0.93 . . . . 61.02 108.489 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.28 27.07 13.2 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.69 1.138 . . . . 73.4 111.509 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 128.341 2.656 . . . . 72.33 106.473 -179.629 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 116.24 1.941 . . . . 71.2 116.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 73.2 m95 67.43 65.0 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.539 1.518 . . . . 73.44 112.106 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.23 139.08 19.4 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.91 -1.276 . . . . 72.33 109.91 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.43 134.7 28.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 118.444 1.122 . . . . 75.13 111.317 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -140.7 114.4 8.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.313 0.645 . . . . 74.35 111.582 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.56 120.03 24.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 105.544 -2.021 . . . . 74.25 105.544 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.4 142.38 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.404 0.682 . . . . 75.4 109.621 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.7 p -161.95 149.0 14.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.646 1.578 . . . . 74.11 107.777 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.356 2.262 . . . . 74.51 105.379 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.5 m95 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 118.764 -0.636 . . . . 65.34 109.437 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -45.68 75.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.423 0.63 . . . . 74.11 110.845 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -60.07 -42.35 94.37 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.53 -0.731 . . . . 75.42 112.208 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -70.3 -32.02 69.61 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.043 0.537 . . . . 72.23 109.909 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.14 -47.94 69.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.279 -1.008 . . . . 72.52 108.279 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -71.1 -76.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.422 1.889 . . . . 72.22 111.485 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.94 126.24 3.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.695 1.198 . . . . 64.02 108.101 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -124.02 -65.6 1.05 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 116.562 -1.685 . . . . 63.21 112.664 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 tp -42.46 -58.33 2.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.457 1.481 . . . . 74.42 114.159 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -60.16 -52.05 66.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.562 0.696 . . . . 72.34 110.632 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.1 -49.1 69.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.318 1.847 . . . . 74.14 111.599 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -39.82 91.61 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.018 1.727 . . . . 64.34 109.458 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.3 m -61.42 -47.18 86.93 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.656 1.116 . . . . 62.14 110.753 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.21 -47.29 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.04 -1.038 . . . . 73.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.29 -52.0 67.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.76 1.224 . . . . 71.25 111.615 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 t -61.04 -48.4 81.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.873 0.869 . . . . 73.3 109.926 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.87 -47.74 73.85 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.147 0.885 . . . . 62.23 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.04 -41.61 77.44 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.53 -0.731 . . . . 74.43 111.552 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.47 -41.33 92.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.008 -0.996 . . . . 72.53 108.947 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -63.45 -41.44 98.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 120.284 1.402 . . . . 73.14 108.473 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.22 72.74 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.452 0.538 . . . . 62.35 112.452 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -76.82 -46.21 25.72 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 114.191 1.182 . . . . 74.22 114.191 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -133.79 79.22 58.85 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 125.02 1.328 . . . . 64.25 111.101 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 -20.38 47.96 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.525 1.484 . . . . 73.11 109.675 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.47 12.33 16.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.971 1.308 . . . . 62.44 112.4 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -127.75 141.41 51.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 119.196 0.907 . . . . 72.24 108.672 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.32 137.29 19.88 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 70.14 108.01 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.76 111.93 2.59 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.671 3.581 . . . . 74.24 113.843 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.89 135.6 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.458 1.103 . . . . 51.03 110.65 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.86 115.14 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 104.454 -2.424 . . . . 71.55 104.454 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.56 126.79 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.629 1.172 . . . . 73.44 109.284 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.82 149.13 48.86 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.378 1.071 . . . . 74.32 109.651 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -83.73 141.15 31.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.234 -1.025 . . . . 73.14 108.234 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.23 124.55 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 103.093 -2.929 . . . . 45.43 103.093 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.0 141.24 54.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.646 -0.659 . . . . 72.23 110.283 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.0 -1.84 78.44 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 116.13 -2.483 . . . . 61.34 113.655 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -83.95 145.07 28.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 121.575 2.688 . . . . 71.12 109.283 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.03 -20.16 64.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.976 1.71 . . . . 70.32 112.108 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.59 158.23 3.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.321 1.057 . . . . 70.22 113.441 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.52 134.54 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.129 -1.804 . . . . 74.34 106.129 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.24 171.98 14.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.859 1.664 . . . . 74.24 109.058 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 tt -126.64 152.02 33.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 123.742 0.817 . . . . 75.22 110.431 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.43 161.53 27.91 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.022 1.329 . . . . 73.05 109.141 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -77.89 91.05 4.13 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -131.34 151.92 51.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 106.548 -1.649 . . . . 72.41 106.548 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -99.98 106.35 18.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.729 -1.211 . . . . 73.21 107.729 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -87.98 121.07 29.95 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 122.401 1.096 . . . . 74.01 113.072 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.92 112.52 24.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.762 2.025 . . . . 73.1 108.246 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 m -111.34 142.03 25.62 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.074 -0.965 . . . . 75.23 110.704 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.02 139.25 38.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 120.86 1.343 . . . . 63.14 110.889 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 p -65.57 -12.77 56.04 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.85 1.26 . . . . 62.32 112.145 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.88 -35.37 43.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.166 1.786 . . . . 70.12 113.965 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -74.53 170.24 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.957 0.884 . . . . 73.43 111.444 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 p -97.8 162.84 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.896 1.278 . . . . 65.25 111.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.21 -35.28 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.368 1.067 . . . . 74.24 108.129 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.31 90.25 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.82 0.848 . . . . 63.3 109.682 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -62.95 -46.06 89.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.182 -0.673 . . . . 75.03 109.182 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.38 -51.08 71.46 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.983 -0.377 . . . . 65.43 109.983 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.42 -47.99 72.15 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.596 1.158 . . . . 74.14 109.619 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -59.79 -44.67 93.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.594 -0.521 . . . . 75.34 109.594 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.6 mt -62.95 -40.28 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.63 -1.176 . . . . 74.14 109.453 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.17 -50.15 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.955 1.707 . . . . 74.24 108.906 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -63.66 -35.25 79.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.787 0.722 . . . . 75.42 111.16 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -66.89 -43.61 82.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.794 0.724 . . . . 73.54 109.198 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.59 -49.16 78.64 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.866 1.266 . . . . 75.14 111.341 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -80.39 0.65 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.026 0.204 . . . . 71.32 110.781 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 49.46 64.4 1.76 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.618 1.967 . . . . 73.43 110.016 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.14 111.39 7.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.296 1.438 . . . . 73.32 111.01 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.66 152.9 69.91 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.998 2.465 . . . . 75.12 109.94 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 m -62.2 -15.38 46.12 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.809 1.04 . . . . 74.24 113.809 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.16 -32.07 66.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.516 0.726 . . . . 73.25 110.431 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.37 164.33 11.71 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 122.073 0.94 . . . . 72.14 109.861 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.28 4.79 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.934 1.694 . . . . 74.2 107.49 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 tp -139.63 138.23 39.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.99 -1.855 . . . . 63.22 105.99 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -144.08 133.14 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.371 1.469 . . . . 75.34 107.17 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.5 mt -114.61 151.42 33.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.407 1.083 . . . . 64.45 108.172 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.0 142.49 29.83 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.709 1.204 . . . . 75.44 109.565 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.66 124.8 20.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 117.148 -1.406 . . . . 75.21 107.347 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 46.35 38.45 5.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 120.358 1.435 . . . . 72.03 110.882 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt 64.57 18.68 11.5 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.286 -1.509 . . . . 71.15 113.588 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 p -119.48 162.76 18.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.435 2.294 . . . . 74.24 111.234 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 t -101.39 107.84 52.61 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.97 1.308 . . . . 73.02 107.966 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.17 140.49 45.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.158 2.572 . . . . 74.3 109.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -77.63 121.81 24.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.506 0.722 . . . . 73.24 110.945 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.1 p -52.58 -35.45 54.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.758 1.223 . . . . 74.31 114.159 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -77.84 -17.3 57.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.624 0.972 . . . . 74.4 113.624 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.14 149.81 49.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.803 1.183 . . . . 73.44 109.787 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.6 p -85.98 152.38 22.98 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.767 0.794 . . . . 71.54 109.722 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.4 mmt -56.12 -43.43 78.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.181 0.992 . . . . 73.4 112.032 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.62 -36.8 83.95 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.563 -1.132 . . . . 75.44 113.288 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -66.49 -49.14 67.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.213 1.506 . . . . 74.43 107.739 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.07 -43.1 95.68 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.859 0.864 . . . . 72.31 110.102 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -59.55 -54.46 46.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.313 1.845 . . . . 74.11 108.991 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.14 -43.35 99.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.098 -0.641 . . . . 73.45 112.69 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -32.38 60.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.895 1.072 . . . . 74.14 113.895 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -100.44 0.89 40.62 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.23 1.196 . . . . 74.24 114.23 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.49 121.54 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.635 1.574 . . . . 74.52 112.384 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.15 175.51 7.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.712 0.405 . . . . 73.54 109.978 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.64 -34.03 66.9 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.888 -1.133 . . . . 75.32 110.827 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.23 10.39 29.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.457 1.903 . . . . 45.34 112.186 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.97 -1.2 1.39 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.848 2.642 . . . . 61.41 114.264 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.42 170.83 15.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.023 1.411 . . . . 72.23 111.073 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.68 136.75 54.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.78 0.832 . . . . 74.25 111.075 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -122.18 122.91 40.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.889 1.676 . . . . 74.05 109.898 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.17 137.51 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.693 -1.254 . . . . 71.32 109.461 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.16 147.62 32.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.746 -1.205 . . . . 75.33 107.746 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.85 152.44 48.51 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.315 0.646 . . . . 61.42 110.641 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 t -147.29 163.55 36.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.495 0.718 . . . . 62.44 109.895 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.86 17.22 22.84 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.896 1.712 . . . . 55.22 113.654 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 . . . . . 0 C--O 1.237 0.411 0 C-N-CA 126.076 1.75 . . . . 73.54 109.201 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 115.902 1.815 . . . . 62.14 115.902 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 59.4 m95 51.96 52.21 14.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.883 1.673 . . . . 75.11 111.984 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.48 130.49 9.82 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.789 -1.194 . . . . 75.11 111.498 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.78 132.39 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.956 1.702 . . . . 72.44 110.992 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.96 141.48 36.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.959 2.104 . . . . 71.42 110.961 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.15 124.02 37.9 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.061 -1.089 . . . . 72.05 108.061 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.97 109.97 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.678 1.191 . . . . 74.54 109.129 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 160.1 40.96 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.659 1.184 . . . . 74.32 110.694 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.277 1.031 . . . . 73.11 108.564 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.3 m95 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 112.099 0.407 . . . . 63.22 112.099 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -35.19 77.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.22 -0.289 . . . . 72.21 110.22 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.68 -45.77 91.09 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.915 -1.116 . . . . 64.13 109.992 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -65.22 -33.98 77.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.842 0.857 . . . . 75.43 110.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.75 -45.29 92.68 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.023 0.929 . . . . 60.25 108.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.09 -75.48 0.3 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.146 0.978 . . . . 72.11 112.87 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 133.35 6.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.467 1.507 . . . . 74.32 109.504 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.4 t -130.65 -53.29 1.08 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.787 -1.101 . . . . 51.44 109.551 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 tp -49.59 -59.94 3.32 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.232 1.567 . . . . 73.41 115.232 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.63 -58.87 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.249 0.931 . . . . 75.12 110.847 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' HH21 ' A' ' 14' ' ' ARG . 2.0 t-160 -50.6 -50.33 54.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.885 1.674 . . . . 71.15 111.892 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.436 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.8 mmp_? -70.27 -42.04 72.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.721 -1.862 . . . . 73.41 110.734 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.14 -54.45 39.41 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.22 1.373 . . . . 75.25 110.015 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -47.64 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.027 1.331 . . . . 72.33 111.476 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.0 -42.59 99.89 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.85 -0.595 . . . . 71.11 109.837 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -55.34 -48.18 74.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.277 1.031 . . . . 74.14 108.681 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.62 72.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 0.598 . . . . 72.24 111.864 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.67 -45.61 91.99 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.971 -0.456 . . . . 73.42 110.887 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.4 -41.44 89.89 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 108.52 -0.919 . . . . 65.24 108.52 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -67.57 -29.82 69.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.39 1.45 . . . . 71.42 110.648 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.36 -47.44 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.681 -0.637 . . . . 72.22 110.076 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.99 -46.51 29.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.935 0.717 . . . . 73.12 112.935 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.91 73.65 70.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.773 2.029 . . . . 75.44 110.492 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -18.37 47.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.162 2.575 . . . . 74.25 111.831 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.52 14.03 31.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.712 1.205 . . . . 75.14 111.839 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -123.53 152.37 41.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.77 0.828 . . . . 73.44 109.458 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 m -114.51 129.39 24.97 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.577 1.551 . . . . 74.52 108.525 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.66 116.99 3.89 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.22 3.947 . . . . 60.55 112.601 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.72 146.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.759 0.79 . . . . 75.42 109.455 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.36 112.77 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.486 -2.783 . . . . 73.13 103.486 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.33 127.71 61.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.198 -1.408 . . . . 73.23 107.198 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -128.08 143.61 51.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.226 0.611 . . . . 73.31 109.841 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.49 136.5 32.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -68.48 112.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.345 -1.354 . . . . 73.32 107.345 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.05 148.64 2.25 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.366 1.466 . . . . 63.45 111.345 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.23 -20.49 13.3 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 118.471 -1.183 . . . . 60.44 111.93 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -65.16 144.93 56.88 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.96 1.88 . . . . 54.21 110.346 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -70.67 -28.76 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.638 1.575 . . . . 65.21 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 42' ' ' VAL . 5.6 tp -59.79 157.34 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.369 0.668 . . . . 63.21 111.198 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' H ' HD13 ' A' ' 41' ' ' ILE . 33.7 m -63.46 138.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.178 -1.045 . . . . 64.52 108.178 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.82 177.58 6.05 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.927 1.691 . . . . 75.33 110.082 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.97 158.79 35.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.659 1.184 . . . . 73.32 109.936 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -78.92 166.19 22.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 128.278 2.631 . . . . 75.22 109.228 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -80.88 80.85 7.28 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 104.009 -2.589 . . . . 71.53 104.009 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -135.04 145.11 47.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.023 -1.843 . . . . 74.42 106.023 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -92.02 144.29 25.6 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.558 1.143 . . . . 75.54 111.745 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.03 116.96 30.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.322 1.449 . . . . 61.13 107.518 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -108.12 110.32 21.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.981 1.313 . . . . 73.42 109.379 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.0 143.55 27.59 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 119.6 1.091 . . . . 71.24 112.808 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.87 138.83 59.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.911 2.407 . . . . 73.15 110.603 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.77 -16.47 58.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.656 -0.652 . . . . 74.53 112.301 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -26.21 59.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.459 1.904 . . . . 61.13 113.7 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.91 170.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 122.11 0.957 . . . . 72.44 111.523 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -107.38 162.15 14.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.491 1.116 . . . . 62.41 109.6 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.3 t -52.36 -37.29 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.083 . . . . 71.54 108.077 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.36 -46.68 73.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.313 1.445 . . . . 74.22 112.225 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -70.47 -44.4 67.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.36 -0.607 . . . . 74.52 109.36 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -58.44 -49.91 75.6 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.962 0.41 . . . . 71.31 109.896 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.6 ttp -62.56 -49.19 76.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.554 -0.736 . . . . 75.51 110.177 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -57.59 -44.49 85.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.455 1.025 . . . . 71.44 111.077 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.9 mt -64.79 -42.96 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.534 -0.913 . . . . 73.11 108.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.6 mt -57.67 -50.08 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.274 1.397 . . . . 75.51 110.07 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.54 -35.2 77.08 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.328 -1.483 . . . . 72.11 111.016 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -70.35 -35.47 73.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.407 0.548 . . . . 74.13 109.717 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -67.02 -45.3 77.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.608 1.563 . . . . 74.31 111.682 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 pt -79.6 -3.39 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 123.667 0.604 . . . . 74.14 110.887 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.72 46.57 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.394 1.077 . . . . 61.12 109.802 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.92 109.28 3.64 Favored Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.369 1.468 . . . . 54.41 110.223 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.58 149.91 56.29 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.975 1.783 . . . . 75.14 108.811 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -61.5 -18.15 57.8 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.507 -0.746 . . . . 72.42 113.007 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -66.33 -26.17 67.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.241 0.928 . . . . 65.31 110.449 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.99 164.89 11.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.062 0.945 . . . . 73.11 109.593 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 166.3 10.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.281 1.433 . . . . 74.41 109.52 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 tt -149.75 113.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 121.254 -0.904 . . . . 72.34 109.698 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -123.42 138.03 54.68 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.449 -1.315 . . . . 74.13 107.449 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.97 149.85 36.7 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.233 1.813 . . . . 74.32 107.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -141.74 133.36 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.41 1.084 . . . . 75.35 109.436 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.44 144.2 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 106.743 -1.577 . . . . 72.41 106.743 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.72 36.45 1.28 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.924 1.29 . . . . 74.42 112.651 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.51 38.21 29.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.235 1.414 . . . . 73.21 110.662 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -147.67 162.22 39.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.8 -1.185 . . . . 74.22 107.8 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.76 114.05 60.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 103.388 -2.819 . . . . 64.42 103.388 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.77 123.95 10.97 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 N-CA-C 107.427 -1.797 . . . . 74.35 107.427 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.96 126.56 27.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.461 -0.57 . . . . 65.45 109.461 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.0 m -45.88 -46.78 16.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 65.25 113.471 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.7 m -77.04 -3.18 37.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.389 1.45 . . . . 74.31 114.692 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.0 tp -67.47 141.17 57.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.691 1.587 . . . . 74.43 106.809 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.1 p -85.52 151.98 23.53 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.705 -0.622 . . . . 64.41 109.544 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 mmt -62.27 -42.13 99.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 118.206 -0.902 . . . . 73.31 113.153 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.33 -47.03 92.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.401 -1.079 . . . . 44.12 110.401 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -61.83 -49.15 77.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.774 0.83 . . . . 75.12 110.181 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.47 -49.31 75.92 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.384 0.674 . . . . 71.31 111.216 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -62.72 -45.53 92.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.629 -1.295 . . . . 73.45 108.915 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.05 -26.06 67.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 120.297 1.408 . . . . 74.23 111.736 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -24.35 20.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 116.911 -1.519 . . . . 73.35 112.335 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -112.36 1.1 15.88 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.877 1.436 . . . . 74.21 114.877 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -46.94 121.5 3.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.936 1.695 . . . . 73.14 112.148 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -80.85 171.51 14.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.544 -1.28 . . . . 73.12 107.544 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.1 -20.6 18.03 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.281 1.832 . . . . 55.01 113.795 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -102.03 13.71 33.98 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.901 1.68 . . . . 75.41 112.222 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.9 31.76 77.31 Favored Glycine 0 CA--C 1.524 0.623 0 O-C-N 120.547 -1.346 . . . . 64.45 114.092 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -129.16 172.94 10.94 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.361 -1.082 . . . . 75.13 108.44 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.12 125.36 45.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.946 -1.131 . . . . 72.34 107.946 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -102.96 120.04 39.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.903 1.281 . . . . 74.25 108.775 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.239 -1.023 . . . . 73.35 108.239 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.31 148.65 40.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.375 1.47 . . . . 71.11 107.628 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -138.12 145.81 42.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.433 0.56 . . . . 75.23 110.443 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 p -143.47 161.5 38.26 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 122.107 0.956 . . . . 74.32 110.228 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.32 13.31 21.26 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.993 -1.643 . . . . 73.32 108.993 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 125.76 1.624 . . . . 64.34 108.509 -178.892 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 115.754 1.761 . . . . 75.14 115.754 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 77.0 m95 60.7 59.2 2.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 74.33 113.045 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.78 129.21 9.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.644 -1.382 . . . . 72.24 109.644 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 55.2 mt -77.31 132.99 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.276 1.538 . . . . 74.31 112.184 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.02 139.81 39.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 73.33 109.183 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.4 tt -98.68 118.78 36.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.869 2.068 . . . . 74.55 107.638 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.41 125.66 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 122.917 0.487 . . . . 74.14 110.636 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.0 p -161.49 149.71 15.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.904 -1.887 . . . . 73.44 105.904 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.489 0.716 . . . . 72.42 110.112 -179.685 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.7 m95 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 mmt -58.76 -46.8 86.63 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.729 -1.212 . . . . 53.21 107.729 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -59.86 -43.33 94.72 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.497 -0.763 . . . . 73.23 112.307 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -69.33 -35.91 76.39 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.287 0.949 . . . . 70.13 110.924 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.05 -41.26 91.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.511 -0.552 . . . . 73.42 109.511 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.64 -75.45 0.31 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.745 0.818 . . . . 74.2 111.393 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 119.38 3.23 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.548 -1.649 . . . . 75.45 106.548 177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -104.68 -65.48 1.03 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.51 1.124 . . . . 74.13 112.361 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.61 -58.47 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.072 1.349 . . . . 75.44 112.922 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.76 -58.79 6.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.717 0.636 . . . . 73.54 112.717 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -55.63 -54.97 37.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.0 0.429 . . . . 75.42 111.808 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.33 82.53 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.526 -1.226 . . . . 74.12 110.982 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -61.8 -56.31 20.8 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.621 1.168 . . . . 73.13 112.919 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 -44.79 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 120.669 -1.269 . . . . 64.1 110.124 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.63 -42.76 99.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 117.661 -1.161 . . . . 72.42 110.405 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.5 p -60.49 -45.1 95.0 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.632 1.56 . . . . 63.44 109.423 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.22 74.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.983 0.81 . . . . 74.02 111.95 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.88 -39.84 95.12 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.632 -0.667 . . . . 72.11 111.132 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.47 -41.2 88.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-O 117.584 -1.198 . . . . 71.42 108.539 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -65.83 -39.2 90.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.869 1.668 . . . . 75.34 109.556 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.01 74.76 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.842 -0.743 . . . . 73.34 110.909 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -78.51 -47.05 18.14 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.855 1.798 . . . . 74.3 115.855 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -126.24 70.53 69.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 126.585 1.954 . . . . 63.31 110.647 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.12 -19.47 51.06 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.502 2.134 . . . . 71.41 110.231 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.46 12.92 17.07 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.44 1.096 . . . . 70.24 112.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -129.65 160.7 32.52 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.734 1.614 . . . . 65.12 111.393 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.21 136.97 28.9 Favored Pre-proline 0 C--O 1.247 0.948 0 C-N-CA 124.422 1.089 . . . . 73.21 108.471 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.98 113.7 3.48 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 126.078 4.519 . . . . 64.45 111.683 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.1 144.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.666 0.786 . . . . 73.45 110.477 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -122.6 128.88 75.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 103.861 -2.644 . . . . 75.31 103.861 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.93 119.69 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 127.124 2.169 . . . . 74.44 106.692 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -124.4 146.96 48.57 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.614 1.097 . . . . 75.44 109.051 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -89.35 139.41 30.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.242 0.474 . . . . 73.23 109.905 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.0 130.24 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.568 -1.271 . . . . 74.41 107.568 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 p -61.04 122.04 13.97 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.214 -1.402 . . . . 74.34 107.214 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.93 -13.8 29.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.902 -1.499 . . . . 44.21 112.87 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.54 131.08 35.93 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.503 2.151 . . . . 74.05 106.318 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -63.48 -19.66 64.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.813 0.845 . . . . 73.54 113.012 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 tp -51.74 155.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.817 1.647 . . . . 75.11 112.71 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.16 145.27 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.437 1.095 . . . . 74.3 111.78 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.79 164.24 25.39 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.036 0.534 . . . . 74.21 109.798 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.68 132.72 70.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.455 1.102 . . . . 73.53 112.082 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -67.54 153.6 43.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.996 1.719 . . . . 75.13 107.821 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.69 99.13 3.6 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.327 -1.731 . . . . 71.43 106.327 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -134.41 160.96 36.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.429 -0.952 . . . . 75.05 108.429 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -109.81 103.01 11.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.018 1.727 . . . . 75.14 108.372 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -84.38 125.84 32.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.735 -1.209 . . . . 75.04 107.735 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.74 107.57 18.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.322 -2.103 . . . . 71.24 105.322 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -109.61 143.01 26.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 117.011 -1.471 . . . . 63.52 110.492 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.12 134.73 25.75 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.452 2.768 . . . . 72.14 111.995 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 p -59.63 -17.2 31.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.885 1.274 . . . . 75.55 113.993 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.6 -34.26 60.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.434 1.894 . . . . 75.52 113.213 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.39 167.22 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 119.969 1.259 . . . . 71.22 111.095 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.418 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 57.4 p -107.38 166.66 10.48 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.38 1.072 . . . . 75.22 110.712 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.12 -37.94 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.378 1.071 . . . . 74.41 110.085 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.56 93.28 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.238 0.926 . . . . 71.33 111.311 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' NE2' ' H ' ' A' ' 56' ' ' THR . 58.3 mt-30 -65.79 -46.2 79.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.053 0.941 . . . . 75.21 108.572 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.95 -50.66 72.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.697 1.199 . . . . 75.32 110.46 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttp -55.06 -49.07 72.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.61 1.164 . . . . 63.43 110.35 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -57.51 -42.17 82.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.491 -0.559 . . . . 75.32 109.491 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.21 -48.66 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.822 -1.085 . . . . 74.43 110.374 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.28 -50.39 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.794 1.179 . . . . 74.31 110.071 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.0 -36.86 82.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.022 -0.99 . . . . 74.45 111.51 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -71.19 -37.1 72.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.072 1.305 . . . . 74.45 110.673 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.66 -49.53 74.79 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.491 1.516 . . . . 75.0 109.658 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 pt -79.53 0.7 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 119.605 -0.236 . . . . 73.23 111.006 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 50.29 58.41 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.498 1.919 . . . . 71.34 110.039 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 110.14 4.44 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.736 -1.209 . . . . 70.3 107.736 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.07 162.52 39.65 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.112 2.541 . . . . 74.11 112.434 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 m -67.35 -22.33 65.59 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.745 -0.597 . . . . 73.21 110.969 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.66 -34.06 77.01 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.11 0.868 . . . . 63.22 111.697 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -104.15 164.63 11.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.987 1.315 . . . . 71.33 111.726 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 175.13 5.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.413 1.885 . . . . 73.53 106.558 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -144.55 143.1 23.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 74.51 107.542 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -145.49 134.63 22.78 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.78 1.632 . . . . 74.32 108.129 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -114.7 142.26 46.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.988 1.315 . . . . 74.45 109.803 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.59 136.94 36.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.023 1.329 . . . . 74.23 108.766 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.67 125.7 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 104.305 -2.48 . . . . 71.32 104.305 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t70 43.72 42.7 4.46 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.252 1.204 . . . . 72.13 114.252 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? 69.51 18.58 7.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.712 1.605 . . . . 74.11 114.291 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.1 p -124.03 162.57 23.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 120.48 1.491 . . . . 75.22 112.165 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.24 105.12 11.47 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 105.737 -1.949 . . . . 74.55 105.737 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.45 133.75 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.065 1.844 . . . . 71.24 109.844 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -67.57 118.59 11.07 Favored 'General case' 0 C--O 1.227 -0.113 0 O-C-N 121.439 -0.788 . . . . 74.12 109.366 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m -50.56 -39.32 49.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.224 1.01 . . . . 75.14 113.563 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.69 -8.07 59.66 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.052 1.501 . . . . 72.33 115.052 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.47 141.69 50.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.156 1.798 . . . . 72.03 110.307 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.52 143.39 34.92 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.631 -1.248 . . . . 75.35 107.631 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.19 -43.39 70.69 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.208 -0.901 . . . . 73.41 111.09 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.45 -38.0 92.88 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.868 1.213 . . . . 75.02 112.904 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.65 -53.83 16.79 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.513 -0.993 . . . . 64.42 108.808 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.26 -38.32 83.13 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.194 -0.912 . . . . 74.21 110.319 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -61.44 -54.43 43.58 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 117.082 -1.437 . . . . 73.04 107.461 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -55.12 -53.62 53.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.75 1.159 . . . . 62.32 111.925 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -24.93 64.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 117.963 -1.018 . . . . 75.22 113.659 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -105.95 4.32 29.37 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.233 1.379 . . . . 71.33 112.861 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -55.37 120.25 6.82 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.126 1.77 . . . . 74.54 110.041 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.43 172.37 13.05 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.133 -1.062 . . . . 65.31 108.133 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.51 -33.96 68.6 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.774 -1.204 . . . . 73.33 109.926 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -88.35 16.35 6.49 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.734 1.214 . . . . 73.32 112.193 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.2 28.38 66.64 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.361 1.458 . . . . 71.42 116.294 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -119.51 175.74 5.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.445 1.622 . . . . 74.24 111.013 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.68 137.89 54.63 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.161 0.985 . . . . 75.24 110.502 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.84 101.76 8.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.081 1.353 . . . . 73.11 109.97 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.72 122.84 69.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.559 0.695 . . . . 74.21 111.149 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.78 145.86 25.44 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.595 -1.261 . . . . 71.11 107.595 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -128.67 147.42 50.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.459 -0.941 . . . . 75.35 108.459 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 p -144.8 154.8 43.06 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.508 -0.923 . . . . 74.3 108.508 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.74 20.97 14.53 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.983 1.277 . . . . 53.4 110.064 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 C--O 1.239 0.548 0 C-N-CA 125.694 1.598 . . . . 62.2 107.828 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 113.006 0.743 . . . . 75.21 113.006 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 44.5 m95 51.91 59.38 4.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.25 1.82 . . . . 74.22 112.506 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.24 135.54 14.71 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.982 -1.247 . . . . 75.42 109.982 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 82.7 mt -80.61 134.47 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.712 1.756 . . . . 75.53 112.446 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -140.03 133.64 30.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.085 0.954 . . . . 72.41 111.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 73.6 mt -88.27 116.66 26.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.322 -2.103 . . . . 75.44 105.322 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.68 121.81 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.743 -0.836 . . . . 73.21 108.743 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -157.3 128.09 6.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.023 -1.103 . . . . 73.55 108.023 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 105.728 -1.952 . . . . 71.34 105.728 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.6 m95 . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 106.959 -1.497 . . . . 65.34 106.959 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 mtt -49.64 -46.83 49.96 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.61 0.764 . . . . 63.24 109.749 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -56.65 -44.14 81.01 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.038 -0.982 . . . . 74.33 113.108 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -74.52 -27.72 60.66 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.353 1.061 . . . . 73.23 113.332 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -72.42 -48.16 43.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.515 -0.92 . . . . 64.1 108.515 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -74.73 -77.29 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 124.271 0.982 . . . . 63.14 109.085 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.66 117.85 2.11 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 119.773 -1.83 . . . . 73.52 108.228 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p -112.86 -66.4 1.09 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.839 -1.553 . . . . 74.02 109.428 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 2.0 pp -44.14 -58.13 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.387 1.875 . . . . 71.21 115.299 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 1.3 tp10 -57.59 -58.93 6.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.452 1.901 . . . . 73.44 111.237 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -63.15 -50.73 69.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.913 1.285 . . . . 70.25 111.141 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -40.92 85.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 116.996 -1.478 . . . . 75.15 109.824 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.11 -55.6 20.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.821 1.191 . . . . 74.1 110.117 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.03 -47.71 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.454 0.57 . . . . 74.22 111.031 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' CB ' ' HE2' ' A' ' 48' ' ' LYS . 53.9 mm-40 -65.27 -38.59 90.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.412 -0.804 . . . . 71.42 109.74 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -58.77 -48.44 81.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 120.315 1.416 . . . . 73.42 108.419 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.42 69.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.88 0.764 . . . . 71.31 110.485 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.84 -49.92 70.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.479 -0.296 . . . . 75.43 111.677 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -59.13 -42.02 85.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 124.085 0.954 . . . . 64.24 110.621 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -69.12 -38.89 79.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.686 1.13 . . . . 71.55 109.379 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.49 70.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.591 -0.693 . . . . 64.51 110.468 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -73.2 -46.38 50.8 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 113.153 0.797 . . . . 75.53 113.153 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -129.0 77.75 77.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.857 1.263 . . . . 75.51 109.887 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.42 -28.03 71.03 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.731 2.287 . . . . 74.34 113.581 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.6 13.8 13.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.288 0.949 . . . . 74.21 110.653 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -118.1 152.44 35.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.584 -0.895 . . . . 72.35 108.584 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.61 135.2 24.94 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.52 -1.289 . . . . 73.21 107.52 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.47 114.44 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.293 3.329 . . . . 73.35 114.108 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.84 149.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 O-C-N 120.938 -1.101 . . . . 72.33 109.926 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.6 mm -123.1 115.19 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 103.056 -2.942 . . . . 75.31 103.056 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.08 119.38 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.054 -1.091 . . . . 75.01 108.054 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.48 159.67 37.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.709 1.14 . . . . 63.32 111.616 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.31 153.59 22.47 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.586 -0.696 . . . . 74.15 112.052 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.47 135.32 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.55 -2.389 . . . . 65.31 104.55 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.66 120.97 9.89 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.668 -1.234 . . . . 62.32 107.668 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.32 -11.82 54.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.538 -1.146 . . . . 61.23 112.443 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -69.5 113.27 6.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 103.635 -2.728 . . . . 62.34 103.635 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -72.07 -13.36 61.57 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.411 0.893 . . . . 73.53 113.411 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 tp -62.54 166.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.547 1.139 . . . . 74.24 111.723 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 m -55.68 123.49 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.437 1.095 . . . . 72.51 109.181 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.62 178.16 5.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.795 1.638 . . . . 74.43 110.05 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.11 149.7 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.453 1.101 . . . . 75.22 110.867 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.16 166.07 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.475 1.51 . . . . 64.31 107.26 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.45 103.02 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.562 -1.336 . . . . 75.03 109.448 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -141.44 154.52 45.63 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.136 1.774 . . . . 74.44 109.865 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mtpp -98.97 104.27 16.3 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.964 1.706 . . . . 74.5 108.766 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -84.22 118.23 24.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.766 -1.568 . . . . 72.34 106.766 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.27 116.83 32.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.885 -1.524 . . . . 61.21 106.885 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -111.59 141.25 24.24 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.888 -1.053 . . . . 74.24 110.399 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.27 141.1 35.04 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.333 2.022 . . . . 75.31 108.229 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -65.9 -13.03 58.94 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 114.616 1.339 . . . . 75.22 114.616 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.54 -32.07 24.06 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.417 1.265 . . . . 62.15 114.417 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.37 164.8 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.305 0.957 . . . . 72.42 109.319 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -103.21 165.32 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.443 0.697 . . . . 72.21 110.74 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.81 -35.63 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.037 1.335 . . . . 64.24 109.259 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.89 -46.12 85.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.244 0.929 . . . . 72.25 109.933 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -67.57 -46.41 72.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.573 -0.727 . . . . 73.14 109.919 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.38 -46.97 87.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.513 0.597 . . . . 75.22 110.097 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.4 ttt -55.73 -52.19 64.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.243 1.017 . . . . 74.41 108.982 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -57.29 -40.35 77.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.581 -0.723 . . . . 75.31 110.663 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.73 -44.03 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.127 . . . . 71.11 109.282 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.89 -51.1 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.731 1.605 . . . . 75.54 110.393 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -36.16 82.85 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.672 -0.68 . . . . 75.24 110.904 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -68.07 -43.69 77.99 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.173 0.589 . . . . 72.22 110.689 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -60.23 -51.33 70.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.857 1.663 . . . . 74.12 110.033 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.53 -2.97 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.125 -0.464 . . . . 75.2 111.57 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 50.05 65.4 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.756 2.022 . . . . 73.2 109.532 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.82 115.16 22.05 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.56 0.744 . . . . 74.23 109.252 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.26 164.47 17.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.668 3.579 . . . . 74.41 113.817 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -67.92 -29.52 68.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.368 0.667 . . . . 73.11 111.509 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -62.09 -38.52 89.15 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.061 -0.495 . . . . 75.34 112.237 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.42 164.44 11.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.7 0.762 . . . . 74.43 111.756 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 -178.2 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.976 1.711 . . . . 62.24 107.506 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.2 140.59 22.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.411 1.084 . . . . 74.42 108.26 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -145.34 140.7 27.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.006 -1.479 . . . . 71.43 107.006 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.72 153.14 30.82 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.845 1.658 . . . . 72.44 109.637 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -147.03 132.85 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.525 1.13 . . . . 74.35 108.946 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -126.61 119.6 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 103.121 -2.918 . . . . 64.43 103.121 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 46.77 45.8 14.89 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 124.71 2.195 . . . . 73.52 111.603 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt 56.59 30.38 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.452 -1.405 . . . . 72.53 112.224 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 p -118.64 159.87 22.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.547 -1.649 . . . . 72.34 106.547 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.36 109.58 41.25 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.674 -1.973 . . . . 74.52 105.674 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.38 124.0 13.07 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.093 1.862 . . . . 70.14 110.51 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -73.93 116.03 14.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.641 1.176 . . . . 64.53 109.954 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 83.6 p -49.13 -34.2 13.59 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.083 1.512 . . . . 65.44 115.083 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -82.6 -9.53 59.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.583 0.957 . . . . 65.31 113.583 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -75.19 144.5 42.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.609 1.095 . . . . 74.32 109.732 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.69 150.04 26.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.623 0.769 . . . . 63.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.2 mmt -54.64 -45.42 73.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.473 1.109 . . . . 75.12 111.785 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.15 91.04 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.456 -0.636 . . . . 55.44 113.259 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.5 -52.94 40.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.342 1.071 . . . . 73.52 108.812 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.38 -45.4 76.57 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 124.732 1.213 . . . . 74.33 108.82 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.28 -56.06 26.9 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.02 1.728 . . . . 73.34 109.28 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.31 -43.19 88.05 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.193 0.906 . . . . 74.01 113.298 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -30.71 39.31 Favored 'General case' 0 N--CA 1.46 0.055 0 CA-C-O 117.324 -1.322 . . . . 73.23 112.844 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -97.58 -7.77 30.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.205 1.366 . . . . 74.12 114.266 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -33.38 120.16 0.37 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.968 2.907 . . . . 73.11 114.94 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.01 169.98 17.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.38 -1.341 . . . . 74.12 107.38 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -54.49 -28.75 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.252 1.421 . . . . 73.35 112.674 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -99.52 17.59 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.273 1.029 . . . . 75.24 112.703 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 30.43 74.63 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.325 -0.859 . . . . 62.52 114.632 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -126.28 174.17 8.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.693 1.246 . . . . 73.23 110.35 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 tp -124.62 142.95 50.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.127 -0.94 . . . . 74.24 110.778 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -117.93 116.1 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.473 1.509 . . . . 73.53 107.761 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.21 131.67 72.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 O-C-N 120.469 -1.394 . . . . 74.35 108.243 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.62 24.36 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.951 0.9 . . . . 72.22 109.798 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -139.96 154.49 47.2 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 124.191 0.932 . . . . 75.45 111.301 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -153.77 169.04 24.31 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.931 1.292 . . . . 74.15 108.829 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.34 24.9 10.19 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.397 0.999 . . . . 71.32 113.821 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.532 0.288 0 C-N-CA 126.015 1.726 . . . . 72.13 109.247 -179.026 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 119.619 -0.229 . . . . 72.1 111.161 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.1 m95 52.36 47.43 24.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.99 0.916 . . . . 75.43 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.28 146.31 28.94 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 108.584 -1.806 . . . . 60.41 108.584 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.57 143.98 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 118.661 1.23 . . . . 74.14 111.527 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -148.62 120.81 8.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.524 1.53 . . . . 74.51 109.781 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.45 119.61 22.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.442 -1.318 . . . . 72.52 107.442 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.47 108.61 22.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.661 1.184 . . . . 74.24 108.639 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.7 p -146.24 162.35 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.247 1.819 . . . . 74.14 109.913 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 123.571 0.748 . . . . 73.2 109.752 -179.656 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 109.02 -0.733 . . . . 74.24 109.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -46.75 68.91 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 124.206 0.942 . . . . 73.34 109.357 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -57.56 -49.25 76.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.743 0.817 . . . . 75.11 112.524 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.06 -43.99 90.44 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.697 0.799 . . . . 73.42 112.521 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -67.13 -44.35 80.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 123.572 0.545 . . . . 75.24 110.608 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.437 ' HB3' ' HD1' ' A' ' 9' ' ' HIS . 0.3 OUTLIER -75.96 -73.25 0.28 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 123.635 0.585 . . . . 71.13 111.448 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.604 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 1.5 p-80 -157.58 119.44 3.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.409 1.004 . . . . 71.34 109.948 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.01 -64.97 0.93 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.653 -1.641 . . . . 75.23 113.588 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.36 -57.82 1.68 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 121.597 1.999 . . . . 65.13 115.374 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -64.5 -52.62 56.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.768 0.794 . . . . 71.05 110.439 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.604 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 2.9 t60 -50.98 -58.99 4.63 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.075 1.75 . . . . 74.13 111.9 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -61.62 -49.43 76.61 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.363 2.665 . . . . 74.2 111.924 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.8 t -57.64 -49.05 77.75 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 118.724 0.693 . . . . 74.34 110.833 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.14 -42.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.331 0.652 . . . . 72.43 110.234 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 18.5 tt0 -60.44 -52.35 65.6 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.52 1.528 . . . . 70.43 110.436 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 t -58.21 -48.03 81.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.189 0.996 . . . . 75.2 108.937 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.42 76.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.25 0.477 . . . . 74.55 111.339 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -60.09 -39.56 86.54 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.35 -0.844 . . . . 74.02 110.332 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.34 -42.18 87.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-O 118.096 -0.954 . . . . 74.44 108.892 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -64.29 -32.52 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 120.515 1.507 . . . . 72.44 109.603 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.71 -47.81 20.77 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.254 0.549 . . . . 73.24 111.45 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -76.85 -46.87 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.859 1.429 . . . . 73.33 114.859 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.79 72.68 78.64 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 127.663 2.385 . . . . 74.43 108.128 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.79 -30.98 93.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.783 2.322 . . . . 75.22 111.326 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -90.92 14.79 12.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.766 0.826 . . . . 72.25 111.928 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 142.85 51.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.492 -1.38 . . . . 74.35 109.611 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.53 142.82 27.28 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.191 0.996 . . . . 73.3 111.779 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.79 118.66 3.84 Favored 'Trans proline' 0 C--N 1.353 0.78 1 C-N-CA 125.496 4.13 . . . . 73.13 114.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 t -125.48 143.85 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.248 1.023 . . . . 73.22 110.09 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mm -119.94 121.19 65.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 100.831 -3.766 . . . . 72.43 100.831 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.58 123.55 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.488 -0.93 . . . . 71.53 108.488 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -134.13 158.71 42.94 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.313 0.578 . . . . 63.02 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -79.12 145.75 33.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.01 0.524 . . . . 75.5 109.798 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.15 113.69 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 101.409 -3.552 . . . . 75.41 101.409 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.0 p -48.51 134.55 15.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.529 0.566 . . . . 72.33 112.529 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.29 -19.38 54.46 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 117.318 -1.823 . . . . 64.32 112.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 t -67.68 146.43 53.81 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.223 2.011 . . . . 73.02 109.937 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -73.7 -19.59 60.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.251 1.421 . . . . 74.44 112.791 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.91 158.14 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.767 -0.457 . . . . 71.12 109.767 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.84 145.48 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 113.738 1.014 . . . . 64.32 113.738 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.99 160.99 17.65 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.637 1.975 . . . . 71.34 111.485 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.53 139.95 50.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.496 1.519 . . . . 75.53 109.545 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.77 159.36 30.38 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.869 -1.16 . . . . 74.22 107.869 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.84 95.05 2.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.586 -1.264 . . . . 73.14 107.586 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -133.09 151.29 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.05 -1.463 . . . . 74.41 107.05 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.5 mttp -99.79 108.25 20.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.472 -1.307 . . . . 75.33 107.472 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.88 119.9 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.448 0.642 . . . . 73.42 111.229 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.85 117.16 32.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.495 -2.039 . . . . 73.53 105.495 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 m -112.91 142.43 27.24 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.266 -1.013 . . . . 74.21 108.266 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.78 138.62 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.324 1.509 . . . . 74.04 110.304 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -15.82 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.622 0.769 . . . . 74.14 111.667 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.73 -34.79 72.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.791 2.436 . . . . 64.4 113.321 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.31 166.5 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.004 -1.06 . . . . 63.42 111.982 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 p -99.87 168.74 9.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.728 0.811 . . . . 75.45 111.815 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.86 -41.24 56.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 125.078 1.351 . . . . 64.33 108.973 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.16 86.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.78 0.718 . . . . 72.01 111.074 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.57 -46.69 81.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.268 -0.642 . . . . 74.41 109.268 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.78 -47.71 84.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.533 0.606 . . . . 73.24 109.745 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.9 ttt -58.41 -46.17 86.98 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.629 1.571 . . . . 74.43 110.775 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -63.13 -44.49 95.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.865 -0.791 . . . . 72.44 108.865 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.24 -40.01 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 117.48 -1.248 . . . . 75.21 108.706 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.12 -50.58 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 120.92 1.691 . . . . 75.42 109.209 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -63.48 -40.48 97.21 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.608 1.094 . . . . 75.11 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -63.49 -46.61 85.35 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.143 0.977 . . . . 73.34 110.593 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -59.97 -49.06 79.15 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.261 1.424 . . . . 73.22 111.473 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -79.93 -0.76 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 123.431 0.457 . . . . 72.02 111.261 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 50.11 68.25 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.688 2.395 . . . . 74.21 109.71 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 111.99 8.97 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.97 1.708 . . . . 71.15 111.098 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.13 157.92 49.91 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.335 2.69 . . . . 73.41 112.313 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.314 0.487 . . . . 71.24 112.314 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.01 -35.98 82.94 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.384 -0.823 . . . . 72.2 109.688 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.66 164.27 11.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.802 1.287 . . . . 74.54 112.33 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.1 177.3 4.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.866 2.467 . . . . 44.42 106.992 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tp -147.06 140.75 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.504 -1.295 . . . . 75.53 107.504 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.31 141.55 28.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.356 1.862 . . . . 73.24 108.833 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.0 mt -114.91 147.45 39.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 75.13 109.348 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -143.82 123.79 13.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.089 -1.449 . . . . 73.23 107.089 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.48 117.4 49.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.235 -1.394 . . . . 74.41 107.235 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t0 43.66 51.13 6.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.097 1.759 . . . . 73.12 111.711 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 63.54 17.9 10.69 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.322 1.449 . . . . 74.23 114.101 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.2 p -121.79 161.52 22.51 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 120.13 1.332 . . . . 75.31 111.02 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.26 110.04 60.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.113 -2.551 . . . . 64.13 104.113 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.65 135.54 33.49 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.446 1.43 . . . . 71.43 111.473 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.92 120.38 18.48 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 107.768 -1.197 . . . . 74.15 107.768 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -53.89 -25.81 21.93 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.123 2.169 . . . . 74.21 114.842 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -92.18 -12.14 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.643 0.777 . . . . 54.23 112.426 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.42 149.61 49.73 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.514 -0.921 . . . . 74.53 108.514 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.04 152.53 21.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.697 0.799 . . . . 74.32 109.489 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.39 -46.36 88.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.582 -0.723 . . . . 75.25 109.867 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.92 96.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.724 0.678 . . . . 65.21 111.793 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -65.19 -51.07 63.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.995 0.918 . . . . 62.23 108.937 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.94 -38.53 88.81 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.946 -0.471 . . . . 74.01 110.855 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -61.89 -52.99 61.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.699 2.0 . . . . 75.53 109.659 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.38 -33.75 73.52 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.686 0.624 . . . . 73.51 112.686 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -26.55 33.82 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 117.555 -1.212 . . . . 74.33 111.724 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -103.95 -2.38 26.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.591 1.087 . . . . 74.45 112.647 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -33.23 121.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 116.324 1.972 . . . . 74.12 116.324 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.14 175.32 6.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.001 0.921 . . . . 63.23 109.688 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -51.76 -39.33 58.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.858 1.663 . . . . 73.31 112.269 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.72 0.35 57.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.603 1.561 . . . . 73.31 112.516 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.93 66.35 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.137 1.351 . . . . 51.43 112.627 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 161.05 16.21 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.546 1.938 . . . . 74.11 108.89 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.2 139.27 54.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.385 0.993 . . . . 75.14 109.937 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.78 132.94 54.45 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.561 1.545 . . . . 73.23 107.619 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.26 146.54 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.45 144.35 44.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.836 -1.172 . . . . 75.12 107.836 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -128.7 149.77 50.54 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 109.032 -0.729 . . . . 73.31 109.032 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.7 t -144.86 163.37 34.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.876 -1.157 . . . . 74.11 107.876 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.3 5.83 55.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.828 -1.709 . . . . 74.14 108.828 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 118.529 1.165 . . . . 74.24 109.921 -178.604 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 CA--C 1.539 0.519 0 N-CA-C 111.819 0.303 . . . . 72.53 111.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 27.8 m95 49.48 52.34 14.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.322 1.449 . . . . 74.43 112.71 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.38 131.87 10.85 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.13 -1.606 . . . . 72.43 110.257 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.5 141.63 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.205 1.502 . . . . 70.4 107.315 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -137.44 151.0 48.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.69 1.996 . . . . 74.41 110.687 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 19.3 tp -113.55 112.23 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.975 1.31 . . . . 75.43 109.525 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 70.1 t -123.95 137.0 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.233 1.413 . . . . 75.35 111.718 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.2 p -162.46 161.0 26.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.707 0.803 . . . . 54.14 111.602 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 102.851 -3.018 . . . . 75.14 102.851 176.498 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m95 . . . . . 0 C--O 1.236 0.384 0 N-CA-C 108.796 -0.816 . . . . 73.35 108.796 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.8 mmt -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.869 0.366 . . . . 75.42 110.465 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -58.29 -46.1 86.7 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 112.732 0.641 . . . . 75.13 112.732 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -63.98 -39.3 93.82 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.114 0.965 . . . . 74.2 111.363 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.08 -42.69 80.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.497 0.498 . . . . 70.14 111.497 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.18 -70.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.272 0.841 . . . . 65.33 113.272 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -158.36 119.98 3.53 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.486 -1.302 . . . . 74.12 107.486 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -128.83 -66.15 0.84 Allowed 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 117.113 -1.422 . . . . 42.41 111.883 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 tp -44.74 -50.34 10.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.092 1.357 . . . . 74.42 114.4 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -66.27 -59.44 3.72 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.939 -1.101 . . . . 72.34 112.235 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.648 ' CD2' HH21 ' A' ' 14' ' ' ARG . 3.0 t-160 -53.94 -51.85 62.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.488 1.115 . . . . 75.13 109.929 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.648 HH21 ' CD2' ' A' ' 13' ' ' HIS . 11.9 mmp_? -58.39 -46.2 86.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 115.599 -2.143 . . . . 74.41 109.867 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.17 -43.33 99.05 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.283 1.856 . . . . 72.32 112.449 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.66 -47.72 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 118.297 0.499 . . . . 74.01 110.008 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.16 -39.9 86.55 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.603 -1.189 . . . . 74.11 110.371 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 m -56.1 -47.78 77.41 Favored 'General case' 0 CA--C 1.523 -0.059 0 CA-C-N 120.722 1.601 . . . . 74.04 107.386 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.83 72.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.967 0.358 . . . . 61.11 111.967 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.52 -51.47 65.34 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.801 -0.562 . . . . 74.32 111.317 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.46 -42.21 87.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 117.513 -1.232 . . . . 72.22 109.908 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -72.58 -29.66 63.73 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 120.556 1.526 . . . . 71.24 111.643 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.23 -46.48 41.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.995 0.816 . . . . 72.41 109.586 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -73.47 -45.93 51.19 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.669 -0.645 . . . . 71.43 110.689 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -122.76 79.76 48.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 125.324 1.45 . . . . 73.14 110.202 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.66 -20.66 52.88 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.877 1.718 . . . . 73.21 110.897 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.06 16.92 25.32 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.306 1.042 . . . . 64.13 112.946 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -120.89 153.45 37.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.867 -1.531 . . . . 74.45 106.867 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 135.11 24.08 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 124.022 0.929 . . . . 71.5 108.788 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.76 111.92 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 125.31 4.007 . . . . 63.42 112.884 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.82 149.73 16.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.873 0.869 . . . . 73.41 109.697 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.63 120.88 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 103.634 -2.728 . . . . 74.11 103.634 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.58 130.72 64.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.075 -1.454 . . . . 73.12 107.075 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.99 148.04 52.7 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.656 1.182 . . . . 64.23 110.3 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.83 132.86 36.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.283 -1.006 . . . . 73.41 108.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.16 111.96 2.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.375 -1.713 . . . . 75.52 106.375 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -57.73 123.83 17.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.457 -1.312 . . . . 74.23 107.457 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.49 -17.99 27.93 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.689 1.137 . . . . 62.41 110.665 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 t -71.93 168.49 17.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.973 1.386 . . . . 74.25 108.398 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.23 -11.82 17.73 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.171 0.988 . . . . 74.11 113.391 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tp -69.72 159.64 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.816 -0.553 . . . . 73.24 109.981 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.09 148.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.186 1.394 . . . . 74.21 110.385 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -77.67 167.65 21.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.069 1.348 . . . . 72.11 111.713 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.63 135.86 62.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.795 0.838 . . . . 73.24 111.166 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.36 152.32 38.37 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.693 1.197 . . . . 73.51 108.395 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -74.75 92.99 2.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.786 -1.19 . . . . 72.33 107.786 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -132.81 162.63 31.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.67 1.988 . . . . 75.21 109.838 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -113.32 108.42 17.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.239 -2.134 . . . . 75.22 105.239 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -84.37 122.95 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.278 -1.008 . . . . 74.04 108.278 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.87 110.75 23.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.197 -1.779 . . . . 72.14 106.197 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.29 142.29 26.11 Favored Pre-proline 0 N--CA 1.453 -0.296 0 O-C-N 124.033 0.833 . . . . 75.51 109.02 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 135.43 39.42 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.986 . . . . 73.42 111.147 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -14.91 32.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.513 0.725 . . . . 72.13 111.698 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.23 -31.2 43.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.752 1.221 . . . . 72.32 114.154 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pt -73.39 170.32 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.392 0.996 . . . . 75.43 110.708 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -105.33 166.98 10.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.032 0.933 . . . . 74.31 110.359 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.91 -39.48 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.615 1.166 . . . . 71.31 109.382 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.02 95.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.877 0.762 . . . . 73.51 111.447 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -61.62 -47.39 85.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.933 -0.766 . . . . 75.3 108.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.05 -51.64 68.76 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.592 -0.521 . . . . 75.35 109.592 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.02 -47.91 71.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.857 1.663 . . . . 74.1 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -62.47 -41.22 98.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.795 0.271 . . . . 75.32 110.512 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.3 -39.73 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 118.091 -0.957 . . . . 73.5 108.432 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.1 mt -59.14 -50.47 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.523 1.511 . . . . 71.23 109.541 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -60.21 -35.06 74.58 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.119 -0.988 . . . . 64.31 110.37 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.3 -43.17 74.34 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.162 0.892 . . . . 74.01 109.822 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -60.7 -32.48 71.71 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 63.02 112.823 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.77 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.373 0.533 . . . . 73.31 111.46 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 54.56 57.65 5.58 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.161 -1.051 . . . . 65.33 108.161 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.43 108.82 2.87 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 107.105 -1.443 . . . . 74.31 107.105 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.03 147.42 67.53 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.346 -1.828 . . . . 72.14 107.346 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 m -62.72 -14.98 50.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.3 -0.875 . . . . 74.54 112.861 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -67.5 -28.61 67.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.131 0.878 . . . . 75.34 110.176 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -103.41 165.29 11.12 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.875 1.27 . . . . 73.32 108.525 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.69 176.03 5.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.043 1.337 . . . . 70.33 107.896 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.38 141.39 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.593 1.157 . . . . 63.24 108.265 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.26 135.96 24.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.808 2.043 . . . . 73.45 108.293 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.2 mt -114.94 156.14 25.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.75 1.62 . . . . 71.23 110.389 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -147.14 142.5 27.4 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.201 0.938 . . . . 74.42 109.878 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.96 119.91 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.424 -2.065 . . . . 75.3 105.424 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.1 t0 44.06 52.15 6.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.023 1.329 . . . . 75.22 111.347 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 60.19 19.11 8.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.471 1.509 . . . . 70.41 113.998 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 p -122.59 161.5 23.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 120.748 1.613 . . . . 74.53 110.606 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.42 113.8 64.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 102.181 -3.266 . . . . 73.44 102.181 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 138.84 35.15 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.327 1.152 . . . . 75.22 111.119 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -68.08 120.37 14.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.538 -1.282 . . . . 74.12 107.538 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 p -54.98 -18.67 5.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.967 1.707 . . . . 61.35 113.863 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -97.59 -0.83 45.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.909 1.684 . . . . 63.22 112.321 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 tp -80.96 151.55 28.45 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.381 1.446 . . . . 74.21 108.722 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -87.65 151.44 22.95 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 73.14 108.525 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.2 mmt -60.1 -39.28 85.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.761 -0.637 . . . . 73.32 110.386 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.89 -43.27 99.16 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.321 -0.712 . . . . 73.2 111.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -52.5 51.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.671 -0.863 . . . . 74.01 108.671 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.89 -36.71 72.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.946 0.499 . . . . 71.53 111.247 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -65.56 -55.16 19.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.151 -1.426 . . . . 74.43 107.151 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.85 -42.37 75.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.462 1.105 . . . . 71.54 112.479 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -26.71 29.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 117.466 -1.254 . . . . 74.23 114.229 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -109.89 9.11 24.57 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.89 1.223 . . . . 75.41 112.47 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -52.21 121.39 6.77 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.358 1.863 . . . . 75.34 111.251 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.43 169.29 17.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.511 -1.292 . . . . 74.14 107.511 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.99 -28.05 55.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.475 1.034 . . . . 71.44 111.42 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.57 7.33 20.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.982 1.313 . . . . 75.13 112.58 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.58 29.35 71.65 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 120.744 -1.223 . . . . 75.23 113.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -126.93 178.31 6.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.099 1.36 . . . . 62.2 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.82 129.92 51.79 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.211 1.004 . . . . 73.2 110.281 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -108.23 121.68 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.255 -1.387 . . . . 75.22 107.255 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.35 141.15 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.043 0.937 . . . . 74.11 109.529 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.27 151.26 37.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.164 -1.05 . . . . 72.32 108.164 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -135.67 152.79 51.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.573 0.624 . . . . 74.33 110.703 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -144.02 157.05 44.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.782 -1.192 . . . . 70.41 107.782 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 13.53 21.69 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.779 -1.328 . . . . 74.41 109.779 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 . . . . . 0 N--CA 1.441 -0.89 0 C-N-CA 125.761 1.625 . . . . 72.41 107.549 -179.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 113.221 0.822 . . . . 71.23 113.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 80.4 m95 55.16 59.45 3.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.819 1.248 . . . . 74.41 111.306 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -74.9 133.88 16.12 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.066 -1.214 . . . . 74.21 110.066 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 56.0 mt -74.13 119.24 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.59 1.556 . . . . 75.13 107.526 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -124.07 145.85 48.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.979 1.312 . . . . 73.53 110.325 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 20.5 tp -99.81 115.54 29.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.235 1.414 . . . . 75.1 108.439 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.93 120.43 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.866 1.266 . . . . 63.34 109.965 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 8.6 p -161.11 159.2 28.8 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.511 1.051 . . . . 70.3 112.595 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--O 1.249 1.036 0 C-N-CA 127.576 2.35 . . . . 74.12 108.559 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.7 m95 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 108.479 -0.934 . . . . 73.55 108.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 mtt -64.51 -43.0 95.44 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.438 1.087 . . . . 75.23 108.818 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -59.77 -51.72 68.54 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.558 -0.734 . . . . 73.43 110.668 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.17 -31.71 73.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 117.879 -1.058 . . . . 74.24 111.672 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -59.76 -45.31 92.65 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.57 -74.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.549 0.531 . . . . 73.43 110.325 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CE1' ' HD1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -160.34 143.03 13.27 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.74 2.816 . . . . 72.1 108.914 -178.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 p -120.68 -66.39 1.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 117.268 -1.349 . . . . 72.53 111.311 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -45.71 -59.0 3.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.355 1.862 . . . . 73.1 113.915 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.97 -48.02 72.66 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.356 -0.84 . . . . 71.41 111.754 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.407 ' HD1' ' CE1' ' A' ' 9' ' ' HIS . 6.1 t60 -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.599 0.36 . . . . 73.54 110.228 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -47.24 85.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.165 1.386 . . . . 75.41 108.559 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 t -61.75 -51.93 66.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 120.036 1.289 . . . . 62.11 111.481 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.42 -47.99 86.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.383 -0.823 . . . . 74.5 110.503 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.83 -52.03 65.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.837 0.855 . . . . 75.41 110.741 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 p -59.13 -48.13 82.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.293 -0.86 . . . . 75.43 110.456 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.27 78.14 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.668 1.122 . . . . 74.45 111.536 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -67.61 -40.25 84.71 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.517 -0.739 . . . . 75.25 110.628 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.1 -41.94 79.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 118.157 -0.925 . . . . 74.54 110.017 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -62.63 -38.25 89.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 120.208 1.367 . . . . 73.54 108.509 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.31 69.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.559 -0.856 . . . . 73.1 110.895 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -78.08 -46.8 19.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 118.448 2.758 . . . . 74.23 118.448 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -131.59 76.92 74.17 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.397 2.279 . . . . 75.14 108.789 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.69 -23.5 36.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.756 2.304 . . . . 71.31 112.364 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.62 12.85 17.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 73.43 112.426 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -122.0 153.81 38.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.493 -1.669 . . . . 75.11 106.493 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.32 138.41 24.28 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.483 -0.932 . . . . 72.11 108.483 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.6 122.27 5.45 Favored 'Trans proline' 0 C--N 1.353 0.792 1 C-N-CA 125.879 4.386 . . . . 63.11 111.449 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -131.93 143.27 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.121 0.968 . . . . 72.15 111.56 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.1 mm -117.38 120.48 65.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 103.695 -2.705 . . . . 74.4 103.695 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -108.16 110.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.978 1.711 . . . . 75.2 108.65 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -123.02 153.09 40.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.208 0.913 . . . . 74.23 110.911 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -93.54 146.22 23.95 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.345 0.521 . . . . 72.3 110.501 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.23 136.55 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.328 1.451 . . . . 63.22 107.816 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 m -49.19 142.19 7.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.961 0.904 . . . . 63.53 111.572 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.82 1.57 1.44 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.781 2.134 . . . . 45.12 116.543 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t -58.85 147.3 34.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 119.241 1.52 . . . . 74.11 111.699 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 -0.79 31.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.906 1.282 . . . . 72.4 112.449 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -82.92 156.79 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.556 1.071 . . . . 74.33 109.118 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 151.9 9.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.684 0.754 . . . . 72.15 109.267 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.02 165.23 23.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.35 1.241 . . . . 75.32 114.35 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.62 139.5 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 127.572 2.349 . . . . 74.43 108.177 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.47 161.29 26.17 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.793 -1.558 . . . . 63.43 106.793 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.5 104.92 3.98 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.234 -1.395 . . . . 65.15 107.234 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -136.61 160.12 39.76 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.755 1.622 . . . . 74.21 110.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 11.2 mttt -107.96 116.29 31.69 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.296 1.839 . . . . 72.1 106.51 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -98.26 138.82 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.762 1.165 . . . . 75.1 111.91 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.6 mt -120.75 110.9 16.92 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.299 1.44 . . . . 74.53 108.626 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.45 142.11 25.83 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 118.137 -0.935 . . . . 75.54 111.099 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.55 137.54 27.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.196 2.597 . . . . 72.32 110.863 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -61.52 -12.5 15.48 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.914 1.45 . . . . 70.31 114.914 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.95 -34.88 29.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.831 1.196 . . . . 74.31 113.639 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.64 168.1 2.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.145 0.497 . . . . 72.3 112.004 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 p -107.54 163.37 13.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.305 0.483 . . . . 73.15 112.305 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.06 -34.67 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.583 1.153 . . . . 73.12 109.758 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.66 88.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.635 1.174 . . . . 65.22 111.237 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -69.63 -42.6 74.1 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 124.073 0.949 . . . . 71.3 110.206 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -59.54 -46.94 87.42 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.586 -0.894 . . . . 73.42 108.586 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.6 ttt -58.69 -43.7 90.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.706 1.203 . . . . 75.14 109.553 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -58.55 -46.8 86.09 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.851 0.751 . . . . 74.44 110.297 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -61.78 -42.67 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 118.585 -0.721 . . . . 75.11 109.804 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.2 mt -58.15 -50.36 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.634 1.107 . . . . 72.43 109.7 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -64.73 -31.71 73.06 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.961 -1.087 . . . . 75.04 112.655 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -70.76 -48.4 54.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.523 0.729 . . . . 73.33 109.746 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -59.45 -49.26 78.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.05 1.74 . . . . 74.34 111.682 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 pt -78.87 -5.87 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.793 -0.363 . . . . 75.32 111.152 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 56.29 62.32 2.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.565 1.546 . . . . 74.35 108.289 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 108.53 2.96 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.069 0.948 . . . . 74.02 108.847 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.8 164.51 35.44 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.137 2.558 . . . . 73.14 111.059 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -67.01 -17.03 64.73 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.216 -0.928 . . . . 73.4 112.142 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.76 -42.83 97.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.354 0.979 . . . . 70.22 109.189 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -102.53 164.74 11.48 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 122.6 1.191 . . . . 72.3 110.802 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.2 -176.78 3.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.336 -1.727 . . . . 75.52 106.336 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 tp -144.52 139.25 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.145 -1.428 . . . . 64.31 107.145 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -145.3 134.46 22.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.143 1.377 . . . . 75.42 108.665 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.28 135.14 54.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.661 1.584 . . . . 74.33 107.907 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.49 124.29 29.83 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.407 1.083 . . . . 75.1 109.237 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.28 129.67 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.478 1.111 . . . . 75.05 108.255 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.42 33.24 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.929 1.692 . . . . 71.54 112.145 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 66.31 23.31 10.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.066 1.347 . . . . 64.33 111.278 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -123.15 162.25 22.87 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.372 1.869 . . . . 72.31 110.561 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.2 103.34 13.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 105.591 -2.003 . . . . 74.12 105.591 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.11 139.33 42.18 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.869 1.713 . . . . 72.34 111.734 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -74.06 120.26 19.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.601 -0.888 . . . . 63.52 108.601 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 p -46.75 -37.82 9.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.441 1.896 . . . . 75.34 114.753 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 p -86.38 -6.1 59.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 115.156 1.539 . . . . 64.13 115.156 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.41 141.54 57.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.555 -1.646 . . . . 70.12 106.555 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.3 p -80.61 154.74 27.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.391 -0.818 . . . . 75.21 109.087 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.2 mmt -59.24 -40.88 87.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.123 0.969 . . . . 72.31 108.978 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 -44.47 97.45 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.196 -1.336 . . . . 63.13 110.802 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.74 -48.35 54.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.005 1.403 . . . . 74.32 111.053 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -45.98 76.5 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.121 -0.696 . . . . 75.41 109.121 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -63.14 -52.4 62.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.731 0.696 . . . . 73.43 109.374 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -54.54 -40.42 68.66 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.237 0.828 . . . . 74.34 113.237 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -23.73 22.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.167 -1.397 . . . . 74.5 113.518 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -103.98 9.55 36.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.058 1.299 . . . . 63.33 110.842 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -52.42 121.33 6.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.384 2.273 . . . . 75.04 111.322 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -89.18 175.61 7.3 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.658 0.783 . . . . 74.54 108.942 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.85 -37.9 60.81 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.199 1.4 . . . . 74.14 111.571 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.39 -2.78 50.65 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.238 1.815 . . . . 70.11 111.966 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.62 29.33 71.65 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.911 1.243 . . . . 72.13 112.724 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 166.67 13.31 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.336 1.454 . . . . 75.52 109.377 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.3 tp -122.41 131.21 53.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.916 -1.142 . . . . 74.34 107.916 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -122.5 116.35 23.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.347 1.859 . . . . 75.32 107.432 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.69 150.15 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 O-C-N 121.227 -0.921 . . . . 62.41 110.058 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.2 152.51 33.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.089 -0.708 . . . . 74.34 109.089 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -135.24 154.2 51.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.861 0.839 . . . . 74.32 110.703 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.9 p -149.22 155.79 41.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.662 1.185 . . . . 71.53 108.137 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.18 21.86 12.8 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 111.383 -0.687 . . . . 45.34 111.383 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 126.46 1.904 . . . . 74.12 108.417 -178.399 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.746 0.647 . . . . 71.31 112.746 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . 0.455 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 48.8 m95 54.71 64.71 1.72 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.212 1.405 . . . . 72.14 110.863 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.88 138.78 17.15 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 107.517 -2.233 . . . . 62.52 107.517 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.68 142.94 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.446 1.623 . . . . 73.22 110.636 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.05 156.49 46.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.358 1.463 . . . . 73.43 110.489 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.29 119.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.104 2.162 . . . . 74.52 106.43 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.97 119.16 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 122.511 1.148 . . . . 71.33 109.808 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.9 p -161.76 152.76 18.08 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.688 -1.142 . . . . 61.12 110.248 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 129.466 3.106 . . . . 65.14 113.506 179.252 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.8 m95 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 106.622 -1.622 . . . . 74.11 106.622 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.21 -38.93 88.34 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.198 -0.667 . . . . 74.43 109.198 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -59.97 -39.63 86.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.412 1.005 . . . . 75.12 110.198 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.564 0.62 . . . . 73.52 109.431 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.0 -44.87 91.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.355 -0.98 . . . . 73.23 108.355 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.83 -75.97 0.18 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.746 1.017 . . . . 64.31 113.746 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -158.56 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.536 1.934 . . . . 72.13 108.229 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 p -102.36 -67.25 0.88 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.409 0.892 . . . . 74.53 113.409 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 -55.07 22.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 117.176 2.287 . . . . 75.31 117.176 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.0 -54.92 26.71 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.061 0.846 . . . . 72.53 111.23 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.75 -43.59 65.86 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.629 1.571 . . . . 74.42 111.078 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -47.06 63.34 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.891 -1.131 . . . . 75.5 109.626 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.91 -58.46 7.52 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.589 0.756 . . . . 72.32 111.065 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.39 -46.19 92.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.048 0.539 . . . . 74.02 110.916 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -64.98 -40.04 94.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.847 -1.073 . . . . 71.44 110.997 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 t -57.66 -46.92 83.61 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.273 1.397 . . . . 74.14 108.541 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.43 72.33 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.017 0.371 . . . . 70.52 111.325 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -59.0 -49.13 79.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.855 1.262 . . . . 74.45 110.328 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.33 -42.89 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 117.393 -1.289 . . . . 74.13 111.403 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -71.05 -29.81 65.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.527 1.512 . . . . 73.22 110.242 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.29 -47.29 57.76 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.676 -0.861 . . . . 73.23 108.676 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.53 -47.96 18.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.429 1.27 . . . . 74.45 114.429 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.73 73.43 69.55 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 127.869 2.468 . . . . 74.24 111.222 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.97 -29.36 89.17 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.063 1.842 . . . . 72.42 112.457 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.67 11.81 16.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.518 0.599 . . . . 75.41 111.086 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -112.42 143.33 43.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.61 1.55 . . . . 73.35 109.414 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -107.06 133.49 20.27 Favored Pre-proline 0 C--O 1.246 0.883 0 C-N-CA 124.323 1.049 . . . . 73.11 108.295 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.19 119.81 5.45 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.89 3.727 . . . . 74.32 112.606 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.23 149.67 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 74.51 111.115 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -122.13 134.4 65.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 102.669 -3.086 . . . . 73.3 102.669 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.77 119.57 53.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.379 1.471 . . . . 61.11 109.326 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.7 157.41 46.83 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.453 1.024 . . . . 74.42 113.279 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.7 150.98 23.28 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.872 0.368 . . . . 72.43 110.602 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.88 135.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.999 -1.482 . . . . 72.2 106.999 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -64.11 115.74 5.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.118 -1.068 . . . . 71.2 108.118 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.85 30.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.39 1.471 . . . . 63.33 112.374 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.9 m -85.23 112.58 20.87 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.623 1.711 . . . . 65.44 107.727 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.78 -20.98 60.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.267 1.827 . . . . 74.4 114.548 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.1 tp -53.42 158.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.449 1.5 . . . . 75.31 114.809 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.6 m -49.07 114.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.785 1.634 . . . . 73.01 109.64 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -82.1 167.76 18.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.453 1.501 . . . . 74.41 108.727 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -126.15 139.14 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.724 -1.213 . . . . 72.22 107.724 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.72 166.15 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.77 0.795 . . . . 64.41 109.47 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.35 105.81 4.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.267 -2.123 . . . . 70.52 105.267 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -139.92 152.41 46.37 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 124.243 1.017 . . . . 74.53 111.087 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -93.95 94.75 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.577 -2.009 . . . . 74.42 105.577 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -85.08 117.07 23.82 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.197 -1.038 . . . . 72.3 108.197 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.53 115.48 30.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.145 1.378 . . . . 73.41 110.471 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.01 142.92 27.7 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 119.966 1.257 . . . . 73.43 111.945 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 141.67 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.08 2.52 . . . . 73.23 110.691 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -62.5 -13.62 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.7 2.0 . . . . 63.12 113.28 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -30.03 25.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.636 0.976 . . . . 75.54 113.636 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.66 166.68 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 119.391 0.996 . . . . 74.1 110.403 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 p -107.51 163.01 13.42 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.373 -0.829 . . . . 75.33 112.989 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.79 -35.98 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.11 0.964 . . . . 74.35 109.201 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.72 78.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.484 0.714 . . . . 73.0 110.717 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -71.92 -43.22 65.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.413 1.085 . . . . 75.41 109.942 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.79 -41.97 87.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.123 0.874 . . . . 75.21 109.474 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 42.3 ttp -63.31 -48.8 76.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.041 -0.725 . . . . 74.31 109.041 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -58.89 -44.94 91.27 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.398 0.544 . . . . 75.2 111.092 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.91 -50.91 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.329 1.052 . . . . 73.34 108.307 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.79 -49.96 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.055 0.843 . . . . 74.42 111.009 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -64.05 -32.93 74.66 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.937 -1.102 . . . . 74.55 112.183 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -71.89 -46.47 57.66 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.77 -0.826 . . . . 65.45 108.77 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.3 -51.41 64.73 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.26 1.824 . . . . 74.25 111.942 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -3.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.142 0.423 . . . . 72.32 112.142 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 55.29 63.71 2.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.26 1.824 . . . . 73.32 107.776 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.67 114.28 18.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.229 -1.026 . . . . 74.23 108.229 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.98 164.37 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.781 2.987 . . . . 71.13 113.054 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.5 p -66.8 -32.32 73.53 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.929 -1.107 . . . . 71.45 112.659 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -59.44 -36.0 75.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.034 1.734 . . . . 75.53 112.337 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.83 165.04 11.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.471 1.108 . . . . 74.52 111.01 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.27 -179.4 3.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.963 2.105 . . . . 74.22 108.895 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.3 136.37 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.087 1.355 . . . . 73.12 107.886 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.34 136.67 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.424 -1.324 . . . . 75.21 107.424 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.28 148.85 31.09 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.469 1.108 . . . . 73.33 108.728 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -137.01 123.26 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.071 1.749 . . . . 73.24 108.417 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.06 144.49 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.582 1.153 . . . . 72.33 108.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 48.92 35.77 7.22 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.149 1.341 . . . . 70.2 111.853 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tttt 55.02 31.44 16.11 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.112 0.965 . . . . 74.11 111.476 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -152.19 163.96 38.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.642 1.177 . . . . 70.32 109.9 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 115.12 61.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 104.912 -2.255 . . . . 74.34 104.912 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.74 141.29 40.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.105 1.87 . . . . 72.32 110.606 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -72.09 127.28 32.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.736 -0.838 . . . . 73.21 108.736 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 p -53.81 -35.47 61.43 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.012 2.125 . . . . 61.44 112.218 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 t -70.02 -14.96 62.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.779 1.632 . . . . 72.31 112.39 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.73 147.78 48.67 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.45 -0.945 . . . . 72.43 108.45 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 m -98.88 149.09 23.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.871 -1.159 . . . . 72.53 107.871 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.7 mmt -55.04 -46.19 75.29 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.066 0.547 . . . . 74.44 111.745 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.91 -46.63 83.37 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.919 -0.873 . . . . 55.04 110.919 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -65.08 -52.92 52.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.48 0.712 . . . . 73.22 109.818 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.03 -50.28 64.58 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.045 0.938 . . . . 73.13 110.814 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.9 -49.14 75.97 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.067 -1.021 . . . . 73.52 109.838 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -68.22 -24.51 64.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.98 0.809 . . . . 74.1 112.797 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -37.4 13.87 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 119.687 1.13 . . . . 75.21 111.179 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.17 -3.77 50.32 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.318 1.229 . . . . 71.14 114.318 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -36.26 121.78 0.71 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.451 2.389 . . . . 72.24 117.451 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.31 165.92 23.85 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.206 -1.405 . . . . 61.1 107.206 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.18 -34.64 57.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.529 1.132 . . . . 54.13 111.871 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -96.77 14.08 26.33 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.552 1.141 . . . . 75.34 113.579 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.2 70.59 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 120.688 -1.258 . . . . 61.2 113.853 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.39 154.48 29.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.526 1.163 . . . . 73.54 108.382 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.49 133.89 55.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.826 -1.176 . . . . 73.12 107.826 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.81 124.3 42.99 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.257 1.423 . . . . 72.24 109.121 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 143.64 40.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-O 122.091 0.948 . . . . 71.44 108.59 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.85 155.96 22.79 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.551 -0.718 . . . . 75.34 109.132 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -140.99 161.34 38.07 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.531 0.732 . . . . 75.33 111.525 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -151.61 156.95 41.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.811 -1.181 . . . . 71.24 107.811 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.0 26.26 9.43 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 126.54 2.019 . . . . 70.24 109.918 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.445 -0.676 0 C-N-CA 127.376 2.271 . . . . 72.03 106.72 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 119.385 -0.34 . . . . 72.11 111.846 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 75.4 m95 58.68 58.93 3.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 74.54 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -78.85 145.29 28.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.967 -1.653 . . . . 75.01 108.967 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 33.0 mt -77.51 141.16 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.821 1.31 . . . . 74.03 111.138 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.66 122.91 16.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.672 0.789 . . . . 74.44 108.972 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.31 108.54 20.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.666 -2.346 . . . . 74.21 104.666 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.62 134.78 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.181 0.808 . . . . 70.32 113.181 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 12.8 p -161.47 158.64 26.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.642 1.577 . . . . 64.21 107.388 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 127.999 2.519 . . . . 73.45 112.504 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m95 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.5 mmm -57.66 -46.89 83.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.133 -0.692 . . . . 73.1 109.133 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -58.16 -45.05 88.12 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 119.721 -0.181 . . . . 74.5 111.082 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -64.79 -35.03 79.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.279 -0.391 . . . . 75.14 111.622 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.76 -48.09 78.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.24 -1.022 . . . . 74.34 108.24 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -71.34 0.22 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 115.081 1.511 . . . . 75.1 115.081 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -156.22 128.19 7.42 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.785 2.034 . . . . 75.3 108.203 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -124.9 -66.15 0.98 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 116.529 -1.701 . . . . 75.33 114.069 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -56.55 13.7 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.265 1.393 . . . . 74.45 114.471 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.7 -36.13 82.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.054 0.843 . . . . 72.33 111.58 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -64.75 -55.09 21.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.702 0.801 . . . . 75.24 110.831 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -49.24 75.32 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.303 1.441 . . . . 75.43 109.294 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.2 t -54.15 -61.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.926 0.784 . . . . 74.03 112.033 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.91 -47.61 90.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 123.874 0.734 . . . . 73.34 112.279 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -47.08 70.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.151 -1.02 . . . . 72.05 111.642 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -55.03 -45.41 75.18 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 120.046 1.294 . . . . 73.11 109.493 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.77 72.09 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.261 0.553 . . . . 72.42 112.253 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.69 -40.0 88.35 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.331 0.652 . . . . 72.3 110.276 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.15 -42.09 93.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 117.78 -1.105 . . . . 75.33 108.624 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -63.86 -39.18 93.59 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 120.092 1.314 . . . . 70.21 109.423 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.94 67.07 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.935 0.398 . . . . 75.31 111.633 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -72.23 -44.99 62.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.415 -0.803 . . . . 74.43 112.783 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -128.75 78.72 75.64 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.121 1.368 . . . . 73.13 109.694 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.45 -17.65 49.05 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.659 2.239 . . . . 72.51 112.044 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -99.87 13.17 34.75 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.415 0.686 . . . . 72.21 110.061 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -123.21 155.64 36.71 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.842 1.201 . . . . 74.32 108.728 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.76 136.85 27.83 Favored Pre-proline 0 C--O 1.241 0.656 0 C-N-CA 124.126 0.97 . . . . 74.11 109.846 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.78 114.73 3.7 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 125.251 3.967 . . . . 72.23 111.769 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.52 143.99 34.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.555 1.142 . . . . 73.24 109.358 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 mm -120.73 127.05 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 102.375 -3.194 . . . . 75.15 102.375 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.67 124.55 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.319 1.447 . . . . 73.4 108.896 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -136.59 154.26 50.73 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.25 1.386 . . . . 74.5 110.513 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -91.78 152.71 20.02 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.944 -0.473 . . . . 75.43 111.685 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.8 t -66.83 126.1 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.681 1.593 . . . . 74.14 107.212 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 p -58.72 121.85 12.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.729 0.695 . . . . 74.31 110.296 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.51 -18.8 49.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.626 2.06 . . . . 73.31 111.847 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -55.65 136.94 50.18 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.896 1.348 . . . . 71.22 111.289 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -64.49 -28.73 69.86 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.859 1.264 . . . . 75.34 114.096 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.11 154.33 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.471 0.708 . . . . 62.31 112.124 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.78 140.11 20.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.172 -1.418 . . . . 75.14 107.172 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -84.36 167.6 16.37 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.515 -0.92 . . . . 62.31 108.515 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.81 144.17 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.745 -1.576 . . . . 75.43 106.745 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 165.61 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.549 0.69 . . . . 71.12 110.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.3 95.29 2.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.767 -1.197 . . . . 73.42 107.767 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -136.25 151.74 49.99 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.153 0.981 . . . . 74.1 109.562 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -95.7 102.09 13.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.058 -2.201 . . . . 74.41 105.058 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -84.58 136.73 33.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.158 0.89 . . . . 74.43 109.162 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 mt -120.19 108.56 14.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.975 -1.491 . . . . 71.34 106.975 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.17 141.99 25.42 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 117.946 -1.026 . . . . 74.43 110.408 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 141.29 38.87 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.141 1.894 . . . . 74.12 113.568 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 m -62.58 -17.32 59.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.874 1.67 . . . . 74.24 110.877 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -68.37 -35.34 77.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.733 2.413 . . . . 73.51 112.751 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -86.26 171.0 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 122.014 0.911 . . . . 74.52 112.648 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.6 p -107.23 166.12 10.87 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.492 1.517 . . . . 71.41 110.541 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.75 -34.32 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 65.14 108.559 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -47.86 83.55 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 121.495 -0.753 . . . . 54.34 112.69 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.54 -37.5 71.12 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 123.162 0.585 . . . . 74.22 110.095 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.9 -45.1 91.07 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.934 -0.765 . . . . 74.53 108.934 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 ttt -63.57 -44.96 92.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.069 -0.967 . . . . 74.25 110.105 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -57.04 -41.29 78.37 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.996 0.816 . . . . 74.54 111.09 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.01 -51.12 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.533 -0.914 . . . . 75.51 108.533 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.46 -50.36 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.262 0.937 . . . . 71.51 111.049 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -62.31 -39.42 92.96 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.062 -1.024 . . . . 74.54 112.064 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -74.34 -33.75 63.23 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.77 1.168 . . . . 75.12 111.305 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.47 -48.73 78.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.998 0.817 . . . . 71.54 109.552 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -79.98 -3.18 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.013 0.196 . . . . 74.52 110.88 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 53.1 57.93 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.203 1.801 . . . . 64.22 109.532 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.11 109.98 4.87 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 124.979 1.312 . . . . 74.53 108.735 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.73 159.46 52.61 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.442 2.761 . . . . 74.42 111.205 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 m -67.3 -14.47 62.95 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.091 -1.005 . . . . 74.12 112.706 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.46 -34.11 67.51 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.112 -0.47 . . . . 74.3 110.157 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.55 164.41 11.68 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.355 1.062 . . . . 73.02 108.942 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 175.72 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.97 1.308 . . . . 72.12 109.21 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.76 140.63 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 125.278 1.431 . . . . 71.42 107.722 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -145.06 129.84 18.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.429 1.892 . . . . 65.43 106.916 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.99 146.57 41.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.004 1.322 . . . . 75.52 109.244 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -142.66 132.89 24.67 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.707 1.203 . . . . 71.2 110.303 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.63 121.89 64.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 C-N-CA 124.712 1.205 . . . . 74.04 107.99 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 43.05 51.83 5.39 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.361 1.465 . . . . 72.35 113.119 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.51 25.3 15.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.066 1.346 . . . . 75.33 113.392 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 p -132.66 161.47 33.86 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.479 1.036 . . . . 72.34 111.049 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.35 105.53 36.93 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 103.184 -2.895 . . . . 73.33 103.184 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.2 130.57 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.766 2.311 . . . . 74.41 111.967 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.32 125.84 27.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.166 -1.42 . . . . 74.34 107.166 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -55.75 -22.48 24.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 63.23 113.904 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -79.31 -18.41 52.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.466 1.107 . . . . 64.01 111.652 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.66 141.67 56.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.41 -0.806 . . . . 72.22 110.09 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.481 ' HG1' ' NE2' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -84.47 152.0 24.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.029 -1.1 . . . . 73.21 108.029 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 45.3 mmm -62.93 -42.46 99.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.175 -0.917 . . . . 61.4 110.278 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.42 97.6 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.798 0.727 . . . . 43.23 111.566 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' NE2' ' HG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.58 -46.89 71.33 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.322 0.649 . . . . 72.42 109.4 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.43 -46.26 86.86 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.727 -0.472 . . . . 75.4 109.727 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.81 -45.3 94.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.245 1.418 . . . . 74.32 109.765 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.55 -33.35 75.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.968 0.907 . . . . 71.24 111.597 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -90.54 -23.5 20.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.264 -1.35 . . . . 75.4 113.488 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -110.35 -2.1 16.85 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.921 1.452 . . . . 71.11 114.921 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -45.23 121.85 3.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.969 1.259 . . . . 72.52 114.377 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -71.45 176.09 4.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.811 1.244 . . . . 64.11 108.36 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.82 -33.14 55.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.83 2.052 . . . . 74.24 111.81 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 10.34 36.01 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.151 1.78 . . . . 73.12 111.563 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.92 68.74 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.899 -1.126 . . . . 63.05 113.255 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.88 168.81 9.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.21 1.505 . . . . 74.32 109.889 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.53 136.43 54.55 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.685 0.394 . . . . 74.3 110.273 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -119.75 119.21 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.254 1.822 . . . . 74.44 109.084 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.18 144.0 38.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 121.11 -0.994 . . . . 74.44 109.294 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.56 21.02 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.698 0.799 . . . . 71.04 109.849 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -146.19 160.84 41.42 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.425 0.631 . . . . 61.13 110.797 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 p -151.62 161.35 42.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.719 1.208 . . . . 75.12 108.774 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.88 22.89 12.17 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.298 0.952 . . . . 72.24 111.909 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.308 1.843 . . . . 75.25 106.961 -178.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 114.159 1.17 . . . . 74.12 114.159 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 51.3 m95 53.33 57.34 6.31 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.473 1.509 . . . . 73.41 111.823 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -77.7 141.09 25.06 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.789 -1.324 . . . . 63.34 109.789 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 28.8 mt -74.1 128.84 36.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 119.142 1.471 . . . . 75.44 109.437 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.22 126.75 30.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.073 0.949 . . . . 75.14 109.896 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.44 122.35 31.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 104.179 -2.526 . . . . 75.14 104.179 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 51.6 t -120.58 124.02 71.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.562 1.145 . . . . 64.34 109.163 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.4 p -161.19 151.65 17.85 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.947 0.34 . . . . 72.42 111.524 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 126.675 1.99 . . . . 75.13 111.408 -179.615 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 CA--C 1.511 -0.55 0 CA-C-O 119.576 -0.249 . . . . 74.13 110.573 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.3 tpt -55.35 -46.27 76.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.433 1.083 . . . . 63.12 108.327 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -60.53 -42.27 96.16 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 113.241 0.83 . . . . 74.25 113.241 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.13 -37.44 83.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 118.946 0.794 . . . . 73.32 110.672 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.04 -47.73 76.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.335 1.022 . . . . 64.43 108.467 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.48 -75.87 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.025 1.33 . . . . 52.54 113.033 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.431 ' HD1' ' CG ' ' A' ' 13' ' ' HIS . 6.9 p80 -160.38 131.73 5.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.883 1.673 . . . . 74.22 107.798 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.2 t -130.2 -58.66 1.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 115.724 1.75 . . . . 62.33 115.724 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.44 -57.29 12.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.728 1.604 . . . . 75.54 114.927 -176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 13' ' ' HIS . 1.3 pm0 -62.95 -51.02 68.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.083 0.468 . . . . 74.24 110.229 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.515 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 84.4 t60 -52.07 -44.83 64.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.022 2.129 . . . . 74.42 110.073 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -49.84 63.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 116.872 -1.537 . . . . 75.42 110.136 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.4 m -60.54 -48.83 80.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.917 1.08 . . . . 74.1 113.917 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.97 -47.53 90.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 121.705 -0.622 . . . . 72.03 109.894 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.35 -42.49 79.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.518 -0.754 . . . . 73.21 111.848 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -59.83 -45.02 93.7 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.272 -1.01 . . . . 75.12 108.272 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.85 -49.17 77.59 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.955 0.798 . . . . 65.21 110.851 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -61.03 -46.09 92.15 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.864 -1.148 . . . . 71.04 110.883 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.94 -41.65 93.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-O 117.735 -1.126 . . . . 74.24 109.441 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -66.69 -41.07 88.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.581 1.537 . . . . 74.43 110.521 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.76 68.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.596 -0.441 . . . . 74.12 110.852 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -77.71 -33.11 53.2 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.651 0.982 . . . . 73.43 113.651 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 82.07 25.04 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.429 1.492 . . . . 75.11 111.009 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.77 -29.1 36.06 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.888 2.392 . . . . 73.34 112.602 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.81 13.23 13.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.876 0.871 . . . . 72.13 110.956 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -121.56 152.35 39.32 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.525 -1.359 . . . . 73.44 109.749 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.24 140.73 31.71 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 124.007 0.923 . . . . 73.02 108.584 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 117.66 3.57 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 125.141 3.894 . . . . 71.45 111.931 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.2 t -120.45 140.91 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.047 1.339 . . . . 64.33 108.675 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.09 135.33 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.585 -2.376 . . . . 72.41 104.585 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.73 134.85 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.251 0.62 . . . . 70.12 109.491 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.85 143.66 43.19 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.888 0.875 . . . . 65.51 108.701 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.62 143.09 31.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.299 -1.371 . . . . 74.14 107.299 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.82 108.12 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 103.07 -2.937 . . . . 65.42 103.07 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -53.75 132.67 41.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.785 -0.82 . . . . 54.02 108.785 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.2 40.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.836 1.207 . . . . 74.31 112.235 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -81.98 137.63 35.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.539 1.67 . . . . 71.01 108.027 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -66.2 -11.26 48.62 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.524 0.729 . . . . 55.24 112.803 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.96 154.37 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.602 0.761 . . . . 75.51 109.323 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.65 144.97 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.405 1.082 . . . . 72.52 110.186 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.77 167.13 18.44 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.26 2.224 . . . . 72.03 112.508 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.61 148.33 31.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 125.194 1.398 . . . . 73.31 110.267 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.5 163.47 20.45 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.923 0.889 . . . . 74.13 108.954 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.89 95.83 5.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.019 -1.104 . . . . 75.01 108.019 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.03 168.23 18.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.137 0.975 . . . . 74.52 109.895 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -116.35 99.26 7.07 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.294 -2.113 . . . . 73.24 105.294 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -83.89 136.66 34.02 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.609 -0.723 . . . . 74.5 109.053 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.94 119.2 33.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.494 1.118 . . . . 75.31 110.232 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 142.12 26.07 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 117.577 -1.202 . . . . 74.34 112.232 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.12 141.33 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.713 2.275 . . . . 75.43 109.579 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -63.4 -12.84 33.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.585 0.957 . . . . 75.25 113.585 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.89 -34.26 66.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.645 2.778 . . . . 71.44 113.445 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 pt -85.09 165.87 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.745 1.157 . . . . 73.45 111.775 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 54.8 p -99.92 168.79 9.65 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.784 0.834 . . . . 75.41 111.255 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.92 -36.43 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.714 -1.217 . . . . 65.33 107.714 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.83 90.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.737 0.815 . . . . 74.43 110.936 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -66.4 -44.96 81.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.614 -0.708 . . . . 65.22 109.744 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -58.8 -54.51 46.23 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.253 -1.017 . . . . 73.51 108.253 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.4 ttp -52.63 -49.19 65.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.512 1.525 . . . . 73.23 110.935 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -57.11 -42.28 80.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.464 0.705 . . . . 74.34 111.693 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.46 -39.63 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 118.086 -0.959 . . . . 72.54 108.792 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.31 -50.04 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 120.701 1.591 . . . . 75.45 109.607 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.15 -39.16 81.58 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 118.186 -0.912 . . . . 75.21 111.962 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -68.58 -40.59 80.45 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.051 0.841 . . . . 72.42 109.223 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -59.51 -49.07 79.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.275 1.03 . . . . 73.22 111.498 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 pt -79.46 -0.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 119.468 -0.301 . . . . 62.45 111.277 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 57.51 52.32 8.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.741 1.617 . . . . 73.32 110.984 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.18 108.96 3.24 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.416 1.486 . . . . 72.34 110.553 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.82 152.8 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.122 2.548 . . . . 75.53 109.968 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 m -58.95 -20.83 55.99 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.403 -0.811 . . . . 75.31 113.181 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -39.51 90.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.407 1.003 . . . . 61.11 109.734 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -96.48 163.61 12.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.285 1.034 . . . . 73.01 108.865 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.92 171.08 7.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.001 1.321 . . . . 74.44 108.579 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 tp -146.12 133.75 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.554 1.142 . . . . 74.41 108.158 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -145.46 142.26 29.11 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.179 1.792 . . . . 75.12 108.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -114.14 155.83 25.32 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.525 1.53 . . . . 70.35 111.039 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -147.31 126.84 13.24 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 125.115 1.509 . . . . 64.24 111.18 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.87 126.03 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.474 -2.047 . . . . 74.31 105.474 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 49.48 34.53 6.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.761 1.164 . . . . 60.14 112.961 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp 60.88 31.14 20.0 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.063 -1.648 . . . . 64.23 110.154 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -130.18 161.38 31.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.324 1.85 . . . . 74.41 109.788 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -102.49 103.68 33.25 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 126.508 1.923 . . . . 74.35 108.832 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.6 136.99 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.539 1.492 . . . . 73.5 108.965 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.0 132.17 44.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.76 0.314 . . . . 72.22 110.311 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 p -51.89 -45.54 64.22 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.282 2.233 . . . . 64.31 112.703 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -73.74 -11.84 60.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.694 1.197 . . . . 51.44 114.047 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.42 146.74 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.037 1.289 . . . . 72.13 108.665 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 30.4 p -86.08 156.57 20.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.694 -0.629 . . . . 63.11 109.424 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.38 -44.44 97.15 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 118.538 -0.744 . . . . 74.15 110.641 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.11 -45.49 95.2 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.351 -0.928 . . . . 61.33 111.396 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.86 -49.46 72.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.799 0.8 . . . . 74.34 111.2 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.59 -46.69 88.19 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 123.055 0.542 . . . . 61.3 110.459 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.43 -56.92 14.89 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.252 1.021 . . . . 74.2 108.943 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.28 -32.0 64.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.623 -0.703 . . . . 73.02 111.37 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -25.26 20.26 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 116.342 -1.79 . . . . 71.3 113.828 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -103.42 -2.22 27.28 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.298 1.863 . . . . 71.42 112.604 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.23 121.72 1.18 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.114 2.165 . . . . 74.4 113.955 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.71 174.64 8.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.454 1.502 . . . . 71.15 110.132 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.49 -35.58 72.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.877 1.217 . . . . 63.33 108.525 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.15 12.92 31.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.77 0.828 . . . . 64.34 112.51 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.38 28.38 67.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.351 -1.249 . . . . 61.43 114.862 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -109.44 158.71 17.68 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.948 1.874 . . . . 75.42 107.932 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 138.0 54.13 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.608 -1.256 . . . . 71.35 107.608 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -122.35 131.5 53.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.657 1.183 . . . . 74.53 108.287 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.63 138.73 53.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.545 -1.28 . . . . 72.43 107.545 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.69 142.14 44.4 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.954 -2.239 . . . . 73.31 104.954 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -133.96 151.63 51.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.345 0.593 . . . . 75.55 110.432 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.9 t -147.21 165.04 31.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.689 -1.226 . . . . 65.22 107.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.81 15.61 19.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.079 -2.008 . . . . 74.22 108.079 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 126.401 1.88 . . . . 72.13 107.006 -179.392 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 71.0 113.324 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 58.1 m95 57.22 61.16 2.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.91 0.777 . . . . 75.23 111.62 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.49 135.68 15.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.384 -1.086 . . . . 74.01 110.384 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.9 123.79 32.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 118.756 1.278 . . . . 73.24 110.006 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -132.37 118.83 19.89 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.534 1.134 . . . . 72.22 109.14 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.9 tt -83.17 118.57 23.69 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.724 1.61 . . . . 72.13 108.44 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.31 128.63 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.679 1.192 . . . . 65.43 110.741 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.9 p -159.31 153.46 23.62 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 74.13 108.639 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.172 1.789 . . . . 73.44 106.515 178.535 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.3 m95 . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.089 -0.708 . . . . 74.21 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -51.53 -45.76 63.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.082 0.944 . . . . 74.43 110.737 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -60.55 -40.62 92.25 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 121.499 -0.75 . . . . 74.31 112.726 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -67.1 -36.31 81.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.616 0.766 . . . . 74.22 112.177 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -67.59 -41.01 84.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.626 -0.879 . . . . 73.15 108.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -75.12 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.738 -0.664 . . . . 70.1 111.6 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.413 ' CE1' ' HD1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -160.61 125.13 3.67 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.696 1.998 . . . . 74.25 110.374 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.3 p -117.11 -65.85 1.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 116.305 -1.807 . . . . 73.03 114.211 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.1 mt -48.0 -58.36 4.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.326 1.875 . . . . 73.31 114.842 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.5 -37.09 85.95 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.215 -0.928 . . . . 70.34 111.785 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.413 ' HD1' ' CE1' ' A' ' 9' ' ' HIS . 6.7 t60 -62.97 -57.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.303 1.041 . . . . 65.44 108.403 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -47.48 85.01 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.72 1.608 . . . . 65.23 110.987 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -56.57 -53.97 51.35 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.445 1.021 . . . . 72.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 HG11 ' HE2' ' A' ' 20' ' ' LYS . 43.6 t -63.07 -47.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 122.398 -0.189 . . . . 75.02 111.262 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -57.0 -52.11 66.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.947 1.299 . . . . 75.14 110.335 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -60.19 -48.28 82.39 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.985 1.314 . . . . 73.0 110.455 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -49.39 76.74 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.42 0.555 . . . . 54.42 110.943 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HE2' HG11 ' A' ' 16' ' ' VAL . 55.3 mtmt -65.39 -44.31 87.89 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.631 0.372 . . . . 72.45 110.55 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.72 -42.64 95.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.365 -1.303 . . . . 73.33 110.402 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.08 -33.76 72.31 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 120.325 1.421 . . . . 73.34 110.263 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -47.12 74.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 119.465 -0.894 . . . . 75.11 109.986 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -77.75 -47.27 19.46 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.346 1.239 . . . . 73.11 114.346 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -129.25 77.27 77.88 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.562 1.945 . . . . 70.42 109.755 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.63 -28.71 44.38 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.159 2.572 . . . . 75.34 112.487 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -89.66 14.02 12.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.905 0.482 . . . . 72.22 111.948 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -120.48 146.24 46.46 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.849 -1.537 . . . . 74.24 106.849 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.57 143.49 28.27 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.191 -1.04 . . . . 74.4 108.191 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.03 127.2 8.35 Favored 'Trans proline' 0 C--N 1.352 0.752 1 C-N-CA 125.725 4.283 . . . . 72.15 113.095 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.59 145.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.863 0.865 . . . . 75.01 111.16 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.4 mm -122.09 135.44 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 103.8 -2.667 . . . . 71.12 103.8 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -122.68 114.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.854 1.262 . . . . 74.45 108.511 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.86 153.92 46.98 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 71.1 108.893 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -93.48 153.4 18.49 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.147 -0.971 . . . . 75.54 113.036 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.66 126.07 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.616 -1.994 . . . . 75.35 105.616 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.0 t -58.79 141.09 54.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.75 -0.463 . . . . 74.05 109.75 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.52 23.95 77.05 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.233 -1.315 . . . . 74.01 113.964 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 t -97.58 142.3 29.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.527 1.663 . . . . 71.24 108.211 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -65.81 -9.74 31.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.227 1.195 . . . . 70.12 114.227 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.37 160.82 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.277 0.944 . . . . 74.02 111.138 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -64.2 142.24 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.272 -1.01 . . . . 74.21 108.272 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.32 161.27 28.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.635 1.174 . . . . 73.12 107.852 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 tt -120.68 135.48 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.677 -1.231 . . . . 74.34 107.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.49 159.7 32.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.885 -1.524 . . . . 74.24 106.885 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -73.9 108.17 6.56 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.495 -1.378 . . . . 73.4 110.285 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -136.04 159.07 42.82 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.823 1.249 . . . . 75.44 112.021 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 14.8 mttt -104.68 99.26 8.92 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 105.42 -2.067 . . . . 74.24 105.42 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.73 116.76 23.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.706 1.602 . . . . 74.44 110.016 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.6 120.0 40.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 117.43 -1.271 . . . . 74.22 109.394 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -113.07 142.97 28.26 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 120.281 1.401 . . . . 74.13 111.527 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.18 141.17 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.767 1.645 . . . . 71.43 108.576 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -62.98 -18.25 63.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.206 2.202 . . . . 73.23 113.227 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -82.67 -30.69 29.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.213 1.19 . . . . 64.12 114.213 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.89 170.52 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.715 0.769 . . . . 73.42 111.393 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -107.13 156.92 18.28 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.124 0.97 . . . . 74.12 111.688 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.28 -35.91 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.858 1.663 . . . . 74.44 109.631 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.39 93.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.768 1.227 . . . . 75.32 111.539 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.33 -42.15 93.24 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.925 -0.768 . . . . 73.34 108.925 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.46 -44.04 93.07 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.165 -1.05 . . . . 65.41 108.165 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.5 ttp -59.65 -48.39 81.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.43 -0.795 . . . . 71.31 110.927 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -58.89 -42.0 88.5 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.342 0.974 . . . . 75.04 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -66.42 -43.27 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.015 -0.993 . . . . 74.32 109.699 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.48 -50.7 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 120.212 1.369 . . . . 75.42 110.1 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -59.67 -39.19 83.65 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.996 -1.065 . . . . 71.34 111.513 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -70.81 -39.07 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.018 0.826 . . . . 63.35 110.615 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -60.15 -49.3 78.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.529 1.132 . . . . 75.22 109.708 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.4 pt -79.23 -0.95 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.949 0.34 . . . . 73.3 111.476 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 55.65 52.86 10.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.386 1.474 . . . . 75.3 108.696 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.49 106.63 1.62 Allowed Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 126.856 2.062 . . . . 73.24 108.452 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.32 157.69 56.26 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.327 2.018 . . . . 73.11 109.653 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -58.48 -28.08 65.03 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.485 -0.76 . . . . 60.31 112.713 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.65 -33.04 71.02 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.335 1.054 . . . . 75.04 112.214 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.33 164.26 11.78 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.36 -1.348 . . . . 75.13 107.36 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.4 172.31 6.93 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.876 1.271 . . . . 54.42 108.789 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -143.98 117.22 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.44 1.096 . . . . 74.43 108.587 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.59 137.55 54.38 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.67 -1.604 . . . . 71.4 106.67 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.9 148.92 33.94 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.008 1.323 . . . . 75.02 109.532 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -143.55 128.26 18.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.692 1.197 . . . . 75.14 109.962 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.95 122.12 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.204 -1.406 . . . . 72.42 107.204 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.06 34.46 14.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.34 1.456 . . . . 72.22 111.251 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 63.9 26.62 14.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.721 1.208 . . . . 73.53 110.322 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -119.58 161.88 19.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.456 1.102 . . . . 64.11 109.326 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.7 103.34 27.61 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 104.524 -2.399 . . . . 74.21 104.524 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.56 142.83 45.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.047 1.831 . . . . 73.41 110.374 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -77.47 114.22 16.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.825 -1.546 . . . . 61.35 106.825 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.0 m -54.39 -26.84 32.73 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.129 1.772 . . . . 71.44 112.818 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -86.89 -6.61 58.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.399 -0.813 . . . . 74.32 113.056 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 tp -75.15 158.58 32.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.569 1.077 . . . . 75.34 108.933 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.3 p -93.24 161.81 14.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.465 0.575 . . . . 74.15 109.72 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.9 mmm -64.27 -46.68 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.906 -1.045 . . . . 75.3 111.653 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.04 74.72 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.333 0.97 . . . . 62.12 111.172 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.72 -51.96 62.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.751 0.82 . . . . 72.43 110.628 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 tt -59.04 -44.14 91.75 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.511 -0.28 . . . . 75.44 110.58 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -65.69 -54.71 23.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.876 0.762 . . . . 74.31 109.544 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -58.67 -30.7 67.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.043 0.838 . . . . 72.51 111.638 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -40.85 16.76 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.367 -1.301 . . . . 73.35 110.36 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.53 6.51 43.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.042 1.292 . . . . 70.24 113.306 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.51 121.26 6.11 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.429 1.468 . . . . 74.32 111.731 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.14 174.89 4.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.047 2.139 . . . . 73.0 110.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.15 -30.76 68.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.654 -1.279 . . . . 73.52 108.939 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.31 6.82 40.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.184 2.194 . . . . 72.54 112.768 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.73 28.41 65.51 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.482 -1.176 . . . . 71.51 116.007 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.06 134.96 54.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.08 1.94 . . . . 73.45 107.453 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.38 133.45 39.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.509 1.05 . . . . 71.23 109.408 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -123.14 123.72 41.44 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.843 1.657 . . . . 74.55 107.726 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.04 136.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 124.729 1.212 . . . . 73.12 109.543 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.39 148.86 32.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.446 0.698 . . . . 73.13 110.815 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -132.96 155.16 49.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.51 0.929 . . . . 75.34 113.51 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.8 p -146.61 159.47 43.4 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.506 0.67 . . . . 71.22 110.881 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.21 22.31 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.818 1.675 . . . . 61.44 112.08 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 . . . . . 0 C--O 1.236 0.345 0 C-N-CA 125.794 1.638 . . . . 74.21 107.593 -179.529 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 118.469 -0.777 . . . . 65.14 112.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . 0.42 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 50.8 m95 51.85 66.48 1.19 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.85 1.205 . . . . 75.14 112.956 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.69 145.0 21.59 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.027 -1.629 . . . . 60.32 109.027 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.0 134.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.418 1.609 . . . . 75.24 110.003 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -138.61 126.2 22.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.938 0.895 . . . . 65.31 110.579 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.81 118.51 29.46 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.386 -1.709 . . . . 71.25 106.386 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 14.7 t -122.35 113.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.279 0.474 . . . . 75.12 112.279 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 65.8 p -155.13 154.14 31.88 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.796 -1.187 . . . . 73.02 107.796 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.243 0.732 0 C-N-CA 126.936 2.095 . . . . 72.55 106.228 -179.728 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.7 m95 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -62.63 -42.74 99.76 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.394 -0.224 . . . . 74.32 110.394 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -56.77 -52.14 66.19 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.507 -0.553 . . . . 75.12 109.507 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -64.94 -34.11 77.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.063 1.345 . . . . 74.32 112.44 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -60.74 -48.89 79.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.441 -0.948 . . . . 73.31 108.441 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.49 -69.24 0.42 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.858 0.724 . . . . 70.33 110.147 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.01 143.66 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.962 1.305 . . . . 73.2 111.474 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 t -130.57 -65.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 117.322 -1.323 . . . . 75.31 112.566 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.2 mt -43.08 -60.69 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 116.477 2.028 . . . . 75.21 116.477 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.27 -48.01 68.98 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 120.719 -1.238 . . . . 73.14 110.418 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -51.91 -46.39 64.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.647 1.179 . . . . 74.24 111.052 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -43.69 91.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.683 -1.627 . . . . 71.31 108.439 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -64.38 -40.11 95.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.61 1.095 . . . . 73.51 110.46 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.15 -48.05 79.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 120.083 -1.635 . . . . 75.13 108.066 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -38.26 90.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.526 -0.749 . . . . 73.33 110.749 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -59.82 -48.05 83.27 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.448 -1.316 . . . . 61.44 107.448 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -50.56 71.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.821 0.448 . . . . 74.54 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -61.77 -52.03 65.91 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.843 0.857 . . . . 73.42 112.399 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.48 -41.79 72.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 116.689 -1.624 . . . . 74.33 111.037 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -64.5 -31.22 72.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.811 2.096 . . . . 70.11 109.263 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.03 -46.67 56.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.094 0.406 . . . . 54.23 110.84 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -77.81 -47.77 18.12 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.774 1.398 . . . . 73.21 114.774 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -126.22 80.59 68.32 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 126.273 1.829 . . . . 75.34 108.107 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.35 -35.3 51.23 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.556 2.171 . . . . 71.45 109.353 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.86 20.76 3.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.733 1.213 . . . . 71.42 114.272 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -125.84 155.77 40.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 120.214 -1.553 . . . . 75.55 108.01 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 m -126.91 138.73 33.26 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.019 0.928 . . . . 75.13 110.25 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.89 120.03 4.93 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 125.279 3.986 . . . . 72.43 113.307 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.5 135.61 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.003 1.321 . . . . 74.15 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.94 118.36 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.962 -2.236 . . . . 72.35 104.962 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.65 124.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.063 1.745 . . . . 75.15 106.895 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.97 139.17 54.06 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.54 -1.281 . . . . 72.21 107.54 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tmmt? -72.66 140.4 47.9 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.637 0.775 . . . . 75.11 110.414 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.84 126.17 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 125.008 1.323 . . . . 74.23 107.57 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.2 p -55.47 122.18 10.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.877 0.871 . . . . 64.3 109.359 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.73 9.42 66.34 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.618 -1.101 . . . . 75.41 114.723 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 t -86.06 146.44 26.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.364 1.582 . . . . 74.53 110.653 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -65.25 -24.86 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.411 1.084 . . . . 75.24 111.383 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -66.11 162.79 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.426 -1.422 . . . . 75.42 113.475 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.3 141.47 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 125.15 1.38 . . . . 75.33 108.359 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.401 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 2.6 p30 -81.78 170.21 15.99 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.588 0.755 . . . . 74.32 110.312 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 tt -126.65 149.56 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.222 1.409 . . . . 74.03 107.803 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -76.57 166.01 23.99 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.347 1.059 . . . . 75.34 109.164 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -73.71 95.77 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 74.52 106.402 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -134.94 159.07 42.62 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.239 1.416 . . . . 75.24 107.336 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -113.56 104.28 12.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.733 -1.21 . . . . 74.23 107.733 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -84.17 145.67 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.337 0.971 . . . . 74.14 110.381 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.44 112.1 18.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.594 1.558 . . . . 74.31 108.631 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.69 142.19 25.26 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.096 -0.954 . . . . 73.21 110.676 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.94 141.39 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.572 2.848 . . . . 72.54 112.72 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.29 -21.7 60.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.373 1.469 . . . . 75.31 114.562 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -78.54 -32.87 48.11 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 114.961 1.467 . . . . 63.4 114.961 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -73.52 166.07 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.707 1.14 . . . . 71.01 110.709 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -102.43 161.24 13.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.38 1.072 . . . . 71.54 109.934 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.16 -35.9 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.569 1.148 . . . . 75.21 110.396 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.3 93.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.909 0.777 . . . . 63.04 109.977 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -63.43 -46.32 86.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.619 -0.882 . . . . 73.23 108.619 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.49 -45.75 90.79 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.53 -0.545 . . . . 75.24 109.53 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.21 -40.18 84.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.992 0.917 . . . . 71.43 109.78 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -68.11 -39.18 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.647 0.658 . . . . 75.14 110.321 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.31 -44.49 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.888 -1.153 . . . . 74.31 107.888 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.76 -51.12 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.742 1.155 . . . . 71.01 111.147 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -59.93 -39.03 84.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.034 0.834 . . . . 74.21 110.834 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -70.06 -43.34 71.41 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.778 0.717 . . . . 75.0 109.967 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.84 -49.55 72.98 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.115 1.366 . . . . 74.34 110.936 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.69 -0.47 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.062 0.851 . . . . 72.2 112.181 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 58.3 55.74 4.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.328 1.451 . . . . 75.11 111.571 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.79 109.22 3.86 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 106.623 -1.621 . . . . 70.33 106.623 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.06 164.65 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.986 3.124 . . . . 73.22 111.683 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 m -60.09 -27.39 66.96 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.516 0.326 . . . . 70.32 111.114 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.48 -38.46 89.92 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.253 -0.879 . . . . 64.41 113.367 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 165.35 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.113 1.324 . . . . 65.41 112.115 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.03 177.36 4.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.968 1.707 . . . . 74.4 107.921 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tp -145.98 138.85 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.349 1.06 . . . . 74.31 110.353 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.39 139.49 26.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.351 1.86 . . . . 62.03 109.642 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.04 147.39 40.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.988 2.115 . . . . 74.41 107.598 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.46 123.18 17.49 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.741 -1.577 . . . . 73.11 106.741 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.94 123.36 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 108.52 -0.919 . . . . 64.44 108.52 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.88 35.34 1.08 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.053 1.741 . . . . 63.32 112.601 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 66.04 38.07 5.0 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.158 1.783 . . . . 74.41 113.484 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.0 p -135.1 157.59 46.54 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.942 2.097 . . . . 74.15 107.501 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.99 110.81 63.23 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 105.446 -2.057 . . . . 72.53 105.446 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.39 123.48 10.89 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.763 1.642 . . . . 72.41 109.545 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -67.23 124.41 23.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.47 0.708 . . . . 72.34 109.409 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.42 -33.26 65.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.668 1.187 . . . . 73.32 112.317 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -4.65 51.17 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.947 -1.095 . . . . 73.02 112.551 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.17 146.44 37.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.324 1.42 . . . . 74.33 108.936 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.21 149.07 26.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.977 0.911 . . . . 74.43 108.906 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.3 mmt -55.43 -49.41 72.49 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.721 -1.133 . . . . 73.22 110.109 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.91 -41.74 94.38 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.838 0.745 . . . . 73.43 112.295 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.49 -49.58 70.82 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.279 1.039 . . . . 74.32 109.247 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -44.43 96.0 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 124.661 1.184 . . . . 75.13 111.147 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.71 -50.68 72.51 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.154 1.381 . . . . 75.43 108.172 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -65.18 -28.51 69.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.184 -0.912 . . . . 73.51 112.357 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -28.56 17.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.309 -1.329 . . . . 72.34 113.644 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -105.17 -2.88 23.66 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.882 1.438 . . . . 74.42 114.882 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -37.92 121.42 0.93 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.351 2.261 . . . . 71.23 113.799 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.91 162.99 26.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.012 -1.107 . . . . 74.33 108.012 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.86 -31.76 67.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.901 0.88 . . . . 73.02 110.423 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -85.97 -35.36 20.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.898 -1.149 . . . . 64.0 107.898 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.21 3.84 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 117.626 1.81 . . . . 72.42 117.626 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -82.86 179.18 7.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.747 0.773 . . . . 73.32 111.246 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tp -122.51 124.49 43.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.365 -0.976 . . . . 75.11 108.365 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -108.19 113.27 26.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.148 1.379 . . . . 73.43 109.782 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.07 147.07 32.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.255 1.026 . . . . 75.43 109.991 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.81 148.52 36.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.744 -1.206 . . . . 73.13 107.744 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -137.27 153.94 50.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.382 0.61 . . . . 71.23 111.621 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -147.43 168.86 20.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.572 1.149 . . . . 54.5 108.204 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.38 18.28 15.76 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-O 118.761 -1.022 . . . . 74.32 112.049 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-N 119.448 1.624 . . . . 71.03 108.001 -177.129 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 109.534 -0.543 . . . . 70.41 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 17.6 m95 48.97 55.62 9.01 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 126.072 1.749 . . . . 74.14 111.974 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.82 126.82 7.61 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.588 -1.005 . . . . 73.11 110.588 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 59.5 mt -68.77 138.13 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.132 0.966 . . . . 63.41 109.657 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.93 139.93 36.28 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.638 0.775 . . . . 75.54 112.836 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 77.6 mt -88.41 111.1 21.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.75 -1.574 . . . . 74.24 106.75 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.8 112.69 36.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.904 0.881 . . . . 72.02 110.645 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.4 p -161.24 160.83 30.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.184 0.994 . . . . 74.12 112.528 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 129.32 3.048 . . . . 72.32 113.7 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.6 m95 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 119.756 -0.164 . . . . 74.1 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.974 0.51 . . . . 75.55 110.139 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -59.65 -46.82 87.86 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.067 -0.396 . . . . 75.44 111.523 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.93 -36.57 84.81 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.474 -0.774 . . . . 74.23 112.641 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -71.82 -41.01 68.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.859 0.754 . . . . 71.45 111.662 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' HB3' ' HD1' ' A' ' 9' ' ' HIS . 21.2 m-20 -75.02 -76.22 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.647 1.179 . . . . 73.12 110.854 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.432 ' HD1' ' HB3' ' A' ' 8' ' ' ASP . 1.6 p-80 -160.96 119.68 2.52 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.79 1.636 . . . . 71.13 107.417 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -106.89 -65.92 1.05 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.75 -0.594 . . . . 74.22 112.519 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -44.24 -59.24 2.46 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.986 2.115 . . . . 71.33 116.61 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 72.5 mt-10 -66.32 -36.55 83.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.667 1.121 . . . . 73.05 110.33 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.08 -54.73 37.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.202 -0.666 . . . . 75.43 109.202 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.11 89.54 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.835 1.654 . . . . 73.22 111.467 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -54.9 -53.28 57.5 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.814 0.734 . . . . 62.02 110.375 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.66 -46.73 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 122.795 0.438 . . . . 74.42 110.752 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.01 62.97 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.543 1.137 . . . . 62.13 112.462 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 m -65.03 -44.26 89.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.22 -0.895 . . . . 75.43 109.676 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.99 66.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.755 1.161 . . . . 74.52 110.602 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -47.95 83.71 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.939 1.295 . . . . 71.04 110.472 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.3 mt -64.16 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 117.472 -1.251 . . . . 72.4 110.046 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -62.68 -36.64 83.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 121.051 1.75 . . . . 73.42 109.386 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.55 59.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.125 -0.63 . . . . 75.33 111.805 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -79.03 -46.5 18.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.0 2.593 . . . . 73.53 118.0 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.38 81.62 54.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.786 2.035 . . . . 74.44 109.025 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.69 -23.9 55.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.044 2.496 . . . . 75.55 112.922 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.63 14.02 26.29 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.614 0.365 . . . . 74.43 110.365 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -121.57 154.05 37.22 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.913 -1.143 . . . . 75.24 107.913 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.86 142.75 46.09 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 123.753 0.821 . . . . 70.14 111.092 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.03 125.43 9.29 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.623 3.549 . . . . 64.43 111.438 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.02 140.87 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.989 -1.115 . . . . 74.44 107.989 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.89 117.86 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 103.034 -2.95 . . . . 74.52 103.034 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -105.78 120.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.911 -1.885 . . . . 72.5 105.911 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -124.67 146.21 49.24 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.602 0.761 . . . . 72.13 109.611 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -93.3 135.65 34.32 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.049 0.94 . . . . 75.44 109.735 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.21 130.65 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.377 -0.827 . . . . 73.41 109.193 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -63.72 156.59 26.6 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.45 -0.574 . . . . 71.34 109.45 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.86 -20.33 39.94 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.94 1.257 . . . . 63.12 112.996 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.531 ' HG ' ' HG2' ' A' ' 112' ' ' GLU . 16.3 t -84.56 142.95 29.63 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.15 -1.796 . . . . 74.05 106.15 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.44 -11.64 60.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.485 1.114 . . . . 73.41 112.484 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.429 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 2.1 tt -62.69 157.43 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.012 1.325 . . . . 75.4 111.498 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -66.11 156.19 6.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.12 1.368 . . . . 75.15 110.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -101.53 173.21 6.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.188 2.195 . . . . 63.14 114.652 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -125.22 136.44 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.612 1.565 . . . . 74.13 108.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.72 165.0 25.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.389 1.076 . . . . 72.4 108.203 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.06 94.81 2.44 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.259 -0.901 . . . . 75.33 111.393 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -129.56 162.42 28.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 125.205 1.402 . . . . 73.22 108.891 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 33.3 mtmt -108.81 101.74 10.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 104.385 -2.45 . . . . 72.23 104.385 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -93.46 120.73 34.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.223 0.465 . . . . 75.0 111.546 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.91 121.19 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.654 -0.869 . . . . 75.24 108.654 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.73 142.42 26.61 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.139 0.975 . . . . 73.51 109.257 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 138.69 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.954 1.769 . . . . 72.25 111.073 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -60.75 -16.77 43.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.27 2.628 . . . . 64.53 111.206 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.46 -34.66 58.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.914 1.45 . . . . 72.23 114.914 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.25 170.28 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.962 0.801 . . . . 74.51 112.199 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -100.26 166.32 11.04 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.909 0.883 . . . . 65.43 111.651 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.65 -34.73 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 O-C-N 121.597 -0.69 . . . . 74.14 109.244 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.89 92.46 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.363 1.065 . . . . 71.12 110.353 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -65.88 -45.25 82.76 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.875 0.87 . . . . 71.4 109.123 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.79 -48.22 82.01 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.719 -0.845 . . . . 75.4 108.719 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.8 ttp -59.51 -45.01 92.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.837 0.855 . . . . 74.11 110.856 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -60.18 -39.72 87.46 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.875 0.47 . . . . 65.25 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.34 -47.29 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 117.368 -1.301 . . . . 74.44 109.521 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.4 -50.89 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 120.374 1.443 . . . . 71.12 109.509 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -61.72 -36.97 82.49 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.346 -0.846 . . . . 63.53 112.183 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -67.4 -43.68 80.71 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-O 118.062 -0.971 . . . . 75.51 110.434 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -63.22 -47.56 81.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.744 1.618 . . . . 75.45 111.01 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -79.39 1.65 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.351 0.596 . . . . 74.55 110.977 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 50.56 59.44 4.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.795 2.438 . . . . 73.34 111.141 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.56 111.26 6.98 Favored Pre-proline 0 C--O 1.24 0.593 0 C-N-CA 125.66 1.584 . . . . 72.33 109.662 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.05 165.58 29.68 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.851 3.701 . . . . 72.41 113.329 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 p -60.91 -23.32 65.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.635 1.574 . . . . 73.14 113.7 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.27 -54.13 10.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.675 1.59 . . . . 74.32 112.826 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.52 163.47 23.71 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 113.284 0.846 . . . . 75.12 113.284 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.06 166.66 10.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.416 1.886 . . . . 73.44 107.62 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tt -154.4 130.5 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 125.218 1.407 . . . . 75.11 107.744 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -139.16 149.54 44.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.845 1.658 . . . . 73.13 107.713 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.1 mt -112.83 156.57 22.68 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.896 1.278 . . . . 72.34 109.5 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -147.41 140.24 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.286 1.435 . . . . 73.44 109.288 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 p -134.14 120.78 35.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 125.345 1.458 . . . . 74.23 107.211 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 t0 43.22 52.46 5.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 73.41 111.837 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 62.43 18.87 10.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.78 1.632 . . . . 75.04 113.766 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.4 p -125.9 160.12 30.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.788 1.631 . . . . 73.23 111.31 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.8 104.16 37.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.52 1.928 . . . . 74.31 106.542 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.43 155.41 69.24 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.528 2.152 . . . . 63.2 110.639 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -79.86 121.63 25.65 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.018 -0.734 . . . . 72.45 109.018 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 m -53.68 -31.4 47.63 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.243 1.201 . . . . 62.41 114.243 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 t -83.7 -8.29 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.706 1.002 . . . . 70.22 113.706 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.82 152.39 44.63 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.309 1.413 . . . . 64.31 109.625 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -88.88 150.01 23.08 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.037 -0.727 . . . . 72.3 109.037 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.8 mmt -58.15 -47.53 83.05 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 117.337 -1.316 . . . . 73.35 110.23 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.07 -48.52 46.08 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 121.227 1.83 . . . . 72.04 113.298 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -64.32 -50.0 69.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.281 1.032 . . . . 75.43 109.533 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.31 -47.86 80.42 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.699 0.8 . . . . 74.44 110.187 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -58.84 -55.17 38.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.912 1.285 . . . . 74.24 108.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -54.71 -43.55 72.66 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.401 0.889 . . . . 71.34 113.401 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -24.81 28.25 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 117.593 -1.194 . . . . 74.22 114.222 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.6 2.74 36.48 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.115 1.325 . . . . 71.33 112.72 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -53.77 126.4 21.94 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.604 1.562 . . . . 75.21 112.258 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.71 165.38 25.32 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.988 -1.116 . . . . 64.34 107.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.75 62.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.696 -1.253 . . . . 71.55 111.023 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.92 17.05 12.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.439 2.295 . . . . 62.02 111.014 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.43 15.33 38.52 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.663 3.03 . . . . 62.03 119.513 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -122.04 179.48 4.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.49 2.145 . . . . 73.3 111.124 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.14 124.47 45.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.796 . . . . 74.42 111.023 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -105.14 118.52 36.74 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.74 -1.207 . . . . 71.42 107.74 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.0 140.22 49.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.524 -0.735 . . . . 73.23 109.026 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 156.89 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.977 -1.077 . . . . 72.35 108.51 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -145.23 156.39 43.81 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.407 0.622 . . . . 74.2 110.083 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.35 170.43 17.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.513 -0.921 . . . . 73.11 108.513 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.84 30.28 7.25 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.522 1.535 . . . . 71.51 109.963 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HG2' ' HG ' ' A' ' 39' ' ' SER . 6.1 mm-40 . . . . . 0 C--O 1.236 0.368 0 C-N-CA 125.09 1.356 . . . . 72.23 110.449 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 C--O 1.235 0.33 0 N-CA-C 114.281 1.215 . . . . 73.51 114.281 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . 0.496 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 28.0 m95 55.12 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.567 1.147 . . . . 74.3 109.552 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -87.12 130.08 9.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.439 -1.413 . . . . 75.12 112.693 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 39.6 mt -68.78 128.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.3 1.55 . . . . 75.31 110.123 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -134.44 161.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.893 1.677 . . . . 65.31 111.282 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.5 116.51 31.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.119 -2.549 . . . . 74.14 104.119 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.13 104.3 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.959 -1.126 . . . . 74.31 107.959 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.7 p -147.56 160.6 42.45 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.217 1.407 . . . . 74.31 108.391 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 131.284 3.834 . . . . 73.42 116.148 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 105.382 -2.081 . . . . 75.44 105.382 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -52.48 -38.74 60.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.638 0.775 . . . . 74.44 110.372 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -60.14 -41.08 91.95 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.099 -0.375 . . . . 74.14 111.874 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -67.16 -40.46 86.65 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.627 1.171 . . . . 71.11 109.354 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.57 -40.86 93.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.204 0.601 . . . . 74.5 110.352 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.78 -75.79 0.3 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.117 0.967 . . . . 73.43 112.102 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.423 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -160.78 119.9 2.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.056 1.342 . . . . 74.0 108.852 -178.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -119.65 -65.83 1.12 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 117.243 -1.36 . . . . 73.42 113.358 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.2 tp -47.23 -59.67 3.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 115.97 1.841 . . . . 74.55 115.97 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.44 -50.69 62.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.719 0.771 . . . . 74.02 111.122 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.423 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 1.8 t60 -53.88 -49.83 67.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.735 1.214 . . . . 74.51 111.123 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -67.22 -39.34 86.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 116.587 -1.673 . . . . 74.4 109.93 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.25 -55.52 33.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.252 1.387 . . . . 72.54 110.917 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.73 -48.0 81.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.053 1.341 . . . . 73.34 109.925 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.32 -42.79 87.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 118.182 -0.913 . . . . 72.23 112.151 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.6 p -61.56 -43.04 99.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.81 1.186 . . . . 63.32 108.82 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.6 -50.42 73.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.902 0.773 . . . . 73.04 109.938 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.05 -48.18 77.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.889 -0.507 . . . . 74.01 111.771 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.91 -42.34 94.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 118.004 -0.998 . . . . 75.21 109.97 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -65.73 -34.38 78.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.992 1.269 . . . . 72.4 110.068 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.54 -45.86 51.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.244 -0.408 . . . . 72.35 111.042 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -77.1 -46.46 23.52 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.059 0.845 . . . . 73.2 113.096 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -122.22 79.35 44.05 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.953 2.101 . . . . 74.33 109.977 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.49 -13.46 30.26 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.534 2.823 . . . . 72.23 112.95 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 18.28 20.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.682 1.593 . . . . 74.32 110.569 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -125.11 147.75 48.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.478 1.111 . . . . 73.24 108.511 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.16 133.14 23.18 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.621 1.168 . . . . 74.2 109.781 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.07 117.5 3.55 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.533 3.488 . . . . 74.52 112.13 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.56 151.19 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.852 1.261 . . . . 64.44 110.129 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.36 120.88 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 104.467 -2.42 . . . . 74.21 104.467 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.75 115.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.147 1.779 . . . . 72.32 108.684 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.38 151.3 51.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 74.51 110.184 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -94.06 158.49 15.59 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.108 -0.995 . . . . 72.34 113.372 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.61 129.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.005 -2.591 . . . . 75.44 104.005 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.1 p -53.0 153.19 3.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.654 0.74 . . . . 75.51 112.142 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.89 -17.69 1.23 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.064 1.793 . . . . 52.23 113.136 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -62.16 124.49 20.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 119.272 1.536 . . . . 62.12 108.69 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -64.4 -12.89 47.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.961 1.304 . . . . 73.41 112.9 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.45 151.54 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.475 -1.306 . . . . 75.53 107.475 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -46.97 141.89 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.733 1.213 . . . . 74.41 112.576 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.15 150.74 41.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.799 -1.546 . . . . 73.44 110.616 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.27 123.46 63.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.724 -1.584 . . . . 75.53 106.724 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.51 165.86 24.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.526 -0.916 . . . . 72.02 108.526 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.82 95.18 1.89 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.272 0.558 . . . . 73.4 111.365 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -132.12 161.86 32.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.562 1.945 . . . . 72.05 109.009 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -112.3 142.27 45.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.69 1.196 . . . . 73.11 108.624 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -122.94 132.63 54.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.792 0.437 . . . . 64.4 109.848 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.66 113.17 21.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.888 1.675 . . . . 70.51 108.282 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.11 142.87 26.83 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-O 118.218 -0.896 . . . . 74.13 110.224 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.34 139.73 55.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.697 1.598 . . . . 74.24 111.274 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -12.29 30.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.708 1.203 . . . . 61.21 112.6 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.54 -35.07 58.47 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.155 1.782 . . . . 63.42 112.94 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.24 169.46 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 122.018 0.913 . . . . 75.32 110.69 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -107.16 168.47 9.19 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.282 -0.886 . . . . 64.32 112.086 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.19 -35.26 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.86 -1.533 . . . . 64.24 106.86 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.18 87.35 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 121.381 -0.824 . . . . 75.52 110.654 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.17 -45.69 76.22 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 118.33 -0.843 . . . . 74.03 110.923 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.25 -44.14 88.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.663 0.665 . . . . 73.44 109.602 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 34.5 ttp -65.11 -43.98 90.22 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 117.772 -1.109 . . . . 72.43 111.733 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -59.67 -46.77 88.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.545 1.066 . . . . 75.33 109.182 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.3 mt -60.35 -48.08 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 117.862 -1.066 . . . . 74.44 108.63 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.35 -50.27 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.874 1.215 . . . . 70.12 110.121 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -61.19 -33.17 73.02 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.864 -1.147 . . . . 74.41 111.74 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.15 -38.34 60.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.085 0.857 . . . . 73.14 110.209 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -60.28 -46.02 91.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.334 1.454 . . . . 71.13 110.291 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.6 pt -79.25 -6.47 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 109.969 -0.382 . . . . 72.34 109.969 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 54.93 59.78 3.86 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 126.55 1.94 . . . . 74.31 109.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.04 108.85 3.09 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.443 1.897 . . . . 72.53 111.098 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.48 151.09 70.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.451 2.101 . . . . 73.53 108.586 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 p -60.28 -25.05 65.42 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.257 -0.902 . . . . 74.15 112.431 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.87 -38.44 78.82 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.719 0.807 . . . . 73.42 110.402 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -96.14 164.7 12.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.513 1.125 . . . . 74.25 108.775 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.88 174.89 5.67 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.145 1.378 . . . . 73.34 108.257 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tp -153.15 136.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.696 -1.224 . . . . 75.51 107.696 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.98 141.12 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.106 1.362 . . . . 72.44 108.149 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.18 151.3 32.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.595 -1.261 . . . . 61.13 107.595 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -141.21 123.59 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.182 0.993 . . . . 74.23 108.575 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.68 140.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.226 -1.398 . . . . 74.03 107.226 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t0 52.11 31.93 9.68 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 122.114 0.959 . . . . 73.51 112.197 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.6 mttm 65.83 25.17 11.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.399 1.88 . . . . 74.4 111.821 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -152.08 163.03 40.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.404 1.082 . . . . 73.43 110.816 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 121.01 74.62 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.038 -2.208 . . . . 70.54 105.038 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.31 140.0 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.057 2.505 . . . . 73.33 109.695 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -67.69 124.76 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.505 1.122 . . . . 73.42 109.841 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.9 m -53.17 -27.8 23.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.849 1.66 . . . . 72.14 113.693 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.6 m -75.18 -17.93 60.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.256 1.022 . . . . 62.44 112.214 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.69 153.08 44.51 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.631 1.172 . . . . 74.44 108.812 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -101.03 153.74 19.29 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.109 -0.7 . . . . 75.42 109.109 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.33 -49.61 76.59 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 119.132 -0.461 . . . . 74.25 111.682 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.96 -44.97 92.57 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.237 -0.745 . . . . 64.34 111.237 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.44 -53.33 59.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.733 1.213 . . . . 72.51 110.977 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.74 -51.48 69.58 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.238 1.015 . . . . 72.04 109.718 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.29 -44.6 79.97 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.159 1.383 . . . . 71.34 110.085 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.58 -38.53 91.34 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.839 0.745 . . . . 72.4 111.939 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.05 -24.28 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.484 -1.246 . . . . 63.24 113.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.76 -4.18 22.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.001 1.273 . . . . 75.4 114.301 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.73 120.66 2.72 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.301 1.041 . . . . 74.12 113.647 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.74 175.29 10.57 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.654 -1.98 . . . . 73.34 105.654 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.41 -12.44 14.43 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.762 -1.837 . . . . 74.22 112.873 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.71 6.04 43.85 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.958 1.703 . . . . 74.35 113.651 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.39 68.56 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.706 -0.622 . . . . 71.35 111.815 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.27 164.6 21.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.538 1.535 . . . . 75.25 108.863 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.04 139.67 53.72 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 124.57 1.169 . . . . 74.03 108.667 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -121.48 122.92 40.81 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.284 -1.006 . . . . 72.1 108.284 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.32 133.06 67.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 120.776 -1.202 . . . . 74.11 108.979 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.81 160.27 14.75 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.683 -0.636 . . . . 70.45 110.009 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 35' ' ' LYS . 21.3 p90 -142.13 157.07 45.31 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.446 0.699 . . . . 71.03 111.924 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.9 p -149.22 158.54 44.26 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.988 -0.745 . . . . 55.31 108.988 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.43 29.98 7.26 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.218 1.39 . . . . 74.32 111.542 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.234 0.254 0 C-N-CA 125.475 1.51 . . . . 74.44 107.549 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 115.354 1.613 . . . . 72.14 115.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 30.4 m95 50.07 60.45 3.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.023 1.729 . . . . 73.32 115.307 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.53 137.17 17.12 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.746 -1.341 . . . . 60.21 109.746 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 26.0 mt -77.63 137.1 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.658 1.583 . . . . 75.3 113.154 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.06 142.83 50.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.299 2.24 . . . . 75.22 108.141 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.02 111.17 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.022 1.729 . . . . 74.21 110.931 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.91 125.82 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 113.523 0.934 . . . . 70.03 113.523 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -143.15 110.51 5.76 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.522 1.529 . . . . 73.25 108.198 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.022 1.729 . . . . 71.43 111.661 179.784 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 C--O 1.244 0.793 0 N-CA-C 109.076 -0.713 . . . . 74.42 109.076 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.64 -48.41 81.89 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.714 -0.847 . . . . 72.21 108.714 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.83 -34.37 74.45 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 118.863 -0.589 . . . . 72.04 111.282 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -64.74 -42.09 95.45 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 120.038 1.29 . . . . 72.41 109.643 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.88 -47.16 86.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.645 -0.872 . . . . 65.23 108.645 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.52 -75.45 0.1 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.212 1.805 . . . . 73.21 113.021 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.23 130.94 5.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.703 2.801 . . . . 73.43 109.505 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.3 p -114.73 -66.63 1.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.215 -1.553 . . . . 75.11 114.266 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -57.36 10.48 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 124.83 1.252 . . . . 73.35 113.943 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.22 -56.13 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.172 0.442 . . . . 74.33 111.398 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -52.26 -49.95 63.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.529 1.132 . . . . 73.12 110.836 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.86 76.05 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 117.882 -1.056 . . . . 75.5 112.183 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.6 m -60.35 -51.74 68.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 120.379 1.445 . . . . 74.44 109.264 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.57 -47.34 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.353 -0.61 . . . . 74.44 109.353 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -55.64 -49.98 71.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.434 1.094 . . . . 75.14 109.982 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.1 m -60.51 -48.56 81.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.944 0.897 . . . . 72.53 110.198 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.43 90.58 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.694 1.134 . . . . 71.32 111.562 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -47.64 77.32 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.226 1.411 . . . . 73.21 109.475 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.05 -42.38 79.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-O 117.784 -1.103 . . . . 73.14 111.807 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -65.16 -39.1 92.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 119.572 1.078 . . . . 70.44 109.7 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.2 -46.91 66.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.07 -0.652 . . . . 70.54 110.921 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -78.16 -38.31 43.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.276 1.954 . . . . 74.34 116.276 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -136.55 74.14 53.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.352 1.861 . . . . 73.25 109.777 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.78 -24.09 54.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.421 2.747 . . . . 75.3 110.726 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.99 12.17 18.38 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.6 -0.687 . . . . 74.55 112.726 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -119.89 154.08 34.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.572 -1.27 . . . . 74.32 107.572 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.82 139.98 27.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.166 -0.679 . . . . 74.54 109.166 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.075 3.85 . . . . 75.41 112.169 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.2 131.93 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.909 -0.775 . . . . 74.21 108.909 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.75 133.59 55.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.367 -2.457 . . . . 75.24 104.367 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.57 137.45 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.777 1.399 . . . . 72.53 114.777 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.84 152.61 43.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.115 0.966 . . . . 70.42 109.913 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -93.39 155.74 17.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.15 135.08 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.088 -1.819 . . . . 73.41 106.088 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.09 133.13 38.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.107 0.563 . . . . 73.22 111.975 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.57 3.95 43.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.645 -1.086 . . . . 64.13 114.144 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 t -62.5 146.02 52.74 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.685 1.742 . . . . 75.34 111.048 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -65.86 -14.89 62.32 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.825 2.05 . . . . 72.21 112.856 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -77.66 159.08 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.398 -0.814 . . . . 65.23 109.965 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.25 150.06 11.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.789 -0.819 . . . . 74.14 108.789 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.6 164.58 25.79 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.522 0.729 . . . . 70.34 112.105 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.82 148.57 20.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.161 1.785 . . . . 71.21 106.317 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -87.14 157.44 19.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.452 -0.944 . . . . 65.54 108.452 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.87 100.72 3.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.5 -1.296 . . . . 75.23 107.5 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -136.41 161.99 34.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.118 1.767 . . . . 75.44 110.198 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -108.81 95.48 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.178 2.591 . . . . 73.11 104.018 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -89.29 120.02 30.28 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.16 -0.963 . . . . 71.53 112.383 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.71 115.16 28.83 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.96 1.704 . . . . 74.23 109.625 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 141.47 25.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 117.82 -1.085 . . . . 71.03 111.361 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.43 140.7 48.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.281 2.654 . . . . 51.22 110.893 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 m -63.87 -16.33 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.489 1.516 . . . . 75.14 113.34 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.82 -30.43 28.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.295 1.438 . . . . 72.11 113.743 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -71.03 165.59 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 119.018 -1.073 . . . . 74.42 109.257 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -107.02 165.39 11.38 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.587 0.755 . . . . 75.23 110.25 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 t -53.99 -34.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.942 -1.132 . . . . 75.45 107.942 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.38 90.48 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.16 1.384 . . . . 74.52 111.135 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -69.21 -44.62 71.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.838 -0.801 . . . . 75.31 108.838 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.06 -48.6 81.03 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.429 -0.582 . . . . 75.5 109.429 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ttt -54.05 -48.07 70.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.626 1.17 . . . . 71.42 109.553 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.007 -0.521 . . . . 73.22 111.767 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.4 mt -57.32 -44.18 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.067 -0.716 . . . . 73.33 109.067 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mt -59.53 -50.63 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.427 0.558 . . . . 74.54 110.725 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -65.33 -37.27 86.59 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.08 -1.012 . . . . 71.12 111.949 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -64.94 -47.09 78.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.063 0.945 . . . . 72.31 110.29 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.89 -42.29 97.5 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.816 1.246 . . . . 74.34 113.011 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.65 -8.64 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 119.818 -0.753 . . . . 73.34 109.747 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.68 60.52 1.6 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.797 2.039 . . . . 73.35 108.841 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.32 110.44 8.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.664 1.186 . . . . 74.13 110.015 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.84 164.47 29.41 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.715 2.943 . . . . 72.14 112.389 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 p -64.28 -21.05 66.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.99 0.916 . . . . 74.21 111.498 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.47 -50.54 25.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.406 0.683 . . . . 73.42 112.794 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.12 164.24 15.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.777 -0.824 . . . . 71.31 108.777 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.23 -178.45 3.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.971 -1.122 . . . . 74.1 107.971 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -150.74 141.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.648 1.579 . . . . 74.21 107.171 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -145.27 139.41 27.1 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 127.288 2.235 . . . . 75.33 107.965 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.9 150.49 35.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.877 0.871 . . . . 74.42 111.135 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -145.25 133.83 22.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.549 1.14 . . . . 73.44 109.75 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 p -132.91 127.93 56.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 105.043 -2.206 . . . . 75.32 105.043 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.32 30.55 10.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.178 1.354 . . . . 74.01 110.863 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt 61.13 25.27 15.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 72.15 110.928 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -119.37 161.57 20.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.623 1.569 . . . . 71.41 109.72 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.2 103.62 21.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.356 -2.09 . . . . 75.15 105.356 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.15 142.7 38.47 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.31 2.007 . . . . 74.33 111.569 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -75.41 121.91 23.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.071 -0.715 . . . . 72.33 109.071 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -49.06 -42.21 37.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.854 2.062 . . . . 63.42 112.665 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -72.92 -11.37 60.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.769 1.228 . . . . 74.2 113.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.69 157.34 36.72 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.579 1.536 . . . . 71.51 109.733 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.03 152.45 18.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.192 1.397 . . . . 64.12 110.085 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.3 mmm -60.7 -43.56 97.62 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.034 -0.53 . . . . 73.01 111.613 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.51 99.71 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.479 -0.623 . . . . 71.25 111.782 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -66.15 -50.18 64.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.017 0.909 . . . . 63.54 109.412 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.23 -35.17 76.5 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.204 -0.295 . . . . 74.2 110.204 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.72 -48.96 67.59 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 120.063 -1.648 . . . . 63.12 109.619 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.92 -28.68 68.5 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.496 -0.752 . . . . 73.23 112.087 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -24.36 19.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 116.6 -1.667 . . . . 53.24 113.86 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.13 -2.97 13.3 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.704 1.742 . . . . 74.51 115.704 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 124.29 6.39 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.259 1.39 . . . . 74.31 113.967 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -77.62 175.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.937 -1.505 . . . . 74.42 106.937 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -58.91 -27.39 65.21 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 119.838 -1.789 . . . . 71.43 113.896 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -79.11 7.76 6.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 75.4 111.131 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.49 69.3 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.616 1.579 . . . . 72.23 114.94 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.77 172.65 10.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.447 1.899 . . . . 74.33 110.789 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.63 141.56 52.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.616 -0.513 . . . . 71.44 109.616 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -113.23 123.67 50.72 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.766 1.226 . . . . 75.11 111.795 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.2 136.81 57.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 122.801 1.286 . . . . 65.33 111.117 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.19 142.74 46.42 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.628 -1.619 . . . . 54.42 106.628 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -133.21 155.54 49.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.457 0.646 . . . . 74.25 110.758 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.3 p -150.97 155.9 40.06 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.567 -0.901 . . . . 73.24 108.567 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.36 9.21 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 119.39 -0.672 . . . . 71.43 112.769 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 118.219 1.01 . . . . 72.24 109.169 -177.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 115.572 1.693 . . . . 73.2 115.572 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.3 m95 53.74 58.52 5.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.398 1.079 . . . . 75.55 109.758 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.15 139.86 20.86 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 108.252 -1.939 . . . . 64.22 108.252 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 133.83 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 118.871 1.335 . . . . 74.14 109.698 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.09 138.36 48.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.747 1.219 . . . . 72.13 109.444 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.72 118.97 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 103.152 -2.907 . . . . 71.44 103.152 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.45 119.24 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.898 0.879 . . . . 75.34 109.522 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -161.47 123.99 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.42 0.688 . . . . 72.24 109.748 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 128.234 2.614 . . . . 75.45 112.902 -179.213 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 107.933 -1.136 . . . . 74.23 107.933 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -58.7 -41.99 87.57 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 124.024 0.828 . . . . 75.43 109.531 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -58.82 -42.34 88.96 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.693 -0.629 . . . . 74.03 110.992 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -68.37 -38.06 81.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.312 0.96 . . . . 74.32 111.376 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.62 -46.77 74.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.96 -1.019 . . . . 72.32 108.829 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.92 -77.53 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.561 1.145 . . . . 73.14 110.266 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 119.21 2.13 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.254 1.821 . . . . 74.24 108.223 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.7 t -106.88 -65.82 1.06 Allowed 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 106.706 -1.59 . . . . 62.32 106.706 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -41.13 -58.07 1.88 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.512 1.525 . . . . 75.23 115.101 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.35 -51.66 54.94 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.918 -0.488 . . . . 75.32 112.0 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.66 -44.35 73.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.146 0.979 . . . . 74.22 110.325 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.27 70.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.73 1.612 . . . . 63.22 108.782 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.69 -47.71 79.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.359 0.527 . . . . 73.22 111.63 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.79 -48.3 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 C-N-CA 123.035 0.534 . . . . 74.45 109.953 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.486 ' CD ' ' HZ1' ' A' ' 48' ' ' LYS . 50.6 mm-40 -64.06 -49.46 72.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.673 -1.156 . . . . 73.35 111.274 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.4 m -55.27 -46.57 76.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.08 1.309 . . . . 62.01 109.733 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.68 70.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.154 0.888 . . . . 64.02 111.576 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -62.47 -39.51 93.66 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.604 -1.31 . . . . 72.22 111.725 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.5 -42.77 56.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 116.008 -1.948 . . . . 73.25 109.285 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.79 -34.67 78.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 121.182 1.81 . . . . 74.44 108.967 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.27 82.21 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.922 -0.486 . . . . 70.32 110.895 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -76.95 -47.23 21.5 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.785 1.032 . . . . 75.2 113.785 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -138.06 89.13 14.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.061 1.744 . . . . 74.51 108.494 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.85 -22.27 36.78 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.626 2.217 . . . . 74.13 112.403 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.29 14.14 25.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.034 2.134 . . . . 71.24 113.588 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -120.02 156.8 30.19 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.158 -1.423 . . . . 72.0 107.158 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.92 138.2 28.37 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.353 1.061 . . . . 73.43 111.2 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.48 116.85 3.91 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.216 3.944 . . . . 75.12 112.347 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.21 146.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.745 1.218 . . . . 72.21 108.974 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.9 mt -122.31 128.26 75.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.165 -2.532 . . . . 74.43 104.165 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 120.81 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.643 1.577 . . . . 74.35 107.274 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -131.94 147.09 52.44 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.38 -0.971 . . . . 74.44 108.38 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.11 155.15 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.635 1.107 . . . . 71.35 111.078 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.55 130.89 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.453 -1.314 . . . . 75.41 107.453 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -62.3 130.24 44.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.266 -1.753 . . . . 73.31 106.266 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.9 -2.77 80.25 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 118.031 -1.427 . . . . 63.24 112.289 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -77.42 139.78 39.75 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.053 -2.203 . . . . 74.31 105.053 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.01 -28.2 68.05 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.4 1.48 . . . . 74.44 112.578 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -55.84 152.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.047 1.339 . . . . 74.44 111.431 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.14 134.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.46 1.104 . . . . 54.32 111.421 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.33 158.75 34.49 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.617 -1.253 . . . . 75.23 107.617 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.47 141.13 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.836 -1.172 . . . . 74.34 107.836 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.77 164.44 17.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.405 -0.961 . . . . 72.0 108.405 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 99.37 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.534 -2.765 . . . . 73.33 103.534 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -130.48 155.1 47.02 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.771 0.796 . . . . 73.02 109.499 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HZ1' ' CD ' ' A' ' 17' ' ' GLU . 38.1 mtmt -106.46 100.26 9.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.671 -1.233 . . . . 70.31 107.671 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.82 124.47 30.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.996 -1.113 . . . . 73.51 107.996 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.13 112.92 26.05 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.513 -0.921 . . . . 73.51 108.513 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -111.44 141.18 23.97 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 63.42 113.426 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.06 141.71 33.27 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 124.158 3.239 . . . . 75.04 112.216 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -18.43 60.94 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.831 1.049 . . . . 53.35 113.831 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.56 -34.48 70.02 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.906 1.379 . . . . 74.02 114.136 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -78.84 163.52 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.5 0.667 . . . . 73.44 110.219 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 p -104.65 167.78 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.357 1.063 . . . . 72.51 109.795 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.27 -35.31 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.021 -0.733 . . . . 75.11 109.021 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.1 -45.93 82.99 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.246 0.93 . . . . 73.3 109.911 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -68.0 -45.95 72.63 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.19 -0.67 . . . . 72.05 109.19 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.19 -52.0 67.58 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 119.067 -0.492 . . . . 75.24 111.038 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.8 ttp -57.69 -46.9 83.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.434 1.094 . . . . 75.24 110.347 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -59.25 -43.63 92.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.194 0.452 . . . . 74.02 110.785 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.48 -40.04 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 117.851 -1.071 . . . . 73.0 109.561 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.34 -50.22 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 120.611 1.55 . . . . 73.4 108.902 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -59.86 -39.15 84.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.025 -0.988 . . . . 73.51 111.402 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.79 -39.38 69.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 119.588 1.085 . . . . 73.05 110.828 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -62.96 -42.99 99.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.723 1.147 . . . . 74.12 110.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -79.22 -2.63 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.297 0.499 . . . . 74.43 109.7 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 55.47 61.02 3.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.01 2.124 . . . . 74.21 109.734 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.42 107.2 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.602 1.561 . . . . 73.05 109.935 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.97 156.1 66.41 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.485 2.124 . . . . 74.15 109.171 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -65.27 -20.79 66.58 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.183 -0.948 . . . . 71.52 112.703 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.6 -30.63 71.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.483 0.713 . . . . 73.14 110.453 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -103.72 164.9 11.38 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.009 1.324 . . . . 72.13 111.376 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.38 177.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.74 1.616 . . . . 71.3 108.093 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 tp -145.72 135.81 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -143.1 141.95 31.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.055 -1.461 . . . . 70.11 107.055 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.75 142.34 46.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.403 1.081 . . . . 63.31 108.109 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -144.3 123.66 13.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.294 -1.373 . . . . 74.3 107.294 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -130.21 131.3 65.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 117.046 -1.454 . . . . 65.34 107.255 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 47.89 30.82 2.07 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.519 1.508 . . . . 75.42 113.365 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mttp 64.74 29.11 12.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.235 -1.541 . . . . 72.22 110.61 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.9 p -132.7 161.8 33.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.104 2.562 . . . . 71.42 110.779 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.76 110.9 63.22 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.261 1.424 . . . . 73.33 109.118 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.09 124.81 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.361 2.04 . . . . 75.14 107.417 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -69.31 133.88 48.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.54 1.136 . . . . 72.51 109.655 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -62.72 -40.38 97.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 114.253 1.205 . . . . 73.11 114.253 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -21.62 59.08 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.97 -1.014 . . . . 62.52 113.093 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.95 142.8 58.31 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.268 1.395 . . . . 74.3 111.137 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 p -78.22 153.68 31.72 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.944 . . . . 74.2 110.004 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.1 mmt -59.36 -41.6 89.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.304 -0.855 . . . . 73.32 108.811 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.9 92.3 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.146 0.884 . . . . 73.53 112.964 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -49.76 52.77 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.064 0.932 . . . . 63.14 111.13 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.29 -48.01 81.83 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 123.527 0.731 . . . . 73.12 109.796 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -56.87 -52.99 62.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.13 1.372 . . . . 72.12 109.461 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.04 -47.38 84.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 118.971 -0.538 . . . . 74.4 111.964 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -32.74 67.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.373 0.988 . . . . 74.23 112.768 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -93.86 -5.84 47.12 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.683 1.129 . . . . 73.13 113.887 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -38.79 125.14 1.44 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.587 1.955 . . . . 65.33 113.727 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.91 163.47 16.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.927 0.891 . . . . 71.45 110.024 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.82 -29.26 26.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.465 1.106 . . . . 74.42 111.277 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -95.32 -33.88 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.481 1.112 . . . . 75.1 112.541 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.03 4.04 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 117.742 1.857 . . . . 75.21 117.742 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -96.27 178.99 5.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.366 2.083 . . . . 62.03 112.024 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tp -125.74 138.2 53.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.584 -0.722 . . . . 75.34 111.302 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -123.13 108.32 12.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.043 1.337 . . . . 64.34 109.561 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.98 145.11 20.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 122.332 1.063 . . . . 73.43 110.382 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.96 145.54 38.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.169 -0.923 . . . . 72.24 108.509 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -130.96 157.62 42.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.364 0.602 . . . . 73.22 109.863 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.1 p -148.28 161.82 40.75 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.408 -0.96 . . . . 75.52 108.408 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.14 17.85 16.65 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 117.959 -1.467 . . . . 65.33 114.136 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.285 -1.376 . . . . 74.34 107.285 -179.733 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.557 1.248 1 N-CA-C 122.043 4.09 . . . . 71.52 122.043 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . 0.426 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 10.4 m95 50.67 66.14 1.25 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.479 3.112 . . . . 74.3 112.081 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -99.8 124.89 8.38 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.421 -1.872 . . . . 65.53 108.421 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . 0.421 HG12 ' HE3' ' A' ' 48' ' ' LYS . 61.5 mt -68.37 139.9 19.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.585 1.192 . . . . 74.3 108.212 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -141.72 112.21 7.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.071 1.748 . . . . 63.34 106.584 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.48 120.71 22.08 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.374 -2.084 . . . . 74.42 105.374 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.48 110.86 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.458 0.703 . . . . 73.41 111.934 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.1 p -144.48 127.5 16.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.338 1.055 . . . . 71.02 108.958 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 128.94 2.896 . . . . 74.4 114.56 179.549 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.5 m95 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 108.714 -0.847 . . . . 73.14 108.714 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 mmt -60.17 -34.14 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.398 -0.921 . . . . 75.13 110.749 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -60.23 -47.66 85.02 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.232 -0.917 . . . . 74.44 109.982 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -64.43 -32.67 74.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.827 -0.606 . . . . 73.32 110.227 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -60.21 -47.35 86.35 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.87 -1.159 . . . . 73.24 107.87 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.17 -76.26 0.16 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.648 0.779 . . . . 73.33 111.284 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.4 143.08 11.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 127.339 2.256 . . . . 54.12 109.615 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 t -122.89 -59.7 1.57 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.099 -0.953 . . . . 74.21 109.377 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.4 mt -45.42 -58.22 3.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.075 1.35 . . . . 74.52 114.235 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -64.86 -49.99 68.36 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.426 -0.796 . . . . 73.34 110.916 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -52.5 -55.43 22.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.319 1.012 . . . . 74.11 110.377 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -44.71 91.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.637 1.575 . . . . 63.45 111.041 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.51 -50.85 72.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.088 1.313 . . . . 72.41 111.702 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 74.6 t -69.1 -47.34 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.826 0.85 . . . . 61.42 111.772 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.4 -51.18 70.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.843 1.257 . . . . 62.42 109.443 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -63.63 -40.77 97.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.117 -0.944 . . . . 75.41 110.038 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -49.83 76.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.52 1.509 . . . . 55.13 110.175 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HE2' ' CG1' ' A' ' 16' ' ' VAL . 50.6 mttm -61.45 -48.42 81.23 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.431 -0.793 . . . . 74.14 110.989 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.68 -41.77 85.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-O 117.564 -1.208 . . . . 75.45 110.403 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -63.51 -33.79 76.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.526 1.966 . . . . 73.31 109.138 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.18 51.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.496 0.589 . . . . 61.44 110.153 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -75.44 -46.34 33.2 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.165 1.172 . . . . 71.44 114.165 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -124.08 74.74 58.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.938 2.895 . . . . 75.44 112.022 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.59 -9.17 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.132 3.221 . . . . 72.21 110.96 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.66 12.53 27.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.171 2.188 . . . . 73.53 111.894 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -127.41 160.08 32.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.87 -1.144 . . . . 75.54 109.791 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.5 142.62 37.72 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.604 1.161 . . . . 75.42 108.909 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.64 119.02 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.669 1 C-N-CA 125.372 4.048 . . . . 75.34 112.185 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.1 t -126.46 148.87 31.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.184 0.994 . . . . 74.13 109.764 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.24 133.41 68.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.52 -2.4 . . . . 75.13 104.52 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.73 118.5 52.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.559 1.544 . . . . 74.24 108.888 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -130.56 153.91 48.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.864 -0.791 . . . . 75.51 108.864 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -93.06 158.38 15.81 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.143 -0.973 . . . . 74.3 110.503 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.06 119.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.545 -2.02 . . . . 74.54 105.545 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 p -54.68 110.8 0.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.968 1.707 . . . . 75.33 111.946 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.4 30.99 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.846 1.688 . . . . 72.45 113.422 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 p -63.95 146.38 54.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.136 1.468 . . . . 70.45 109.816 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -69.59 -0.62 7.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.797 1.639 . . . . 74.41 114.502 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -86.75 169.2 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 119.386 0.994 . . . . 75.13 109.738 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.9 155.72 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.526 1.13 . . . . 75.14 111.358 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.16 163.13 18.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.94 0.896 . . . . 72.05 111.032 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.42 124.5 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.745 1.618 . . . . 62.24 106.675 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.12 164.62 15.15 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.893 0.877 . . . . 55.43 110.175 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 101.51 4.28 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.981 -1.489 . . . . 75.35 106.981 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -134.44 161.79 34.03 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.934 1.294 . . . . 73.42 108.765 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 17.1 mttt -111.26 105.84 14.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.745 -1.946 . . . . 74.42 105.745 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -88.01 118.39 27.54 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.325 0.861 . . . . 73.53 113.325 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.57 108.29 20.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.32 2.248 . . . . 74.23 108.783 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.62 141.35 24.46 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.049 -0.977 . . . . 72.43 110.062 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.19 141.43 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.13 1.887 . . . . 62.51 111.582 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -62.51 -16.15 54.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.098 0.777 . . . . 72.41 113.098 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.72 -34.21 64.69 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.308 1.225 . . . . 71.13 114.308 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.8 168.94 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.206 0.912 . . . . 72.52 111.58 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.1 p -107.88 169.4 8.63 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.082 0.953 . . . . 73.43 111.605 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.86 -36.1 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.002 0.921 . . . . 75.21 109.193 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.25 93.81 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.411 1.005 . . . . 71.43 110.541 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -60.91 -46.49 90.44 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 108.15 -1.056 . . . . 75.04 108.15 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -59.65 -49.3 78.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.961 0.504 . . . . 74.44 110.464 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ttt -58.49 -44.15 89.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.329 1.452 . . . . 72.23 109.467 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -63.64 -39.5 94.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.318 0.508 . . . . 74.04 110.212 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -67.05 -47.65 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 107.832 -1.173 . . . . 74.22 107.832 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.86 -50.83 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.66 1.118 . . . . 74.1 110.987 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.31 -41.92 97.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.558 -0.734 . . . . 75.54 110.894 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -69.21 -41.92 76.43 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.185 0.902 . . . . 74.35 111.165 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -58.88 -47.65 84.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.462 1.505 . . . . 72.12 110.825 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 pt -83.96 -0.87 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.069 0.395 . . . . 73.33 111.266 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 54.36 71.23 0.54 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 126.521 1.928 . . . . 75.11 108.095 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -82.6 104.96 4.02 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.271 -2.122 . . . . 75.21 105.271 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -66.31 165.53 24.34 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 124.232 3.288 . . . . 73.12 113.816 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -57.86 -37.91 74.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.418 1.087 . . . . 74.3 110.202 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -59.92 -38.64 82.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 116.859 -1.543 . . . . 74.35 113.906 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.51 162.4 13.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.306 1.412 . . . . 71.14 110.673 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.87 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.13 1.372 . . . . 53.32 108.807 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.0 tp -132.58 139.59 49.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.486 1.114 . . . . 75.35 108.225 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -137.7 120.15 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.619 -1.623 . . . . 74.41 106.619 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.79 140.18 49.12 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.931 1.692 . . . . 75.34 109.126 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -145.09 141.51 28.89 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.232 -1.025 . . . . 72.25 108.232 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.68 122.57 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 125.162 1.385 . . . . 75.4 107.681 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 t0 43.49 45.79 5.61 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.338 1.236 . . . . 73.34 114.338 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tptm 71.44 18.79 5.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.22 1.808 . . . . 70.14 114.37 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.4 p -129.18 162.38 27.93 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 120.081 1.31 . . . . 74.2 111.043 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.26 109.55 50.29 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 106.43 -1.693 . . . . 73.21 106.43 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 123.86 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 N-CA-C 107.573 -1.741 . . . . 71.41 107.573 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -69.96 121.5 17.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.685 -0.635 . . . . 65.34 110.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 76.6 p -47.65 -37.59 13.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.972 2.109 . . . . 72.44 114.045 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 m -75.92 -19.19 58.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.529 1.132 . . . . 73.31 113.968 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.06 144.64 53.93 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.174 0.897 . . . . 74.21 109.879 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.7 p -83.09 154.55 24.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.449 0.642 . . . . 75.11 109.677 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.84 -42.27 97.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.702 -0.666 . . . . 72.12 111.384 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.31 -43.13 98.88 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.193 -0.782 . . . . 62.34 111.744 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -68.49 -48.46 64.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.247 1.024 . . . . 74.51 109.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -57.43 -44.43 84.65 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.472 0.709 . . . . 72.03 110.308 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -61.07 -49.74 76.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.17 0.988 . . . . 75.22 108.546 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.09 -32.25 72.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.647 0.98 . . . . 74.42 113.647 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -25.84 18.93 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.971 1.471 . . . . 74.13 114.971 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.22 0.35 23.2 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.711 1.004 . . . . 74.34 113.711 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -48.21 135.17 13.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.355 0.979 . . . . 74.21 112.965 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.77 161.23 29.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.564 -0.902 . . . . 75.44 108.564 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -54.64 -29.94 53.66 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.403 1.481 . . . . 70.01 112.01 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -79.77 -33.1 40.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.145 0.578 . . . . 64.25 111.684 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.45 -6.86 4.97 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 117.434 1.734 . . . . 73.31 117.434 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.77 -179.61 3.7 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.805 2.042 . . . . 74.14 111.957 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.5 tp -123.68 143.63 50.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.395 0.543 . . . . 73.4 111.937 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -122.69 134.52 54.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 64.04 110.602 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.84 140.64 48.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 124.498 1.119 . . . . 71.31 108.264 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.01 149.04 40.93 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.575 -0.898 . . . . 51.21 108.575 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -139.73 159.9 41.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.929 0.871 . . . . 75.24 112.793 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.2 p -149.59 155.94 41.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.014 -1.847 . . . . 50.43 106.014 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 26.16 12.64 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.156 -0.778 . . . . 65.25 111.156 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 125.417 1.487 . . . . 75.14 107.026 -178.874 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 112.499 0.555 . . . . 74.13 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . 0.426 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 52.5 m95 54.02 63.91 2.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.754 1.622 . . . . 73.32 111.792 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.78 126.34 7.34 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.009 -2.436 . . . . 62.34 107.009 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.6 132.08 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.792 1.296 . . . . 75.42 108.016 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -129.9 149.5 51.61 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.227 1.011 . . . . 71.02 109.553 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.8 tt -111.39 114.35 27.43 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.679 1.592 . . . . 73.22 109.159 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 37.8 t -121.77 136.11 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.1 0.96 . . . . 74.41 111.401 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 160.41 28.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.152 1.781 . . . . 74.44 109.331 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 127.33 2.252 . . . . 71.31 107.32 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.6 m95 . . . . . 0 C--O 1.239 0.551 0 N-CA-C 108.814 -0.81 . . . . 74.45 108.814 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.451 ' HG2' ' HE2' ' A' ' 46' ' ' LYS . 16.3 tpt -62.01 -47.11 86.23 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.422 -0.955 . . . . 72.4 108.422 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -60.26 -41.04 92.42 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 119.116 -0.469 . . . . 72.52 111.369 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -64.38 -33.27 75.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.879 0.763 . . . . 74.11 109.476 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.18 -48.31 62.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.506 0.594 . . . . 74.45 110.15 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -75.0 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.178 0.991 . . . . 73.41 112.621 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 130.63 10.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.968 1.307 . . . . 72.31 107.989 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -124.22 -65.93 1.02 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.472 0.916 . . . . 74.4 113.472 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mt -48.49 -58.88 4.01 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.444 1.497 . . . . 70.52 114.539 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.49 -44.37 87.3 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.61 -0.681 . . . . 73.35 112.06 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -59.62 -40.02 86.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.055 0.942 . . . . 74.32 108.688 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -43.12 84.7 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-O 117.437 -1.268 . . . . 74.34 110.054 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.6 m -63.85 -47.01 82.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.182 1.356 . . . . 71.53 112.752 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.39 -47.13 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 O-C-N 121.736 -0.603 . . . . 75.35 109.637 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.04 -40.01 95.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 117.416 -1.278 . . . . 75.32 110.967 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -61.76 -47.45 85.12 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 121.15 1.795 . . . . 71.53 108.767 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.83 72.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.874 0.694 . . . . 74.02 112.874 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.0 -44.94 75.43 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.637 -0.664 . . . . 65.43 112.661 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.2 -41.89 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.296 -0.859 . . . . 74.43 110.237 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -66.15 -38.0 87.05 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.468 1.031 . . . . 72.05 109.484 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.63 78.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.094 -0.642 . . . . 64.22 110.601 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.39 -46.43 22.77 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.138 1.533 . . . . 74.43 115.138 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.15 72.12 55.37 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 127.064 2.146 . . . . 74.31 110.533 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.5 -19.31 48.91 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.778 2.318 . . . . 73.53 112.523 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -97.76 13.02 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.441 0.564 . . . . 73.31 110.871 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -118.54 155.4 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.989 -1.115 . . . . 73.44 107.989 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 27.12 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.879 -1.156 . . . . 73.34 107.879 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.59 122.15 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.98 3.787 . . . . 72.05 112.392 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.55 140.77 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.274 1.83 . . . . 74.52 111.82 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.68 136.76 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 105.764 -1.939 . . . . 75.32 105.764 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.87 110.58 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.99 0.813 . . . . 72.14 110.432 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -112.88 146.81 38.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.118 -1.067 . . . . 72.33 108.118 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 141.94 31.88 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.067 -1.021 . . . . 75.31 109.652 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.34 127.94 23.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.558 -1.275 . . . . 73.42 107.558 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.07 128.77 22.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.115 1.366 . . . . 71.21 109.636 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.1 42.28 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.58 -1.122 . . . . 75.13 113.934 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.19 109.23 2.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.319 -2.104 . . . . 44.11 105.319 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.73 -0.98 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.602 1.561 . . . . 74.0 114.792 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -68.39 163.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.139 -0.975 . . . . 75.32 109.043 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.83 129.68 14.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.219 1.407 . . . . 71.32 110.364 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -84.37 163.94 19.23 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.633 1.573 . . . . 75.4 108.444 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -125.41 135.57 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.871 -1.529 . . . . 75.21 106.871 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.83 165.15 8.97 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.304 0.573 . . . . 74.31 110.609 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.451 ' HE2' ' HG2' ' A' ' 4' ' ' MET . 10.2 mptt -73.88 103.19 4.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.089 -1.448 . . . . 75.11 107.089 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -136.62 158.28 44.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.953 2.101 . . . . 75.2 107.846 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.51 102.11 11.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 104.033 -2.58 . . . . 74.41 104.033 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -83.97 142.14 30.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.576 -1.268 . . . . 74.43 107.576 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.97 123.35 30.43 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 117.921 -1.038 . . . . 74.12 108.844 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.57 143.01 28.11 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 117.787 -1.101 . . . . 74.3 112.785 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.81 141.28 48.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.268 1.978 . . . . 73.23 108.481 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 t -59.25 -12.68 5.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.936 2.494 . . . . 72.23 113.303 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.71 -27.16 17.42 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 115.528 1.677 . . . . 75.32 115.528 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.55 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.031 1.287 . . . . 74.31 110.184 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.9 p -107.28 160.17 15.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.987 0.915 . . . . 64.33 111.053 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.12 -38.13 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.458 1.503 . . . . 74.35 111.465 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.05 91.93 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.556 0.743 . . . . 72.23 110.778 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.62 -42.37 95.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.017 0.927 . . . . 73.44 109.742 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.45 -46.2 89.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.833 -0.803 . . . . 73.44 108.833 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.5 ttp -60.51 -42.36 96.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.574 0.75 . . . . 73.12 110.581 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -61.25 -40.31 93.61 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.49 0.716 . . . . 75.22 109.915 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.9 mt -66.18 -51.01 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 118.511 -0.757 . . . . 74.14 109.326 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.7 mt -55.15 -49.98 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.142 0.883 . . . . 72.22 110.339 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.54 -38.71 88.42 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.017 -1.052 . . . . 74.42 111.328 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.712 0.687 . . . . 75.31 110.063 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -61.83 -51.33 68.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.507 1.123 . . . . 74.22 109.888 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.11 5.86 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.002 0.371 . . . . 74.12 112.002 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 46.21 63.4 1.87 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 127.634 2.374 . . . . 70.43 110.651 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 108.58 3.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.97 1.308 . . . . 71.4 110.877 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.31 158.65 36.98 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.116 3.21 . . . . 71.01 110.955 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -26.78 55.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.801 0.84 . . . . 54.44 112.757 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.91 -34.48 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.153 0.981 . . . . 73.11 111.501 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 164.29 11.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.912 1.233 . . . . 75.04 108.106 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.65 175.27 5.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.628 1.171 . . . . 74.33 107.98 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -148.34 130.12 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.512 0.725 . . . . 75.24 111.617 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -141.53 148.28 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.454 1.101 . . . . 74.12 110.213 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.9 152.18 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.569 1.948 . . . . 73.21 108.098 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -144.42 126.87 15.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.444 1.498 . . . . 72.32 108.347 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.66 124.55 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.326 1.05 . . . . 71.1 108.457 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 43.83 38.44 2.1 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.162 1.385 . . . . 73.42 113.898 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttm 65.05 39.94 5.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.83 2.052 . . . . 74.14 111.063 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 p -141.25 156.61 45.87 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.163 0.985 . . . . 72.25 110.048 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.07 104.0 33.49 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 102.837 -3.023 . . . . 63.2 102.837 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.59 147.18 69.71 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.554 2.17 . . . . 75.34 110.722 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -70.69 120.89 16.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.799 -1.185 . . . . 62.31 107.799 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 p -51.84 -34.92 42.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.374 1.469 . . . . 64.24 113.813 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -83.68 -6.42 59.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.36 0.874 . . . . 53.3 113.36 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.73 144.58 54.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.678 1.126 . . . . 75.11 108.141 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.17 149.88 25.87 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.888 -0.782 . . . . 64.41 108.888 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.57 -50.75 64.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.264 1.025 . . . . 54.4 112.249 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.67 96.97 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 118.854 0.752 . . . . 75.34 112.378 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -62.07 -53.39 56.14 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.833 0.853 . . . . 75.14 109.261 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.02 -44.92 87.57 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.993 0.917 . . . . 71.54 110.231 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -60.31 -51.97 67.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.611 1.164 . . . . 73.42 108.994 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -35.91 74.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.205 -0.902 . . . . 74.33 112.747 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -24.41 20.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.735 -1.126 . . . . 74.43 113.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -107.21 5.3 27.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.566 1.076 . . . . 74.5 112.993 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -48.82 127.65 14.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.22 1.808 . . . . 75.22 113.513 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.46 175.22 10.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.49 0.716 . . . . 73.42 109.121 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -60.53 -30.47 69.77 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.225 -1.547 . . . . 75.15 110.886 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.28 16.78 12.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.502 1.121 . . . . 75.14 112.283 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.06 28.59 69.14 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.198 -1.335 . . . . 64.44 114.946 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -126.42 177.05 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.647 1.724 . . . . 73.1 111.472 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -123.43 135.32 54.04 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.491 1.116 . . . . 74.23 109.986 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -122.66 127.64 49.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.189 1.396 . . . . 72.41 107.698 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.3 t -129.2 149.02 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 120.505 -1.372 . . . . 75.32 109.457 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.68 150.97 37.29 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.753 -1.573 . . . . 64.15 106.753 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.27 151.92 46.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.097 0.862 . . . . 71.11 111.324 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.2 p -142.88 171.83 13.52 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.451 0.643 . . . . 72.23 111.262 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.62 9.18 21.89 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.597 1.57 . . . . 72.44 112.308 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.45 -0.443 0 C-N-CA 126.343 1.857 . . . . 73.32 107.968 -178.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 119.542 -0.266 . . . . 64.42 110.761 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 18.3 m95 52.93 55.93 8.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.0 0.92 . . . . 74.34 110.316 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.49 128.35 8.44 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.308 -1.517 . . . . 62.44 109.308 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.94 133.62 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 126.903 2.081 . . . . 74.11 106.914 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.84 104.82 5.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.074 -1.454 . . . . 74.44 107.074 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.5 114.76 19.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.632 1.173 . . . . 73.54 107.882 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.04 150.42 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.426 1.091 . . . . 72.11 110.723 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -162.89 161.72 25.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.904 2.482 . . . . 74.42 107.04 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.657 -1.609 . . . . 74.31 106.657 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 105.399 -2.074 . . . . 73.33 105.399 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.453 ' SD ' ' HE3' ' A' ' 46' ' ' LYS . 9.5 mtp -56.38 -46.29 80.16 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.966 -0.754 . . . . 72.03 108.966 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -57.18 -43.56 82.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.458 0.703 . . . . 74.43 112.401 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -37.73 87.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.469 0.577 . . . . 72.4 110.689 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -67.37 -48.2 68.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.487 -0.931 . . . . 75.22 108.487 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.84 -76.9 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.118 1.767 . . . . 72.12 113.092 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.75 120.13 2.32 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.207 2.203 . . . . 73.55 108.692 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -131.48 -35.17 1.33 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 116.979 -1.486 . . . . 74.01 114.119 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.67 -60.4 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 121.872 2.124 . . . . 74.44 112.214 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.86 -32.58 73.95 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.519 -0.738 . . . . 73.33 110.721 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -57.09 -59.23 5.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.033 -1.099 . . . . 73.54 108.033 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -39.65 95.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.589 1.156 . . . . 74.12 109.691 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -56.05 -58.03 9.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.758 1.163 . . . . 65.35 111.658 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.95 -42.99 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.83 0.852 . . . . 74.53 110.106 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.21 -47.64 84.6 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.523 -0.751 . . . . 75.41 109.96 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.7 t -58.53 -49.6 76.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.139 -1.06 . . . . 73.34 108.139 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.49 73.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.98 0.809 . . . . 73.02 112.771 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.74 -39.25 84.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 O-C-N 120.535 -1.353 . . . . 74.21 112.17 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.8 -42.13 82.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 O-C-N 120.762 -1.211 . . . . 73.05 108.897 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -67.07 -32.36 73.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.7 1.136 . . . . 74.55 110.96 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.0 -47.49 24.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.238 -0.411 . . . . 72.04 110.529 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -78.49 -44.03 25.49 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.591 1.701 . . . . 75.11 115.591 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.73 72.86 81.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.598 1.959 . . . . 75.31 109.789 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.41 -26.09 76.51 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.433 2.089 . . . . 72.35 111.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.37 12.07 17.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.161 -0.447 . . . . 75.2 111.564 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -123.46 139.07 54.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.737 1.153 . . . . 73.42 108.213 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -107.18 143.83 27.92 Favored Pre-proline 0 C--O 1.249 1.026 0 C-N-CA 123.703 0.801 . . . . 74.51 110.374 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.52 117.37 3.38 Favored 'Trans proline' 0 C--N 1.355 0.903 1 C-N-CA 125.888 4.392 . . . . 75.33 112.885 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 146.91 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.397 1.079 . . . . 74.01 110.611 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.16 135.41 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 104.459 -2.423 . . . . 73.11 104.459 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -123.13 111.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.443 -1.688 . . . . 71.51 106.443 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -128.13 150.42 49.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.195 0.452 . . . . 75.53 110.788 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.76 132.91 34.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.019 -0.734 . . . . 74.13 109.019 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.83 116.86 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.72 -1.585 . . . . 75.24 106.72 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 m -53.76 125.34 18.08 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.8 0.727 . . . . 65.43 109.683 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.97 -3.18 35.58 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.285 1.421 . . . . 72.15 112.642 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.8 m -89.92 127.69 36.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.9 1.35 . . . . 71.35 108.288 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.57 -18.87 62.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 118.453 -0.784 . . . . 75.12 111.708 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.46 156.51 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.065 0.848 . . . . 75.35 111.158 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.0 m -52.28 125.76 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.656 0.782 . . . . 73.21 109.996 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.38 172.47 9.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.603 1.161 . . . . 74.44 108.876 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -125.85 150.88 31.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 123.766 0.826 . . . . 75.4 110.415 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.34 165.37 24.63 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.788 -1.56 . . . . 52.45 106.788 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE3' ' SD ' ' A' ' 4' ' ' MET . 1.0 OUTLIER -74.76 105.75 5.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.03 -1.841 . . . . 74.3 106.03 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -134.11 163.74 28.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.873 0.844 . . . . 75.0 112.508 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -105.55 106.95 17.69 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 103.001 -2.962 . . . . 75.33 103.001 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.04 127.05 37.37 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.604 -1.628 . . . . 74.31 106.604 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.45 112.55 21.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.897 1.679 . . . . 65.25 108.092 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.39 142.83 27.7 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-N 119.565 1.075 . . . . 62.15 110.525 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.91 132.32 21.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.317 2.012 . . . . 75.12 108.698 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -58.73 -12.61 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.441 1.897 . . . . 71.21 113.123 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.99 -34.46 50.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 60.22 114.141 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 170.49 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.734 1.012 . . . . 75.34 113.734 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -102.63 167.35 9.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.998 1.719 . . . . 73.32 112.529 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.23 -35.87 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.965 0.906 . . . . 74.31 109.247 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.25 91.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.901 0.773 . . . . 75.13 110.362 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -63.85 -45.76 88.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.746 -0.835 . . . . 75.5 108.746 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.64 -48.91 79.79 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.8 -0.444 . . . . 75.13 109.8 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.9 ttt -55.89 -51.98 65.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.365 1.466 . . . . 74.41 110.114 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -58.27 -41.64 84.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.727 0.811 . . . . 73.5 109.042 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.1 mt -66.87 -45.2 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 120.828 1.649 . . . . 75.32 109.323 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.59 -50.81 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 120.588 1.54 . . . . 61.24 110.554 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -31.91 73.12 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.161 -0.962 . . . . 74.33 111.531 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -68.95 -48.51 63.03 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.537 -0.542 . . . . 74.42 109.537 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -59.98 -51.38 69.89 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 126.926 2.091 . . . . 75.42 111.51 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.23 3.65 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 122.379 -0.2 . . . . 74.5 110.961 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 44.24 63.34 1.67 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 126.849 2.06 . . . . 74.14 109.503 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.22 111.19 5.98 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.993 -1.114 . . . . 75.22 107.993 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.71 165.43 27.67 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 125.177 3.918 . . . . 75.51 114.309 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -26.67 67.66 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.356 0.662 . . . . 62.24 111.411 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.64 -47.07 79.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.347 0.869 . . . . 70.31 113.347 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -100.3 165.35 11.51 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.169 0.895 . . . . 73.4 113.158 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.05 -178.63 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.596 1.958 . . . . 74.51 107.148 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 tp -137.47 135.55 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.664 -1.606 . . . . 74.11 106.664 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.79 130.25 33.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.705 -1.591 . . . . 74.21 106.705 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.43 146.32 40.77 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.084 1.754 . . . . 74.41 107.821 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.62 128.28 19.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.893 1.277 . . . . 73.03 108.501 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.23 123.83 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 107.632 -1.248 . . . . 70.44 107.632 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 47.92 38.27 8.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.11 0.964 . . . . 74.01 111.813 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 23.05 11.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.272 1.429 . . . . 72.15 112.947 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 162.8 21.32 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.978 1.711 . . . . 62.31 112.352 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.14 103.46 12.07 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.823 2.449 . . . . 75.32 106.901 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.37 123.68 7.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.75 2.3 . . . . 74.4 111.887 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.81 127.62 32.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.569 -1.271 . . . . 71.42 107.569 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.4 p -57.23 -28.44 62.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.246 1.419 . . . . 75.14 112.881 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.1 t -85.24 -4.79 59.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.387 1.475 . . . . 53.33 112.064 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.5 tp -76.51 143.93 40.11 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.439 -1.413 . . . . 74.04 107.632 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 m -84.85 152.42 23.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.456 -0.572 . . . . 74.31 109.456 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.64 -51.89 67.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.149 0.98 . . . . 74.14 110.198 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.63 -45.02 60.23 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.528 0.604 . . . . 73.13 111.655 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -66.97 -49.11 66.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.63 0.772 . . . . 72.11 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.91 -42.39 97.96 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.641 -0.662 . . . . 73.01 110.476 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.07 -57.89 8.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.949 1.699 . . . . 75.0 109.455 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.07 -27.69 69.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 118.56 -0.733 . . . . 73.01 112.868 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -38.85 12.75 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.863 -1.065 . . . . 74.43 113.118 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -88.02 -8.78 55.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 117.838 -1.077 . . . . 42.1 113.123 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -33.32 120.83 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.399 1.629 . . . . 74.12 115.399 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.84 177.21 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.057 1.743 . . . . 72.42 109.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -35.1 56.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.025 -1.672 . . . . 73.4 112.056 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -95.62 10.9 35.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.747 1.219 . . . . 74.42 111.786 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.73 60.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.462 1.506 . . . . 74.11 115.151 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -105.07 163.67 12.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.031 1.415 . . . . 64.42 109.133 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.9 tp -120.67 134.81 55.25 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.352 0.661 . . . . 75.22 109.709 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.71 121.91 37.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.889 0.876 . . . . 74.44 108.982 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.07 137.9 54.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 107.826 -1.176 . . . . 75.25 107.826 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.06 152.1 29.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.224 1.01 . . . . 64.42 108.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -140.24 161.19 38.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.556 0.947 . . . . 75.31 113.556 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.4 t -159.05 173.35 16.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.956 1.702 . . . . 72.43 108.947 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.24 17.26 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.65 2.548 . . . . 74.1 112.493 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 C--O 1.235 0.329 0 C-N-CA 126.326 1.85 . . . . 75.23 109.196 -178.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 119.308 -0.377 . . . . 71.43 111.545 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 62.9 m95 58.15 66.03 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.209 1.404 . . . . 72.34 110.362 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -83.98 136.12 14.49 Favored Glycine 0 C--N 1.344 0.996 0 O-C-N 121.535 -0.728 . . . . 73.32 111.387 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.35 125.28 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.46 1.904 . . . . 72.12 107.722 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -139.88 130.03 25.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.283 1.033 . . . . 75.34 108.249 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.14 127.11 52.75 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.201 -0.937 . . . . 73.05 110.579 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.48 117.52 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 125.05 1.34 . . . . 71.43 107.812 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 22.8 p -162.15 126.39 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 104.943 -2.243 . . . . 51.44 104.943 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.135 2.174 . . . . 74.12 111.899 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 17.1 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.787 -0.82 . . . . 72.51 108.787 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.477 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . 164.63 169.19 27.89 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.031 -2.028 . . . . 71.4 108.031 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -103.21 105.51 15.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.894 0.854 . . . . 72.54 109.143 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tpt -55.97 -46.74 78.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 113.941 -1.481 . . . . 75.24 109.35 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -59.01 -50.32 74.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.046 0.938 . . . . 75.31 111.747 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -65.05 -27.31 68.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.549 1.539 . . . . 75.12 111.672 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.67 -47.94 28.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.536 -0.913 . . . . 74.41 108.536 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -74.95 0.15 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.58 1.152 . . . . 72.55 113.086 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -158.98 122.26 3.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 105.815 -1.92 . . . . 72.44 105.815 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -130.73 -65.14 0.8 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.66 -1.162 . . . . 74.12 112.686 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.5 mt -39.85 -57.12 1.64 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.562 1.689 . . . . 74.44 115.562 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.38 -52.71 51.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.254 -0.904 . . . . 72.12 110.073 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' HH21 ' A' ' 14' ' ' ARG . 6.6 t60 -54.37 -55.22 30.8 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.315 1.446 . . . . 75.51 111.39 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.543 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.0 mmp_? -58.53 -39.88 81.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 116.495 -1.717 . . . . 71.31 109.031 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -60.64 -55.38 33.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.246 1.384 . . . . 71.34 111.26 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.67 -47.88 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 117.974 0.352 . . . . 74.53 111.267 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -62.08 -39.88 93.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.626 -0.702 . . . . 72.21 110.805 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 t -59.73 -46.78 88.09 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.56 -1.274 . . . . 74.24 107.56 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.63 86.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.487 1.039 . . . . 72.02 112.251 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.23 -47.71 83.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.321 0.51 . . . . 73.24 110.747 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.13 -42.36 96.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 C-N-CA 123.923 0.889 . . . . 74.43 110.322 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -67.6 -40.26 84.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.955 1.252 . . . . 75.42 109.29 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.07 68.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.771 -0.58 . . . . 62.34 111.053 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -77.55 -46.72 21.44 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.599 0.963 . . . . 74.14 113.599 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -119.94 71.95 16.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.305 1.842 . . . . 75.33 111.024 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.28 -25.4 49.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.139 1.893 . . . . 75.32 112.644 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.21 11.92 21.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.488 0.715 . . . . 61.24 111.265 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -115.92 158.76 22.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.318 1.417 . . . . 74.14 109.539 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 m -119.68 129.92 25.11 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.621 1.568 . . . . 72.41 108.171 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.76 111.66 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.18 3.92 . . . . 74.32 112.694 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.12 151.45 20.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.306 1.442 . . . . 75.3 111.206 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.58 133.39 68.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 103.166 -2.901 . . . . 74.13 103.166 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.31 121.77 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.362 -0.828 . . . . 74.25 110.516 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.6 151.09 46.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.191 0.905 . . . . 73.34 111.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 123.46 31.75 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.764 1.626 . . . . 73.54 108.931 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.58 128.55 33.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.81 -1.552 . . . . 71.12 106.81 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 p -61.95 147.63 46.32 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.905 0.859 . . . . 73.14 112.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.91 -20.68 45.93 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 116.375 -2.347 . . . . 74.32 116.415 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 160.9 25.06 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 122.041 2.921 . . . . 75.53 110.668 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -72.86 -13.0 61.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.953 2.205 . . . . 71.25 116.953 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.07 162.59 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 120.595 1.543 . . . . 74.11 114.548 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.2 152.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.173 1.389 . . . . 73.33 109.578 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -81.1 169.15 17.79 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.016 0.526 . . . . 74.42 111.417 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -125.61 142.0 43.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.961 1.305 . . . . 75.45 111.485 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.12 161.49 30.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.889 2.076 . . . . 71.44 107.986 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -84.2 98.26 9.84 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.768 -2.308 . . . . 75.31 104.768 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -136.02 159.13 42.64 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.763 0.71 . . . . 73.23 111.459 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -106.25 99.01 8.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.583 1.553 . . . . 72.44 107.064 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.43 120.76 26.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.922 0.889 . . . . 70.44 110.337 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.79 105.46 14.69 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.972 1.309 . . . . 73.43 108.021 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.51 143.16 27.23 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-O 118.227 -0.892 . . . . 72.53 112.143 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.16 138.82 57.92 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.369 2.046 . . . . 73.44 110.329 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.0 p -63.61 -15.75 59.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.803 1.641 . . . . 62.1 112.431 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -75.07 -35.59 61.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.027 1.731 . . . . 74.11 113.712 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.06 165.54 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.866 0.841 . . . . 73.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -99.87 165.35 11.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.783 0.833 . . . . 75.41 110.905 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.25 -35.6 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.676 1.19 . . . . 75.23 108.143 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.77 88.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.966 1.306 . . . . 74.34 110.447 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.97 -45.63 66.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.373 -0.822 . . . . 64.43 110.006 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -59.07 -48.54 81.21 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.858 0.754 . . . . 73.45 109.483 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.2 ttp -55.19 -51.37 66.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.766 0.826 . . . . 75.02 109.949 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.96 -38.94 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.432 -0.318 . . . . 75.54 110.436 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.0 mt -66.38 -43.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 116.997 -1.477 . . . . 74.4 110.367 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.86 -50.81 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.636 1.562 . . . . 74.41 108.417 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -61.93 -39.62 92.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.91 -0.716 . . . . 75.13 112.616 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -66.93 -40.39 87.58 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.246 0.93 . . . . 74.14 110.392 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.43 -47.24 86.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 121.348 -0.845 . . . . 71.42 110.054 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -81.48 -1.24 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.837 0.68 . . . . 74.51 112.837 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 57.5 58.04 4.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.346 2.258 . . . . 74.55 112.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.27 108.13 2.55 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.073 0.949 . . . . 75.23 111.644 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.08 156.67 64.4 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 62.4 111.296 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.1 m -63.29 -13.97 44.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.696 -0.668 . . . . 74.44 112.463 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -37.37 76.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.863 1.21 . . . . 71.55 109.686 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -103.25 164.25 11.75 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.508 1.049 . . . . 73.41 111.059 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.18 170.79 7.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.044 1.738 . . . . 64.41 106.843 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 tt -151.62 129.78 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.915 -1.143 . . . . 75.22 107.915 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.26 147.76 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.889 1.275 . . . . 75.44 109.145 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.9 mt -114.16 154.59 27.57 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.152 1.381 . . . . 71.13 109.435 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -145.15 139.83 27.54 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.797 1.239 . . . . 72.44 108.533 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.37 128.81 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 106.035 -1.839 . . . . 74.13 106.035 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 45.96 37.13 3.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.447 1.022 . . . . 75.22 112.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.0 tptt 68.02 22.1 8.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.571 0.952 . . . . 74.21 113.571 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 p -127.28 162.16 26.89 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.985 1.714 . . . . 63.24 111.191 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.56 108.01 53.78 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 104.096 -2.557 . . . . 73.3 104.096 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.09 148.72 51.08 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.877 1.718 . . . . 74.4 111.881 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.41 117.97 16.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.94 1.296 . . . . 73.11 108.329 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 p -51.28 -38.79 54.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.134 1.373 . . . . 70.12 112.953 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -74.36 -12.36 60.5 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.755 1.02 . . . . 72.1 113.755 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.61 150.62 47.77 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.552 -1.343 . . . . 73.12 109.631 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.92 26.57 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.162 0.985 . . . . 60.43 110.798 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.8 mmt -57.2 -47.33 81.55 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.841 0.856 . . . . 74.33 111.063 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.58 96.59 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.526 -0.597 . . . . 71.41 113.138 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -67.76 -51.0 54.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.948 0.874 . . . . 75.31 110.508 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.47 -35.84 80.61 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.068 -0.716 . . . . 74.44 109.068 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -66.26 -57.19 8.09 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.428 -0.796 . . . . 72.53 108.906 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.7 -41.97 87.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.43 1.013 . . . . 74.32 112.734 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -32.9 65.48 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 118.398 -0.811 . . . . 73.03 111.73 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.59 7.09 44.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.071 0.85 . . . . 73.41 112.584 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.29 119.54 3.04 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 126.783 2.033 . . . . 74.43 109.13 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.54 175.69 9.59 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.725 0.639 . . . . 72.13 112.725 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.15 -25.41 61.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.172 1.389 . . . . 75.34 110.498 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.42 4.98 39.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.215 1.806 . . . . 73.23 111.248 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.23 28.93 69.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.511 -1.16 . . . . 72.41 114.78 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -123.78 168.62 12.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.352 1.576 . . . . 72.04 109.125 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tp -122.02 139.97 53.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.511 1.124 . . . . 75.31 110.58 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -113.84 115.72 28.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.305 1.442 . . . . 74.34 109.489 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.54 131.53 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 O-C-N 120.746 -1.221 . . . . 72.45 108.592 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.59 151.83 31.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.983 -1.117 . . . . 74.34 107.983 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -131.04 154.42 48.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.607 0.363 . . . . 74.55 110.588 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.8 m -140.39 155.1 46.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.489 -0.93 . . . . 61.02 108.489 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.28 27.07 13.2 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.69 1.138 . . . . 73.4 111.509 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -143.8 152.32 41.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.341 2.656 . . . . 72.33 106.473 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -89.3 -28.21 20.02 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.114 0.566 . . . . 63.32 111.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.92 108.59 14.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.987 -1.486 . . . . 74.41 106.987 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -79.74 7.85 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.324 1.45 . . . . 74.3 111.888 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 104.417 -3.473 . . . . 63.33 104.417 -178.296 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.027 -1.229 . . . . 74.23 110.027 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 40.72 60.73 1.85 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.399 1.88 . . . . 72.22 112.065 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 70.8 mtm -82.73 48.17 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.759 0.824 . . . . 72.53 109.147 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.16 52.54 0.13 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 130.21 3.404 . . . . 74.55 110.082 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 37.0 pt -49.66 144.33 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.453 1.501 . . . . 63.3 111.266 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 1.4 pp -73.39 -0.43 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.046 0.539 . . . . 71.43 111.646 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -102.16 26.55 7.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.328 2.251 . . . . 75.45 113.463 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -54.28 124.01 14.59 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.529 1.058 . . . . 70.34 109.183 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.53 -59.42 2.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.289 0.95 . . . . 74.41 108.562 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.75 122.29 28.91 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 105.483 -2.043 . . . . 74.42 105.483 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.58 -61.92 1.67 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.24 1.941 . . . . 71.2 116.24 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 73.2 m95 67.43 65.0 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.539 1.518 . . . . 73.44 112.106 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.23 139.08 19.4 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.91 -1.276 . . . . 72.33 109.91 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.43 134.7 28.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 118.444 1.122 . . . . 75.13 111.317 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -140.7 114.4 8.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.313 0.645 . . . . 74.35 111.582 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.56 120.03 24.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 105.544 -2.021 . . . . 74.25 105.544 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.4 142.38 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.404 0.682 . . . . 75.4 109.621 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.7 p -161.95 149.0 14.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.646 1.578 . . . . 74.11 107.777 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.356 2.262 . . . . 74.51 105.379 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tpt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.248 -0.649 . . . . 75.01 109.248 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.65 136.16 0.31 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.788 1.185 . . . . 65.0 114.197 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -106.92 105.77 15.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.176 0.99 . . . . 65.34 109.437 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -45.68 75.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.423 0.63 . . . . 74.11 110.845 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -60.07 -42.35 94.37 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.53 -0.731 . . . . 75.42 112.208 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -70.3 -32.02 69.61 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.043 0.537 . . . . 72.23 109.909 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.14 -47.94 69.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.279 -1.008 . . . . 72.52 108.279 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -71.1 -76.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.422 1.889 . . . . 72.22 111.485 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.94 126.24 3.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.695 1.198 . . . . 64.02 108.101 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -124.02 -65.6 1.05 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 116.562 -1.685 . . . . 63.21 112.664 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 tp -42.46 -58.33 2.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.457 1.481 . . . . 74.42 114.159 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -60.16 -52.05 66.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.562 0.696 . . . . 72.34 110.632 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.1 -49.1 69.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.318 1.847 . . . . 74.14 111.599 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -39.82 91.61 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.018 1.727 . . . . 64.34 109.458 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.3 m -61.42 -47.18 86.93 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.656 1.116 . . . . 62.14 110.753 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.21 -47.29 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.04 -1.038 . . . . 73.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.29 -52.0 67.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.76 1.224 . . . . 71.25 111.615 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 t -61.04 -48.4 81.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.873 0.869 . . . . 73.3 109.926 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.87 -47.74 73.85 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.147 0.885 . . . . 62.23 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.04 -41.61 77.44 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.53 -0.731 . . . . 74.43 111.552 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.47 -41.33 92.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.008 -0.996 . . . . 72.53 108.947 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -63.45 -41.44 98.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 120.284 1.402 . . . . 73.14 108.473 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.22 72.74 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.452 0.538 . . . . 62.35 112.452 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -76.82 -46.21 25.72 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 114.191 1.182 . . . . 74.22 114.191 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -133.79 79.22 58.85 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 125.02 1.328 . . . . 64.25 111.101 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 -20.38 47.96 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.525 1.484 . . . . 73.11 109.675 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.47 12.33 16.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.971 1.308 . . . . 62.44 112.4 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -127.75 141.41 51.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 119.196 0.907 . . . . 72.24 108.672 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.32 137.29 19.88 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 70.14 108.01 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.76 111.93 2.59 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.671 3.581 . . . . 74.24 113.843 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.89 135.6 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.458 1.103 . . . . 51.03 110.65 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.86 115.14 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 104.454 -2.424 . . . . 71.55 104.454 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.56 126.79 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.629 1.172 . . . . 73.44 109.284 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.82 149.13 48.86 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.378 1.071 . . . . 74.32 109.651 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -83.73 141.15 31.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.234 -1.025 . . . . 73.14 108.234 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.23 124.55 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 103.093 -2.929 . . . . 45.43 103.093 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.0 141.24 54.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.646 -0.659 . . . . 72.23 110.283 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.0 -1.84 78.44 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 116.13 -2.483 . . . . 61.34 113.655 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -83.95 145.07 28.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 121.575 2.688 . . . . 71.12 109.283 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.03 -20.16 64.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.976 1.71 . . . . 70.32 112.108 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.59 158.23 3.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.321 1.057 . . . . 70.22 113.441 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.52 134.54 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.129 -1.804 . . . . 74.34 106.129 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.24 171.98 14.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.859 1.664 . . . . 74.24 109.058 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 tt -126.64 152.02 33.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 123.742 0.817 . . . . 75.22 110.431 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.43 161.53 27.91 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.022 1.329 . . . . 73.05 109.141 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -77.89 91.05 4.13 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -131.34 151.92 51.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 106.548 -1.649 . . . . 72.41 106.548 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -99.98 106.35 18.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.729 -1.211 . . . . 73.21 107.729 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -87.98 121.07 29.95 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 122.401 1.096 . . . . 74.01 113.072 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.92 112.52 24.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.762 2.025 . . . . 73.1 108.246 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 m -111.34 142.03 25.62 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.074 -0.965 . . . . 75.23 110.704 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.02 139.25 38.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 120.86 1.343 . . . . 63.14 110.889 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 p -65.57 -12.77 56.04 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.85 1.26 . . . . 62.32 112.145 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.88 -35.37 43.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.166 1.786 . . . . 70.12 113.965 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -74.53 170.24 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.957 0.884 . . . . 73.43 111.444 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 p -97.8 162.84 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.896 1.278 . . . . 65.25 111.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.21 -35.28 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.368 1.067 . . . . 74.24 108.129 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.31 90.25 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.82 0.848 . . . . 63.3 109.682 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -62.95 -46.06 89.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.182 -0.673 . . . . 75.03 109.182 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.38 -51.08 71.46 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.983 -0.377 . . . . 65.43 109.983 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.42 -47.99 72.15 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.596 1.158 . . . . 74.14 109.619 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -59.79 -44.67 93.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.594 -0.521 . . . . 75.34 109.594 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.6 mt -62.95 -40.28 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.63 -1.176 . . . . 74.14 109.453 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.17 -50.15 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.955 1.707 . . . . 74.24 108.906 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -63.66 -35.25 79.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.787 0.722 . . . . 75.42 111.16 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -66.89 -43.61 82.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.794 0.724 . . . . 73.54 109.198 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.59 -49.16 78.64 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.866 1.266 . . . . 75.14 111.341 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -80.39 0.65 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.026 0.204 . . . . 71.32 110.781 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 49.46 64.4 1.76 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.618 1.967 . . . . 73.43 110.016 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.14 111.39 7.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.296 1.438 . . . . 73.32 111.01 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.66 152.9 69.91 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.998 2.465 . . . . 75.12 109.94 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 m -62.2 -15.38 46.12 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.809 1.04 . . . . 74.24 113.809 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.16 -32.07 66.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.516 0.726 . . . . 73.25 110.431 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.37 164.33 11.71 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 122.073 0.94 . . . . 72.14 109.861 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.28 4.79 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.934 1.694 . . . . 74.2 107.49 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 tp -139.63 138.23 39.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.99 -1.855 . . . . 63.22 105.99 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -144.08 133.14 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.371 1.469 . . . . 75.34 107.17 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.5 mt -114.61 151.42 33.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.407 1.083 . . . . 64.45 108.172 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.0 142.49 29.83 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.709 1.204 . . . . 75.44 109.565 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.66 124.8 20.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 117.148 -1.406 . . . . 75.21 107.347 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 46.35 38.45 5.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 120.358 1.435 . . . . 72.03 110.882 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt 64.57 18.68 11.5 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.286 -1.509 . . . . 71.15 113.588 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 p -119.48 162.76 18.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.435 2.294 . . . . 74.24 111.234 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 t -101.39 107.84 52.61 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.97 1.308 . . . . 73.02 107.966 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.17 140.49 45.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.158 2.572 . . . . 74.3 109.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -77.63 121.81 24.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.506 0.722 . . . . 73.24 110.945 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.1 p -52.58 -35.45 54.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.758 1.223 . . . . 74.31 114.159 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -77.84 -17.3 57.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.624 0.972 . . . . 74.4 113.624 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.14 149.81 49.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.803 1.183 . . . . 73.44 109.787 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.6 p -85.98 152.38 22.98 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.767 0.794 . . . . 71.54 109.722 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.4 mmt -56.12 -43.43 78.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.181 0.992 . . . . 73.4 112.032 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.62 -36.8 83.95 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.563 -1.132 . . . . 75.44 113.288 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -66.49 -49.14 67.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.213 1.506 . . . . 74.43 107.739 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.07 -43.1 95.68 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.859 0.864 . . . . 72.31 110.102 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -59.55 -54.46 46.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.313 1.845 . . . . 74.11 108.991 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.14 -43.35 99.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.098 -0.641 . . . . 73.45 112.69 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -32.38 60.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.895 1.072 . . . . 74.14 113.895 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -100.44 0.89 40.62 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.23 1.196 . . . . 74.24 114.23 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.49 121.54 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.635 1.574 . . . . 74.52 112.384 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.15 175.51 7.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.712 0.405 . . . . 73.54 109.978 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.64 -34.03 66.9 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.888 -1.133 . . . . 75.32 110.827 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.23 10.39 29.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.457 1.903 . . . . 45.34 112.186 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.97 -1.2 1.39 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.848 2.642 . . . . 61.41 114.264 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.42 170.83 15.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.023 1.411 . . . . 72.23 111.073 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.68 136.75 54.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.78 0.832 . . . . 74.25 111.075 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -122.18 122.91 40.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.889 1.676 . . . . 74.05 109.898 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.17 137.51 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.693 -1.254 . . . . 71.32 109.461 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.16 147.62 32.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.746 -1.205 . . . . 75.33 107.746 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.85 152.44 48.51 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.315 0.646 . . . . 61.42 110.641 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 t -147.29 163.55 36.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.495 0.718 . . . . 62.44 109.895 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.86 17.22 22.84 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.896 1.712 . . . . 55.22 113.654 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.69 150.61 42.08 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.076 1.75 . . . . 73.54 109.201 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -92.43 -13.63 29.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.731 1.212 . . . . 62.44 111.484 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 p -129.53 109.57 11.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.983 1.313 . . . . 63.42 111.264 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -97.07 9.55 41.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.375 2.27 . . . . 74.24 111.381 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.922 0 N-CA-C 106.624 -2.59 . . . . 73.24 106.624 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.43 0 N-CA-C 108.441 -1.864 . . . . 74.21 108.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -149.06 176.51 10.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.329 1.052 . . . . 43.11 109.322 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.3 36.77 3.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.761 1.624 . . . . 73.42 110.848 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.54 51.81 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 63.14 108.379 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 40.6 pt -59.22 157.9 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 120.795 -1.19 . . . . 73.5 110.122 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 5.2 mp -64.45 -51.74 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.734 -1.58 . . . . 73.23 106.734 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -74.51 54.1 0.57 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.904 2.082 . . . . 73.23 111.108 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.37 129.63 28.98 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.421 -1.326 . . . . 75.2 107.421 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.45 -73.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.818 1.647 . . . . 75.01 113.151 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -77.98 136.17 37.93 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 108.208 -1.034 . . . . 75.31 108.208 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -62.73 1.43 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 128.08 2.552 . . . . 62.14 115.902 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 59.4 m95 51.96 52.21 14.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.883 1.673 . . . . 75.11 111.984 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.48 130.49 9.82 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.789 -1.194 . . . . 75.11 111.498 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.78 132.39 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.956 1.702 . . . . 72.44 110.992 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.96 141.48 36.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.959 2.104 . . . . 71.42 110.961 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.15 124.02 37.9 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.061 -1.089 . . . . 72.05 108.061 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.97 109.97 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.678 1.191 . . . . 74.54 109.129 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 160.1 40.96 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.659 1.184 . . . . 74.32 110.694 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.277 1.031 . . . . 73.11 108.564 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 mtm . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 110.502 -0.184 . . . . 73.23 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.6 61.67 0.25 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 106.961 -2.456 . . . . 74.44 106.961 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -74.84 119.26 18.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.985 0.914 . . . . 63.22 112.099 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -35.19 77.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.22 -0.289 . . . . 72.21 110.22 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.68 -45.77 91.09 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.915 -1.116 . . . . 64.13 109.992 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -65.22 -33.98 77.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.842 0.857 . . . . 75.43 110.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.75 -45.29 92.68 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.023 0.929 . . . . 60.25 108.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.09 -75.48 0.3 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.146 0.978 . . . . 72.11 112.87 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 133.35 6.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.467 1.507 . . . . 74.32 109.504 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.4 t -130.65 -53.29 1.08 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.787 -1.101 . . . . 51.44 109.551 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 tp -49.59 -59.94 3.32 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.232 1.567 . . . . 73.41 115.232 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.63 -58.87 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.249 0.931 . . . . 75.12 110.847 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' HH21 ' A' ' 14' ' ' ARG . 2.0 t-160 -50.6 -50.33 54.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.885 1.674 . . . . 71.15 111.892 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.436 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.8 mmp_? -70.27 -42.04 72.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.721 -1.862 . . . . 73.41 110.734 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.14 -54.45 39.41 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.22 1.373 . . . . 75.25 110.015 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -47.64 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.027 1.331 . . . . 72.33 111.476 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.0 -42.59 99.89 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.85 -0.595 . . . . 71.11 109.837 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -55.34 -48.18 74.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.277 1.031 . . . . 74.14 108.681 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.62 72.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 0.598 . . . . 72.24 111.864 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.67 -45.61 91.99 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.971 -0.456 . . . . 73.42 110.887 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.4 -41.44 89.89 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 108.52 -0.919 . . . . 65.24 108.52 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -67.57 -29.82 69.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.39 1.45 . . . . 71.42 110.648 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.36 -47.44 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.681 -0.637 . . . . 72.22 110.076 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.99 -46.51 29.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.935 0.717 . . . . 73.12 112.935 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.91 73.65 70.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.773 2.029 . . . . 75.44 110.492 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -18.37 47.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.162 2.575 . . . . 74.25 111.831 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.52 14.03 31.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.712 1.205 . . . . 75.14 111.839 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -123.53 152.37 41.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.77 0.828 . . . . 73.44 109.458 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 m -114.51 129.39 24.97 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.577 1.551 . . . . 74.52 108.525 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.66 116.99 3.89 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.22 3.947 . . . . 60.55 112.601 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.72 146.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.759 0.79 . . . . 75.42 109.455 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.36 112.77 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.486 -2.783 . . . . 73.13 103.486 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.33 127.71 61.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.198 -1.408 . . . . 73.23 107.198 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -128.08 143.61 51.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.226 0.611 . . . . 73.31 109.841 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.49 136.5 32.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -68.48 112.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.345 -1.354 . . . . 73.32 107.345 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.05 148.64 2.25 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.366 1.466 . . . . 63.45 111.345 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.23 -20.49 13.3 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 118.471 -1.183 . . . . 60.44 111.93 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -65.16 144.93 56.88 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.96 1.88 . . . . 54.21 110.346 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -70.67 -28.76 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.638 1.575 . . . . 65.21 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 42' ' ' VAL . 5.6 tp -59.79 157.34 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.369 0.668 . . . . 63.21 111.198 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' H ' HD13 ' A' ' 41' ' ' ILE . 33.7 m -63.46 138.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.178 -1.045 . . . . 64.52 108.178 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.82 177.58 6.05 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.927 1.691 . . . . 75.33 110.082 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.97 158.79 35.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.659 1.184 . . . . 73.32 109.936 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -78.92 166.19 22.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 128.278 2.631 . . . . 75.22 109.228 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HE2' ' OD1' ' B' ' 339' ' ' ASN . 9.2 mptt -80.88 80.85 7.28 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 104.009 -2.589 . . . . 71.53 104.009 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -135.04 145.11 47.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.023 -1.843 . . . . 74.42 106.023 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -92.02 144.29 25.6 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.558 1.143 . . . . 75.54 111.745 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.03 116.96 30.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.322 1.449 . . . . 61.13 107.518 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -108.12 110.32 21.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.981 1.313 . . . . 73.42 109.379 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.0 143.55 27.59 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 119.6 1.091 . . . . 71.24 112.808 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.87 138.83 59.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.911 2.407 . . . . 73.15 110.603 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.77 -16.47 58.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.656 -0.652 . . . . 74.53 112.301 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -26.21 59.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.459 1.904 . . . . 61.13 113.7 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.91 170.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 122.11 0.957 . . . . 72.44 111.523 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -107.38 162.15 14.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.491 1.116 . . . . 62.41 109.6 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.3 t -52.36 -37.29 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.083 . . . . 71.54 108.077 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.36 -46.68 73.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.313 1.445 . . . . 74.22 112.225 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -70.47 -44.4 67.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.36 -0.607 . . . . 74.52 109.36 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -58.44 -49.91 75.6 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.962 0.41 . . . . 71.31 109.896 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.6 ttp -62.56 -49.19 76.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.554 -0.736 . . . . 75.51 110.177 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -57.59 -44.49 85.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.455 1.025 . . . . 71.44 111.077 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.9 mt -64.79 -42.96 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.534 -0.913 . . . . 73.11 108.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.6 mt -57.67 -50.08 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.274 1.397 . . . . 75.51 110.07 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.54 -35.2 77.08 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.328 -1.483 . . . . 72.11 111.016 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -70.35 -35.47 73.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.407 0.548 . . . . 74.13 109.717 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -67.02 -45.3 77.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.608 1.563 . . . . 74.31 111.682 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 pt -79.6 -3.39 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 123.667 0.604 . . . . 74.14 110.887 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.72 46.57 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.394 1.077 . . . . 61.12 109.802 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.92 109.28 3.64 Favored Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.369 1.468 . . . . 54.41 110.223 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.58 149.91 56.29 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.975 1.783 . . . . 75.14 108.811 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -61.5 -18.15 57.8 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.507 -0.746 . . . . 72.42 113.007 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -66.33 -26.17 67.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.241 0.928 . . . . 65.31 110.449 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.99 164.89 11.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.062 0.945 . . . . 73.11 109.593 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 166.3 10.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.281 1.433 . . . . 74.41 109.52 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 tt -149.75 113.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 121.254 -0.904 . . . . 72.34 109.698 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -123.42 138.03 54.68 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.449 -1.315 . . . . 74.13 107.449 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.97 149.85 36.7 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.233 1.813 . . . . 74.32 107.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -141.74 133.36 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.41 1.084 . . . . 75.35 109.436 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.44 144.2 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 106.743 -1.577 . . . . 72.41 106.743 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.72 36.45 1.28 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.924 1.29 . . . . 74.42 112.651 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.51 38.21 29.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.235 1.414 . . . . 73.21 110.662 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -147.67 162.22 39.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.8 -1.185 . . . . 74.22 107.8 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.76 114.05 60.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 103.388 -2.819 . . . . 64.42 103.388 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.77 123.95 10.97 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 N-CA-C 107.427 -1.797 . . . . 74.35 107.427 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.96 126.56 27.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.461 -0.57 . . . . 65.45 109.461 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.0 m -45.88 -46.78 16.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 65.25 113.471 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.7 m -77.04 -3.18 37.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.389 1.45 . . . . 74.31 114.692 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.0 tp -67.47 141.17 57.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.691 1.587 . . . . 74.43 106.809 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.1 p -85.52 151.98 23.53 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.705 -0.622 . . . . 64.41 109.544 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 mmt -62.27 -42.13 99.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 118.206 -0.902 . . . . 73.31 113.153 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.33 -47.03 92.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.401 -1.079 . . . . 44.12 110.401 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -61.83 -49.15 77.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.774 0.83 . . . . 75.12 110.181 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.47 -49.31 75.92 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.384 0.674 . . . . 71.31 111.216 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -62.72 -45.53 92.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.629 -1.295 . . . . 73.45 108.915 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.05 -26.06 67.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 120.297 1.408 . . . . 74.23 111.736 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -24.35 20.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 116.911 -1.519 . . . . 73.35 112.335 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -112.36 1.1 15.88 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.877 1.436 . . . . 74.21 114.877 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -46.94 121.5 3.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.936 1.695 . . . . 73.14 112.148 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -80.85 171.51 14.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.544 -1.28 . . . . 73.12 107.544 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.1 -20.6 18.03 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.281 1.832 . . . . 55.01 113.795 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -102.03 13.71 33.98 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.901 1.68 . . . . 75.41 112.222 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.9 31.76 77.31 Favored Glycine 0 CA--C 1.524 0.623 0 O-C-N 120.547 -1.346 . . . . 64.45 114.092 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -129.16 172.94 10.94 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.361 -1.082 . . . . 75.13 108.44 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.12 125.36 45.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.946 -1.131 . . . . 72.34 107.946 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -102.96 120.04 39.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.903 1.281 . . . . 74.25 108.775 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.239 -1.023 . . . . 73.35 108.239 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.31 148.65 40.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.375 1.47 . . . . 71.11 107.628 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -138.12 145.81 42.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.433 0.56 . . . . 75.23 110.443 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 p -143.47 161.5 38.26 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 122.107 0.956 . . . . 74.32 110.228 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.32 13.31 21.26 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.993 -1.643 . . . . 73.32 108.993 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -123.52 124.59 43.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.76 1.624 . . . . 64.34 108.509 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -68.59 -18.02 64.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.285 0.634 . . . . 75.41 111.338 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.9 109.99 10.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.412 1.885 . . . . 75.41 107.637 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.25 9.23 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.813 1.042 . . . . 74.44 113.813 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 126.033 1.778 . . . . 62.43 109.611 179.339 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 CA-C-O 118.76 -1.022 . . . . 65.24 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -145.97 90.27 1.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.896 1.278 . . . . 74.31 108.18 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 65.7 mtt -95.62 70.57 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.072 -1.825 . . . . 64.53 106.072 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -108.15 50.37 0.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.174 1.789 . . . . 75.41 109.053 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 40.0 pt -87.81 152.21 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.156 -0.965 . . . . 75.22 111.489 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 18.4 pt -68.23 -33.65 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 114.892 1.442 . . . . 61.22 114.892 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -81.33 82.74 7.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.45 -0.945 . . . . 75.34 108.45 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.88 135.69 51.47 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.796 -1.187 . . . . 63.41 107.796 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.75 -48.72 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.856 -1.905 . . . . 54.13 105.856 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . 0.426 ' OD1' ' HE2' ' A' ' 46' ' ' LYS . 72.7 m-80 -108.68 113.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.45 2.3 . . . . 73.32 110.416 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -61.21 -51.85 67.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.232 2.213 . . . . 75.14 115.754 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 77.0 m95 60.7 59.2 2.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 74.33 113.045 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.78 129.21 9.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.644 -1.382 . . . . 72.24 109.644 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 55.2 mt -77.31 132.99 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.276 1.538 . . . . 74.31 112.184 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.02 139.81 39.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 73.33 109.183 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.4 tt -98.68 118.78 36.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.869 2.068 . . . . 74.55 107.638 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.41 125.66 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 122.917 0.487 . . . . 74.14 110.636 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.0 p -161.49 149.71 15.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.904 -1.887 . . . . 73.44 105.904 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.489 0.716 . . . . 72.42 110.112 -179.685 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 109.978 -0.378 . . . . 75.34 109.978 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.02 -134.01 4.43 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 124.09 0.852 . . . . 74.25 111.569 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -82.38 124.24 29.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.701 0.8 . . . . 73.25 109.012 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 mmt -58.76 -46.8 86.63 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.729 -1.212 . . . . 53.21 107.729 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -59.86 -43.33 94.72 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.497 -0.763 . . . . 73.23 112.307 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -69.33 -35.91 76.39 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.287 0.949 . . . . 70.13 110.924 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.05 -41.26 91.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.511 -0.552 . . . . 73.42 109.511 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.64 -75.45 0.31 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.745 0.818 . . . . 74.2 111.393 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 119.38 3.23 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.548 -1.649 . . . . 75.45 106.548 177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -104.68 -65.48 1.03 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.51 1.124 . . . . 74.13 112.361 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.61 -58.47 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.072 1.349 . . . . 75.44 112.922 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.76 -58.79 6.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.717 0.636 . . . . 73.54 112.717 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -55.63 -54.97 37.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.0 0.429 . . . . 75.42 111.808 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.33 82.53 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.526 -1.226 . . . . 74.12 110.982 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -61.8 -56.31 20.8 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.621 1.168 . . . . 73.13 112.919 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 -44.79 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 120.669 -1.269 . . . . 64.1 110.124 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.63 -42.76 99.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 117.661 -1.161 . . . . 72.42 110.405 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.5 p -60.49 -45.1 95.0 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.632 1.56 . . . . 63.44 109.423 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.22 74.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.983 0.81 . . . . 74.02 111.95 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.88 -39.84 95.12 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.632 -0.667 . . . . 72.11 111.132 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.47 -41.2 88.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-O 117.584 -1.198 . . . . 71.42 108.539 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -65.83 -39.2 90.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.869 1.668 . . . . 75.34 109.556 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.01 74.76 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.842 -0.743 . . . . 73.34 110.909 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -78.51 -47.05 18.14 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.855 1.798 . . . . 74.3 115.855 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -126.24 70.53 69.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 126.585 1.954 . . . . 63.31 110.647 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.12 -19.47 51.06 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.502 2.134 . . . . 71.41 110.231 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.46 12.92 17.07 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.44 1.096 . . . . 70.24 112.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -129.65 160.7 32.52 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.734 1.614 . . . . 65.12 111.393 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.21 136.97 28.9 Favored Pre-proline 0 C--O 1.247 0.948 0 C-N-CA 124.422 1.089 . . . . 73.21 108.471 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.98 113.7 3.48 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 126.078 4.519 . . . . 64.45 111.683 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.1 144.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.666 0.786 . . . . 73.45 110.477 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -122.6 128.88 75.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 103.861 -2.644 . . . . 75.31 103.861 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.93 119.69 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 127.124 2.169 . . . . 74.44 106.692 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -124.4 146.96 48.57 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.614 1.097 . . . . 75.44 109.051 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -89.35 139.41 30.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.242 0.474 . . . . 73.23 109.905 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.0 130.24 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.568 -1.271 . . . . 74.41 107.568 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 p -61.04 122.04 13.97 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.214 -1.402 . . . . 74.34 107.214 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.93 -13.8 29.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.902 -1.499 . . . . 44.21 112.87 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.54 131.08 35.93 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.503 2.151 . . . . 74.05 106.318 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -63.48 -19.66 64.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.813 0.845 . . . . 73.54 113.012 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 tp -51.74 155.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.817 1.647 . . . . 75.11 112.71 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.16 145.27 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.437 1.095 . . . . 74.3 111.78 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.79 164.24 25.39 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.036 0.534 . . . . 74.21 109.798 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.68 132.72 70.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.455 1.102 . . . . 73.53 112.082 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -67.54 153.6 43.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.996 1.719 . . . . 75.13 107.821 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.69 99.13 3.6 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.327 -1.731 . . . . 71.43 106.327 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -134.41 160.96 36.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.429 -0.952 . . . . 75.05 108.429 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -109.81 103.01 11.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.018 1.727 . . . . 75.14 108.372 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -84.38 125.84 32.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.735 -1.209 . . . . 75.04 107.735 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.74 107.57 18.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.322 -2.103 . . . . 71.24 105.322 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -109.61 143.01 26.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 117.011 -1.471 . . . . 63.52 110.492 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.12 134.73 25.75 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.452 2.768 . . . . 72.14 111.995 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 p -59.63 -17.2 31.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.885 1.274 . . . . 75.55 113.993 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.6 -34.26 60.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.434 1.894 . . . . 75.52 113.213 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.39 167.22 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 119.969 1.259 . . . . 71.22 111.095 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 57.4 p -107.38 166.66 10.48 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.38 1.072 . . . . 75.22 110.712 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.12 -37.94 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.378 1.071 . . . . 74.41 110.085 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.56 93.28 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.238 0.926 . . . . 71.33 111.311 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' NE2' ' H ' ' A' ' 56' ' ' THR . 58.3 mt-30 -65.79 -46.2 79.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.053 0.941 . . . . 75.21 108.572 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.95 -50.66 72.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.697 1.199 . . . . 75.32 110.46 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttp -55.06 -49.07 72.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.61 1.164 . . . . 63.43 110.35 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -57.51 -42.17 82.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.491 -0.559 . . . . 75.32 109.491 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.21 -48.66 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.822 -1.085 . . . . 74.43 110.374 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.28 -50.39 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.794 1.179 . . . . 74.31 110.071 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.0 -36.86 82.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.022 -0.99 . . . . 74.45 111.51 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -71.19 -37.1 72.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.072 1.305 . . . . 74.45 110.673 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.66 -49.53 74.79 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.491 1.516 . . . . 75.0 109.658 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 pt -79.53 0.7 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 119.605 -0.236 . . . . 73.23 111.006 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 50.29 58.41 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.498 1.919 . . . . 71.34 110.039 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 110.14 4.44 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.736 -1.209 . . . . 70.3 107.736 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.07 162.52 39.65 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.112 2.541 . . . . 74.11 112.434 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 m -67.35 -22.33 65.59 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.745 -0.597 . . . . 73.21 110.969 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.66 -34.06 77.01 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.11 0.868 . . . . 63.22 111.697 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -104.15 164.63 11.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.987 1.315 . . . . 71.33 111.726 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 175.13 5.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.413 1.885 . . . . 73.53 106.558 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -144.55 143.1 23.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 74.51 107.542 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -145.49 134.63 22.78 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.78 1.632 . . . . 74.32 108.129 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -114.7 142.26 46.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.988 1.315 . . . . 74.45 109.803 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.59 136.94 36.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.023 1.329 . . . . 74.23 108.766 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.67 125.7 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 104.305 -2.48 . . . . 71.32 104.305 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t70 43.72 42.7 4.46 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.252 1.204 . . . . 72.13 114.252 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? 69.51 18.58 7.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.712 1.605 . . . . 74.11 114.291 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.1 p -124.03 162.57 23.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 120.48 1.491 . . . . 75.22 112.165 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.24 105.12 11.47 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 105.737 -1.949 . . . . 74.55 105.737 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.45 133.75 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.065 1.844 . . . . 71.24 109.844 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -67.57 118.59 11.07 Favored 'General case' 0 C--O 1.227 -0.113 0 O-C-N 121.439 -0.788 . . . . 74.12 109.366 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m -50.56 -39.32 49.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.224 1.01 . . . . 75.14 113.563 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.69 -8.07 59.66 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.052 1.501 . . . . 72.33 115.052 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.47 141.69 50.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.156 1.798 . . . . 72.03 110.307 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.52 143.39 34.92 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.631 -1.248 . . . . 75.35 107.631 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.19 -43.39 70.69 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.208 -0.901 . . . . 73.41 111.09 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.45 -38.0 92.88 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.868 1.213 . . . . 75.02 112.904 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.65 -53.83 16.79 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.513 -0.993 . . . . 64.42 108.808 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.26 -38.32 83.13 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.194 -0.912 . . . . 74.21 110.319 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -61.44 -54.43 43.58 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 117.082 -1.437 . . . . 73.04 107.461 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -55.12 -53.62 53.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.75 1.159 . . . . 62.32 111.925 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -24.93 64.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 117.963 -1.018 . . . . 75.22 113.659 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -105.95 4.32 29.37 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.233 1.379 . . . . 71.33 112.861 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -55.37 120.25 6.82 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.126 1.77 . . . . 74.54 110.041 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.43 172.37 13.05 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.133 -1.062 . . . . 65.31 108.133 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.51 -33.96 68.6 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.774 -1.204 . . . . 73.33 109.926 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -88.35 16.35 6.49 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.734 1.214 . . . . 73.32 112.193 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.2 28.38 66.64 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.361 1.458 . . . . 71.42 116.294 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -119.51 175.74 5.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.445 1.622 . . . . 74.24 111.013 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.68 137.89 54.63 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.161 0.985 . . . . 75.24 110.502 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.84 101.76 8.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.081 1.353 . . . . 73.11 109.97 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.72 122.84 69.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.559 0.695 . . . . 74.21 111.149 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.78 145.86 25.44 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.595 -1.261 . . . . 71.11 107.595 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -128.67 147.42 50.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.459 -0.941 . . . . 75.35 108.459 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 p -144.8 154.8 43.06 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.508 -0.923 . . . . 74.3 108.508 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.74 20.97 14.53 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.983 1.277 . . . . 53.4 110.064 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -135.05 112.71 10.78 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.694 1.598 . . . . 62.2 107.828 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -66.05 -40.92 91.35 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.915 -0.772 . . . . 75.34 108.915 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.29 124.24 38.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.491 -1.67 . . . . 74.3 106.491 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -116.62 9.76 14.23 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.738 1.215 . . . . 75.21 111.702 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.857 0 N-CA-C 107.927 -2.069 . . . . 51.33 107.927 179.386 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.765 -1.334 . . . . 72.0 109.765 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -165.19 106.32 0.79 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.706 -1.22 . . . . 61.32 107.706 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 27.5 mmm -116.43 13.23 15.42 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.774 1.23 . . . . 74.44 110.984 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -67.43 51.46 0.05 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 129.766 3.226 . . . . 75.31 112.978 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 4.5 mt -101.85 160.6 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.427 1.891 . . . . 74.43 107.627 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.14 8.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 126.491 1.917 . . . . 74.42 113.036 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -112.1 7.08 19.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.555 1.542 . . . . 74.5 111.522 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.33 109.21 0.51 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.436 1.494 . . . . 75.44 107.446 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.41 -16.03 29.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.544 0.572 . . . . 75.23 112.544 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -109.91 108.91 19.35 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 105.415 -2.069 . . . . 73.03 105.415 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -77.71 -36.08 51.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.006 0.743 . . . . 75.21 113.006 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 44.5 m95 51.91 59.38 4.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.25 1.82 . . . . 74.22 112.506 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.24 135.54 14.71 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.982 -1.247 . . . . 75.42 109.982 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 82.7 mt -80.61 134.47 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.712 1.756 . . . . 75.53 112.446 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -140.03 133.64 30.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.085 0.954 . . . . 72.41 111.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 73.6 mt -88.27 116.66 26.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.322 -2.103 . . . . 75.44 105.322 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.68 121.81 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.743 -0.836 . . . . 73.21 108.743 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -157.3 128.09 6.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.023 -1.103 . . . . 73.55 108.023 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 105.728 -1.952 . . . . 71.34 105.728 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mmm . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 109.435 -0.579 . . . . 73.41 109.435 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.92 55.93 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.382 -1.087 . . . . 73.44 110.382 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -73.65 114.43 11.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.959 -1.497 . . . . 65.34 106.959 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 mtt -49.64 -46.83 49.96 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.61 0.764 . . . . 63.24 109.749 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -56.65 -44.14 81.01 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.038 -0.982 . . . . 74.33 113.108 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -74.52 -27.72 60.66 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.353 1.061 . . . . 73.23 113.332 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -72.42 -48.16 43.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.515 -0.92 . . . . 64.1 108.515 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -74.73 -77.29 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 124.271 0.982 . . . . 63.14 109.085 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.66 117.85 2.11 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 119.773 -1.83 . . . . 73.52 108.228 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p -112.86 -66.4 1.09 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.839 -1.553 . . . . 74.02 109.428 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 2.0 pp -44.14 -58.13 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.387 1.875 . . . . 71.21 115.299 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 1.3 tp10 -57.59 -58.93 6.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.452 1.901 . . . . 73.44 111.237 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -63.15 -50.73 69.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.913 1.285 . . . . 70.25 111.141 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -40.92 85.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 116.996 -1.478 . . . . 75.15 109.824 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.11 -55.6 20.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.821 1.191 . . . . 74.1 110.117 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.03 -47.71 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.454 0.57 . . . . 74.22 111.031 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' CB ' ' HE2' ' A' ' 48' ' ' LYS . 53.9 mm-40 -65.27 -38.59 90.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.412 -0.804 . . . . 71.42 109.74 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -58.77 -48.44 81.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 120.315 1.416 . . . . 73.42 108.419 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.42 69.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.88 0.764 . . . . 71.31 110.485 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.84 -49.92 70.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.479 -0.296 . . . . 75.43 111.677 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -59.13 -42.02 85.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 124.085 0.954 . . . . 64.24 110.621 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -69.12 -38.89 79.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.686 1.13 . . . . 71.55 109.379 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.49 70.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.591 -0.693 . . . . 64.51 110.468 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -73.2 -46.38 50.8 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 113.153 0.797 . . . . 75.53 113.153 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -129.0 77.75 77.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.857 1.263 . . . . 75.51 109.887 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.42 -28.03 71.03 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.731 2.287 . . . . 74.34 113.581 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.6 13.8 13.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.288 0.949 . . . . 74.21 110.653 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -118.1 152.44 35.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.584 -0.895 . . . . 72.35 108.584 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.61 135.2 24.94 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.52 -1.289 . . . . 73.21 107.52 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.47 114.44 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.293 3.329 . . . . 73.35 114.108 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.84 149.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 O-C-N 120.938 -1.101 . . . . 72.33 109.926 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.6 mm -123.1 115.19 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 103.056 -2.942 . . . . 75.31 103.056 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.08 119.38 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.054 -1.091 . . . . 75.01 108.054 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.48 159.67 37.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.709 1.14 . . . . 63.32 111.616 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.31 153.59 22.47 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.586 -0.696 . . . . 74.15 112.052 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.47 135.32 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.55 -2.389 . . . . 65.31 104.55 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.66 120.97 9.89 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.668 -1.234 . . . . 62.32 107.668 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.32 -11.82 54.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.538 -1.146 . . . . 61.23 112.443 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -69.5 113.27 6.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 103.635 -2.728 . . . . 62.34 103.635 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -72.07 -13.36 61.57 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.411 0.893 . . . . 73.53 113.411 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 tp -62.54 166.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.547 1.139 . . . . 74.24 111.723 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 m -55.68 123.49 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.437 1.095 . . . . 72.51 109.181 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.62 178.16 5.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.795 1.638 . . . . 74.43 110.05 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.11 149.7 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.453 1.101 . . . . 75.22 110.867 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.16 166.07 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.475 1.51 . . . . 64.31 107.26 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.45 103.02 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.562 -1.336 . . . . 75.03 109.448 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -141.44 154.52 45.63 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.136 1.774 . . . . 74.44 109.865 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mtpp -98.97 104.27 16.3 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.964 1.706 . . . . 74.5 108.766 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -84.22 118.23 24.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.766 -1.568 . . . . 72.34 106.766 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.27 116.83 32.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.885 -1.524 . . . . 61.21 106.885 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -111.59 141.25 24.24 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.888 -1.053 . . . . 74.24 110.399 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.27 141.1 35.04 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.333 2.022 . . . . 75.31 108.229 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -65.9 -13.03 58.94 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 114.616 1.339 . . . . 75.22 114.616 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.54 -32.07 24.06 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.417 1.265 . . . . 62.15 114.417 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.37 164.8 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.305 0.957 . . . . 72.42 109.319 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -103.21 165.32 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.443 0.697 . . . . 72.21 110.74 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.81 -35.63 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.037 1.335 . . . . 64.24 109.259 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.89 -46.12 85.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.244 0.929 . . . . 72.25 109.933 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -67.57 -46.41 72.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.573 -0.727 . . . . 73.14 109.919 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.38 -46.97 87.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.513 0.597 . . . . 75.22 110.097 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.4 ttt -55.73 -52.19 64.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.243 1.017 . . . . 74.41 108.982 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -57.29 -40.35 77.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.581 -0.723 . . . . 75.31 110.663 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.73 -44.03 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.127 . . . . 71.11 109.282 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.89 -51.1 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.731 1.605 . . . . 75.54 110.393 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -36.16 82.85 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.672 -0.68 . . . . 75.24 110.904 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -68.07 -43.69 77.99 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.173 0.589 . . . . 72.22 110.689 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -60.23 -51.33 70.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.857 1.663 . . . . 74.12 110.033 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.53 -2.97 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.125 -0.464 . . . . 75.2 111.57 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 50.05 65.4 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.756 2.022 . . . . 73.2 109.532 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.82 115.16 22.05 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.56 0.744 . . . . 74.23 109.252 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.26 164.47 17.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.668 3.579 . . . . 74.41 113.817 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -67.92 -29.52 68.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.368 0.667 . . . . 73.11 111.509 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -62.09 -38.52 89.15 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.061 -0.495 . . . . 75.34 112.237 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.42 164.44 11.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.7 0.762 . . . . 74.43 111.756 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 -178.2 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.976 1.711 . . . . 62.24 107.506 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.2 140.59 22.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.411 1.084 . . . . 74.42 108.26 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -145.34 140.7 27.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.006 -1.479 . . . . 71.43 107.006 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.72 153.14 30.82 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.845 1.658 . . . . 72.44 109.637 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -147.03 132.85 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.525 1.13 . . . . 74.35 108.946 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -126.61 119.6 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 103.121 -2.918 . . . . 64.43 103.121 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 46.77 45.8 14.89 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 124.71 2.195 . . . . 73.52 111.603 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt 56.59 30.38 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.452 -1.405 . . . . 72.53 112.224 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 p -118.64 159.87 22.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.547 -1.649 . . . . 72.34 106.547 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.36 109.58 41.25 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.674 -1.973 . . . . 74.52 105.674 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.38 124.0 13.07 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.093 1.862 . . . . 70.14 110.51 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -73.93 116.03 14.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.641 1.176 . . . . 64.53 109.954 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 83.6 p -49.13 -34.2 13.59 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.083 1.512 . . . . 65.44 115.083 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -82.6 -9.53 59.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.583 0.957 . . . . 65.31 113.583 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -75.19 144.5 42.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.609 1.095 . . . . 74.32 109.732 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.69 150.04 26.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.623 0.769 . . . . 63.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.2 mmt -54.64 -45.42 73.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.473 1.109 . . . . 75.12 111.785 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.15 91.04 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.456 -0.636 . . . . 55.44 113.259 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.5 -52.94 40.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.342 1.071 . . . . 73.52 108.812 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.38 -45.4 76.57 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 124.732 1.213 . . . . 74.33 108.82 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.28 -56.06 26.9 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.02 1.728 . . . . 73.34 109.28 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.31 -43.19 88.05 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.193 0.906 . . . . 74.01 113.298 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -30.71 39.31 Favored 'General case' 0 N--CA 1.46 0.055 0 CA-C-O 117.324 -1.322 . . . . 73.23 112.844 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -97.58 -7.77 30.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.205 1.366 . . . . 74.12 114.266 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -33.38 120.16 0.37 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.968 2.907 . . . . 73.11 114.94 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.01 169.98 17.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.38 -1.341 . . . . 74.12 107.38 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -54.49 -28.75 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.252 1.421 . . . . 73.35 112.674 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -99.52 17.59 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.273 1.029 . . . . 75.24 112.703 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 30.43 74.63 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.325 -0.859 . . . . 62.52 114.632 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -126.28 174.17 8.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.693 1.246 . . . . 73.23 110.35 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 tp -124.62 142.95 50.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.127 -0.94 . . . . 74.24 110.778 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -117.93 116.1 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.473 1.509 . . . . 73.53 107.761 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.21 131.67 72.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 O-C-N 120.469 -1.394 . . . . 74.35 108.243 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.62 24.36 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.951 0.9 . . . . 72.22 109.798 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -139.96 154.49 47.2 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 124.191 0.932 . . . . 75.45 111.301 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -153.77 169.04 24.31 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.931 1.292 . . . . 74.15 108.829 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.34 24.9 10.19 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.397 0.999 . . . . 71.32 113.821 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.46 117.36 18.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.015 1.726 . . . . 72.13 109.247 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.86 -17.05 47.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.153 1.168 . . . . 74.41 114.153 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.862 -1.149 . . . . 75.15 108.749 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -80.9 71.11 7.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 105.335 -2.098 . . . . 74.45 105.335 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 117.609 -1.662 . . . . 50.14 109.672 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 110.884 -0.886 . . . . 71.31 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 48.18 32.0 2.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.409 1.484 . . . . 74.13 111.87 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.31 17.67 0.47 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.506 1.923 . . . . 73.43 111.471 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.01 51.23 0.64 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.047 2.539 . . . . 74.23 110.308 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 46.8 pt -62.74 148.11 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 O-C-N 121.667 -0.645 . . . . 74.31 109.757 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 10.2 mt -75.06 -28.65 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.861 1.265 . . . . 73.14 108.689 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -84.66 61.62 6.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.617 1.567 . . . . 73.52 110.299 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -71.83 130.72 41.76 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.02 -29.82 35.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.929 -1.107 . . . . 75.1 110.707 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -108.73 164.51 12.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.705 -1.247 . . . . 73.24 111.67 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.04 -59.37 2.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.505 0.722 . . . . 72.1 111.161 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.1 m95 52.36 47.43 24.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.99 0.916 . . . . 75.43 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.28 146.31 28.94 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 108.584 -1.806 . . . . 60.41 108.584 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.57 143.98 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 118.661 1.23 . . . . 74.14 111.527 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -148.62 120.81 8.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.524 1.53 . . . . 74.51 109.781 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.45 119.61 22.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.442 -1.318 . . . . 72.52 107.442 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.47 108.61 22.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.661 1.184 . . . . 74.24 108.639 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.7 p -146.24 162.35 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.247 1.819 . . . . 74.14 109.913 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 123.571 0.748 . . . . 73.2 109.752 -179.656 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ptt? . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.085 -0.007 . . . . 75.03 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.6 146.51 10.4 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.52 -1.432 . . . . 74.4 109.52 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -105.56 111.76 24.59 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.966 0.907 . . . . 74.24 109.02 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -46.75 68.91 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 124.206 0.942 . . . . 73.34 109.357 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -57.56 -49.25 76.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.743 0.817 . . . . 75.11 112.524 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.06 -43.99 90.44 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.697 0.799 . . . . 73.42 112.521 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -67.13 -44.35 80.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 123.572 0.545 . . . . 75.24 110.608 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' HB3' ' HD1' ' A' ' 9' ' ' HIS . 0.3 OUTLIER -75.96 -73.25 0.28 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 123.635 0.585 . . . . 71.13 111.448 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.604 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 1.5 p-80 -157.58 119.44 3.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.409 1.004 . . . . 71.34 109.948 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.01 -64.97 0.93 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.653 -1.641 . . . . 75.23 113.588 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.36 -57.82 1.68 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 121.597 1.999 . . . . 65.13 115.374 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -64.5 -52.62 56.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.768 0.794 . . . . 71.05 110.439 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.604 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 2.9 t60 -50.98 -58.99 4.63 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.075 1.75 . . . . 74.13 111.9 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -61.62 -49.43 76.61 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.363 2.665 . . . . 74.2 111.924 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.8 t -57.64 -49.05 77.75 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 118.724 0.693 . . . . 74.34 110.833 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.14 -42.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.331 0.652 . . . . 72.43 110.234 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 18.5 tt0 -60.44 -52.35 65.6 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.52 1.528 . . . . 70.43 110.436 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 t -58.21 -48.03 81.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.189 0.996 . . . . 75.2 108.937 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.42 76.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.25 0.477 . . . . 74.55 111.339 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -60.09 -39.56 86.54 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.35 -0.844 . . . . 74.02 110.332 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.34 -42.18 87.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-O 118.096 -0.954 . . . . 74.44 108.892 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -64.29 -32.52 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 120.515 1.507 . . . . 72.44 109.603 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.71 -47.81 20.77 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.254 0.549 . . . . 73.24 111.45 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -76.85 -46.87 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.859 1.429 . . . . 73.33 114.859 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.79 72.68 78.64 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 127.663 2.385 . . . . 74.43 108.128 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.79 -30.98 93.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.783 2.322 . . . . 75.22 111.326 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -90.92 14.79 12.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.766 0.826 . . . . 72.25 111.928 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 142.85 51.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.492 -1.38 . . . . 74.35 109.611 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.53 142.82 27.28 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.191 0.996 . . . . 73.3 111.779 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.79 118.66 3.84 Favored 'Trans proline' 0 C--N 1.353 0.78 1 C-N-CA 125.496 4.13 . . . . 73.13 114.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 t -125.48 143.85 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.248 1.023 . . . . 73.22 110.09 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mm -119.94 121.19 65.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 100.831 -3.766 . . . . 72.43 100.831 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.58 123.55 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.488 -0.93 . . . . 71.53 108.488 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -134.13 158.71 42.94 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.313 0.578 . . . . 63.02 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -79.12 145.75 33.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.01 0.524 . . . . 75.5 109.798 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.15 113.69 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 101.409 -3.552 . . . . 75.41 101.409 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.0 p -48.51 134.55 15.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.529 0.566 . . . . 72.33 112.529 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.29 -19.38 54.46 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 117.318 -1.823 . . . . 64.32 112.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 t -67.68 146.43 53.81 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.223 2.011 . . . . 73.02 109.937 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -73.7 -19.59 60.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.251 1.421 . . . . 74.44 112.791 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.91 158.14 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.767 -0.457 . . . . 71.12 109.767 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.84 145.48 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 113.738 1.014 . . . . 64.32 113.738 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.99 160.99 17.65 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.637 1.975 . . . . 71.34 111.485 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.53 139.95 50.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.496 1.519 . . . . 75.53 109.545 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.77 159.36 30.38 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.869 -1.16 . . . . 74.22 107.869 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.84 95.05 2.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.586 -1.264 . . . . 73.14 107.586 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -133.09 151.29 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.05 -1.463 . . . . 74.41 107.05 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.5 mttp -99.79 108.25 20.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.472 -1.307 . . . . 75.33 107.472 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.88 119.9 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.448 0.642 . . . . 73.42 111.229 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.85 117.16 32.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.495 -2.039 . . . . 73.53 105.495 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 m -112.91 142.43 27.24 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.266 -1.013 . . . . 74.21 108.266 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.78 138.62 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.324 1.509 . . . . 74.04 110.304 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -15.82 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.622 0.769 . . . . 74.14 111.667 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.73 -34.79 72.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.791 2.436 . . . . 64.4 113.321 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.31 166.5 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.004 -1.06 . . . . 63.42 111.982 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 p -99.87 168.74 9.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.728 0.811 . . . . 75.45 111.815 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.86 -41.24 56.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 125.078 1.351 . . . . 64.33 108.973 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.16 86.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.78 0.718 . . . . 72.01 111.074 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.57 -46.69 81.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.268 -0.642 . . . . 74.41 109.268 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.78 -47.71 84.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.533 0.606 . . . . 73.24 109.745 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.9 ttt -58.41 -46.17 86.98 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.629 1.571 . . . . 74.43 110.775 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -63.13 -44.49 95.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.865 -0.791 . . . . 72.44 108.865 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.24 -40.01 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 117.48 -1.248 . . . . 75.21 108.706 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.12 -50.58 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 120.92 1.691 . . . . 75.42 109.209 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -63.48 -40.48 97.21 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.608 1.094 . . . . 75.11 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -63.49 -46.61 85.35 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.143 0.977 . . . . 73.34 110.593 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -59.97 -49.06 79.15 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.261 1.424 . . . . 73.22 111.473 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -79.93 -0.76 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 123.431 0.457 . . . . 72.02 111.261 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 50.11 68.25 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.688 2.395 . . . . 74.21 109.71 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 111.99 8.97 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.97 1.708 . . . . 71.15 111.098 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.13 157.92 49.91 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.335 2.69 . . . . 73.41 112.313 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.314 0.487 . . . . 71.24 112.314 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.01 -35.98 82.94 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.384 -0.823 . . . . 72.2 109.688 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.66 164.27 11.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.802 1.287 . . . . 74.54 112.33 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.1 177.3 4.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.866 2.467 . . . . 44.42 106.992 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tp -147.06 140.75 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.504 -1.295 . . . . 75.53 107.504 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.31 141.55 28.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.356 1.862 . . . . 73.24 108.833 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.0 mt -114.91 147.45 39.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 75.13 109.348 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -143.82 123.79 13.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.089 -1.449 . . . . 73.23 107.089 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.48 117.4 49.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.235 -1.394 . . . . 74.41 107.235 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t0 43.66 51.13 6.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.097 1.759 . . . . 73.12 111.711 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 63.54 17.9 10.69 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.322 1.449 . . . . 74.23 114.101 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.2 p -121.79 161.52 22.51 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 120.13 1.332 . . . . 75.31 111.02 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.26 110.04 60.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.113 -2.551 . . . . 64.13 104.113 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.65 135.54 33.49 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.446 1.43 . . . . 71.43 111.473 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.92 120.38 18.48 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 107.768 -1.197 . . . . 74.15 107.768 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -53.89 -25.81 21.93 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.123 2.169 . . . . 74.21 114.842 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -92.18 -12.14 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.643 0.777 . . . . 54.23 112.426 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.42 149.61 49.73 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.514 -0.921 . . . . 74.53 108.514 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.04 152.53 21.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.697 0.799 . . . . 74.32 109.489 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.39 -46.36 88.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.582 -0.723 . . . . 75.25 109.867 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.92 96.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.724 0.678 . . . . 65.21 111.793 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -65.19 -51.07 63.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.995 0.918 . . . . 62.23 108.937 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.94 -38.53 88.81 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.946 -0.471 . . . . 74.01 110.855 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -61.89 -52.99 61.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.699 2.0 . . . . 75.53 109.659 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.38 -33.75 73.52 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.686 0.624 . . . . 73.51 112.686 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -26.55 33.82 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 117.555 -1.212 . . . . 74.33 111.724 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -103.95 -2.38 26.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.591 1.087 . . . . 74.45 112.647 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -33.23 121.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 116.324 1.972 . . . . 74.12 116.324 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.14 175.32 6.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.001 0.921 . . . . 63.23 109.688 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -51.76 -39.33 58.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.858 1.663 . . . . 73.31 112.269 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.72 0.35 57.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.603 1.561 . . . . 73.31 112.516 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.93 66.35 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.137 1.351 . . . . 51.43 112.627 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 161.05 16.21 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.546 1.938 . . . . 74.11 108.89 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.2 139.27 54.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.385 0.993 . . . . 75.14 109.937 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.78 132.94 54.45 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.561 1.545 . . . . 73.23 107.619 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.26 146.54 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.45 144.35 44.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.836 -1.172 . . . . 75.12 107.836 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -128.7 149.77 50.54 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 109.032 -0.729 . . . . 73.31 109.032 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.7 t -144.86 163.37 34.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.876 -1.157 . . . . 74.11 107.876 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.3 5.83 55.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.828 -1.709 . . . . 74.14 108.828 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -135.88 150.62 49.43 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 118.529 1.165 . . . . 74.24 109.921 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -82.09 -23.16 35.9 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.983 2.113 . . . . 74.13 109.367 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 p -89.66 125.66 35.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.853 2.061 . . . . 74.44 105.89 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -116.32 9.61 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.928 0.891 . . . . 72.13 110.942 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 N-CA-C 106.98 -2.448 . . . . 71.55 106.98 178.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.567 0 N-CA-C 109.883 -1.287 . . . . 52.14 109.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.33 135.75 47.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.58 0.752 . . . . 71.1 109.424 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.03 53.31 2.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.573 1.549 . . . . 73.01 108.826 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.95 50.85 0.91 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.644 1.977 . . . . 63.32 110.686 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 42.5 pt -67.36 157.31 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.963 1.705 . . . . 72.13 112.938 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 45.7 mt -74.83 -38.55 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.742 -1.207 . . . . 72.31 107.742 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -82.41 51.13 1.76 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.659 1.184 . . . . 65.3 110.578 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -60.06 123.71 17.95 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.375 1.47 . . . . 74.22 107.321 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -45.01 59.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.719 0.69 . . . . 75.24 111.481 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.87 108.78 19.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.491 1.117 . . . . 74.42 113.301 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -69.52 -32.51 71.39 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.707 -0.621 . . . . 72.53 111.819 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 27.8 m95 49.48 52.34 14.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.322 1.449 . . . . 74.43 112.71 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.38 131.87 10.85 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.13 -1.606 . . . . 72.43 110.257 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.5 141.63 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.205 1.502 . . . . 70.4 107.315 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -137.44 151.0 48.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.69 1.996 . . . . 74.41 110.687 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 19.3 tp -113.55 112.23 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.975 1.31 . . . . 75.43 109.525 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 70.1 t -123.95 137.0 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.233 1.413 . . . . 75.35 111.718 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.2 p -162.46 161.0 26.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.707 0.803 . . . . 54.14 111.602 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 102.851 -3.018 . . . . 75.14 102.851 176.498 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 108.793 -0.817 . . . . 71.33 108.793 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.04 47.54 4.96 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.383 -0.687 . . . . 73.43 111.383 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -77.18 116.51 17.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.796 -0.816 . . . . 73.35 108.796 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.8 mmt -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.869 0.366 . . . . 75.42 110.465 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -58.29 -46.1 86.7 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 112.732 0.641 . . . . 75.13 112.732 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -63.98 -39.3 93.82 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.114 0.965 . . . . 74.2 111.363 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.08 -42.69 80.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.497 0.498 . . . . 70.14 111.497 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.18 -70.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.272 0.841 . . . . 65.33 113.272 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -158.36 119.98 3.53 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.486 -1.302 . . . . 74.12 107.486 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -128.83 -66.15 0.84 Allowed 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 117.113 -1.422 . . . . 42.41 111.883 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 tp -44.74 -50.34 10.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.092 1.357 . . . . 74.42 114.4 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -66.27 -59.44 3.72 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.939 -1.101 . . . . 72.34 112.235 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.648 ' CD2' HH21 ' A' ' 14' ' ' ARG . 3.0 t-160 -53.94 -51.85 62.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.488 1.115 . . . . 75.13 109.929 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.648 HH21 ' CD2' ' A' ' 13' ' ' HIS . 11.9 mmp_? -58.39 -46.2 86.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 115.599 -2.143 . . . . 74.41 109.867 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.17 -43.33 99.05 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.283 1.856 . . . . 72.32 112.449 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.66 -47.72 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 118.297 0.499 . . . . 74.01 110.008 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.16 -39.9 86.55 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.603 -1.189 . . . . 74.11 110.371 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 m -56.1 -47.78 77.41 Favored 'General case' 0 CA--C 1.523 -0.059 0 CA-C-N 120.722 1.601 . . . . 74.04 107.386 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.83 72.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.967 0.358 . . . . 61.11 111.967 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.52 -51.47 65.34 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.801 -0.562 . . . . 74.32 111.317 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.46 -42.21 87.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 117.513 -1.232 . . . . 72.22 109.908 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -72.58 -29.66 63.73 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 120.556 1.526 . . . . 71.24 111.643 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.23 -46.48 41.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.995 0.816 . . . . 72.41 109.586 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -73.47 -45.93 51.19 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.669 -0.645 . . . . 71.43 110.689 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -122.76 79.76 48.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 125.324 1.45 . . . . 73.14 110.202 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.66 -20.66 52.88 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.877 1.718 . . . . 73.21 110.897 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.06 16.92 25.32 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.306 1.042 . . . . 64.13 112.946 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -120.89 153.45 37.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.867 -1.531 . . . . 74.45 106.867 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 135.11 24.08 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 124.022 0.929 . . . . 71.5 108.788 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.76 111.92 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 125.31 4.007 . . . . 63.42 112.884 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.82 149.73 16.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.873 0.869 . . . . 73.41 109.697 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.63 120.88 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 103.634 -2.728 . . . . 74.11 103.634 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.58 130.72 64.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.075 -1.454 . . . . 73.12 107.075 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.99 148.04 52.7 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.656 1.182 . . . . 64.23 110.3 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.83 132.86 36.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.283 -1.006 . . . . 73.41 108.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.16 111.96 2.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.375 -1.713 . . . . 75.52 106.375 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -57.73 123.83 17.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.457 -1.312 . . . . 74.23 107.457 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.49 -17.99 27.93 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.689 1.137 . . . . 62.41 110.665 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 t -71.93 168.49 17.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.973 1.386 . . . . 74.25 108.398 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.23 -11.82 17.73 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.171 0.988 . . . . 74.11 113.391 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tp -69.72 159.64 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.816 -0.553 . . . . 73.24 109.981 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.09 148.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.186 1.394 . . . . 74.21 110.385 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -77.67 167.65 21.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.069 1.348 . . . . 72.11 111.713 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.63 135.86 62.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.795 0.838 . . . . 73.24 111.166 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.36 152.32 38.37 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.693 1.197 . . . . 73.51 108.395 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -74.75 92.99 2.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.786 -1.19 . . . . 72.33 107.786 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -132.81 162.63 31.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.67 1.988 . . . . 75.21 109.838 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -113.32 108.42 17.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.239 -2.134 . . . . 75.22 105.239 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -84.37 122.95 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.278 -1.008 . . . . 74.04 108.278 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.87 110.75 23.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.197 -1.779 . . . . 72.14 106.197 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.29 142.29 26.11 Favored Pre-proline 0 N--CA 1.453 -0.296 0 O-C-N 124.033 0.833 . . . . 75.51 109.02 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 135.43 39.42 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.986 . . . . 73.42 111.147 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -14.91 32.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.513 0.725 . . . . 72.13 111.698 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.23 -31.2 43.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.752 1.221 . . . . 72.32 114.154 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pt -73.39 170.32 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.392 0.996 . . . . 75.43 110.708 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -105.33 166.98 10.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.032 0.933 . . . . 74.31 110.359 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.91 -39.48 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.615 1.166 . . . . 71.31 109.382 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.02 95.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.877 0.762 . . . . 73.51 111.447 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -61.62 -47.39 85.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.933 -0.766 . . . . 75.3 108.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.05 -51.64 68.76 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.592 -0.521 . . . . 75.35 109.592 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.02 -47.91 71.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.857 1.663 . . . . 74.1 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -62.47 -41.22 98.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.795 0.271 . . . . 75.32 110.512 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.3 -39.73 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 118.091 -0.957 . . . . 73.5 108.432 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.1 mt -59.14 -50.47 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.523 1.511 . . . . 71.23 109.541 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -60.21 -35.06 74.58 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.119 -0.988 . . . . 64.31 110.37 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.3 -43.17 74.34 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.162 0.892 . . . . 74.01 109.822 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -60.7 -32.48 71.71 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 63.02 112.823 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.77 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.373 0.533 . . . . 73.31 111.46 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 54.56 57.65 5.58 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.161 -1.051 . . . . 65.33 108.161 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.43 108.82 2.87 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 107.105 -1.443 . . . . 74.31 107.105 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.03 147.42 67.53 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.346 -1.828 . . . . 72.14 107.346 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 m -62.72 -14.98 50.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.3 -0.875 . . . . 74.54 112.861 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -67.5 -28.61 67.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.131 0.878 . . . . 75.34 110.176 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -103.41 165.29 11.12 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.875 1.27 . . . . 73.32 108.525 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.69 176.03 5.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.043 1.337 . . . . 70.33 107.896 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.38 141.39 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.593 1.157 . . . . 63.24 108.265 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.26 135.96 24.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.808 2.043 . . . . 73.45 108.293 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.2 mt -114.94 156.14 25.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.75 1.62 . . . . 71.23 110.389 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -147.14 142.5 27.4 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.201 0.938 . . . . 74.42 109.878 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.96 119.91 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.424 -2.065 . . . . 75.3 105.424 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.1 t0 44.06 52.15 6.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.023 1.329 . . . . 75.22 111.347 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 60.19 19.11 8.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.471 1.509 . . . . 70.41 113.998 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 p -122.59 161.5 23.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 120.748 1.613 . . . . 74.53 110.606 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.42 113.8 64.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 102.181 -3.266 . . . . 73.44 102.181 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 138.84 35.15 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.327 1.152 . . . . 75.22 111.119 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -68.08 120.37 14.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.538 -1.282 . . . . 74.12 107.538 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 p -54.98 -18.67 5.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.967 1.707 . . . . 61.35 113.863 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -97.59 -0.83 45.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.909 1.684 . . . . 63.22 112.321 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 tp -80.96 151.55 28.45 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.381 1.446 . . . . 74.21 108.722 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -87.65 151.44 22.95 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 73.14 108.525 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.2 mmt -60.1 -39.28 85.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.761 -0.637 . . . . 73.32 110.386 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.89 -43.27 99.16 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.321 -0.712 . . . . 73.2 111.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -52.5 51.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.671 -0.863 . . . . 74.01 108.671 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.89 -36.71 72.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.946 0.499 . . . . 71.53 111.247 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -65.56 -55.16 19.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.151 -1.426 . . . . 74.43 107.151 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.85 -42.37 75.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.462 1.105 . . . . 71.54 112.479 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -26.71 29.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 117.466 -1.254 . . . . 74.23 114.229 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -109.89 9.11 24.57 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.89 1.223 . . . . 75.41 112.47 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -52.21 121.39 6.77 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.358 1.863 . . . . 75.34 111.251 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.43 169.29 17.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.511 -1.292 . . . . 74.14 107.511 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.99 -28.05 55.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.475 1.034 . . . . 71.44 111.42 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.57 7.33 20.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.982 1.313 . . . . 75.13 112.58 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.58 29.35 71.65 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 120.744 -1.223 . . . . 75.23 113.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -126.93 178.31 6.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.099 1.36 . . . . 62.2 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.82 129.92 51.79 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.211 1.004 . . . . 73.2 110.281 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -108.23 121.68 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.255 -1.387 . . . . 75.22 107.255 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.35 141.15 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.043 0.937 . . . . 74.11 109.529 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.27 151.26 37.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.164 -1.05 . . . . 72.32 108.164 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -135.67 152.79 51.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.573 0.624 . . . . 74.33 110.703 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -144.02 157.05 44.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.782 -1.192 . . . . 70.41 107.782 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 13.53 21.69 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.779 -1.328 . . . . 74.41 109.779 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -125.88 127.95 46.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.761 1.625 . . . . 72.41 107.549 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -62.83 -31.92 73.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.87 1.268 . . . . 73.34 109.534 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.71 122.23 38.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.52 1.528 . . . . 72.05 108.14 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -110.13 24.79 12.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.282 1.833 . . . . 64.25 109.176 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 116.189 -2.45 . . . . 75.1 112.45 -179.36 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.304 0 N-CA-C 111.005 -0.838 . . . . 65.1 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -147.74 22.91 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.474 1.109 . . . . 72.24 110.901 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 22.8 mmt -83.03 49.3 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.301 1.04 . . . . 74.34 111.231 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -85.6 50.43 1.96 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.419 -1.697 . . . . 74.05 106.419 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 22.3 pt -71.3 152.36 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.999 1.72 . . . . 64.35 112.196 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 5.9 pt -61.74 -41.49 90.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.041 1.336 . . . . 73.25 114.206 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -87.23 53.64 2.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.762 1.164 . . . . 74.45 108.802 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -66.21 108.76 2.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.284 -2.487 . . . . 74.23 104.284 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.097 -1.002 . . . . 75.44 112.168 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.89 107.54 17.51 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.803 1.641 . . . . 74.14 108.974 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.06 -37.71 28.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.395 1.478 . . . . 71.23 113.221 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 80.4 m95 55.16 59.45 3.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.819 1.248 . . . . 74.41 111.306 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -74.9 133.88 16.12 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.066 -1.214 . . . . 74.21 110.066 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 56.0 mt -74.13 119.24 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.59 1.556 . . . . 75.13 107.526 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -124.07 145.85 48.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.979 1.312 . . . . 73.53 110.325 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 20.5 tp -99.81 115.54 29.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.235 1.414 . . . . 75.1 108.439 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.93 120.43 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.866 1.266 . . . . 63.34 109.965 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 8.6 p -161.11 159.2 28.8 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.511 1.051 . . . . 70.3 112.595 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--O 1.249 1.036 0 C-N-CA 127.576 2.35 . . . . 74.12 108.559 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tmm? . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 108.243 -1.021 . . . . 75.1 108.243 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.4 95.5 0.31 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 106.366 -2.694 . . . . 71.44 106.366 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -102.67 130.32 49.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.316 1.046 . . . . 73.55 108.479 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 mtt -64.51 -43.0 95.44 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.438 1.087 . . . . 75.23 108.818 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -59.77 -51.72 68.54 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.558 -0.734 . . . . 73.43 110.668 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.17 -31.71 73.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 117.879 -1.058 . . . . 74.24 111.672 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -59.76 -45.31 92.65 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.57 -74.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.549 0.531 . . . . 73.43 110.325 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.407 ' CE1' ' HD1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -160.34 143.03 13.27 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.74 2.816 . . . . 72.1 108.914 -178.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 p -120.68 -66.39 1.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 117.268 -1.349 . . . . 72.53 111.311 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -45.71 -59.0 3.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.355 1.862 . . . . 73.1 113.915 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.97 -48.02 72.66 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.356 -0.84 . . . . 71.41 111.754 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.407 ' HD1' ' CE1' ' A' ' 9' ' ' HIS . 6.1 t60 -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.599 0.36 . . . . 73.54 110.228 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -47.24 85.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.165 1.386 . . . . 75.41 108.559 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 t -61.75 -51.93 66.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 120.036 1.289 . . . . 62.11 111.481 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.42 -47.99 86.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.383 -0.823 . . . . 74.5 110.503 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.83 -52.03 65.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.837 0.855 . . . . 75.41 110.741 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 p -59.13 -48.13 82.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.293 -0.86 . . . . 75.43 110.456 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.27 78.14 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.668 1.122 . . . . 74.45 111.536 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -67.61 -40.25 84.71 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.517 -0.739 . . . . 75.25 110.628 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.1 -41.94 79.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 118.157 -0.925 . . . . 74.54 110.017 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -62.63 -38.25 89.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 120.208 1.367 . . . . 73.54 108.509 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.31 69.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.559 -0.856 . . . . 73.1 110.895 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -78.08 -46.8 19.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 118.448 2.758 . . . . 74.23 118.448 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -131.59 76.92 74.17 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.397 2.279 . . . . 75.14 108.789 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.69 -23.5 36.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.756 2.304 . . . . 71.31 112.364 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.62 12.85 17.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 73.43 112.426 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -122.0 153.81 38.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.493 -1.669 . . . . 75.11 106.493 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.32 138.41 24.28 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.483 -0.932 . . . . 72.11 108.483 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.6 122.27 5.45 Favored 'Trans proline' 0 C--N 1.353 0.792 1 C-N-CA 125.879 4.386 . . . . 63.11 111.449 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -131.93 143.27 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.121 0.968 . . . . 72.15 111.56 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.1 mm -117.38 120.48 65.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 103.695 -2.705 . . . . 74.4 103.695 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -108.16 110.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.978 1.711 . . . . 75.2 108.65 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -123.02 153.09 40.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.208 0.913 . . . . 74.23 110.911 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -93.54 146.22 23.95 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.345 0.521 . . . . 72.3 110.501 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.23 136.55 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.328 1.451 . . . . 63.22 107.816 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 m -49.19 142.19 7.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.961 0.904 . . . . 63.53 111.572 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.82 1.57 1.44 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.781 2.134 . . . . 45.12 116.543 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t -58.85 147.3 34.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 119.241 1.52 . . . . 74.11 111.699 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 -0.79 31.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.906 1.282 . . . . 72.4 112.449 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -82.92 156.79 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.556 1.071 . . . . 74.33 109.118 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 151.9 9.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.684 0.754 . . . . 72.15 109.267 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.02 165.23 23.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.35 1.241 . . . . 75.32 114.35 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.62 139.5 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 127.572 2.349 . . . . 74.43 108.177 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.47 161.29 26.17 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.793 -1.558 . . . . 63.43 106.793 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.5 104.92 3.98 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.234 -1.395 . . . . 65.15 107.234 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -136.61 160.12 39.76 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.755 1.622 . . . . 74.21 110.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 11.2 mttt -107.96 116.29 31.69 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.296 1.839 . . . . 72.1 106.51 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -98.26 138.82 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.762 1.165 . . . . 75.1 111.91 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.6 mt -120.75 110.9 16.92 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.299 1.44 . . . . 74.53 108.626 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.45 142.11 25.83 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 118.137 -0.935 . . . . 75.54 111.099 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.55 137.54 27.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.196 2.597 . . . . 72.32 110.863 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -61.52 -12.5 15.48 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.914 1.45 . . . . 70.31 114.914 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.95 -34.88 29.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.831 1.196 . . . . 74.31 113.639 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.64 168.1 2.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.145 0.497 . . . . 72.3 112.004 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 p -107.54 163.37 13.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.305 0.483 . . . . 73.15 112.305 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.06 -34.67 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.583 1.153 . . . . 73.12 109.758 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.66 88.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.635 1.174 . . . . 65.22 111.237 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -69.63 -42.6 74.1 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 124.073 0.949 . . . . 71.3 110.206 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -59.54 -46.94 87.42 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.586 -0.894 . . . . 73.42 108.586 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.6 ttt -58.69 -43.7 90.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.706 1.203 . . . . 75.14 109.553 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -58.55 -46.8 86.09 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.851 0.751 . . . . 74.44 110.297 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -61.78 -42.67 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 118.585 -0.721 . . . . 75.11 109.804 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.2 mt -58.15 -50.36 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.634 1.107 . . . . 72.43 109.7 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -64.73 -31.71 73.06 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.961 -1.087 . . . . 75.04 112.655 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -70.76 -48.4 54.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.523 0.729 . . . . 73.33 109.746 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -59.45 -49.26 78.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.05 1.74 . . . . 74.34 111.682 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 pt -78.87 -5.87 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.793 -0.363 . . . . 75.32 111.152 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 56.29 62.32 2.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.565 1.546 . . . . 74.35 108.289 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 108.53 2.96 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.069 0.948 . . . . 74.02 108.847 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.8 164.51 35.44 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.137 2.558 . . . . 73.14 111.059 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -67.01 -17.03 64.73 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.216 -0.928 . . . . 73.4 112.142 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.76 -42.83 97.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.354 0.979 . . . . 70.22 109.189 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -102.53 164.74 11.48 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 122.6 1.191 . . . . 72.3 110.802 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.2 -176.78 3.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.336 -1.727 . . . . 75.52 106.336 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 tp -144.52 139.25 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.145 -1.428 . . . . 64.31 107.145 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -145.3 134.46 22.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.143 1.377 . . . . 75.42 108.665 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.28 135.14 54.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.661 1.584 . . . . 74.33 107.907 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.49 124.29 29.83 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.407 1.083 . . . . 75.1 109.237 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.28 129.67 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.478 1.111 . . . . 75.05 108.255 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.42 33.24 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.929 1.692 . . . . 71.54 112.145 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 66.31 23.31 10.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.066 1.347 . . . . 64.33 111.278 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -123.15 162.25 22.87 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.372 1.869 . . . . 72.31 110.561 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.2 103.34 13.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 105.591 -2.003 . . . . 74.12 105.591 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.11 139.33 42.18 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.869 1.713 . . . . 72.34 111.734 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -74.06 120.26 19.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.601 -0.888 . . . . 63.52 108.601 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 p -46.75 -37.82 9.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.441 1.896 . . . . 75.34 114.753 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 p -86.38 -6.1 59.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 115.156 1.539 . . . . 64.13 115.156 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.41 141.54 57.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.555 -1.646 . . . . 70.12 106.555 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.3 p -80.61 154.74 27.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.391 -0.818 . . . . 75.21 109.087 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.2 mmt -59.24 -40.88 87.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.123 0.969 . . . . 72.31 108.978 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 -44.47 97.45 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.196 -1.336 . . . . 63.13 110.802 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.74 -48.35 54.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.005 1.403 . . . . 74.32 111.053 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -45.98 76.5 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.121 -0.696 . . . . 75.41 109.121 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -63.14 -52.4 62.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.731 0.696 . . . . 73.43 109.374 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -54.54 -40.42 68.66 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.237 0.828 . . . . 74.34 113.237 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -23.73 22.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.167 -1.397 . . . . 74.5 113.518 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -103.98 9.55 36.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.058 1.299 . . . . 63.33 110.842 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -52.42 121.33 6.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.384 2.273 . . . . 75.04 111.322 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -89.18 175.61 7.3 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.658 0.783 . . . . 74.54 108.942 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.85 -37.9 60.81 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.199 1.4 . . . . 74.14 111.571 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.39 -2.78 50.65 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.238 1.815 . . . . 70.11 111.966 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.62 29.33 71.65 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.911 1.243 . . . . 72.13 112.724 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 166.67 13.31 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.336 1.454 . . . . 75.52 109.377 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.3 tp -122.41 131.21 53.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.916 -1.142 . . . . 74.34 107.916 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -122.5 116.35 23.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.347 1.859 . . . . 75.32 107.432 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.69 150.15 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 O-C-N 121.227 -0.921 . . . . 62.41 110.058 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.2 152.51 33.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.089 -0.708 . . . . 74.34 109.089 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -135.24 154.2 51.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.861 0.839 . . . . 74.32 110.703 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.9 p -149.22 155.79 41.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.662 1.185 . . . . 71.53 108.137 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.18 21.86 12.8 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 111.383 -0.687 . . . . 45.34 111.383 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -117.57 125.38 50.7 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.46 1.904 . . . . 74.12 108.417 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.79 -25.01 61.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.488 1.515 . . . . 63.42 109.819 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -135.65 133.65 38.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.011 2.125 . . . . 73.34 106.344 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -97.72 70.77 2.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.396 1.078 . . . . 75.51 110.712 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.039 -1.423 . . . . 74.11 110.142 179.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 109.841 -1.303 . . . . 75.34 109.841 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 54.35 31.71 14.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.475 1.51 . . . . 74.41 112.235 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 7.3 mtp -86.47 70.08 10.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.048 -1.464 . . . . 71.24 107.048 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -111.52 27.67 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.84 1.256 . . . . 71.23 109.23 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.44 152.95 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.204 1.401 . . . . 74.41 107.424 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 48.2 mt -119.4 -34.06 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 124.084 0.954 . . . . 74.34 111.359 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -112.3 61.26 0.63 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.301 1.041 . . . . 75.43 109.071 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -67.26 160.02 27.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.545 -1.28 . . . . 74.14 107.545 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.12 -42.01 99.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.461 1.652 . . . . 63.52 115.461 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -108.48 144.39 36.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.405 1.002 . . . . 65.31 109.842 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -62.16 1.52 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.746 0.647 . . . . 71.31 112.746 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . 0.455 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 48.8 m95 54.71 64.71 1.72 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.212 1.405 . . . . 72.14 110.863 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.88 138.78 17.15 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 107.517 -2.233 . . . . 62.52 107.517 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.68 142.94 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.446 1.623 . . . . 73.22 110.636 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.05 156.49 46.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.358 1.463 . . . . 73.43 110.489 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.29 119.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.104 2.162 . . . . 74.52 106.43 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.97 119.16 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 122.511 1.148 . . . . 71.33 109.808 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.9 p -161.76 152.76 18.08 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.688 -1.142 . . . . 61.12 110.248 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 129.466 3.106 . . . . 65.14 113.506 179.252 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.89 -1.152 . . . . 74.2 107.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.93 -163.03 24.0 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 108.401 -1.88 . . . . 54.55 108.401 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -74.09 125.68 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.622 -1.622 . . . . 74.11 106.622 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.21 -38.93 88.34 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.198 -0.667 . . . . 74.43 109.198 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -59.97 -39.63 86.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.412 1.005 . . . . 75.12 110.198 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.564 0.62 . . . . 73.52 109.431 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.0 -44.87 91.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.355 -0.98 . . . . 73.23 108.355 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.83 -75.97 0.18 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.746 1.017 . . . . 64.31 113.746 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -158.56 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.536 1.934 . . . . 72.13 108.229 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 p -102.36 -67.25 0.88 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.409 0.892 . . . . 74.53 113.409 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 -55.07 22.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 117.176 2.287 . . . . 75.31 117.176 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.0 -54.92 26.71 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.061 0.846 . . . . 72.53 111.23 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.75 -43.59 65.86 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.629 1.571 . . . . 74.42 111.078 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -47.06 63.34 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.891 -1.131 . . . . 75.5 109.626 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.91 -58.46 7.52 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.589 0.756 . . . . 72.32 111.065 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.39 -46.19 92.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.048 0.539 . . . . 74.02 110.916 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -64.98 -40.04 94.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.847 -1.073 . . . . 71.44 110.997 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 t -57.66 -46.92 83.61 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.273 1.397 . . . . 74.14 108.541 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.43 72.33 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.017 0.371 . . . . 70.52 111.325 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -59.0 -49.13 79.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.855 1.262 . . . . 74.45 110.328 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.33 -42.89 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 117.393 -1.289 . . . . 74.13 111.403 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -71.05 -29.81 65.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.527 1.512 . . . . 73.22 110.242 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.29 -47.29 57.76 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.676 -0.861 . . . . 73.23 108.676 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.53 -47.96 18.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.429 1.27 . . . . 74.45 114.429 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.73 73.43 69.55 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 127.869 2.468 . . . . 74.24 111.222 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.97 -29.36 89.17 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.063 1.842 . . . . 72.42 112.457 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.67 11.81 16.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.518 0.599 . . . . 75.41 111.086 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -112.42 143.33 43.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.61 1.55 . . . . 73.35 109.414 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -107.06 133.49 20.27 Favored Pre-proline 0 C--O 1.246 0.883 0 C-N-CA 124.323 1.049 . . . . 73.11 108.295 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.19 119.81 5.45 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.89 3.727 . . . . 74.32 112.606 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.23 149.67 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 74.51 111.115 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -122.13 134.4 65.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 102.669 -3.086 . . . . 73.3 102.669 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.77 119.57 53.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.379 1.471 . . . . 61.11 109.326 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.7 157.41 46.83 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.453 1.024 . . . . 74.42 113.279 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.7 150.98 23.28 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.872 0.368 . . . . 72.43 110.602 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.88 135.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.999 -1.482 . . . . 72.2 106.999 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -64.11 115.74 5.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.118 -1.068 . . . . 71.2 108.118 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.85 30.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.39 1.471 . . . . 63.33 112.374 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.9 m -85.23 112.58 20.87 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.623 1.711 . . . . 65.44 107.727 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.78 -20.98 60.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.267 1.827 . . . . 74.4 114.548 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.1 tp -53.42 158.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.449 1.5 . . . . 75.31 114.809 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.6 m -49.07 114.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.785 1.634 . . . . 73.01 109.64 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -82.1 167.76 18.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.453 1.501 . . . . 74.41 108.727 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -126.15 139.14 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.724 -1.213 . . . . 72.22 107.724 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.72 166.15 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.77 0.795 . . . . 64.41 109.47 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.35 105.81 4.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.267 -2.123 . . . . 70.52 105.267 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -139.92 152.41 46.37 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 124.243 1.017 . . . . 74.53 111.087 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -93.95 94.75 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.577 -2.009 . . . . 74.42 105.577 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -85.08 117.07 23.82 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.197 -1.038 . . . . 72.3 108.197 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.53 115.48 30.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.145 1.378 . . . . 73.41 110.471 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.01 142.92 27.7 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 119.966 1.257 . . . . 73.43 111.945 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 141.67 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.08 2.52 . . . . 73.23 110.691 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -62.5 -13.62 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.7 2.0 . . . . 63.12 113.28 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -30.03 25.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.636 0.976 . . . . 75.54 113.636 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.66 166.68 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 119.391 0.996 . . . . 74.1 110.403 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 p -107.51 163.01 13.42 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.373 -0.829 . . . . 75.33 112.989 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.79 -35.98 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.11 0.964 . . . . 74.35 109.201 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.72 78.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.484 0.714 . . . . 73.0 110.717 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -71.92 -43.22 65.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.413 1.085 . . . . 75.41 109.942 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.79 -41.97 87.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.123 0.874 . . . . 75.21 109.474 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 42.3 ttp -63.31 -48.8 76.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.041 -0.725 . . . . 74.31 109.041 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -58.89 -44.94 91.27 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.398 0.544 . . . . 75.2 111.092 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.91 -50.91 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.329 1.052 . . . . 73.34 108.307 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.79 -49.96 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.055 0.843 . . . . 74.42 111.009 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -64.05 -32.93 74.66 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.937 -1.102 . . . . 74.55 112.183 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -71.89 -46.47 57.66 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.77 -0.826 . . . . 65.45 108.77 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.3 -51.41 64.73 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.26 1.824 . . . . 74.25 111.942 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -3.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.142 0.423 . . . . 72.32 112.142 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 55.29 63.71 2.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.26 1.824 . . . . 73.32 107.776 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.67 114.28 18.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.229 -1.026 . . . . 74.23 108.229 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.98 164.37 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.781 2.987 . . . . 71.13 113.054 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.5 p -66.8 -32.32 73.53 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.929 -1.107 . . . . 71.45 112.659 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -59.44 -36.0 75.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.034 1.734 . . . . 75.53 112.337 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.83 165.04 11.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.471 1.108 . . . . 74.52 111.01 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.27 -179.4 3.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.963 2.105 . . . . 74.22 108.895 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.3 136.37 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.087 1.355 . . . . 73.12 107.886 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.34 136.67 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.424 -1.324 . . . . 75.21 107.424 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.28 148.85 31.09 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.469 1.108 . . . . 73.33 108.728 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -137.01 123.26 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.071 1.749 . . . . 73.24 108.417 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.06 144.49 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.582 1.153 . . . . 72.33 108.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 48.92 35.77 7.22 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.149 1.341 . . . . 70.2 111.853 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tttt 55.02 31.44 16.11 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.112 0.965 . . . . 74.11 111.476 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -152.19 163.96 38.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.642 1.177 . . . . 70.32 109.9 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 115.12 61.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 104.912 -2.255 . . . . 74.34 104.912 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.74 141.29 40.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.105 1.87 . . . . 72.32 110.606 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -72.09 127.28 32.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.736 -0.838 . . . . 73.21 108.736 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 p -53.81 -35.47 61.43 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.012 2.125 . . . . 61.44 112.218 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 t -70.02 -14.96 62.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.779 1.632 . . . . 72.31 112.39 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.73 147.78 48.67 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.45 -0.945 . . . . 72.43 108.45 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 m -98.88 149.09 23.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.871 -1.159 . . . . 72.53 107.871 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.7 mmt -55.04 -46.19 75.29 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.066 0.547 . . . . 74.44 111.745 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.91 -46.63 83.37 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.919 -0.873 . . . . 55.04 110.919 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -65.08 -52.92 52.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.48 0.712 . . . . 73.22 109.818 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.03 -50.28 64.58 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.045 0.938 . . . . 73.13 110.814 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.9 -49.14 75.97 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.067 -1.021 . . . . 73.52 109.838 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -68.22 -24.51 64.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.98 0.809 . . . . 74.1 112.797 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -37.4 13.87 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 119.687 1.13 . . . . 75.21 111.179 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.17 -3.77 50.32 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.318 1.229 . . . . 71.14 114.318 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -36.26 121.78 0.71 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.451 2.389 . . . . 72.24 117.451 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.31 165.92 23.85 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.206 -1.405 . . . . 61.1 107.206 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.18 -34.64 57.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.529 1.132 . . . . 54.13 111.871 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -96.77 14.08 26.33 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.552 1.141 . . . . 75.34 113.579 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.2 70.59 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 120.688 -1.258 . . . . 61.2 113.853 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.39 154.48 29.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.526 1.163 . . . . 73.54 108.382 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.49 133.89 55.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.826 -1.176 . . . . 73.12 107.826 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.81 124.3 42.99 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.257 1.423 . . . . 72.24 109.121 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 143.64 40.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-O 122.091 0.948 . . . . 71.44 108.59 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.85 155.96 22.79 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.551 -0.718 . . . . 75.34 109.132 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -140.99 161.34 38.07 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.531 0.732 . . . . 75.33 111.525 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -151.61 156.95 41.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.811 -1.181 . . . . 71.24 107.811 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.0 26.26 9.43 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 126.54 2.019 . . . . 70.24 109.918 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -132.23 141.44 49.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.376 2.271 . . . . 72.03 106.72 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -81.09 -48.02 12.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.982 -1.008 . . . . 73.24 108.383 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m -94.46 124.23 38.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.69 0.796 . . . . 63.02 108.971 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -118.65 12.29 13.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.904 2.081 . . . . 74.13 111.043 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 C-N-CA 125.255 1.407 . . . . 62.23 112.144 -179.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 109.769 -1.332 . . . . 72.24 109.769 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 68.0 96.25 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 128.418 2.687 . . . . 74.0 110.348 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.9 19.94 14.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.673 1.189 . . . . 72.51 110.432 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.08 50.75 0.21 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.484 1.914 . . . . 71.32 112.391 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.67 118.95 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.123 1.369 . . . . 75.44 107.609 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.48 -15.5 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 119.202 -0.428 . . . . 72.43 111.196 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -78.89 62.0 3.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.975 1.31 . . . . 71.42 107.611 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.96 108.96 2.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.31 -2.478 . . . . 63.02 104.31 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.94 -27.11 63.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.567 1.147 . . . . 74.54 111.224 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.74 156.8 20.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.946 -1.501 . . . . 73.31 106.946 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.9 -57.16 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.557 -0.714 . . . . 72.11 111.846 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 75.4 m95 58.68 58.93 3.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 74.54 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -78.85 145.29 28.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.967 -1.653 . . . . 75.01 108.967 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 33.0 mt -77.51 141.16 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.821 1.31 . . . . 74.03 111.138 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.66 122.91 16.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.672 0.789 . . . . 74.44 108.972 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.31 108.54 20.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.666 -2.346 . . . . 74.21 104.666 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.62 134.78 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.181 0.808 . . . . 70.32 113.181 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 12.8 p -161.47 158.64 26.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.642 1.577 . . . . 64.21 107.388 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 127.999 2.519 . . . . 73.45 112.504 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.5 mtp . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.858 -0.423 . . . . 75.03 109.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.49 -127.73 1.91 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 108.486 -1.846 . . . . 70.43 108.486 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -73.42 112.9 9.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.5 mmm -57.66 -46.89 83.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.133 -0.692 . . . . 73.1 109.133 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -58.16 -45.05 88.12 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 119.721 -0.181 . . . . 74.5 111.082 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -64.79 -35.03 79.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.279 -0.391 . . . . 75.14 111.622 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.76 -48.09 78.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.24 -1.022 . . . . 74.34 108.24 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -71.34 0.22 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 115.081 1.511 . . . . 75.1 115.081 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -156.22 128.19 7.42 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.785 2.034 . . . . 75.3 108.203 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -124.9 -66.15 0.98 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 116.529 -1.701 . . . . 75.33 114.069 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -56.55 13.7 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.265 1.393 . . . . 74.45 114.471 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.7 -36.13 82.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.054 0.843 . . . . 72.33 111.58 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -64.75 -55.09 21.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.702 0.801 . . . . 75.24 110.831 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -49.24 75.32 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.303 1.441 . . . . 75.43 109.294 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.2 t -54.15 -61.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.926 0.784 . . . . 74.03 112.033 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.91 -47.61 90.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 123.874 0.734 . . . . 73.34 112.279 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -47.08 70.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.151 -1.02 . . . . 72.05 111.642 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -55.03 -45.41 75.18 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 120.046 1.294 . . . . 73.11 109.493 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.77 72.09 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.261 0.553 . . . . 72.42 112.253 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.69 -40.0 88.35 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.331 0.652 . . . . 72.3 110.276 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.15 -42.09 93.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 117.78 -1.105 . . . . 75.33 108.624 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -63.86 -39.18 93.59 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 120.092 1.314 . . . . 70.21 109.423 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.94 67.07 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.935 0.398 . . . . 75.31 111.633 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -72.23 -44.99 62.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.415 -0.803 . . . . 74.43 112.783 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -128.75 78.72 75.64 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.121 1.368 . . . . 73.13 109.694 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.45 -17.65 49.05 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.659 2.239 . . . . 72.51 112.044 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -99.87 13.17 34.75 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.415 0.686 . . . . 72.21 110.061 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -123.21 155.64 36.71 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.842 1.201 . . . . 74.32 108.728 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.76 136.85 27.83 Favored Pre-proline 0 C--O 1.241 0.656 0 C-N-CA 124.126 0.97 . . . . 74.11 109.846 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.78 114.73 3.7 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 125.251 3.967 . . . . 72.23 111.769 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.52 143.99 34.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.555 1.142 . . . . 73.24 109.358 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 mm -120.73 127.05 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 102.375 -3.194 . . . . 75.15 102.375 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.67 124.55 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.319 1.447 . . . . 73.4 108.896 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -136.59 154.26 50.73 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.25 1.386 . . . . 74.5 110.513 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -91.78 152.71 20.02 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.944 -0.473 . . . . 75.43 111.685 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.8 t -66.83 126.1 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.681 1.593 . . . . 74.14 107.212 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 p -58.72 121.85 12.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.729 0.695 . . . . 74.31 110.296 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.51 -18.8 49.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.626 2.06 . . . . 73.31 111.847 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -55.65 136.94 50.18 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.896 1.348 . . . . 71.22 111.289 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -64.49 -28.73 69.86 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.859 1.264 . . . . 75.34 114.096 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.11 154.33 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.471 0.708 . . . . 62.31 112.124 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.78 140.11 20.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.172 -1.418 . . . . 75.14 107.172 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -84.36 167.6 16.37 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.515 -0.92 . . . . 62.31 108.515 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.81 144.17 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.745 -1.576 . . . . 75.43 106.745 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 165.61 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.549 0.69 . . . . 71.12 110.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.3 95.29 2.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.767 -1.197 . . . . 73.42 107.767 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -136.25 151.74 49.99 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.153 0.981 . . . . 74.1 109.562 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -95.7 102.09 13.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.058 -2.201 . . . . 74.41 105.058 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -84.58 136.73 33.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.158 0.89 . . . . 74.43 109.162 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 mt -120.19 108.56 14.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.975 -1.491 . . . . 71.34 106.975 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.17 141.99 25.42 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 117.946 -1.026 . . . . 74.43 110.408 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 141.29 38.87 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.141 1.894 . . . . 74.12 113.568 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 m -62.58 -17.32 59.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.874 1.67 . . . . 74.24 110.877 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -68.37 -35.34 77.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.733 2.413 . . . . 73.51 112.751 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -86.26 171.0 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 122.014 0.911 . . . . 74.52 112.648 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.6 p -107.23 166.12 10.87 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.492 1.517 . . . . 71.41 110.541 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.75 -34.32 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 65.14 108.559 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -47.86 83.55 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 121.495 -0.753 . . . . 54.34 112.69 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.54 -37.5 71.12 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 123.162 0.585 . . . . 74.22 110.095 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.9 -45.1 91.07 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.934 -0.765 . . . . 74.53 108.934 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 ttt -63.57 -44.96 92.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.069 -0.967 . . . . 74.25 110.105 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -57.04 -41.29 78.37 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.996 0.816 . . . . 74.54 111.09 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.01 -51.12 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.533 -0.914 . . . . 75.51 108.533 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.46 -50.36 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.262 0.937 . . . . 71.51 111.049 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -62.31 -39.42 92.96 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.062 -1.024 . . . . 74.54 112.064 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -74.34 -33.75 63.23 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.77 1.168 . . . . 75.12 111.305 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.47 -48.73 78.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.998 0.817 . . . . 71.54 109.552 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -79.98 -3.18 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.013 0.196 . . . . 74.52 110.88 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 53.1 57.93 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.203 1.801 . . . . 64.22 109.532 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.11 109.98 4.87 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 124.979 1.312 . . . . 74.53 108.735 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.73 159.46 52.61 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.442 2.761 . . . . 74.42 111.205 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 m -67.3 -14.47 62.95 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.091 -1.005 . . . . 74.12 112.706 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.46 -34.11 67.51 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.112 -0.47 . . . . 74.3 110.157 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.55 164.41 11.68 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.355 1.062 . . . . 73.02 108.942 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 175.72 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.97 1.308 . . . . 72.12 109.21 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.76 140.63 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 125.278 1.431 . . . . 71.42 107.722 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -145.06 129.84 18.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.429 1.892 . . . . 65.43 106.916 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.99 146.57 41.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.004 1.322 . . . . 75.52 109.244 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -142.66 132.89 24.67 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.707 1.203 . . . . 71.2 110.303 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.63 121.89 64.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 C-N-CA 124.712 1.205 . . . . 74.04 107.99 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 43.05 51.83 5.39 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.361 1.465 . . . . 72.35 113.119 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.51 25.3 15.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.066 1.346 . . . . 75.33 113.392 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 p -132.66 161.47 33.86 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.479 1.036 . . . . 72.34 111.049 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.35 105.53 36.93 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 103.184 -2.895 . . . . 73.33 103.184 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.2 130.57 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.766 2.311 . . . . 74.41 111.967 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.32 125.84 27.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.166 -1.42 . . . . 74.34 107.166 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -55.75 -22.48 24.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 63.23 113.904 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -79.31 -18.41 52.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.466 1.107 . . . . 64.01 111.652 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.66 141.67 56.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.41 -0.806 . . . . 72.22 110.09 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.481 ' HG1' ' NE2' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -84.47 152.0 24.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.029 -1.1 . . . . 73.21 108.029 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 45.3 mmm -62.93 -42.46 99.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.175 -0.917 . . . . 61.4 110.278 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.42 97.6 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.798 0.727 . . . . 43.23 111.566 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' NE2' ' HG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.58 -46.89 71.33 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.322 0.649 . . . . 72.42 109.4 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.43 -46.26 86.86 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.727 -0.472 . . . . 75.4 109.727 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.81 -45.3 94.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.245 1.418 . . . . 74.32 109.765 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.55 -33.35 75.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.968 0.907 . . . . 71.24 111.597 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -90.54 -23.5 20.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.264 -1.35 . . . . 75.4 113.488 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -110.35 -2.1 16.85 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.921 1.452 . . . . 71.11 114.921 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -45.23 121.85 3.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.969 1.259 . . . . 72.52 114.377 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -71.45 176.09 4.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.811 1.244 . . . . 64.11 108.36 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.82 -33.14 55.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.83 2.052 . . . . 74.24 111.81 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 10.34 36.01 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.151 1.78 . . . . 73.12 111.563 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.92 68.74 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.899 -1.126 . . . . 63.05 113.255 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.88 168.81 9.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.21 1.505 . . . . 74.32 109.889 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.53 136.43 54.55 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.685 0.394 . . . . 74.3 110.273 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -119.75 119.21 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.254 1.822 . . . . 74.44 109.084 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.18 144.0 38.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 121.11 -0.994 . . . . 74.44 109.294 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.56 21.02 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.698 0.799 . . . . 71.04 109.849 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -146.19 160.84 41.42 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.425 0.631 . . . . 61.13 110.797 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 p -151.62 161.35 42.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.719 1.208 . . . . 75.12 108.774 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.88 22.89 12.17 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.298 0.952 . . . . 72.24 111.909 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 132.2 37.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.308 1.843 . . . . 75.25 106.961 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -77.0 -27.54 54.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.086 0.47 . . . . 74.01 110.353 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.5 p -100.74 114.65 28.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.059 -1.83 . . . . 75.34 106.059 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -116.61 9.66 14.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.115 0.966 . . . . 74.54 111.767 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.695 0 CA-C-O 116.902 -2.054 . . . . 64.11 110.585 179.15 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 112.074 -0.41 . . . . 75.41 112.074 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.65 162.12 29.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.258 0.623 . . . . 64.01 110.826 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 50.2 mtt -76.62 70.6 3.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.408 1.483 . . . . 74.14 112.009 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -117.17 32.62 6.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.444 1.098 . . . . 63.3 109.566 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . 0.45 HD11 ' H ' ' B' ' 334' ' ' ILE . 1.1 mp -69.07 148.71 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.264 -1.013 . . . . 74.1 108.264 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 87.9 mt -72.03 -22.41 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.748 1.219 . . . . 74.45 109.792 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -89.15 77.2 7.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.2 143.66 33.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.501 1.92 . . . . 73.41 106.498 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.97 -33.5 11.18 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.426 0.632 . . . . 61.34 110.824 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -109.02 137.41 46.97 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.648 1.179 . . . . 71.33 108.688 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.73 -58.94 4.5 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.159 1.17 . . . . 74.12 114.159 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 51.3 m95 53.33 57.34 6.31 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.473 1.509 . . . . 73.41 111.823 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -77.7 141.09 25.06 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.789 -1.324 . . . . 63.34 109.789 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 28.8 mt -74.1 128.84 36.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 119.142 1.471 . . . . 75.44 109.437 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.22 126.75 30.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.073 0.949 . . . . 75.14 109.896 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.44 122.35 31.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 104.179 -2.526 . . . . 75.14 104.179 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 51.6 t -120.58 124.02 71.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.562 1.145 . . . . 64.34 109.163 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.4 p -161.19 151.65 17.85 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.947 0.34 . . . . 72.42 111.524 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 126.675 1.99 . . . . 75.13 111.408 -179.615 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.834 -0.432 . . . . 75.02 109.834 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.37 146.76 5.36 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.548 -1.421 . . . . 75.41 109.548 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -106.46 118.92 37.92 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.262 0.625 . . . . 74.13 110.573 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.3 tpt -55.35 -46.27 76.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.433 1.083 . . . . 63.12 108.327 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -60.53 -42.27 96.16 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 113.241 0.83 . . . . 74.25 113.241 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.13 -37.44 83.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 118.946 0.794 . . . . 73.32 110.672 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.04 -47.73 76.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.335 1.022 . . . . 64.43 108.467 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.48 -75.87 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.025 1.33 . . . . 52.54 113.033 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' HD1' ' CG ' ' A' ' 13' ' ' HIS . 6.9 p80 -160.38 131.73 5.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.883 1.673 . . . . 74.22 107.798 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.2 t -130.2 -58.66 1.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 115.724 1.75 . . . . 62.33 115.724 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.44 -57.29 12.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.728 1.604 . . . . 75.54 114.927 -176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 13' ' ' HIS . 1.3 pm0 -62.95 -51.02 68.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.083 0.468 . . . . 74.24 110.229 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.515 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 84.4 t60 -52.07 -44.83 64.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.022 2.129 . . . . 74.42 110.073 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -49.84 63.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 116.872 -1.537 . . . . 75.42 110.136 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.4 m -60.54 -48.83 80.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.917 1.08 . . . . 74.1 113.917 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.97 -47.53 90.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 121.705 -0.622 . . . . 72.03 109.894 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.35 -42.49 79.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.518 -0.754 . . . . 73.21 111.848 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -59.83 -45.02 93.7 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.272 -1.01 . . . . 75.12 108.272 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.85 -49.17 77.59 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.955 0.798 . . . . 65.21 110.851 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -61.03 -46.09 92.15 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.864 -1.148 . . . . 71.04 110.883 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.94 -41.65 93.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-O 117.735 -1.126 . . . . 74.24 109.441 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -66.69 -41.07 88.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.581 1.537 . . . . 74.43 110.521 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.76 68.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.596 -0.441 . . . . 74.12 110.852 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -77.71 -33.11 53.2 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.651 0.982 . . . . 73.43 113.651 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 82.07 25.04 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.429 1.492 . . . . 75.11 111.009 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.77 -29.1 36.06 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.888 2.392 . . . . 73.34 112.602 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.81 13.23 13.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.876 0.871 . . . . 72.13 110.956 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -121.56 152.35 39.32 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.525 -1.359 . . . . 73.44 109.749 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.24 140.73 31.71 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 124.007 0.923 . . . . 73.02 108.584 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 117.66 3.57 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 125.141 3.894 . . . . 71.45 111.931 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.2 t -120.45 140.91 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.047 1.339 . . . . 64.33 108.675 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.09 135.33 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.585 -2.376 . . . . 72.41 104.585 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.73 134.85 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.251 0.62 . . . . 70.12 109.491 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.85 143.66 43.19 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.888 0.875 . . . . 65.51 108.701 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.62 143.09 31.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.299 -1.371 . . . . 74.14 107.299 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.82 108.12 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 103.07 -2.937 . . . . 65.42 103.07 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -53.75 132.67 41.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.785 -0.82 . . . . 54.02 108.785 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.2 40.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.836 1.207 . . . . 74.31 112.235 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -81.98 137.63 35.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.539 1.67 . . . . 71.01 108.027 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -66.2 -11.26 48.62 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.524 0.729 . . . . 55.24 112.803 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.96 154.37 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.602 0.761 . . . . 75.51 109.323 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.65 144.97 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.405 1.082 . . . . 72.52 110.186 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.77 167.13 18.44 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.26 2.224 . . . . 72.03 112.508 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.61 148.33 31.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 125.194 1.398 . . . . 73.31 110.267 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.5 163.47 20.45 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.923 0.889 . . . . 74.13 108.954 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.89 95.83 5.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.019 -1.104 . . . . 75.01 108.019 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.03 168.23 18.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.137 0.975 . . . . 74.52 109.895 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -116.35 99.26 7.07 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.294 -2.113 . . . . 73.24 105.294 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -83.89 136.66 34.02 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.609 -0.723 . . . . 74.5 109.053 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.94 119.2 33.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.494 1.118 . . . . 75.31 110.232 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 142.12 26.07 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 117.577 -1.202 . . . . 74.34 112.232 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.12 141.33 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.713 2.275 . . . . 75.43 109.579 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -63.4 -12.84 33.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.585 0.957 . . . . 75.25 113.585 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.89 -34.26 66.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.645 2.778 . . . . 71.44 113.445 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 pt -85.09 165.87 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.745 1.157 . . . . 73.45 111.775 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 54.8 p -99.92 168.79 9.65 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.784 0.834 . . . . 75.41 111.255 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.92 -36.43 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.714 -1.217 . . . . 65.33 107.714 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.83 90.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.737 0.815 . . . . 74.43 110.936 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -66.4 -44.96 81.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.614 -0.708 . . . . 65.22 109.744 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -58.8 -54.51 46.23 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.253 -1.017 . . . . 73.51 108.253 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.4 ttp -52.63 -49.19 65.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.512 1.525 . . . . 73.23 110.935 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -57.11 -42.28 80.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.464 0.705 . . . . 74.34 111.693 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.46 -39.63 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 118.086 -0.959 . . . . 72.54 108.792 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.31 -50.04 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 120.701 1.591 . . . . 75.45 109.607 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.15 -39.16 81.58 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 118.186 -0.912 . . . . 75.21 111.962 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -68.58 -40.59 80.45 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.051 0.841 . . . . 72.42 109.223 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -59.51 -49.07 79.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.275 1.03 . . . . 73.22 111.498 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 pt -79.46 -0.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 119.468 -0.301 . . . . 62.45 111.277 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 57.51 52.32 8.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.741 1.617 . . . . 73.32 110.984 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -68.18 108.96 3.24 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.416 1.486 . . . . 72.34 110.553 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.82 152.8 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.122 2.548 . . . . 75.53 109.968 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 m -58.95 -20.83 55.99 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.403 -0.811 . . . . 75.31 113.181 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -39.51 90.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.407 1.003 . . . . 61.11 109.734 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -96.48 163.61 12.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.285 1.034 . . . . 73.01 108.865 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.92 171.08 7.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.001 1.321 . . . . 74.44 108.579 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 tp -146.12 133.75 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.554 1.142 . . . . 74.41 108.158 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -145.46 142.26 29.11 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.179 1.792 . . . . 75.12 108.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -114.14 155.83 25.32 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.525 1.53 . . . . 70.35 111.039 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -147.31 126.84 13.24 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 125.115 1.509 . . . . 64.24 111.18 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.87 126.03 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.474 -2.047 . . . . 74.31 105.474 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 49.48 34.53 6.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.761 1.164 . . . . 60.14 112.961 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp 60.88 31.14 20.0 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.063 -1.648 . . . . 64.23 110.154 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -130.18 161.38 31.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.324 1.85 . . . . 74.41 109.788 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -102.49 103.68 33.25 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 126.508 1.923 . . . . 74.35 108.832 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.6 136.99 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.539 1.492 . . . . 73.5 108.965 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.0 132.17 44.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.76 0.314 . . . . 72.22 110.311 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 p -51.89 -45.54 64.22 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.282 2.233 . . . . 64.31 112.703 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -73.74 -11.84 60.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.694 1.197 . . . . 51.44 114.047 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.42 146.74 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.037 1.289 . . . . 72.13 108.665 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 30.4 p -86.08 156.57 20.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.694 -0.629 . . . . 63.11 109.424 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.38 -44.44 97.15 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 118.538 -0.744 . . . . 74.15 110.641 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.11 -45.49 95.2 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.351 -0.928 . . . . 61.33 111.396 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.86 -49.46 72.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.799 0.8 . . . . 74.34 111.2 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.59 -46.69 88.19 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 123.055 0.542 . . . . 61.3 110.459 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.43 -56.92 14.89 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.252 1.021 . . . . 74.2 108.943 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.28 -32.0 64.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.623 -0.703 . . . . 73.02 111.37 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -25.26 20.26 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 116.342 -1.79 . . . . 71.3 113.828 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -103.42 -2.22 27.28 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.298 1.863 . . . . 71.42 112.604 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.23 121.72 1.18 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.114 2.165 . . . . 74.4 113.955 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.71 174.64 8.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.454 1.502 . . . . 71.15 110.132 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.49 -35.58 72.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.877 1.217 . . . . 63.33 108.525 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.15 12.92 31.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.77 0.828 . . . . 64.34 112.51 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.38 28.38 67.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.351 -1.249 . . . . 61.43 114.862 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -109.44 158.71 17.68 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.948 1.874 . . . . 75.42 107.932 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 138.0 54.13 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.608 -1.256 . . . . 71.35 107.608 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -122.35 131.5 53.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.657 1.183 . . . . 74.53 108.287 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.63 138.73 53.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.545 -1.28 . . . . 72.43 107.545 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.69 142.14 44.4 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.954 -2.239 . . . . 73.31 104.954 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -133.96 151.63 51.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.345 0.593 . . . . 75.55 110.432 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.9 t -147.21 165.04 31.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.689 -1.226 . . . . 65.22 107.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.81 15.61 19.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.079 -2.008 . . . . 74.22 108.079 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -115.42 115.94 27.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.401 1.88 . . . . 72.13 107.006 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -5.76 5.56 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.467 1.284 . . . . 74.05 114.467 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.19 131.66 25.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.502 1.521 . . . . 73.2 108.894 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -117.22 9.56 13.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.533 1.533 . . . . 73.44 111.78 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.845 1.688 . . . . 73.41 110.69 -179.481 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 110.87 -0.892 . . . . 72.21 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -95.04 68.86 3.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.282 1.433 . . . . 74.43 108.799 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -115.79 13.98 16.22 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.424 1.268 . . . . 73.11 114.424 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -71.25 51.27 0.16 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.479 2.312 . . . . 72.04 112.826 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 13.9 pt -64.35 140.4 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.707 -1.245 . . . . 70.44 109.104 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 63.7 mt -108.24 -21.76 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.456 1.502 . . . . 73.34 110.129 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -83.65 83.54 7.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 120.911 -1.118 . . . . 75.12 111.939 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.07 109.49 14.57 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 101.864 -3.384 . . . . 75.22 101.864 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.52 -30.58 59.85 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.154 -0.966 . . . . 75.3 112.092 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -88.1 155.19 19.92 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.432 1.093 . . . . 75.15 110.729 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.26 -63.16 1.47 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 71.0 113.324 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 58.1 m95 57.22 61.16 2.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.91 0.777 . . . . 75.23 111.62 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.49 135.68 15.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.384 -1.086 . . . . 74.01 110.384 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.9 123.79 32.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 118.756 1.278 . . . . 73.24 110.006 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -132.37 118.83 19.89 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.534 1.134 . . . . 72.22 109.14 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.9 tt -83.17 118.57 23.69 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.724 1.61 . . . . 72.13 108.44 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.31 128.63 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.679 1.192 . . . . 65.43 110.741 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.9 p -159.31 153.46 23.62 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 74.13 108.639 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.172 1.789 . . . . 73.44 106.515 178.535 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.658 -0.497 . . . . 75.13 109.658 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.88 -168.61 14.18 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.686 1.612 . . . . 74.31 110.02 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -76.08 111.13 11.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.089 -0.708 . . . . 74.21 109.089 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -51.53 -45.76 63.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.082 0.944 . . . . 74.43 110.737 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -60.55 -40.62 92.25 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 121.499 -0.75 . . . . 74.31 112.726 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -67.1 -36.31 81.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.616 0.766 . . . . 74.22 112.177 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -67.59 -41.01 84.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.626 -0.879 . . . . 73.15 108.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -75.12 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.738 -0.664 . . . . 70.1 111.6 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.413 ' CE1' ' HD1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -160.61 125.13 3.67 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.696 1.998 . . . . 74.25 110.374 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.3 p -117.11 -65.85 1.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 116.305 -1.807 . . . . 73.03 114.211 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.1 mt -48.0 -58.36 4.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.326 1.875 . . . . 73.31 114.842 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.5 -37.09 85.95 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.215 -0.928 . . . . 70.34 111.785 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.413 ' HD1' ' CE1' ' A' ' 9' ' ' HIS . 6.7 t60 -62.97 -57.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.303 1.041 . . . . 65.44 108.403 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -47.48 85.01 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.72 1.608 . . . . 65.23 110.987 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -56.57 -53.97 51.35 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.445 1.021 . . . . 72.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 HG11 ' HE2' ' A' ' 20' ' ' LYS . 43.6 t -63.07 -47.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 122.398 -0.189 . . . . 75.02 111.262 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -57.0 -52.11 66.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.947 1.299 . . . . 75.14 110.335 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -60.19 -48.28 82.39 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.985 1.314 . . . . 73.0 110.455 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -49.39 76.74 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.42 0.555 . . . . 54.42 110.943 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HE2' HG11 ' A' ' 16' ' ' VAL . 55.3 mtmt -65.39 -44.31 87.89 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.631 0.372 . . . . 72.45 110.55 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.72 -42.64 95.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.365 -1.303 . . . . 73.33 110.402 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.08 -33.76 72.31 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 120.325 1.421 . . . . 73.34 110.263 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -47.12 74.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 119.465 -0.894 . . . . 75.11 109.986 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -77.75 -47.27 19.46 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.346 1.239 . . . . 73.11 114.346 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -129.25 77.27 77.88 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.562 1.945 . . . . 70.42 109.755 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.63 -28.71 44.38 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.159 2.572 . . . . 75.34 112.487 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -89.66 14.02 12.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.905 0.482 . . . . 72.22 111.948 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -120.48 146.24 46.46 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.849 -1.537 . . . . 74.24 106.849 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.57 143.49 28.27 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.191 -1.04 . . . . 74.4 108.191 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.03 127.2 8.35 Favored 'Trans proline' 0 C--N 1.352 0.752 1 C-N-CA 125.725 4.283 . . . . 72.15 113.095 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.59 145.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.863 0.865 . . . . 75.01 111.16 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.4 mm -122.09 135.44 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 103.8 -2.667 . . . . 71.12 103.8 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -122.68 114.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.854 1.262 . . . . 74.45 108.511 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.86 153.92 46.98 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 71.1 108.893 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -93.48 153.4 18.49 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.147 -0.971 . . . . 75.54 113.036 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.66 126.07 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.616 -1.994 . . . . 75.35 105.616 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.0 t -58.79 141.09 54.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.75 -0.463 . . . . 74.05 109.75 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.52 23.95 77.05 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.233 -1.315 . . . . 74.01 113.964 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 t -97.58 142.3 29.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.527 1.663 . . . . 71.24 108.211 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -65.81 -9.74 31.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.227 1.195 . . . . 70.12 114.227 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.37 160.82 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.277 0.944 . . . . 74.02 111.138 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -64.2 142.24 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.272 -1.01 . . . . 74.21 108.272 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.32 161.27 28.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.635 1.174 . . . . 73.12 107.852 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 tt -120.68 135.48 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.677 -1.231 . . . . 74.34 107.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.49 159.7 32.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.885 -1.524 . . . . 74.24 106.885 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -73.9 108.17 6.56 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.495 -1.378 . . . . 73.4 110.285 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -136.04 159.07 42.82 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.823 1.249 . . . . 75.44 112.021 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 14.8 mttt -104.68 99.26 8.92 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 105.42 -2.067 . . . . 74.24 105.42 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.73 116.76 23.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.706 1.602 . . . . 74.44 110.016 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.6 120.0 40.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 117.43 -1.271 . . . . 74.22 109.394 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -113.07 142.97 28.26 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 120.281 1.401 . . . . 74.13 111.527 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.18 141.17 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.767 1.645 . . . . 71.43 108.576 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -62.98 -18.25 63.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.206 2.202 . . . . 73.23 113.227 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -82.67 -30.69 29.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.213 1.19 . . . . 64.12 114.213 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.89 170.52 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.715 0.769 . . . . 73.42 111.393 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -107.13 156.92 18.28 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.124 0.97 . . . . 74.12 111.688 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.28 -35.91 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.858 1.663 . . . . 74.44 109.631 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.39 93.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.768 1.227 . . . . 75.32 111.539 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.33 -42.15 93.24 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.925 -0.768 . . . . 73.34 108.925 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.46 -44.04 93.07 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.165 -1.05 . . . . 65.41 108.165 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.5 ttp -59.65 -48.39 81.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.43 -0.795 . . . . 71.31 110.927 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -58.89 -42.0 88.5 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.342 0.974 . . . . 75.04 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -66.42 -43.27 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.015 -0.993 . . . . 74.32 109.699 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.48 -50.7 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 120.212 1.369 . . . . 75.42 110.1 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -59.67 -39.19 83.65 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.996 -1.065 . . . . 71.34 111.513 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -70.81 -39.07 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.018 0.826 . . . . 63.35 110.615 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -60.15 -49.3 78.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.529 1.132 . . . . 75.22 109.708 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.4 pt -79.23 -0.95 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.949 0.34 . . . . 73.3 111.476 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 55.65 52.86 10.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.386 1.474 . . . . 75.3 108.696 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.49 106.63 1.62 Allowed Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 126.856 2.062 . . . . 73.24 108.452 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.32 157.69 56.26 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.327 2.018 . . . . 73.11 109.653 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -58.48 -28.08 65.03 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.485 -0.76 . . . . 60.31 112.713 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.65 -33.04 71.02 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.335 1.054 . . . . 75.04 112.214 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.33 164.26 11.78 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.36 -1.348 . . . . 75.13 107.36 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.4 172.31 6.93 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.876 1.271 . . . . 54.42 108.789 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -143.98 117.22 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.44 1.096 . . . . 74.43 108.587 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.59 137.55 54.38 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.67 -1.604 . . . . 71.4 106.67 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.9 148.92 33.94 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.008 1.323 . . . . 75.02 109.532 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -143.55 128.26 18.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.692 1.197 . . . . 75.14 109.962 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.95 122.12 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.204 -1.406 . . . . 72.42 107.204 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.06 34.46 14.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.34 1.456 . . . . 72.22 111.251 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 63.9 26.62 14.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.721 1.208 . . . . 73.53 110.322 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -119.58 161.88 19.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.456 1.102 . . . . 64.11 109.326 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.7 103.34 27.61 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 104.524 -2.399 . . . . 74.21 104.524 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.56 142.83 45.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.047 1.831 . . . . 73.41 110.374 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -77.47 114.22 16.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.825 -1.546 . . . . 61.35 106.825 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.0 m -54.39 -26.84 32.73 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.129 1.772 . . . . 71.44 112.818 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -86.89 -6.61 58.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.399 -0.813 . . . . 74.32 113.056 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 tp -75.15 158.58 32.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.569 1.077 . . . . 75.34 108.933 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.3 p -93.24 161.81 14.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.465 0.575 . . . . 74.15 109.72 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.9 mmm -64.27 -46.68 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.906 -1.045 . . . . 75.3 111.653 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.04 74.72 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.333 0.97 . . . . 62.12 111.172 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.72 -51.96 62.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.751 0.82 . . . . 72.43 110.628 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 tt -59.04 -44.14 91.75 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.511 -0.28 . . . . 75.44 110.58 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -65.69 -54.71 23.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.876 0.762 . . . . 74.31 109.544 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -58.67 -30.7 67.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.043 0.838 . . . . 72.51 111.638 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -40.85 16.76 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.367 -1.301 . . . . 73.35 110.36 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.53 6.51 43.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.042 1.292 . . . . 70.24 113.306 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.51 121.26 6.11 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.429 1.468 . . . . 74.32 111.731 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.14 174.89 4.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.047 2.139 . . . . 73.0 110.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.15 -30.76 68.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.654 -1.279 . . . . 73.52 108.939 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.31 6.82 40.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.184 2.194 . . . . 72.54 112.768 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.73 28.41 65.51 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.482 -1.176 . . . . 71.51 116.007 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.06 134.96 54.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.08 1.94 . . . . 73.45 107.453 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.38 133.45 39.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.509 1.05 . . . . 71.23 109.408 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -123.14 123.72 41.44 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.843 1.657 . . . . 74.55 107.726 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.04 136.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 124.729 1.212 . . . . 73.12 109.543 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.39 148.86 32.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.446 0.698 . . . . 73.13 110.815 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -132.96 155.16 49.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.51 0.929 . . . . 75.34 113.51 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.8 p -146.61 159.47 43.4 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.506 0.67 . . . . 71.22 110.881 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.21 22.31 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.818 1.675 . . . . 61.44 112.08 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -121.14 127.38 51.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.794 1.638 . . . . 74.21 107.593 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.0 -28.03 64.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.059 0.944 . . . . 73.21 109.938 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.19 121.06 28.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.604 1.961 . . . . 65.01 106.147 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -117.06 11.03 14.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.598 1.159 . . . . 71.23 111.909 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 116.488 -2.284 . . . . 73.25 110.666 -179.47 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 109.123 -1.591 . . . . 72.34 109.123 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -56.64 164.84 1.32 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.389 1.076 . . . . 72.4 111.107 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 35.0 mtm -108.32 70.49 0.76 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.459 1.103 . . . . 71.23 108.525 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.07 49.9 1.08 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.107 1.763 . . . . 75.23 109.754 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 47.5 pt -67.79 164.66 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 120.56 -1.338 . . . . 61.42 111.705 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.15 -6.07 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.181 0.592 . . . . 73.43 111.972 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -113.1 50.24 0.9 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.779 1.631 . . . . 73.21 109.791 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -82.95 108.67 16.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.143 -1.799 . . . . 71.42 106.143 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.43 -29.15 30.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.547 0.689 . . . . 72.34 111.572 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.77 124.28 27.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.91 1.684 . . . . 70.53 109.939 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -92.45 -63.41 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.296 0.953 . . . . 65.14 112.221 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . 0.42 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 50.8 m95 51.85 66.48 1.19 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.85 1.205 . . . . 75.14 112.956 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.69 145.0 21.59 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.027 -1.629 . . . . 60.32 109.027 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.0 134.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.418 1.609 . . . . 75.24 110.003 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -138.61 126.2 22.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.938 0.895 . . . . 65.31 110.579 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.81 118.51 29.46 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.386 -1.709 . . . . 71.25 106.386 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 14.7 t -122.35 113.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.279 0.474 . . . . 75.12 112.279 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 65.8 p -155.13 154.14 31.88 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.796 -1.187 . . . . 73.02 107.796 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.243 0.732 0 C-N-CA 126.936 2.095 . . . . 72.55 106.228 -179.728 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.055 -0.498 . . . . 74.14 110.108 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.83 64.6 4.21 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.282 0.944 . . . . 73.41 112.921 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -76.1 113.58 13.79 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -62.63 -42.74 99.76 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.394 -0.224 . . . . 74.32 110.394 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -56.77 -52.14 66.19 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.507 -0.553 . . . . 75.12 109.507 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -64.94 -34.11 77.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.063 1.345 . . . . 74.32 112.44 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -60.74 -48.89 79.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.441 -0.948 . . . . 73.31 108.441 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.49 -69.24 0.42 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.858 0.724 . . . . 70.33 110.147 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.01 143.66 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.962 1.305 . . . . 73.2 111.474 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 t -130.57 -65.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 117.322 -1.323 . . . . 75.31 112.566 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.2 mt -43.08 -60.69 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 116.477 2.028 . . . . 75.21 116.477 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.27 -48.01 68.98 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 120.719 -1.238 . . . . 73.14 110.418 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -51.91 -46.39 64.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.647 1.179 . . . . 74.24 111.052 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -43.69 91.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.683 -1.627 . . . . 71.31 108.439 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -64.38 -40.11 95.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.61 1.095 . . . . 73.51 110.46 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.15 -48.05 79.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 120.083 -1.635 . . . . 75.13 108.066 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -38.26 90.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.526 -0.749 . . . . 73.33 110.749 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -59.82 -48.05 83.27 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.448 -1.316 . . . . 61.44 107.448 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -50.56 71.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.821 0.448 . . . . 74.54 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -61.77 -52.03 65.91 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.843 0.857 . . . . 73.42 112.399 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.48 -41.79 72.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 116.689 -1.624 . . . . 74.33 111.037 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -64.5 -31.22 72.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.811 2.096 . . . . 70.11 109.263 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.03 -46.67 56.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.094 0.406 . . . . 54.23 110.84 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -77.81 -47.77 18.12 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.774 1.398 . . . . 73.21 114.774 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -126.22 80.59 68.32 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 126.273 1.829 . . . . 75.34 108.107 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.35 -35.3 51.23 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.556 2.171 . . . . 71.45 109.353 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.86 20.76 3.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.733 1.213 . . . . 71.42 114.272 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -125.84 155.77 40.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 120.214 -1.553 . . . . 75.55 108.01 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 m -126.91 138.73 33.26 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.019 0.928 . . . . 75.13 110.25 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.89 120.03 4.93 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 125.279 3.986 . . . . 72.43 113.307 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.5 135.61 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.003 1.321 . . . . 74.15 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.94 118.36 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.962 -2.236 . . . . 72.35 104.962 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.65 124.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.063 1.745 . . . . 75.15 106.895 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.97 139.17 54.06 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.54 -1.281 . . . . 72.21 107.54 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tmmt? -72.66 140.4 47.9 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.637 0.775 . . . . 75.11 110.414 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.84 126.17 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 125.008 1.323 . . . . 74.23 107.57 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.2 p -55.47 122.18 10.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.877 0.871 . . . . 64.3 109.359 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.73 9.42 66.34 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.618 -1.101 . . . . 75.41 114.723 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 t -86.06 146.44 26.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.364 1.582 . . . . 74.53 110.653 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -65.25 -24.86 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.411 1.084 . . . . 75.24 111.383 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -66.11 162.79 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.426 -1.422 . . . . 75.42 113.475 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.3 141.47 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 125.15 1.38 . . . . 75.33 108.359 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.401 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 2.6 p30 -81.78 170.21 15.99 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.588 0.755 . . . . 74.32 110.312 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 tt -126.65 149.56 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.222 1.409 . . . . 74.03 107.803 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -76.57 166.01 23.99 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.347 1.059 . . . . 75.34 109.164 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -73.71 95.77 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 74.52 106.402 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -134.94 159.07 42.62 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.239 1.416 . . . . 75.24 107.336 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -113.56 104.28 12.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.733 -1.21 . . . . 74.23 107.733 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -84.17 145.67 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.337 0.971 . . . . 74.14 110.381 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.44 112.1 18.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.594 1.558 . . . . 74.31 108.631 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.69 142.19 25.26 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.096 -0.954 . . . . 73.21 110.676 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.94 141.39 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.572 2.848 . . . . 72.54 112.72 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.29 -21.7 60.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.373 1.469 . . . . 75.31 114.562 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -78.54 -32.87 48.11 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 114.961 1.467 . . . . 63.4 114.961 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -73.52 166.07 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.707 1.14 . . . . 71.01 110.709 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -102.43 161.24 13.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.38 1.072 . . . . 71.54 109.934 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.16 -35.9 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.569 1.148 . . . . 75.21 110.396 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.3 93.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.909 0.777 . . . . 63.04 109.977 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -63.43 -46.32 86.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.619 -0.882 . . . . 73.23 108.619 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.49 -45.75 90.79 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.53 -0.545 . . . . 75.24 109.53 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.21 -40.18 84.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.992 0.917 . . . . 71.43 109.78 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -68.11 -39.18 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.647 0.658 . . . . 75.14 110.321 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.31 -44.49 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.888 -1.153 . . . . 74.31 107.888 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.76 -51.12 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.742 1.155 . . . . 71.01 111.147 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -59.93 -39.03 84.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.034 0.834 . . . . 74.21 110.834 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -70.06 -43.34 71.41 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.778 0.717 . . . . 75.0 109.967 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.84 -49.55 72.98 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.115 1.366 . . . . 74.34 110.936 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.69 -0.47 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.062 0.851 . . . . 72.2 112.181 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 58.3 55.74 4.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.328 1.451 . . . . 75.11 111.571 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.79 109.22 3.86 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 106.623 -1.621 . . . . 70.33 106.623 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.06 164.65 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.986 3.124 . . . . 73.22 111.683 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 m -60.09 -27.39 66.96 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.516 0.326 . . . . 70.32 111.114 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.48 -38.46 89.92 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.253 -0.879 . . . . 64.41 113.367 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 165.35 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.113 1.324 . . . . 65.41 112.115 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.03 177.36 4.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.968 1.707 . . . . 74.4 107.921 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tp -145.98 138.85 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.349 1.06 . . . . 74.31 110.353 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.39 139.49 26.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.351 1.86 . . . . 62.03 109.642 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.04 147.39 40.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.988 2.115 . . . . 74.41 107.598 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.46 123.18 17.49 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.741 -1.577 . . . . 73.11 106.741 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.94 123.36 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 108.52 -0.919 . . . . 64.44 108.52 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.88 35.34 1.08 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.053 1.741 . . . . 63.32 112.601 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 66.04 38.07 5.0 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.158 1.783 . . . . 74.41 113.484 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.0 p -135.1 157.59 46.54 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.942 2.097 . . . . 74.15 107.501 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.99 110.81 63.23 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 105.446 -2.057 . . . . 72.53 105.446 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.39 123.48 10.89 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.763 1.642 . . . . 72.41 109.545 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -67.23 124.41 23.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.47 0.708 . . . . 72.34 109.409 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.42 -33.26 65.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.668 1.187 . . . . 73.32 112.317 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -4.65 51.17 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.947 -1.095 . . . . 73.02 112.551 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.17 146.44 37.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.324 1.42 . . . . 74.33 108.936 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.21 149.07 26.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.977 0.911 . . . . 74.43 108.906 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.3 mmt -55.43 -49.41 72.49 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.721 -1.133 . . . . 73.22 110.109 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.91 -41.74 94.38 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.838 0.745 . . . . 73.43 112.295 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.49 -49.58 70.82 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.279 1.039 . . . . 74.32 109.247 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -44.43 96.0 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 124.661 1.184 . . . . 75.13 111.147 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.71 -50.68 72.51 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.154 1.381 . . . . 75.43 108.172 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -65.18 -28.51 69.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.184 -0.912 . . . . 73.51 112.357 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -28.56 17.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.309 -1.329 . . . . 72.34 113.644 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -105.17 -2.88 23.66 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.882 1.438 . . . . 74.42 114.882 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -37.92 121.42 0.93 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.351 2.261 . . . . 71.23 113.799 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.91 162.99 26.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.012 -1.107 . . . . 74.33 108.012 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.86 -31.76 67.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.901 0.88 . . . . 73.02 110.423 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -85.97 -35.36 20.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.898 -1.149 . . . . 64.0 107.898 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.21 3.84 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 117.626 1.81 . . . . 72.42 117.626 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -82.86 179.18 7.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.747 0.773 . . . . 73.32 111.246 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tp -122.51 124.49 43.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.365 -0.976 . . . . 75.11 108.365 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -108.19 113.27 26.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.148 1.379 . . . . 73.43 109.782 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.07 147.07 32.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.255 1.026 . . . . 75.43 109.991 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.81 148.52 36.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.744 -1.206 . . . . 73.13 107.744 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -137.27 153.94 50.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.382 0.61 . . . . 71.23 111.621 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -147.43 168.86 20.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.572 1.149 . . . . 54.5 108.204 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.38 18.28 15.76 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-O 118.761 -1.022 . . . . 74.32 112.049 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -137.47 134.21 35.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.448 1.624 . . . . 71.03 108.001 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -69.08 -6.44 28.33 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.946 2.202 . . . . 75.02 116.946 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.98 108.88 10.12 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.687 -1.597 . . . . 75.32 106.687 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -106.74 22.51 15.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.317 1.847 . . . . 74.45 112.816 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 127.126 2.298 . . . . 52.31 115.013 -179.627 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.56 0 N-CA-C 109.308 -1.517 . . . . 62.23 109.308 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -170.26 85.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.469 1.908 . . . . 55.13 106.102 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 43.1 mtt -82.56 28.82 0.46 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.44 -1.412 . . . . 73.42 112.188 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -67.98 47.72 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 130.245 3.418 . . . . 65.41 112.808 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 2.0 pp -69.37 162.43 3.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.05 -1.093 . . . . 75.22 108.05 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 35.9 mt -118.14 -58.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.095 -1.076 . . . . 75.33 108.095 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -74.62 83.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.4 1.08 . . . . 73.14 109.056 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -70.75 109.82 5.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 104.186 -2.524 . . . . 73.5 104.186 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -50.43 -33.43 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.867 1.667 . . . . 74.25 113.753 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -109.61 164.28 12.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.002 1.321 . . . . 74.31 111.405 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.9 -57.57 3.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.534 -0.543 . . . . 70.41 109.534 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 17.6 m95 48.97 55.62 9.01 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 126.072 1.749 . . . . 74.14 111.974 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.82 126.82 7.61 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.588 -1.005 . . . . 73.11 110.588 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 59.5 mt -68.77 138.13 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.132 0.966 . . . . 63.41 109.657 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.93 139.93 36.28 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.638 0.775 . . . . 75.54 112.836 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 77.6 mt -88.41 111.1 21.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.75 -1.574 . . . . 74.24 106.75 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.8 112.69 36.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.904 0.881 . . . . 72.02 110.645 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.4 p -161.24 160.83 30.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.184 0.994 . . . . 74.12 112.528 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 129.32 3.048 . . . . 72.32 113.7 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 109.373 -0.603 . . . . 74.34 109.373 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.38 159.93 18.7 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.54 2.019 . . . . 74.21 109.178 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -106.05 114.62 28.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.479 1.14 . . . . 74.1 111.206 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.974 0.51 . . . . 75.55 110.139 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -59.65 -46.82 87.86 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.067 -0.396 . . . . 75.44 111.523 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.93 -36.57 84.81 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.474 -0.774 . . . . 74.23 112.641 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -71.82 -41.01 68.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.859 0.754 . . . . 71.45 111.662 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' HB3' ' HD1' ' A' ' 9' ' ' HIS . 21.2 m-20 -75.02 -76.22 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.647 1.179 . . . . 73.12 110.854 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.432 ' HD1' ' HB3' ' A' ' 8' ' ' ASP . 1.6 p-80 -160.96 119.68 2.52 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.79 1.636 . . . . 71.13 107.417 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -106.89 -65.92 1.05 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.75 -0.594 . . . . 74.22 112.519 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -44.24 -59.24 2.46 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.986 2.115 . . . . 71.33 116.61 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 72.5 mt-10 -66.32 -36.55 83.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.667 1.121 . . . . 73.05 110.33 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.08 -54.73 37.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.202 -0.666 . . . . 75.43 109.202 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.11 89.54 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.835 1.654 . . . . 73.22 111.467 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -54.9 -53.28 57.5 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.814 0.734 . . . . 62.02 110.375 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.66 -46.73 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 122.795 0.438 . . . . 74.42 110.752 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.01 62.97 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.543 1.137 . . . . 62.13 112.462 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 m -65.03 -44.26 89.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.22 -0.895 . . . . 75.43 109.676 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.99 66.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.755 1.161 . . . . 74.52 110.602 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -47.95 83.71 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.939 1.295 . . . . 71.04 110.472 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.3 mt -64.16 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 117.472 -1.251 . . . . 72.4 110.046 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -62.68 -36.64 83.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 121.051 1.75 . . . . 73.42 109.386 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.55 59.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.125 -0.63 . . . . 75.33 111.805 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -79.03 -46.5 18.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.0 2.593 . . . . 73.53 118.0 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.38 81.62 54.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.786 2.035 . . . . 74.44 109.025 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.69 -23.9 55.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.044 2.496 . . . . 75.55 112.922 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.63 14.02 26.29 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.614 0.365 . . . . 74.43 110.365 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -121.57 154.05 37.22 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.913 -1.143 . . . . 75.24 107.913 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.86 142.75 46.09 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 123.753 0.821 . . . . 70.14 111.092 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.03 125.43 9.29 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.623 3.549 . . . . 64.43 111.438 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.02 140.87 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.989 -1.115 . . . . 74.44 107.989 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.89 117.86 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 103.034 -2.95 . . . . 74.52 103.034 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -105.78 120.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.911 -1.885 . . . . 72.5 105.911 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -124.67 146.21 49.24 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.602 0.761 . . . . 72.13 109.611 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -93.3 135.65 34.32 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.049 0.94 . . . . 75.44 109.735 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.21 130.65 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.377 -0.827 . . . . 73.41 109.193 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -63.72 156.59 26.6 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.45 -0.574 . . . . 71.34 109.45 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.86 -20.33 39.94 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.94 1.257 . . . . 63.12 112.996 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.531 ' HG ' ' HG2' ' A' ' 112' ' ' GLU . 16.3 t -84.56 142.95 29.63 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.15 -1.796 . . . . 74.05 106.15 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.44 -11.64 60.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.485 1.114 . . . . 73.41 112.484 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.429 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 2.1 tt -62.69 157.43 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.012 1.325 . . . . 75.4 111.498 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -66.11 156.19 6.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.12 1.368 . . . . 75.15 110.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -101.53 173.21 6.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.188 2.195 . . . . 63.14 114.652 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -125.22 136.44 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.612 1.565 . . . . 74.13 108.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.72 165.0 25.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.389 1.076 . . . . 72.4 108.203 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.06 94.81 2.44 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.259 -0.901 . . . . 75.33 111.393 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -129.56 162.42 28.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 125.205 1.402 . . . . 73.22 108.891 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 33.3 mtmt -108.81 101.74 10.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 104.385 -2.45 . . . . 72.23 104.385 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -93.46 120.73 34.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.223 0.465 . . . . 75.0 111.546 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.91 121.19 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.654 -0.869 . . . . 75.24 108.654 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.73 142.42 26.61 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.139 0.975 . . . . 73.51 109.257 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 138.69 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.954 1.769 . . . . 72.25 111.073 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -60.75 -16.77 43.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.27 2.628 . . . . 64.53 111.206 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.46 -34.66 58.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.914 1.45 . . . . 72.23 114.914 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.25 170.28 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.962 0.801 . . . . 74.51 112.199 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -100.26 166.32 11.04 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.909 0.883 . . . . 65.43 111.651 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.65 -34.73 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 O-C-N 121.597 -0.69 . . . . 74.14 109.244 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.89 92.46 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.363 1.065 . . . . 71.12 110.353 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -65.88 -45.25 82.76 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.875 0.87 . . . . 71.4 109.123 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.79 -48.22 82.01 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.719 -0.845 . . . . 75.4 108.719 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.8 ttp -59.51 -45.01 92.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.837 0.855 . . . . 74.11 110.856 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -60.18 -39.72 87.46 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.875 0.47 . . . . 65.25 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.34 -47.29 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 117.368 -1.301 . . . . 74.44 109.521 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.4 -50.89 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 120.374 1.443 . . . . 71.12 109.509 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -61.72 -36.97 82.49 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.346 -0.846 . . . . 63.53 112.183 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -67.4 -43.68 80.71 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-O 118.062 -0.971 . . . . 75.51 110.434 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -63.22 -47.56 81.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.744 1.618 . . . . 75.45 111.01 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -79.39 1.65 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.351 0.596 . . . . 74.55 110.977 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 50.56 59.44 4.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.795 2.438 . . . . 73.34 111.141 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.56 111.26 6.98 Favored Pre-proline 0 C--O 1.24 0.593 0 C-N-CA 125.66 1.584 . . . . 72.33 109.662 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.05 165.58 29.68 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.851 3.701 . . . . 72.41 113.329 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 p -60.91 -23.32 65.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.635 1.574 . . . . 73.14 113.7 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.27 -54.13 10.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.675 1.59 . . . . 74.32 112.826 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.52 163.47 23.71 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 113.284 0.846 . . . . 75.12 113.284 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.06 166.66 10.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.416 1.886 . . . . 73.44 107.62 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tt -154.4 130.5 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 125.218 1.407 . . . . 75.11 107.744 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -139.16 149.54 44.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.845 1.658 . . . . 73.13 107.713 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.1 mt -112.83 156.57 22.68 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.896 1.278 . . . . 72.34 109.5 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -147.41 140.24 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.286 1.435 . . . . 73.44 109.288 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 p -134.14 120.78 35.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 125.345 1.458 . . . . 74.23 107.211 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 t0 43.22 52.46 5.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 73.41 111.837 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 62.43 18.87 10.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.78 1.632 . . . . 75.04 113.766 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.4 p -125.9 160.12 30.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.788 1.631 . . . . 73.23 111.31 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.8 104.16 37.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.52 1.928 . . . . 74.31 106.542 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.43 155.41 69.24 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.528 2.152 . . . . 63.2 110.639 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -79.86 121.63 25.65 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.018 -0.734 . . . . 72.45 109.018 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 m -53.68 -31.4 47.63 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.243 1.201 . . . . 62.41 114.243 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 t -83.7 -8.29 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.706 1.002 . . . . 70.22 113.706 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.82 152.39 44.63 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.309 1.413 . . . . 64.31 109.625 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -88.88 150.01 23.08 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.037 -0.727 . . . . 72.3 109.037 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.8 mmt -58.15 -47.53 83.05 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 117.337 -1.316 . . . . 73.35 110.23 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.07 -48.52 46.08 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 121.227 1.83 . . . . 72.04 113.298 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -64.32 -50.0 69.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.281 1.032 . . . . 75.43 109.533 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.31 -47.86 80.42 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.699 0.8 . . . . 74.44 110.187 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -58.84 -55.17 38.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.912 1.285 . . . . 74.24 108.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -54.71 -43.55 72.66 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.401 0.889 . . . . 71.34 113.401 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -24.81 28.25 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 117.593 -1.194 . . . . 74.22 114.222 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.6 2.74 36.48 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.115 1.325 . . . . 71.33 112.72 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -53.77 126.4 21.94 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.604 1.562 . . . . 75.21 112.258 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.71 165.38 25.32 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.988 -1.116 . . . . 64.34 107.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.75 62.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.696 -1.253 . . . . 71.55 111.023 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.92 17.05 12.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.439 2.295 . . . . 62.02 111.014 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.43 15.33 38.52 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.663 3.03 . . . . 62.03 119.513 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -122.04 179.48 4.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.49 2.145 . . . . 73.3 111.124 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.14 124.47 45.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.796 . . . . 74.42 111.023 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -105.14 118.52 36.74 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.74 -1.207 . . . . 71.42 107.74 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.0 140.22 49.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.524 -0.735 . . . . 73.23 109.026 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 156.89 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.977 -1.077 . . . . 72.35 108.51 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -145.23 156.39 43.81 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.407 0.622 . . . . 74.2 110.083 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.35 170.43 17.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.513 -0.921 . . . . 73.11 108.513 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.84 30.28 7.25 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.522 1.535 . . . . 71.51 109.963 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HG2' ' HG ' ' A' ' 39' ' ' SER . 6.1 mm-40 -122.56 116.43 23.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.09 1.356 . . . . 72.23 110.449 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -62.22 -14.01 33.67 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.905 1.446 . . . . 72.35 114.905 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.81 141.73 33.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.281 1.401 . . . . 61.42 108.861 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -88.74 51.03 2.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.16 0.984 . . . . 74.51 111.756 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.636 0 CA-C-O 117.35 -1.806 . . . . 53.42 109.483 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.505 0 N-CA-C 109.135 -1.586 . . . . 75.21 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -153.4 -7.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 75.42 111.327 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 24.2 ttp -77.36 29.93 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.195 1.398 . . . . 73.4 112.555 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -74.65 51.09 0.46 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.064 2.146 . . . . 64.43 108.733 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 38.8 pt -76.92 165.24 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.957 1.703 . . . . 73.01 111.695 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 29.1 mt -99.31 -34.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.51 1.524 . . . . 74.3 109.199 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 44.28 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 73.55 112.975 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.8 152.96 43.98 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.796 -1.557 . . . . 71.24 106.796 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -74.99 -46.27 36.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.255 -1.017 . . . . 74.52 108.255 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.58 109.87 21.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.582 1.553 . . . . 64.42 110.544 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -58.61 -51.68 68.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.281 1.215 . . . . 73.51 114.281 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . 0.496 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 28.0 m95 55.12 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.567 1.147 . . . . 74.3 109.552 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -87.12 130.08 9.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.439 -1.413 . . . . 75.12 112.693 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 39.6 mt -68.78 128.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.3 1.55 . . . . 75.31 110.123 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -134.44 161.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.893 1.677 . . . . 65.31 111.282 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.5 116.51 31.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.119 -2.549 . . . . 74.14 104.119 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.13 104.3 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.959 -1.126 . . . . 74.31 107.959 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.7 p -147.56 160.6 42.45 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.217 1.407 . . . . 74.31 108.391 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 131.284 3.834 . . . . 73.42 116.148 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tmm? . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 117.697 -1.144 . . . . 73.52 108.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.28 90.65 0.08 OUTLIER Glycine 0 C--N 1.338 0.693 0 CA-C-N 119.97 1.259 . . . . 61.34 113.393 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -91.97 105.72 17.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.382 -2.081 . . . . 75.44 105.382 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -52.48 -38.74 60.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.638 0.775 . . . . 74.44 110.372 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -60.14 -41.08 91.95 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.099 -0.375 . . . . 74.14 111.874 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -67.16 -40.46 86.65 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.627 1.171 . . . . 71.11 109.354 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.57 -40.86 93.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.204 0.601 . . . . 74.5 110.352 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.78 -75.79 0.3 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.117 0.967 . . . . 73.43 112.102 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.423 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -160.78 119.9 2.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.056 1.342 . . . . 74.0 108.852 -178.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -119.65 -65.83 1.12 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 117.243 -1.36 . . . . 73.42 113.358 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.2 tp -47.23 -59.67 3.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 115.97 1.841 . . . . 74.55 115.97 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.44 -50.69 62.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.719 0.771 . . . . 74.02 111.122 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.423 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 1.8 t60 -53.88 -49.83 67.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.735 1.214 . . . . 74.51 111.123 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -67.22 -39.34 86.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 116.587 -1.673 . . . . 74.4 109.93 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.25 -55.52 33.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.252 1.387 . . . . 72.54 110.917 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.73 -48.0 81.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.053 1.341 . . . . 73.34 109.925 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.32 -42.79 87.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 118.182 -0.913 . . . . 72.23 112.151 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.6 p -61.56 -43.04 99.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.81 1.186 . . . . 63.32 108.82 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.6 -50.42 73.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.902 0.773 . . . . 73.04 109.938 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.05 -48.18 77.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.889 -0.507 . . . . 74.01 111.771 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.91 -42.34 94.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 118.004 -0.998 . . . . 75.21 109.97 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -65.73 -34.38 78.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.992 1.269 . . . . 72.4 110.068 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.54 -45.86 51.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.244 -0.408 . . . . 72.35 111.042 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -77.1 -46.46 23.52 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.059 0.845 . . . . 73.2 113.096 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -122.22 79.35 44.05 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.953 2.101 . . . . 74.33 109.977 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.49 -13.46 30.26 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.534 2.823 . . . . 72.23 112.95 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 18.28 20.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.682 1.593 . . . . 74.32 110.569 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -125.11 147.75 48.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.478 1.111 . . . . 73.24 108.511 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.16 133.14 23.18 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.621 1.168 . . . . 74.2 109.781 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.07 117.5 3.55 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.533 3.488 . . . . 74.52 112.13 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.56 151.19 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.852 1.261 . . . . 64.44 110.129 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.36 120.88 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 104.467 -2.42 . . . . 74.21 104.467 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.75 115.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.147 1.779 . . . . 72.32 108.684 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.38 151.3 51.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 74.51 110.184 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -94.06 158.49 15.59 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.108 -0.995 . . . . 72.34 113.372 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.61 129.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.005 -2.591 . . . . 75.44 104.005 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.1 p -53.0 153.19 3.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.654 0.74 . . . . 75.51 112.142 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.89 -17.69 1.23 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.064 1.793 . . . . 52.23 113.136 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -62.16 124.49 20.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 119.272 1.536 . . . . 62.12 108.69 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -64.4 -12.89 47.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.961 1.304 . . . . 73.41 112.9 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.45 151.54 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.475 -1.306 . . . . 75.53 107.475 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -46.97 141.89 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.733 1.213 . . . . 74.41 112.576 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.15 150.74 41.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.799 -1.546 . . . . 73.44 110.616 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.27 123.46 63.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.724 -1.584 . . . . 75.53 106.724 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.51 165.86 24.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.526 -0.916 . . . . 72.02 108.526 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.82 95.18 1.89 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.272 0.558 . . . . 73.4 111.365 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -132.12 161.86 32.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.562 1.945 . . . . 72.05 109.009 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -112.3 142.27 45.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.69 1.196 . . . . 73.11 108.624 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -122.94 132.63 54.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.792 0.437 . . . . 64.4 109.848 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.66 113.17 21.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.888 1.675 . . . . 70.51 108.282 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.11 142.87 26.83 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-O 118.218 -0.896 . . . . 74.13 110.224 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.34 139.73 55.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.697 1.598 . . . . 74.24 111.274 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -12.29 30.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.708 1.203 . . . . 61.21 112.6 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.54 -35.07 58.47 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.155 1.782 . . . . 63.42 112.94 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.24 169.46 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 122.018 0.913 . . . . 75.32 110.69 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -107.16 168.47 9.19 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.282 -0.886 . . . . 64.32 112.086 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.19 -35.26 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.86 -1.533 . . . . 64.24 106.86 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.18 87.35 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 121.381 -0.824 . . . . 75.52 110.654 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.17 -45.69 76.22 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 118.33 -0.843 . . . . 74.03 110.923 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.25 -44.14 88.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.663 0.665 . . . . 73.44 109.602 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 34.5 ttp -65.11 -43.98 90.22 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 117.772 -1.109 . . . . 72.43 111.733 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -59.67 -46.77 88.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.545 1.066 . . . . 75.33 109.182 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.3 mt -60.35 -48.08 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 117.862 -1.066 . . . . 74.44 108.63 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.35 -50.27 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.874 1.215 . . . . 70.12 110.121 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -61.19 -33.17 73.02 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.864 -1.147 . . . . 74.41 111.74 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.15 -38.34 60.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.085 0.857 . . . . 73.14 110.209 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -60.28 -46.02 91.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.334 1.454 . . . . 71.13 110.291 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.6 pt -79.25 -6.47 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 109.969 -0.382 . . . . 72.34 109.969 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 54.93 59.78 3.86 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 126.55 1.94 . . . . 74.31 109.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.04 108.85 3.09 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.443 1.897 . . . . 72.53 111.098 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.48 151.09 70.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.451 2.101 . . . . 73.53 108.586 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 p -60.28 -25.05 65.42 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.257 -0.902 . . . . 74.15 112.431 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.87 -38.44 78.82 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.719 0.807 . . . . 73.42 110.402 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -96.14 164.7 12.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.513 1.125 . . . . 74.25 108.775 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.88 174.89 5.67 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.145 1.378 . . . . 73.34 108.257 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tp -153.15 136.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.696 -1.224 . . . . 75.51 107.696 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.98 141.12 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.106 1.362 . . . . 72.44 108.149 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.18 151.3 32.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.595 -1.261 . . . . 61.13 107.595 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -141.21 123.59 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.182 0.993 . . . . 74.23 108.575 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.68 140.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.226 -1.398 . . . . 74.03 107.226 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t0 52.11 31.93 9.68 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 122.114 0.959 . . . . 73.51 112.197 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.6 mttm 65.83 25.17 11.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.399 1.88 . . . . 74.4 111.821 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -152.08 163.03 40.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.404 1.082 . . . . 73.43 110.816 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 121.01 74.62 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.038 -2.208 . . . . 70.54 105.038 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.31 140.0 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.057 2.505 . . . . 73.33 109.695 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -67.69 124.76 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.505 1.122 . . . . 73.42 109.841 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.9 m -53.17 -27.8 23.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.849 1.66 . . . . 72.14 113.693 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.6 m -75.18 -17.93 60.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.256 1.022 . . . . 62.44 112.214 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.69 153.08 44.51 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.631 1.172 . . . . 74.44 108.812 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -101.03 153.74 19.29 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.109 -0.7 . . . . 75.42 109.109 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.33 -49.61 76.59 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 119.132 -0.461 . . . . 74.25 111.682 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.96 -44.97 92.57 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.237 -0.745 . . . . 64.34 111.237 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.44 -53.33 59.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.733 1.213 . . . . 72.51 110.977 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.74 -51.48 69.58 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.238 1.015 . . . . 72.04 109.718 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.29 -44.6 79.97 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.159 1.383 . . . . 71.34 110.085 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.58 -38.53 91.34 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.839 0.745 . . . . 72.4 111.939 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.05 -24.28 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.484 -1.246 . . . . 63.24 113.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.76 -4.18 22.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.001 1.273 . . . . 75.4 114.301 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.73 120.66 2.72 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.301 1.041 . . . . 74.12 113.647 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.74 175.29 10.57 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.654 -1.98 . . . . 73.34 105.654 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.41 -12.44 14.43 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.762 -1.837 . . . . 74.22 112.873 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.71 6.04 43.85 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.958 1.703 . . . . 74.35 113.651 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.39 68.56 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.706 -0.622 . . . . 71.35 111.815 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.27 164.6 21.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.538 1.535 . . . . 75.25 108.863 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.04 139.67 53.72 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 124.57 1.169 . . . . 74.03 108.667 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -121.48 122.92 40.81 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.284 -1.006 . . . . 72.1 108.284 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.32 133.06 67.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 120.776 -1.202 . . . . 74.11 108.979 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.81 160.27 14.75 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.683 -0.636 . . . . 70.45 110.009 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 35' ' ' LYS . 21.3 p90 -142.13 157.07 45.31 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.446 0.699 . . . . 71.03 111.924 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.9 p -149.22 158.54 44.26 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.988 -0.745 . . . . 55.31 108.988 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.43 29.98 7.26 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.218 1.39 . . . . 74.32 111.542 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.0 142.51 25.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.475 1.51 . . . . 74.44 107.549 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.81 -44.4 73.6 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.095 0.958 . . . . 73.21 111.007 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.73 141.59 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.083 1.753 . . . . 65.13 109.162 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.48 14.87 24.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.92 1.688 . . . . 65.21 109.75 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 N-CA-C 106.565 -2.614 . . . . 54.23 106.565 -179.457 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.891 0 N-CA-C 109.391 -1.483 . . . . 54.24 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -142.58 77.59 1.58 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.381 -2.081 . . . . 71.32 105.381 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 90.1 mmm -112.47 15.44 20.19 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.041 1.337 . . . . 72.12 112.696 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -101.31 45.0 0.98 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.564 -0.902 . . . . 71.34 108.564 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 15.7 mm -82.57 158.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.186 -2.894 . . . . 74.05 103.186 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 35.2 pt -62.41 -6.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 114.156 1.169 . . . . 75.53 114.156 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -111.92 65.24 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.001 1.32 . . . . 72.43 110.326 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -68.71 127.65 33.83 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.395 -0.965 . . . . 74.54 108.395 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.81 -59.1 4.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.273 -1.381 . . . . 74.14 107.273 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -83.91 116.86 22.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.839 -1.541 . . . . 75.1 106.839 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.67 -40.57 69.52 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.354 1.613 . . . . 72.14 115.354 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 30.4 m95 50.07 60.45 3.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.023 1.729 . . . . 73.32 115.307 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.53 137.17 17.12 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.746 -1.341 . . . . 60.21 109.746 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 26.0 mt -77.63 137.1 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.658 1.583 . . . . 75.3 113.154 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.06 142.83 50.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.299 2.24 . . . . 75.22 108.141 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.02 111.17 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.022 1.729 . . . . 74.21 110.931 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.91 125.82 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 113.523 0.934 . . . . 70.03 113.523 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -143.15 110.51 5.76 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.522 1.529 . . . . 73.25 108.198 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.022 1.729 . . . . 71.43 111.661 179.784 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.53 0.681 . . . . 73.43 111.992 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.6 -145.18 17.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 107.094 -2.402 . . . . 60.1 107.094 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -74.23 125.37 28.27 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.131 0.972 . . . . 74.42 109.076 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.64 -48.41 81.89 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.714 -0.847 . . . . 72.21 108.714 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.83 -34.37 74.45 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 118.863 -0.589 . . . . 72.04 111.282 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -64.74 -42.09 95.45 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 120.038 1.29 . . . . 72.41 109.643 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.88 -47.16 86.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.645 -0.872 . . . . 65.23 108.645 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.52 -75.45 0.1 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.212 1.805 . . . . 73.21 113.021 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.23 130.94 5.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.703 2.801 . . . . 73.43 109.505 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.3 p -114.73 -66.63 1.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.215 -1.553 . . . . 75.11 114.266 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.84 -57.36 10.48 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 124.83 1.252 . . . . 73.35 113.943 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.22 -56.13 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.172 0.442 . . . . 74.33 111.398 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -52.26 -49.95 63.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.529 1.132 . . . . 73.12 110.836 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.86 76.05 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 117.882 -1.056 . . . . 75.5 112.183 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.6 m -60.35 -51.74 68.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 120.379 1.445 . . . . 74.44 109.264 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.57 -47.34 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.353 -0.61 . . . . 74.44 109.353 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -55.64 -49.98 71.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.434 1.094 . . . . 75.14 109.982 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.1 m -60.51 -48.56 81.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.944 0.897 . . . . 72.53 110.198 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.43 90.58 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.694 1.134 . . . . 71.32 111.562 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -47.64 77.32 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.226 1.411 . . . . 73.21 109.475 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.05 -42.38 79.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-O 117.784 -1.103 . . . . 73.14 111.807 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -65.16 -39.1 92.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 119.572 1.078 . . . . 70.44 109.7 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.2 -46.91 66.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.07 -0.652 . . . . 70.54 110.921 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -78.16 -38.31 43.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.276 1.954 . . . . 74.34 116.276 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -136.55 74.14 53.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.352 1.861 . . . . 73.25 109.777 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.78 -24.09 54.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.421 2.747 . . . . 75.3 110.726 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.99 12.17 18.38 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.6 -0.687 . . . . 74.55 112.726 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -119.89 154.08 34.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.572 -1.27 . . . . 74.32 107.572 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.82 139.98 27.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.166 -0.679 . . . . 74.54 109.166 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.075 3.85 . . . . 75.41 112.169 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.2 131.93 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.909 -0.775 . . . . 74.21 108.909 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.75 133.59 55.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.367 -2.457 . . . . 75.24 104.367 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.57 137.45 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.777 1.399 . . . . 72.53 114.777 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.84 152.61 43.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.115 0.966 . . . . 70.42 109.913 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -93.39 155.74 17.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.15 135.08 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.088 -1.819 . . . . 73.41 106.088 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.09 133.13 38.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.107 0.563 . . . . 73.22 111.975 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.57 3.95 43.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.645 -1.086 . . . . 64.13 114.144 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 t -62.5 146.02 52.74 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.685 1.742 . . . . 75.34 111.048 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -65.86 -14.89 62.32 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.825 2.05 . . . . 72.21 112.856 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -77.66 159.08 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.398 -0.814 . . . . 65.23 109.965 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.25 150.06 11.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.789 -0.819 . . . . 74.14 108.789 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.6 164.58 25.79 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.522 0.729 . . . . 70.34 112.105 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.82 148.57 20.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.161 1.785 . . . . 71.21 106.317 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -87.14 157.44 19.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.452 -0.944 . . . . 65.54 108.452 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.87 100.72 3.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.5 -1.296 . . . . 75.23 107.5 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -136.41 161.99 34.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.118 1.767 . . . . 75.44 110.198 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -108.81 95.48 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.178 2.591 . . . . 73.11 104.018 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -89.29 120.02 30.28 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.16 -0.963 . . . . 71.53 112.383 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.71 115.16 28.83 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.96 1.704 . . . . 74.23 109.625 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 141.47 25.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 117.82 -1.085 . . . . 71.03 111.361 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.43 140.7 48.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.281 2.654 . . . . 51.22 110.893 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 m -63.87 -16.33 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.489 1.516 . . . . 75.14 113.34 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.82 -30.43 28.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.295 1.438 . . . . 72.11 113.743 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -71.03 165.59 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 119.018 -1.073 . . . . 74.42 109.257 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -107.02 165.39 11.38 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.587 0.755 . . . . 75.23 110.25 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 t -53.99 -34.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.942 -1.132 . . . . 75.45 107.942 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.38 90.48 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.16 1.384 . . . . 74.52 111.135 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -69.21 -44.62 71.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.838 -0.801 . . . . 75.31 108.838 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.06 -48.6 81.03 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.429 -0.582 . . . . 75.5 109.429 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ttt -54.05 -48.07 70.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.626 1.17 . . . . 71.42 109.553 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.007 -0.521 . . . . 73.22 111.767 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.4 mt -57.32 -44.18 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.067 -0.716 . . . . 73.33 109.067 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mt -59.53 -50.63 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.427 0.558 . . . . 74.54 110.725 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -65.33 -37.27 86.59 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.08 -1.012 . . . . 71.12 111.949 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -64.94 -47.09 78.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.063 0.945 . . . . 72.31 110.29 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.89 -42.29 97.5 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.816 1.246 . . . . 74.34 113.011 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.65 -8.64 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 119.818 -0.753 . . . . 73.34 109.747 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.68 60.52 1.6 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.797 2.039 . . . . 73.35 108.841 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.32 110.44 8.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.664 1.186 . . . . 74.13 110.015 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.84 164.47 29.41 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.715 2.943 . . . . 72.14 112.389 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 p -64.28 -21.05 66.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.99 0.916 . . . . 74.21 111.498 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.47 -50.54 25.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.406 0.683 . . . . 73.42 112.794 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.12 164.24 15.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.777 -0.824 . . . . 71.31 108.777 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.23 -178.45 3.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.971 -1.122 . . . . 74.1 107.971 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -150.74 141.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.648 1.579 . . . . 74.21 107.171 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -145.27 139.41 27.1 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 127.288 2.235 . . . . 75.33 107.965 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.9 150.49 35.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.877 0.871 . . . . 74.42 111.135 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -145.25 133.83 22.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.549 1.14 . . . . 73.44 109.75 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 p -132.91 127.93 56.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 105.043 -2.206 . . . . 75.32 105.043 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.32 30.55 10.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.178 1.354 . . . . 74.01 110.863 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt 61.13 25.27 15.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 72.15 110.928 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -119.37 161.57 20.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.623 1.569 . . . . 71.41 109.72 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.2 103.62 21.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.356 -2.09 . . . . 75.15 105.356 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.15 142.7 38.47 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.31 2.007 . . . . 74.33 111.569 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -75.41 121.91 23.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.071 -0.715 . . . . 72.33 109.071 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -49.06 -42.21 37.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.854 2.062 . . . . 63.42 112.665 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -72.92 -11.37 60.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.769 1.228 . . . . 74.2 113.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.69 157.34 36.72 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.579 1.536 . . . . 71.51 109.733 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.03 152.45 18.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.192 1.397 . . . . 64.12 110.085 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.3 mmm -60.7 -43.56 97.62 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.034 -0.53 . . . . 73.01 111.613 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.51 99.71 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.479 -0.623 . . . . 71.25 111.782 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -66.15 -50.18 64.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.017 0.909 . . . . 63.54 109.412 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.23 -35.17 76.5 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.204 -0.295 . . . . 74.2 110.204 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.72 -48.96 67.59 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 120.063 -1.648 . . . . 63.12 109.619 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.92 -28.68 68.5 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.496 -0.752 . . . . 73.23 112.087 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -24.36 19.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 116.6 -1.667 . . . . 53.24 113.86 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.13 -2.97 13.3 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.704 1.742 . . . . 74.51 115.704 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 124.29 6.39 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.259 1.39 . . . . 74.31 113.967 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -77.62 175.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.937 -1.505 . . . . 74.42 106.937 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -58.91 -27.39 65.21 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 119.838 -1.789 . . . . 71.43 113.896 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -79.11 7.76 6.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 75.4 111.131 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.49 69.3 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.616 1.579 . . . . 72.23 114.94 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.77 172.65 10.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.447 1.899 . . . . 74.33 110.789 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.63 141.56 52.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.616 -0.513 . . . . 71.44 109.616 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -113.23 123.67 50.72 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.766 1.226 . . . . 75.11 111.795 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.2 136.81 57.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 122.801 1.286 . . . . 65.33 111.117 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.19 142.74 46.42 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.628 -1.619 . . . . 54.42 106.628 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -133.21 155.54 49.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.457 0.646 . . . . 74.25 110.758 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.3 p -150.97 155.9 40.06 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.567 -0.901 . . . . 73.24 108.567 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.36 9.21 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 119.39 -0.672 . . . . 71.43 112.769 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.28 135.86 41.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.219 1.01 . . . . 72.24 109.169 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -78.12 -15.76 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.216 1.406 . . . . 74.42 112.243 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -131.78 126.76 35.2 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.087 1.355 . . . . 71.3 109.655 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.62 9.72 13.21 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.614 1.966 . . . . 74.54 114.892 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 C-N-CA 128.1 2.762 . . . . 53.15 114.483 -178.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.585 0 N-CA-C 108.734 -1.746 . . . . 74.44 108.734 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -144.02 156.23 44.31 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.842 0.857 . . . . 74.14 111.529 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 20.6 ttt -117.15 46.73 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.734 2.014 . . . . 74.31 110.564 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.68 51.58 0.61 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.596 1.558 . . . . 64.25 108.323 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 pt -69.31 165.69 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.951 1.7 . . . . 74.41 110.534 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.12 -34.16 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.723 1.209 . . . . 71.03 109.415 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -82.25 81.51 8.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.428 0.691 . . . . 73.12 109.98 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -127.27 139.6 52.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.755 1.622 . . . . 63.44 106.738 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.88 -27.14 62.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 65.1 113.634 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -109.33 147.33 32.88 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.737 -1.208 . . . . 71.24 107.737 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -81.96 -53.62 5.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 115.572 1.693 . . . . 73.2 115.572 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.3 m95 53.74 58.52 5.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.398 1.079 . . . . 75.55 109.758 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.15 139.86 20.86 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 108.252 -1.939 . . . . 64.22 108.252 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 133.83 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 118.871 1.335 . . . . 74.14 109.698 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.09 138.36 48.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.747 1.219 . . . . 72.13 109.444 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.72 118.97 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 103.152 -2.907 . . . . 71.44 103.152 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.45 119.24 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.898 0.879 . . . . 75.34 109.522 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -161.47 123.99 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.42 0.688 . . . . 72.24 109.748 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 128.234 2.614 . . . . 75.45 112.902 -179.213 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.211 0.529 . . . . 74.23 111.673 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.73 -84.08 1.77 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 107.806 -2.118 . . . . 52.24 107.806 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -105.91 116.68 32.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.244 1.818 . . . . 74.23 107.933 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -58.7 -41.99 87.57 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 124.024 0.828 . . . . 75.43 109.531 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -58.82 -42.34 88.96 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.693 -0.629 . . . . 74.03 110.992 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -68.37 -38.06 81.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.312 0.96 . . . . 74.32 111.376 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.62 -46.77 74.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.96 -1.019 . . . . 72.32 108.829 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.92 -77.53 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.561 1.145 . . . . 73.14 110.266 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 119.21 2.13 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.254 1.821 . . . . 74.24 108.223 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.7 t -106.88 -65.82 1.06 Allowed 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 106.706 -1.59 . . . . 62.32 106.706 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -41.13 -58.07 1.88 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.512 1.525 . . . . 75.23 115.101 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.35 -51.66 54.94 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.918 -0.488 . . . . 75.32 112.0 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.66 -44.35 73.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.146 0.979 . . . . 74.22 110.325 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.27 70.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.73 1.612 . . . . 63.22 108.782 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.69 -47.71 79.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.359 0.527 . . . . 73.22 111.63 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.79 -48.3 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 C-N-CA 123.035 0.534 . . . . 74.45 109.953 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.486 ' CD ' ' HZ1' ' A' ' 48' ' ' LYS . 50.6 mm-40 -64.06 -49.46 72.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.673 -1.156 . . . . 73.35 111.274 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.4 m -55.27 -46.57 76.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.08 1.309 . . . . 62.01 109.733 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.68 70.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.154 0.888 . . . . 64.02 111.576 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -62.47 -39.51 93.66 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.604 -1.31 . . . . 72.22 111.725 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.5 -42.77 56.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 116.008 -1.948 . . . . 73.25 109.285 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.79 -34.67 78.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 121.182 1.81 . . . . 74.44 108.967 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.27 82.21 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.922 -0.486 . . . . 70.32 110.895 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -76.95 -47.23 21.5 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.785 1.032 . . . . 75.2 113.785 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -138.06 89.13 14.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.061 1.744 . . . . 74.51 108.494 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.85 -22.27 36.78 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.626 2.217 . . . . 74.13 112.403 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.29 14.14 25.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.034 2.134 . . . . 71.24 113.588 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -120.02 156.8 30.19 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.158 -1.423 . . . . 72.0 107.158 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.92 138.2 28.37 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.353 1.061 . . . . 73.43 111.2 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.48 116.85 3.91 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.216 3.944 . . . . 75.12 112.347 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.21 146.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.745 1.218 . . . . 72.21 108.974 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.9 mt -122.31 128.26 75.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.165 -2.532 . . . . 74.43 104.165 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 120.81 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.643 1.577 . . . . 74.35 107.274 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -131.94 147.09 52.44 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.38 -0.971 . . . . 74.44 108.38 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.11 155.15 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.635 1.107 . . . . 71.35 111.078 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.55 130.89 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.453 -1.314 . . . . 75.41 107.453 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -62.3 130.24 44.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.266 -1.753 . . . . 73.31 106.266 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.9 -2.77 80.25 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 118.031 -1.427 . . . . 63.24 112.289 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -77.42 139.78 39.75 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.053 -2.203 . . . . 74.31 105.053 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.01 -28.2 68.05 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.4 1.48 . . . . 74.44 112.578 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -55.84 152.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.047 1.339 . . . . 74.44 111.431 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.14 134.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.46 1.104 . . . . 54.32 111.421 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.33 158.75 34.49 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.617 -1.253 . . . . 75.23 107.617 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.47 141.13 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.836 -1.172 . . . . 74.34 107.836 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.77 164.44 17.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.405 -0.961 . . . . 72.0 108.405 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 99.37 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.534 -2.765 . . . . 73.33 103.534 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -130.48 155.1 47.02 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.771 0.796 . . . . 73.02 109.499 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HZ1' ' CD ' ' A' ' 17' ' ' GLU . 38.1 mtmt -106.46 100.26 9.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.671 -1.233 . . . . 70.31 107.671 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.82 124.47 30.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.996 -1.113 . . . . 73.51 107.996 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.13 112.92 26.05 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.513 -0.921 . . . . 73.51 108.513 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -111.44 141.18 23.97 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 63.42 113.426 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.06 141.71 33.27 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 124.158 3.239 . . . . 75.04 112.216 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -18.43 60.94 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.831 1.049 . . . . 53.35 113.831 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.56 -34.48 70.02 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.906 1.379 . . . . 74.02 114.136 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -78.84 163.52 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.5 0.667 . . . . 73.44 110.219 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 p -104.65 167.78 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.357 1.063 . . . . 72.51 109.795 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.27 -35.31 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.021 -0.733 . . . . 75.11 109.021 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.1 -45.93 82.99 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.246 0.93 . . . . 73.3 109.911 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -68.0 -45.95 72.63 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.19 -0.67 . . . . 72.05 109.19 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.19 -52.0 67.58 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 119.067 -0.492 . . . . 75.24 111.038 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.8 ttp -57.69 -46.9 83.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.434 1.094 . . . . 75.24 110.347 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -59.25 -43.63 92.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.194 0.452 . . . . 74.02 110.785 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.48 -40.04 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 117.851 -1.071 . . . . 73.0 109.561 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.34 -50.22 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 120.611 1.55 . . . . 73.4 108.902 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -59.86 -39.15 84.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.025 -0.988 . . . . 73.51 111.402 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.79 -39.38 69.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 119.588 1.085 . . . . 73.05 110.828 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -62.96 -42.99 99.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.723 1.147 . . . . 74.12 110.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -79.22 -2.63 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.297 0.499 . . . . 74.43 109.7 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 55.47 61.02 3.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.01 2.124 . . . . 74.21 109.734 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.42 107.2 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.602 1.561 . . . . 73.05 109.935 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.97 156.1 66.41 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.485 2.124 . . . . 74.15 109.171 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -65.27 -20.79 66.58 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.183 -0.948 . . . . 71.52 112.703 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.6 -30.63 71.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.483 0.713 . . . . 73.14 110.453 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -103.72 164.9 11.38 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.009 1.324 . . . . 72.13 111.376 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.38 177.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.74 1.616 . . . . 71.3 108.093 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 tp -145.72 135.81 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -143.1 141.95 31.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.055 -1.461 . . . . 70.11 107.055 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.75 142.34 46.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.403 1.081 . . . . 63.31 108.109 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -144.3 123.66 13.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.294 -1.373 . . . . 74.3 107.294 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -130.21 131.3 65.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 117.046 -1.454 . . . . 65.34 107.255 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 47.89 30.82 2.07 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.519 1.508 . . . . 75.42 113.365 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mttp 64.74 29.11 12.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.235 -1.541 . . . . 72.22 110.61 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.9 p -132.7 161.8 33.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.104 2.562 . . . . 71.42 110.779 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.76 110.9 63.22 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.261 1.424 . . . . 73.33 109.118 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.09 124.81 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.361 2.04 . . . . 75.14 107.417 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -69.31 133.88 48.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.54 1.136 . . . . 72.51 109.655 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -62.72 -40.38 97.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 114.253 1.205 . . . . 73.11 114.253 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -21.62 59.08 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.97 -1.014 . . . . 62.52 113.093 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.95 142.8 58.31 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.268 1.395 . . . . 74.3 111.137 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 p -78.22 153.68 31.72 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.944 . . . . 74.2 110.004 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.1 mmt -59.36 -41.6 89.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.304 -0.855 . . . . 73.32 108.811 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.9 92.3 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.146 0.884 . . . . 73.53 112.964 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -49.76 52.77 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.064 0.932 . . . . 63.14 111.13 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.29 -48.01 81.83 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 123.527 0.731 . . . . 73.12 109.796 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -56.87 -52.99 62.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.13 1.372 . . . . 72.12 109.461 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.04 -47.38 84.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 118.971 -0.538 . . . . 74.4 111.964 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -32.74 67.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.373 0.988 . . . . 74.23 112.768 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -93.86 -5.84 47.12 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.683 1.129 . . . . 73.13 113.887 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -38.79 125.14 1.44 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.587 1.955 . . . . 65.33 113.727 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.91 163.47 16.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.927 0.891 . . . . 71.45 110.024 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.82 -29.26 26.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.465 1.106 . . . . 74.42 111.277 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -95.32 -33.88 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.481 1.112 . . . . 75.1 112.541 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.03 4.04 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 117.742 1.857 . . . . 75.21 117.742 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -96.27 178.99 5.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.366 2.083 . . . . 62.03 112.024 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tp -125.74 138.2 53.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.584 -0.722 . . . . 75.34 111.302 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -123.13 108.32 12.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.043 1.337 . . . . 64.34 109.561 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.98 145.11 20.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 122.332 1.063 . . . . 73.43 110.382 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.96 145.54 38.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.169 -0.923 . . . . 72.24 108.509 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -130.96 157.62 42.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.364 0.602 . . . . 73.22 109.863 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.1 p -148.28 161.82 40.75 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.408 -0.96 . . . . 75.52 108.408 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.14 17.85 16.65 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 117.959 -1.467 . . . . 65.33 114.136 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -132.03 141.05 49.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.285 -1.376 . . . . 74.34 107.285 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -80.62 -18.88 46.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.867 0.867 . . . . 75.12 109.645 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.77 138.29 45.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.449 1.1 . . . . 74.54 108.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -117.66 71.13 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.091 1.757 . . . . 74.52 106.959 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 N-CA-C 110.509 -1.036 . . . . 75.04 110.509 -179.306 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.328 0 N-CA-C 109.186 -1.566 . . . . 73.44 109.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -139.49 77.57 1.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.186 1.794 . . . . 52.44 106.474 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 71.7 mtm -115.84 68.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.026 -1.102 . . . . 75.21 108.026 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.18 40.74 2.77 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.903 1.281 . . . . 72.33 107.674 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 11.3 pt -65.97 155.79 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.452 0.644 . . . . 74.3 110.985 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 95.6 mt -101.68 -55.79 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 126.872 2.069 . . . . 74.03 109.755 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -77.44 83.06 3.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.498 0.59 . . . . 71.22 111.006 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -69.1 153.05 44.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.955 -1.498 . . . . 71.25 106.955 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.03 -54.52 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.312 1.045 . . . . 72.11 112.959 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -77.11 161.7 28.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.754 0.822 . . . . 65.15 111.823 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 -62.29 1.58 Allowed 'General case' 0 CA--C 1.557 1.248 1 N-CA-C 122.043 4.09 . . . . 71.52 122.043 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . 0.426 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 10.4 m95 50.67 66.14 1.25 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.479 3.112 . . . . 74.3 112.081 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -99.8 124.89 8.38 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.421 -1.872 . . . . 65.53 108.421 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . 0.421 HG12 ' HE3' ' A' ' 48' ' ' LYS . 61.5 mt -68.37 139.9 19.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.585 1.192 . . . . 74.3 108.212 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -141.72 112.21 7.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.071 1.748 . . . . 63.34 106.584 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.48 120.71 22.08 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.374 -2.084 . . . . 74.42 105.374 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.48 110.86 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.458 0.703 . . . . 73.41 111.934 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.1 p -144.48 127.5 16.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.338 1.055 . . . . 71.02 108.958 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 128.94 2.896 . . . . 74.4 114.56 179.549 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 108.88 -0.785 . . . . 75.33 108.88 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.28 110.67 3.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 105.227 -3.149 . . . . 71.25 105.227 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -79.92 113.46 18.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.026 0.93 . . . . 73.14 108.714 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 mmt -60.17 -34.14 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.398 -0.921 . . . . 75.13 110.749 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -60.23 -47.66 85.02 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.232 -0.917 . . . . 74.44 109.982 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -64.43 -32.67 74.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.827 -0.606 . . . . 73.32 110.227 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -60.21 -47.35 86.35 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.87 -1.159 . . . . 73.24 107.87 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.17 -76.26 0.16 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.648 0.779 . . . . 73.33 111.284 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.4 143.08 11.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 127.339 2.256 . . . . 54.12 109.615 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 t -122.89 -59.7 1.57 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.099 -0.953 . . . . 74.21 109.377 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.4 mt -45.42 -58.22 3.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.075 1.35 . . . . 74.52 114.235 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -64.86 -49.99 68.36 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.426 -0.796 . . . . 73.34 110.916 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -52.5 -55.43 22.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.319 1.012 . . . . 74.11 110.377 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -44.71 91.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.637 1.575 . . . . 63.45 111.041 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.51 -50.85 72.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.088 1.313 . . . . 72.41 111.702 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 74.6 t -69.1 -47.34 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.826 0.85 . . . . 61.42 111.772 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.4 -51.18 70.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.843 1.257 . . . . 62.42 109.443 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -63.63 -40.77 97.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.117 -0.944 . . . . 75.41 110.038 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -49.83 76.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.52 1.509 . . . . 55.13 110.175 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HE2' ' CG1' ' A' ' 16' ' ' VAL . 50.6 mttm -61.45 -48.42 81.23 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.431 -0.793 . . . . 74.14 110.989 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.68 -41.77 85.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-O 117.564 -1.208 . . . . 75.45 110.403 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -63.51 -33.79 76.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.526 1.966 . . . . 73.31 109.138 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.18 51.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.496 0.589 . . . . 61.44 110.153 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -75.44 -46.34 33.2 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.165 1.172 . . . . 71.44 114.165 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -124.08 74.74 58.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.938 2.895 . . . . 75.44 112.022 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.59 -9.17 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.132 3.221 . . . . 72.21 110.96 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.66 12.53 27.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.171 2.188 . . . . 73.53 111.894 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -127.41 160.08 32.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.87 -1.144 . . . . 75.54 109.791 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.5 142.62 37.72 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.604 1.161 . . . . 75.42 108.909 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.64 119.02 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.669 1 C-N-CA 125.372 4.048 . . . . 75.34 112.185 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.1 t -126.46 148.87 31.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.184 0.994 . . . . 74.13 109.764 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.24 133.41 68.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.52 -2.4 . . . . 75.13 104.52 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.73 118.5 52.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.559 1.544 . . . . 74.24 108.888 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -130.56 153.91 48.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.864 -0.791 . . . . 75.51 108.864 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -93.06 158.38 15.81 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.143 -0.973 . . . . 74.3 110.503 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.06 119.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.545 -2.02 . . . . 74.54 105.545 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 p -54.68 110.8 0.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.968 1.707 . . . . 75.33 111.946 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.4 30.99 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.846 1.688 . . . . 72.45 113.422 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 p -63.95 146.38 54.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.136 1.468 . . . . 70.45 109.816 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -69.59 -0.62 7.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.797 1.639 . . . . 74.41 114.502 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -86.75 169.2 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 119.386 0.994 . . . . 75.13 109.738 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.9 155.72 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.526 1.13 . . . . 75.14 111.358 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.16 163.13 18.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.94 0.896 . . . . 72.05 111.032 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.42 124.5 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.745 1.618 . . . . 62.24 106.675 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.12 164.62 15.15 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.893 0.877 . . . . 55.43 110.175 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 101.51 4.28 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.981 -1.489 . . . . 75.35 106.981 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -134.44 161.79 34.03 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.934 1.294 . . . . 73.42 108.765 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 17.1 mttt -111.26 105.84 14.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.745 -1.946 . . . . 74.42 105.745 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -88.01 118.39 27.54 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.325 0.861 . . . . 73.53 113.325 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.57 108.29 20.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.32 2.248 . . . . 74.23 108.783 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.62 141.35 24.46 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.049 -0.977 . . . . 72.43 110.062 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.19 141.43 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.13 1.887 . . . . 62.51 111.582 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -62.51 -16.15 54.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.098 0.777 . . . . 72.41 113.098 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.72 -34.21 64.69 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.308 1.225 . . . . 71.13 114.308 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.8 168.94 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.206 0.912 . . . . 72.52 111.58 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.1 p -107.88 169.4 8.63 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.082 0.953 . . . . 73.43 111.605 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.86 -36.1 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.002 0.921 . . . . 75.21 109.193 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.25 93.81 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.411 1.005 . . . . 71.43 110.541 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -60.91 -46.49 90.44 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 108.15 -1.056 . . . . 75.04 108.15 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -59.65 -49.3 78.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.961 0.504 . . . . 74.44 110.464 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ttt -58.49 -44.15 89.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.329 1.452 . . . . 72.23 109.467 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -63.64 -39.5 94.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.318 0.508 . . . . 74.04 110.212 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -67.05 -47.65 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 107.832 -1.173 . . . . 74.22 107.832 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.86 -50.83 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.66 1.118 . . . . 74.1 110.987 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.31 -41.92 97.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.558 -0.734 . . . . 75.54 110.894 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -69.21 -41.92 76.43 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.185 0.902 . . . . 74.35 111.165 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -58.88 -47.65 84.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.462 1.505 . . . . 72.12 110.825 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 pt -83.96 -0.87 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.069 0.395 . . . . 73.33 111.266 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 54.36 71.23 0.54 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 126.521 1.928 . . . . 75.11 108.095 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -82.6 104.96 4.02 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.271 -2.122 . . . . 75.21 105.271 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -66.31 165.53 24.34 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 124.232 3.288 . . . . 73.12 113.816 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -57.86 -37.91 74.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.418 1.087 . . . . 74.3 110.202 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -59.92 -38.64 82.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 116.859 -1.543 . . . . 74.35 113.906 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.51 162.4 13.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.306 1.412 . . . . 71.14 110.673 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.87 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.13 1.372 . . . . 53.32 108.807 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.0 tp -132.58 139.59 49.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.486 1.114 . . . . 75.35 108.225 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -137.7 120.15 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.619 -1.623 . . . . 74.41 106.619 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.79 140.18 49.12 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.931 1.692 . . . . 75.34 109.126 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -145.09 141.51 28.89 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.232 -1.025 . . . . 72.25 108.232 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.68 122.57 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 125.162 1.385 . . . . 75.4 107.681 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 t0 43.49 45.79 5.61 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.338 1.236 . . . . 73.34 114.338 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tptm 71.44 18.79 5.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.22 1.808 . . . . 70.14 114.37 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.4 p -129.18 162.38 27.93 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 120.081 1.31 . . . . 74.2 111.043 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.26 109.55 50.29 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 106.43 -1.693 . . . . 73.21 106.43 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 123.86 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 N-CA-C 107.573 -1.741 . . . . 71.41 107.573 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -69.96 121.5 17.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.685 -0.635 . . . . 65.34 110.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 76.6 p -47.65 -37.59 13.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.972 2.109 . . . . 72.44 114.045 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 m -75.92 -19.19 58.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.529 1.132 . . . . 73.31 113.968 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.06 144.64 53.93 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.174 0.897 . . . . 74.21 109.879 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.7 p -83.09 154.55 24.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.449 0.642 . . . . 75.11 109.677 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.84 -42.27 97.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.702 -0.666 . . . . 72.12 111.384 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.31 -43.13 98.88 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.193 -0.782 . . . . 62.34 111.744 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -68.49 -48.46 64.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.247 1.024 . . . . 74.51 109.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -57.43 -44.43 84.65 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.472 0.709 . . . . 72.03 110.308 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -61.07 -49.74 76.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.17 0.988 . . . . 75.22 108.546 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.09 -32.25 72.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.647 0.98 . . . . 74.42 113.647 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -25.84 18.93 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.971 1.471 . . . . 74.13 114.971 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.22 0.35 23.2 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.711 1.004 . . . . 74.34 113.711 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -48.21 135.17 13.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.355 0.979 . . . . 74.21 112.965 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.77 161.23 29.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.564 -0.902 . . . . 75.44 108.564 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -54.64 -29.94 53.66 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.403 1.481 . . . . 70.01 112.01 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -79.77 -33.1 40.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.145 0.578 . . . . 64.25 111.684 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.45 -6.86 4.97 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 117.434 1.734 . . . . 73.31 117.434 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.77 -179.61 3.7 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.805 2.042 . . . . 74.14 111.957 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.5 tp -123.68 143.63 50.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.395 0.543 . . . . 73.4 111.937 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -122.69 134.52 54.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 64.04 110.602 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.84 140.64 48.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 124.498 1.119 . . . . 71.31 108.264 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.01 149.04 40.93 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.575 -0.898 . . . . 51.21 108.575 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -139.73 159.9 41.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.929 0.871 . . . . 75.24 112.793 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.2 p -149.59 155.94 41.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.014 -1.847 . . . . 50.43 106.014 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 26.16 12.64 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.156 -0.778 . . . . 65.25 111.156 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -134.74 128.75 33.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.417 1.487 . . . . 75.14 107.026 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.07 -45.06 90.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.161 0.505 . . . . 72.22 109.78 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.85 110.78 22.21 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.805 2.042 . . . . 72.0 107.791 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.36 71.35 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.235 2.614 . . . . 74.12 110.293 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 N-CA-C 108.99 -1.644 . . . . 65.21 108.99 179.632 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.569 0 N-CA-C 110.46 -1.056 . . . . 73.24 110.46 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -140.71 -3.88 1.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.193 1.797 . . . . 62.32 113.484 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -55.27 -9.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.595 1.958 . . . . 73.55 116.17 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.81 51.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.558 2.743 . . . . 74.22 111.596 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 31.7 pt -116.32 160.44 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 119.897 -1.752 . . . . 75.12 109.123 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 19.2 pt -110.7 6.84 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.69 1.196 . . . . 75.24 109.885 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -113.33 46.74 1.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.828 1.651 . . . . 75.2 111.381 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -73.06 115.7 12.7 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.432 -2.062 . . . . 74.25 105.432 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.45 -26.63 68.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.598 1.703 . . . . 75.54 115.598 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -109.92 155.53 21.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.741 1.216 . . . . 75.42 110.282 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -83.41 -55.59 4.23 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.349 0.977 . . . . 74.13 112.499 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . 0.426 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 52.5 m95 54.02 63.91 2.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.754 1.622 . . . . 73.32 111.792 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.78 126.34 7.34 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.009 -2.436 . . . . 62.34 107.009 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.6 132.08 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.792 1.296 . . . . 75.42 108.016 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -129.9 149.5 51.61 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.227 1.011 . . . . 71.02 109.553 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.8 tt -111.39 114.35 27.43 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.679 1.592 . . . . 73.22 109.159 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 37.8 t -121.77 136.11 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.1 0.96 . . . . 74.41 111.401 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 160.41 28.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.152 1.781 . . . . 74.44 109.331 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 127.33 2.252 . . . . 71.31 107.32 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 121.249 0.547 . . . . 65.05 109.9 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.58 -109.2 0.3 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.797 -2.121 . . . . 73.12 107.797 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -82.62 132.26 35.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 118.543 1.172 . . . . 74.45 108.814 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.451 ' HG2' ' HE2' ' A' ' 46' ' ' LYS . 16.3 tpt -62.01 -47.11 86.23 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.422 -0.955 . . . . 72.4 108.422 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -60.26 -41.04 92.42 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 119.116 -0.469 . . . . 72.52 111.369 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -64.38 -33.27 75.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.879 0.763 . . . . 74.11 109.476 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.18 -48.31 62.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.506 0.594 . . . . 74.45 110.15 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -75.0 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.178 0.991 . . . . 73.41 112.621 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 130.63 10.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.968 1.307 . . . . 72.31 107.989 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -124.22 -65.93 1.02 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.472 0.916 . . . . 74.4 113.472 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mt -48.49 -58.88 4.01 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.444 1.497 . . . . 70.52 114.539 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.49 -44.37 87.3 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.61 -0.681 . . . . 73.35 112.06 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -59.62 -40.02 86.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.055 0.942 . . . . 74.32 108.688 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -43.12 84.7 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-O 117.437 -1.268 . . . . 74.34 110.054 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.6 m -63.85 -47.01 82.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.182 1.356 . . . . 71.53 112.752 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.39 -47.13 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 O-C-N 121.736 -0.603 . . . . 75.35 109.637 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.04 -40.01 95.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 117.416 -1.278 . . . . 75.32 110.967 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -61.76 -47.45 85.12 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 121.15 1.795 . . . . 71.53 108.767 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.83 72.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.874 0.694 . . . . 74.02 112.874 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.0 -44.94 75.43 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.637 -0.664 . . . . 65.43 112.661 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.2 -41.89 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.296 -0.859 . . . . 74.43 110.237 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -66.15 -38.0 87.05 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.468 1.031 . . . . 72.05 109.484 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.63 78.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.094 -0.642 . . . . 64.22 110.601 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.39 -46.43 22.77 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.138 1.533 . . . . 74.43 115.138 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.15 72.12 55.37 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 127.064 2.146 . . . . 74.31 110.533 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.5 -19.31 48.91 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.778 2.318 . . . . 73.53 112.523 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -97.76 13.02 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.441 0.564 . . . . 73.31 110.871 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -118.54 155.4 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.989 -1.115 . . . . 73.44 107.989 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 27.12 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.879 -1.156 . . . . 73.34 107.879 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.59 122.15 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.98 3.787 . . . . 72.05 112.392 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.55 140.77 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.274 1.83 . . . . 74.52 111.82 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.68 136.76 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 105.764 -1.939 . . . . 75.32 105.764 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.87 110.58 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.99 0.813 . . . . 72.14 110.432 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -112.88 146.81 38.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.118 -1.067 . . . . 72.33 108.118 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 141.94 31.88 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.067 -1.021 . . . . 75.31 109.652 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.34 127.94 23.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.558 -1.275 . . . . 73.42 107.558 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.07 128.77 22.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.115 1.366 . . . . 71.21 109.636 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.1 42.28 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.58 -1.122 . . . . 75.13 113.934 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.19 109.23 2.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.319 -2.104 . . . . 44.11 105.319 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.73 -0.98 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.602 1.561 . . . . 74.0 114.792 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -68.39 163.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.139 -0.975 . . . . 75.32 109.043 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.83 129.68 14.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.219 1.407 . . . . 71.32 110.364 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -84.37 163.94 19.23 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.633 1.573 . . . . 75.4 108.444 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -125.41 135.57 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.871 -1.529 . . . . 75.21 106.871 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.83 165.15 8.97 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.304 0.573 . . . . 74.31 110.609 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.451 ' HE2' ' HG2' ' A' ' 4' ' ' MET . 10.2 mptt -73.88 103.19 4.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.089 -1.448 . . . . 75.11 107.089 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -136.62 158.28 44.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.953 2.101 . . . . 75.2 107.846 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.51 102.11 11.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 104.033 -2.58 . . . . 74.41 104.033 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -83.97 142.14 30.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.576 -1.268 . . . . 74.43 107.576 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.97 123.35 30.43 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 117.921 -1.038 . . . . 74.12 108.844 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.57 143.01 28.11 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 117.787 -1.101 . . . . 74.3 112.785 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.81 141.28 48.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.268 1.978 . . . . 73.23 108.481 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 t -59.25 -12.68 5.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.936 2.494 . . . . 72.23 113.303 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.71 -27.16 17.42 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 115.528 1.677 . . . . 75.32 115.528 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.55 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.031 1.287 . . . . 74.31 110.184 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.9 p -107.28 160.17 15.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.987 0.915 . . . . 64.33 111.053 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.12 -38.13 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.458 1.503 . . . . 74.35 111.465 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.05 91.93 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.556 0.743 . . . . 72.23 110.778 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.62 -42.37 95.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.017 0.927 . . . . 73.44 109.742 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.45 -46.2 89.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.833 -0.803 . . . . 73.44 108.833 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.5 ttp -60.51 -42.36 96.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.574 0.75 . . . . 73.12 110.581 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -61.25 -40.31 93.61 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.49 0.716 . . . . 75.22 109.915 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.9 mt -66.18 -51.01 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 118.511 -0.757 . . . . 74.14 109.326 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.7 mt -55.15 -49.98 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.142 0.883 . . . . 72.22 110.339 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.54 -38.71 88.42 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.017 -1.052 . . . . 74.42 111.328 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.712 0.687 . . . . 75.31 110.063 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -61.83 -51.33 68.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.507 1.123 . . . . 74.22 109.888 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.11 5.86 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.002 0.371 . . . . 74.12 112.002 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 46.21 63.4 1.87 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 127.634 2.374 . . . . 70.43 110.651 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 108.58 3.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.97 1.308 . . . . 71.4 110.877 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.31 158.65 36.98 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.116 3.21 . . . . 71.01 110.955 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -26.78 55.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.801 0.84 . . . . 54.44 112.757 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.91 -34.48 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.153 0.981 . . . . 73.11 111.501 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 164.29 11.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.912 1.233 . . . . 75.04 108.106 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.65 175.27 5.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.628 1.171 . . . . 74.33 107.98 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -148.34 130.12 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.512 0.725 . . . . 75.24 111.617 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -141.53 148.28 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.454 1.101 . . . . 74.12 110.213 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.9 152.18 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.569 1.948 . . . . 73.21 108.098 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -144.42 126.87 15.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.444 1.498 . . . . 72.32 108.347 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.66 124.55 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.326 1.05 . . . . 71.1 108.457 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 43.83 38.44 2.1 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.162 1.385 . . . . 73.42 113.898 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttm 65.05 39.94 5.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.83 2.052 . . . . 74.14 111.063 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 p -141.25 156.61 45.87 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.163 0.985 . . . . 72.25 110.048 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.07 104.0 33.49 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 102.837 -3.023 . . . . 63.2 102.837 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.59 147.18 69.71 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.554 2.17 . . . . 75.34 110.722 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -70.69 120.89 16.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.799 -1.185 . . . . 62.31 107.799 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 p -51.84 -34.92 42.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.374 1.469 . . . . 64.24 113.813 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -83.68 -6.42 59.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.36 0.874 . . . . 53.3 113.36 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.73 144.58 54.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.678 1.126 . . . . 75.11 108.141 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.17 149.88 25.87 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.888 -0.782 . . . . 64.41 108.888 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.57 -50.75 64.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.264 1.025 . . . . 54.4 112.249 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.67 96.97 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 118.854 0.752 . . . . 75.34 112.378 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -62.07 -53.39 56.14 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.833 0.853 . . . . 75.14 109.261 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.02 -44.92 87.57 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.993 0.917 . . . . 71.54 110.231 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -60.31 -51.97 67.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.611 1.164 . . . . 73.42 108.994 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -35.91 74.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.205 -0.902 . . . . 74.33 112.747 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -24.41 20.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.735 -1.126 . . . . 74.43 113.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -107.21 5.3 27.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.566 1.076 . . . . 74.5 112.993 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -48.82 127.65 14.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.22 1.808 . . . . 75.22 113.513 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.46 175.22 10.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.49 0.716 . . . . 73.42 109.121 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -60.53 -30.47 69.77 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.225 -1.547 . . . . 75.15 110.886 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.28 16.78 12.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.502 1.121 . . . . 75.14 112.283 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.06 28.59 69.14 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.198 -1.335 . . . . 64.44 114.946 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -126.42 177.05 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.647 1.724 . . . . 73.1 111.472 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -123.43 135.32 54.04 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.491 1.116 . . . . 74.23 109.986 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -122.66 127.64 49.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.189 1.396 . . . . 72.41 107.698 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.3 t -129.2 149.02 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 120.505 -1.372 . . . . 75.32 109.457 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.68 150.97 37.29 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.753 -1.573 . . . . 64.15 106.753 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.27 151.92 46.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.097 0.862 . . . . 71.11 111.324 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.2 p -142.88 171.83 13.52 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.451 0.643 . . . . 72.23 111.262 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.62 9.18 21.89 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.597 1.57 . . . . 72.44 112.308 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.16 142.26 28.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.343 1.857 . . . . 73.32 107.968 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.53 -16.33 54.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.518 0.727 . . . . 75.55 111.683 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 p -89.04 119.81 29.89 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.527 1.931 . . . . 65.22 106.081 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -117.36 11.66 14.03 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.908 0.707 . . . . 72.12 112.908 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 CA-C-O 116.83 -2.094 . . . . 71.33 112.29 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 109.201 -1.56 . . . . 71.4 109.201 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -134.43 42.44 2.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.532 0.733 . . . . 63.32 110.122 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 332' ' ' MET . . . . . 0.431 ' C ' ' H ' ' B' ' 334' ' ' ILE . 52.7 mtm -79.75 13.36 2.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.695 1.598 . . . . 74.4 112.909 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.51 20.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.254 2.622 . . . . 73.53 115.506 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . 0.431 ' H ' ' C ' ' B' ' 332' ' ' MET . 24.2 mm -76.68 162.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 125.467 1.507 . . . . 74.31 109.421 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.04 -9.3 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.333 1.453 . . . . 72.03 112.432 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -83.15 14.69 3.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.942 1.297 . . . . 75.12 111.681 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.32 140.07 46.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.192 1.797 . . . . 73.2 110.903 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.73 -40.74 24.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.449 -0.945 . . . . 75.21 108.449 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.51 109.14 10.0 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.03 0.932 . . . . 74.34 110.287 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -74.9 -37.78 62.02 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.011 -0.431 . . . . 64.42 110.761 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 18.3 m95 52.93 55.93 8.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.0 0.92 . . . . 74.34 110.316 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.49 128.35 8.44 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.308 -1.517 . . . . 62.44 109.308 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 93.8 mt -61.94 133.62 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 126.903 2.081 . . . . 74.11 106.914 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.84 104.82 5.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.074 -1.454 . . . . 74.44 107.074 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.5 114.76 19.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.632 1.173 . . . . 73.54 107.882 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.04 150.42 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.426 1.091 . . . . 72.11 110.723 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -162.89 161.72 25.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.904 2.482 . . . . 74.42 107.04 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.657 -1.609 . . . . 74.31 106.657 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 108.744 -0.836 . . . . 75.14 108.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.53 -73.19 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.054 -2.418 . . . . 75.45 107.054 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -92.71 104.66 16.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.399 -2.074 . . . . 73.33 105.399 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.453 ' SD ' ' HE3' ' A' ' 46' ' ' LYS . 9.5 mtp -56.38 -46.29 80.16 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.966 -0.754 . . . . 72.03 108.966 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -57.18 -43.56 82.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.458 0.703 . . . . 74.43 112.401 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -37.73 87.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.469 0.577 . . . . 72.4 110.689 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -67.37 -48.2 68.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.487 -0.931 . . . . 75.22 108.487 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.84 -76.9 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.118 1.767 . . . . 72.12 113.092 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.75 120.13 2.32 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.207 2.203 . . . . 73.55 108.692 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -131.48 -35.17 1.33 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 116.979 -1.486 . . . . 74.01 114.119 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.67 -60.4 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 121.872 2.124 . . . . 74.44 112.214 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.86 -32.58 73.95 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.519 -0.738 . . . . 73.33 110.721 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -57.09 -59.23 5.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.033 -1.099 . . . . 73.54 108.033 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -39.65 95.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.589 1.156 . . . . 74.12 109.691 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -56.05 -58.03 9.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.758 1.163 . . . . 65.35 111.658 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.95 -42.99 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.83 0.852 . . . . 74.53 110.106 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.21 -47.64 84.6 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.523 -0.751 . . . . 75.41 109.96 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.7 t -58.53 -49.6 76.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.139 -1.06 . . . . 73.34 108.139 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.49 73.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.98 0.809 . . . . 73.02 112.771 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.74 -39.25 84.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 O-C-N 120.535 -1.353 . . . . 74.21 112.17 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.8 -42.13 82.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 O-C-N 120.762 -1.211 . . . . 73.05 108.897 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -67.07 -32.36 73.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.7 1.136 . . . . 74.55 110.96 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.0 -47.49 24.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.238 -0.411 . . . . 72.04 110.529 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -78.49 -44.03 25.49 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.591 1.701 . . . . 75.11 115.591 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.73 72.86 81.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.598 1.959 . . . . 75.31 109.789 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.41 -26.09 76.51 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.433 2.089 . . . . 72.35 111.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.37 12.07 17.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.161 -0.447 . . . . 75.2 111.564 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -123.46 139.07 54.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.737 1.153 . . . . 73.42 108.213 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -107.18 143.83 27.92 Favored Pre-proline 0 C--O 1.249 1.026 0 C-N-CA 123.703 0.801 . . . . 74.51 110.374 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.52 117.37 3.38 Favored 'Trans proline' 0 C--N 1.355 0.903 1 C-N-CA 125.888 4.392 . . . . 75.33 112.885 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 146.91 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.397 1.079 . . . . 74.01 110.611 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.16 135.41 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 104.459 -2.423 . . . . 73.11 104.459 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -123.13 111.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.443 -1.688 . . . . 71.51 106.443 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -128.13 150.42 49.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.195 0.452 . . . . 75.53 110.788 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.76 132.91 34.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.019 -0.734 . . . . 74.13 109.019 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.83 116.86 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.72 -1.585 . . . . 75.24 106.72 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 m -53.76 125.34 18.08 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.8 0.727 . . . . 65.43 109.683 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.97 -3.18 35.58 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.285 1.421 . . . . 72.15 112.642 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.8 m -89.92 127.69 36.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.9 1.35 . . . . 71.35 108.288 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.57 -18.87 62.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 118.453 -0.784 . . . . 75.12 111.708 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.46 156.51 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.065 0.848 . . . . 75.35 111.158 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.0 m -52.28 125.76 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.656 0.782 . . . . 73.21 109.996 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.38 172.47 9.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.603 1.161 . . . . 74.44 108.876 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -125.85 150.88 31.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 123.766 0.826 . . . . 75.4 110.415 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.34 165.37 24.63 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.788 -1.56 . . . . 52.45 106.788 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE3' ' SD ' ' A' ' 4' ' ' MET . 1.0 OUTLIER -74.76 105.75 5.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.03 -1.841 . . . . 74.3 106.03 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -134.11 163.74 28.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.873 0.844 . . . . 75.0 112.508 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -105.55 106.95 17.69 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 103.001 -2.962 . . . . 75.33 103.001 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.04 127.05 37.37 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.604 -1.628 . . . . 74.31 106.604 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.45 112.55 21.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.897 1.679 . . . . 65.25 108.092 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.39 142.83 27.7 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-N 119.565 1.075 . . . . 62.15 110.525 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.91 132.32 21.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.317 2.012 . . . . 75.12 108.698 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -58.73 -12.61 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.441 1.897 . . . . 71.21 113.123 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.99 -34.46 50.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 60.22 114.141 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 170.49 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.734 1.012 . . . . 75.34 113.734 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -102.63 167.35 9.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.998 1.719 . . . . 73.32 112.529 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.23 -35.87 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.965 0.906 . . . . 74.31 109.247 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.25 91.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.901 0.773 . . . . 75.13 110.362 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -63.85 -45.76 88.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.746 -0.835 . . . . 75.5 108.746 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.64 -48.91 79.79 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.8 -0.444 . . . . 75.13 109.8 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.9 ttt -55.89 -51.98 65.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.365 1.466 . . . . 74.41 110.114 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -58.27 -41.64 84.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.727 0.811 . . . . 73.5 109.042 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.1 mt -66.87 -45.2 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 120.828 1.649 . . . . 75.32 109.323 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.59 -50.81 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 120.588 1.54 . . . . 61.24 110.554 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -31.91 73.12 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.161 -0.962 . . . . 74.33 111.531 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -68.95 -48.51 63.03 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.537 -0.542 . . . . 74.42 109.537 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -59.98 -51.38 69.89 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 126.926 2.091 . . . . 75.42 111.51 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.23 3.65 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 122.379 -0.2 . . . . 74.5 110.961 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 44.24 63.34 1.67 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 126.849 2.06 . . . . 74.14 109.503 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.22 111.19 5.98 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.993 -1.114 . . . . 75.22 107.993 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.71 165.43 27.67 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 125.177 3.918 . . . . 75.51 114.309 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -26.67 67.66 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.356 0.662 . . . . 62.24 111.411 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.64 -47.07 79.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.347 0.869 . . . . 70.31 113.347 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -100.3 165.35 11.51 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.169 0.895 . . . . 73.4 113.158 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.05 -178.63 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.596 1.958 . . . . 74.51 107.148 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 tp -137.47 135.55 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.664 -1.606 . . . . 74.11 106.664 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.79 130.25 33.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.705 -1.591 . . . . 74.21 106.705 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.43 146.32 40.77 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.084 1.754 . . . . 74.41 107.821 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.62 128.28 19.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.893 1.277 . . . . 73.03 108.501 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.23 123.83 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 107.632 -1.248 . . . . 70.44 107.632 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 47.92 38.27 8.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.11 0.964 . . . . 74.01 111.813 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 23.05 11.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.272 1.429 . . . . 72.15 112.947 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 162.8 21.32 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.978 1.711 . . . . 62.31 112.352 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.14 103.46 12.07 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.823 2.449 . . . . 75.32 106.901 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.37 123.68 7.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.75 2.3 . . . . 74.4 111.887 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.81 127.62 32.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.569 -1.271 . . . . 71.42 107.569 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.4 p -57.23 -28.44 62.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.246 1.419 . . . . 75.14 112.881 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.1 t -85.24 -4.79 59.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.387 1.475 . . . . 53.33 112.064 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.5 tp -76.51 143.93 40.11 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.439 -1.413 . . . . 74.04 107.632 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 m -84.85 152.42 23.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.456 -0.572 . . . . 74.31 109.456 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.64 -51.89 67.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.149 0.98 . . . . 74.14 110.198 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.63 -45.02 60.23 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.528 0.604 . . . . 73.13 111.655 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -66.97 -49.11 66.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.63 0.772 . . . . 72.11 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.91 -42.39 97.96 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.641 -0.662 . . . . 73.01 110.476 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.07 -57.89 8.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.949 1.699 . . . . 75.0 109.455 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.07 -27.69 69.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 118.56 -0.733 . . . . 73.01 112.868 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -38.85 12.75 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.863 -1.065 . . . . 74.43 113.118 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -88.02 -8.78 55.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 117.838 -1.077 . . . . 42.1 113.123 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -33.32 120.83 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.399 1.629 . . . . 74.12 115.399 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.84 177.21 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.057 1.743 . . . . 72.42 109.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -35.1 56.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.025 -1.672 . . . . 73.4 112.056 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -95.62 10.9 35.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.747 1.219 . . . . 74.42 111.786 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.73 60.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.462 1.506 . . . . 74.11 115.151 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -105.07 163.67 12.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.031 1.415 . . . . 64.42 109.133 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.9 tp -120.67 134.81 55.25 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.352 0.661 . . . . 75.22 109.709 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.71 121.91 37.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.889 0.876 . . . . 74.44 108.982 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.07 137.9 54.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 107.826 -1.176 . . . . 75.25 107.826 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.06 152.1 29.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.224 1.01 . . . . 64.42 108.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -140.24 161.19 38.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.556 0.947 . . . . 75.31 113.556 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.4 t -159.05 173.35 16.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.956 1.702 . . . . 72.43 108.947 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.24 17.26 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.65 2.548 . . . . 74.1 112.493 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.8 135.58 51.23 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.326 1.85 . . . . 75.23 109.196 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -66.89 -29.75 69.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.728 1.211 . . . . 73.1 112.716 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.36 131.0 57.07 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.503 1.121 . . . . 71.35 109.119 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -116.13 9.23 14.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.234 1.014 . . . . 64.14 112.657 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 CA-C-O 118.266 -1.297 . . . . 64.34 110.44 179.674 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.773 0 N-CA-C 110.939 -0.864 . . . . 65.25 110.939 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 52.51 10.72 0.15 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.343 2.257 . . . . 71.11 116.023 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 25.5 ttt -85.2 68.01 10.37 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 106.164 -1.791 . . . . 75.12 106.164 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -116.45 49.37 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.971 -1.863 . . . . 72.44 105.971 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 15.0 pt -65.95 142.26 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.855 -0.528 . . . . 74.24 110.525 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.1 4.64 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.701 0.63 . . . . 75.34 112.701 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -110.35 71.45 0.75 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.014 1.726 . . . . 75.23 109.04 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.31 168.35 15.64 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.911 1.284 . . . . 72.54 109.267 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.03 -12.69 43.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.476 0.71 . . . . 74.12 109.228 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.58 106.94 18.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.021 -1.474 . . . . 75.2 107.021 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -92.63 -62.09 1.47 Allowed 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.056 -0.402 . . . . 71.43 111.545 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 62.9 m95 58.15 66.03 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.209 1.404 . . . . 72.34 110.362 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -83.98 136.12 14.49 Favored Glycine 0 C--N 1.344 0.996 0 O-C-N 121.535 -0.728 . . . . 73.32 111.387 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.35 125.28 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.46 1.904 . . . . 72.12 107.722 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -139.88 130.03 25.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.283 1.033 . . . . 75.34 108.249 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.14 127.11 52.75 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.201 -0.937 . . . . 73.05 110.579 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.48 117.52 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 125.05 1.34 . . . . 71.43 107.812 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 22.8 p -162.15 126.39 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 104.943 -2.243 . . . . 51.44 104.943 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.135 2.174 . . . . 74.12 111.899 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 121.894 0.854 . . . . 64.02 109.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tpt -55.97 -46.74 78.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 113.941 -1.481 . . . . 75.24 109.35 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -59.01 -50.32 74.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.046 0.938 . . . . 75.31 111.747 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -65.05 -27.31 68.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.549 1.539 . . . . 71.12 111.672 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.67 -47.94 28.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.536 -0.913 . . . . 64.22 108.536 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -74.95 0.15 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.58 1.152 . . . . 72.55 113.086 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -158.98 122.26 3.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 105.815 -1.92 . . . . 63.14 105.815 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -130.73 -65.14 0.8 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.66 -1.162 . . . . 73.34 112.686 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.5 mt -39.85 -57.12 1.64 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.562 1.689 . . . . 74.44 115.562 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.38 -52.71 51.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.254 -0.904 . . . . 64.23 110.073 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.553 ' CD2' HH21 ' A' ' 14' ' ' ARG . 6.6 t60 -54.37 -55.22 30.8 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.315 1.446 . . . . 74.22 111.39 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.553 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.0 mmp_? -58.53 -39.88 81.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 116.495 -1.717 . . . . 71.01 109.031 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -60.64 -55.38 33.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.246 1.384 . . . . 65.43 111.26 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.67 -47.88 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 117.974 0.352 . . . . 74.25 111.267 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -62.08 -39.88 93.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.626 -0.702 . . . . 72.21 110.805 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 t -59.73 -46.78 88.09 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.56 -1.274 . . . . 74.24 107.56 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.63 86.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.487 1.039 . . . . 55.4 112.251 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.23 -47.71 83.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.321 0.51 . . . . 71.2 110.747 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.13 -42.36 96.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 C-N-CA 123.923 0.889 . . . . 71.03 110.322 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -67.6 -40.26 84.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.955 1.252 . . . . 72.11 109.29 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.07 68.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.771 -0.58 . . . . 62.34 111.053 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -77.55 -46.72 21.44 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.599 0.963 . . . . 74.14 113.599 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -119.94 71.95 16.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.305 1.842 . . . . 72.34 111.024 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.28 -25.4 49.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.139 1.893 . . . . 71.0 112.644 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.21 11.92 21.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.488 0.715 . . . . 61.24 111.265 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -115.92 158.76 22.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.318 1.417 . . . . 74.04 109.539 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 m -119.68 129.92 25.11 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.621 1.568 . . . . 72.41 108.171 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.76 111.66 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.18 3.92 . . . . 74.32 112.694 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.12 151.45 20.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.306 1.442 . . . . 74.22 111.206 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.58 133.39 68.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 103.166 -2.901 . . . . 74.13 103.166 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.31 121.77 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.362 -0.828 . . . . 74.25 110.516 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.6 151.09 46.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.191 0.905 . . . . 61.34 111.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 123.46 31.75 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.764 1.626 . . . . 73.52 108.931 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.58 128.55 33.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.81 -1.552 . . . . 71.12 106.81 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 p -61.95 147.63 46.32 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.905 0.859 . . . . 72.03 112.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.91 -20.68 45.93 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 116.375 -2.347 . . . . 74.32 116.415 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 160.9 25.06 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 122.041 2.921 . . . . 72.13 110.668 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.86 -13.0 61.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.953 2.205 . . . . 62.42 116.953 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.07 162.59 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 120.595 1.543 . . . . 64.34 114.548 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.2 152.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.173 1.389 . . . . 73.12 109.578 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -81.1 169.15 17.79 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.016 0.526 . . . . 74.42 111.417 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -125.61 142.0 43.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.961 1.305 . . . . 73.14 111.485 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.12 161.49 30.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.889 2.076 . . . . 71.44 107.986 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -84.2 98.26 9.84 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.768 -2.308 . . . . 75.31 104.768 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 13.5 mmm180 -136.02 159.13 42.64 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.763 0.71 . . . . 73.23 111.459 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HE3' HG12 ' B' ' 343' ' ' ILE . 2.4 mtmp? -106.25 99.01 8.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.583 1.553 . . . . 71.42 107.064 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.43 120.76 26.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.922 0.889 . . . . 70.44 110.337 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.79 105.46 14.69 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.972 1.309 . . . . 71.53 108.021 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.51 143.16 27.23 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-O 118.227 -0.892 . . . . 72.53 112.143 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.16 138.82 57.92 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.369 2.046 . . . . 64.43 110.329 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.0 p -63.61 -15.75 59.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.803 1.641 . . . . 62.1 112.431 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -75.07 -35.59 61.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.027 1.731 . . . . 74.11 113.712 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.06 165.54 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.866 0.841 . . . . 73.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -99.87 165.35 11.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.783 0.833 . . . . 62.5 110.905 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.25 -35.6 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.676 1.19 . . . . 75.23 108.143 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.77 88.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.966 1.306 . . . . 74.34 110.447 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.97 -45.63 66.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.373 -0.822 . . . . 64.43 110.006 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 6.4 t80 -59.07 -48.54 81.21 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.858 0.754 . . . . 70.41 109.483 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.2 ttp -55.19 -51.37 66.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.766 0.826 . . . . 75.02 109.949 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.96 -38.94 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.432 -0.318 . . . . 72.14 110.436 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' B' ' 346' ' ' VAL . 38.0 mt -66.38 -43.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 116.997 -1.477 . . . . 73.45 110.367 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 83.8 mt -58.86 -50.81 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.636 1.562 . . . . 65.12 108.417 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -61.93 -39.62 92.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.91 -0.716 . . . . 74.52 112.616 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -66.93 -40.39 87.58 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.246 0.93 . . . . 74.14 110.392 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.43 -47.24 86.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 121.348 -0.845 . . . . 71.42 110.054 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -81.48 -1.24 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.837 0.68 . . . . 74.51 112.837 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 57.5 58.04 4.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.346 2.258 . . . . 73.23 112.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.27 108.13 2.55 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.073 0.949 . . . . 75.23 111.644 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.08 156.67 64.4 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 51.14 111.296 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.1 m -63.29 -13.97 44.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.696 -0.668 . . . . 74.44 112.463 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -37.37 76.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.863 1.21 . . . . 71.55 109.686 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -103.25 164.25 11.75 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.508 1.049 . . . . 70.52 111.059 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.18 170.79 7.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.044 1.738 . . . . 64.41 106.843 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 tt -151.62 129.78 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.915 -1.143 . . . . 75.22 107.915 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.26 147.76 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.889 1.275 . . . . 62.11 109.145 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.9 mt -114.16 154.59 27.57 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.152 1.381 . . . . 71.13 109.435 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -145.15 139.83 27.54 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.797 1.239 . . . . 70.44 108.533 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.37 128.81 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 106.035 -1.839 . . . . 73.42 106.035 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 45.96 37.13 3.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.447 1.022 . . . . 75.22 112.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.0 tptt 68.02 22.1 8.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.571 0.952 . . . . 74.21 113.571 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 p -127.28 162.16 26.89 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.985 1.714 . . . . 52.2 111.191 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.56 108.01 53.78 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 104.096 -2.557 . . . . 73.3 104.096 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.09 148.72 51.08 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.877 1.718 . . . . 74.4 111.881 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.41 117.97 16.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.94 1.296 . . . . 73.11 108.329 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 p -51.28 -38.79 54.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.134 1.373 . . . . 64.14 112.953 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -74.36 -12.36 60.5 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.755 1.02 . . . . 72.1 113.755 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.61 150.62 47.77 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.552 -1.343 . . . . 73.12 109.631 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.92 26.57 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.162 0.985 . . . . 60.43 110.798 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.8 mmt -57.2 -47.33 81.55 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.841 0.856 . . . . 74.33 111.063 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.58 96.59 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.526 -0.597 . . . . 61.31 113.138 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -67.76 -51.0 54.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.948 0.874 . . . . 75.31 110.508 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.47 -35.84 80.61 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.068 -0.716 . . . . 71.15 109.068 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -66.26 -57.19 8.09 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.428 -0.796 . . . . 72.53 108.906 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.7 -41.97 87.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.43 1.013 . . . . 74.32 112.734 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -32.9 65.48 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 118.398 -0.811 . . . . 73.03 111.73 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.59 7.09 44.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.071 0.85 . . . . 73.41 112.584 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.29 119.54 3.04 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 126.783 2.033 . . . . 61.1 109.13 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.54 175.69 9.59 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.725 0.639 . . . . 72.13 112.725 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.15 -25.41 61.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.172 1.389 . . . . 75.34 110.498 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.42 4.98 39.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.215 1.806 . . . . 73.23 111.248 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.23 28.93 69.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.511 -1.16 . . . . 72.41 114.78 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -123.78 168.62 12.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.352 1.576 . . . . 64.34 109.125 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tp -122.02 139.97 53.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.511 1.124 . . . . 74.32 110.58 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -113.84 115.72 28.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.305 1.442 . . . . 74.34 109.489 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.54 131.53 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 O-C-N 120.746 -1.221 . . . . 54.1 108.592 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.59 151.83 31.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.983 -1.117 . . . . 74.34 107.983 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -131.04 154.42 48.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.607 0.363 . . . . 74.55 110.588 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.8 m -140.39 155.1 46.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.489 -0.93 . . . . 61.02 108.489 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.28 27.07 13.2 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.69 1.138 . . . . 43.15 111.509 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 128.341 2.656 . . . . 72.33 106.473 -179.629 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 116.24 1.941 . . . . 70.12 116.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 73.2 m95 67.43 65.0 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.539 1.518 . . . . 73.44 112.106 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.23 139.08 19.4 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.91 -1.276 . . . . 54.24 109.91 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 343' ' ' ILE . . . . . 0.439 HG12 ' HE3' ' A' ' 48' ' ' LYS . 24.3 mt -75.43 134.7 28.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 118.444 1.122 . . . . 73.14 111.317 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -140.7 114.4 8.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.313 0.645 . . . . 74.35 111.582 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.56 120.03 24.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 105.544 -2.021 . . . . 63.2 105.544 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 63' ' ' ILE . 92.5 t -122.4 142.38 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.404 0.682 . . . . 75.4 109.621 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.7 p -161.95 149.0 14.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.646 1.578 . . . . 24.33 107.777 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.356 2.262 . . . . 65.41 105.379 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.5 m95 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 118.764 -0.636 . . . . 65.34 109.437 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -45.68 75.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.423 0.63 . . . . 74.11 110.845 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -60.07 -42.35 94.37 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.53 -0.731 . . . . 75.42 112.208 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -70.3 -32.02 69.61 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.043 0.537 . . . . 72.23 109.909 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.14 -47.94 69.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.279 -1.008 . . . . 72.52 108.279 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -71.1 -76.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.422 1.889 . . . . 72.22 111.485 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.94 126.24 3.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.695 1.198 . . . . 64.02 108.101 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -124.02 -65.6 1.05 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 116.562 -1.685 . . . . 63.21 112.664 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 tp -42.46 -58.33 2.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.457 1.481 . . . . 65.02 114.159 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -60.16 -52.05 66.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.562 0.696 . . . . 72.34 110.632 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.1 -49.1 69.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.318 1.847 . . . . 74.14 111.599 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -39.82 91.61 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.018 1.727 . . . . 64.34 109.458 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.3 m -61.42 -47.18 86.93 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.656 1.116 . . . . 61.42 110.753 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.21 -47.29 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.04 -1.038 . . . . 72.04 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 21' ' ' ILE . 37.4 tt0 -58.29 -52.0 67.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.76 1.224 . . . . 70.53 111.615 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 t -61.04 -48.4 81.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.873 0.869 . . . . 73.3 109.926 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.87 -47.74 73.85 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.147 0.885 . . . . 62.23 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.04 -41.61 77.44 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.53 -0.731 . . . . 60.53 111.552 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 17' ' ' GLU . 68.8 mt -64.47 -41.33 92.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.008 -0.996 . . . . 70.14 108.947 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -63.45 -41.44 98.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 120.284 1.402 . . . . 62.31 108.473 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.22 72.74 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.452 0.538 . . . . 62.35 112.452 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -76.82 -46.21 25.72 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 114.191 1.182 . . . . 64.23 114.191 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -133.79 79.22 58.85 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 125.02 1.328 . . . . 64.25 111.101 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 -20.38 47.96 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.525 1.484 . . . . 41.02 109.675 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.47 12.33 16.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.971 1.308 . . . . 62.44 112.4 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -127.75 141.41 51.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 119.196 0.907 . . . . 63.42 108.672 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.32 137.29 19.88 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 54.21 108.01 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.76 111.93 2.59 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.671 3.581 . . . . 74.24 113.843 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.89 135.6 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.458 1.103 . . . . 51.03 110.65 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.86 115.14 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 104.454 -2.424 . . . . 71.55 104.454 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.56 126.79 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.629 1.172 . . . . 73.44 109.284 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.82 149.13 48.86 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.378 1.071 . . . . 74.32 109.651 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -83.73 141.15 31.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.234 -1.025 . . . . 71.4 108.234 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.23 124.55 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 103.093 -2.929 . . . . 45.3 103.093 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.0 141.24 54.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.646 -0.659 . . . . 64.41 110.283 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.0 -1.84 78.44 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 116.13 -2.483 . . . . 61.34 113.655 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -83.95 145.07 28.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 121.575 2.688 . . . . 65.34 109.283 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.03 -20.16 64.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.976 1.71 . . . . 70.32 112.108 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.59 158.23 3.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.321 1.057 . . . . 70.22 113.441 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.52 134.54 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.129 -1.804 . . . . 74.34 106.129 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.24 171.98 14.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.859 1.664 . . . . 74.24 109.058 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 tt -126.64 152.02 33.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 123.742 0.817 . . . . 64.24 110.431 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.43 161.53 27.91 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.022 1.329 . . . . 73.05 109.141 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -77.89 91.05 4.13 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 14.3 mmm180 -131.34 151.92 51.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 106.548 -1.649 . . . . 72.41 106.548 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -99.98 106.35 18.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.729 -1.211 . . . . 64.33 107.729 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -87.98 121.07 29.95 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 122.401 1.096 . . . . 64.14 113.072 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.92 112.52 24.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.762 2.025 . . . . 73.1 108.246 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 m -111.34 142.03 25.62 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.074 -0.965 . . . . 75.23 110.704 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.02 139.25 38.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 120.86 1.343 . . . . 61.04 110.889 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 p -65.57 -12.77 56.04 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.85 1.26 . . . . 62.14 112.145 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.88 -35.37 43.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.166 1.786 . . . . 70.12 113.965 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -74.53 170.24 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.957 0.884 . . . . 73.43 111.444 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 p -97.8 162.84 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.896 1.278 . . . . 65.25 111.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.21 -35.28 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.368 1.067 . . . . 64.03 108.129 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.31 90.25 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.82 0.848 . . . . 50.43 109.682 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -62.95 -46.06 89.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.182 -0.673 . . . . 75.03 109.182 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.38 -51.08 71.46 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.983 -0.377 . . . . 65.43 109.983 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.42 -47.99 72.15 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.596 1.158 . . . . 62.41 109.619 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -59.79 -44.67 93.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.594 -0.521 . . . . 75.34 109.594 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.6 mt -62.95 -40.28 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.63 -1.176 . . . . 74.14 109.453 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.17 -50.15 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.955 1.707 . . . . 74.24 108.906 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -63.66 -35.25 79.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.787 0.722 . . . . 54.55 111.16 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -66.89 -43.61 82.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.794 0.724 . . . . 64.34 109.198 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.59 -49.16 78.64 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.866 1.266 . . . . 71.33 111.341 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -80.39 0.65 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.026 0.204 . . . . 71.32 110.781 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 49.46 64.4 1.76 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.618 1.967 . . . . 73.43 110.016 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.14 111.39 7.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.296 1.438 . . . . 54.23 111.01 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.66 152.9 69.91 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.998 2.465 . . . . 73.11 109.94 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 m -62.2 -15.38 46.12 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.809 1.04 . . . . 60.54 113.809 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.16 -32.07 66.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.516 0.726 . . . . 73.25 110.431 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.37 164.33 11.71 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 122.073 0.94 . . . . 72.14 109.861 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.28 4.79 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.934 1.694 . . . . 74.2 107.49 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 tp -139.63 138.23 39.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.99 -1.855 . . . . 41.32 105.99 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -144.08 133.14 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.371 1.469 . . . . 75.11 107.17 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.5 mt -114.61 151.42 33.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.407 1.083 . . . . 52.02 108.172 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.0 142.49 29.83 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.709 1.204 . . . . 75.44 109.565 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.66 124.8 20.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 117.148 -1.406 . . . . 64.03 107.347 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 46.35 38.45 5.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 120.358 1.435 . . . . 72.03 110.882 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt 64.57 18.68 11.5 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.286 -1.509 . . . . 71.15 113.588 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 p -119.48 162.76 18.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.435 2.294 . . . . 65.03 111.234 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 t -101.39 107.84 52.61 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.97 1.308 . . . . 63.24 107.966 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.17 140.49 45.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.158 2.572 . . . . 74.3 109.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -77.63 121.81 24.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.506 0.722 . . . . 73.24 110.945 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.1 p -52.58 -35.45 54.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.758 1.223 . . . . 73.11 114.159 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -77.84 -17.3 57.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.624 0.972 . . . . 54.23 113.624 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.14 149.81 49.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.803 1.183 . . . . 54.1 109.787 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.6 p -85.98 152.38 22.98 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.767 0.794 . . . . 71.54 109.722 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.4 mmt -56.12 -43.43 78.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.181 0.992 . . . . 73.4 112.032 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.62 -36.8 83.95 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.563 -1.132 . . . . 75.44 113.288 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -66.49 -49.14 67.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.213 1.506 . . . . 74.43 107.739 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.07 -43.1 95.68 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.859 0.864 . . . . 72.31 110.102 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -59.55 -54.46 46.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.313 1.845 . . . . 71.42 108.991 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.14 -43.35 99.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.098 -0.641 . . . . 73.45 112.69 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.43 -32.38 60.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.895 1.072 . . . . 71.22 113.895 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -100.44 0.89 40.62 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.23 1.196 . . . . 74.24 114.23 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.49 121.54 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.635 1.574 . . . . 74.35 112.384 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.15 175.51 7.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.712 0.405 . . . . 73.54 109.978 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.64 -34.03 66.9 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.888 -1.133 . . . . 75.32 110.827 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.23 10.39 29.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.457 1.903 . . . . 45.34 112.186 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.97 -1.2 1.39 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.848 2.642 . . . . 54.02 114.264 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.42 170.83 15.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.023 1.411 . . . . 72.23 111.073 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.68 136.75 54.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.78 0.832 . . . . 74.25 111.075 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -122.18 122.91 40.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.889 1.676 . . . . 71.13 109.898 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.17 137.51 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.693 -1.254 . . . . 71.32 109.461 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.16 147.62 32.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.746 -1.205 . . . . 75.33 107.746 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.85 152.44 48.51 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.315 0.646 . . . . 61.42 110.641 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 t -147.29 163.55 36.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.495 0.718 . . . . 35.4 109.895 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.86 17.22 22.84 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.896 1.712 . . . . 55.22 113.654 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 . . . . . 0 C--O 1.237 0.411 0 C-N-CA 126.076 1.75 . . . . 73.54 109.201 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 115.902 1.815 . . . . 50.34 115.902 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 59.4 m95 51.96 52.21 14.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.883 1.673 . . . . 75.11 111.984 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 342' ' ' GLY . . . . . 0.448 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -84.48 130.49 9.82 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.789 -1.194 . . . . 41.25 111.498 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.78 132.39 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.956 1.702 . . . . 72.44 110.992 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.96 141.48 36.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.959 2.104 . . . . 52.12 110.961 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.15 124.02 37.9 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.061 -1.089 . . . . 62.3 108.061 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.97 109.97 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.678 1.191 . . . . 74.54 109.129 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 160.1 40.96 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.659 1.184 . . . . 74.32 110.694 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.277 1.031 . . . . 71.32 108.564 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.3 m95 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 112.099 0.407 . . . . 63.22 112.099 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -35.19 77.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.22 -0.289 . . . . 72.21 110.22 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.68 -45.77 91.09 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.915 -1.116 . . . . 64.13 109.992 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -65.22 -33.98 77.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.842 0.857 . . . . 75.43 110.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.75 -45.29 92.68 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.023 0.929 . . . . 60.25 108.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.09 -75.48 0.3 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.146 0.978 . . . . 72.11 112.87 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 133.35 6.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.467 1.507 . . . . 74.32 109.504 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.4 t -130.65 -53.29 1.08 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.787 -1.101 . . . . 24.44 109.551 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 tp -49.59 -59.94 3.32 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.232 1.567 . . . . 73.41 115.232 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.63 -58.87 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.249 0.931 . . . . 63.33 110.847 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CD2' HH21 ' A' ' 14' ' ' ARG . 2.0 t-160 -50.6 -50.33 54.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.885 1.674 . . . . 71.15 111.892 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.455 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.8 mmp_? -70.27 -42.04 72.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.721 -1.862 . . . . 73.41 110.734 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.14 -54.45 39.41 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.22 1.373 . . . . 74.11 110.015 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -47.64 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.027 1.331 . . . . 72.33 111.476 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.0 -42.59 99.89 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.85 -0.595 . . . . 62.44 109.837 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -55.34 -48.18 74.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.277 1.031 . . . . 74.14 108.681 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.62 72.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 0.598 . . . . 72.24 111.864 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.67 -45.61 91.99 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.971 -0.456 . . . . 72.24 110.887 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.4 -41.44 89.89 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 108.52 -0.919 . . . . 65.24 108.52 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -67.57 -29.82 69.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.39 1.45 . . . . 64.24 110.648 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.36 -47.44 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.681 -0.637 . . . . 71.32 110.076 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.99 -46.51 29.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.935 0.717 . . . . 63.42 112.935 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.91 73.65 70.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.773 2.029 . . . . 75.14 110.492 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -18.37 47.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.162 2.575 . . . . 55.33 111.831 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.52 14.03 31.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.712 1.205 . . . . 52.34 111.839 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -123.53 152.37 41.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.77 0.828 . . . . 62.31 109.458 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 m -114.51 129.39 24.97 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.577 1.551 . . . . 71.31 108.525 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.66 116.99 3.89 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.22 3.947 . . . . 60.55 112.601 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.72 146.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.759 0.79 . . . . 43.35 109.455 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.36 112.77 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.486 -2.783 . . . . 73.13 103.486 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.33 127.71 61.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.198 -1.408 . . . . 63.23 107.198 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -128.08 143.61 51.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.226 0.611 . . . . 73.31 109.841 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.49 136.5 32.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -68.48 112.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.345 -1.354 . . . . 73.32 107.345 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.05 148.64 2.25 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.366 1.466 . . . . 63.45 111.345 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.23 -20.49 13.3 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 118.471 -1.183 . . . . 60.44 111.93 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -65.16 144.93 56.88 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.96 1.88 . . . . 44.02 110.346 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -70.67 -28.76 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.638 1.575 . . . . 65.14 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 42' ' ' VAL . 5.6 tp -59.79 157.34 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.369 0.668 . . . . 63.21 111.198 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' H ' HD12 ' A' ' 41' ' ' ILE . 33.7 m -63.46 138.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.178 -1.045 . . . . 42.24 108.178 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.82 177.58 6.05 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.927 1.691 . . . . 64.44 110.082 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.97 158.79 35.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.659 1.184 . . . . 73.32 109.936 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -78.92 166.19 22.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 128.278 2.631 . . . . 75.22 109.228 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -80.88 80.85 7.28 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 104.009 -2.589 . . . . 71.53 104.009 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -135.04 145.11 47.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.023 -1.843 . . . . 73.15 106.023 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -92.02 144.29 25.6 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.558 1.143 . . . . 75.54 111.745 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.03 116.96 30.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.322 1.449 . . . . 61.13 107.518 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -108.12 110.32 21.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.981 1.313 . . . . 73.42 109.379 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -108.0 143.55 27.59 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 119.6 1.091 . . . . 71.24 112.808 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HG2' HG23 ' A' ' 55' ' ' ILE . 58.4 Cg_endo -64.87 138.83 59.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.911 2.407 . . . . 73.15 110.603 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.77 -16.47 58.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.656 -0.652 . . . . 74.53 112.301 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -26.21 59.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.459 1.904 . . . . 60.51 113.7 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.444 HG23 ' HG2' ' A' ' 52' ' ' PRO . 1.1 pp -80.91 170.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 122.11 0.957 . . . . 72.44 111.523 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -107.38 162.15 14.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.491 1.116 . . . . 62.41 109.6 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.3 t -52.36 -37.29 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.083 . . . . 71.54 108.077 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.36 -46.68 73.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.313 1.445 . . . . 74.22 112.225 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -70.47 -44.4 67.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.36 -0.607 . . . . 74.52 109.36 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 51' ' ' VAL . 2.3 t80 -58.44 -49.91 75.6 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.962 0.41 . . . . 71.24 109.896 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.6 ttp -62.56 -49.19 76.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.554 -0.736 . . . . 73.23 110.177 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -57.59 -44.49 85.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.455 1.025 . . . . 71.44 111.077 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.9 mt -64.79 -42.96 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.534 -0.913 . . . . 72.14 108.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.426 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.6 mt -57.67 -50.08 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.274 1.397 . . . . 75.51 110.07 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.54 -35.2 77.08 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.328 -1.483 . . . . 54.35 111.016 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -70.35 -35.47 73.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.407 0.548 . . . . 74.13 109.717 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -67.02 -45.3 77.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.608 1.563 . . . . 71.14 111.682 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 pt -79.6 -3.39 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 123.667 0.604 . . . . 73.12 110.887 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.72 46.57 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.394 1.077 . . . . 61.12 109.802 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.92 109.28 3.64 Favored Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.369 1.468 . . . . 52.23 110.223 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.58 149.91 56.29 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.975 1.783 . . . . 75.14 108.811 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -61.5 -18.15 57.8 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.507 -0.746 . . . . 44.21 113.007 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -66.33 -26.17 67.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.241 0.928 . . . . 65.31 110.449 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.99 164.89 11.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.062 0.945 . . . . 73.11 109.593 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 166.3 10.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.281 1.433 . . . . 74.41 109.52 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 tt -149.75 113.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 121.254 -0.904 . . . . 72.24 109.698 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -123.42 138.03 54.68 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.449 -1.315 . . . . 73.53 107.449 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.97 149.85 36.7 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.233 1.813 . . . . 74.32 107.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -141.74 133.36 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.41 1.084 . . . . 75.35 109.436 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.44 144.2 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 106.743 -1.577 . . . . 72.23 106.743 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.72 36.45 1.28 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.924 1.29 . . . . 74.42 112.651 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.51 38.21 29.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.235 1.414 . . . . 73.21 110.662 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -147.67 162.22 39.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.8 -1.185 . . . . 64.31 107.8 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.76 114.05 60.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 103.388 -2.819 . . . . 64.42 103.388 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.77 123.95 10.97 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 N-CA-C 107.427 -1.797 . . . . 72.33 107.427 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.96 126.56 27.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.461 -0.57 . . . . 52.53 109.461 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.0 m -45.88 -46.78 16.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 63.11 113.471 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.7 m -77.04 -3.18 37.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.389 1.45 . . . . 72.13 114.692 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.0 tp -67.47 141.17 57.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.691 1.587 . . . . 32.33 106.809 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.1 p -85.52 151.98 23.53 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.705 -0.622 . . . . 64.41 109.544 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 mmt -62.27 -42.13 99.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 118.206 -0.902 . . . . 72.41 113.153 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.33 -47.03 92.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.401 -1.079 . . . . 25.51 110.401 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -61.83 -49.15 77.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.774 0.83 . . . . 75.12 110.181 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.47 -49.31 75.92 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.384 0.674 . . . . 71.31 111.216 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -62.72 -45.53 92.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.629 -1.295 . . . . 73.45 108.915 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.05 -26.06 67.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 120.297 1.408 . . . . 74.13 111.736 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -24.35 20.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 116.911 -1.519 . . . . 71.43 112.335 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -112.36 1.1 15.88 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.877 1.436 . . . . 74.21 114.877 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -46.94 121.5 3.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.936 1.695 . . . . 60.15 112.148 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -80.85 171.51 14.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.544 -1.28 . . . . 73.12 107.544 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.1 -20.6 18.03 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.281 1.832 . . . . 55.01 113.795 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -102.03 13.71 33.98 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.901 1.68 . . . . 75.41 112.222 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.9 31.76 77.31 Favored Glycine 0 CA--C 1.524 0.623 0 O-C-N 120.547 -1.346 . . . . 62.32 114.092 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -129.16 172.94 10.94 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.361 -1.082 . . . . 75.13 108.44 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.12 125.36 45.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.946 -1.131 . . . . 72.34 107.946 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -102.96 120.04 39.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.903 1.281 . . . . 74.25 108.775 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.239 -1.023 . . . . 73.35 108.239 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.31 148.65 40.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.375 1.47 . . . . 40.45 107.628 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -138.12 145.81 42.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.433 0.56 . . . . 75.23 110.443 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 p -143.47 161.5 38.26 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 122.107 0.956 . . . . 74.32 110.228 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.32 13.31 21.26 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.993 -1.643 . . . . 73.32 108.993 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 125.76 1.624 . . . . 64.34 108.509 -178.892 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 115.754 1.761 . . . . 74.32 115.754 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 77.0 m95 60.7 59.2 2.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 74.33 113.045 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.78 129.21 9.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.644 -1.382 . . . . 25.33 109.644 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 55.2 mt -77.31 132.99 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.276 1.538 . . . . 62.43 112.184 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.02 139.81 39.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 71.13 109.183 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.4 tt -98.68 118.78 36.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.869 2.068 . . . . 74.55 107.638 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.41 125.66 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 122.917 0.487 . . . . 74.14 110.636 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.0 p -161.49 149.71 15.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.904 -1.887 . . . . 73.44 105.904 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.489 0.716 . . . . 55.23 110.112 -179.685 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.7 m95 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 mmt -58.76 -46.8 86.63 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.729 -1.212 . . . . 51.11 107.729 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -59.86 -43.33 94.72 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.497 -0.763 . . . . 73.23 112.307 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -69.33 -35.91 76.39 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.287 0.949 . . . . 63.32 110.924 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.05 -41.26 91.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.511 -0.552 . . . . 73.42 109.511 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.64 -75.45 0.31 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.745 0.818 . . . . 73.01 111.393 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 119.38 3.23 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.548 -1.649 . . . . 74.13 106.548 177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -104.68 -65.48 1.03 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.51 1.124 . . . . 61.55 112.361 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.61 -58.47 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.072 1.349 . . . . 70.43 112.922 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.76 -58.79 6.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.717 0.636 . . . . 73.54 112.717 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -55.63 -54.97 37.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.0 0.429 . . . . 75.42 111.808 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.33 82.53 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.526 -1.226 . . . . 74.12 110.982 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -61.8 -56.31 20.8 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.621 1.168 . . . . 73.13 112.919 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 -44.79 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 120.669 -1.269 . . . . 60.34 110.124 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 48.4 mm-40 -61.63 -42.76 99.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 117.661 -1.161 . . . . 71.04 110.405 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.5 p -60.49 -45.1 95.0 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.632 1.56 . . . . 32.22 109.423 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.22 74.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.983 0.81 . . . . 74.02 111.95 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.88 -39.84 95.12 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.632 -0.667 . . . . 72.11 111.132 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.47 -41.2 88.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-O 117.584 -1.198 . . . . 63.23 108.539 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -65.83 -39.2 90.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.869 1.668 . . . . 75.34 109.556 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.01 74.76 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.842 -0.743 . . . . 52.14 110.909 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -78.51 -47.05 18.14 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.855 1.798 . . . . 62.34 115.855 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -126.24 70.53 69.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 126.585 1.954 . . . . 63.31 110.647 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.12 -19.47 51.06 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.502 2.134 . . . . 52.44 110.231 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.46 12.92 17.07 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.44 1.096 . . . . 64.1 112.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -129.65 160.7 32.52 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.734 1.614 . . . . 54.52 111.393 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.21 136.97 28.9 Favored Pre-proline 0 C--O 1.247 0.948 0 C-N-CA 124.422 1.089 . . . . 73.21 108.471 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.98 113.7 3.48 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 126.078 4.519 . . . . 51.11 111.683 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.1 144.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.666 0.786 . . . . 73.45 110.477 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -122.6 128.88 75.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 103.861 -2.644 . . . . 75.31 103.861 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.93 119.69 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 127.124 2.169 . . . . 73.53 106.692 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -124.4 146.96 48.57 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.614 1.097 . . . . 75.44 109.051 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -89.35 139.41 30.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.242 0.474 . . . . 71.42 109.905 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.0 130.24 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.568 -1.271 . . . . 74.41 107.568 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 p -61.04 122.04 13.97 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.214 -1.402 . . . . 70.52 107.214 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.93 -13.8 29.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.902 -1.499 . . . . 44.21 112.87 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.641 ' HB3' HG22 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -79.54 131.08 35.93 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.503 2.151 . . . . 73.03 106.318 177.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -63.48 -19.66 64.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.813 0.845 . . . . 73.44 113.012 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 39' ' ' SER . 9.4 tp -51.74 155.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.817 1.647 . . . . 73.41 112.71 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.16 145.27 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.437 1.095 . . . . 74.3 111.78 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.79 164.24 25.39 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.036 0.534 . . . . 41.34 109.798 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.68 132.72 70.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.455 1.102 . . . . 72.33 112.082 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -67.54 153.6 43.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.996 1.719 . . . . 75.13 107.821 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.69 99.13 3.6 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.327 -1.731 . . . . 71.41 106.327 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -134.41 160.96 36.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.429 -0.952 . . . . 74.23 108.429 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.9 mtpp -109.81 103.01 11.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.018 1.727 . . . . 75.14 108.372 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -84.38 125.84 32.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.735 -1.209 . . . . 74.21 107.735 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.74 107.57 18.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.322 -2.103 . . . . 71.24 105.322 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -109.61 143.01 26.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 117.011 -1.471 . . . . 63.52 110.492 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.12 134.73 25.75 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.452 2.768 . . . . 45.34 111.995 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 p -59.63 -17.2 31.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.885 1.274 . . . . 64.42 113.993 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.6 -34.26 60.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.434 1.894 . . . . 75.52 113.213 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.39 167.22 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 119.969 1.259 . . . . 71.22 111.095 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -107.38 166.66 10.48 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.38 1.072 . . . . 62.51 110.712 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.12 -37.94 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.378 1.071 . . . . 74.41 110.085 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.56 93.28 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.238 0.926 . . . . 71.33 111.311 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.79 -46.2 79.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.053 0.941 . . . . 74.41 108.572 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.95 -50.66 72.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.697 1.199 . . . . 75.32 110.46 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttp -55.06 -49.07 72.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.61 1.164 . . . . 63.43 110.35 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -57.51 -42.17 82.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.491 -0.559 . . . . 75.32 109.491 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.21 -48.66 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.822 -1.085 . . . . 74.43 110.374 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.28 -50.39 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.794 1.179 . . . . 61.25 110.071 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.0 -36.86 82.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.022 -0.99 . . . . 73.23 111.51 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -71.19 -37.1 72.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.072 1.305 . . . . 71.52 110.673 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.66 -49.53 74.79 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.491 1.516 . . . . 75.0 109.658 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 pt -79.53 0.7 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 119.605 -0.236 . . . . 73.23 111.006 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 50.29 58.41 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.498 1.919 . . . . 65.44 110.039 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 110.14 4.44 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.736 -1.209 . . . . 55.22 107.736 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.07 162.52 39.65 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.112 2.541 . . . . 74.11 112.434 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 m -67.35 -22.33 65.59 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.745 -0.597 . . . . 53.34 110.969 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.66 -34.06 77.01 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.11 0.868 . . . . 63.22 111.697 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -104.15 164.63 11.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.987 1.315 . . . . 71.33 111.726 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 175.13 5.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.413 1.885 . . . . 73.53 106.558 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -144.55 143.1 23.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 64.51 107.542 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -145.49 134.63 22.78 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.78 1.632 . . . . 74.32 108.129 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -114.7 142.26 46.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.988 1.315 . . . . 74.45 109.803 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.59 136.94 36.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.023 1.329 . . . . 74.23 108.766 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.67 125.7 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 104.305 -2.48 . . . . 45.11 104.305 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t70 43.72 42.7 4.46 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.252 1.204 . . . . 72.13 114.252 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? 69.51 18.58 7.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.712 1.605 . . . . 73.0 114.291 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.1 p -124.03 162.57 23.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 120.48 1.491 . . . . 75.22 112.165 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.24 105.12 11.47 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 105.737 -1.949 . . . . 51.14 105.737 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.45 133.75 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.065 1.844 . . . . 71.24 109.844 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -67.57 118.59 11.07 Favored 'General case' 0 C--O 1.227 -0.113 0 O-C-N 121.439 -0.788 . . . . 73.31 109.366 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m -50.56 -39.32 49.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.224 1.01 . . . . 62.31 113.563 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.69 -8.07 59.66 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.052 1.501 . . . . 72.33 115.052 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.47 141.69 50.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.156 1.798 . . . . 63.41 110.307 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.52 143.39 34.92 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.631 -1.248 . . . . 75.35 107.631 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.19 -43.39 70.69 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.208 -0.901 . . . . 63.34 111.09 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.45 -38.0 92.88 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.868 1.213 . . . . 33.13 112.904 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.65 -53.83 16.79 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.513 -0.993 . . . . 63.02 108.808 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.26 -38.32 83.13 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.194 -0.912 . . . . 55.22 110.319 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -61.44 -54.43 43.58 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 117.082 -1.437 . . . . 72.15 107.461 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -55.12 -53.62 53.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.75 1.159 . . . . 62.32 111.925 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -24.93 64.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 117.963 -1.018 . . . . 75.22 113.659 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -105.95 4.32 29.37 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.233 1.379 . . . . 65.12 112.861 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -55.37 120.25 6.82 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.126 1.77 . . . . 64.43 110.041 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.43 172.37 13.05 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.133 -1.062 . . . . 65.31 108.133 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.51 -33.96 68.6 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.774 -1.204 . . . . 73.11 109.926 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -88.35 16.35 6.49 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.734 1.214 . . . . 73.32 112.193 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.2 28.38 66.64 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.361 1.458 . . . . 71.42 116.294 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -119.51 175.74 5.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.445 1.622 . . . . 74.24 111.013 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.68 137.89 54.63 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.161 0.985 . . . . 52.51 110.502 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.84 101.76 8.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.081 1.353 . . . . 73.11 109.97 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.72 122.84 69.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.559 0.695 . . . . 72.11 111.149 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.78 145.86 25.44 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.595 -1.261 . . . . 71.11 107.595 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -128.67 147.42 50.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.459 -0.941 . . . . 64.23 108.459 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 p -144.8 154.8 43.06 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.508 -0.923 . . . . 72.21 108.508 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.74 20.97 14.53 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.983 1.277 . . . . 53.4 110.064 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 C--O 1.239 0.548 0 C-N-CA 125.694 1.598 . . . . 53.2 107.828 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 113.006 0.743 . . . . 74.23 113.006 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 44.5 m95 51.91 59.38 4.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.25 1.82 . . . . 74.22 112.506 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.24 135.54 14.71 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.982 -1.247 . . . . 75.42 109.982 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 82.7 mt -80.61 134.47 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.712 1.756 . . . . 74.12 112.446 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -140.03 133.64 30.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.085 0.954 . . . . 72.41 111.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 73.6 mt -88.27 116.66 26.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.322 -2.103 . . . . 63.43 105.322 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.68 121.81 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.743 -0.836 . . . . 71.33 108.743 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -157.3 128.09 6.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.023 -1.103 . . . . 73.55 108.023 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 105.728 -1.952 . . . . 64.11 105.728 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.6 m95 . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 106.959 -1.497 . . . . 61.15 106.959 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 mtt -49.64 -46.83 49.96 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.61 0.764 . . . . 63.24 109.749 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -56.65 -44.14 81.01 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.038 -0.982 . . . . 74.33 113.108 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -74.52 -27.72 60.66 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.353 1.061 . . . . 73.23 113.332 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -72.42 -48.16 43.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.515 -0.92 . . . . 64.1 108.515 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -74.73 -77.29 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 124.271 0.982 . . . . 61.25 109.085 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.66 117.85 2.11 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 119.773 -1.83 . . . . 73.52 108.228 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p -112.86 -66.4 1.09 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.839 -1.553 . . . . 72.21 109.428 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 pp -44.14 -58.13 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.387 1.875 . . . . 62.13 115.299 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.59 -58.93 6.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.452 1.901 . . . . 73.3 111.237 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -63.15 -50.73 69.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.913 1.285 . . . . 54.53 111.141 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -40.92 85.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 116.996 -1.478 . . . . 73.43 109.824 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.11 -55.6 20.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.821 1.191 . . . . 71.41 110.117 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.03 -47.71 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.454 0.57 . . . . 74.22 111.031 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 48' ' ' LYS . 53.9 mm-40 -65.27 -38.59 90.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.412 -0.804 . . . . 65.11 109.74 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -58.77 -48.44 81.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 120.315 1.416 . . . . 62.4 108.419 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.42 69.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.88 0.764 . . . . 71.31 110.485 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.84 -49.92 70.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.479 -0.296 . . . . 64.13 111.677 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -59.13 -42.02 85.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 124.085 0.954 . . . . 61.31 110.621 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -69.12 -38.89 79.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.686 1.13 . . . . 71.55 109.379 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.49 70.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.591 -0.693 . . . . 51.33 110.468 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -73.2 -46.38 50.8 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 113.153 0.797 . . . . 64.4 113.153 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -129.0 77.75 77.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.857 1.263 . . . . 75.51 109.887 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.42 -28.03 71.03 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.731 2.287 . . . . 74.34 113.581 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.6 13.8 13.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.288 0.949 . . . . 71.14 110.653 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -118.1 152.44 35.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.584 -0.895 . . . . 72.35 108.584 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.61 135.2 24.94 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.52 -1.289 . . . . 70.12 107.52 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.47 114.44 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.293 3.329 . . . . 73.35 114.108 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.84 149.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 O-C-N 120.938 -1.101 . . . . 72.33 109.926 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.6 mm -123.1 115.19 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 103.056 -2.942 . . . . 75.31 103.056 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.08 119.38 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.054 -1.091 . . . . 75.01 108.054 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.48 159.67 37.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.709 1.14 . . . . 63.32 111.616 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.31 153.59 22.47 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.586 -0.696 . . . . 74.15 112.052 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.47 135.32 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.55 -2.389 . . . . 60.14 104.55 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.66 120.97 9.89 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.668 -1.234 . . . . 44.13 107.668 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.32 -11.82 54.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.538 -1.146 . . . . 31.31 112.443 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -69.5 113.27 6.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 103.635 -2.728 . . . . 62.34 103.635 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -72.07 -13.36 61.57 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.411 0.893 . . . . 73.53 113.411 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 tp -62.54 166.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.547 1.139 . . . . 74.21 111.723 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 m -55.68 123.49 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.437 1.095 . . . . 72.51 109.181 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.62 178.16 5.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.795 1.638 . . . . 74.43 110.05 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.11 149.7 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.453 1.101 . . . . 72.14 110.867 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.16 166.07 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.475 1.51 . . . . 64.31 107.26 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.45 103.02 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.562 -1.336 . . . . 73.11 109.448 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 67.9 mmt-85 -141.44 154.52 45.63 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.136 1.774 . . . . 73.0 109.865 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mtpp -98.97 104.27 16.3 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.964 1.706 . . . . 74.5 108.766 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -84.22 118.23 24.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.766 -1.568 . . . . 72.32 106.766 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.27 116.83 32.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.885 -1.524 . . . . 53.12 106.885 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -111.59 141.25 24.24 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.888 -1.053 . . . . 74.24 110.399 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 71.2 Cg_endo -72.27 141.1 35.04 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.333 2.022 . . . . 75.31 108.229 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -65.9 -13.03 58.94 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 114.616 1.339 . . . . 75.22 114.616 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.54 -32.07 24.06 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.417 1.265 . . . . 62.15 114.417 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.37 164.8 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.305 0.957 . . . . 70.23 109.319 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -103.21 165.32 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.443 0.697 . . . . 65.01 110.74 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.81 -35.63 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.037 1.335 . . . . 63.2 109.259 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.89 -46.12 85.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.244 0.929 . . . . 72.25 109.933 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -67.57 -46.41 72.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.573 -0.727 . . . . 73.14 109.919 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.38 -46.97 87.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.513 0.597 . . . . 73.33 110.097 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.4 ttt -55.73 -52.19 64.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.243 1.017 . . . . 74.41 108.982 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -57.29 -40.35 77.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.581 -0.723 . . . . 75.31 110.663 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.73 -44.03 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.127 . . . . 71.11 109.282 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.89 -51.1 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.731 1.605 . . . . 62.23 110.393 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -36.16 82.85 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.672 -0.68 . . . . 73.22 110.904 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -68.07 -43.69 77.99 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.173 0.589 . . . . 70.41 110.689 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -60.23 -51.33 70.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.857 1.663 . . . . 74.12 110.033 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.53 -2.97 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.125 -0.464 . . . . 75.2 111.57 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 50.05 65.4 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.756 2.022 . . . . 73.2 109.532 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.82 115.16 22.05 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.56 0.744 . . . . 74.23 109.252 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.26 164.47 17.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.668 3.579 . . . . 74.41 113.817 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -67.92 -29.52 68.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.368 0.667 . . . . 73.11 111.509 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -62.09 -38.52 89.15 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.061 -0.495 . . . . 75.34 112.237 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.42 164.44 11.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.7 0.762 . . . . 74.43 111.756 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 -178.2 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.976 1.711 . . . . 60.13 107.506 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.2 140.59 22.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.411 1.084 . . . . 74.42 108.26 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -145.34 140.7 27.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.006 -1.479 . . . . 63.24 107.006 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.72 153.14 30.82 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.845 1.658 . . . . 72.44 109.637 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -147.03 132.85 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.525 1.13 . . . . 74.35 108.946 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -126.61 119.6 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 103.121 -2.918 . . . . 64.43 103.121 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 46.77 45.8 14.89 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 124.71 2.195 . . . . 73.52 111.603 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt 56.59 30.38 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.452 -1.405 . . . . 55.45 112.224 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 p -118.64 159.87 22.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.547 -1.649 . . . . 72.34 106.547 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.36 109.58 41.25 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.674 -1.973 . . . . 70.43 105.674 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.38 124.0 13.07 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.093 1.862 . . . . 70.14 110.51 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -73.93 116.03 14.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.641 1.176 . . . . 44.12 109.954 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 83.6 p -49.13 -34.2 13.59 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.083 1.512 . . . . 65.44 115.083 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -82.6 -9.53 59.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.583 0.957 . . . . 63.53 113.583 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -75.19 144.5 42.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.609 1.095 . . . . 72.4 109.732 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.69 150.04 26.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.623 0.769 . . . . 44.41 109.739 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.2 mmt -54.64 -45.42 73.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.473 1.109 . . . . 61.21 111.785 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.15 91.04 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.456 -0.636 . . . . 55.44 113.259 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.5 -52.94 40.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.342 1.071 . . . . 73.21 108.812 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.38 -45.4 76.57 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 124.732 1.213 . . . . 74.33 108.82 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.28 -56.06 26.9 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.02 1.728 . . . . 61.12 109.28 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.31 -43.19 88.05 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.193 0.906 . . . . 73.32 113.298 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -30.71 39.31 Favored 'General case' 0 N--CA 1.46 0.055 0 CA-C-O 117.324 -1.322 . . . . 73.23 112.844 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -97.58 -7.77 30.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.205 1.366 . . . . 74.12 114.266 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -33.38 120.16 0.37 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.968 2.907 . . . . 73.11 114.94 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.01 169.98 17.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.38 -1.341 . . . . 74.12 107.38 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -54.49 -28.75 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.252 1.421 . . . . 72.23 112.674 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -99.52 17.59 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.273 1.029 . . . . 75.24 112.703 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 30.43 74.63 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.325 -0.859 . . . . 62.52 114.632 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -126.28 174.17 8.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.693 1.246 . . . . 73.23 110.35 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 tp -124.62 142.95 50.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.127 -0.94 . . . . 74.24 110.778 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -117.93 116.1 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.473 1.509 . . . . 73.53 107.761 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.21 131.67 72.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 O-C-N 120.469 -1.394 . . . . 73.33 108.243 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.62 24.36 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.951 0.9 . . . . 72.22 109.798 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -139.96 154.49 47.2 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 124.191 0.932 . . . . 74.11 111.301 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -153.77 169.04 24.31 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.931 1.292 . . . . 72.44 108.829 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.34 24.9 10.19 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.397 0.999 . . . . 71.32 113.821 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.532 0.288 0 C-N-CA 126.015 1.726 . . . . 70.1 109.247 -179.026 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 119.619 -0.229 . . . . 72.1 111.161 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.1 m95 52.36 47.43 24.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.99 0.916 . . . . 74.25 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 342' ' ' GLY . . . . . 0.415 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -79.28 146.31 28.94 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 108.584 -1.806 . . . . 52.12 108.584 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.57 143.98 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 118.661 1.23 . . . . 72.45 111.527 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -148.62 120.81 8.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.524 1.53 . . . . 73.43 109.781 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.45 119.61 22.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.442 -1.318 . . . . 72.52 107.442 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.47 108.61 22.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.661 1.184 . . . . 73.53 108.639 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 347' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 p -146.24 162.35 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.247 1.819 . . . . 54.21 109.913 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 123.571 0.748 . . . . 54.23 109.752 -179.656 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 109.02 -0.733 . . . . 71.2 109.02 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -46.75 68.91 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 124.206 0.942 . . . . 73.34 109.357 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -57.56 -49.25 76.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.743 0.817 . . . . 75.11 112.524 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.06 -43.99 90.44 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.697 0.799 . . . . 73.22 112.521 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -67.13 -44.35 80.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 123.572 0.545 . . . . 73.53 110.608 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -73.25 0.28 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 123.635 0.585 . . . . 71.13 111.448 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.604 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 1.5 p-80 -157.58 119.44 3.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.409 1.004 . . . . 71.34 109.948 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.01 -64.97 0.93 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.653 -1.641 . . . . 75.23 113.588 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.36 -57.82 1.68 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 121.597 1.999 . . . . 54.45 115.374 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -64.5 -52.62 56.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.768 0.794 . . . . 63.21 110.439 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.604 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 2.9 t60 -50.98 -58.99 4.63 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.075 1.75 . . . . 45.41 111.9 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -61.62 -49.43 76.61 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.363 2.665 . . . . 74.2 111.924 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.8 t -57.64 -49.05 77.75 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 118.724 0.693 . . . . 74.34 110.833 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.14 -42.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.331 0.652 . . . . 61.04 110.234 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 18.5 tt0 -60.44 -52.35 65.6 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.52 1.528 . . . . 70.43 110.436 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 t -58.21 -48.03 81.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.189 0.996 . . . . 73.32 108.937 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.42 76.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.25 0.477 . . . . 74.55 111.339 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -60.09 -39.56 86.54 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.35 -0.844 . . . . 72.21 110.332 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.34 -42.18 87.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-O 118.096 -0.954 . . . . 74.44 108.892 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -64.29 -32.52 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 120.515 1.507 . . . . 71.13 109.603 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.71 -47.81 20.77 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.254 0.549 . . . . 73.24 111.45 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -76.85 -46.87 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.859 1.429 . . . . 73.15 114.859 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.79 72.68 78.64 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 127.663 2.385 . . . . 74.43 108.128 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.79 -30.98 93.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.783 2.322 . . . . 75.22 111.326 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -90.92 14.79 12.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.766 0.826 . . . . 72.25 111.928 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -126.43 142.85 51.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.492 -1.38 . . . . 71.53 109.611 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.53 142.82 27.28 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.191 0.996 . . . . 73.1 111.779 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.79 118.66 3.84 Favored 'Trans proline' 0 C--N 1.353 0.78 1 C-N-CA 125.496 4.13 . . . . 72.32 114.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 t -125.48 143.85 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.248 1.023 . . . . 72.31 110.09 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mm -119.94 121.19 65.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 100.831 -3.766 . . . . 41.5 100.831 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.58 123.55 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.488 -0.93 . . . . 71.53 108.488 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -134.13 158.71 42.94 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.313 0.578 . . . . 63.02 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -79.12 145.75 33.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.01 0.524 . . . . 72.52 109.798 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.15 113.69 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 101.409 -3.552 . . . . 74.33 101.409 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.0 p -48.51 134.55 15.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.529 0.566 . . . . 72.33 112.529 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.29 -19.38 54.46 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 117.318 -1.823 . . . . 63.13 112.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 t -67.68 146.43 53.81 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.223 2.011 . . . . 61.21 109.937 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -73.7 -19.59 60.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.251 1.421 . . . . 71.45 112.791 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.3 tp -60.91 158.14 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.767 -0.457 . . . . 65.05 109.767 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.84 145.48 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 113.738 1.014 . . . . 41.11 113.738 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.99 160.99 17.65 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.637 1.975 . . . . 42.24 111.485 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.53 139.95 50.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.496 1.519 . . . . 75.53 109.545 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.77 159.36 30.38 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.869 -1.16 . . . . 64.24 107.869 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.84 95.05 2.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.586 -1.264 . . . . 73.14 107.586 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -133.09 151.29 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.05 -1.463 . . . . 73.11 107.05 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.5 mttp -99.79 108.25 20.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.472 -1.307 . . . . 75.33 107.472 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.88 119.9 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.448 0.642 . . . . 72.03 111.229 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.85 117.16 32.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.495 -2.039 . . . . 70.42 105.495 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 m -112.91 142.43 27.24 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.266 -1.013 . . . . 42.12 108.266 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 55.3 Cg_endo -66.78 138.62 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.324 1.509 . . . . 70.44 110.304 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -15.82 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.622 0.769 . . . . 64.51 111.667 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.73 -34.79 72.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.791 2.436 . . . . 64.4 113.321 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.31 166.5 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.004 -1.06 . . . . 53.32 111.982 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 p -99.87 168.74 9.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.728 0.811 . . . . 55.53 111.815 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.86 -41.24 56.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 125.078 1.351 . . . . 64.33 108.973 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.16 86.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.78 0.718 . . . . 72.01 111.074 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.57 -46.69 81.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.268 -0.642 . . . . 63.5 109.268 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.78 -47.71 84.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.533 0.606 . . . . 73.24 109.745 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.9 ttt -58.41 -46.17 86.98 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.629 1.571 . . . . 73.42 110.775 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -63.13 -44.49 95.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.865 -0.791 . . . . 72.44 108.865 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.53 HG21 ' CG1' ' B' ' 346' ' ' VAL . 29.8 mt -63.24 -40.01 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 117.48 -1.248 . . . . 74.25 108.706 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.12 -50.58 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 120.92 1.691 . . . . 44.41 109.209 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -63.48 -40.48 97.21 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.608 1.094 . . . . 75.11 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -63.49 -46.61 85.35 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.143 0.977 . . . . 73.34 110.593 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -59.97 -49.06 79.15 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.261 1.424 . . . . 73.22 111.473 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -79.93 -0.76 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 123.431 0.457 . . . . 72.02 111.261 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 50.11 68.25 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.688 2.395 . . . . 71.33 109.71 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 111.99 8.97 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.97 1.708 . . . . 64.43 111.098 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.13 157.92 49.91 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.335 2.69 . . . . 73.41 112.313 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.314 0.487 . . . . 71.24 112.314 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.01 -35.98 82.94 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.384 -0.823 . . . . 72.2 109.688 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.66 164.27 11.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.802 1.287 . . . . 74.54 112.33 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.1 177.3 4.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.866 2.467 . . . . 44.42 106.992 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tp -147.06 140.75 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.504 -1.295 . . . . 75.53 107.504 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.31 141.55 28.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.356 1.862 . . . . 73.24 108.833 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.0 mt -114.91 147.45 39.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 73.43 109.348 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -143.82 123.79 13.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.089 -1.449 . . . . 65.02 107.089 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.48 117.4 49.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.235 -1.394 . . . . 74.41 107.235 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t0 43.66 51.13 6.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.097 1.759 . . . . 44.31 111.711 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 63.54 17.9 10.69 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.322 1.449 . . . . 72.45 114.101 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.2 p -121.79 161.52 22.51 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 120.13 1.332 . . . . 71.51 111.02 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.26 110.04 60.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.113 -2.551 . . . . 64.13 104.113 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.65 135.54 33.49 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.446 1.43 . . . . 33.22 111.473 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.92 120.38 18.48 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 107.768 -1.197 . . . . 72.23 107.768 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -53.89 -25.81 21.93 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.123 2.169 . . . . 74.21 114.842 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -92.18 -12.14 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.643 0.777 . . . . 54.23 112.426 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.42 149.61 49.73 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.514 -0.921 . . . . 74.53 108.514 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.04 152.53 21.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.697 0.799 . . . . 74.32 109.489 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.39 -46.36 88.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.582 -0.723 . . . . 72.22 109.867 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.92 96.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.724 0.678 . . . . 44.14 111.793 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -65.19 -51.07 63.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.995 0.918 . . . . 62.23 108.937 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.94 -38.53 88.81 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.946 -0.471 . . . . 43.13 110.855 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -61.89 -52.99 61.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.699 2.0 . . . . 75.53 109.659 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.38 -33.75 73.52 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.686 0.624 . . . . 73.51 112.686 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -26.55 33.82 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 117.555 -1.212 . . . . 63.32 111.724 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -103.95 -2.38 26.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.591 1.087 . . . . 71.13 112.647 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -33.23 121.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 116.324 1.972 . . . . 74.12 116.324 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.14 175.32 6.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.001 0.921 . . . . 63.23 109.688 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -51.76 -39.33 58.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.858 1.663 . . . . 72.54 112.269 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.72 0.35 57.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.603 1.561 . . . . 73.31 112.516 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.93 66.35 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.137 1.351 . . . . 51.43 112.627 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 161.05 16.21 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.546 1.938 . . . . 63.54 108.89 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.2 139.27 54.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.385 0.993 . . . . 71.12 109.937 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.78 132.94 54.45 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.561 1.545 . . . . 73.23 107.619 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.26 146.54 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.45 144.35 44.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.836 -1.172 . . . . 75.12 107.836 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -128.7 149.77 50.54 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 109.032 -0.729 . . . . 73.31 109.032 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.7 t -144.86 163.37 34.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.876 -1.157 . . . . 52.22 107.876 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.3 5.83 55.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.828 -1.709 . . . . 74.14 108.828 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 118.529 1.165 . . . . 74.24 109.921 -178.604 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 CA--C 1.539 0.519 0 N-CA-C 111.819 0.303 . . . . 51.21 111.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 27.8 m95 49.48 52.34 14.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.322 1.449 . . . . 74.43 112.71 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.38 131.87 10.85 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.13 -1.606 . . . . 72.43 110.257 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.5 141.63 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.205 1.502 . . . . 70.4 107.315 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -137.44 151.0 48.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.69 1.996 . . . . 55.1 110.687 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 19.3 tp -113.55 112.23 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.975 1.31 . . . . 74.52 109.525 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.53 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.1 t -123.95 137.0 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.233 1.413 . . . . 75.35 111.718 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.2 p -162.46 161.0 26.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.707 0.803 . . . . 52.02 111.602 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 102.851 -3.018 . . . . 75.14 102.851 176.498 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m95 . . . . . 0 C--O 1.236 0.384 0 N-CA-C 108.796 -0.816 . . . . 73.35 108.796 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.8 mmt -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.869 0.366 . . . . 75.42 110.465 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -58.29 -46.1 86.7 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 112.732 0.641 . . . . 55.33 112.732 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -63.98 -39.3 93.82 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.114 0.965 . . . . 73.13 111.363 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.08 -42.69 80.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.497 0.498 . . . . 55.14 111.497 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.18 -70.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.272 0.841 . . . . 65.33 113.272 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -158.36 119.98 3.53 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.486 -1.302 . . . . 74.12 107.486 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -128.83 -66.15 0.84 Allowed 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 117.113 -1.422 . . . . 42.41 111.883 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 tp -44.74 -50.34 10.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.092 1.357 . . . . 74.42 114.4 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -66.27 -59.44 3.72 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.939 -1.101 . . . . 61.43 112.235 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.576 ' CD2' HH21 ' A' ' 14' ' ' ARG . 3.0 t-160 -53.94 -51.85 62.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.488 1.115 . . . . 75.13 109.929 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.576 HH21 ' CD2' ' A' ' 13' ' ' HIS . 11.9 mmp_? -58.39 -46.2 86.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 115.599 -2.143 . . . . 71.14 109.867 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.17 -43.33 99.05 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.283 1.856 . . . . 71.32 112.449 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.66 -47.72 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 118.297 0.499 . . . . 74.01 110.008 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' HD11 ' B' ' 343' ' ' ILE . 0.5 OUTLIER -67.16 -39.9 86.55 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.603 -1.189 . . . . 64.42 110.371 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 m -56.1 -47.78 77.41 Favored 'General case' 0 CA--C 1.523 -0.059 0 CA-C-N 120.722 1.601 . . . . 74.04 107.386 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.83 72.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.967 0.358 . . . . 61.11 111.967 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.52 -51.47 65.34 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.801 -0.562 . . . . 74.32 111.317 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.46 -42.21 87.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 117.513 -1.232 . . . . 71.43 109.908 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -72.58 -29.66 63.73 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 120.556 1.526 . . . . 71.21 111.643 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.23 -46.48 41.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.995 0.816 . . . . 72.03 109.586 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -73.47 -45.93 51.19 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.669 -0.645 . . . . 71.43 110.689 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -122.76 79.76 48.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 125.324 1.45 . . . . 71.14 110.202 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.66 -20.66 52.88 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.877 1.718 . . . . 73.21 110.897 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.06 16.92 25.32 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.306 1.042 . . . . 64.13 112.946 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -120.89 153.45 37.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.867 -1.531 . . . . 72.04 106.867 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 135.11 24.08 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 124.022 0.929 . . . . 54.42 108.788 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.76 111.92 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 125.31 4.007 . . . . 63.1 112.884 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.82 149.73 16.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.873 0.869 . . . . 53.35 109.697 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.63 120.88 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 103.634 -2.728 . . . . 73.22 103.634 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.58 130.72 64.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.075 -1.454 . . . . 60.35 107.075 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.99 148.04 52.7 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.656 1.182 . . . . 63.22 110.3 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.83 132.86 36.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.283 -1.006 . . . . 73.41 108.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.16 111.96 2.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.375 -1.713 . . . . 75.52 106.375 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -57.73 123.83 17.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.457 -1.312 . . . . 74.23 107.457 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.49 -17.99 27.93 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.689 1.137 . . . . 62.41 110.665 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 t -71.93 168.49 17.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.973 1.386 . . . . 61.42 108.398 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.23 -11.82 17.73 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.171 0.988 . . . . 74.11 113.391 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tp -69.72 159.64 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.816 -0.553 . . . . 73.24 109.981 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.09 148.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.186 1.394 . . . . 63.32 110.385 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -77.67 167.65 21.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.069 1.348 . . . . 61.11 111.713 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.63 135.86 62.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.795 0.838 . . . . 61.32 111.166 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.36 152.32 38.37 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.693 1.197 . . . . 72.13 108.395 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -74.75 92.99 2.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.786 -1.19 . . . . 71.42 107.786 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -132.81 162.63 31.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.67 1.988 . . . . 75.21 109.838 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -113.32 108.42 17.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.239 -2.134 . . . . 70.03 105.239 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -84.37 122.95 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.278 -1.008 . . . . 74.04 108.278 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.87 110.75 23.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.197 -1.779 . . . . 72.14 106.197 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.29 142.29 26.11 Favored Pre-proline 0 N--CA 1.453 -0.296 0 O-C-N 124.033 0.833 . . . . 75.51 109.02 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 135.43 39.42 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.986 . . . . 73.42 111.147 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -14.91 32.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.513 0.725 . . . . 72.13 111.698 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.23 -31.2 43.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.752 1.221 . . . . 72.32 114.154 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pt -73.39 170.32 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.392 0.996 . . . . 73.32 110.708 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -105.33 166.98 10.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.032 0.933 . . . . 62.01 110.359 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.91 -39.48 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.615 1.166 . . . . 53.22 109.382 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.02 95.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.877 0.762 . . . . 50.21 111.447 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -61.62 -47.39 85.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.933 -0.766 . . . . 75.3 108.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 64' ' ' ILE . 2.3 t80 -60.05 -51.64 68.76 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.592 -0.521 . . . . 73.41 109.592 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.02 -47.91 71.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.857 1.663 . . . . 74.1 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -62.47 -41.22 98.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.795 0.271 . . . . 74.2 110.512 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.3 -39.73 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 118.091 -0.957 . . . . 62.45 108.432 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 ' CE2' ' A' ' 60' ' ' PHE . 22.1 mt -59.14 -50.47 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.523 1.511 . . . . 63.23 109.541 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -60.21 -35.06 74.58 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.119 -0.988 . . . . 64.1 110.37 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.3 -43.17 74.34 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.162 0.892 . . . . 74.01 109.822 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -60.7 -32.48 71.71 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 52.53 112.823 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.77 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.373 0.533 . . . . 35.22 111.46 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 54.56 57.65 5.58 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.161 -1.051 . . . . 65.33 108.161 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.43 108.82 2.87 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 107.105 -1.443 . . . . 74.31 107.105 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.03 147.42 67.53 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.346 -1.828 . . . . 62.05 107.346 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 m -62.72 -14.98 50.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.3 -0.875 . . . . 72.35 112.861 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -67.5 -28.61 67.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.131 0.878 . . . . 75.34 110.176 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -103.41 165.29 11.12 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.875 1.27 . . . . 72.43 108.525 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.69 176.03 5.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.043 1.337 . . . . 65.23 107.896 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.38 141.39 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.593 1.157 . . . . 55.23 108.265 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.26 135.96 24.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.808 2.043 . . . . 73.45 108.293 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.2 mt -114.94 156.14 25.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.75 1.62 . . . . 62.32 110.389 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -147.14 142.5 27.4 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.201 0.938 . . . . 74.02 109.878 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.96 119.91 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.424 -2.065 . . . . 73.3 105.424 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.1 t0 44.06 52.15 6.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.023 1.329 . . . . 75.22 111.347 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 60.19 19.11 8.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.471 1.509 . . . . 65.25 113.998 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 p -122.59 161.5 23.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 120.748 1.613 . . . . 74.02 110.606 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.42 113.8 64.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 102.181 -3.266 . . . . 73.44 102.181 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 138.84 35.15 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.327 1.152 . . . . 75.22 111.119 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -68.08 120.37 14.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.538 -1.282 . . . . 71.11 107.538 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 p -54.98 -18.67 5.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.967 1.707 . . . . 40.43 113.863 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -97.59 -0.83 45.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.909 1.684 . . . . 63.22 112.321 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 tp -80.96 151.55 28.45 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.381 1.446 . . . . 74.21 108.722 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -87.65 151.44 22.95 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 71.13 108.525 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.2 mmt -60.1 -39.28 85.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.761 -0.637 . . . . 73.32 110.386 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.89 -43.27 99.16 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.321 -0.712 . . . . 52.23 111.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -52.5 51.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.671 -0.863 . . . . 74.01 108.671 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.89 -36.71 72.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.946 0.499 . . . . 62.45 111.247 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -65.56 -55.16 19.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.151 -1.426 . . . . 74.43 107.151 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.85 -42.37 75.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.462 1.105 . . . . 71.54 112.479 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -26.71 29.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 117.466 -1.254 . . . . 74.23 114.229 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -109.89 9.11 24.57 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.89 1.223 . . . . 75.41 112.47 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -52.21 121.39 6.77 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.358 1.863 . . . . 73.01 111.251 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.43 169.29 17.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.511 -1.292 . . . . 74.14 107.511 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.99 -28.05 55.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.475 1.034 . . . . 71.44 111.42 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.57 7.33 20.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.982 1.313 . . . . 64.35 112.58 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.58 29.35 71.65 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 120.744 -1.223 . . . . 75.23 113.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -126.93 178.31 6.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.099 1.36 . . . . 62.2 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.82 129.92 51.79 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.211 1.004 . . . . 64.44 110.281 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -108.23 121.68 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.255 -1.387 . . . . 75.22 107.255 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.35 141.15 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.043 0.937 . . . . 72.21 109.529 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.27 151.26 37.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.164 -1.05 . . . . 72.32 108.164 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -135.67 152.79 51.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.573 0.624 . . . . 73.42 110.703 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -144.02 157.05 44.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.782 -1.192 . . . . 62.4 107.782 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 13.53 21.69 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.779 -1.328 . . . . 55.33 109.779 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 . . . . . 0 N--CA 1.441 -0.89 0 C-N-CA 125.761 1.625 . . . . 72.41 107.549 -179.552 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 113.221 0.822 . . . . 61.21 113.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 80.4 m95 55.16 59.45 3.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.819 1.248 . . . . 74.1 111.306 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -74.9 133.88 16.12 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.066 -1.214 . . . . 63.13 110.066 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 343' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 17' ' ' GLU . 56.0 mt -74.13 119.24 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.59 1.556 . . . . 64.51 107.526 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -124.07 145.85 48.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.979 1.312 . . . . 73.53 110.325 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 20.5 tp -99.81 115.54 29.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.235 1.414 . . . . 75.1 108.439 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.93 120.43 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.866 1.266 . . . . 63.34 109.965 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 8.6 p -161.11 159.2 28.8 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.511 1.051 . . . . 64.12 112.595 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--O 1.249 1.036 0 C-N-CA 127.576 2.35 . . . . 73.3 108.559 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.7 m95 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 108.479 -0.934 . . . . 73.55 108.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 mtt -64.51 -43.0 95.44 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.438 1.087 . . . . 75.23 108.818 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -59.77 -51.72 68.54 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.558 -0.734 . . . . 72.3 110.668 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.17 -31.71 73.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 117.879 -1.058 . . . . 70.44 111.672 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -59.76 -45.31 92.65 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.57 -74.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.549 0.531 . . . . 64.42 110.325 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 143.03 13.27 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.74 2.816 . . . . 72.1 108.914 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 p -120.68 -66.39 1.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 117.268 -1.349 . . . . 72.53 111.311 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -45.71 -59.0 3.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.355 1.862 . . . . 73.1 113.915 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.97 -48.02 72.66 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.356 -0.84 . . . . 71.41 111.754 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.419 ' HE2' ' HZ3' ' A' ' 48' ' ' LYS . 6.1 t60 -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.599 0.36 . . . . 73.54 110.228 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -47.24 85.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.165 1.386 . . . . 73.42 108.559 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 t -61.75 -51.93 66.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 120.036 1.289 . . . . 51.54 111.481 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.42 -47.99 86.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.383 -0.823 . . . . 74.5 110.503 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.83 -52.03 65.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.837 0.855 . . . . 75.41 110.741 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 p -59.13 -48.13 82.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.293 -0.86 . . . . 63.0 110.456 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.27 78.14 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.668 1.122 . . . . 74.45 111.536 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -67.61 -40.25 84.71 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.517 -0.739 . . . . 71.11 110.628 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.1 -41.94 79.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 118.157 -0.925 . . . . 63.04 110.017 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -62.63 -38.25 89.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 120.208 1.367 . . . . 73.54 108.509 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.31 69.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.559 -0.856 . . . . 24.15 110.895 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -78.08 -46.8 19.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 118.448 2.758 . . . . 73.51 118.448 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -131.59 76.92 74.17 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.397 2.279 . . . . 75.14 108.789 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.69 -23.5 36.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.756 2.304 . . . . 71.31 112.364 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.62 12.85 17.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 73.43 112.426 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -122.0 153.81 38.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.493 -1.669 . . . . 75.11 106.493 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.32 138.41 24.28 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.483 -0.932 . . . . 62.22 108.483 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.6 122.27 5.45 Favored 'Trans proline' 0 C--N 1.353 0.792 1 C-N-CA 125.879 4.386 . . . . 54.22 111.449 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -131.93 143.27 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.121 0.968 . . . . 72.15 111.56 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.1 mm -117.38 120.48 65.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 103.695 -2.705 . . . . 52.51 103.695 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -108.16 110.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.978 1.711 . . . . 71.2 108.65 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -123.02 153.09 40.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.208 0.913 . . . . 74.23 110.911 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -93.54 146.22 23.95 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.345 0.521 . . . . 72.3 110.501 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.23 136.55 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.328 1.451 . . . . 63.22 107.816 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 m -49.19 142.19 7.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.961 0.904 . . . . 61.4 111.572 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.82 1.57 1.44 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.781 2.134 . . . . 44.43 116.543 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t -58.85 147.3 34.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 119.241 1.52 . . . . 74.11 111.699 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 -0.79 31.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.906 1.282 . . . . 44.3 112.449 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -82.92 156.79 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.556 1.071 . . . . 63.31 109.118 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 151.9 9.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.684 0.754 . . . . 72.15 109.267 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.02 165.23 23.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.35 1.241 . . . . 72.11 114.35 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.62 139.5 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 127.572 2.349 . . . . 71.43 108.177 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.47 161.29 26.17 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.793 -1.558 . . . . 63.43 106.793 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.5 104.92 3.98 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.234 -1.395 . . . . 65.15 107.234 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -136.61 160.12 39.76 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.755 1.622 . . . . 74.21 110.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 11.2 mttt -107.96 116.29 31.69 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.296 1.839 . . . . 72.1 106.51 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -98.26 138.82 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.762 1.165 . . . . 75.1 111.91 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.6 mt -120.75 110.9 16.92 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.299 1.44 . . . . 74.53 108.626 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.45 142.11 25.83 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 118.137 -0.935 . . . . 75.54 111.099 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.55 137.54 27.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.196 2.597 . . . . 72.32 110.863 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -61.52 -12.5 15.48 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.914 1.45 . . . . 34.23 114.914 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.95 -34.88 29.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.831 1.196 . . . . 74.31 113.639 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.64 168.1 2.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.145 0.497 . . . . 51.34 112.004 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 p -107.54 163.37 13.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.305 0.483 . . . . 62.41 112.305 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.6 t -50.06 -34.67 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.583 1.153 . . . . 64.21 109.758 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.66 88.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.635 1.174 . . . . 64.25 111.237 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -69.63 -42.6 74.1 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 124.073 0.949 . . . . 62.11 110.206 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -59.54 -46.94 87.42 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.586 -0.894 . . . . 72.51 108.586 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.6 ttt -58.69 -43.7 90.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.706 1.203 . . . . 75.02 109.553 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -58.55 -46.8 86.09 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.851 0.751 . . . . 70.45 110.297 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.432 HG21 HG13 ' B' ' 346' ' ' VAL . 12.0 mt -61.78 -42.67 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 118.585 -0.721 . . . . 75.11 109.804 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.2 mt -58.15 -50.36 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.634 1.107 . . . . 72.41 109.7 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -64.73 -31.71 73.06 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.961 -1.087 . . . . 71.31 112.655 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -70.76 -48.4 54.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.523 0.729 . . . . 72.25 109.746 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -59.45 -49.26 78.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.05 1.74 . . . . 74.34 111.682 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 pt -78.87 -5.87 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.793 -0.363 . . . . 71.15 111.152 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 56.29 62.32 2.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.565 1.546 . . . . 74.35 108.289 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 108.53 2.96 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.069 0.948 . . . . 74.02 108.847 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.8 164.51 35.44 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.137 2.558 . . . . 62.33 111.059 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -67.01 -17.03 64.73 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.216 -0.928 . . . . 73.4 112.142 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.76 -42.83 97.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.354 0.979 . . . . 64.25 109.189 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -102.53 164.74 11.48 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 122.6 1.191 . . . . 64.44 110.802 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.2 -176.78 3.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.336 -1.727 . . . . 75.52 106.336 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 tp -144.52 139.25 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.145 -1.428 . . . . 63.44 107.145 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -145.3 134.46 22.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.143 1.377 . . . . 72.43 108.665 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.28 135.14 54.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.661 1.584 . . . . 65.25 107.907 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.49 124.29 29.83 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.407 1.083 . . . . 74.02 109.237 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.28 129.67 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.478 1.111 . . . . 44.04 108.255 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.42 33.24 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.929 1.692 . . . . 71.54 112.145 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 66.31 23.31 10.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.066 1.347 . . . . 62.25 111.278 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -123.15 162.25 22.87 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.372 1.869 . . . . 51.52 110.561 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.2 103.34 13.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 105.591 -2.003 . . . . 74.12 105.591 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.11 139.33 42.18 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.869 1.713 . . . . 71.12 111.734 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -74.06 120.26 19.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.601 -0.888 . . . . 63.12 108.601 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 13.0 p -46.75 -37.82 9.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.441 1.896 . . . . 75.34 114.753 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 p -86.38 -6.1 59.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 115.156 1.539 . . . . 61.14 115.156 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.41 141.54 57.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.555 -1.646 . . . . 53.04 106.555 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.3 p -80.61 154.74 27.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.391 -0.818 . . . . 72.54 109.087 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.2 mmt -59.24 -40.88 87.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.123 0.969 . . . . 72.31 108.978 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 -44.47 97.45 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.196 -1.336 . . . . 62.44 110.802 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.74 -48.35 54.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.005 1.403 . . . . 74.32 111.053 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -45.98 76.5 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.121 -0.696 . . . . 75.41 109.121 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -63.14 -52.4 62.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.731 0.696 . . . . 64.3 109.374 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -54.54 -40.42 68.66 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.237 0.828 . . . . 74.34 113.237 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -23.73 22.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.167 -1.397 . . . . 74.5 113.518 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -103.98 9.55 36.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.058 1.299 . . . . 63.33 110.842 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -52.42 121.33 6.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.384 2.273 . . . . 75.04 111.322 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -89.18 175.61 7.3 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.658 0.783 . . . . 74.54 108.942 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.85 -37.9 60.81 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.199 1.4 . . . . 74.14 111.571 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.39 -2.78 50.65 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.238 1.815 . . . . 52.42 111.966 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.62 29.33 71.65 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.911 1.243 . . . . 72.1 112.724 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 166.67 13.31 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.336 1.454 . . . . 75.52 109.377 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.3 tp -122.41 131.21 53.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.916 -1.142 . . . . 72.14 107.916 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -122.5 116.35 23.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.347 1.859 . . . . 75.32 107.432 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.69 150.15 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 O-C-N 121.227 -0.921 . . . . 62.41 110.058 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.2 152.51 33.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.089 -0.708 . . . . 73.1 109.089 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -135.24 154.2 51.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.861 0.839 . . . . 55.44 110.703 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.9 p -149.22 155.79 41.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.662 1.185 . . . . 71.53 108.137 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.18 21.86 12.8 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 111.383 -0.687 . . . . 45.34 111.383 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 126.46 1.904 . . . . 73.21 108.417 -178.399 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.746 0.647 . . . . 71.31 112.746 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.494 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 48.8 m95 54.71 64.71 1.72 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.212 1.405 . . . . 64.0 110.863 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.88 138.78 17.15 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 107.517 -2.233 . . . . 62.52 107.517 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.68 142.94 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.446 1.623 . . . . 73.05 110.636 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.05 156.49 46.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.358 1.463 . . . . 73.43 110.489 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.29 119.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.104 2.162 . . . . 74.52 106.43 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 63' ' ' ILE . 2.7 t -120.97 119.16 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 122.511 1.148 . . . . 65.34 109.808 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.9 p -161.76 152.76 18.08 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.688 -1.142 . . . . 61.12 110.248 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 129.466 3.106 . . . . 61.34 113.506 179.252 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.8 m95 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 106.622 -1.622 . . . . 74.11 106.622 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.21 -38.93 88.34 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.198 -0.667 . . . . 74.43 109.198 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -59.97 -39.63 86.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.412 1.005 . . . . 75.12 110.198 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.564 0.62 . . . . 72.13 109.431 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.0 -44.87 91.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.355 -0.98 . . . . 73.23 108.355 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.83 -75.97 0.18 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.746 1.017 . . . . 64.31 113.746 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -158.56 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.536 1.934 . . . . 70.5 108.229 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 p -102.36 -67.25 0.88 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.409 0.892 . . . . 74.53 113.409 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 -55.07 22.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 117.176 2.287 . . . . 75.31 117.176 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.0 -54.92 26.71 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.061 0.846 . . . . 72.53 111.23 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.75 -43.59 65.86 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.629 1.571 . . . . 74.42 111.078 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -47.06 63.34 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.891 -1.131 . . . . 75.5 109.626 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.91 -58.46 7.52 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.589 0.756 . . . . 72.32 111.065 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.39 -46.19 92.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.048 0.539 . . . . 73.1 110.916 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 48' ' ' LYS . 29.8 mm-40 -64.98 -40.04 94.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.847 -1.073 . . . . 71.44 110.997 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 t -57.66 -46.92 83.61 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.273 1.397 . . . . 52.02 108.541 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.43 72.33 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.017 0.371 . . . . 40.31 111.325 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -59.0 -49.13 79.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.855 1.262 . . . . 71.32 110.328 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.33 -42.89 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 117.393 -1.289 . . . . 65.4 111.403 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -71.05 -29.81 65.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.527 1.512 . . . . 73.12 110.242 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.29 -47.29 57.76 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.676 -0.861 . . . . 73.23 108.676 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.53 -47.96 18.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.429 1.27 . . . . 74.45 114.429 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.73 73.43 69.55 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 127.869 2.468 . . . . 74.24 111.222 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.97 -29.36 89.17 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.063 1.842 . . . . 72.42 112.457 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.67 11.81 16.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.518 0.599 . . . . 75.41 111.086 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -112.42 143.33 43.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.61 1.55 . . . . 52.13 109.414 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -107.06 133.49 20.27 Favored Pre-proline 0 C--O 1.246 0.883 0 C-N-CA 124.323 1.049 . . . . 71.45 108.295 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.19 119.81 5.45 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.89 3.727 . . . . 74.32 112.606 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.23 149.67 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 74.51 111.115 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -122.13 134.4 65.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 102.669 -3.086 . . . . 72.32 102.669 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.77 119.57 53.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.379 1.471 . . . . 61.11 109.326 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.7 157.41 46.83 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.453 1.024 . . . . 74.42 113.279 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.7 150.98 23.28 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.872 0.368 . . . . 71.25 110.602 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.88 135.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.999 -1.482 . . . . 72.2 106.999 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -64.11 115.74 5.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.118 -1.068 . . . . 54.53 108.118 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.85 30.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.39 1.471 . . . . 44.41 112.374 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.9 m -85.23 112.58 20.87 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.623 1.711 . . . . 52.15 107.727 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.78 -20.98 60.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.267 1.827 . . . . 73.43 114.548 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.1 tp -53.42 158.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.449 1.5 . . . . 61.52 114.809 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.6 m -49.07 114.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.785 1.634 . . . . 73.01 109.64 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -82.1 167.76 18.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.453 1.501 . . . . 74.41 108.727 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -126.15 139.14 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.724 -1.213 . . . . 71.01 107.724 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.72 166.15 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.77 0.795 . . . . 64.41 109.47 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.35 105.81 4.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.267 -2.123 . . . . 64.23 105.267 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 12.1 mmm180 -139.92 152.41 46.37 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 124.243 1.017 . . . . 74.53 111.087 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 21.5 mttp -93.95 94.75 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.577 -2.009 . . . . 65.43 105.577 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -85.08 117.07 23.82 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.197 -1.038 . . . . 71.35 108.197 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.53 115.48 30.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.145 1.378 . . . . 45.42 110.471 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.01 142.92 27.7 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 119.966 1.257 . . . . 73.31 111.945 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 141.67 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.08 2.52 . . . . 54.41 110.691 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -62.5 -13.62 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.7 2.0 . . . . 63.12 113.28 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -30.03 25.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.636 0.976 . . . . 75.54 113.636 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.66 166.68 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 119.391 0.996 . . . . 74.1 110.403 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 p -107.51 163.01 13.42 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.373 -0.829 . . . . 75.33 112.989 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.79 -35.98 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.11 0.964 . . . . 73.15 109.201 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.72 78.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.484 0.714 . . . . 65.11 110.717 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -71.92 -43.22 65.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.413 1.085 . . . . 75.41 109.942 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.79 -41.97 87.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.123 0.874 . . . . 75.21 109.474 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 42.3 ttp -63.31 -48.8 76.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.041 -0.725 . . . . 74.31 109.041 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -58.89 -44.94 91.27 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.398 0.544 . . . . 62.23 111.092 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.91 -50.91 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.329 1.052 . . . . 73.34 108.307 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.79 -49.96 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.055 0.843 . . . . 73.13 111.009 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -64.05 -32.93 74.66 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.937 -1.102 . . . . 74.41 112.183 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -71.89 -46.47 57.66 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.77 -0.826 . . . . 62.51 108.77 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.3 -51.41 64.73 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.26 1.824 . . . . 74.25 111.942 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -3.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.142 0.423 . . . . 60.44 112.142 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 55.29 63.71 2.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.26 1.824 . . . . 73.32 107.776 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.67 114.28 18.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.229 -1.026 . . . . 74.23 108.229 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.98 164.37 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.781 2.987 . . . . 71.13 113.054 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.5 p -66.8 -32.32 73.53 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.929 -1.107 . . . . 53.44 112.659 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -59.44 -36.0 75.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.034 1.734 . . . . 72.34 112.337 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.83 165.04 11.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.471 1.108 . . . . 74.52 111.01 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.27 -179.4 3.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.963 2.105 . . . . 73.41 108.895 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.3 136.37 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.087 1.355 . . . . 71.01 107.886 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.34 136.67 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.424 -1.324 . . . . 75.21 107.424 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.28 148.85 31.09 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.469 1.108 . . . . 72.52 108.728 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -137.01 123.26 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.071 1.749 . . . . 73.24 108.417 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.06 144.49 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.582 1.153 . . . . 64.51 108.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 48.92 35.77 7.22 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.149 1.341 . . . . 70.2 111.853 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tttt 55.02 31.44 16.11 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.112 0.965 . . . . 55.14 111.476 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -152.19 163.96 38.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.642 1.177 . . . . 61.21 109.9 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 115.12 61.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 104.912 -2.255 . . . . 74.34 104.912 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.74 141.29 40.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.105 1.87 . . . . 71.42 110.606 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -72.09 127.28 32.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.736 -0.838 . . . . 73.1 108.736 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 p -53.81 -35.47 61.43 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.012 2.125 . . . . 61.44 112.218 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 t -70.02 -14.96 62.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.779 1.632 . . . . 63.33 112.39 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.73 147.78 48.67 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.45 -0.945 . . . . 72.43 108.45 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 m -98.88 149.09 23.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.871 -1.159 . . . . 65.24 107.871 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.7 mmt -55.04 -46.19 75.29 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.066 0.547 . . . . 74.44 111.745 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.91 -46.63 83.37 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.919 -0.873 . . . . 55.04 110.919 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -65.08 -52.92 52.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.48 0.712 . . . . 73.22 109.818 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.03 -50.28 64.58 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.045 0.938 . . . . 70.54 110.814 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.9 -49.14 75.97 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.067 -1.021 . . . . 73.52 109.838 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -68.22 -24.51 64.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.98 0.809 . . . . 74.1 112.797 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -37.4 13.87 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 119.687 1.13 . . . . 75.21 111.179 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.17 -3.77 50.32 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.318 1.229 . . . . 71.14 114.318 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -36.26 121.78 0.71 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.451 2.389 . . . . 52.33 117.451 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.31 165.92 23.85 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.206 -1.405 . . . . 61.1 107.206 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.18 -34.64 57.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.529 1.132 . . . . 54.13 111.871 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -96.77 14.08 26.33 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.552 1.141 . . . . 75.34 113.579 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.2 70.59 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 120.688 -1.258 . . . . 60.24 113.853 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.39 154.48 29.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.526 1.163 . . . . 71.3 108.382 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.49 133.89 55.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.826 -1.176 . . . . 73.12 107.826 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.81 124.3 42.99 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.257 1.423 . . . . 72.21 109.121 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 143.64 40.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-O 122.091 0.948 . . . . 63.01 108.59 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.85 155.96 22.79 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.551 -0.718 . . . . 75.34 109.132 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -140.99 161.34 38.07 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.531 0.732 . . . . 61.51 111.525 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -151.61 156.95 41.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.811 -1.181 . . . . 63.43 107.811 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.0 26.26 9.43 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 126.54 2.019 . . . . 70.1 109.918 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.445 -0.676 0 C-N-CA 127.376 2.271 . . . . 72.03 106.72 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 119.385 -0.34 . . . . 72.11 111.846 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.433 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 75.4 m95 58.68 58.93 3.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 74.04 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 342' ' ' GLY . . . . . 0.421 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.85 145.29 28.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.967 -1.653 . . . . 65.53 108.967 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 33.0 mt -77.51 141.16 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.821 1.31 . . . . 64.11 111.138 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.66 122.91 16.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.672 0.789 . . . . 74.44 108.972 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.31 108.54 20.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.666 -2.346 . . . . 62.2 104.666 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.62 134.78 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.181 0.808 . . . . 70.32 113.181 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 12.8 p -161.47 158.64 26.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.642 1.577 . . . . 64.21 107.388 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 127.999 2.519 . . . . 72.34 112.504 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m95 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.599 -0.889 . . . . 72.13 108.599 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.5 mmm -57.66 -46.89 83.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.133 -0.692 . . . . 73.1 109.133 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -58.16 -45.05 88.12 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 119.721 -0.181 . . . . 74.5 111.082 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -64.79 -35.03 79.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.279 -0.391 . . . . 64.35 111.622 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.76 -48.09 78.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.24 -1.022 . . . . 73.02 108.24 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -71.34 0.22 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 115.081 1.511 . . . . 75.1 115.081 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -156.22 128.19 7.42 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.785 2.034 . . . . 74.24 108.203 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -124.9 -66.15 0.98 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 116.529 -1.701 . . . . 61.33 114.069 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -56.55 13.7 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.265 1.393 . . . . 71.32 114.471 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.7 -36.13 82.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.054 0.843 . . . . 72.33 111.58 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -64.75 -55.09 21.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.702 0.801 . . . . 73.12 110.831 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -49.24 75.32 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.303 1.441 . . . . 65.42 109.294 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.2 t -54.15 -61.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.926 0.784 . . . . 72.24 112.033 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.91 -47.61 90.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 123.874 0.734 . . . . 73.34 112.279 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -47.08 70.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.151 -1.02 . . . . 65.4 111.642 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -55.03 -45.41 75.18 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 120.046 1.294 . . . . 73.11 109.493 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.77 72.09 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.261 0.553 . . . . 72.42 112.253 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.69 -40.0 88.35 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.331 0.652 . . . . 65.01 110.276 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.15 -42.09 93.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 117.78 -1.105 . . . . 75.33 108.624 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -63.86 -39.18 93.59 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 120.092 1.314 . . . . 65.04 109.423 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.94 67.07 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.935 0.398 . . . . 64.3 111.633 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -72.23 -44.99 62.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.415 -0.803 . . . . 74.11 112.783 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -128.75 78.72 75.64 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.121 1.368 . . . . 73.13 109.694 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.45 -17.65 49.05 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.659 2.239 . . . . 72.45 112.044 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -99.87 13.17 34.75 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.415 0.686 . . . . 72.04 110.061 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -123.21 155.64 36.71 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.842 1.201 . . . . 74.32 108.728 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.76 136.85 27.83 Favored Pre-proline 0 C--O 1.241 0.656 0 C-N-CA 124.126 0.97 . . . . 74.11 109.846 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.78 114.73 3.7 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 125.251 3.967 . . . . 72.23 111.769 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.52 143.99 34.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.555 1.142 . . . . 42.14 109.358 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 mm -120.73 127.05 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 102.375 -3.194 . . . . 73.24 102.375 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.67 124.55 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.319 1.447 . . . . 70.34 108.896 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -136.59 154.26 50.73 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.25 1.386 . . . . 74.5 110.513 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -91.78 152.71 20.02 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.944 -0.473 . . . . 73.34 111.685 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.8 t -66.83 126.1 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.681 1.593 . . . . 74.14 107.212 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 p -58.72 121.85 12.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.729 0.695 . . . . 74.31 110.296 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.51 -18.8 49.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.626 2.06 . . . . 73.31 111.847 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -55.65 136.94 50.18 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.896 1.348 . . . . 63.54 111.289 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -64.49 -28.73 69.86 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.859 1.264 . . . . 75.13 114.096 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.11 154.33 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.471 0.708 . . . . 62.31 112.124 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.78 140.11 20.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.172 -1.418 . . . . 73.12 107.172 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -84.36 167.6 16.37 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.515 -0.92 . . . . 62.31 108.515 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.81 144.17 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.745 -1.576 . . . . 65.51 106.745 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 165.61 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.549 0.69 . . . . 70.41 110.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.3 95.29 2.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.767 -1.197 . . . . 52.04 107.767 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -136.25 151.74 49.99 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.153 0.981 . . . . 74.1 109.562 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 29.8 mttp -95.7 102.09 13.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.058 -2.201 . . . . 74.41 105.058 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -84.58 136.73 33.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.158 0.89 . . . . 74.42 109.162 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 mt -120.19 108.56 14.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.975 -1.491 . . . . 70.45 106.975 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.17 141.99 25.42 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 117.946 -1.026 . . . . 63.42 110.408 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 141.29 38.87 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.141 1.894 . . . . 72.31 113.568 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 m -62.58 -17.32 59.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.874 1.67 . . . . 52.13 110.877 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -68.37 -35.34 77.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.733 2.413 . . . . 73.51 112.751 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -86.26 171.0 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 122.014 0.911 . . . . 62.34 112.648 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.6 p -107.23 166.12 10.87 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.492 1.517 . . . . 71.41 110.541 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.75 -34.32 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 62.41 108.559 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -47.86 83.55 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 121.495 -0.753 . . . . 54.34 112.69 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.54 -37.5 71.12 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 123.162 0.585 . . . . 71.5 110.095 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.9 -45.1 91.07 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.934 -0.765 . . . . 74.53 108.934 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 ttt -63.57 -44.96 92.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.069 -0.967 . . . . 61.34 110.105 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -57.04 -41.29 78.37 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.996 0.816 . . . . 74.54 111.09 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.01 -51.12 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.533 -0.914 . . . . 75.1 108.533 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 60' ' ' PHE . 29.9 mt -52.46 -50.36 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.262 0.937 . . . . 64.14 111.049 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -62.31 -39.42 92.96 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.062 -1.024 . . . . 74.54 112.064 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -74.34 -33.75 63.23 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.77 1.168 . . . . 75.12 111.305 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.47 -48.73 78.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.998 0.817 . . . . 62.2 109.552 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -79.98 -3.18 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.013 0.196 . . . . 41.25 110.88 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 53.1 57.93 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.203 1.801 . . . . 62.42 109.532 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.11 109.98 4.87 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 124.979 1.312 . . . . 70.23 108.735 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.73 159.46 52.61 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.442 2.761 . . . . 74.42 111.205 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 m -67.3 -14.47 62.95 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.091 -1.005 . . . . 74.12 112.706 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.46 -34.11 67.51 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.112 -0.47 . . . . 71.04 110.157 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.55 164.41 11.68 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.355 1.062 . . . . 73.02 108.942 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 175.72 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.97 1.308 . . . . 72.02 109.21 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.76 140.63 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 125.278 1.431 . . . . 62.02 107.722 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -145.06 129.84 18.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.429 1.892 . . . . 65.43 106.916 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.99 146.57 41.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.004 1.322 . . . . 75.52 109.244 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -142.66 132.89 24.67 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.707 1.203 . . . . 71.2 110.303 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.63 121.89 64.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 C-N-CA 124.712 1.205 . . . . 62.14 107.99 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 43.05 51.83 5.39 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.361 1.465 . . . . 72.35 113.119 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.51 25.3 15.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.066 1.346 . . . . 74.45 113.392 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 p -132.66 161.47 33.86 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.479 1.036 . . . . 72.34 111.049 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.35 105.53 36.93 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 103.184 -2.895 . . . . 73.33 103.184 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.2 130.57 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.766 2.311 . . . . 74.41 111.967 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.32 125.84 27.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.166 -1.42 . . . . 74.34 107.166 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -55.75 -22.48 24.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 63.03 113.904 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -79.31 -18.41 52.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.466 1.107 . . . . 62.32 111.652 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.66 141.67 56.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.41 -0.806 . . . . 64.5 110.09 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.47 152.0 24.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.029 -1.1 . . . . 73.21 108.029 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 45.3 mmm -62.93 -42.46 99.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.175 -0.917 . . . . 50.43 110.278 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.42 97.6 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.798 0.727 . . . . 43.23 111.566 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -46.89 71.33 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.322 0.649 . . . . 72.42 109.4 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.43 -46.26 86.86 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.727 -0.472 . . . . 75.4 109.727 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.81 -45.3 94.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.245 1.418 . . . . 74.32 109.765 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.55 -33.35 75.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.968 0.907 . . . . 71.24 111.597 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -90.54 -23.5 20.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.264 -1.35 . . . . 75.4 113.488 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -110.35 -2.1 16.85 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.921 1.452 . . . . 71.11 114.921 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -45.23 121.85 3.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.969 1.259 . . . . 65.23 114.377 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -71.45 176.09 4.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.811 1.244 . . . . 64.11 108.36 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.82 -33.14 55.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.83 2.052 . . . . 74.24 111.81 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 10.34 36.01 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.151 1.78 . . . . 73.12 111.563 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.92 68.74 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.899 -1.126 . . . . 63.05 113.255 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.88 168.81 9.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.21 1.505 . . . . 71.04 109.889 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.53 136.43 54.55 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.685 0.394 . . . . 72.34 110.273 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -119.75 119.21 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.254 1.822 . . . . 74.44 109.084 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.18 144.0 38.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 121.11 -0.994 . . . . 74.44 109.294 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.56 21.02 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.698 0.799 . . . . 71.04 109.849 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -146.19 160.84 41.42 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.425 0.631 . . . . 61.13 110.797 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 p -151.62 161.35 42.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.719 1.208 . . . . 75.12 108.774 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.88 22.89 12.17 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.298 0.952 . . . . 72.24 111.909 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.308 1.843 . . . . 75.25 106.961 -178.655 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 114.159 1.17 . . . . 74.12 114.159 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.452 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 51.3 m95 53.33 57.34 6.31 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.473 1.509 . . . . 73.41 111.823 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -77.7 141.09 25.06 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.789 -1.324 . . . . 63.34 109.789 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 28.8 mt -74.1 128.84 36.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 119.142 1.471 . . . . 75.44 109.437 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.22 126.75 30.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.073 0.949 . . . . 72.4 109.896 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.44 122.35 31.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 104.179 -2.526 . . . . 73.54 104.179 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 51.6 t -120.58 124.02 71.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.562 1.145 . . . . 41.31 109.163 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.4 p -161.19 151.65 17.85 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.947 0.34 . . . . 72.42 111.524 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 126.675 1.99 . . . . 75.13 111.408 -179.615 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 CA--C 1.511 -0.55 0 CA-C-O 119.576 -0.249 . . . . 74.13 110.573 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.3 tpt -55.35 -46.27 76.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.433 1.083 . . . . 63.12 108.327 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -60.53 -42.27 96.16 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 113.241 0.83 . . . . 74.25 113.241 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.13 -37.44 83.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 118.946 0.794 . . . . 73.32 110.672 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.04 -47.73 76.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.335 1.022 . . . . 64.43 108.467 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.48 -75.87 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.025 1.33 . . . . 52.54 113.033 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.38 131.73 5.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.883 1.673 . . . . 74.22 107.798 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.2 t -130.2 -58.66 1.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 115.724 1.75 . . . . 62.33 115.724 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.44 -57.29 12.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.728 1.604 . . . . 75.54 114.927 -176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 13' ' ' HIS . 1.3 pm0 -62.95 -51.02 68.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.083 0.468 . . . . 64.23 110.229 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.464 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 84.4 t60 -52.07 -44.83 64.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.022 2.129 . . . . 74.42 110.073 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -49.84 63.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 116.872 -1.537 . . . . 62.44 110.136 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.4 m -60.54 -48.83 80.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.917 1.08 . . . . 74.1 113.917 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.97 -47.53 90.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 121.705 -0.622 . . . . 72.03 109.894 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.35 -42.49 79.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.518 -0.754 . . . . 73.21 111.848 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -59.83 -45.02 93.7 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.272 -1.01 . . . . 75.12 108.272 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.85 -49.17 77.59 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.955 0.798 . . . . 60.21 110.851 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -61.03 -46.09 92.15 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.864 -1.148 . . . . 53.24 110.883 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.94 -41.65 93.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-O 117.735 -1.126 . . . . 71.2 109.441 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -66.69 -41.07 88.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.581 1.537 . . . . 72.3 110.521 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.76 68.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.596 -0.441 . . . . 63.4 110.852 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -77.71 -33.11 53.2 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.651 0.982 . . . . 53.52 113.651 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 82.07 25.04 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.429 1.492 . . . . 63.3 111.009 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.77 -29.1 36.06 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.888 2.392 . . . . 72.14 112.602 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.81 13.23 13.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.876 0.871 . . . . 72.13 110.956 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -121.56 152.35 39.32 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.525 -1.359 . . . . 72.03 109.749 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.24 140.73 31.71 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 124.007 0.923 . . . . 73.02 108.584 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 117.66 3.57 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 125.141 3.894 . . . . 71.45 111.931 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.2 t -120.45 140.91 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.047 1.339 . . . . 64.33 108.675 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.09 135.33 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.585 -2.376 . . . . 72.41 104.585 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.73 134.85 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.251 0.62 . . . . 63.21 109.491 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.85 143.66 43.19 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.888 0.875 . . . . 65.51 108.701 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.62 143.09 31.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.299 -1.371 . . . . 71.11 107.299 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.82 108.12 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 103.07 -2.937 . . . . 62.22 103.07 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -53.75 132.67 41.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.785 -0.82 . . . . 52.32 108.785 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.2 40.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.836 1.207 . . . . 40.23 112.235 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -81.98 137.63 35.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.539 1.67 . . . . 71.01 108.027 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -66.2 -11.26 48.62 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.524 0.729 . . . . 53.14 112.803 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.441 ' CD1' HD23 ' A' ' 70' ' ' LEU . 8.8 tp -60.96 154.37 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.602 0.761 . . . . 75.51 109.323 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.65 144.97 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.405 1.082 . . . . 55.24 110.186 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.77 167.13 18.44 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.26 2.224 . . . . 72.03 112.508 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.61 148.33 31.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 125.194 1.398 . . . . 73.31 110.267 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.5 163.47 20.45 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.923 0.889 . . . . 74.13 108.954 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.89 95.83 5.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.019 -1.104 . . . . 72.44 108.019 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.03 168.23 18.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.137 0.975 . . . . 74.52 109.895 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -116.35 99.26 7.07 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.294 -2.113 . . . . 73.24 105.294 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -83.89 136.66 34.02 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.609 -0.723 . . . . 74.5 109.053 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.94 119.2 33.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.494 1.118 . . . . 75.31 110.232 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.439 HG21 ' SD ' ' A' ' 91' ' ' MET . 17.6 m -111.81 142.12 26.07 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 117.577 -1.202 . . . . 72.11 112.232 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.12 141.33 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.713 2.275 . . . . 71.31 109.579 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -63.4 -12.84 33.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.585 0.957 . . . . 75.25 113.585 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.89 -34.26 66.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.645 2.778 . . . . 71.44 113.445 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 pt -85.09 165.87 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.745 1.157 . . . . 70.35 111.775 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 54.8 p -99.92 168.79 9.65 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.784 0.834 . . . . 75.41 111.255 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.92 -36.43 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.714 -1.217 . . . . 65.33 107.714 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.83 90.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.737 0.815 . . . . 74.43 110.936 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -66.4 -44.96 81.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.614 -0.708 . . . . 65.22 109.744 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 4.1 t80 -58.8 -54.51 46.23 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.253 -1.017 . . . . 73.51 108.253 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.4 ttp -52.63 -49.19 65.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.512 1.525 . . . . 53.33 110.935 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -57.11 -42.28 80.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.464 0.705 . . . . 72.52 111.693 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.46 -39.63 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 118.086 -0.959 . . . . 71.54 108.792 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 4.4 mt -62.31 -50.04 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 120.701 1.591 . . . . 75.45 109.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.15 -39.16 81.58 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 118.186 -0.912 . . . . 75.03 111.962 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -68.58 -40.59 80.45 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.051 0.841 . . . . 72.42 109.223 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -59.51 -49.07 79.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.275 1.03 . . . . 73.22 111.498 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 pt -79.46 -0.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 119.468 -0.301 . . . . 62.45 111.277 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 57.51 52.32 8.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.741 1.617 . . . . 73.32 110.984 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.5 tm? -68.18 108.96 3.24 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.416 1.486 . . . . 72.34 110.553 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.82 152.8 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.122 2.548 . . . . 75.53 109.968 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 m -58.95 -20.83 55.99 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.403 -0.811 . . . . 75.31 113.181 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -39.51 90.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.407 1.003 . . . . 52.11 109.734 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -96.48 163.61 12.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.285 1.034 . . . . 55.03 108.865 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.92 171.08 7.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.001 1.321 . . . . 73.42 108.579 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 tp -146.12 133.75 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.554 1.142 . . . . 65.21 108.158 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -145.46 142.26 29.11 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.179 1.792 . . . . 75.12 108.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -114.14 155.83 25.32 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.525 1.53 . . . . 64.44 111.039 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -147.31 126.84 13.24 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 125.115 1.509 . . . . 64.15 111.18 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.87 126.03 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.474 -2.047 . . . . 74.31 105.474 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 49.48 34.53 6.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.761 1.164 . . . . 60.14 112.961 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp 60.88 31.14 20.0 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.063 -1.648 . . . . 54.15 110.154 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -130.18 161.38 31.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.324 1.85 . . . . 74.41 109.788 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -102.49 103.68 33.25 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 126.508 1.923 . . . . 74.35 108.832 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.6 136.99 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.539 1.492 . . . . 72.44 108.965 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.0 132.17 44.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.76 0.314 . . . . 72.22 110.311 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 p -51.89 -45.54 64.22 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.282 2.233 . . . . 40.04 112.703 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -73.74 -11.84 60.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.694 1.197 . . . . 51.44 114.047 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.42 146.74 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.037 1.289 . . . . 65.44 108.665 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 30.4 p -86.08 156.57 20.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.694 -0.629 . . . . 63.11 109.424 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 51' ' ' VAL . 14.4 mmt -61.38 -44.44 97.15 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 118.538 -0.744 . . . . 74.14 110.641 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.11 -45.49 95.2 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.351 -0.928 . . . . 61.33 111.396 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.86 -49.46 72.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.799 0.8 . . . . 73.54 111.2 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.59 -46.69 88.19 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 123.055 0.542 . . . . 44.02 110.459 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.43 -56.92 14.89 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.252 1.021 . . . . 53.04 108.943 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.28 -32.0 64.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.623 -0.703 . . . . 72.14 111.37 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -25.26 20.26 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 116.342 -1.79 . . . . 63.43 113.828 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -103.42 -2.22 27.28 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.298 1.863 . . . . 71.42 112.604 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.23 121.72 1.18 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.114 2.165 . . . . 74.4 113.955 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.71 174.64 8.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.454 1.502 . . . . 53.12 110.132 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.49 -35.58 72.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.877 1.217 . . . . 63.33 108.525 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.15 12.92 31.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.77 0.828 . . . . 64.34 112.51 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.38 28.38 67.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.351 -1.249 . . . . 61.22 114.862 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -109.44 158.71 17.68 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.948 1.874 . . . . 65.32 107.932 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 138.0 54.13 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.608 -1.256 . . . . 64.55 107.608 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -122.35 131.5 53.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.657 1.183 . . . . 74.53 108.287 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.63 138.73 53.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.545 -1.28 . . . . 72.43 107.545 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.69 142.14 44.4 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.954 -2.239 . . . . 62.22 104.954 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -133.96 151.63 51.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.345 0.593 . . . . 75.55 110.432 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.9 t -147.21 165.04 31.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.689 -1.226 . . . . 65.22 107.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.81 15.61 19.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.079 -2.008 . . . . 74.22 108.079 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 126.401 1.88 . . . . 50.05 107.006 -179.392 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 71.0 113.324 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 58.1 m95 57.22 61.16 2.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.91 0.777 . . . . 74.31 111.62 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.49 135.68 15.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.384 -1.086 . . . . 74.0 110.384 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.9 123.79 32.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 118.756 1.278 . . . . 72.34 110.006 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -132.37 118.83 19.89 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.534 1.134 . . . . 72.22 109.14 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.9 tt -83.17 118.57 23.69 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.724 1.61 . . . . 62.25 108.44 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.31 128.63 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.679 1.192 . . . . 62.42 110.741 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.9 p -159.31 153.46 23.62 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 71.4 108.639 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.172 1.789 . . . . 73.44 106.515 178.535 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.3 m95 . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.089 -0.708 . . . . 74.21 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -51.53 -45.76 63.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.082 0.944 . . . . 74.43 110.737 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -60.55 -40.62 92.25 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 121.499 -0.75 . . . . 74.31 112.726 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -67.1 -36.31 81.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.616 0.766 . . . . 74.22 112.177 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -67.59 -41.01 84.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.626 -0.879 . . . . 73.15 108.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -75.12 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.738 -0.664 . . . . 65.23 111.6 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.61 125.13 3.67 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.696 1.998 . . . . 74.25 110.374 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.3 p -117.11 -65.85 1.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 116.305 -1.807 . . . . 73.03 114.211 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.1 mt -48.0 -58.36 4.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.326 1.875 . . . . 64.21 114.842 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.5 -37.09 85.95 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.215 -0.928 . . . . 63.23 111.785 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -62.97 -57.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.303 1.041 . . . . 65.44 108.403 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -47.48 85.01 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.72 1.608 . . . . 62.53 110.987 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -56.57 -53.97 51.35 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.445 1.021 . . . . 72.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.598 HG12 ' HE2' ' A' ' 20' ' ' LYS . 43.6 t -63.07 -47.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 122.398 -0.189 . . . . 74.04 111.262 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' HD12 ' A' ' 21' ' ' ILE . 65.0 tt0 -57.0 -52.11 66.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.947 1.299 . . . . 75.14 110.335 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -60.19 -48.28 82.39 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.985 1.314 . . . . 73.0 110.455 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -49.39 76.74 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.42 0.555 . . . . 54.33 110.943 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HE2' HG12 ' A' ' 16' ' ' VAL . 55.3 mtmt -65.39 -44.31 87.89 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.631 0.372 . . . . 52.12 110.55 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 17' ' ' GLU . 49.8 mt -61.72 -42.64 95.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.365 -1.303 . . . . 72.52 110.402 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.08 -33.76 72.31 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 120.325 1.421 . . . . 73.34 110.263 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -47.12 74.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 119.465 -0.894 . . . . 75.11 109.986 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -77.75 -47.27 19.46 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.346 1.239 . . . . 73.11 114.346 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -129.25 77.27 77.88 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.562 1.945 . . . . 61.2 109.755 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.63 -28.71 44.38 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.159 2.572 . . . . 75.34 112.487 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -89.66 14.02 12.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.905 0.482 . . . . 72.22 111.948 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -120.48 146.24 46.46 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.849 -1.537 . . . . 71.04 106.849 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.57 143.49 28.27 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.191 -1.04 . . . . 54.53 108.191 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.03 127.2 8.35 Favored 'Trans proline' 0 C--N 1.352 0.752 1 C-N-CA 125.725 4.283 . . . . 65.42 113.095 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.59 145.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.863 0.865 . . . . 64.33 111.16 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.4 mm -122.09 135.44 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 103.8 -2.667 . . . . 61.22 103.8 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -122.68 114.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.854 1.262 . . . . 74.45 108.511 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.86 153.92 46.98 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 71.1 108.893 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -93.48 153.4 18.49 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.147 -0.971 . . . . 72.34 113.036 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.66 126.07 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.616 -1.994 . . . . 75.35 105.616 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.0 t -58.79 141.09 54.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.75 -0.463 . . . . 51.22 109.75 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.52 23.95 77.05 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.233 -1.315 . . . . 74.01 113.964 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 t -97.58 142.3 29.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.527 1.663 . . . . 71.24 108.211 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -65.81 -9.74 31.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.227 1.195 . . . . 70.12 114.227 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.37 160.82 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.277 0.944 . . . . 74.02 111.138 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -64.2 142.24 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.272 -1.01 . . . . 74.21 108.272 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.32 161.27 28.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.635 1.174 . . . . 73.12 107.852 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 tt -120.68 135.48 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.677 -1.231 . . . . 74.34 107.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.49 159.7 32.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.885 -1.524 . . . . 74.24 106.885 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -73.9 108.17 6.56 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.495 -1.378 . . . . 73.4 110.285 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -136.04 159.07 42.82 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.823 1.249 . . . . 72.54 112.021 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 14.8 mttt -104.68 99.26 8.92 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 105.42 -2.067 . . . . 64.45 105.42 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.73 116.76 23.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.706 1.602 . . . . 73.43 110.016 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.6 120.0 40.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 117.43 -1.271 . . . . 62.14 109.394 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -113.07 142.97 28.26 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 120.281 1.401 . . . . 74.13 111.527 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.18 141.17 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.767 1.645 . . . . 65.22 108.576 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -62.98 -18.25 63.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.206 2.202 . . . . 73.23 113.227 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -82.67 -30.69 29.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.213 1.19 . . . . 64.12 114.213 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.89 170.52 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.715 0.769 . . . . 73.42 111.393 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -107.13 156.92 18.28 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.124 0.97 . . . . 74.12 111.688 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.28 -35.91 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.858 1.663 . . . . 74.44 109.631 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.39 93.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.768 1.227 . . . . 75.32 111.539 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.33 -42.15 93.24 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.925 -0.768 . . . . 73.34 108.925 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.46 -44.04 93.07 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.165 -1.05 . . . . 53.13 108.165 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.5 ttp -59.65 -48.39 81.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.43 -0.795 . . . . 64.11 110.927 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -58.89 -42.0 88.5 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.342 0.974 . . . . 75.04 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -66.42 -43.27 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.015 -0.993 . . . . 74.32 109.699 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.48 -50.7 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 120.212 1.369 . . . . 74.43 110.1 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -59.67 -39.19 83.65 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.996 -1.065 . . . . 63.41 111.513 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -70.81 -39.07 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.018 0.826 . . . . 45.23 110.615 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -60.15 -49.3 78.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.529 1.132 . . . . 75.22 109.708 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.4 pt -79.23 -0.95 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.949 0.34 . . . . 73.3 111.476 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 55.65 52.86 10.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.386 1.474 . . . . 75.3 108.696 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.49 106.63 1.62 Allowed Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 126.856 2.062 . . . . 73.24 108.452 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.32 157.69 56.26 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.327 2.018 . . . . 55.12 109.653 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -58.48 -28.08 65.03 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.485 -0.76 . . . . 60.31 112.713 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.65 -33.04 71.02 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.335 1.054 . . . . 75.04 112.214 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.33 164.26 11.78 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.36 -1.348 . . . . 65.14 107.36 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.4 172.31 6.93 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.876 1.271 . . . . 54.42 108.789 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -143.98 117.22 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.44 1.096 . . . . 74.43 108.587 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.59 137.55 54.38 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.67 -1.604 . . . . 71.4 106.67 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.9 148.92 33.94 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.008 1.323 . . . . 75.02 109.532 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -143.55 128.26 18.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.692 1.197 . . . . 75.14 109.962 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.95 122.12 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.204 -1.406 . . . . 72.42 107.204 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.06 34.46 14.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.34 1.456 . . . . 71.24 111.251 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 63.9 26.62 14.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.721 1.208 . . . . 73.53 110.322 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -119.58 161.88 19.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.456 1.102 . . . . 61.44 109.326 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.7 103.34 27.61 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 104.524 -2.399 . . . . 64.32 104.524 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.56 142.83 45.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.047 1.831 . . . . 73.31 110.374 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -77.47 114.22 16.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.825 -1.546 . . . . 61.3 106.825 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.0 m -54.39 -26.84 32.73 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.129 1.772 . . . . 71.35 112.818 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -86.89 -6.61 58.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.399 -0.813 . . . . 52.22 113.056 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 tp -75.15 158.58 32.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.569 1.077 . . . . 75.34 108.933 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.3 p -93.24 161.81 14.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.465 0.575 . . . . 35.22 109.72 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.9 mmm -64.27 -46.68 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.906 -1.045 . . . . 75.3 111.653 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.04 74.72 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.333 0.97 . . . . 54.13 111.172 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.72 -51.96 62.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.751 0.82 . . . . 71.42 110.628 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 tt -59.04 -44.14 91.75 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.511 -0.28 . . . . 75.44 110.58 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -65.69 -54.71 23.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.876 0.762 . . . . 71.51 109.544 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -58.67 -30.7 67.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.043 0.838 . . . . 72.51 111.638 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -40.85 16.76 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.367 -1.301 . . . . 73.21 110.36 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.53 6.51 43.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.042 1.292 . . . . 70.24 113.306 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.51 121.26 6.11 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.429 1.468 . . . . 71.12 111.731 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.14 174.89 4.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.047 2.139 . . . . 73.0 110.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.15 -30.76 68.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.654 -1.279 . . . . 73.52 108.939 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.31 6.82 40.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.184 2.194 . . . . 64.01 112.768 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.73 28.41 65.51 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.482 -1.176 . . . . 71.51 116.007 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.06 134.96 54.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.08 1.94 . . . . 73.45 107.453 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.38 133.45 39.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.509 1.05 . . . . 45.45 109.408 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -123.14 123.72 41.44 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.843 1.657 . . . . 74.5 107.726 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.04 136.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 124.729 1.212 . . . . 73.12 109.543 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.39 148.86 32.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.446 0.698 . . . . 73.13 110.815 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -132.96 155.16 49.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.51 0.929 . . . . 75.34 113.51 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.8 p -146.61 159.47 43.4 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.506 0.67 . . . . 51.15 110.881 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.21 22.31 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.818 1.675 . . . . 61.44 112.08 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 . . . . . 0 C--O 1.236 0.345 0 C-N-CA 125.794 1.638 . . . . 74.21 107.593 -179.529 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 118.469 -0.777 . . . . 52.31 112.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.489 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 50.8 m95 51.85 66.48 1.19 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.85 1.205 . . . . 75.14 112.956 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.69 145.0 21.59 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.027 -1.629 . . . . 30.12 109.027 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.0 134.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.418 1.609 . . . . 72.2 110.003 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -138.61 126.2 22.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.938 0.895 . . . . 65.31 110.579 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.81 118.51 29.46 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.386 -1.709 . . . . 70.14 106.386 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 14.7 t -122.35 113.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.279 0.474 . . . . 43.43 112.279 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 65.8 p -155.13 154.14 31.88 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.796 -1.187 . . . . 73.02 107.796 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.243 0.732 0 C-N-CA 126.936 2.095 . . . . 72.55 106.228 -179.728 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.7 m95 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -62.63 -42.74 99.76 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.394 -0.224 . . . . 74.32 110.394 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -56.77 -52.14 66.19 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.507 -0.553 . . . . 75.12 109.507 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -64.94 -34.11 77.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.063 1.345 . . . . 74.32 112.44 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -60.74 -48.89 79.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.441 -0.948 . . . . 70.25 108.441 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.49 -69.24 0.42 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.858 0.724 . . . . 70.33 110.147 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.01 143.66 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.962 1.305 . . . . 72.31 111.474 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 t -130.57 -65.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 117.322 -1.323 . . . . 75.31 112.566 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.2 mt -43.08 -60.69 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 116.477 2.028 . . . . 73.14 116.477 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.27 -48.01 68.98 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 120.719 -1.238 . . . . 73.14 110.418 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -51.91 -46.39 64.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.647 1.179 . . . . 71.44 111.052 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -43.69 91.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.683 -1.627 . . . . 64.13 108.439 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -64.38 -40.11 95.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.61 1.095 . . . . 64.45 110.46 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.15 -48.05 79.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 120.083 -1.635 . . . . 60.23 108.066 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -38.26 90.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.526 -0.749 . . . . 64.53 110.749 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -59.82 -48.05 83.27 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.448 -1.316 . . . . 61.44 107.448 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -50.56 71.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.821 0.448 . . . . 73.5 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -61.77 -52.03 65.91 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.843 0.857 . . . . 61.24 112.399 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.48 -41.79 72.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 116.689 -1.624 . . . . 74.33 111.037 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -64.5 -31.22 72.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.811 2.096 . . . . 70.11 109.263 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.03 -46.67 56.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.094 0.406 . . . . 54.23 110.84 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -77.81 -47.77 18.12 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.774 1.398 . . . . 73.21 114.774 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -126.22 80.59 68.32 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 126.273 1.829 . . . . 74.03 108.107 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.35 -35.3 51.23 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.556 2.171 . . . . 52.13 109.353 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.86 20.76 3.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.733 1.213 . . . . 71.42 114.272 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -125.84 155.77 40.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 120.214 -1.553 . . . . 63.41 108.01 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 m -126.91 138.73 33.26 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.019 0.928 . . . . 74.51 110.25 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HG2' ' HA ' ' A' ' 104' ' ' PHE . 68.5 Cg_endo -77.89 120.03 4.93 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 125.279 3.986 . . . . 63.31 113.307 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.5 135.61 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.003 1.321 . . . . 74.15 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.94 118.36 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.962 -2.236 . . . . 72.35 104.962 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.65 124.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.063 1.745 . . . . 75.15 106.895 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.97 139.17 54.06 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.54 -1.281 . . . . 72.21 107.54 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tmmt? -72.66 140.4 47.9 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.637 0.775 . . . . 75.11 110.414 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.84 126.17 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 125.008 1.323 . . . . 74.23 107.57 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.2 p -55.47 122.18 10.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.877 0.871 . . . . 62.13 109.359 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.73 9.42 66.34 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.618 -1.101 . . . . 75.41 114.723 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 t -86.06 146.44 26.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.364 1.582 . . . . 74.53 110.653 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -65.25 -24.86 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.411 1.084 . . . . 75.24 111.383 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -66.11 162.79 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.426 -1.422 . . . . 75.42 113.475 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.3 141.47 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 125.15 1.38 . . . . 51.12 108.359 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 2.6 p30 -81.78 170.21 15.99 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.588 0.755 . . . . 74.32 110.312 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 tt -126.65 149.56 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.222 1.409 . . . . 74.03 107.803 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -76.57 166.01 23.99 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.347 1.059 . . . . 73.11 109.164 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -73.71 95.77 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 72.22 106.402 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -134.94 159.07 42.62 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.239 1.416 . . . . 75.24 107.336 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -113.56 104.28 12.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.733 -1.21 . . . . 63.42 107.733 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' B' ' 346' ' ' VAL . 5.1 m-30 -84.17 145.67 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.337 0.971 . . . . 71.51 110.381 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.44 112.1 18.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.594 1.558 . . . . 72.1 108.631 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.69 142.19 25.26 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.096 -0.954 . . . . 62.3 110.676 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 76.8 Cg_endo -74.94 141.39 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.572 2.848 . . . . 72.54 112.72 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.29 -21.7 60.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.373 1.469 . . . . 74.31 114.562 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -78.54 -32.87 48.11 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 114.961 1.467 . . . . 63.4 114.961 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -73.52 166.07 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.707 1.14 . . . . 71.01 110.709 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -102.43 161.24 13.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.38 1.072 . . . . 71.54 109.934 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.16 -35.9 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.569 1.148 . . . . 73.41 110.396 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.3 93.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.909 0.777 . . . . 54.5 109.977 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -63.43 -46.32 86.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.619 -0.882 . . . . 73.23 108.619 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.49 -45.75 90.79 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.53 -0.545 . . . . 72.52 109.53 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.21 -40.18 84.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.992 0.917 . . . . 64.41 109.78 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -68.11 -39.18 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.647 0.658 . . . . 75.14 110.321 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.31 -44.49 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.888 -1.153 . . . . 74.31 107.888 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.76 -51.12 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.742 1.155 . . . . 61.34 111.147 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -59.93 -39.03 84.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.034 0.834 . . . . 74.21 110.834 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -70.06 -43.34 71.41 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.778 0.717 . . . . 75.0 109.967 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.84 -49.55 72.98 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.115 1.366 . . . . 74.34 110.936 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.69 -0.47 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.062 0.851 . . . . 64.14 112.181 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 58.3 55.74 4.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.328 1.451 . . . . 75.11 111.571 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' HD2' ' A' ' 71' ' ' PRO . 1.1 tm? -68.79 109.22 3.86 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 106.623 -1.621 . . . . 45.54 106.623 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD2' HD22 ' A' ' 70' ' ' LEU . 88.3 Cg_endo -73.06 164.65 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.986 3.124 . . . . 71.52 111.683 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 m -60.09 -27.39 66.96 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.516 0.326 . . . . 70.32 111.114 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.48 -38.46 89.92 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.253 -0.879 . . . . 64.41 113.367 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 165.35 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.113 1.324 . . . . 65.41 112.115 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.03 177.36 4.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.968 1.707 . . . . 71.32 107.921 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tp -145.98 138.85 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.349 1.06 . . . . 65.25 110.353 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.39 139.49 26.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.351 1.86 . . . . 61.03 109.642 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.04 147.39 40.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.988 2.115 . . . . 64.31 107.598 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.46 123.18 17.49 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.741 -1.577 . . . . 63.21 106.741 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.94 123.36 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 108.52 -0.919 . . . . 32.21 108.52 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.88 35.34 1.08 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.053 1.741 . . . . 63.32 112.601 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 66.04 38.07 5.0 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.158 1.783 . . . . 74.41 113.484 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.0 p -135.1 157.59 46.54 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.942 2.097 . . . . 74.15 107.501 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.99 110.81 63.23 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 105.446 -2.057 . . . . 65.21 105.446 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.39 123.48 10.89 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.763 1.642 . . . . 40.1 109.545 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -67.23 124.41 23.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.47 0.708 . . . . 55.3 109.409 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.42 -33.26 65.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.668 1.187 . . . . 73.32 112.317 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -4.65 51.17 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.947 -1.095 . . . . 72.25 112.551 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.17 146.44 37.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.324 1.42 . . . . 74.33 108.936 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.21 149.07 26.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.977 0.911 . . . . 72.05 108.906 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.3 mmt -55.43 -49.41 72.49 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.721 -1.133 . . . . 73.22 110.109 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.91 -41.74 94.38 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.838 0.745 . . . . 73.43 112.295 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.49 -49.58 70.82 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.279 1.039 . . . . 74.03 109.247 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -44.43 96.0 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 124.661 1.184 . . . . 75.13 111.147 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.71 -50.68 72.51 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.154 1.381 . . . . 75.43 108.172 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -65.18 -28.51 69.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.184 -0.912 . . . . 73.51 112.357 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -28.56 17.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.309 -1.329 . . . . 50.43 113.644 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -105.17 -2.88 23.66 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.882 1.438 . . . . 74.42 114.882 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -37.92 121.42 0.93 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.351 2.261 . . . . 71.23 113.799 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.91 162.99 26.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.012 -1.107 . . . . 74.33 108.012 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.86 -31.76 67.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.901 0.88 . . . . 73.02 110.423 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -85.97 -35.36 20.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.898 -1.149 . . . . 64.0 107.898 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.21 3.84 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 117.626 1.81 . . . . 72.42 117.626 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 7.3 p90 -82.86 179.18 7.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.747 0.773 . . . . 73.32 111.246 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tp -122.51 124.49 43.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.365 -0.976 . . . . 72.05 108.365 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -108.19 113.27 26.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.148 1.379 . . . . 71.23 109.782 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.07 147.07 32.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.255 1.026 . . . . 75.43 109.991 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.81 148.52 36.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.744 -1.206 . . . . 73.13 107.744 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -137.27 153.94 50.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.382 0.61 . . . . 63.02 111.621 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -147.43 168.86 20.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.572 1.149 . . . . 54.5 108.204 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.38 18.28 15.76 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-O 118.761 -1.022 . . . . 74.32 112.049 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-N 119.448 1.624 . . . . 71.03 108.001 -177.129 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 109.534 -0.543 . . . . 63.22 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 17.6 m95 48.97 55.62 9.01 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 126.072 1.749 . . . . 65.21 111.974 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.82 126.82 7.61 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.588 -1.005 . . . . 71.21 110.588 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 59.5 mt -68.77 138.13 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.132 0.966 . . . . 52.31 109.657 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.93 139.93 36.28 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.638 0.775 . . . . 75.54 112.836 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 77.6 mt -88.41 111.1 21.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.75 -1.574 . . . . 74.24 106.75 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 49' ' ' TYR . 41.1 t -121.8 112.69 36.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.904 0.881 . . . . 71.54 110.645 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 347' ' ' SER . . . . . 0.41 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.4 p -161.24 160.83 30.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.184 0.994 . . . . 73.44 112.528 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 129.32 3.048 . . . . 63.51 113.7 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.6 m95 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 119.756 -0.164 . . . . 74.1 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.974 0.51 . . . . 75.55 110.139 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -59.65 -46.82 87.86 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.067 -0.396 . . . . 75.44 111.523 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.93 -36.57 84.81 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.474 -0.774 . . . . 74.23 112.641 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -71.82 -41.01 68.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.859 0.754 . . . . 71.45 111.662 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.02 -76.22 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.647 1.179 . . . . 73.12 110.854 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -160.96 119.68 2.52 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.79 1.636 . . . . 71.13 107.417 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -106.89 -65.92 1.05 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.75 -0.594 . . . . 74.22 112.519 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -44.24 -59.24 2.46 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.986 2.115 . . . . 63.23 116.61 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 72.5 mt-10 -66.32 -36.55 83.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.667 1.121 . . . . 64.23 110.33 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.08 -54.73 37.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.202 -0.666 . . . . 75.43 109.202 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.11 89.54 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.835 1.654 . . . . 70.4 111.467 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -54.9 -53.28 57.5 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.814 0.734 . . . . 61.45 110.375 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.66 -46.73 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 122.795 0.438 . . . . 72.33 110.752 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.01 62.97 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.543 1.137 . . . . 62.13 112.462 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 m -65.03 -44.26 89.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.22 -0.895 . . . . 75.43 109.676 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.99 66.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.755 1.161 . . . . 71.22 110.602 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -47.95 83.71 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.939 1.295 . . . . 52.34 110.472 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.3 mt -64.16 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 117.472 -1.251 . . . . 65.32 110.046 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -62.68 -36.64 83.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 121.051 1.75 . . . . 73.42 109.386 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.55 59.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.125 -0.63 . . . . 72.05 111.805 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -79.03 -46.5 18.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.0 2.593 . . . . 71.4 118.0 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.38 81.62 54.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.786 2.035 . . . . 64.32 109.025 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.69 -23.9 55.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.044 2.496 . . . . 75.55 112.922 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.63 14.02 26.29 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.614 0.365 . . . . 74.43 110.365 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -121.57 154.05 37.22 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.913 -1.143 . . . . 73.0 107.913 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.86 142.75 46.09 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 123.753 0.821 . . . . 65.24 111.092 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.03 125.43 9.29 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.623 3.549 . . . . 55.24 111.438 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.02 140.87 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.989 -1.115 . . . . 71.42 107.989 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.89 117.86 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 103.034 -2.95 . . . . 74.52 103.034 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -105.78 120.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.911 -1.885 . . . . 64.01 105.911 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -124.67 146.21 49.24 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.602 0.761 . . . . 72.13 109.611 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -93.3 135.65 34.32 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.049 0.94 . . . . 74.53 109.735 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.21 130.65 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.377 -0.827 . . . . 71.52 109.193 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -63.72 156.59 26.6 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.45 -0.574 . . . . 71.34 109.45 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.86 -20.33 39.94 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.94 1.257 . . . . 63.12 112.996 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.3 t -84.56 142.95 29.63 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.15 -1.796 . . . . 74.05 106.15 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.44 -11.64 60.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.485 1.114 . . . . 53.44 112.484 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.486 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 2.1 tt -62.69 157.43 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.012 1.325 . . . . 71.43 111.498 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -66.11 156.19 6.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.12 1.368 . . . . 75.15 110.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -101.53 173.21 6.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.188 2.195 . . . . 63.14 114.652 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -125.22 136.44 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.612 1.565 . . . . 74.13 108.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.72 165.0 25.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.389 1.076 . . . . 72.4 108.203 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.06 94.81 2.44 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.259 -0.901 . . . . 75.33 111.393 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -129.56 162.42 28.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 125.205 1.402 . . . . 73.22 108.891 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 33.3 mtmt -108.81 101.74 10.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 104.385 -2.45 . . . . 72.23 104.385 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -93.46 120.73 34.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.223 0.465 . . . . 75.0 111.546 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.91 121.19 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.654 -0.869 . . . . 74.41 108.654 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.73 142.42 26.61 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.139 0.975 . . . . 70.24 109.257 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 138.69 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.954 1.769 . . . . 72.25 111.073 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -60.75 -16.77 43.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.27 2.628 . . . . 50.52 111.206 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.46 -34.66 58.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.914 1.45 . . . . 72.23 114.914 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.25 170.28 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.962 0.801 . . . . 74.51 112.199 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -100.26 166.32 11.04 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.909 0.883 . . . . 53.21 111.651 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.0 t -56.65 -34.73 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 O-C-N 121.597 -0.69 . . . . 73.02 109.244 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.89 92.46 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.363 1.065 . . . . 54.42 110.353 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -65.88 -45.25 82.76 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.875 0.87 . . . . 71.4 109.123 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.79 -48.22 82.01 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.719 -0.845 . . . . 74.31 108.719 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.8 ttp -59.51 -45.01 92.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.837 0.855 . . . . 74.11 110.856 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -60.18 -39.72 87.46 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.875 0.47 . . . . 65.25 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.34 -47.29 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 117.368 -1.301 . . . . 55.45 109.521 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.4 -50.89 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 120.374 1.443 . . . . 71.12 109.509 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -61.72 -36.97 82.49 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.346 -0.846 . . . . 62.43 112.183 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -67.4 -43.68 80.71 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-O 118.062 -0.971 . . . . 71.1 110.434 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -63.22 -47.56 81.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.744 1.618 . . . . 75.45 111.01 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -79.39 1.65 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.351 0.596 . . . . 74.55 110.977 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 50.56 59.44 4.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.795 2.438 . . . . 73.34 111.141 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.56 111.26 6.98 Favored Pre-proline 0 C--O 1.24 0.593 0 C-N-CA 125.66 1.584 . . . . 72.15 109.662 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.05 165.58 29.68 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.851 3.701 . . . . 72.41 113.329 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 p -60.91 -23.32 65.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.635 1.574 . . . . 73.14 113.7 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.6 pt-20 -72.27 -54.13 10.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.675 1.59 . . . . 73.43 112.826 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.52 163.47 23.71 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 113.284 0.846 . . . . 75.12 113.284 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.06 166.66 10.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.416 1.886 . . . . 73.44 107.62 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tt -154.4 130.5 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 125.218 1.407 . . . . 74.53 107.744 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -139.16 149.54 44.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.845 1.658 . . . . 72.42 107.713 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.1 mt -112.83 156.57 22.68 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.896 1.278 . . . . 61.14 109.5 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -147.41 140.24 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.286 1.435 . . . . 73.44 109.288 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.459 HG12 ' HD3' ' A' ' 85' ' ' PRO . 12.0 p -134.14 120.78 35.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 125.345 1.458 . . . . 63.42 107.211 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 t0 43.22 52.46 5.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 73.41 111.837 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 62.43 18.87 10.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.78 1.632 . . . . 75.04 113.766 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.4 p -125.9 160.12 30.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.788 1.631 . . . . 73.23 111.31 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.8 104.16 37.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.52 1.928 . . . . 74.31 106.542 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' HG12 ' A' ' 80' ' ' VAL . 38.7 Cg_endo -68.43 155.41 69.24 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.528 2.152 . . . . 51.44 110.639 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -79.86 121.63 25.65 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.018 -0.734 . . . . 64.22 109.018 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.2 m -53.68 -31.4 47.63 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.243 1.201 . . . . 62.41 114.243 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 t -83.7 -8.29 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.706 1.002 . . . . 70.22 113.706 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.82 152.39 44.63 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.309 1.413 . . . . 64.31 109.625 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -88.88 150.01 23.08 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.037 -0.727 . . . . 61.11 109.037 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.8 mmt -58.15 -47.53 83.05 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 117.337 -1.316 . . . . 73.35 110.23 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.07 -48.52 46.08 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 121.227 1.83 . . . . 53.01 113.298 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -64.32 -50.0 69.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.281 1.032 . . . . 74.5 109.533 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.31 -47.86 80.42 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.699 0.8 . . . . 73.22 110.187 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -58.84 -55.17 38.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.912 1.285 . . . . 74.01 108.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -54.71 -43.55 72.66 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.401 0.889 . . . . 65.23 113.401 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -24.81 28.25 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 117.593 -1.194 . . . . 74.1 114.222 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.6 2.74 36.48 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.115 1.325 . . . . 71.33 112.72 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -53.77 126.4 21.94 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.604 1.562 . . . . 62.31 112.258 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.71 165.38 25.32 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.988 -1.116 . . . . 64.34 107.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.75 62.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.696 -1.253 . . . . 71.55 111.023 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.92 17.05 12.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.439 2.295 . . . . 62.02 111.014 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.43 15.33 38.52 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.663 3.03 . . . . 62.03 119.513 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -122.04 179.48 4.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.49 2.145 . . . . 72.03 111.124 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.14 124.47 45.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.796 . . . . 74.42 111.023 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -105.14 118.52 36.74 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.74 -1.207 . . . . 71.42 107.74 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.0 140.22 49.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.524 -0.735 . . . . 73.23 109.026 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 156.89 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.977 -1.077 . . . . 72.35 108.51 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -145.23 156.39 43.81 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.407 0.622 . . . . 74.2 110.083 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.35 170.43 17.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.513 -0.921 . . . . 44.21 108.513 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.84 30.28 7.25 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.522 1.535 . . . . 71.51 109.963 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--O 1.236 0.368 0 C-N-CA 125.09 1.356 . . . . 72.23 110.449 -179.245 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 C--O 1.235 0.33 0 N-CA-C 114.281 1.215 . . . . 73.51 114.281 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.598 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 28.0 m95 55.12 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.567 1.147 . . . . 72.0 109.552 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -87.12 130.08 9.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.439 -1.413 . . . . 64.41 112.693 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 39.6 mt -68.78 128.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.3 1.55 . . . . 73.34 110.123 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -134.44 161.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.893 1.677 . . . . 65.31 111.282 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.5 116.51 31.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.119 -2.549 . . . . 74.14 104.119 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.13 104.3 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.959 -1.126 . . . . 74.31 107.959 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.7 p -147.56 160.6 42.45 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.217 1.407 . . . . 74.31 108.391 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 131.284 3.834 . . . . 73.42 116.148 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 105.382 -2.081 . . . . 73.11 105.382 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -52.48 -38.74 60.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.638 0.775 . . . . 73.22 110.372 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -60.14 -41.08 91.95 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.099 -0.375 . . . . 73.25 111.874 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -67.16 -40.46 86.65 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.627 1.171 . . . . 63.35 109.354 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.57 -40.86 93.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.204 0.601 . . . . 74.5 110.352 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.78 -75.79 0.3 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.117 0.967 . . . . 72.43 112.102 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.78 119.9 2.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.056 1.342 . . . . 65.51 108.852 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -119.65 -65.83 1.12 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 117.243 -1.36 . . . . 73.42 113.358 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.2 tp -47.23 -59.67 3.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 115.97 1.841 . . . . 62.33 115.97 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.44 -50.69 62.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.719 0.771 . . . . 72.5 111.122 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -53.88 -49.83 67.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.735 1.214 . . . . 74.51 111.123 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -67.22 -39.34 86.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 116.587 -1.673 . . . . 74.3 109.93 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.25 -55.52 33.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.252 1.387 . . . . 72.54 110.917 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.73 -48.0 81.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.053 1.341 . . . . 63.12 109.925 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.32 -42.79 87.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 118.182 -0.913 . . . . 72.23 112.151 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.6 p -61.56 -43.04 99.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.81 1.186 . . . . 63.32 108.82 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.6 -50.42 73.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.902 0.773 . . . . 60.23 109.938 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.05 -48.18 77.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.889 -0.507 . . . . 74.01 111.771 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.91 -42.34 94.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 118.004 -0.998 . . . . 63.44 109.97 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -65.73 -34.38 78.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.992 1.269 . . . . 65.44 110.068 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.54 -45.86 51.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.244 -0.408 . . . . 72.35 111.042 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -77.1 -46.46 23.52 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.059 0.845 . . . . 62.43 113.096 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -122.22 79.35 44.05 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.953 2.101 . . . . 74.01 109.977 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.49 -13.46 30.26 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.534 2.823 . . . . 72.23 112.95 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 18.28 20.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.682 1.593 . . . . 74.32 110.569 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 54.4 mtt85 -125.11 147.75 48.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.478 1.111 . . . . 51.32 108.511 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.16 133.14 23.18 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.621 1.168 . . . . 74.2 109.781 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.07 117.5 3.55 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.533 3.488 . . . . 74.52 112.13 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.56 151.19 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.852 1.261 . . . . 53.23 110.129 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.36 120.88 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 104.467 -2.42 . . . . 54.35 104.467 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.75 115.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.147 1.779 . . . . 72.32 108.684 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.38 151.3 51.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 72.41 110.184 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -94.06 158.49 15.59 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.108 -0.995 . . . . 72.34 113.372 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.61 129.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.005 -2.591 . . . . 53.33 104.005 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.1 p -53.0 153.19 3.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.654 0.74 . . . . 65.23 112.142 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.89 -17.69 1.23 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.064 1.793 . . . . 52.23 113.136 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -62.16 124.49 20.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 119.272 1.536 . . . . 53.32 108.69 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -64.4 -12.89 47.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.961 1.304 . . . . 73.12 112.9 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.45 151.54 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.475 -1.306 . . . . 64.44 107.475 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -46.97 141.89 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.733 1.213 . . . . 72.1 112.576 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.15 150.74 41.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.799 -1.546 . . . . 73.44 110.616 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.27 123.46 63.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.724 -1.584 . . . . 71.11 106.724 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.51 165.86 24.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.526 -0.916 . . . . 65.14 108.526 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.82 95.18 1.89 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.272 0.558 . . . . 73.4 111.365 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -132.12 161.86 32.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.562 1.945 . . . . 70.4 109.009 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -112.3 142.27 45.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.69 1.196 . . . . 63.02 108.624 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -122.94 132.63 54.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.792 0.437 . . . . 64.35 109.848 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.66 113.17 21.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.888 1.675 . . . . 70.51 108.282 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.11 142.87 26.83 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-O 118.218 -0.896 . . . . 74.13 110.224 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 51.8 Cg_endo -66.34 139.73 55.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.697 1.598 . . . . 73.43 111.274 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -12.29 30.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.708 1.203 . . . . 61.21 112.6 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.54 -35.07 58.47 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.155 1.782 . . . . 62.33 112.94 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.24 169.46 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 122.018 0.913 . . . . 74.01 110.69 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -107.16 168.47 9.19 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.282 -0.886 . . . . 64.32 112.086 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.19 -35.26 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.86 -1.533 . . . . 64.24 106.86 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 87' ' ' SER . . . -60.61 -47.18 87.35 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 121.381 -0.824 . . . . 75.52 110.654 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.17 -45.69 76.22 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 118.33 -0.843 . . . . 74.03 110.923 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.25 -44.14 88.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.663 0.665 . . . . 73.44 109.602 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 34.5 ttp -65.11 -43.98 90.22 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 117.772 -1.109 . . . . 72.43 111.733 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -59.67 -46.77 88.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.545 1.066 . . . . 75.33 109.182 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.455 HG21 ' CG1' ' B' ' 346' ' ' VAL . 40.3 mt -60.35 -48.08 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 117.862 -1.066 . . . . 74.44 108.63 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 ' CE2' ' A' ' 60' ' ' PHE . 55.1 mt -56.35 -50.27 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.874 1.215 . . . . 65.33 110.121 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -61.19 -33.17 73.02 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.864 -1.147 . . . . 74.41 111.74 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.15 -38.34 60.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.085 0.857 . . . . 73.14 110.209 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -60.28 -46.02 91.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.334 1.454 . . . . 71.13 110.291 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.6 pt -79.25 -6.47 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 109.969 -0.382 . . . . 72.34 109.969 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 54.93 59.78 3.86 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 126.55 1.94 . . . . 74.31 109.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.04 108.85 3.09 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.443 1.897 . . . . 72.53 111.098 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.48 151.09 70.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.451 2.101 . . . . 64.24 108.586 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 p -60.28 -25.05 65.42 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.257 -0.902 . . . . 74.15 112.431 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.87 -38.44 78.82 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.719 0.807 . . . . 73.42 110.402 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -96.14 164.7 12.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.513 1.125 . . . . 72.34 108.775 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.88 174.89 5.67 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.145 1.378 . . . . 43.13 108.257 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tp -153.15 136.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.696 -1.224 . . . . 62.55 107.696 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.98 141.12 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.106 1.362 . . . . 72.44 108.149 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.18 151.3 32.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.595 -1.261 . . . . 54.32 107.595 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -141.21 123.59 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.182 0.993 . . . . 73.3 108.575 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.68 140.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.226 -1.398 . . . . 71.32 107.226 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t0 52.11 31.93 9.68 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 122.114 0.959 . . . . 73.02 112.197 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.6 mttm 65.83 25.17 11.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.399 1.88 . . . . 74.04 111.821 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -152.08 163.03 40.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.404 1.082 . . . . 73.31 110.816 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 121.01 74.62 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.038 -2.208 . . . . 70.54 105.038 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.31 140.0 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.057 2.505 . . . . 71.44 109.695 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -67.69 124.76 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.505 1.122 . . . . 73.42 109.841 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 29.9 m -53.17 -27.8 23.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.849 1.66 . . . . 72.14 113.693 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.6 m -75.18 -17.93 60.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.256 1.022 . . . . 61.34 112.214 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.69 153.08 44.51 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.631 1.172 . . . . 64.4 108.812 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -101.03 153.74 19.29 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.109 -0.7 . . . . 61.4 109.109 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.33 -49.61 76.59 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 119.132 -0.461 . . . . 74.25 111.682 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.96 -44.97 92.57 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.237 -0.745 . . . . 51.2 111.237 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.44 -53.33 59.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.733 1.213 . . . . 51.12 110.977 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.74 -51.48 69.58 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.238 1.015 . . . . 72.04 109.718 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.29 -44.6 79.97 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.159 1.383 . . . . 61.02 110.085 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.58 -38.53 91.34 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.839 0.745 . . . . 61.42 111.939 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.05 -24.28 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.484 -1.246 . . . . 55.43 113.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.76 -4.18 22.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.001 1.273 . . . . 75.4 114.301 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.73 120.66 2.72 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.301 1.041 . . . . 71.32 113.647 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.74 175.29 10.57 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.654 -1.98 . . . . 73.34 105.654 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.41 -12.44 14.43 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.762 -1.837 . . . . 70.24 112.873 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.71 6.04 43.85 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.958 1.703 . . . . 74.35 113.651 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.39 68.56 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.706 -0.622 . . . . 71.34 111.815 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.27 164.6 21.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.538 1.535 . . . . 75.25 108.863 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.04 139.67 53.72 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 124.57 1.169 . . . . 74.03 108.667 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -121.48 122.92 40.81 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.284 -1.006 . . . . 72.1 108.284 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.32 133.06 67.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 120.776 -1.202 . . . . 64.41 108.979 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.81 160.27 14.75 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.683 -0.636 . . . . 60.32 110.009 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 35' ' ' LYS . 21.3 p90 -142.13 157.07 45.31 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.446 0.699 . . . . 71.03 111.924 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.9 p -149.22 158.54 44.26 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.988 -0.745 . . . . 54.12 108.988 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.43 29.98 7.26 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.218 1.39 . . . . 74.32 111.542 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.234 0.254 0 C-N-CA 125.475 1.51 . . . . 70.15 107.549 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 115.354 1.613 . . . . 72.14 115.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 30.4 m95 50.07 60.45 3.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.023 1.729 . . . . 73.31 115.307 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.53 137.17 17.12 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.746 -1.341 . . . . 60.21 109.746 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 26.0 mt -77.63 137.1 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.658 1.583 . . . . 73.12 113.154 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.06 142.83 50.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.299 2.24 . . . . 75.22 108.141 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.02 111.17 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.022 1.729 . . . . 74.21 110.931 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.4 t -122.91 125.82 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 113.523 0.934 . . . . 60.24 113.523 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -143.15 110.51 5.76 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.522 1.529 . . . . 73.25 108.198 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.022 1.729 . . . . 71.43 111.661 179.784 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 C--O 1.244 0.793 0 N-CA-C 109.076 -0.713 . . . . 74.42 109.076 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.64 -48.41 81.89 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.714 -0.847 . . . . 72.21 108.714 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.83 -34.37 74.45 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 118.863 -0.589 . . . . 63.54 111.282 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -64.74 -42.09 95.45 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 120.038 1.29 . . . . 55.13 109.643 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.88 -47.16 86.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.645 -0.872 . . . . 65.23 108.645 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.52 -75.45 0.1 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.212 1.805 . . . . 73.21 113.021 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.23 130.94 5.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.703 2.801 . . . . 73.43 109.505 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.3 p -114.73 -66.63 1.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.215 -1.553 . . . . 74.43 114.266 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -52.84 -57.36 10.48 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 124.83 1.252 . . . . 73.35 113.943 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.22 -56.13 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.172 0.442 . . . . 74.21 111.398 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -52.26 -49.95 63.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.529 1.132 . . . . 73.12 110.836 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.86 76.05 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 117.882 -1.056 . . . . 71.23 112.183 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.6 m -60.35 -51.74 68.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 120.379 1.445 . . . . 61.54 109.264 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.57 -47.34 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.353 -0.61 . . . . 71.02 109.353 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 21' ' ' ILE . 56.5 tt0 -55.64 -49.98 71.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.434 1.094 . . . . 73.31 109.982 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.1 m -60.51 -48.56 81.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.944 0.897 . . . . 64.14 110.198 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.43 90.58 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.694 1.134 . . . . 64.33 111.562 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -47.64 77.32 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.226 1.411 . . . . 72.43 109.475 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 17' ' ' GLU . 62.5 mt -70.05 -42.38 79.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-O 117.784 -1.103 . . . . 73.14 111.807 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -65.16 -39.1 92.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 119.572 1.078 . . . . 62.25 109.7 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.2 -46.91 66.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.07 -0.652 . . . . 70.54 110.921 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -78.16 -38.31 43.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.276 1.954 . . . . 74.34 116.276 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -136.55 74.14 53.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.352 1.861 . . . . 72.31 109.777 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.78 -24.09 54.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.421 2.747 . . . . 75.3 110.726 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.99 12.17 18.38 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.6 -0.687 . . . . 74.55 112.726 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -119.89 154.08 34.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.572 -1.27 . . . . 74.32 107.572 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.82 139.98 27.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.166 -0.679 . . . . 74.54 109.166 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.075 3.85 . . . . 74.1 112.169 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.2 131.93 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.909 -0.775 . . . . 74.21 108.909 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.75 133.59 55.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.367 -2.457 . . . . 75.24 104.367 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.57 137.45 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.777 1.399 . . . . 72.04 114.777 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.84 152.61 43.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.115 0.966 . . . . 70.42 109.913 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -93.39 155.74 17.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.256 -1.016 . . . . 72.12 108.256 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.15 135.08 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.088 -1.819 . . . . 63.22 106.088 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.09 133.13 38.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.107 0.563 . . . . 73.22 111.975 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.57 3.95 43.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.645 -1.086 . . . . 64.13 114.144 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 t -62.5 146.02 52.74 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.685 1.742 . . . . 75.34 111.048 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -65.86 -14.89 62.32 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.825 2.05 . . . . 64.04 112.856 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.409 ' CD1' HD23 ' A' ' 70' ' ' LEU . 9.6 tp -77.66 159.08 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.398 -0.814 . . . . 61.54 109.965 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.25 150.06 11.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.789 -0.819 . . . . 72.14 108.789 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.6 164.58 25.79 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.522 0.729 . . . . 63.32 112.105 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.82 148.57 20.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.161 1.785 . . . . 71.21 106.317 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -87.14 157.44 19.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.452 -0.944 . . . . 65.54 108.452 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.87 100.72 3.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.5 -1.296 . . . . 52.01 107.5 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 87.2 mmt-85 -136.41 161.99 34.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.118 1.767 . . . . 75.44 110.198 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -108.81 95.48 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.178 2.591 . . . . 64.35 104.018 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -89.29 120.02 30.28 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.16 -0.963 . . . . 71.53 112.383 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.71 115.16 28.83 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.96 1.704 . . . . 74.23 109.625 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 141.47 25.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 117.82 -1.085 . . . . 53.22 111.361 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.43 140.7 48.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.281 2.654 . . . . 44.01 110.893 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 m -63.87 -16.33 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.489 1.516 . . . . 75.14 113.34 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.82 -30.43 28.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.295 1.438 . . . . 72.11 113.743 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -71.03 165.59 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 119.018 -1.073 . . . . 73.32 109.257 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -107.02 165.39 11.38 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.587 0.755 . . . . 75.23 110.25 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 t -53.99 -34.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.942 -1.132 . . . . 75.45 107.942 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.38 90.48 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.16 1.384 . . . . 74.52 111.135 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -69.21 -44.62 71.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.838 -0.801 . . . . 75.31 108.838 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.06 -48.6 81.03 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.429 -0.582 . . . . 75.5 109.429 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ttt -54.05 -48.07 70.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.626 1.17 . . . . 71.42 109.553 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.007 -0.521 . . . . 73.22 111.767 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.4 mt -57.32 -44.18 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.067 -0.716 . . . . 55.44 109.067 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mt -59.53 -50.63 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.427 0.558 . . . . 62.42 110.725 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -65.33 -37.27 86.59 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.08 -1.012 . . . . 70.41 111.949 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -64.94 -47.09 78.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.063 0.945 . . . . 72.31 110.29 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.89 -42.29 97.5 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.816 1.246 . . . . 70.31 113.011 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.65 -8.64 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 119.818 -0.753 . . . . 64.44 109.747 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.68 60.52 1.6 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.797 2.039 . . . . 73.35 108.841 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.1 tm? -73.32 110.44 8.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.664 1.186 . . . . 65.3 110.015 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.84 164.47 29.41 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.715 2.943 . . . . 72.14 112.389 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 p -64.28 -21.05 66.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.99 0.916 . . . . 72.25 111.498 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.47 -50.54 25.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.406 0.683 . . . . 73.42 112.794 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.12 164.24 15.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.777 -0.824 . . . . 64.11 108.777 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.23 -178.45 3.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.971 -1.122 . . . . 74.1 107.971 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -150.74 141.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.648 1.579 . . . . 73.12 107.171 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -145.27 139.41 27.1 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 127.288 2.235 . . . . 74.4 107.965 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.9 150.49 35.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.877 0.871 . . . . 42.51 111.135 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -145.25 133.83 22.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.549 1.14 . . . . 73.44 109.75 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 p -132.91 127.93 56.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 105.043 -2.206 . . . . 71.43 105.043 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.32 30.55 10.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.178 1.354 . . . . 74.01 110.863 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt 61.13 25.27 15.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 72.15 110.928 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -119.37 161.57 20.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.623 1.569 . . . . 60.25 109.72 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.2 103.62 21.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.356 -2.09 . . . . 75.15 105.356 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.15 142.7 38.47 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.31 2.007 . . . . 74.33 111.569 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -75.41 121.91 23.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.071 -0.715 . . . . 65.42 109.071 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -49.06 -42.21 37.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.854 2.062 . . . . 43.5 112.665 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -72.92 -11.37 60.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.769 1.228 . . . . 74.2 113.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.69 157.34 36.72 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.579 1.536 . . . . 71.51 109.733 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.03 152.45 18.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.192 1.397 . . . . 64.12 110.085 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.3 mmm -60.7 -43.56 97.62 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.034 -0.53 . . . . 73.01 111.613 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.51 99.71 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.479 -0.623 . . . . 52.43 111.782 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -66.15 -50.18 64.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.017 0.909 . . . . 63.54 109.412 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.23 -35.17 76.5 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.204 -0.295 . . . . 74.2 110.204 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.72 -48.96 67.59 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 120.063 -1.648 . . . . 60.35 109.619 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.92 -28.68 68.5 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.496 -0.752 . . . . 71.24 112.087 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -24.36 19.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 116.6 -1.667 . . . . 53.24 113.86 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.13 -2.97 13.3 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.704 1.742 . . . . 74.51 115.704 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 124.29 6.39 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.259 1.39 . . . . 74.3 113.967 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -77.62 175.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.937 -1.505 . . . . 73.32 106.937 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -58.91 -27.39 65.21 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 119.838 -1.789 . . . . 71.43 113.896 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -79.11 7.76 6.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 75.4 111.131 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.49 69.3 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.616 1.579 . . . . 72.23 114.94 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.77 172.65 10.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.447 1.899 . . . . 73.32 110.789 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.63 141.56 52.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.616 -0.513 . . . . 71.14 109.616 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -113.23 123.67 50.72 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.766 1.226 . . . . 75.11 111.795 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.2 136.81 57.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 122.801 1.286 . . . . 65.33 111.117 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.19 142.74 46.42 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.628 -1.619 . . . . 52.32 106.628 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -133.21 155.54 49.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.457 0.646 . . . . 74.25 110.758 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.3 p -150.97 155.9 40.06 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.567 -0.901 . . . . 55.23 108.567 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.36 9.21 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 119.39 -0.672 . . . . 71.43 112.769 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 118.219 1.01 . . . . 71.12 109.169 -177.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 115.572 1.693 . . . . 64.04 115.572 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.3 m95 53.74 58.52 5.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.398 1.079 . . . . 75.32 109.758 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 342' ' ' GLY . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -81.15 139.86 20.86 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 108.252 -1.939 . . . . 63.13 108.252 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 133.83 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 118.871 1.335 . . . . 60.4 109.698 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.09 138.36 48.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.747 1.219 . . . . 72.13 109.444 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.72 118.97 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 103.152 -2.907 . . . . 71.44 103.152 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.45 119.24 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.898 0.879 . . . . 71.53 109.522 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -161.47 123.99 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.42 0.688 . . . . 72.24 109.748 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 128.234 2.614 . . . . 64.43 112.902 -179.213 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 107.933 -1.136 . . . . 74.23 107.933 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -58.7 -41.99 87.57 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 124.024 0.828 . . . . 72.03 109.531 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -58.82 -42.34 88.96 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.693 -0.629 . . . . 62.11 110.992 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 11.3 ttmm -68.37 -38.06 81.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.312 0.96 . . . . 71.34 111.376 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.62 -46.77 74.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.96 -1.019 . . . . 72.32 108.829 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.92 -77.53 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.561 1.145 . . . . 73.14 110.266 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 119.21 2.13 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.254 1.821 . . . . 74.24 108.223 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 28.7 t -106.88 -65.82 1.06 Allowed 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 106.706 -1.59 . . . . 62.32 106.706 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -41.13 -58.07 1.88 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.512 1.525 . . . . 63.14 115.101 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.35 -51.66 54.94 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.918 -0.488 . . . . 54.43 112.0 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.66 -44.35 73.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.146 0.979 . . . . 74.22 110.325 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.27 70.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.73 1.612 . . . . 63.22 108.782 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.69 -47.71 79.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.359 0.527 . . . . 70.32 111.63 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.79 -48.3 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 C-N-CA 123.035 0.534 . . . . 71.32 109.953 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -64.06 -49.46 72.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.673 -1.156 . . . . 44.34 111.274 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.4 m -55.27 -46.57 76.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.08 1.309 . . . . 61.02 109.733 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.68 70.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.154 0.888 . . . . 62.13 111.576 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -62.47 -39.51 93.66 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.604 -1.31 . . . . 72.22 111.725 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.5 -42.77 56.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 116.008 -1.948 . . . . 62.55 109.285 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.79 -34.67 78.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 121.182 1.81 . . . . 74.44 108.967 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.27 82.21 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.922 -0.486 . . . . 43.45 110.895 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -76.95 -47.23 21.5 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.785 1.032 . . . . 75.11 113.785 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -138.06 89.13 14.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.061 1.744 . . . . 73.35 108.494 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.85 -22.27 36.78 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.626 2.217 . . . . 74.13 112.403 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.29 14.14 25.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.034 2.134 . . . . 62.03 113.588 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -120.02 156.8 30.19 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.158 -1.423 . . . . 72.0 107.158 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.519 HG11 ' CG ' ' A' ' 95' ' ' TYR . 15.7 m -121.92 138.2 28.37 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.353 1.061 . . . . 62.5 111.2 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.48 116.85 3.91 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.216 3.944 . . . . 75.12 112.347 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.21 146.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.745 1.218 . . . . 64.25 108.974 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.9 mt -122.31 128.26 75.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.165 -2.532 . . . . 74.43 104.165 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 120.81 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.643 1.577 . . . . 54.22 107.274 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -131.94 147.09 52.44 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.38 -0.971 . . . . 71.52 108.38 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.11 155.15 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.635 1.107 . . . . 64.12 111.078 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.55 130.89 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.453 -1.314 . . . . 55.51 107.453 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -62.3 130.24 44.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.266 -1.753 . . . . 73.31 106.266 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.9 -2.77 80.25 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 118.031 -1.427 . . . . 63.24 112.289 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -77.42 139.78 39.75 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.053 -2.203 . . . . 74.31 105.053 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.01 -28.2 68.05 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.4 1.48 . . . . 74.44 112.578 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -55.84 152.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.047 1.339 . . . . 74.44 111.431 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.14 134.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.46 1.104 . . . . 53.02 111.421 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.33 158.75 34.49 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.617 -1.253 . . . . 54.12 107.617 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.47 141.13 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.836 -1.172 . . . . 73.21 107.836 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.77 164.44 17.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.405 -0.961 . . . . 72.0 108.405 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 99.37 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.534 -2.765 . . . . 73.33 103.534 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -130.48 155.1 47.02 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.771 0.796 . . . . 70.21 109.499 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 38.1 mtmt -106.46 100.26 9.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.671 -1.233 . . . . 53.44 107.671 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.82 124.47 30.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.996 -1.113 . . . . 73.43 107.996 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.13 112.92 26.05 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.513 -0.921 . . . . 44.14 108.513 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -111.44 141.18 23.97 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 54.22 113.426 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.06 141.71 33.27 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 124.158 3.239 . . . . 55.3 112.216 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -18.43 60.94 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.831 1.049 . . . . 42.23 113.831 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.56 -34.48 70.02 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.906 1.379 . . . . 74.02 114.136 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -78.84 163.52 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.5 0.667 . . . . 73.44 110.219 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 p -104.65 167.78 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.357 1.063 . . . . 71.5 109.795 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.27 -35.31 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.021 -0.733 . . . . 74.33 109.021 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.1 -45.93 82.99 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.246 0.93 . . . . 64.21 109.911 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -68.0 -45.95 72.63 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.19 -0.67 . . . . 72.05 109.19 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.19 -52.0 67.58 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 119.067 -0.492 . . . . 75.24 111.038 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.8 ttp -57.69 -46.9 83.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.434 1.094 . . . . 74.03 110.347 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -59.25 -43.63 92.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.194 0.452 . . . . 74.02 110.785 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.48 -40.04 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 117.851 -1.071 . . . . 70.34 109.561 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.34 -50.22 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 120.611 1.55 . . . . 73.4 108.902 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -59.86 -39.15 84.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.025 -0.988 . . . . 72.4 111.402 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.79 -39.38 69.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 119.588 1.085 . . . . 61.42 110.828 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -62.96 -42.99 99.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.723 1.147 . . . . 73.43 110.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -79.22 -2.63 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.297 0.499 . . . . 74.43 109.7 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 55.47 61.02 3.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.01 2.124 . . . . 63.35 109.734 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.42 107.2 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.602 1.561 . . . . 73.05 109.935 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.97 156.1 66.41 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.485 2.124 . . . . 74.15 109.171 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -65.27 -20.79 66.58 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.183 -0.948 . . . . 71.52 112.703 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.6 -30.63 71.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.483 0.713 . . . . 73.14 110.453 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -103.72 164.9 11.38 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.009 1.324 . . . . 72.13 111.376 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.38 177.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.74 1.616 . . . . 71.3 108.093 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 tp -145.72 135.81 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.559 -1.645 . . . . 43.43 106.559 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -143.1 141.95 31.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.055 -1.461 . . . . 70.11 107.055 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.75 142.34 46.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.403 1.081 . . . . 54.32 108.109 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -144.3 123.66 13.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.294 -1.373 . . . . 72.52 107.294 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -130.21 131.3 65.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 117.046 -1.454 . . . . 65.33 107.255 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 47.89 30.82 2.07 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.519 1.508 . . . . 75.42 113.365 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mttp 64.74 29.11 12.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.235 -1.541 . . . . 71.34 110.61 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.9 p -132.7 161.8 33.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.104 2.562 . . . . 65.22 110.779 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.76 110.9 63.22 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.261 1.424 . . . . 73.33 109.118 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.09 124.81 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.361 2.04 . . . . 64.2 107.417 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -69.31 133.88 48.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.54 1.136 . . . . 72.34 109.655 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -62.72 -40.38 97.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 114.253 1.205 . . . . 51.15 114.253 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -21.62 59.08 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.97 -1.014 . . . . 54.21 113.093 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.95 142.8 58.31 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.268 1.395 . . . . 72.11 111.137 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 p -78.22 153.68 31.72 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.944 . . . . 73.43 110.004 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.1 mmt -59.36 -41.6 89.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.304 -0.855 . . . . 72.41 108.811 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.9 92.3 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.146 0.884 . . . . 73.53 112.964 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -49.76 52.77 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.064 0.932 . . . . 53.41 111.13 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.29 -48.01 81.83 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 123.527 0.731 . . . . 70.51 109.796 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.519 ' CG ' HG11 ' A' ' 29' ' ' VAL . 45.8 t80 -56.87 -52.99 62.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.13 1.372 . . . . 72.12 109.461 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.04 -47.38 84.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 118.971 -0.538 . . . . 74.4 111.964 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -32.74 67.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.373 0.988 . . . . 74.23 112.768 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -93.86 -5.84 47.12 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.683 1.129 . . . . 71.41 113.887 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -38.79 125.14 1.44 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.587 1.955 . . . . 65.21 113.727 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.91 163.47 16.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.927 0.891 . . . . 71.45 110.024 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.82 -29.26 26.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.465 1.106 . . . . 74.42 111.277 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -95.32 -33.88 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.481 1.112 . . . . 75.1 112.541 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.03 4.04 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 117.742 1.857 . . . . 75.21 117.742 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -96.27 178.99 5.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.366 2.083 . . . . 60.24 112.024 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tp -125.74 138.2 53.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.584 -0.722 . . . . 72.41 111.302 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -123.13 108.32 12.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.043 1.337 . . . . 64.34 109.561 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.98 145.11 20.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 122.332 1.063 . . . . 73.43 110.382 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.96 145.54 38.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.169 -0.923 . . . . 71.13 108.509 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -130.96 157.62 42.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.364 0.602 . . . . 65.33 109.863 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.1 p -148.28 161.82 40.75 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.408 -0.96 . . . . 75.52 108.408 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.14 17.85 16.65 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 117.959 -1.467 . . . . 65.33 114.136 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.285 -1.376 . . . . 72.43 107.285 -179.733 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.557 1.248 1 N-CA-C 122.043 4.09 . . . . 71.24 122.043 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.433 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 10.4 m95 50.67 66.14 1.25 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.479 3.112 . . . . 74.3 112.081 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -99.8 124.89 8.38 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.421 -1.872 . . . . 61.33 108.421 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 343' ' ' ILE . . . . . 0.432 HG12 ' HE3' ' A' ' 48' ' ' LYS . 61.5 mt -68.37 139.9 19.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.585 1.192 . . . . 74.3 108.212 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -141.72 112.21 7.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.071 1.748 . . . . 63.34 106.584 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.48 120.71 22.08 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.374 -2.084 . . . . 74.42 105.374 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.48 110.86 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.458 0.703 . . . . 73.41 111.934 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.1 p -144.48 127.5 16.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.338 1.055 . . . . 62.5 108.958 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 128.94 2.896 . . . . 74.4 114.56 179.549 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.5 m95 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 108.714 -0.847 . . . . 61.23 108.714 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 mmt -60.17 -34.14 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.398 -0.921 . . . . 61.22 110.749 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -60.23 -47.66 85.02 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.232 -0.917 . . . . 74.44 109.982 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -64.43 -32.67 74.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.827 -0.606 . . . . 65.01 110.227 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -60.21 -47.35 86.35 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.87 -1.159 . . . . 54.21 107.87 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.17 -76.26 0.16 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.648 0.779 . . . . 73.33 111.284 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.4 143.08 11.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 127.339 2.256 . . . . 54.12 109.615 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 t -122.89 -59.7 1.57 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.099 -0.953 . . . . 74.21 109.377 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.4 mt -45.42 -58.22 3.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.075 1.35 . . . . 74.52 114.235 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -64.86 -49.99 68.36 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.426 -0.796 . . . . 73.34 110.916 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -52.5 -55.43 22.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.319 1.012 . . . . 74.11 110.377 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -44.71 91.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.637 1.575 . . . . 63.45 111.041 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.51 -50.85 72.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.088 1.313 . . . . 72.41 111.702 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.458 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 74.6 t -69.1 -47.34 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.826 0.85 . . . . 61.42 111.772 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.4 -51.18 70.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.843 1.257 . . . . 62.11 109.443 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -63.63 -40.77 97.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.117 -0.944 . . . . 75.41 110.038 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -49.83 76.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.52 1.509 . . . . 53.41 110.175 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' CG1' ' A' ' 16' ' ' VAL . 50.6 mttm -61.45 -48.42 81.23 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.431 -0.793 . . . . 73.23 110.989 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.68 -41.77 85.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-O 117.564 -1.208 . . . . 75.45 110.403 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -63.51 -33.79 76.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.526 1.966 . . . . 73.12 109.138 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.18 51.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.496 0.589 . . . . 61.44 110.153 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -75.44 -46.34 33.2 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.165 1.172 . . . . 64.45 114.165 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -124.08 74.74 58.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.938 2.895 . . . . 75.44 112.022 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.59 -9.17 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.132 3.221 . . . . 64.14 110.96 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.66 12.53 27.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.171 2.188 . . . . 63.22 111.894 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -127.41 160.08 32.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.87 -1.144 . . . . 74.32 109.791 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.5 142.62 37.72 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.604 1.161 . . . . 61.11 108.909 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.64 119.02 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.669 1 C-N-CA 125.372 4.048 . . . . 75.34 112.185 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.1 t -126.46 148.87 31.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.184 0.994 . . . . 74.13 109.764 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.24 133.41 68.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.52 -2.4 . . . . 72.22 104.52 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.73 118.5 52.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.559 1.544 . . . . 74.24 108.888 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -130.56 153.91 48.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.864 -0.791 . . . . 74.42 108.864 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -93.06 158.38 15.81 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.143 -0.973 . . . . 74.3 110.503 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.06 119.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.545 -2.02 . . . . 74.54 105.545 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 p -54.68 110.8 0.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.968 1.707 . . . . 41.24 111.946 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.4 30.99 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.846 1.688 . . . . 72.45 113.422 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 p -63.95 146.38 54.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.136 1.468 . . . . 63.13 109.816 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -69.59 -0.62 7.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.797 1.639 . . . . 74.41 114.502 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -86.75 169.2 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 119.386 0.994 . . . . 75.13 109.738 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.9 155.72 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.526 1.13 . . . . 63.54 111.358 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.16 163.13 18.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.94 0.896 . . . . 72.05 111.032 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.42 124.5 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.745 1.618 . . . . 62.24 106.675 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.12 164.62 15.15 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.893 0.877 . . . . 55.43 110.175 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 101.51 4.28 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.981 -1.489 . . . . 75.35 106.981 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -134.44 161.79 34.03 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.934 1.294 . . . . 72.23 108.765 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 17.1 mttt -111.26 105.84 14.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.745 -1.946 . . . . 64.12 105.745 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -88.01 118.39 27.54 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.325 0.861 . . . . 73.53 113.325 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.57 108.29 20.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.32 2.248 . . . . 62.15 108.783 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.62 141.35 24.46 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.049 -0.977 . . . . 51.44 110.062 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.19 141.43 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.13 1.887 . . . . 62.51 111.582 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -62.51 -16.15 54.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.098 0.777 . . . . 72.41 113.098 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.72 -34.21 64.69 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.308 1.225 . . . . 71.13 114.308 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.8 168.94 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.206 0.912 . . . . 72.12 111.58 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.1 p -107.88 169.4 8.63 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.082 0.953 . . . . 45.2 111.605 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 60.2 t -55.86 -36.1 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.002 0.921 . . . . 62.4 109.193 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.25 93.81 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.411 1.005 . . . . 71.43 110.541 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -60.91 -46.49 90.44 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 108.15 -1.056 . . . . 73.52 108.15 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -59.65 -49.3 78.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.961 0.504 . . . . 74.44 110.464 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ttt -58.49 -44.15 89.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.329 1.452 . . . . 72.23 109.467 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -63.64 -39.5 94.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.318 0.508 . . . . 74.04 110.212 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.757 HG21 HG13 ' B' ' 346' ' ' VAL . 5.9 mt -67.05 -47.65 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 107.832 -1.173 . . . . 74.22 107.832 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.86 -50.83 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.66 1.118 . . . . 73.33 110.987 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.31 -41.92 97.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.558 -0.734 . . . . 75.54 110.894 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -69.21 -41.92 76.43 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.185 0.902 . . . . 71.21 111.165 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -58.88 -47.65 84.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.462 1.505 . . . . 72.12 110.825 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 pt -83.96 -0.87 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.069 0.395 . . . . 73.3 111.266 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 54.36 71.23 0.54 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 126.521 1.928 . . . . 75.11 108.095 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -82.6 104.96 4.02 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.271 -2.122 . . . . 73.01 105.271 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -66.31 165.53 24.34 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 124.232 3.288 . . . . 72.24 113.816 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -57.86 -37.91 74.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.418 1.087 . . . . 74.3 110.202 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -59.92 -38.64 82.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 116.859 -1.543 . . . . 74.35 113.906 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.51 162.4 13.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.306 1.412 . . . . 70.13 110.673 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.87 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.13 1.372 . . . . 44.34 108.807 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.0 tp -132.58 139.59 49.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.486 1.114 . . . . 61.13 108.225 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -137.7 120.15 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.619 -1.623 . . . . 74.41 106.619 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.79 140.18 49.12 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.931 1.692 . . . . 65.43 109.126 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -145.09 141.51 28.89 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.232 -1.025 . . . . 72.25 108.232 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.68 122.57 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 125.162 1.385 . . . . 74.32 107.681 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 t0 43.49 45.79 5.61 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.338 1.236 . . . . 73.34 114.338 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tptm 71.44 18.79 5.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.22 1.808 . . . . 65.44 114.37 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.4 p -129.18 162.38 27.93 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 120.081 1.31 . . . . 74.2 111.043 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.26 109.55 50.29 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 106.43 -1.693 . . . . 72.01 106.43 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 123.86 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 N-CA-C 107.573 -1.741 . . . . 64.52 107.573 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -69.96 121.5 17.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.685 -0.635 . . . . 63.41 110.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 76.6 p -47.65 -37.59 13.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.972 2.109 . . . . 72.44 114.045 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 m -75.92 -19.19 58.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.529 1.132 . . . . 73.31 113.968 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.06 144.64 53.93 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.174 0.897 . . . . 74.21 109.879 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.7 p -83.09 154.55 24.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.449 0.642 . . . . 72.32 109.677 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.84 -42.27 97.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.702 -0.666 . . . . 72.12 111.384 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.31 -43.13 98.88 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.193 -0.782 . . . . 62.04 111.744 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -68.49 -48.46 64.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.247 1.024 . . . . 72.01 109.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -57.43 -44.43 84.65 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.472 0.709 . . . . 64.53 110.308 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -61.07 -49.74 76.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.17 0.988 . . . . 75.22 108.546 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.09 -32.25 72.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.647 0.98 . . . . 74.14 113.647 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -25.84 18.93 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.971 1.471 . . . . 52.43 114.971 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.22 0.35 23.2 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.711 1.004 . . . . 60.1 113.711 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -48.21 135.17 13.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.355 0.979 . . . . 74.21 112.965 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.77 161.23 29.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.564 -0.902 . . . . 75.44 108.564 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -54.64 -29.94 53.66 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.403 1.481 . . . . 55.24 112.01 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -79.77 -33.1 40.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.145 0.578 . . . . 63.33 111.684 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.45 -6.86 4.97 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 117.434 1.734 . . . . 73.31 117.434 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.77 -179.61 3.7 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.805 2.042 . . . . 73.02 111.957 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.5 tp -123.68 143.63 50.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.395 0.543 . . . . 63.43 111.937 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -122.69 134.52 54.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 41.24 110.602 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.84 140.64 48.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 124.498 1.119 . . . . 53.24 108.264 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.01 149.04 40.93 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.575 -0.898 . . . . 42.33 108.575 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -139.73 159.9 41.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.929 0.871 . . . . 75.24 112.793 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.2 p -149.59 155.94 41.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.014 -1.847 . . . . 50.43 106.014 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 26.16 12.64 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.156 -0.778 . . . . 65.25 111.156 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 125.417 1.487 . . . . 75.14 107.026 -178.874 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 112.499 0.555 . . . . 73.43 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 341' ' ' TRP . . . . . 0.5 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 52.5 m95 54.02 63.91 2.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.754 1.622 . . . . 73.32 111.792 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.78 126.34 7.34 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.009 -2.436 . . . . 62.34 107.009 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.6 132.08 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.792 1.296 . . . . 73.53 108.016 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -129.9 149.5 51.61 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.227 1.011 . . . . 65.01 109.553 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.8 tt -111.39 114.35 27.43 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.679 1.592 . . . . 71.25 109.159 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.757 HG13 HG21 ' A' ' 63' ' ' ILE . 37.8 t -121.77 136.11 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.1 0.96 . . . . 43.31 111.401 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 160.41 28.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.152 1.781 . . . . 74.33 109.331 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 127.33 2.252 . . . . 71.31 107.32 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.6 m95 . . . . . 0 C--O 1.239 0.551 0 N-CA-C 108.814 -0.81 . . . . 73.24 108.814 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.476 ' HG2' ' HE2' ' A' ' 46' ' ' LYS . 16.3 tpt -62.01 -47.11 86.23 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.422 -0.955 . . . . 70.15 108.422 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -60.26 -41.04 92.42 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 119.116 -0.469 . . . . 64.32 111.369 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -64.38 -33.27 75.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.879 0.763 . . . . 74.11 109.476 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.18 -48.31 62.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.506 0.594 . . . . 74.45 110.15 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -75.0 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.178 0.991 . . . . 73.41 112.621 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 130.63 10.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.968 1.307 . . . . 72.31 107.989 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -124.22 -65.93 1.02 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.472 0.916 . . . . 61.13 113.472 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mt -48.49 -58.88 4.01 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.444 1.497 . . . . 62.54 114.539 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.49 -44.37 87.3 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.61 -0.681 . . . . 73.35 112.06 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -59.62 -40.02 86.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.055 0.942 . . . . 74.32 108.688 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -43.12 84.7 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-O 117.437 -1.268 . . . . 73.31 110.054 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.6 m -63.85 -47.01 82.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.182 1.356 . . . . 71.53 112.752 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.39 -47.13 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 O-C-N 121.736 -0.603 . . . . 75.35 109.637 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.04 -40.01 95.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 117.416 -1.278 . . . . 72.31 110.967 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -61.76 -47.45 85.12 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 121.15 1.795 . . . . 61.12 108.767 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.83 72.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.874 0.694 . . . . 74.02 112.874 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.0 -44.94 75.43 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.637 -0.664 . . . . 65.43 112.661 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.2 -41.89 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.296 -0.859 . . . . 73.31 110.237 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -66.15 -38.0 87.05 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.468 1.031 . . . . 70.22 109.484 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.63 78.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.094 -0.642 . . . . 64.22 110.601 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.39 -46.43 22.77 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.138 1.533 . . . . 62.23 115.138 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.15 72.12 55.37 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 127.064 2.146 . . . . 74.31 110.533 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.5 -19.31 48.91 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.778 2.318 . . . . 73.53 112.523 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -97.76 13.02 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.441 0.564 . . . . 63.51 110.871 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -118.54 155.4 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.989 -1.115 . . . . 63.14 107.989 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 27.12 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.879 -1.156 . . . . 72.51 107.879 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.59 122.15 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.98 3.787 . . . . 63.35 112.392 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.55 140.77 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.274 1.83 . . . . 74.52 111.82 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.68 136.76 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 105.764 -1.939 . . . . 75.32 105.764 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.87 110.58 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.99 0.813 . . . . 72.14 110.432 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -112.88 146.81 38.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.118 -1.067 . . . . 72.33 108.118 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 141.94 31.88 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.067 -1.021 . . . . 50.34 109.652 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.34 127.94 23.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.558 -1.275 . . . . 71.41 107.558 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.07 128.77 22.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.115 1.366 . . . . 63.33 109.636 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.1 42.28 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.58 -1.122 . . . . 72.22 113.934 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.19 109.23 2.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.319 -2.104 . . . . 44.11 105.319 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.73 -0.98 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.602 1.561 . . . . 72.05 114.792 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -68.39 163.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.139 -0.975 . . . . 72.12 109.043 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.83 129.68 14.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.219 1.407 . . . . 71.13 110.364 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -84.37 163.94 19.23 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.633 1.573 . . . . 64.2 108.444 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -125.41 135.57 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.871 -1.529 . . . . 63.42 106.871 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.83 165.15 8.97 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.304 0.573 . . . . 74.01 110.609 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE2' ' HG2' ' A' ' 4' ' ' MET . 10.2 mptt -73.88 103.19 4.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.089 -1.448 . . . . 70.0 107.089 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -136.62 158.28 44.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.953 2.101 . . . . 73.23 107.846 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.51 102.11 11.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 104.033 -2.58 . . . . 71.15 104.033 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -83.97 142.14 30.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.576 -1.268 . . . . 74.43 107.576 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD11 HG23 ' B' ' 343' ' ' ILE . 5.0 mp -129.97 123.35 30.43 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 117.921 -1.038 . . . . 74.12 108.844 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.57 143.01 28.11 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 117.787 -1.101 . . . . 73.33 112.785 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.81 141.28 48.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.268 1.978 . . . . 73.23 108.481 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 t -59.25 -12.68 5.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.936 2.494 . . . . 45.35 113.303 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.71 -27.16 17.42 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 115.528 1.677 . . . . 75.32 115.528 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.55 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.031 1.287 . . . . 74.31 110.184 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.9 p -107.28 160.17 15.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.987 0.915 . . . . 53.45 111.053 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.12 -38.13 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.458 1.503 . . . . 64.15 111.465 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.05 91.93 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.556 0.743 . . . . 72.23 110.778 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.62 -42.37 95.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.017 0.927 . . . . 73.44 109.742 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.45 -46.2 89.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.833 -0.803 . . . . 73.44 108.833 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.5 ttp -60.51 -42.36 96.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.574 0.75 . . . . 64.45 110.581 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -61.25 -40.31 93.61 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.49 0.716 . . . . 73.23 109.915 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.433 HG21 ' CG1' ' B' ' 346' ' ' VAL . 34.9 mt -66.18 -51.01 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 118.511 -0.757 . . . . 74.14 109.326 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.7 mt -55.15 -49.98 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.142 0.883 . . . . 72.22 110.339 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.54 -38.71 88.42 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.017 -1.052 . . . . 74.42 111.328 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.712 0.687 . . . . 65.13 110.063 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -61.83 -51.33 68.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.507 1.123 . . . . 72.33 109.888 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.11 5.86 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.002 0.371 . . . . 74.02 112.002 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 46.21 63.4 1.87 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 127.634 2.374 . . . . 70.43 110.651 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 108.58 3.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.97 1.308 . . . . 71.4 110.877 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.31 158.65 36.98 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.116 3.21 . . . . 62.21 110.955 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -26.78 55.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.801 0.84 . . . . 54.44 112.757 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.91 -34.48 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.153 0.981 . . . . 64.31 111.501 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 164.29 11.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.912 1.233 . . . . 53.15 108.106 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.65 175.27 5.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.628 1.171 . . . . 73.23 107.98 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -148.34 130.12 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.512 0.725 . . . . 75.24 111.617 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -141.53 148.28 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.454 1.101 . . . . 74.12 110.213 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.9 152.18 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.569 1.948 . . . . 64.31 108.098 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -144.42 126.87 15.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.444 1.498 . . . . 71.11 108.347 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 85' ' ' PRO . 14.6 p -126.66 124.55 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.326 1.05 . . . . 70.33 108.457 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 43.83 38.44 2.1 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.162 1.385 . . . . 73.42 113.898 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttm 65.05 39.94 5.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.83 2.052 . . . . 74.14 111.063 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 p -141.25 156.61 45.87 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.163 0.985 . . . . 72.12 110.048 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.07 104.0 33.49 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 102.837 -3.023 . . . . 63.2 102.837 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.423 ' HD3' HG12 ' A' ' 80' ' ' VAL . 55.1 Cg_endo -68.59 147.18 69.71 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.554 2.17 . . . . 75.34 110.722 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -70.69 120.89 16.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.799 -1.185 . . . . 62.31 107.799 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 p -51.84 -34.92 42.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.374 1.469 . . . . 52.13 113.813 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -83.68 -6.42 59.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.36 0.874 . . . . 53.3 113.36 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.73 144.58 54.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.678 1.126 . . . . 75.11 108.141 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.17 149.88 25.87 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.888 -0.782 . . . . 64.41 108.888 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.57 -50.75 64.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.264 1.025 . . . . 54.4 112.249 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.67 96.97 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 118.854 0.752 . . . . 75.34 112.378 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -62.07 -53.39 56.14 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.833 0.853 . . . . 74.42 109.261 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.02 -44.92 87.57 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.993 0.917 . . . . 71.54 110.231 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -60.31 -51.97 67.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.611 1.164 . . . . 73.42 108.994 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -35.91 74.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.205 -0.902 . . . . 62.53 112.747 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -24.41 20.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.735 -1.126 . . . . 74.43 113.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -107.21 5.3 27.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.566 1.076 . . . . 74.5 112.993 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -48.82 127.65 14.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.22 1.808 . . . . 72.45 113.513 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.46 175.22 10.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.49 0.716 . . . . 73.42 109.121 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -60.53 -30.47 69.77 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.225 -1.547 . . . . 75.15 110.886 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.28 16.78 12.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.502 1.121 . . . . 61.35 112.283 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.06 28.59 69.14 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.198 -1.335 . . . . 64.44 114.946 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -126.42 177.05 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.647 1.724 . . . . 73.1 111.472 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -123.43 135.32 54.04 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.491 1.116 . . . . 74.23 109.986 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -122.66 127.64 49.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.189 1.396 . . . . 70.11 107.698 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.3 t -129.2 149.02 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 120.505 -1.372 . . . . 70.42 109.457 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.68 150.97 37.29 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.753 -1.573 . . . . 64.15 106.753 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.27 151.92 46.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.097 0.862 . . . . 64.24 111.324 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.2 p -142.88 171.83 13.52 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.451 0.643 . . . . 72.23 111.262 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.62 9.18 21.89 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.597 1.57 . . . . 72.44 112.308 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.45 -0.443 0 C-N-CA 126.343 1.857 . . . . 73.32 107.968 -178.982 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 119.542 -0.266 . . . . 64.42 110.761 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 18.3 m95 52.93 55.93 8.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.0 0.92 . . . . 74.34 110.316 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.49 128.35 8.44 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.308 -1.517 . . . . 62.42 109.308 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 343' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 50' ' ' LEU . 93.8 mt -61.94 133.62 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 126.903 2.081 . . . . 74.11 106.914 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.84 104.82 5.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.074 -1.454 . . . . 74.44 107.074 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.5 114.76 19.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.632 1.173 . . . . 73.24 107.882 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 63' ' ' ILE . 53.5 t -122.04 150.42 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.426 1.091 . . . . 72.11 110.723 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -162.89 161.72 25.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.904 2.482 . . . . 62.34 107.04 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.657 -1.609 . . . . 74.31 106.657 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 105.399 -2.074 . . . . 71.13 105.399 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 46' ' ' LYS . 9.5 mtp -56.38 -46.29 80.16 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.966 -0.754 . . . . 72.03 108.966 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -57.18 -43.56 82.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.458 0.703 . . . . 71.02 112.401 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -37.73 87.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.469 0.577 . . . . 72.4 110.689 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -67.37 -48.2 68.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.487 -0.931 . . . . 75.22 108.487 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.84 -76.9 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.118 1.767 . . . . 53.54 113.092 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.75 120.13 2.32 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.207 2.203 . . . . 73.55 108.692 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -131.48 -35.17 1.33 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 116.979 -1.486 . . . . 74.01 114.119 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.67 -60.4 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 121.872 2.124 . . . . 71.32 112.214 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.86 -32.58 73.95 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.519 -0.738 . . . . 73.33 110.721 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -57.09 -59.23 5.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.033 -1.099 . . . . 73.54 108.033 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -39.65 95.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.589 1.156 . . . . 73.22 109.691 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -56.05 -58.03 9.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.758 1.163 . . . . 65.35 111.658 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.95 -42.99 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.83 0.852 . . . . 74.03 110.106 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.21 -47.64 84.6 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.523 -0.751 . . . . 75.41 109.96 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.7 t -58.53 -49.6 76.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.139 -1.06 . . . . 73.34 108.139 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.49 73.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.98 0.809 . . . . 73.02 112.771 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.74 -39.25 84.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 O-C-N 120.535 -1.353 . . . . 74.21 112.17 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.8 -42.13 82.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 O-C-N 120.762 -1.211 . . . . 73.05 108.897 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -67.07 -32.36 73.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.7 1.136 . . . . 74.55 110.96 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.0 -47.49 24.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.238 -0.411 . . . . 60.43 110.529 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -78.49 -44.03 25.49 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.591 1.701 . . . . 75.11 115.591 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.73 72.86 81.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.598 1.959 . . . . 73.44 109.789 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.41 -26.09 76.51 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.433 2.089 . . . . 64.2 111.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.37 12.07 17.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.161 -0.447 . . . . 64.44 111.564 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -123.46 139.07 54.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.737 1.153 . . . . 73.42 108.213 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -107.18 143.83 27.92 Favored Pre-proline 0 C--O 1.249 1.026 0 C-N-CA 123.703 0.801 . . . . 64.12 110.374 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.52 117.37 3.38 Favored 'Trans proline' 0 C--N 1.355 0.903 1 C-N-CA 125.888 4.392 . . . . 50.43 112.885 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 146.91 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.397 1.079 . . . . 73.44 110.611 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.16 135.41 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 104.459 -2.423 . . . . 72.0 104.459 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -123.13 111.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.443 -1.688 . . . . 51.0 106.443 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -128.13 150.42 49.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.195 0.452 . . . . 74.34 110.788 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.76 132.91 34.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.019 -0.734 . . . . 74.11 109.019 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.83 116.86 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.72 -1.585 . . . . 75.24 106.72 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 m -53.76 125.34 18.08 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.8 0.727 . . . . 43.24 109.683 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.97 -3.18 35.58 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.285 1.421 . . . . 72.15 112.642 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.8 m -89.92 127.69 36.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.9 1.35 . . . . 71.35 108.288 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.57 -18.87 62.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 118.453 -0.784 . . . . 61.42 111.708 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.46 156.51 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.065 0.848 . . . . 74.31 111.158 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.0 m -52.28 125.76 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.656 0.782 . . . . 63.34 109.996 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.38 172.47 9.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.603 1.161 . . . . 74.44 108.876 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -125.85 150.88 31.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 123.766 0.826 . . . . 75.4 110.415 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.34 165.37 24.63 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.788 -1.56 . . . . 52.45 106.788 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 4' ' ' MET . 1.0 OUTLIER -74.76 105.75 5.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.03 -1.841 . . . . 74.3 106.03 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -134.11 163.74 28.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.873 0.844 . . . . 72.14 112.508 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -105.55 106.95 17.69 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 103.001 -2.962 . . . . 75.33 103.001 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.04 127.05 37.37 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.604 -1.628 . . . . 74.31 106.604 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.45 112.55 21.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.897 1.679 . . . . 62.55 108.092 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 142.83 27.7 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-N 119.565 1.075 . . . . 62.15 110.525 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.91 132.32 21.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.317 2.012 . . . . 75.12 108.698 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -58.73 -12.61 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.441 1.897 . . . . 63.14 113.123 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.99 -34.46 50.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 60.22 114.141 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 170.49 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.734 1.012 . . . . 62.41 113.734 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -102.63 167.35 9.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.998 1.719 . . . . 73.32 112.529 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.23 -35.87 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.965 0.906 . . . . 72.14 109.247 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.25 91.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.901 0.773 . . . . 64.44 110.362 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -63.85 -45.76 88.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.746 -0.835 . . . . 75.5 108.746 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD2' HG11 ' A' ' 51' ' ' VAL . 6.2 t80 -59.64 -48.91 79.79 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.8 -0.444 . . . . 73.54 109.8 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.9 ttt -55.89 -51.98 65.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.365 1.466 . . . . 74.41 110.114 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -58.27 -41.64 84.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.727 0.811 . . . . 73.5 109.042 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.583 HG21 HG13 ' B' ' 346' ' ' VAL . 21.1 mt -66.87 -45.2 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 120.828 1.649 . . . . 75.32 109.323 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.59 -50.81 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 120.588 1.54 . . . . 61.24 110.554 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -31.91 73.12 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.161 -0.962 . . . . 74.33 111.531 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -68.95 -48.51 63.03 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.537 -0.542 . . . . 74.42 109.537 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -59.98 -51.38 69.89 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 126.926 2.091 . . . . 75.42 111.51 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.23 3.65 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 122.379 -0.2 . . . . 74.5 110.961 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 44.24 63.34 1.67 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 126.849 2.06 . . . . 71.31 109.503 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.22 111.19 5.98 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.993 -1.114 . . . . 71.11 107.993 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.71 165.43 27.67 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 125.177 3.918 . . . . 75.51 114.309 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -26.67 67.66 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.356 0.662 . . . . 54.34 111.411 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.64 -47.07 79.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.347 0.869 . . . . 70.31 113.347 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -100.3 165.35 11.51 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.169 0.895 . . . . 72.14 113.158 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.05 -178.63 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.596 1.958 . . . . 43.14 107.148 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 tp -137.47 135.55 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.664 -1.606 . . . . 70.43 106.664 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.79 130.25 33.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.705 -1.591 . . . . 74.21 106.705 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.43 146.32 40.77 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.084 1.754 . . . . 72.41 107.821 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.62 128.28 19.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.893 1.277 . . . . 64.4 108.501 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.23 123.83 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 107.632 -1.248 . . . . 63.25 107.632 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 47.92 38.27 8.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.11 0.964 . . . . 73.2 111.813 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 23.05 11.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.272 1.429 . . . . 72.15 112.947 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 162.8 21.32 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.978 1.711 . . . . 54.54 112.352 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.14 103.46 12.07 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.823 2.449 . . . . 75.32 106.901 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.37 123.68 7.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.75 2.3 . . . . 74.4 111.887 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 88' ' ' SER . 8.4 tt0 -63.81 127.62 32.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.569 -1.271 . . . . 64.32 107.569 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.4 p -57.23 -28.44 62.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.246 1.419 . . . . 74.13 112.881 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.468 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 25.1 t -85.24 -4.79 59.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.387 1.475 . . . . 53.24 112.064 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.5 tp -76.51 143.93 40.11 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.439 -1.413 . . . . 74.04 107.632 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 m -84.85 152.42 23.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.456 -0.572 . . . . 52.45 109.456 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.64 -51.89 67.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.149 0.98 . . . . 74.14 110.198 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.63 -45.02 60.23 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.528 0.604 . . . . 51.43 111.655 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -66.97 -49.11 66.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.63 0.772 . . . . 72.11 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.91 -42.39 97.96 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.641 -0.662 . . . . 73.01 110.476 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.07 -57.89 8.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.949 1.699 . . . . 75.0 109.455 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.07 -27.69 69.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 118.56 -0.733 . . . . 73.01 112.868 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -38.85 12.75 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.863 -1.065 . . . . 74.03 113.118 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -88.02 -8.78 55.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 117.838 -1.077 . . . . 41.4 113.123 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -33.32 120.83 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.399 1.629 . . . . 63.22 115.399 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.84 177.21 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.057 1.743 . . . . 72.42 109.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -35.1 56.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.025 -1.672 . . . . 73.4 112.056 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -95.62 10.9 35.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.747 1.219 . . . . 74.42 111.786 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.73 60.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.462 1.506 . . . . 61.34 115.151 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -105.07 163.67 12.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.031 1.415 . . . . 64.42 109.133 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.9 tp -120.67 134.81 55.25 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.352 0.661 . . . . 63.04 109.709 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.71 121.91 37.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.889 0.876 . . . . 74.44 108.982 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.07 137.9 54.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 107.826 -1.176 . . . . 71.11 107.826 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.06 152.1 29.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.224 1.01 . . . . 64.42 108.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -140.24 161.19 38.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.556 0.947 . . . . 64.41 113.556 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.4 t -159.05 173.35 16.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.956 1.702 . . . . 72.43 108.947 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.24 17.26 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.65 2.548 . . . . 63.31 112.493 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 C--O 1.235 0.329 0 C-N-CA 126.326 1.85 . . . . 75.23 109.196 -178.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 119.308 -0.377 . . . . 71.43 111.545 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 62.9 m95 58.15 66.03 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.209 1.404 . . . . 72.34 110.362 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -83.98 136.12 14.49 Favored Glycine 0 C--N 1.344 0.996 0 O-C-N 121.535 -0.728 . . . . 73.32 111.387 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.35 125.28 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.46 1.904 . . . . 72.12 107.722 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -139.88 130.03 25.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.283 1.033 . . . . 75.34 108.249 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.14 127.11 52.75 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.201 -0.937 . . . . 73.05 110.579 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 63' ' ' ILE . 1.9 t -121.48 117.52 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 125.05 1.34 . . . . 63.44 107.812 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 22.8 p -162.15 126.39 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 104.943 -2.243 . . . . 51.44 104.943 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.135 2.174 . . . . 52.15 111.899 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 17.1 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.787 -0.82 . . . . 65.24 108.787 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . 164.63 169.19 27.89 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.031 -2.028 . . . . 71.4 108.031 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -103.21 105.51 15.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.894 0.854 . . . . 64.02 109.143 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tpt -55.97 -46.74 78.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 113.941 -1.481 . . . . 75.24 109.35 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -59.01 -50.32 74.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.046 0.938 . . . . 75.31 111.747 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -65.05 -27.31 68.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.549 1.539 . . . . 71.12 111.672 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.67 -47.94 28.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.536 -0.913 . . . . 64.22 108.536 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -74.95 0.15 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.58 1.152 . . . . 72.55 113.086 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -158.98 122.26 3.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 105.815 -1.92 . . . . 63.14 105.815 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -130.73 -65.14 0.8 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.66 -1.162 . . . . 73.34 112.686 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.5 mt -39.85 -57.12 1.64 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.562 1.689 . . . . 74.44 115.562 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.38 -52.71 51.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.254 -0.904 . . . . 64.23 110.073 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.553 ' CD2' HH21 ' A' ' 14' ' ' ARG . 6.6 t60 -54.37 -55.22 30.8 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.315 1.446 . . . . 74.22 111.39 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.553 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.0 mmp_? -58.53 -39.88 81.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 116.495 -1.717 . . . . 71.01 109.031 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -60.64 -55.38 33.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.246 1.384 . . . . 65.43 111.26 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.67 -47.88 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 117.974 0.352 . . . . 74.25 111.267 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -62.08 -39.88 93.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.626 -0.702 . . . . 72.21 110.805 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 t -59.73 -46.78 88.09 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.56 -1.274 . . . . 74.24 107.56 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.63 86.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.487 1.039 . . . . 55.4 112.251 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.23 -47.71 83.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.321 0.51 . . . . 71.2 110.747 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.13 -42.36 96.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 C-N-CA 123.923 0.889 . . . . 71.03 110.322 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -67.6 -40.26 84.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.955 1.252 . . . . 72.11 109.29 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.07 68.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.771 -0.58 . . . . 62.34 111.053 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -77.55 -46.72 21.44 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.599 0.963 . . . . 74.14 113.599 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -119.94 71.95 16.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.305 1.842 . . . . 72.34 111.024 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.28 -25.4 49.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.139 1.893 . . . . 71.0 112.644 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.21 11.92 21.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.488 0.715 . . . . 61.24 111.265 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -115.92 158.76 22.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.318 1.417 . . . . 74.04 109.539 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 m -119.68 129.92 25.11 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.621 1.568 . . . . 72.41 108.171 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.76 111.66 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.18 3.92 . . . . 74.32 112.694 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.12 151.45 20.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.306 1.442 . . . . 74.22 111.206 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.58 133.39 68.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 103.166 -2.901 . . . . 74.13 103.166 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.31 121.77 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.362 -0.828 . . . . 74.25 110.516 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.6 151.09 46.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.191 0.905 . . . . 61.34 111.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 123.46 31.75 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.764 1.626 . . . . 73.52 108.931 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.58 128.55 33.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.81 -1.552 . . . . 71.12 106.81 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 p -61.95 147.63 46.32 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.905 0.859 . . . . 72.03 112.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.91 -20.68 45.93 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 116.375 -2.347 . . . . 74.32 116.415 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 160.9 25.06 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 122.041 2.921 . . . . 72.13 110.668 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.86 -13.0 61.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.953 2.205 . . . . 62.42 116.953 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.07 162.59 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 120.595 1.543 . . . . 64.34 114.548 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.2 152.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.173 1.389 . . . . 73.12 109.578 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -81.1 169.15 17.79 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.016 0.526 . . . . 74.42 111.417 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -125.61 142.0 43.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.961 1.305 . . . . 73.14 111.485 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.12 161.49 30.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.889 2.076 . . . . 71.44 107.986 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -84.2 98.26 9.84 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.768 -2.308 . . . . 75.31 104.768 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 13.5 mmm180 -136.02 159.13 42.64 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.763 0.71 . . . . 73.23 111.459 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HE3' HG12 ' B' ' 343' ' ' ILE . 2.4 mtmp? -106.25 99.01 8.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.583 1.553 . . . . 71.42 107.064 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.43 120.76 26.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.922 0.889 . . . . 70.44 110.337 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.79 105.46 14.69 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.972 1.309 . . . . 71.53 108.021 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.51 143.16 27.23 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-O 118.227 -0.892 . . . . 72.53 112.143 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.16 138.82 57.92 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.369 2.046 . . . . 64.43 110.329 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.0 p -63.61 -15.75 59.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.803 1.641 . . . . 62.1 112.431 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -75.07 -35.59 61.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.027 1.731 . . . . 74.11 113.712 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.06 165.54 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.866 0.841 . . . . 73.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -99.87 165.35 11.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.783 0.833 . . . . 62.5 110.905 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.25 -35.6 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.676 1.19 . . . . 75.23 108.143 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.77 88.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.966 1.306 . . . . 74.34 110.447 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.97 -45.63 66.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.373 -0.822 . . . . 64.43 110.006 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 6.4 t80 -59.07 -48.54 81.21 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.858 0.754 . . . . 70.41 109.483 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.2 ttp -55.19 -51.37 66.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.766 0.826 . . . . 75.02 109.949 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.96 -38.94 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.432 -0.318 . . . . 72.14 110.436 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' B' ' 346' ' ' VAL . 38.0 mt -66.38 -43.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 116.997 -1.477 . . . . 73.45 110.367 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 83.8 mt -58.86 -50.81 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.636 1.562 . . . . 65.12 108.417 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -61.93 -39.62 92.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.91 -0.716 . . . . 74.52 112.616 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -66.93 -40.39 87.58 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.246 0.93 . . . . 74.14 110.392 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.43 -47.24 86.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 121.348 -0.845 . . . . 71.42 110.054 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -81.48 -1.24 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.837 0.68 . . . . 74.51 112.837 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 57.5 58.04 4.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.346 2.258 . . . . 73.23 112.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.27 108.13 2.55 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.073 0.949 . . . . 75.23 111.644 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.08 156.67 64.4 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 51.14 111.296 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.1 m -63.29 -13.97 44.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.696 -0.668 . . . . 74.44 112.463 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -37.37 76.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.863 1.21 . . . . 71.55 109.686 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -103.25 164.25 11.75 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.508 1.049 . . . . 70.52 111.059 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.18 170.79 7.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.044 1.738 . . . . 64.41 106.843 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 tt -151.62 129.78 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.915 -1.143 . . . . 75.22 107.915 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.26 147.76 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.889 1.275 . . . . 62.11 109.145 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.9 mt -114.16 154.59 27.57 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.152 1.381 . . . . 71.13 109.435 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -145.15 139.83 27.54 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.797 1.239 . . . . 70.44 108.533 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.37 128.81 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 106.035 -1.839 . . . . 73.42 106.035 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 45.96 37.13 3.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.447 1.022 . . . . 75.22 112.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.0 tptt 68.02 22.1 8.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.571 0.952 . . . . 74.21 113.571 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 p -127.28 162.16 26.89 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.985 1.714 . . . . 52.2 111.191 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.56 108.01 53.78 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 104.096 -2.557 . . . . 73.3 104.096 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.09 148.72 51.08 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.877 1.718 . . . . 74.4 111.881 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.41 117.97 16.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.94 1.296 . . . . 73.11 108.329 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 p -51.28 -38.79 54.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.134 1.373 . . . . 64.14 112.953 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -74.36 -12.36 60.5 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.755 1.02 . . . . 72.1 113.755 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.61 150.62 47.77 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.552 -1.343 . . . . 73.12 109.631 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.92 26.57 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.162 0.985 . . . . 60.43 110.798 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.8 mmt -57.2 -47.33 81.55 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.841 0.856 . . . . 74.33 111.063 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.58 96.59 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.526 -0.597 . . . . 61.31 113.138 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -67.76 -51.0 54.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.948 0.874 . . . . 75.31 110.508 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.47 -35.84 80.61 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.068 -0.716 . . . . 71.15 109.068 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -66.26 -57.19 8.09 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.428 -0.796 . . . . 72.53 108.906 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.7 -41.97 87.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.43 1.013 . . . . 74.32 112.734 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -32.9 65.48 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 118.398 -0.811 . . . . 73.03 111.73 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.59 7.09 44.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.071 0.85 . . . . 73.41 112.584 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.29 119.54 3.04 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 126.783 2.033 . . . . 61.1 109.13 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.54 175.69 9.59 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.725 0.639 . . . . 72.13 112.725 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.15 -25.41 61.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.172 1.389 . . . . 75.34 110.498 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.42 4.98 39.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.215 1.806 . . . . 73.23 111.248 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.23 28.93 69.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.511 -1.16 . . . . 72.41 114.78 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -123.78 168.62 12.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.352 1.576 . . . . 64.34 109.125 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tp -122.02 139.97 53.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.511 1.124 . . . . 74.32 110.58 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -113.84 115.72 28.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.305 1.442 . . . . 74.34 109.489 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.54 131.53 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 O-C-N 120.746 -1.221 . . . . 54.1 108.592 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.59 151.83 31.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.983 -1.117 . . . . 74.34 107.983 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -131.04 154.42 48.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.607 0.363 . . . . 74.55 110.588 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.8 m -140.39 155.1 46.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.489 -0.93 . . . . 61.02 108.489 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.28 27.07 13.2 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.69 1.138 . . . . 43.15 111.509 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -143.8 152.32 41.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.341 2.656 . . . . 72.33 106.473 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -89.3 -28.21 20.02 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.114 0.566 . . . . 62.44 111.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.92 108.59 14.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.987 -1.486 . . . . 74.41 106.987 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -79.74 7.85 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.324 1.45 . . . . 72.12 111.888 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 104.417 -3.473 . . . . 63.33 104.417 -178.296 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.027 -1.229 . . . . 42.12 110.027 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 40.72 60.73 1.85 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.399 1.88 . . . . 72.22 112.065 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 70.8 mtm -82.73 48.17 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.759 0.824 . . . . 64.21 109.147 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.16 52.54 0.13 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 130.21 3.404 . . . . 72.42 110.082 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 37.0 pt -49.66 144.33 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.453 1.501 . . . . 45.44 111.266 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 1.4 pp -73.39 -0.43 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.046 0.539 . . . . 71.43 111.646 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -102.16 26.55 7.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.328 2.251 . . . . 60.25 113.463 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -54.28 124.01 14.59 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.529 1.058 . . . . 70.34 109.183 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.53 -59.42 2.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.289 0.95 . . . . 74.31 108.562 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.75 122.29 28.91 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 105.483 -2.043 . . . . 73.23 105.483 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.58 -61.92 1.67 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.24 1.941 . . . . 70.12 116.24 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 73.2 m95 67.43 65.0 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.539 1.518 . . . . 73.44 112.106 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.23 139.08 19.4 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.91 -1.276 . . . . 54.24 109.91 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' ILE . . . . . 0.439 HG12 ' HE3' ' A' ' 48' ' ' LYS . 24.3 mt -75.43 134.7 28.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 118.444 1.122 . . . . 73.14 111.317 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -140.7 114.4 8.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.313 0.645 . . . . 74.35 111.582 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.56 120.03 24.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 105.544 -2.021 . . . . 63.2 105.544 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 63' ' ' ILE . 92.5 t -122.4 142.38 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.404 0.682 . . . . 75.4 109.621 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.7 p -161.95 149.0 14.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.646 1.578 . . . . 24.33 107.777 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.356 2.262 . . . . 65.41 105.379 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tpt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.248 -0.649 . . . . 74.35 109.248 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.65 136.16 0.31 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.788 1.185 . . . . 65.0 114.197 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -106.92 105.77 15.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.176 0.99 . . . . 65.34 109.437 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -45.68 75.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.423 0.63 . . . . 74.11 110.845 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -60.07 -42.35 94.37 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.53 -0.731 . . . . 75.42 112.208 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -70.3 -32.02 69.61 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.043 0.537 . . . . 72.23 109.909 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.14 -47.94 69.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.279 -1.008 . . . . 72.52 108.279 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -71.1 -76.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.422 1.889 . . . . 72.22 111.485 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.94 126.24 3.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.695 1.198 . . . . 64.02 108.101 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -124.02 -65.6 1.05 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 116.562 -1.685 . . . . 63.21 112.664 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 tp -42.46 -58.33 2.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.457 1.481 . . . . 65.02 114.159 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -60.16 -52.05 66.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.562 0.696 . . . . 72.34 110.632 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.1 -49.1 69.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.318 1.847 . . . . 74.14 111.599 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -39.82 91.61 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.018 1.727 . . . . 64.34 109.458 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.3 m -61.42 -47.18 86.93 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.656 1.116 . . . . 61.42 110.753 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.21 -47.29 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.04 -1.038 . . . . 72.04 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 21' ' ' ILE . 37.4 tt0 -58.29 -52.0 67.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.76 1.224 . . . . 70.53 111.615 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 t -61.04 -48.4 81.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.873 0.869 . . . . 73.3 109.926 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.87 -47.74 73.85 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.147 0.885 . . . . 62.23 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.04 -41.61 77.44 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.53 -0.731 . . . . 60.53 111.552 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 17' ' ' GLU . 68.8 mt -64.47 -41.33 92.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.008 -0.996 . . . . 70.14 108.947 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -63.45 -41.44 98.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 120.284 1.402 . . . . 62.31 108.473 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.22 72.74 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.452 0.538 . . . . 62.35 112.452 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -76.82 -46.21 25.72 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 114.191 1.182 . . . . 64.23 114.191 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -133.79 79.22 58.85 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 125.02 1.328 . . . . 64.25 111.101 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 -20.38 47.96 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.525 1.484 . . . . 41.02 109.675 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.47 12.33 16.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.971 1.308 . . . . 62.44 112.4 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -127.75 141.41 51.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 119.196 0.907 . . . . 63.42 108.672 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.32 137.29 19.88 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 54.21 108.01 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.76 111.93 2.59 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.671 3.581 . . . . 74.24 113.843 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.89 135.6 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.458 1.103 . . . . 51.03 110.65 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.86 115.14 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 104.454 -2.424 . . . . 71.55 104.454 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.56 126.79 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.629 1.172 . . . . 73.44 109.284 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.82 149.13 48.86 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.378 1.071 . . . . 74.32 109.651 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -83.73 141.15 31.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.234 -1.025 . . . . 71.4 108.234 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.23 124.55 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 103.093 -2.929 . . . . 45.3 103.093 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.0 141.24 54.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.646 -0.659 . . . . 64.41 110.283 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.0 -1.84 78.44 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 116.13 -2.483 . . . . 61.34 113.655 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -83.95 145.07 28.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 121.575 2.688 . . . . 65.34 109.283 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.03 -20.16 64.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.976 1.71 . . . . 70.32 112.108 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.59 158.23 3.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.321 1.057 . . . . 70.22 113.441 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.52 134.54 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.129 -1.804 . . . . 74.34 106.129 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.24 171.98 14.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.859 1.664 . . . . 74.24 109.058 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 tt -126.64 152.02 33.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 123.742 0.817 . . . . 64.24 110.431 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.43 161.53 27.91 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.022 1.329 . . . . 73.05 109.141 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -77.89 91.05 4.13 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 14.3 mmm180 -131.34 151.92 51.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 106.548 -1.649 . . . . 72.41 106.548 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -99.98 106.35 18.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.729 -1.211 . . . . 64.33 107.729 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -87.98 121.07 29.95 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 122.401 1.096 . . . . 64.14 113.072 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.92 112.52 24.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.762 2.025 . . . . 73.1 108.246 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 m -111.34 142.03 25.62 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.074 -0.965 . . . . 75.23 110.704 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.02 139.25 38.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 120.86 1.343 . . . . 61.04 110.889 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 p -65.57 -12.77 56.04 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.85 1.26 . . . . 62.14 112.145 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.88 -35.37 43.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.166 1.786 . . . . 70.12 113.965 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -74.53 170.24 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.957 0.884 . . . . 73.43 111.444 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 p -97.8 162.84 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.896 1.278 . . . . 65.25 111.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.21 -35.28 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.368 1.067 . . . . 64.03 108.129 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.31 90.25 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.82 0.848 . . . . 50.43 109.682 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -62.95 -46.06 89.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.182 -0.673 . . . . 75.03 109.182 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.38 -51.08 71.46 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.983 -0.377 . . . . 65.43 109.983 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.42 -47.99 72.15 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.596 1.158 . . . . 62.41 109.619 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -59.79 -44.67 93.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.594 -0.521 . . . . 75.34 109.594 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.6 mt -62.95 -40.28 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.63 -1.176 . . . . 74.14 109.453 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.17 -50.15 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.955 1.707 . . . . 74.24 108.906 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -63.66 -35.25 79.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.787 0.722 . . . . 54.55 111.16 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -66.89 -43.61 82.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.794 0.724 . . . . 64.34 109.198 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.59 -49.16 78.64 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.866 1.266 . . . . 71.33 111.341 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -80.39 0.65 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.026 0.204 . . . . 71.32 110.781 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 49.46 64.4 1.76 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.618 1.967 . . . . 73.43 110.016 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.14 111.39 7.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.296 1.438 . . . . 54.23 111.01 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.66 152.9 69.91 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.998 2.465 . . . . 73.11 109.94 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 m -62.2 -15.38 46.12 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.809 1.04 . . . . 60.54 113.809 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.16 -32.07 66.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.516 0.726 . . . . 73.25 110.431 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.37 164.33 11.71 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 122.073 0.94 . . . . 72.14 109.861 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.28 4.79 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.934 1.694 . . . . 74.2 107.49 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 tp -139.63 138.23 39.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.99 -1.855 . . . . 41.32 105.99 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -144.08 133.14 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.371 1.469 . . . . 75.11 107.17 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.5 mt -114.61 151.42 33.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.407 1.083 . . . . 52.02 108.172 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.0 142.49 29.83 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.709 1.204 . . . . 75.44 109.565 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.66 124.8 20.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 117.148 -1.406 . . . . 64.03 107.347 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 46.35 38.45 5.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 120.358 1.435 . . . . 72.03 110.882 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt 64.57 18.68 11.5 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.286 -1.509 . . . . 71.15 113.588 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 p -119.48 162.76 18.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.435 2.294 . . . . 65.03 111.234 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 t -101.39 107.84 52.61 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.97 1.308 . . . . 63.24 107.966 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.17 140.49 45.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.158 2.572 . . . . 74.3 109.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -77.63 121.81 24.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.506 0.722 . . . . 73.24 110.945 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.1 p -52.58 -35.45 54.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.758 1.223 . . . . 73.11 114.159 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -77.84 -17.3 57.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.624 0.972 . . . . 54.23 113.624 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.14 149.81 49.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.803 1.183 . . . . 54.1 109.787 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.6 p -85.98 152.38 22.98 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.767 0.794 . . . . 71.54 109.722 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.4 mmt -56.12 -43.43 78.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.181 0.992 . . . . 73.4 112.032 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.62 -36.8 83.95 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.563 -1.132 . . . . 75.44 113.288 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -66.49 -49.14 67.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.213 1.506 . . . . 74.43 107.739 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.07 -43.1 95.68 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.859 0.864 . . . . 72.31 110.102 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -59.55 -54.46 46.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.313 1.845 . . . . 71.42 108.991 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.14 -43.35 99.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.098 -0.641 . . . . 73.45 112.69 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.43 -32.38 60.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.895 1.072 . . . . 71.22 113.895 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -100.44 0.89 40.62 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.23 1.196 . . . . 74.24 114.23 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.49 121.54 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.635 1.574 . . . . 74.35 112.384 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.15 175.51 7.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.712 0.405 . . . . 73.54 109.978 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.64 -34.03 66.9 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.888 -1.133 . . . . 75.32 110.827 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.23 10.39 29.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.457 1.903 . . . . 45.34 112.186 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.97 -1.2 1.39 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.848 2.642 . . . . 54.02 114.264 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.42 170.83 15.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.023 1.411 . . . . 72.23 111.073 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.68 136.75 54.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.78 0.832 . . . . 74.25 111.075 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -122.18 122.91 40.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.889 1.676 . . . . 71.13 109.898 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.17 137.51 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.693 -1.254 . . . . 71.32 109.461 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.16 147.62 32.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.746 -1.205 . . . . 75.33 107.746 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.85 152.44 48.51 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.315 0.646 . . . . 61.42 110.641 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 t -147.29 163.55 36.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.495 0.718 . . . . 35.4 109.895 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.86 17.22 22.84 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.896 1.712 . . . . 55.22 113.654 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.69 150.61 42.08 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.076 1.75 . . . . 73.54 109.201 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -92.43 -13.63 29.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.731 1.212 . . . . 62.44 111.484 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 p -129.53 109.57 11.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.983 1.313 . . . . 44.25 111.264 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -97.07 9.55 41.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.375 2.27 . . . . 72.11 111.381 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.922 0 N-CA-C 106.624 -2.59 . . . . 73.24 106.624 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.43 0 N-CA-C 108.441 -1.864 . . . . 74.21 108.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -149.06 176.51 10.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.329 1.052 . . . . 42.13 109.322 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.3 36.77 3.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.761 1.624 . . . . 73.42 110.848 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.54 51.81 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 63.14 108.379 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 40.6 pt -59.22 157.9 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 120.795 -1.19 . . . . 72.43 110.122 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' ILE . . . . . 0.41 ' H ' HD12 ' B' ' 335' ' ' ILE . 5.2 mp -64.45 -51.74 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.734 -1.58 . . . . 42.23 106.734 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -74.51 54.1 0.57 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.904 2.082 . . . . 73.23 111.108 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.37 129.63 28.98 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.421 -1.326 . . . . 75.2 107.421 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.45 -73.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.818 1.647 . . . . 75.01 113.151 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -77.98 136.17 37.93 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 108.208 -1.034 . . . . 64.12 108.208 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -62.73 1.43 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 128.08 2.552 . . . . 50.34 115.902 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 59.4 m95 51.96 52.21 14.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.883 1.673 . . . . 75.11 111.984 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 342' ' ' GLY . . . . . 0.448 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -84.48 130.49 9.82 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.789 -1.194 . . . . 41.25 111.498 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.78 132.39 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.956 1.702 . . . . 72.44 110.992 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.96 141.48 36.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.959 2.104 . . . . 52.12 110.961 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.15 124.02 37.9 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.061 -1.089 . . . . 62.3 108.061 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.97 109.97 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.678 1.191 . . . . 74.54 109.129 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 160.1 40.96 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.659 1.184 . . . . 74.32 110.694 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.277 1.031 . . . . 71.32 108.564 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 mtm . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 110.502 -0.184 . . . . 73.23 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.6 61.67 0.25 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 106.961 -2.456 . . . . 74.44 106.961 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -74.84 119.26 18.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.985 0.914 . . . . 63.22 112.099 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -35.19 77.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.22 -0.289 . . . . 72.21 110.22 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.68 -45.77 91.09 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.915 -1.116 . . . . 64.13 109.992 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -65.22 -33.98 77.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.842 0.857 . . . . 75.43 110.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.75 -45.29 92.68 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.023 0.929 . . . . 60.25 108.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.09 -75.48 0.3 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.146 0.978 . . . . 72.11 112.87 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 133.35 6.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.467 1.507 . . . . 74.32 109.504 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.4 t -130.65 -53.29 1.08 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.787 -1.101 . . . . 24.44 109.551 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 tp -49.59 -59.94 3.32 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.232 1.567 . . . . 73.41 115.232 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.63 -58.87 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.249 0.931 . . . . 63.33 110.847 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CD2' HH21 ' A' ' 14' ' ' ARG . 2.0 t-160 -50.6 -50.33 54.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.885 1.674 . . . . 71.15 111.892 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.455 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.8 mmp_? -70.27 -42.04 72.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.721 -1.862 . . . . 73.41 110.734 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.14 -54.45 39.41 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.22 1.373 . . . . 74.11 110.015 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -47.64 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.027 1.331 . . . . 72.33 111.476 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.0 -42.59 99.89 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.85 -0.595 . . . . 62.44 109.837 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -55.34 -48.18 74.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.277 1.031 . . . . 74.14 108.681 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.62 72.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 0.598 . . . . 72.24 111.864 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.67 -45.61 91.99 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.971 -0.456 . . . . 72.24 110.887 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.4 -41.44 89.89 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 108.52 -0.919 . . . . 65.24 108.52 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -67.57 -29.82 69.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.39 1.45 . . . . 64.24 110.648 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.36 -47.44 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.681 -0.637 . . . . 71.32 110.076 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.99 -46.51 29.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.935 0.717 . . . . 63.42 112.935 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.91 73.65 70.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.773 2.029 . . . . 75.14 110.492 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -18.37 47.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.162 2.575 . . . . 55.33 111.831 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.52 14.03 31.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.712 1.205 . . . . 52.34 111.839 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -123.53 152.37 41.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.77 0.828 . . . . 62.31 109.458 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 m -114.51 129.39 24.97 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.577 1.551 . . . . 71.31 108.525 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.66 116.99 3.89 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.22 3.947 . . . . 60.55 112.601 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.72 146.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.759 0.79 . . . . 43.35 109.455 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.36 112.77 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.486 -2.783 . . . . 73.13 103.486 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.33 127.71 61.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.198 -1.408 . . . . 63.23 107.198 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -128.08 143.61 51.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.226 0.611 . . . . 73.31 109.841 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.49 136.5 32.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -68.48 112.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.345 -1.354 . . . . 73.32 107.345 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.05 148.64 2.25 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.366 1.466 . . . . 63.45 111.345 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.23 -20.49 13.3 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 118.471 -1.183 . . . . 60.44 111.93 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -65.16 144.93 56.88 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.96 1.88 . . . . 44.02 110.346 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -70.67 -28.76 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.638 1.575 . . . . 65.14 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 42' ' ' VAL . 5.6 tp -59.79 157.34 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.369 0.668 . . . . 63.21 111.198 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' H ' HD12 ' A' ' 41' ' ' ILE . 33.7 m -63.46 138.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.178 -1.045 . . . . 42.24 108.178 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.82 177.58 6.05 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.927 1.691 . . . . 64.44 110.082 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.97 158.79 35.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.659 1.184 . . . . 73.32 109.936 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -78.92 166.19 22.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 128.278 2.631 . . . . 75.22 109.228 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HE2' ' OD1' ' B' ' 339' ' ' ASN . 9.2 mptt -80.88 80.85 7.28 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 104.009 -2.589 . . . . 71.53 104.009 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -135.04 145.11 47.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.023 -1.843 . . . . 73.15 106.023 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -92.02 144.29 25.6 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.558 1.143 . . . . 75.54 111.745 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.03 116.96 30.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.322 1.449 . . . . 61.13 107.518 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -108.12 110.32 21.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.981 1.313 . . . . 73.42 109.379 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -108.0 143.55 27.59 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 119.6 1.091 . . . . 71.24 112.808 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HG2' HG23 ' A' ' 55' ' ' ILE . 58.4 Cg_endo -64.87 138.83 59.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.911 2.407 . . . . 73.15 110.603 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.77 -16.47 58.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.656 -0.652 . . . . 74.53 112.301 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -26.21 59.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.459 1.904 . . . . 60.51 113.7 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.444 HG23 ' HG2' ' A' ' 52' ' ' PRO . 1.1 pp -80.91 170.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 122.11 0.957 . . . . 72.44 111.523 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -107.38 162.15 14.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.491 1.116 . . . . 62.41 109.6 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.3 t -52.36 -37.29 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.083 . . . . 71.54 108.077 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.36 -46.68 73.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.313 1.445 . . . . 74.22 112.225 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -70.47 -44.4 67.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.36 -0.607 . . . . 74.52 109.36 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 51' ' ' VAL . 2.3 t80 -58.44 -49.91 75.6 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.962 0.41 . . . . 71.24 109.896 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.6 ttp -62.56 -49.19 76.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.554 -0.736 . . . . 73.23 110.177 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -57.59 -44.49 85.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.455 1.025 . . . . 71.44 111.077 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.9 mt -64.79 -42.96 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.534 -0.913 . . . . 72.14 108.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.426 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.6 mt -57.67 -50.08 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.274 1.397 . . . . 75.51 110.07 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.54 -35.2 77.08 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.328 -1.483 . . . . 54.35 111.016 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -70.35 -35.47 73.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.407 0.548 . . . . 74.13 109.717 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -67.02 -45.3 77.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.608 1.563 . . . . 71.14 111.682 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 pt -79.6 -3.39 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 123.667 0.604 . . . . 73.12 110.887 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.72 46.57 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.394 1.077 . . . . 61.12 109.802 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.92 109.28 3.64 Favored Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.369 1.468 . . . . 52.23 110.223 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.58 149.91 56.29 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.975 1.783 . . . . 75.14 108.811 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -61.5 -18.15 57.8 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.507 -0.746 . . . . 44.21 113.007 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -66.33 -26.17 67.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.241 0.928 . . . . 65.31 110.449 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.99 164.89 11.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.062 0.945 . . . . 73.11 109.593 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 166.3 10.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.281 1.433 . . . . 74.41 109.52 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 tt -149.75 113.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 121.254 -0.904 . . . . 72.24 109.698 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -123.42 138.03 54.68 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.449 -1.315 . . . . 73.53 107.449 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.97 149.85 36.7 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.233 1.813 . . . . 74.32 107.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -141.74 133.36 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.41 1.084 . . . . 75.35 109.436 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.44 144.2 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 106.743 -1.577 . . . . 72.23 106.743 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.72 36.45 1.28 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.924 1.29 . . . . 74.42 112.651 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.51 38.21 29.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.235 1.414 . . . . 73.21 110.662 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -147.67 162.22 39.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.8 -1.185 . . . . 64.31 107.8 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.76 114.05 60.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 103.388 -2.819 . . . . 64.42 103.388 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.77 123.95 10.97 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 N-CA-C 107.427 -1.797 . . . . 72.33 107.427 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.96 126.56 27.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.461 -0.57 . . . . 52.53 109.461 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.0 m -45.88 -46.78 16.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 63.11 113.471 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.7 m -77.04 -3.18 37.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.389 1.45 . . . . 72.13 114.692 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.0 tp -67.47 141.17 57.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.691 1.587 . . . . 32.33 106.809 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.1 p -85.52 151.98 23.53 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.705 -0.622 . . . . 64.41 109.544 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 mmt -62.27 -42.13 99.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 118.206 -0.902 . . . . 72.41 113.153 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.33 -47.03 92.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.401 -1.079 . . . . 25.51 110.401 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -61.83 -49.15 77.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.774 0.83 . . . . 75.12 110.181 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.47 -49.31 75.92 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.384 0.674 . . . . 71.31 111.216 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -62.72 -45.53 92.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.629 -1.295 . . . . 73.45 108.915 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.05 -26.06 67.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 120.297 1.408 . . . . 74.13 111.736 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -24.35 20.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 116.911 -1.519 . . . . 71.43 112.335 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -112.36 1.1 15.88 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.877 1.436 . . . . 74.21 114.877 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -46.94 121.5 3.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.936 1.695 . . . . 60.15 112.148 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -80.85 171.51 14.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.544 -1.28 . . . . 73.12 107.544 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.1 -20.6 18.03 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.281 1.832 . . . . 55.01 113.795 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -102.03 13.71 33.98 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.901 1.68 . . . . 75.41 112.222 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.9 31.76 77.31 Favored Glycine 0 CA--C 1.524 0.623 0 O-C-N 120.547 -1.346 . . . . 62.32 114.092 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -129.16 172.94 10.94 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.361 -1.082 . . . . 75.13 108.44 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.12 125.36 45.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.946 -1.131 . . . . 72.34 107.946 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -102.96 120.04 39.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.903 1.281 . . . . 74.25 108.775 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.239 -1.023 . . . . 73.35 108.239 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.31 148.65 40.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.375 1.47 . . . . 40.45 107.628 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -138.12 145.81 42.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.433 0.56 . . . . 75.23 110.443 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 p -143.47 161.5 38.26 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 122.107 0.956 . . . . 74.32 110.228 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.32 13.31 21.26 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.993 -1.643 . . . . 73.32 108.993 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -123.52 124.59 43.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.76 1.624 . . . . 64.34 108.509 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -68.59 -18.02 64.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.285 0.634 . . . . 75.41 111.338 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.9 109.99 10.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.412 1.885 . . . . 73.31 107.637 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.25 9.23 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.813 1.042 . . . . 74.44 113.813 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 126.033 1.778 . . . . 62.43 109.611 179.339 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 CA-C-O 118.76 -1.022 . . . . 65.24 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -145.97 90.27 1.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.896 1.278 . . . . 63.21 108.18 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 65.7 mtt -95.62 70.57 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.072 -1.825 . . . . 64.53 106.072 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -108.15 50.37 0.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.174 1.789 . . . . 75.41 109.053 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 40.0 pt -87.81 152.21 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.156 -0.965 . . . . 75.22 111.489 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 18.4 pt -68.23 -33.65 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 114.892 1.442 . . . . 31.23 114.892 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -81.33 82.74 7.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.45 -0.945 . . . . 73.13 108.45 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.88 135.69 51.47 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.796 -1.187 . . . . 63.41 107.796 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.75 -48.72 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.856 -1.905 . . . . 54.13 105.856 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' ASN . . . . . 0.421 ' OD1' ' HE2' ' A' ' 46' ' ' LYS . 72.7 m-80 -108.68 113.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.45 2.3 . . . . 73.32 110.416 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -61.21 -51.85 67.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.232 2.213 . . . . 74.32 115.754 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 77.0 m95 60.7 59.2 2.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 74.33 113.045 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.78 129.21 9.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.644 -1.382 . . . . 25.33 109.644 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 55.2 mt -77.31 132.99 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.276 1.538 . . . . 62.43 112.184 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.02 139.81 39.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 71.13 109.183 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.4 tt -98.68 118.78 36.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.869 2.068 . . . . 74.55 107.638 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.41 125.66 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 122.917 0.487 . . . . 74.14 110.636 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.0 p -161.49 149.71 15.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.904 -1.887 . . . . 73.44 105.904 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.489 0.716 . . . . 55.23 110.112 -179.685 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 109.978 -0.378 . . . . 75.34 109.978 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.02 -134.01 4.43 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 124.09 0.852 . . . . 74.25 111.569 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -82.38 124.24 29.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.701 0.8 . . . . 73.25 109.012 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 mmt -58.76 -46.8 86.63 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.729 -1.212 . . . . 51.11 107.729 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -59.86 -43.33 94.72 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.497 -0.763 . . . . 73.23 112.307 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -69.33 -35.91 76.39 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.287 0.949 . . . . 63.32 110.924 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.05 -41.26 91.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.511 -0.552 . . . . 73.42 109.511 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.64 -75.45 0.31 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.745 0.818 . . . . 73.01 111.393 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 119.38 3.23 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.548 -1.649 . . . . 74.13 106.548 177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -104.68 -65.48 1.03 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.51 1.124 . . . . 61.55 112.361 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.61 -58.47 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.072 1.349 . . . . 70.43 112.922 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.76 -58.79 6.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.717 0.636 . . . . 73.54 112.717 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -55.63 -54.97 37.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.0 0.429 . . . . 75.42 111.808 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.33 82.53 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.526 -1.226 . . . . 74.12 110.982 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -61.8 -56.31 20.8 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.621 1.168 . . . . 73.13 112.919 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 -44.79 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 120.669 -1.269 . . . . 60.34 110.124 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 48.4 mm-40 -61.63 -42.76 99.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 117.661 -1.161 . . . . 71.04 110.405 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.5 p -60.49 -45.1 95.0 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.632 1.56 . . . . 32.22 109.423 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.22 74.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.983 0.81 . . . . 74.02 111.95 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.88 -39.84 95.12 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.632 -0.667 . . . . 72.11 111.132 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.47 -41.2 88.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-O 117.584 -1.198 . . . . 63.23 108.539 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -65.83 -39.2 90.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.869 1.668 . . . . 75.34 109.556 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.01 74.76 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.842 -0.743 . . . . 52.14 110.909 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -78.51 -47.05 18.14 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.855 1.798 . . . . 62.34 115.855 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -126.24 70.53 69.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 126.585 1.954 . . . . 63.31 110.647 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.12 -19.47 51.06 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.502 2.134 . . . . 52.44 110.231 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.46 12.92 17.07 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.44 1.096 . . . . 64.1 112.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -129.65 160.7 32.52 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.734 1.614 . . . . 54.52 111.393 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.21 136.97 28.9 Favored Pre-proline 0 C--O 1.247 0.948 0 C-N-CA 124.422 1.089 . . . . 73.21 108.471 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.98 113.7 3.48 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 126.078 4.519 . . . . 51.11 111.683 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.1 144.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.666 0.786 . . . . 73.45 110.477 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -122.6 128.88 75.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 103.861 -2.644 . . . . 75.31 103.861 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.93 119.69 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 127.124 2.169 . . . . 73.53 106.692 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -124.4 146.96 48.57 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.614 1.097 . . . . 75.44 109.051 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -89.35 139.41 30.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.242 0.474 . . . . 71.42 109.905 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.0 130.24 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.568 -1.271 . . . . 74.41 107.568 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 p -61.04 122.04 13.97 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.214 -1.402 . . . . 70.52 107.214 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.93 -13.8 29.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.902 -1.499 . . . . 44.21 112.87 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.641 ' HB3' HG22 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -79.54 131.08 35.93 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.503 2.151 . . . . 73.03 106.318 177.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -63.48 -19.66 64.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.813 0.845 . . . . 73.44 113.012 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 39' ' ' SER . 9.4 tp -51.74 155.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.817 1.647 . . . . 73.41 112.71 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.16 145.27 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.437 1.095 . . . . 74.3 111.78 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.79 164.24 25.39 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.036 0.534 . . . . 41.34 109.798 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.68 132.72 70.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.455 1.102 . . . . 72.33 112.082 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -67.54 153.6 43.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.996 1.719 . . . . 75.13 107.821 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.69 99.13 3.6 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.327 -1.731 . . . . 71.41 106.327 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -134.41 160.96 36.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.429 -0.952 . . . . 74.23 108.429 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.9 mtpp -109.81 103.01 11.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.018 1.727 . . . . 75.14 108.372 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -84.38 125.84 32.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.735 -1.209 . . . . 74.21 107.735 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.74 107.57 18.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.322 -2.103 . . . . 71.24 105.322 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -109.61 143.01 26.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 117.011 -1.471 . . . . 63.52 110.492 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.12 134.73 25.75 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.452 2.768 . . . . 45.34 111.995 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 p -59.63 -17.2 31.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.885 1.274 . . . . 64.42 113.993 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.6 -34.26 60.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.434 1.894 . . . . 75.52 113.213 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.39 167.22 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 119.969 1.259 . . . . 71.22 111.095 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -107.38 166.66 10.48 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.38 1.072 . . . . 62.51 110.712 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.12 -37.94 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.378 1.071 . . . . 74.41 110.085 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.56 93.28 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.238 0.926 . . . . 71.33 111.311 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.79 -46.2 79.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.053 0.941 . . . . 74.41 108.572 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.95 -50.66 72.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.697 1.199 . . . . 75.32 110.46 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttp -55.06 -49.07 72.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.61 1.164 . . . . 63.43 110.35 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -57.51 -42.17 82.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.491 -0.559 . . . . 75.32 109.491 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.21 -48.66 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.822 -1.085 . . . . 74.43 110.374 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.28 -50.39 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.794 1.179 . . . . 61.25 110.071 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.0 -36.86 82.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.022 -0.99 . . . . 73.23 111.51 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -71.19 -37.1 72.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.072 1.305 . . . . 71.52 110.673 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.66 -49.53 74.79 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.491 1.516 . . . . 75.0 109.658 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 pt -79.53 0.7 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 119.605 -0.236 . . . . 73.23 111.006 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 50.29 58.41 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.498 1.919 . . . . 65.44 110.039 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 110.14 4.44 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.736 -1.209 . . . . 55.22 107.736 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.07 162.52 39.65 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.112 2.541 . . . . 74.11 112.434 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 m -67.35 -22.33 65.59 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.745 -0.597 . . . . 53.34 110.969 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.66 -34.06 77.01 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.11 0.868 . . . . 63.22 111.697 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -104.15 164.63 11.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.987 1.315 . . . . 71.33 111.726 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 175.13 5.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.413 1.885 . . . . 73.53 106.558 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -144.55 143.1 23.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 64.51 107.542 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -145.49 134.63 22.78 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.78 1.632 . . . . 74.32 108.129 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -114.7 142.26 46.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.988 1.315 . . . . 74.45 109.803 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.59 136.94 36.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.023 1.329 . . . . 74.23 108.766 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.67 125.7 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 104.305 -2.48 . . . . 45.11 104.305 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t70 43.72 42.7 4.46 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.252 1.204 . . . . 72.13 114.252 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? 69.51 18.58 7.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.712 1.605 . . . . 73.0 114.291 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.1 p -124.03 162.57 23.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 120.48 1.491 . . . . 75.22 112.165 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.24 105.12 11.47 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 105.737 -1.949 . . . . 51.14 105.737 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.45 133.75 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.065 1.844 . . . . 71.24 109.844 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -67.57 118.59 11.07 Favored 'General case' 0 C--O 1.227 -0.113 0 O-C-N 121.439 -0.788 . . . . 73.31 109.366 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m -50.56 -39.32 49.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.224 1.01 . . . . 62.31 113.563 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.69 -8.07 59.66 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.052 1.501 . . . . 72.33 115.052 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.47 141.69 50.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.156 1.798 . . . . 63.41 110.307 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.52 143.39 34.92 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.631 -1.248 . . . . 75.35 107.631 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.19 -43.39 70.69 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.208 -0.901 . . . . 63.34 111.09 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.45 -38.0 92.88 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.868 1.213 . . . . 33.13 112.904 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.65 -53.83 16.79 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.513 -0.993 . . . . 63.02 108.808 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.26 -38.32 83.13 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.194 -0.912 . . . . 55.22 110.319 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -61.44 -54.43 43.58 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 117.082 -1.437 . . . . 72.15 107.461 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -55.12 -53.62 53.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.75 1.159 . . . . 62.32 111.925 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -24.93 64.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 117.963 -1.018 . . . . 75.22 113.659 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -105.95 4.32 29.37 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.233 1.379 . . . . 65.12 112.861 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -55.37 120.25 6.82 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.126 1.77 . . . . 64.43 110.041 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.43 172.37 13.05 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.133 -1.062 . . . . 65.31 108.133 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.51 -33.96 68.6 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.774 -1.204 . . . . 73.11 109.926 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -88.35 16.35 6.49 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.734 1.214 . . . . 73.32 112.193 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.2 28.38 66.64 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.361 1.458 . . . . 71.42 116.294 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -119.51 175.74 5.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.445 1.622 . . . . 74.24 111.013 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.68 137.89 54.63 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.161 0.985 . . . . 52.51 110.502 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.84 101.76 8.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.081 1.353 . . . . 73.11 109.97 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.72 122.84 69.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.559 0.695 . . . . 72.11 111.149 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.78 145.86 25.44 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.595 -1.261 . . . . 71.11 107.595 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -128.67 147.42 50.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.459 -0.941 . . . . 64.23 108.459 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 p -144.8 154.8 43.06 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.508 -0.923 . . . . 72.21 108.508 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.74 20.97 14.53 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.983 1.277 . . . . 53.4 110.064 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -135.05 112.71 10.78 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.694 1.598 . . . . 53.2 107.828 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -66.05 -40.92 91.35 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.915 -0.772 . . . . 42.12 108.915 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.29 124.24 38.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.491 -1.67 . . . . 72.52 106.491 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -116.62 9.76 14.23 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.738 1.215 . . . . 75.21 111.702 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.857 0 N-CA-C 107.927 -2.069 . . . . 51.33 107.927 179.386 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.765 -1.334 . . . . 71.44 109.765 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -165.19 106.32 0.79 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.706 -1.22 . . . . 61.32 107.706 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 27.5 mmm -116.43 13.23 15.42 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.774 1.23 . . . . 65.04 110.984 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -67.43 51.46 0.05 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 129.766 3.226 . . . . 75.31 112.978 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 4.5 mt -101.85 160.6 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.427 1.891 . . . . 63.52 107.627 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.14 8.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 126.491 1.917 . . . . 64.43 113.036 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -112.1 7.08 19.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.555 1.542 . . . . 74.5 111.522 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.33 109.21 0.51 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.436 1.494 . . . . 75.44 107.446 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.41 -16.03 29.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.544 0.572 . . . . 75.23 112.544 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -109.91 108.91 19.35 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 105.415 -2.069 . . . . 73.03 105.415 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -77.71 -36.08 51.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.006 0.743 . . . . 74.23 113.006 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 44.5 m95 51.91 59.38 4.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.25 1.82 . . . . 74.22 112.506 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.24 135.54 14.71 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.982 -1.247 . . . . 75.42 109.982 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 82.7 mt -80.61 134.47 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.712 1.756 . . . . 74.12 112.446 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -140.03 133.64 30.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.085 0.954 . . . . 72.41 111.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 73.6 mt -88.27 116.66 26.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.322 -2.103 . . . . 63.43 105.322 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.68 121.81 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.743 -0.836 . . . . 71.33 108.743 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -157.3 128.09 6.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.023 -1.103 . . . . 73.55 108.023 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 105.728 -1.952 . . . . 64.11 105.728 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mmm . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 109.435 -0.579 . . . . 73.41 109.435 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.92 55.93 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.382 -1.087 . . . . 73.44 110.382 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -73.65 114.43 11.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.959 -1.497 . . . . 61.15 106.959 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 mtt -49.64 -46.83 49.96 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.61 0.764 . . . . 63.24 109.749 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -56.65 -44.14 81.01 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.038 -0.982 . . . . 74.33 113.108 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -74.52 -27.72 60.66 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.353 1.061 . . . . 73.23 113.332 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -72.42 -48.16 43.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.515 -0.92 . . . . 64.1 108.515 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -74.73 -77.29 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 124.271 0.982 . . . . 61.25 109.085 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.66 117.85 2.11 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 119.773 -1.83 . . . . 73.52 108.228 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p -112.86 -66.4 1.09 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.839 -1.553 . . . . 72.21 109.428 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 pp -44.14 -58.13 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.387 1.875 . . . . 62.13 115.299 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.59 -58.93 6.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.452 1.901 . . . . 73.3 111.237 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -63.15 -50.73 69.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.913 1.285 . . . . 54.53 111.141 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -40.92 85.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 116.996 -1.478 . . . . 73.43 109.824 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.11 -55.6 20.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.821 1.191 . . . . 71.41 110.117 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.03 -47.71 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.454 0.57 . . . . 74.22 111.031 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 48' ' ' LYS . 53.9 mm-40 -65.27 -38.59 90.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.412 -0.804 . . . . 65.11 109.74 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -58.77 -48.44 81.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 120.315 1.416 . . . . 62.4 108.419 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.42 69.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.88 0.764 . . . . 71.31 110.485 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.84 -49.92 70.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.479 -0.296 . . . . 64.13 111.677 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -59.13 -42.02 85.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 124.085 0.954 . . . . 61.31 110.621 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -69.12 -38.89 79.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.686 1.13 . . . . 71.55 109.379 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.49 70.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.591 -0.693 . . . . 51.33 110.468 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -73.2 -46.38 50.8 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 113.153 0.797 . . . . 64.4 113.153 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -129.0 77.75 77.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.857 1.263 . . . . 75.51 109.887 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.42 -28.03 71.03 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.731 2.287 . . . . 74.34 113.581 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.6 13.8 13.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.288 0.949 . . . . 71.14 110.653 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -118.1 152.44 35.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.584 -0.895 . . . . 72.35 108.584 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.61 135.2 24.94 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.52 -1.289 . . . . 70.12 107.52 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.47 114.44 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.293 3.329 . . . . 73.35 114.108 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.84 149.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 O-C-N 120.938 -1.101 . . . . 72.33 109.926 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.6 mm -123.1 115.19 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 103.056 -2.942 . . . . 75.31 103.056 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.08 119.38 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.054 -1.091 . . . . 75.01 108.054 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.48 159.67 37.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.709 1.14 . . . . 63.32 111.616 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.31 153.59 22.47 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.586 -0.696 . . . . 74.15 112.052 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.47 135.32 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.55 -2.389 . . . . 60.14 104.55 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.66 120.97 9.89 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.668 -1.234 . . . . 44.13 107.668 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.32 -11.82 54.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.538 -1.146 . . . . 31.31 112.443 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -69.5 113.27 6.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 103.635 -2.728 . . . . 62.34 103.635 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -72.07 -13.36 61.57 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.411 0.893 . . . . 73.53 113.411 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 tp -62.54 166.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.547 1.139 . . . . 74.21 111.723 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 m -55.68 123.49 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.437 1.095 . . . . 72.51 109.181 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.62 178.16 5.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.795 1.638 . . . . 74.43 110.05 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.11 149.7 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.453 1.101 . . . . 72.14 110.867 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.16 166.07 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.475 1.51 . . . . 64.31 107.26 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.45 103.02 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.562 -1.336 . . . . 73.11 109.448 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 67.9 mmt-85 -141.44 154.52 45.63 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.136 1.774 . . . . 73.0 109.865 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mtpp -98.97 104.27 16.3 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.964 1.706 . . . . 74.5 108.766 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -84.22 118.23 24.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.766 -1.568 . . . . 72.32 106.766 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.27 116.83 32.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.885 -1.524 . . . . 53.12 106.885 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -111.59 141.25 24.24 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.888 -1.053 . . . . 74.24 110.399 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 71.2 Cg_endo -72.27 141.1 35.04 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.333 2.022 . . . . 75.31 108.229 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -65.9 -13.03 58.94 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 114.616 1.339 . . . . 75.22 114.616 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.54 -32.07 24.06 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.417 1.265 . . . . 62.15 114.417 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.37 164.8 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.305 0.957 . . . . 70.23 109.319 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -103.21 165.32 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.443 0.697 . . . . 65.01 110.74 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.81 -35.63 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.037 1.335 . . . . 63.2 109.259 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.89 -46.12 85.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.244 0.929 . . . . 72.25 109.933 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -67.57 -46.41 72.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.573 -0.727 . . . . 73.14 109.919 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.38 -46.97 87.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.513 0.597 . . . . 73.33 110.097 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.4 ttt -55.73 -52.19 64.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.243 1.017 . . . . 74.41 108.982 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -57.29 -40.35 77.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.581 -0.723 . . . . 75.31 110.663 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.73 -44.03 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.127 . . . . 71.11 109.282 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.89 -51.1 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.731 1.605 . . . . 62.23 110.393 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -36.16 82.85 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.672 -0.68 . . . . 73.22 110.904 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -68.07 -43.69 77.99 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.173 0.589 . . . . 70.41 110.689 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -60.23 -51.33 70.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.857 1.663 . . . . 74.12 110.033 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.53 -2.97 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.125 -0.464 . . . . 75.2 111.57 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 50.05 65.4 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.756 2.022 . . . . 73.2 109.532 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.82 115.16 22.05 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.56 0.744 . . . . 74.23 109.252 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.26 164.47 17.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.668 3.579 . . . . 74.41 113.817 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -67.92 -29.52 68.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.368 0.667 . . . . 73.11 111.509 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -62.09 -38.52 89.15 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.061 -0.495 . . . . 75.34 112.237 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.42 164.44 11.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.7 0.762 . . . . 74.43 111.756 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 -178.2 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.976 1.711 . . . . 60.13 107.506 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.2 140.59 22.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.411 1.084 . . . . 74.42 108.26 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -145.34 140.7 27.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.006 -1.479 . . . . 63.24 107.006 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.72 153.14 30.82 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.845 1.658 . . . . 72.44 109.637 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -147.03 132.85 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.525 1.13 . . . . 74.35 108.946 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -126.61 119.6 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 103.121 -2.918 . . . . 64.43 103.121 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 46.77 45.8 14.89 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 124.71 2.195 . . . . 73.52 111.603 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt 56.59 30.38 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.452 -1.405 . . . . 55.45 112.224 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 p -118.64 159.87 22.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.547 -1.649 . . . . 72.34 106.547 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.36 109.58 41.25 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.674 -1.973 . . . . 70.43 105.674 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.38 124.0 13.07 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.093 1.862 . . . . 70.14 110.51 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -73.93 116.03 14.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.641 1.176 . . . . 44.12 109.954 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 83.6 p -49.13 -34.2 13.59 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.083 1.512 . . . . 65.44 115.083 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -82.6 -9.53 59.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.583 0.957 . . . . 63.53 113.583 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -75.19 144.5 42.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.609 1.095 . . . . 72.4 109.732 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.69 150.04 26.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.623 0.769 . . . . 44.41 109.739 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.2 mmt -54.64 -45.42 73.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.473 1.109 . . . . 61.21 111.785 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.15 91.04 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.456 -0.636 . . . . 55.44 113.259 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.5 -52.94 40.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.342 1.071 . . . . 73.21 108.812 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.38 -45.4 76.57 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 124.732 1.213 . . . . 74.33 108.82 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.28 -56.06 26.9 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.02 1.728 . . . . 61.12 109.28 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.31 -43.19 88.05 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.193 0.906 . . . . 73.32 113.298 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -30.71 39.31 Favored 'General case' 0 N--CA 1.46 0.055 0 CA-C-O 117.324 -1.322 . . . . 73.23 112.844 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -97.58 -7.77 30.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.205 1.366 . . . . 74.12 114.266 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -33.38 120.16 0.37 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.968 2.907 . . . . 73.11 114.94 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.01 169.98 17.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.38 -1.341 . . . . 74.12 107.38 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -54.49 -28.75 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.252 1.421 . . . . 72.23 112.674 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -99.52 17.59 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.273 1.029 . . . . 75.24 112.703 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 30.43 74.63 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.325 -0.859 . . . . 62.52 114.632 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -126.28 174.17 8.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.693 1.246 . . . . 73.23 110.35 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 tp -124.62 142.95 50.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.127 -0.94 . . . . 74.24 110.778 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -117.93 116.1 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.473 1.509 . . . . 73.53 107.761 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.21 131.67 72.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 O-C-N 120.469 -1.394 . . . . 73.33 108.243 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.62 24.36 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.951 0.9 . . . . 72.22 109.798 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -139.96 154.49 47.2 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 124.191 0.932 . . . . 74.11 111.301 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -153.77 169.04 24.31 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.931 1.292 . . . . 72.44 108.829 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.34 24.9 10.19 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.397 0.999 . . . . 71.32 113.821 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.46 117.36 18.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.015 1.726 . . . . 70.1 109.247 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.86 -17.05 47.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.153 1.168 . . . . 63.24 114.153 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.862 -1.149 . . . . 73.44 108.749 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -80.9 71.11 7.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 105.335 -2.098 . . . . 74.12 105.335 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 117.609 -1.662 . . . . 50.14 109.672 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 110.884 -0.886 . . . . 71.31 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 48.18 32.0 2.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.409 1.484 . . . . 72.3 111.87 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.31 17.67 0.47 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.506 1.923 . . . . 73.43 111.471 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.01 51.23 0.64 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.047 2.539 . . . . 74.23 110.308 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 46.8 pt -62.74 148.11 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 O-C-N 121.667 -0.645 . . . . 73.21 109.757 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 10.2 mt -75.06 -28.65 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.861 1.265 . . . . 72.12 108.689 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -84.66 61.62 6.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.617 1.567 . . . . 72.12 110.299 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -71.83 130.72 41.76 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.02 -29.82 35.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.929 -1.107 . . . . 71.3 110.707 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 339' ' ' ASN . . . . . 0.469 HD21 ' HE1' ' B' ' 341' ' ' TRP . 79.5 m-20 -108.73 164.51 12.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.705 -1.247 . . . . 63.32 111.67 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.04 -59.37 2.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.505 0.722 . . . . 72.1 111.161 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.469 ' HE1' HD21 ' B' ' 339' ' ' ASN . 60.1 m95 52.36 47.43 24.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.99 0.916 . . . . 74.25 109.231 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 342' ' ' GLY . . . . . 0.415 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -79.28 146.31 28.94 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 108.584 -1.806 . . . . 52.12 108.584 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.57 143.98 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 118.661 1.23 . . . . 72.45 111.527 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -148.62 120.81 8.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.524 1.53 . . . . 73.43 109.781 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.45 119.61 22.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.442 -1.318 . . . . 72.52 107.442 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.47 108.61 22.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.661 1.184 . . . . 73.53 108.639 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 347' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 p -146.24 162.35 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.247 1.819 . . . . 54.21 109.913 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 123.571 0.748 . . . . 54.23 109.752 -179.656 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ptt? . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.085 -0.007 . . . . 75.03 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.6 146.51 10.4 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.52 -1.432 . . . . 74.4 109.52 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -105.56 111.76 24.59 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.966 0.907 . . . . 71.2 109.02 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -46.75 68.91 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 124.206 0.942 . . . . 73.34 109.357 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -57.56 -49.25 76.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.743 0.817 . . . . 75.11 112.524 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.06 -43.99 90.44 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.697 0.799 . . . . 73.22 112.521 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -67.13 -44.35 80.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 123.572 0.545 . . . . 73.53 110.608 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -73.25 0.28 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 123.635 0.585 . . . . 71.13 111.448 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.604 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 1.5 p-80 -157.58 119.44 3.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.409 1.004 . . . . 71.34 109.948 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.01 -64.97 0.93 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.653 -1.641 . . . . 75.23 113.588 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.36 -57.82 1.68 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 121.597 1.999 . . . . 54.45 115.374 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -64.5 -52.62 56.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.768 0.794 . . . . 63.21 110.439 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.604 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 2.9 t60 -50.98 -58.99 4.63 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.075 1.75 . . . . 45.41 111.9 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -61.62 -49.43 76.61 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.363 2.665 . . . . 74.2 111.924 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.8 t -57.64 -49.05 77.75 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 118.724 0.693 . . . . 74.34 110.833 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.14 -42.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.331 0.652 . . . . 61.04 110.234 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 18.5 tt0 -60.44 -52.35 65.6 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.52 1.528 . . . . 70.43 110.436 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 t -58.21 -48.03 81.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.189 0.996 . . . . 73.32 108.937 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.42 76.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.25 0.477 . . . . 74.55 111.339 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -60.09 -39.56 86.54 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.35 -0.844 . . . . 72.21 110.332 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.34 -42.18 87.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-O 118.096 -0.954 . . . . 74.44 108.892 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -64.29 -32.52 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 120.515 1.507 . . . . 71.13 109.603 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.71 -47.81 20.77 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.254 0.549 . . . . 73.24 111.45 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -76.85 -46.87 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.859 1.429 . . . . 73.15 114.859 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.79 72.68 78.64 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 127.663 2.385 . . . . 74.43 108.128 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.79 -30.98 93.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.783 2.322 . . . . 75.22 111.326 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -90.92 14.79 12.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.766 0.826 . . . . 72.25 111.928 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -126.43 142.85 51.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.492 -1.38 . . . . 71.53 109.611 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.53 142.82 27.28 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.191 0.996 . . . . 73.1 111.779 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.79 118.66 3.84 Favored 'Trans proline' 0 C--N 1.353 0.78 1 C-N-CA 125.496 4.13 . . . . 72.32 114.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 t -125.48 143.85 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.248 1.023 . . . . 72.31 110.09 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mm -119.94 121.19 65.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 100.831 -3.766 . . . . 41.5 100.831 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.58 123.55 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.488 -0.93 . . . . 71.53 108.488 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -134.13 158.71 42.94 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.313 0.578 . . . . 63.02 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -79.12 145.75 33.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.01 0.524 . . . . 72.52 109.798 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.15 113.69 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 101.409 -3.552 . . . . 74.33 101.409 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.0 p -48.51 134.55 15.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.529 0.566 . . . . 72.33 112.529 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.29 -19.38 54.46 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 117.318 -1.823 . . . . 63.13 112.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 t -67.68 146.43 53.81 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.223 2.011 . . . . 61.21 109.937 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -73.7 -19.59 60.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.251 1.421 . . . . 71.45 112.791 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.3 tp -60.91 158.14 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.767 -0.457 . . . . 65.05 109.767 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.84 145.48 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 113.738 1.014 . . . . 41.11 113.738 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.99 160.99 17.65 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.637 1.975 . . . . 42.24 111.485 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.53 139.95 50.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.496 1.519 . . . . 75.53 109.545 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.77 159.36 30.38 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.869 -1.16 . . . . 64.24 107.869 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.84 95.05 2.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.586 -1.264 . . . . 73.14 107.586 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -133.09 151.29 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.05 -1.463 . . . . 73.11 107.05 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.5 mttp -99.79 108.25 20.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.472 -1.307 . . . . 75.33 107.472 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.88 119.9 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.448 0.642 . . . . 72.03 111.229 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.85 117.16 32.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.495 -2.039 . . . . 70.42 105.495 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 m -112.91 142.43 27.24 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.266 -1.013 . . . . 42.12 108.266 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 55.3 Cg_endo -66.78 138.62 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.324 1.509 . . . . 70.44 110.304 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -15.82 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.622 0.769 . . . . 64.51 111.667 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.73 -34.79 72.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.791 2.436 . . . . 64.4 113.321 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.31 166.5 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.004 -1.06 . . . . 53.32 111.982 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 p -99.87 168.74 9.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.728 0.811 . . . . 55.53 111.815 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.86 -41.24 56.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 125.078 1.351 . . . . 64.33 108.973 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.16 86.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.78 0.718 . . . . 72.01 111.074 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.57 -46.69 81.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.268 -0.642 . . . . 63.5 109.268 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.78 -47.71 84.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.533 0.606 . . . . 73.24 109.745 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.9 ttt -58.41 -46.17 86.98 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.629 1.571 . . . . 73.42 110.775 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -63.13 -44.49 95.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.865 -0.791 . . . . 72.44 108.865 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.53 HG21 ' CG1' ' B' ' 346' ' ' VAL . 29.8 mt -63.24 -40.01 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 117.48 -1.248 . . . . 74.25 108.706 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.12 -50.58 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 120.92 1.691 . . . . 44.41 109.209 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -63.48 -40.48 97.21 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.608 1.094 . . . . 75.11 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -63.49 -46.61 85.35 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.143 0.977 . . . . 73.34 110.593 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -59.97 -49.06 79.15 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.261 1.424 . . . . 73.22 111.473 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -79.93 -0.76 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 123.431 0.457 . . . . 72.02 111.261 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 50.11 68.25 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.688 2.395 . . . . 71.33 109.71 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 111.99 8.97 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.97 1.708 . . . . 64.43 111.098 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.13 157.92 49.91 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.335 2.69 . . . . 73.41 112.313 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.314 0.487 . . . . 71.24 112.314 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.01 -35.98 82.94 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.384 -0.823 . . . . 72.2 109.688 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.66 164.27 11.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.802 1.287 . . . . 74.54 112.33 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.1 177.3 4.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.866 2.467 . . . . 44.42 106.992 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tp -147.06 140.75 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.504 -1.295 . . . . 75.53 107.504 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.31 141.55 28.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.356 1.862 . . . . 73.24 108.833 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.0 mt -114.91 147.45 39.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 73.43 109.348 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -143.82 123.79 13.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.089 -1.449 . . . . 65.02 107.089 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.48 117.4 49.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.235 -1.394 . . . . 74.41 107.235 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t0 43.66 51.13 6.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.097 1.759 . . . . 44.31 111.711 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 63.54 17.9 10.69 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.322 1.449 . . . . 72.45 114.101 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.2 p -121.79 161.52 22.51 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 120.13 1.332 . . . . 71.51 111.02 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.26 110.04 60.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.113 -2.551 . . . . 64.13 104.113 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.65 135.54 33.49 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.446 1.43 . . . . 33.22 111.473 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.92 120.38 18.48 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 107.768 -1.197 . . . . 72.23 107.768 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -53.89 -25.81 21.93 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.123 2.169 . . . . 74.21 114.842 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -92.18 -12.14 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.643 0.777 . . . . 54.23 112.426 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.42 149.61 49.73 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.514 -0.921 . . . . 74.53 108.514 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.04 152.53 21.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.697 0.799 . . . . 74.32 109.489 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.39 -46.36 88.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.582 -0.723 . . . . 72.22 109.867 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.92 96.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.724 0.678 . . . . 44.14 111.793 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -65.19 -51.07 63.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.995 0.918 . . . . 62.23 108.937 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.94 -38.53 88.81 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.946 -0.471 . . . . 43.13 110.855 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -61.89 -52.99 61.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.699 2.0 . . . . 75.53 109.659 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.38 -33.75 73.52 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.686 0.624 . . . . 73.51 112.686 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -26.55 33.82 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 117.555 -1.212 . . . . 63.32 111.724 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -103.95 -2.38 26.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.591 1.087 . . . . 71.13 112.647 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -33.23 121.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 116.324 1.972 . . . . 74.12 116.324 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.14 175.32 6.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.001 0.921 . . . . 63.23 109.688 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -51.76 -39.33 58.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.858 1.663 . . . . 72.54 112.269 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.72 0.35 57.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.603 1.561 . . . . 73.31 112.516 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.93 66.35 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.137 1.351 . . . . 51.43 112.627 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 161.05 16.21 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.546 1.938 . . . . 63.54 108.89 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.2 139.27 54.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.385 0.993 . . . . 71.12 109.937 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.78 132.94 54.45 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.561 1.545 . . . . 73.23 107.619 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.26 146.54 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.45 144.35 44.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.836 -1.172 . . . . 75.12 107.836 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -128.7 149.77 50.54 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 109.032 -0.729 . . . . 73.31 109.032 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.7 t -144.86 163.37 34.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.876 -1.157 . . . . 52.22 107.876 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.3 5.83 55.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.828 -1.709 . . . . 74.14 108.828 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -135.88 150.62 49.43 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 118.529 1.165 . . . . 74.24 109.921 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -82.09 -23.16 35.9 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.983 2.113 . . . . 73.05 109.367 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 p -89.66 125.66 35.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.853 2.061 . . . . 74.44 105.89 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -116.32 9.61 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.928 0.891 . . . . 72.13 110.942 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 N-CA-C 106.98 -2.448 . . . . 71.32 106.98 178.896 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.567 0 N-CA-C 109.883 -1.287 . . . . 41.05 109.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.33 135.75 47.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.58 0.752 . . . . 71.1 109.424 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.03 53.31 2.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.573 1.549 . . . . 73.01 108.826 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.95 50.85 0.91 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.644 1.977 . . . . 63.32 110.686 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 42.5 pt -67.36 157.31 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.963 1.705 . . . . 52.13 112.938 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 45.7 mt -74.83 -38.55 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.742 -1.207 . . . . 72.05 107.742 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -82.41 51.13 1.76 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.659 1.184 . . . . 65.3 110.578 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -60.06 123.71 17.95 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.375 1.47 . . . . 54.55 107.321 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -45.01 59.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.719 0.69 . . . . 75.24 111.481 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.87 108.78 19.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.491 1.117 . . . . 74.42 113.301 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -69.52 -32.51 71.39 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.707 -0.621 . . . . 51.21 111.819 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 27.8 m95 49.48 52.34 14.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.322 1.449 . . . . 74.43 112.71 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.38 131.87 10.85 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.13 -1.606 . . . . 72.43 110.257 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.5 141.63 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.205 1.502 . . . . 70.4 107.315 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -137.44 151.0 48.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.69 1.996 . . . . 55.1 110.687 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 19.3 tp -113.55 112.23 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.975 1.31 . . . . 74.52 109.525 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.53 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.1 t -123.95 137.0 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.233 1.413 . . . . 75.35 111.718 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.2 p -162.46 161.0 26.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.707 0.803 . . . . 52.02 111.602 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 102.851 -3.018 . . . . 75.14 102.851 176.498 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 108.793 -0.817 . . . . 64.32 108.793 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.04 47.54 4.96 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.383 -0.687 . . . . 73.43 111.383 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -77.18 116.51 17.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.796 -0.816 . . . . 73.35 108.796 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.8 mmt -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.869 0.366 . . . . 75.42 110.465 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -58.29 -46.1 86.7 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 112.732 0.641 . . . . 55.33 112.732 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -63.98 -39.3 93.82 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.114 0.965 . . . . 73.13 111.363 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.08 -42.69 80.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.497 0.498 . . . . 55.14 111.497 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.18 -70.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.272 0.841 . . . . 65.33 113.272 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -158.36 119.98 3.53 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.486 -1.302 . . . . 74.12 107.486 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -128.83 -66.15 0.84 Allowed 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 117.113 -1.422 . . . . 42.41 111.883 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 tp -44.74 -50.34 10.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.092 1.357 . . . . 74.42 114.4 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -66.27 -59.44 3.72 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.939 -1.101 . . . . 61.43 112.235 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.576 ' CD2' HH21 ' A' ' 14' ' ' ARG . 3.0 t-160 -53.94 -51.85 62.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.488 1.115 . . . . 75.13 109.929 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.576 HH21 ' CD2' ' A' ' 13' ' ' HIS . 11.9 mmp_? -58.39 -46.2 86.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 115.599 -2.143 . . . . 71.14 109.867 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.17 -43.33 99.05 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.283 1.856 . . . . 71.32 112.449 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.66 -47.72 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 118.297 0.499 . . . . 74.01 110.008 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' HD11 ' B' ' 343' ' ' ILE . 0.5 OUTLIER -67.16 -39.9 86.55 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.603 -1.189 . . . . 64.42 110.371 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 m -56.1 -47.78 77.41 Favored 'General case' 0 CA--C 1.523 -0.059 0 CA-C-N 120.722 1.601 . . . . 74.04 107.386 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.83 72.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.967 0.358 . . . . 61.11 111.967 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.52 -51.47 65.34 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.801 -0.562 . . . . 74.32 111.317 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.46 -42.21 87.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 117.513 -1.232 . . . . 71.43 109.908 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -72.58 -29.66 63.73 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 120.556 1.526 . . . . 71.21 111.643 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.23 -46.48 41.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.995 0.816 . . . . 72.03 109.586 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -73.47 -45.93 51.19 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.669 -0.645 . . . . 71.43 110.689 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -122.76 79.76 48.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 125.324 1.45 . . . . 71.14 110.202 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.66 -20.66 52.88 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.877 1.718 . . . . 73.21 110.897 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.06 16.92 25.32 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.306 1.042 . . . . 64.13 112.946 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -120.89 153.45 37.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.867 -1.531 . . . . 72.04 106.867 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 135.11 24.08 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 124.022 0.929 . . . . 54.42 108.788 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.76 111.92 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 125.31 4.007 . . . . 63.1 112.884 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.82 149.73 16.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.873 0.869 . . . . 53.35 109.697 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.63 120.88 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 103.634 -2.728 . . . . 73.22 103.634 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.58 130.72 64.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.075 -1.454 . . . . 60.35 107.075 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.99 148.04 52.7 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.656 1.182 . . . . 63.22 110.3 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.83 132.86 36.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.283 -1.006 . . . . 73.41 108.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.16 111.96 2.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.375 -1.713 . . . . 75.52 106.375 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -57.73 123.83 17.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.457 -1.312 . . . . 74.23 107.457 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.49 -17.99 27.93 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.689 1.137 . . . . 62.41 110.665 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 t -71.93 168.49 17.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.973 1.386 . . . . 61.42 108.398 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.23 -11.82 17.73 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.171 0.988 . . . . 74.11 113.391 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tp -69.72 159.64 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.816 -0.553 . . . . 73.24 109.981 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.09 148.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.186 1.394 . . . . 63.32 110.385 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -77.67 167.65 21.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.069 1.348 . . . . 61.11 111.713 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.63 135.86 62.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.795 0.838 . . . . 61.32 111.166 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.36 152.32 38.37 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.693 1.197 . . . . 72.13 108.395 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -74.75 92.99 2.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.786 -1.19 . . . . 71.42 107.786 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -132.81 162.63 31.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.67 1.988 . . . . 75.21 109.838 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -113.32 108.42 17.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.239 -2.134 . . . . 70.03 105.239 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -84.37 122.95 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.278 -1.008 . . . . 74.04 108.278 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.87 110.75 23.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.197 -1.779 . . . . 72.14 106.197 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.29 142.29 26.11 Favored Pre-proline 0 N--CA 1.453 -0.296 0 O-C-N 124.033 0.833 . . . . 75.51 109.02 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 135.43 39.42 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.986 . . . . 73.42 111.147 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -14.91 32.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.513 0.725 . . . . 72.13 111.698 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.23 -31.2 43.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.752 1.221 . . . . 72.32 114.154 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pt -73.39 170.32 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.392 0.996 . . . . 73.32 110.708 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -105.33 166.98 10.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.032 0.933 . . . . 62.01 110.359 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.91 -39.48 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.615 1.166 . . . . 53.22 109.382 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.02 95.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.877 0.762 . . . . 50.21 111.447 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -61.62 -47.39 85.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.933 -0.766 . . . . 75.3 108.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 64' ' ' ILE . 2.3 t80 -60.05 -51.64 68.76 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.592 -0.521 . . . . 73.41 109.592 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.02 -47.91 71.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.857 1.663 . . . . 74.1 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -62.47 -41.22 98.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.795 0.271 . . . . 74.2 110.512 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.3 -39.73 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 118.091 -0.957 . . . . 62.45 108.432 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 ' CE2' ' A' ' 60' ' ' PHE . 22.1 mt -59.14 -50.47 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.523 1.511 . . . . 63.23 109.541 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -60.21 -35.06 74.58 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.119 -0.988 . . . . 64.1 110.37 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.3 -43.17 74.34 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.162 0.892 . . . . 74.01 109.822 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -60.7 -32.48 71.71 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 52.53 112.823 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.77 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.373 0.533 . . . . 35.22 111.46 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 54.56 57.65 5.58 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.161 -1.051 . . . . 65.33 108.161 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.43 108.82 2.87 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 107.105 -1.443 . . . . 74.31 107.105 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.03 147.42 67.53 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.346 -1.828 . . . . 62.05 107.346 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 m -62.72 -14.98 50.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.3 -0.875 . . . . 72.35 112.861 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -67.5 -28.61 67.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.131 0.878 . . . . 75.34 110.176 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -103.41 165.29 11.12 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.875 1.27 . . . . 72.43 108.525 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.69 176.03 5.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.043 1.337 . . . . 65.23 107.896 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.38 141.39 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.593 1.157 . . . . 55.23 108.265 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.26 135.96 24.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.808 2.043 . . . . 73.45 108.293 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.2 mt -114.94 156.14 25.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.75 1.62 . . . . 62.32 110.389 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -147.14 142.5 27.4 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.201 0.938 . . . . 74.02 109.878 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.96 119.91 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.424 -2.065 . . . . 73.3 105.424 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.1 t0 44.06 52.15 6.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.023 1.329 . . . . 75.22 111.347 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 60.19 19.11 8.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.471 1.509 . . . . 65.25 113.998 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 p -122.59 161.5 23.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 120.748 1.613 . . . . 74.02 110.606 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.42 113.8 64.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 102.181 -3.266 . . . . 73.44 102.181 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 138.84 35.15 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.327 1.152 . . . . 75.22 111.119 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -68.08 120.37 14.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.538 -1.282 . . . . 71.11 107.538 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 p -54.98 -18.67 5.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.967 1.707 . . . . 40.43 113.863 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -97.59 -0.83 45.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.909 1.684 . . . . 63.22 112.321 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 tp -80.96 151.55 28.45 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.381 1.446 . . . . 74.21 108.722 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -87.65 151.44 22.95 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 71.13 108.525 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.2 mmt -60.1 -39.28 85.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.761 -0.637 . . . . 73.32 110.386 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.89 -43.27 99.16 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.321 -0.712 . . . . 52.23 111.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -52.5 51.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.671 -0.863 . . . . 74.01 108.671 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.89 -36.71 72.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.946 0.499 . . . . 62.45 111.247 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -65.56 -55.16 19.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.151 -1.426 . . . . 74.43 107.151 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.85 -42.37 75.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.462 1.105 . . . . 71.54 112.479 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -26.71 29.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 117.466 -1.254 . . . . 74.23 114.229 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -109.89 9.11 24.57 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.89 1.223 . . . . 75.41 112.47 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -52.21 121.39 6.77 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.358 1.863 . . . . 73.01 111.251 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.43 169.29 17.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.511 -1.292 . . . . 74.14 107.511 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.99 -28.05 55.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.475 1.034 . . . . 71.44 111.42 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.57 7.33 20.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.982 1.313 . . . . 64.35 112.58 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.58 29.35 71.65 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 120.744 -1.223 . . . . 75.23 113.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -126.93 178.31 6.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.099 1.36 . . . . 62.2 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.82 129.92 51.79 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.211 1.004 . . . . 64.44 110.281 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -108.23 121.68 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.255 -1.387 . . . . 75.22 107.255 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.35 141.15 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.043 0.937 . . . . 72.21 109.529 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.27 151.26 37.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.164 -1.05 . . . . 72.32 108.164 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -135.67 152.79 51.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.573 0.624 . . . . 73.42 110.703 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -144.02 157.05 44.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.782 -1.192 . . . . 62.4 107.782 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 13.53 21.69 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.779 -1.328 . . . . 55.33 109.779 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -125.88 127.95 46.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.761 1.625 . . . . 72.41 107.549 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.83 -31.92 73.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.87 1.268 . . . . 73.34 109.534 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.71 122.23 38.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.52 1.528 . . . . 72.05 108.14 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -110.13 24.79 12.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.282 1.833 . . . . 64.25 109.176 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 116.189 -2.45 . . . . 75.1 112.45 -179.36 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.304 0 N-CA-C 111.005 -0.838 . . . . 65.1 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -147.74 22.91 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.474 1.109 . . . . 72.24 110.901 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 22.8 mmt -83.03 49.3 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.301 1.04 . . . . 74.34 111.231 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -85.6 50.43 1.96 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.419 -1.697 . . . . 71.4 106.419 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 22.3 pt -71.3 152.36 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.999 1.72 . . . . 63.15 112.196 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 5.9 pt -61.74 -41.49 90.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.041 1.336 . . . . 63.43 114.206 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -87.23 53.64 2.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.762 1.164 . . . . 74.45 108.802 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -66.21 108.76 2.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.284 -2.487 . . . . 74.23 104.284 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.097 -1.002 . . . . 63.35 112.168 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.89 107.54 17.51 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.803 1.641 . . . . 74.14 108.974 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.06 -37.71 28.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.395 1.478 . . . . 61.21 113.221 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 80.4 m95 55.16 59.45 3.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.819 1.248 . . . . 74.1 111.306 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -74.9 133.88 16.12 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.066 -1.214 . . . . 63.13 110.066 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 343' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 17' ' ' GLU . 56.0 mt -74.13 119.24 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.59 1.556 . . . . 64.51 107.526 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -124.07 145.85 48.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.979 1.312 . . . . 73.53 110.325 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 20.5 tp -99.81 115.54 29.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.235 1.414 . . . . 75.1 108.439 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.93 120.43 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.866 1.266 . . . . 63.34 109.965 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 8.6 p -161.11 159.2 28.8 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.511 1.051 . . . . 64.12 112.595 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--O 1.249 1.036 0 C-N-CA 127.576 2.35 . . . . 73.3 108.559 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tmm? . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 108.243 -1.021 . . . . 62.1 108.243 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.4 95.5 0.31 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 106.366 -2.694 . . . . 71.44 106.366 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -102.67 130.32 49.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.316 1.046 . . . . 73.55 108.479 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 mtt -64.51 -43.0 95.44 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.438 1.087 . . . . 75.23 108.818 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -59.77 -51.72 68.54 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.558 -0.734 . . . . 72.3 110.668 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.17 -31.71 73.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 117.879 -1.058 . . . . 70.44 111.672 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -59.76 -45.31 92.65 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.57 -74.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.549 0.531 . . . . 64.42 110.325 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 143.03 13.27 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.74 2.816 . . . . 72.1 108.914 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 p -120.68 -66.39 1.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 117.268 -1.349 . . . . 72.53 111.311 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -45.71 -59.0 3.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.355 1.862 . . . . 73.1 113.915 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.97 -48.02 72.66 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.356 -0.84 . . . . 71.41 111.754 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.419 ' HE2' ' HZ3' ' A' ' 48' ' ' LYS . 6.1 t60 -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.599 0.36 . . . . 73.54 110.228 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -47.24 85.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.165 1.386 . . . . 73.42 108.559 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 t -61.75 -51.93 66.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 120.036 1.289 . . . . 51.54 111.481 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.42 -47.99 86.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.383 -0.823 . . . . 74.5 110.503 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.83 -52.03 65.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.837 0.855 . . . . 75.41 110.741 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 p -59.13 -48.13 82.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.293 -0.86 . . . . 63.0 110.456 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.27 78.14 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.668 1.122 . . . . 74.45 111.536 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -67.61 -40.25 84.71 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.517 -0.739 . . . . 71.11 110.628 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.1 -41.94 79.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 118.157 -0.925 . . . . 63.04 110.017 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -62.63 -38.25 89.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 120.208 1.367 . . . . 73.54 108.509 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.31 69.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.559 -0.856 . . . . 24.15 110.895 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -78.08 -46.8 19.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 118.448 2.758 . . . . 73.51 118.448 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -131.59 76.92 74.17 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.397 2.279 . . . . 75.14 108.789 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.69 -23.5 36.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.756 2.304 . . . . 71.31 112.364 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.62 12.85 17.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 73.43 112.426 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -122.0 153.81 38.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.493 -1.669 . . . . 75.11 106.493 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.32 138.41 24.28 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.483 -0.932 . . . . 62.22 108.483 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.6 122.27 5.45 Favored 'Trans proline' 0 C--N 1.353 0.792 1 C-N-CA 125.879 4.386 . . . . 54.22 111.449 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -131.93 143.27 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.121 0.968 . . . . 72.15 111.56 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.1 mm -117.38 120.48 65.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 103.695 -2.705 . . . . 52.51 103.695 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -108.16 110.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.978 1.711 . . . . 71.2 108.65 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -123.02 153.09 40.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.208 0.913 . . . . 74.23 110.911 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -93.54 146.22 23.95 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.345 0.521 . . . . 72.3 110.501 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.23 136.55 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.328 1.451 . . . . 63.22 107.816 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 m -49.19 142.19 7.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.961 0.904 . . . . 61.4 111.572 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.82 1.57 1.44 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.781 2.134 . . . . 44.43 116.543 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t -58.85 147.3 34.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 119.241 1.52 . . . . 74.11 111.699 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 -0.79 31.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.906 1.282 . . . . 44.3 112.449 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -82.92 156.79 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.556 1.071 . . . . 63.31 109.118 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 151.9 9.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.684 0.754 . . . . 72.15 109.267 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.02 165.23 23.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.35 1.241 . . . . 72.11 114.35 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.62 139.5 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 127.572 2.349 . . . . 71.43 108.177 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.47 161.29 26.17 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.793 -1.558 . . . . 63.43 106.793 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.5 104.92 3.98 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.234 -1.395 . . . . 65.15 107.234 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -136.61 160.12 39.76 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.755 1.622 . . . . 74.21 110.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 11.2 mttt -107.96 116.29 31.69 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.296 1.839 . . . . 72.1 106.51 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -98.26 138.82 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.762 1.165 . . . . 75.1 111.91 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.6 mt -120.75 110.9 16.92 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.299 1.44 . . . . 74.53 108.626 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.45 142.11 25.83 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 118.137 -0.935 . . . . 75.54 111.099 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.55 137.54 27.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.196 2.597 . . . . 72.32 110.863 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -61.52 -12.5 15.48 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.914 1.45 . . . . 34.23 114.914 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.95 -34.88 29.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.831 1.196 . . . . 74.31 113.639 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.64 168.1 2.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.145 0.497 . . . . 51.34 112.004 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 p -107.54 163.37 13.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.305 0.483 . . . . 62.41 112.305 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.6 t -50.06 -34.67 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.583 1.153 . . . . 64.21 109.758 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.66 88.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.635 1.174 . . . . 64.25 111.237 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -69.63 -42.6 74.1 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 124.073 0.949 . . . . 62.11 110.206 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -59.54 -46.94 87.42 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.586 -0.894 . . . . 72.51 108.586 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.6 ttt -58.69 -43.7 90.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.706 1.203 . . . . 75.02 109.553 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -58.55 -46.8 86.09 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.851 0.751 . . . . 70.45 110.297 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.432 HG21 HG13 ' B' ' 346' ' ' VAL . 12.0 mt -61.78 -42.67 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 118.585 -0.721 . . . . 75.11 109.804 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.2 mt -58.15 -50.36 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.634 1.107 . . . . 72.41 109.7 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -64.73 -31.71 73.06 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.961 -1.087 . . . . 71.31 112.655 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -70.76 -48.4 54.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.523 0.729 . . . . 72.25 109.746 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -59.45 -49.26 78.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.05 1.74 . . . . 74.34 111.682 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 pt -78.87 -5.87 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.793 -0.363 . . . . 71.15 111.152 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 56.29 62.32 2.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.565 1.546 . . . . 74.35 108.289 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 108.53 2.96 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.069 0.948 . . . . 74.02 108.847 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.8 164.51 35.44 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.137 2.558 . . . . 62.33 111.059 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -67.01 -17.03 64.73 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.216 -0.928 . . . . 73.4 112.142 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.76 -42.83 97.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.354 0.979 . . . . 64.25 109.189 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -102.53 164.74 11.48 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 122.6 1.191 . . . . 64.44 110.802 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.2 -176.78 3.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.336 -1.727 . . . . 75.52 106.336 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 tp -144.52 139.25 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.145 -1.428 . . . . 63.44 107.145 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -145.3 134.46 22.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.143 1.377 . . . . 72.43 108.665 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.28 135.14 54.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.661 1.584 . . . . 65.25 107.907 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.49 124.29 29.83 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.407 1.083 . . . . 74.02 109.237 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.28 129.67 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.478 1.111 . . . . 44.04 108.255 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.42 33.24 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.929 1.692 . . . . 71.54 112.145 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 66.31 23.31 10.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.066 1.347 . . . . 62.25 111.278 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -123.15 162.25 22.87 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.372 1.869 . . . . 51.52 110.561 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.2 103.34 13.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 105.591 -2.003 . . . . 74.12 105.591 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.11 139.33 42.18 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.869 1.713 . . . . 71.12 111.734 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -74.06 120.26 19.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.601 -0.888 . . . . 63.12 108.601 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 13.0 p -46.75 -37.82 9.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.441 1.896 . . . . 75.34 114.753 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 p -86.38 -6.1 59.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 115.156 1.539 . . . . 61.14 115.156 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.41 141.54 57.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.555 -1.646 . . . . 53.04 106.555 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.3 p -80.61 154.74 27.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.391 -0.818 . . . . 72.54 109.087 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.2 mmt -59.24 -40.88 87.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.123 0.969 . . . . 72.31 108.978 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 -44.47 97.45 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.196 -1.336 . . . . 62.44 110.802 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.74 -48.35 54.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.005 1.403 . . . . 74.32 111.053 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -45.98 76.5 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.121 -0.696 . . . . 75.41 109.121 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -63.14 -52.4 62.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.731 0.696 . . . . 64.3 109.374 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -54.54 -40.42 68.66 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.237 0.828 . . . . 74.34 113.237 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -23.73 22.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.167 -1.397 . . . . 74.5 113.518 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -103.98 9.55 36.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.058 1.299 . . . . 63.33 110.842 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -52.42 121.33 6.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.384 2.273 . . . . 75.04 111.322 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -89.18 175.61 7.3 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.658 0.783 . . . . 74.54 108.942 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.85 -37.9 60.81 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.199 1.4 . . . . 74.14 111.571 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.39 -2.78 50.65 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.238 1.815 . . . . 52.42 111.966 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.62 29.33 71.65 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.911 1.243 . . . . 72.1 112.724 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 166.67 13.31 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.336 1.454 . . . . 75.52 109.377 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.3 tp -122.41 131.21 53.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.916 -1.142 . . . . 72.14 107.916 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -122.5 116.35 23.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.347 1.859 . . . . 75.32 107.432 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.69 150.15 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 O-C-N 121.227 -0.921 . . . . 62.41 110.058 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.2 152.51 33.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.089 -0.708 . . . . 73.1 109.089 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -135.24 154.2 51.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.861 0.839 . . . . 55.44 110.703 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.9 p -149.22 155.79 41.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.662 1.185 . . . . 71.53 108.137 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.18 21.86 12.8 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 111.383 -0.687 . . . . 45.34 111.383 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -117.57 125.38 50.7 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.46 1.904 . . . . 73.21 108.417 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.79 -25.01 61.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.488 1.515 . . . . 63.42 109.819 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -135.65 133.65 38.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.011 2.125 . . . . 73.34 106.344 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -97.72 70.77 2.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.396 1.078 . . . . 75.51 110.712 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.039 -1.423 . . . . 70.33 110.142 179.698 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 109.841 -1.303 . . . . 53.01 109.841 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 54.35 31.71 14.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.475 1.51 . . . . 74.41 112.235 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 7.3 mtp -86.47 70.08 10.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.048 -1.464 . . . . 71.24 107.048 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -111.52 27.67 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.84 1.256 . . . . 62.54 109.23 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 334' ' ' ILE . 1.9 mp -60.44 152.95 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.204 1.401 . . . . 54.15 107.424 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 48.2 mt -119.4 -34.06 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 124.084 0.954 . . . . 74.34 111.359 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -112.3 61.26 0.63 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.301 1.041 . . . . 75.43 109.071 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -67.26 160.02 27.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.545 -1.28 . . . . 74.14 107.545 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.12 -42.01 99.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.461 1.652 . . . . 63.52 115.461 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -108.48 144.39 36.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.405 1.002 . . . . 65.31 109.842 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -62.16 1.52 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.746 0.647 . . . . 71.31 112.746 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.494 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 48.8 m95 54.71 64.71 1.72 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.212 1.405 . . . . 64.0 110.863 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.88 138.78 17.15 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 107.517 -2.233 . . . . 62.52 107.517 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.68 142.94 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.446 1.623 . . . . 73.05 110.636 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.05 156.49 46.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.358 1.463 . . . . 73.43 110.489 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.29 119.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.104 2.162 . . . . 74.52 106.43 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 63' ' ' ILE . 2.7 t -120.97 119.16 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 122.511 1.148 . . . . 65.34 109.808 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.9 p -161.76 152.76 18.08 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.688 -1.142 . . . . 61.12 110.248 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 129.466 3.106 . . . . 61.34 113.506 179.252 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.89 -1.152 . . . . 64.32 107.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.93 -163.03 24.0 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 108.401 -1.88 . . . . 54.55 108.401 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -74.09 125.68 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.622 -1.622 . . . . 74.11 106.622 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.21 -38.93 88.34 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.198 -0.667 . . . . 74.43 109.198 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -59.97 -39.63 86.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.412 1.005 . . . . 75.12 110.198 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.564 0.62 . . . . 72.13 109.431 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.0 -44.87 91.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.355 -0.98 . . . . 73.23 108.355 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.83 -75.97 0.18 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.746 1.017 . . . . 64.31 113.746 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -158.56 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.536 1.934 . . . . 70.5 108.229 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 p -102.36 -67.25 0.88 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.409 0.892 . . . . 74.53 113.409 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 -55.07 22.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 117.176 2.287 . . . . 75.31 117.176 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.0 -54.92 26.71 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.061 0.846 . . . . 72.53 111.23 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.75 -43.59 65.86 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.629 1.571 . . . . 74.42 111.078 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -47.06 63.34 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.891 -1.131 . . . . 75.5 109.626 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.91 -58.46 7.52 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.589 0.756 . . . . 72.32 111.065 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.39 -46.19 92.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.048 0.539 . . . . 73.1 110.916 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 48' ' ' LYS . 29.8 mm-40 -64.98 -40.04 94.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.847 -1.073 . . . . 71.44 110.997 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 t -57.66 -46.92 83.61 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.273 1.397 . . . . 52.02 108.541 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.43 72.33 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.017 0.371 . . . . 40.31 111.325 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -59.0 -49.13 79.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.855 1.262 . . . . 71.32 110.328 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.33 -42.89 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 117.393 -1.289 . . . . 65.4 111.403 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -71.05 -29.81 65.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.527 1.512 . . . . 73.12 110.242 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.29 -47.29 57.76 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.676 -0.861 . . . . 73.23 108.676 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.53 -47.96 18.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.429 1.27 . . . . 74.45 114.429 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.73 73.43 69.55 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 127.869 2.468 . . . . 74.24 111.222 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.97 -29.36 89.17 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.063 1.842 . . . . 72.42 112.457 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.67 11.81 16.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.518 0.599 . . . . 75.41 111.086 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -112.42 143.33 43.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.61 1.55 . . . . 52.13 109.414 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -107.06 133.49 20.27 Favored Pre-proline 0 C--O 1.246 0.883 0 C-N-CA 124.323 1.049 . . . . 71.45 108.295 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.19 119.81 5.45 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.89 3.727 . . . . 74.32 112.606 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.23 149.67 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 74.51 111.115 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -122.13 134.4 65.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 102.669 -3.086 . . . . 72.32 102.669 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.77 119.57 53.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.379 1.471 . . . . 61.11 109.326 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.7 157.41 46.83 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.453 1.024 . . . . 74.42 113.279 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.7 150.98 23.28 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.872 0.368 . . . . 71.25 110.602 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.88 135.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.999 -1.482 . . . . 72.2 106.999 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -64.11 115.74 5.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.118 -1.068 . . . . 54.53 108.118 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.85 30.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.39 1.471 . . . . 44.41 112.374 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.9 m -85.23 112.58 20.87 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.623 1.711 . . . . 52.15 107.727 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.78 -20.98 60.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.267 1.827 . . . . 73.43 114.548 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.1 tp -53.42 158.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.449 1.5 . . . . 61.52 114.809 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.6 m -49.07 114.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.785 1.634 . . . . 73.01 109.64 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -82.1 167.76 18.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.453 1.501 . . . . 74.41 108.727 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -126.15 139.14 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.724 -1.213 . . . . 71.01 107.724 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.72 166.15 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.77 0.795 . . . . 64.41 109.47 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.35 105.81 4.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.267 -2.123 . . . . 64.23 105.267 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 12.1 mmm180 -139.92 152.41 46.37 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 124.243 1.017 . . . . 74.53 111.087 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 21.5 mttp -93.95 94.75 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.577 -2.009 . . . . 65.43 105.577 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -85.08 117.07 23.82 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.197 -1.038 . . . . 71.35 108.197 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.53 115.48 30.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.145 1.378 . . . . 45.42 110.471 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.01 142.92 27.7 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 119.966 1.257 . . . . 73.31 111.945 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 141.67 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.08 2.52 . . . . 54.41 110.691 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -62.5 -13.62 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.7 2.0 . . . . 63.12 113.28 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -30.03 25.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.636 0.976 . . . . 75.54 113.636 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.66 166.68 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 119.391 0.996 . . . . 74.1 110.403 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 p -107.51 163.01 13.42 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.373 -0.829 . . . . 75.33 112.989 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.79 -35.98 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.11 0.964 . . . . 73.15 109.201 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.72 78.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.484 0.714 . . . . 65.11 110.717 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -71.92 -43.22 65.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.413 1.085 . . . . 75.41 109.942 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.79 -41.97 87.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.123 0.874 . . . . 75.21 109.474 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 42.3 ttp -63.31 -48.8 76.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.041 -0.725 . . . . 74.31 109.041 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -58.89 -44.94 91.27 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.398 0.544 . . . . 62.23 111.092 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.91 -50.91 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.329 1.052 . . . . 73.34 108.307 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.79 -49.96 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.055 0.843 . . . . 73.13 111.009 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -64.05 -32.93 74.66 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.937 -1.102 . . . . 74.41 112.183 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -71.89 -46.47 57.66 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.77 -0.826 . . . . 62.51 108.77 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.3 -51.41 64.73 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.26 1.824 . . . . 74.25 111.942 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -3.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.142 0.423 . . . . 60.44 112.142 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 55.29 63.71 2.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.26 1.824 . . . . 73.32 107.776 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.67 114.28 18.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.229 -1.026 . . . . 74.23 108.229 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.98 164.37 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.781 2.987 . . . . 71.13 113.054 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.5 p -66.8 -32.32 73.53 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.929 -1.107 . . . . 53.44 112.659 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -59.44 -36.0 75.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.034 1.734 . . . . 72.34 112.337 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.83 165.04 11.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.471 1.108 . . . . 74.52 111.01 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.27 -179.4 3.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.963 2.105 . . . . 73.41 108.895 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.3 136.37 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.087 1.355 . . . . 71.01 107.886 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.34 136.67 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.424 -1.324 . . . . 75.21 107.424 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.28 148.85 31.09 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.469 1.108 . . . . 72.52 108.728 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -137.01 123.26 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.071 1.749 . . . . 73.24 108.417 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.06 144.49 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.582 1.153 . . . . 64.51 108.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 48.92 35.77 7.22 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.149 1.341 . . . . 70.2 111.853 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tttt 55.02 31.44 16.11 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.112 0.965 . . . . 55.14 111.476 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -152.19 163.96 38.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.642 1.177 . . . . 61.21 109.9 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 115.12 61.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 104.912 -2.255 . . . . 74.34 104.912 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.74 141.29 40.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.105 1.87 . . . . 71.42 110.606 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -72.09 127.28 32.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.736 -0.838 . . . . 73.1 108.736 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 p -53.81 -35.47 61.43 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.012 2.125 . . . . 61.44 112.218 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 t -70.02 -14.96 62.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.779 1.632 . . . . 63.33 112.39 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.73 147.78 48.67 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.45 -0.945 . . . . 72.43 108.45 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 m -98.88 149.09 23.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.871 -1.159 . . . . 65.24 107.871 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.7 mmt -55.04 -46.19 75.29 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.066 0.547 . . . . 74.44 111.745 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.91 -46.63 83.37 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.919 -0.873 . . . . 55.04 110.919 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -65.08 -52.92 52.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.48 0.712 . . . . 73.22 109.818 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.03 -50.28 64.58 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.045 0.938 . . . . 70.54 110.814 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.9 -49.14 75.97 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.067 -1.021 . . . . 73.52 109.838 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -68.22 -24.51 64.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.98 0.809 . . . . 74.1 112.797 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -37.4 13.87 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 119.687 1.13 . . . . 75.21 111.179 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.17 -3.77 50.32 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.318 1.229 . . . . 71.14 114.318 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -36.26 121.78 0.71 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.451 2.389 . . . . 52.33 117.451 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.31 165.92 23.85 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.206 -1.405 . . . . 61.1 107.206 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.18 -34.64 57.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.529 1.132 . . . . 54.13 111.871 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -96.77 14.08 26.33 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.552 1.141 . . . . 75.34 113.579 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.2 70.59 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 120.688 -1.258 . . . . 60.24 113.853 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.39 154.48 29.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.526 1.163 . . . . 71.3 108.382 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.49 133.89 55.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.826 -1.176 . . . . 73.12 107.826 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.81 124.3 42.99 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.257 1.423 . . . . 72.21 109.121 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 143.64 40.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-O 122.091 0.948 . . . . 63.01 108.59 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.85 155.96 22.79 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.551 -0.718 . . . . 75.34 109.132 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -140.99 161.34 38.07 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.531 0.732 . . . . 61.51 111.525 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -151.61 156.95 41.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.811 -1.181 . . . . 63.43 107.811 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.0 26.26 9.43 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 126.54 2.019 . . . . 70.1 109.918 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -132.23 141.44 49.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.376 2.271 . . . . 72.03 106.72 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -81.09 -48.02 12.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.982 -1.008 . . . . 72.44 108.383 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m -94.46 124.23 38.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.69 0.796 . . . . 63.02 108.971 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -118.65 12.29 13.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.904 2.081 . . . . 74.13 111.043 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 C-N-CA 125.255 1.407 . . . . 62.23 112.144 -179.226 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 109.769 -1.332 . . . . 72.24 109.769 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 68.0 96.25 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 128.418 2.687 . . . . 71.23 110.348 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.9 19.94 14.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.673 1.189 . . . . 72.51 110.432 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.08 50.75 0.21 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.484 1.914 . . . . 64.23 112.391 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.67 118.95 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.123 1.369 . . . . 75.44 107.609 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.48 -15.5 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 119.202 -0.428 . . . . 72.43 111.196 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -78.89 62.0 3.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.975 1.31 . . . . 62.23 107.611 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.96 108.96 2.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.31 -2.478 . . . . 53.21 104.31 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.94 -27.11 63.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.567 1.147 . . . . 64.14 111.224 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.74 156.8 20.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.946 -1.501 . . . . 73.31 106.946 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.9 -57.16 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.557 -0.714 . . . . 72.11 111.846 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.433 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 75.4 m95 58.68 58.93 3.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 74.04 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 342' ' ' GLY . . . . . 0.421 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.85 145.29 28.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.967 -1.653 . . . . 65.53 108.967 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 33.0 mt -77.51 141.16 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.821 1.31 . . . . 64.11 111.138 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.66 122.91 16.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.672 0.789 . . . . 74.44 108.972 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.31 108.54 20.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.666 -2.346 . . . . 62.2 104.666 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.62 134.78 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.181 0.808 . . . . 70.32 113.181 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 12.8 p -161.47 158.64 26.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.642 1.577 . . . . 64.21 107.388 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 127.999 2.519 . . . . 72.34 112.504 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.5 mtp . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.858 -0.423 . . . . 72.52 109.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.49 -127.73 1.91 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 108.486 -1.846 . . . . 53.33 108.486 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -73.42 112.9 9.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.599 -0.889 . . . . 72.13 108.599 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.5 mmm -57.66 -46.89 83.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.133 -0.692 . . . . 73.1 109.133 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -58.16 -45.05 88.12 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 119.721 -0.181 . . . . 74.5 111.082 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -64.79 -35.03 79.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.279 -0.391 . . . . 64.35 111.622 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.76 -48.09 78.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.24 -1.022 . . . . 73.02 108.24 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -71.34 0.22 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 115.081 1.511 . . . . 75.1 115.081 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -156.22 128.19 7.42 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.785 2.034 . . . . 74.24 108.203 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -124.9 -66.15 0.98 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 116.529 -1.701 . . . . 61.33 114.069 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -56.55 13.7 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.265 1.393 . . . . 71.32 114.471 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.7 -36.13 82.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.054 0.843 . . . . 72.33 111.58 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -64.75 -55.09 21.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.702 0.801 . . . . 73.12 110.831 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -49.24 75.32 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.303 1.441 . . . . 65.42 109.294 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.2 t -54.15 -61.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.926 0.784 . . . . 72.24 112.033 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.91 -47.61 90.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 123.874 0.734 . . . . 73.34 112.279 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -47.08 70.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.151 -1.02 . . . . 65.4 111.642 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -55.03 -45.41 75.18 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 120.046 1.294 . . . . 73.11 109.493 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.77 72.09 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.261 0.553 . . . . 72.42 112.253 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.69 -40.0 88.35 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.331 0.652 . . . . 65.01 110.276 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.15 -42.09 93.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 117.78 -1.105 . . . . 75.33 108.624 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -63.86 -39.18 93.59 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 120.092 1.314 . . . . 65.04 109.423 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.94 67.07 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.935 0.398 . . . . 64.3 111.633 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -72.23 -44.99 62.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.415 -0.803 . . . . 74.11 112.783 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -128.75 78.72 75.64 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.121 1.368 . . . . 73.13 109.694 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.45 -17.65 49.05 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.659 2.239 . . . . 72.45 112.044 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -99.87 13.17 34.75 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.415 0.686 . . . . 72.04 110.061 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -123.21 155.64 36.71 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.842 1.201 . . . . 74.32 108.728 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.76 136.85 27.83 Favored Pre-proline 0 C--O 1.241 0.656 0 C-N-CA 124.126 0.97 . . . . 74.11 109.846 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.78 114.73 3.7 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 125.251 3.967 . . . . 72.23 111.769 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.52 143.99 34.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.555 1.142 . . . . 42.14 109.358 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 mm -120.73 127.05 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 102.375 -3.194 . . . . 73.24 102.375 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.67 124.55 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.319 1.447 . . . . 70.34 108.896 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -136.59 154.26 50.73 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.25 1.386 . . . . 74.5 110.513 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -91.78 152.71 20.02 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.944 -0.473 . . . . 73.34 111.685 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.8 t -66.83 126.1 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.681 1.593 . . . . 74.14 107.212 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 p -58.72 121.85 12.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.729 0.695 . . . . 74.31 110.296 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.51 -18.8 49.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.626 2.06 . . . . 73.31 111.847 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -55.65 136.94 50.18 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.896 1.348 . . . . 63.54 111.289 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -64.49 -28.73 69.86 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.859 1.264 . . . . 75.13 114.096 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.11 154.33 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.471 0.708 . . . . 62.31 112.124 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.78 140.11 20.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.172 -1.418 . . . . 73.12 107.172 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -84.36 167.6 16.37 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.515 -0.92 . . . . 62.31 108.515 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.81 144.17 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.745 -1.576 . . . . 65.51 106.745 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 165.61 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.549 0.69 . . . . 70.41 110.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.3 95.29 2.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.767 -1.197 . . . . 52.04 107.767 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -136.25 151.74 49.99 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.153 0.981 . . . . 74.1 109.562 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 29.8 mttp -95.7 102.09 13.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.058 -2.201 . . . . 74.41 105.058 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -84.58 136.73 33.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.158 0.89 . . . . 74.42 109.162 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 mt -120.19 108.56 14.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.975 -1.491 . . . . 70.45 106.975 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.17 141.99 25.42 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 117.946 -1.026 . . . . 63.42 110.408 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 141.29 38.87 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.141 1.894 . . . . 72.31 113.568 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 m -62.58 -17.32 59.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.874 1.67 . . . . 52.13 110.877 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -68.37 -35.34 77.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.733 2.413 . . . . 73.51 112.751 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -86.26 171.0 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 122.014 0.911 . . . . 62.34 112.648 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.6 p -107.23 166.12 10.87 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.492 1.517 . . . . 71.41 110.541 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.75 -34.32 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 62.41 108.559 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -47.86 83.55 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 121.495 -0.753 . . . . 54.34 112.69 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.54 -37.5 71.12 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 123.162 0.585 . . . . 71.5 110.095 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.9 -45.1 91.07 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.934 -0.765 . . . . 74.53 108.934 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 ttt -63.57 -44.96 92.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.069 -0.967 . . . . 61.34 110.105 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -57.04 -41.29 78.37 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.996 0.816 . . . . 74.54 111.09 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.01 -51.12 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.533 -0.914 . . . . 75.1 108.533 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 60' ' ' PHE . 29.9 mt -52.46 -50.36 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.262 0.937 . . . . 64.14 111.049 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -62.31 -39.42 92.96 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.062 -1.024 . . . . 74.54 112.064 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -74.34 -33.75 63.23 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.77 1.168 . . . . 75.12 111.305 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.47 -48.73 78.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.998 0.817 . . . . 62.2 109.552 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -79.98 -3.18 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.013 0.196 . . . . 41.25 110.88 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 53.1 57.93 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.203 1.801 . . . . 62.42 109.532 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.11 109.98 4.87 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 124.979 1.312 . . . . 70.23 108.735 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.73 159.46 52.61 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.442 2.761 . . . . 74.42 111.205 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 m -67.3 -14.47 62.95 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.091 -1.005 . . . . 74.12 112.706 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.46 -34.11 67.51 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.112 -0.47 . . . . 71.04 110.157 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.55 164.41 11.68 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.355 1.062 . . . . 73.02 108.942 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 175.72 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.97 1.308 . . . . 72.02 109.21 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.76 140.63 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 125.278 1.431 . . . . 62.02 107.722 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -145.06 129.84 18.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.429 1.892 . . . . 65.43 106.916 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.99 146.57 41.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.004 1.322 . . . . 75.52 109.244 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -142.66 132.89 24.67 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.707 1.203 . . . . 71.2 110.303 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.63 121.89 64.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 C-N-CA 124.712 1.205 . . . . 62.14 107.99 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 43.05 51.83 5.39 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.361 1.465 . . . . 72.35 113.119 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.51 25.3 15.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.066 1.346 . . . . 74.45 113.392 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 p -132.66 161.47 33.86 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.479 1.036 . . . . 72.34 111.049 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.35 105.53 36.93 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 103.184 -2.895 . . . . 73.33 103.184 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.2 130.57 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.766 2.311 . . . . 74.41 111.967 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.32 125.84 27.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.166 -1.42 . . . . 74.34 107.166 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -55.75 -22.48 24.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 63.03 113.904 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -79.31 -18.41 52.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.466 1.107 . . . . 62.32 111.652 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.66 141.67 56.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.41 -0.806 . . . . 64.5 110.09 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.47 152.0 24.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.029 -1.1 . . . . 73.21 108.029 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 45.3 mmm -62.93 -42.46 99.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.175 -0.917 . . . . 50.43 110.278 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.42 97.6 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.798 0.727 . . . . 43.23 111.566 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -46.89 71.33 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.322 0.649 . . . . 72.42 109.4 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.43 -46.26 86.86 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.727 -0.472 . . . . 75.4 109.727 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.81 -45.3 94.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.245 1.418 . . . . 74.32 109.765 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.55 -33.35 75.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.968 0.907 . . . . 71.24 111.597 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -90.54 -23.5 20.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.264 -1.35 . . . . 75.4 113.488 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -110.35 -2.1 16.85 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.921 1.452 . . . . 71.11 114.921 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -45.23 121.85 3.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.969 1.259 . . . . 65.23 114.377 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -71.45 176.09 4.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.811 1.244 . . . . 64.11 108.36 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.82 -33.14 55.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.83 2.052 . . . . 74.24 111.81 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 10.34 36.01 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.151 1.78 . . . . 73.12 111.563 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.92 68.74 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.899 -1.126 . . . . 63.05 113.255 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.88 168.81 9.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.21 1.505 . . . . 71.04 109.889 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.53 136.43 54.55 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.685 0.394 . . . . 72.34 110.273 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -119.75 119.21 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.254 1.822 . . . . 74.44 109.084 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.18 144.0 38.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 121.11 -0.994 . . . . 74.44 109.294 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.56 21.02 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.698 0.799 . . . . 71.04 109.849 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -146.19 160.84 41.42 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.425 0.631 . . . . 61.13 110.797 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 p -151.62 161.35 42.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.719 1.208 . . . . 75.12 108.774 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.88 22.89 12.17 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.298 0.952 . . . . 72.24 111.909 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 132.2 37.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.308 1.843 . . . . 75.25 106.961 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -77.0 -27.54 54.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.086 0.47 . . . . 73.04 110.353 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.5 p -100.74 114.65 28.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.059 -1.83 . . . . 75.34 106.059 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -116.61 9.66 14.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.115 0.966 . . . . 74.54 111.767 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.695 0 CA-C-O 116.902 -2.054 . . . . 62.45 110.585 179.15 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 112.074 -0.41 . . . . 75.41 112.074 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.65 162.12 29.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.258 0.623 . . . . 62.4 110.826 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 50.2 mtt -76.62 70.6 3.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.408 1.483 . . . . 74.14 112.009 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -117.17 32.62 6.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.444 1.098 . . . . 63.3 109.566 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 334' ' ' ILE . . . . . 0.549 ' H ' HD12 ' B' ' 334' ' ' ILE . 1.1 mp -69.07 148.71 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.264 -1.013 . . . . 74.1 108.264 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 87.9 mt -72.03 -22.41 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.748 1.219 . . . . 74.45 109.792 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -89.15 77.2 7.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.986 -1.116 . . . . 74.44 107.986 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.2 143.66 33.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.501 1.92 . . . . 72.1 106.498 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.97 -33.5 11.18 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.426 0.632 . . . . 60.3 110.824 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -109.02 137.41 46.97 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.648 1.179 . . . . 71.33 108.688 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.73 -58.94 4.5 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.159 1.17 . . . . 74.12 114.159 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.452 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 51.3 m95 53.33 57.34 6.31 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.473 1.509 . . . . 73.41 111.823 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -77.7 141.09 25.06 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.789 -1.324 . . . . 63.34 109.789 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 28.8 mt -74.1 128.84 36.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 119.142 1.471 . . . . 75.44 109.437 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.22 126.75 30.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.073 0.949 . . . . 72.4 109.896 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.44 122.35 31.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 104.179 -2.526 . . . . 73.54 104.179 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 51.6 t -120.58 124.02 71.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.562 1.145 . . . . 41.31 109.163 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.4 p -161.19 151.65 17.85 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.947 0.34 . . . . 72.42 111.524 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 126.675 1.99 . . . . 75.13 111.408 -179.615 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.834 -0.432 . . . . 63.44 109.834 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.37 146.76 5.36 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.548 -1.421 . . . . 75.41 109.548 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -106.46 118.92 37.92 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.262 0.625 . . . . 74.13 110.573 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.3 tpt -55.35 -46.27 76.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.433 1.083 . . . . 63.12 108.327 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -60.53 -42.27 96.16 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 113.241 0.83 . . . . 74.25 113.241 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.13 -37.44 83.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 118.946 0.794 . . . . 73.32 110.672 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.04 -47.73 76.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.335 1.022 . . . . 64.43 108.467 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.48 -75.87 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.025 1.33 . . . . 52.54 113.033 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.38 131.73 5.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.883 1.673 . . . . 74.22 107.798 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.2 t -130.2 -58.66 1.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 115.724 1.75 . . . . 62.33 115.724 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.44 -57.29 12.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.728 1.604 . . . . 75.54 114.927 -176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 13' ' ' HIS . 1.3 pm0 -62.95 -51.02 68.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.083 0.468 . . . . 64.23 110.229 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.464 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 84.4 t60 -52.07 -44.83 64.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.022 2.129 . . . . 74.42 110.073 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -49.84 63.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 116.872 -1.537 . . . . 62.44 110.136 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.4 m -60.54 -48.83 80.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.917 1.08 . . . . 74.1 113.917 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.97 -47.53 90.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 121.705 -0.622 . . . . 72.03 109.894 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.35 -42.49 79.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.518 -0.754 . . . . 73.21 111.848 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -59.83 -45.02 93.7 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.272 -1.01 . . . . 75.12 108.272 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.85 -49.17 77.59 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.955 0.798 . . . . 60.21 110.851 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -61.03 -46.09 92.15 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.864 -1.148 . . . . 53.24 110.883 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.94 -41.65 93.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-O 117.735 -1.126 . . . . 71.2 109.441 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -66.69 -41.07 88.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.581 1.537 . . . . 72.3 110.521 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.76 68.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.596 -0.441 . . . . 63.4 110.852 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -77.71 -33.11 53.2 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.651 0.982 . . . . 53.52 113.651 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 82.07 25.04 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.429 1.492 . . . . 63.3 111.009 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.77 -29.1 36.06 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.888 2.392 . . . . 72.14 112.602 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.81 13.23 13.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.876 0.871 . . . . 72.13 110.956 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -121.56 152.35 39.32 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.525 -1.359 . . . . 72.03 109.749 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.24 140.73 31.71 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 124.007 0.923 . . . . 73.02 108.584 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 117.66 3.57 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 125.141 3.894 . . . . 71.45 111.931 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.2 t -120.45 140.91 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.047 1.339 . . . . 64.33 108.675 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.09 135.33 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.585 -2.376 . . . . 72.41 104.585 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.73 134.85 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.251 0.62 . . . . 63.21 109.491 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.85 143.66 43.19 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.888 0.875 . . . . 65.51 108.701 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.62 143.09 31.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.299 -1.371 . . . . 71.11 107.299 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.82 108.12 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 103.07 -2.937 . . . . 62.22 103.07 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -53.75 132.67 41.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.785 -0.82 . . . . 52.32 108.785 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.2 40.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.836 1.207 . . . . 40.23 112.235 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -81.98 137.63 35.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.539 1.67 . . . . 71.01 108.027 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -66.2 -11.26 48.62 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.524 0.729 . . . . 53.14 112.803 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.441 ' CD1' HD23 ' A' ' 70' ' ' LEU . 8.8 tp -60.96 154.37 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.602 0.761 . . . . 75.51 109.323 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.65 144.97 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.405 1.082 . . . . 55.24 110.186 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.77 167.13 18.44 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.26 2.224 . . . . 72.03 112.508 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.61 148.33 31.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 125.194 1.398 . . . . 73.31 110.267 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.5 163.47 20.45 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.923 0.889 . . . . 74.13 108.954 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.89 95.83 5.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.019 -1.104 . . . . 72.44 108.019 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.03 168.23 18.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.137 0.975 . . . . 74.52 109.895 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -116.35 99.26 7.07 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.294 -2.113 . . . . 73.24 105.294 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -83.89 136.66 34.02 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.609 -0.723 . . . . 74.5 109.053 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.94 119.2 33.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.494 1.118 . . . . 75.31 110.232 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.439 HG21 ' SD ' ' A' ' 91' ' ' MET . 17.6 m -111.81 142.12 26.07 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 117.577 -1.202 . . . . 72.11 112.232 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.12 141.33 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.713 2.275 . . . . 71.31 109.579 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -63.4 -12.84 33.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.585 0.957 . . . . 75.25 113.585 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.89 -34.26 66.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.645 2.778 . . . . 71.44 113.445 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 pt -85.09 165.87 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.745 1.157 . . . . 70.35 111.775 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 54.8 p -99.92 168.79 9.65 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.784 0.834 . . . . 75.41 111.255 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.92 -36.43 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.714 -1.217 . . . . 65.33 107.714 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.83 90.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.737 0.815 . . . . 74.43 110.936 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -66.4 -44.96 81.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.614 -0.708 . . . . 65.22 109.744 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 4.1 t80 -58.8 -54.51 46.23 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.253 -1.017 . . . . 73.51 108.253 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.4 ttp -52.63 -49.19 65.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.512 1.525 . . . . 53.33 110.935 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -57.11 -42.28 80.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.464 0.705 . . . . 72.52 111.693 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.46 -39.63 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 118.086 -0.959 . . . . 71.54 108.792 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 4.4 mt -62.31 -50.04 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 120.701 1.591 . . . . 75.45 109.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.15 -39.16 81.58 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 118.186 -0.912 . . . . 75.03 111.962 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -68.58 -40.59 80.45 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.051 0.841 . . . . 72.42 109.223 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -59.51 -49.07 79.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.275 1.03 . . . . 73.22 111.498 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 pt -79.46 -0.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 119.468 -0.301 . . . . 62.45 111.277 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 57.51 52.32 8.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.741 1.617 . . . . 73.32 110.984 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.5 tm? -68.18 108.96 3.24 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.416 1.486 . . . . 72.34 110.553 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.82 152.8 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.122 2.548 . . . . 75.53 109.968 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 m -58.95 -20.83 55.99 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.403 -0.811 . . . . 75.31 113.181 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -39.51 90.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.407 1.003 . . . . 52.11 109.734 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -96.48 163.61 12.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.285 1.034 . . . . 55.03 108.865 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.92 171.08 7.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.001 1.321 . . . . 73.42 108.579 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 tp -146.12 133.75 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.554 1.142 . . . . 65.21 108.158 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -145.46 142.26 29.11 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.179 1.792 . . . . 75.12 108.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -114.14 155.83 25.32 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.525 1.53 . . . . 64.44 111.039 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -147.31 126.84 13.24 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 125.115 1.509 . . . . 64.15 111.18 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.87 126.03 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.474 -2.047 . . . . 74.31 105.474 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 49.48 34.53 6.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.761 1.164 . . . . 60.14 112.961 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp 60.88 31.14 20.0 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.063 -1.648 . . . . 54.15 110.154 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -130.18 161.38 31.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.324 1.85 . . . . 74.41 109.788 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -102.49 103.68 33.25 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 126.508 1.923 . . . . 74.35 108.832 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.6 136.99 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.539 1.492 . . . . 72.44 108.965 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.0 132.17 44.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.76 0.314 . . . . 72.22 110.311 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 p -51.89 -45.54 64.22 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.282 2.233 . . . . 40.04 112.703 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -73.74 -11.84 60.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.694 1.197 . . . . 51.44 114.047 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.42 146.74 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.037 1.289 . . . . 65.44 108.665 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 30.4 p -86.08 156.57 20.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.694 -0.629 . . . . 63.11 109.424 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 51' ' ' VAL . 14.4 mmt -61.38 -44.44 97.15 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 118.538 -0.744 . . . . 74.14 110.641 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.11 -45.49 95.2 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.351 -0.928 . . . . 61.33 111.396 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.86 -49.46 72.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.799 0.8 . . . . 73.54 111.2 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.59 -46.69 88.19 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 123.055 0.542 . . . . 44.02 110.459 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.43 -56.92 14.89 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.252 1.021 . . . . 53.04 108.943 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.28 -32.0 64.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.623 -0.703 . . . . 72.14 111.37 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -25.26 20.26 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 116.342 -1.79 . . . . 63.43 113.828 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -103.42 -2.22 27.28 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.298 1.863 . . . . 71.42 112.604 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.23 121.72 1.18 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.114 2.165 . . . . 74.4 113.955 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.71 174.64 8.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.454 1.502 . . . . 53.12 110.132 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.49 -35.58 72.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.877 1.217 . . . . 63.33 108.525 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.15 12.92 31.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.77 0.828 . . . . 64.34 112.51 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.38 28.38 67.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.351 -1.249 . . . . 61.22 114.862 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -109.44 158.71 17.68 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.948 1.874 . . . . 65.32 107.932 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 138.0 54.13 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.608 -1.256 . . . . 64.55 107.608 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -122.35 131.5 53.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.657 1.183 . . . . 74.53 108.287 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.63 138.73 53.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.545 -1.28 . . . . 72.43 107.545 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.69 142.14 44.4 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.954 -2.239 . . . . 62.22 104.954 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -133.96 151.63 51.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.345 0.593 . . . . 75.55 110.432 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.9 t -147.21 165.04 31.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.689 -1.226 . . . . 65.22 107.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.81 15.61 19.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.079 -2.008 . . . . 74.22 108.079 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -115.42 115.94 27.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.401 1.88 . . . . 50.05 107.006 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -5.76 5.56 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.467 1.284 . . . . 74.05 114.467 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.19 131.66 25.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.502 1.521 . . . . 73.2 108.894 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -117.22 9.56 13.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.533 1.533 . . . . 71.22 111.78 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.845 1.688 . . . . 73.41 110.69 -179.481 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 110.87 -0.892 . . . . 72.04 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -95.04 68.86 3.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.282 1.433 . . . . 73.3 108.799 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -115.79 13.98 16.22 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.424 1.268 . . . . 51.33 114.424 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -71.25 51.27 0.16 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.479 2.312 . . . . 71.01 112.826 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 13.9 pt -64.35 140.4 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.707 -1.245 . . . . 65.34 109.104 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 63.7 mt -108.24 -21.76 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.456 1.502 . . . . 70.14 110.129 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -83.65 83.54 7.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 120.911 -1.118 . . . . 52.31 111.939 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.07 109.49 14.57 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 101.864 -3.384 . . . . 75.22 101.864 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.52 -30.58 59.85 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.154 -0.966 . . . . 75.3 112.092 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -88.1 155.19 19.92 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.432 1.093 . . . . 54.45 110.729 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.26 -63.16 1.47 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 71.0 113.324 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 58.1 m95 57.22 61.16 2.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.91 0.777 . . . . 74.31 111.62 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.49 135.68 15.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.384 -1.086 . . . . 74.0 110.384 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.9 123.79 32.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 118.756 1.278 . . . . 72.34 110.006 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -132.37 118.83 19.89 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.534 1.134 . . . . 72.22 109.14 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.9 tt -83.17 118.57 23.69 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.724 1.61 . . . . 62.25 108.44 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.31 128.63 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.679 1.192 . . . . 62.42 110.741 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.9 p -159.31 153.46 23.62 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 71.4 108.639 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.172 1.789 . . . . 73.44 106.515 178.535 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.658 -0.497 . . . . 75.13 109.658 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.88 -168.61 14.18 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.686 1.612 . . . . 52.45 110.02 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -76.08 111.13 11.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.089 -0.708 . . . . 74.21 109.089 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -51.53 -45.76 63.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.082 0.944 . . . . 74.43 110.737 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -60.55 -40.62 92.25 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 121.499 -0.75 . . . . 74.31 112.726 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -67.1 -36.31 81.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.616 0.766 . . . . 74.22 112.177 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -67.59 -41.01 84.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.626 -0.879 . . . . 73.15 108.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -75.12 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.738 -0.664 . . . . 65.23 111.6 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.61 125.13 3.67 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.696 1.998 . . . . 74.25 110.374 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.3 p -117.11 -65.85 1.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 116.305 -1.807 . . . . 73.03 114.211 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.1 mt -48.0 -58.36 4.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.326 1.875 . . . . 64.21 114.842 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.5 -37.09 85.95 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.215 -0.928 . . . . 63.23 111.785 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -62.97 -57.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.303 1.041 . . . . 65.44 108.403 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -47.48 85.01 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.72 1.608 . . . . 62.53 110.987 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -56.57 -53.97 51.35 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.445 1.021 . . . . 72.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.598 HG12 ' HE2' ' A' ' 20' ' ' LYS . 43.6 t -63.07 -47.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 122.398 -0.189 . . . . 74.04 111.262 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' HD12 ' A' ' 21' ' ' ILE . 65.0 tt0 -57.0 -52.11 66.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.947 1.299 . . . . 75.14 110.335 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -60.19 -48.28 82.39 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.985 1.314 . . . . 73.0 110.455 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -49.39 76.74 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.42 0.555 . . . . 54.33 110.943 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HE2' HG12 ' A' ' 16' ' ' VAL . 55.3 mtmt -65.39 -44.31 87.89 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.631 0.372 . . . . 52.12 110.55 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 17' ' ' GLU . 49.8 mt -61.72 -42.64 95.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.365 -1.303 . . . . 72.52 110.402 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.08 -33.76 72.31 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 120.325 1.421 . . . . 73.34 110.263 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -47.12 74.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 119.465 -0.894 . . . . 75.11 109.986 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -77.75 -47.27 19.46 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.346 1.239 . . . . 73.11 114.346 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -129.25 77.27 77.88 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.562 1.945 . . . . 61.2 109.755 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.63 -28.71 44.38 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.159 2.572 . . . . 75.34 112.487 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -89.66 14.02 12.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.905 0.482 . . . . 72.22 111.948 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -120.48 146.24 46.46 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.849 -1.537 . . . . 71.04 106.849 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.57 143.49 28.27 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.191 -1.04 . . . . 54.53 108.191 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.03 127.2 8.35 Favored 'Trans proline' 0 C--N 1.352 0.752 1 C-N-CA 125.725 4.283 . . . . 65.42 113.095 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.59 145.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.863 0.865 . . . . 64.33 111.16 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.4 mm -122.09 135.44 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 103.8 -2.667 . . . . 61.22 103.8 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -122.68 114.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.854 1.262 . . . . 74.45 108.511 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.86 153.92 46.98 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 71.1 108.893 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -93.48 153.4 18.49 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.147 -0.971 . . . . 72.34 113.036 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.66 126.07 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.616 -1.994 . . . . 75.35 105.616 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.0 t -58.79 141.09 54.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.75 -0.463 . . . . 51.22 109.75 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.52 23.95 77.05 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.233 -1.315 . . . . 74.01 113.964 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 t -97.58 142.3 29.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.527 1.663 . . . . 71.24 108.211 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -65.81 -9.74 31.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.227 1.195 . . . . 70.12 114.227 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.37 160.82 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.277 0.944 . . . . 74.02 111.138 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -64.2 142.24 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.272 -1.01 . . . . 74.21 108.272 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.32 161.27 28.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.635 1.174 . . . . 73.12 107.852 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 tt -120.68 135.48 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.677 -1.231 . . . . 74.34 107.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.49 159.7 32.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.885 -1.524 . . . . 74.24 106.885 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -73.9 108.17 6.56 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.495 -1.378 . . . . 73.4 110.285 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -136.04 159.07 42.82 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.823 1.249 . . . . 72.54 112.021 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 14.8 mttt -104.68 99.26 8.92 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 105.42 -2.067 . . . . 64.45 105.42 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.73 116.76 23.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.706 1.602 . . . . 73.43 110.016 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.6 120.0 40.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 117.43 -1.271 . . . . 62.14 109.394 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -113.07 142.97 28.26 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 120.281 1.401 . . . . 74.13 111.527 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.18 141.17 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.767 1.645 . . . . 65.22 108.576 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -62.98 -18.25 63.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.206 2.202 . . . . 73.23 113.227 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -82.67 -30.69 29.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.213 1.19 . . . . 64.12 114.213 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.89 170.52 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.715 0.769 . . . . 73.42 111.393 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -107.13 156.92 18.28 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.124 0.97 . . . . 74.12 111.688 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.28 -35.91 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.858 1.663 . . . . 74.44 109.631 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.39 93.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.768 1.227 . . . . 75.32 111.539 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.33 -42.15 93.24 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.925 -0.768 . . . . 73.34 108.925 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.46 -44.04 93.07 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.165 -1.05 . . . . 53.13 108.165 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.5 ttp -59.65 -48.39 81.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.43 -0.795 . . . . 64.11 110.927 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -58.89 -42.0 88.5 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.342 0.974 . . . . 75.04 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -66.42 -43.27 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.015 -0.993 . . . . 74.32 109.699 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.48 -50.7 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 120.212 1.369 . . . . 74.43 110.1 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -59.67 -39.19 83.65 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.996 -1.065 . . . . 63.41 111.513 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -70.81 -39.07 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.018 0.826 . . . . 45.23 110.615 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -60.15 -49.3 78.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.529 1.132 . . . . 75.22 109.708 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.4 pt -79.23 -0.95 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.949 0.34 . . . . 73.3 111.476 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 55.65 52.86 10.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.386 1.474 . . . . 75.3 108.696 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.49 106.63 1.62 Allowed Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 126.856 2.062 . . . . 73.24 108.452 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.32 157.69 56.26 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.327 2.018 . . . . 55.12 109.653 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -58.48 -28.08 65.03 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.485 -0.76 . . . . 60.31 112.713 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.65 -33.04 71.02 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.335 1.054 . . . . 75.04 112.214 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.33 164.26 11.78 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.36 -1.348 . . . . 65.14 107.36 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.4 172.31 6.93 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.876 1.271 . . . . 54.42 108.789 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -143.98 117.22 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.44 1.096 . . . . 74.43 108.587 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.59 137.55 54.38 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.67 -1.604 . . . . 71.4 106.67 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.9 148.92 33.94 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.008 1.323 . . . . 75.02 109.532 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -143.55 128.26 18.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.692 1.197 . . . . 75.14 109.962 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.95 122.12 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.204 -1.406 . . . . 72.42 107.204 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.06 34.46 14.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.34 1.456 . . . . 71.24 111.251 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 63.9 26.62 14.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.721 1.208 . . . . 73.53 110.322 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -119.58 161.88 19.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.456 1.102 . . . . 61.44 109.326 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.7 103.34 27.61 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 104.524 -2.399 . . . . 64.32 104.524 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.56 142.83 45.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.047 1.831 . . . . 73.31 110.374 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -77.47 114.22 16.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.825 -1.546 . . . . 61.3 106.825 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.0 m -54.39 -26.84 32.73 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.129 1.772 . . . . 71.35 112.818 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -86.89 -6.61 58.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.399 -0.813 . . . . 52.22 113.056 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 tp -75.15 158.58 32.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.569 1.077 . . . . 75.34 108.933 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.3 p -93.24 161.81 14.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.465 0.575 . . . . 35.22 109.72 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.9 mmm -64.27 -46.68 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.906 -1.045 . . . . 75.3 111.653 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.04 74.72 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.333 0.97 . . . . 54.13 111.172 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.72 -51.96 62.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.751 0.82 . . . . 71.42 110.628 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 tt -59.04 -44.14 91.75 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.511 -0.28 . . . . 75.44 110.58 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -65.69 -54.71 23.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.876 0.762 . . . . 71.51 109.544 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -58.67 -30.7 67.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.043 0.838 . . . . 72.51 111.638 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -40.85 16.76 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.367 -1.301 . . . . 73.21 110.36 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.53 6.51 43.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.042 1.292 . . . . 70.24 113.306 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.51 121.26 6.11 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.429 1.468 . . . . 71.12 111.731 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.14 174.89 4.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.047 2.139 . . . . 73.0 110.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.15 -30.76 68.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.654 -1.279 . . . . 73.52 108.939 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.31 6.82 40.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.184 2.194 . . . . 64.01 112.768 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.73 28.41 65.51 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.482 -1.176 . . . . 71.51 116.007 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.06 134.96 54.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.08 1.94 . . . . 73.45 107.453 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.38 133.45 39.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.509 1.05 . . . . 45.45 109.408 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -123.14 123.72 41.44 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.843 1.657 . . . . 74.5 107.726 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.04 136.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 124.729 1.212 . . . . 73.12 109.543 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.39 148.86 32.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.446 0.698 . . . . 73.13 110.815 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -132.96 155.16 49.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.51 0.929 . . . . 75.34 113.51 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.8 p -146.61 159.47 43.4 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.506 0.67 . . . . 51.15 110.881 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.21 22.31 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.818 1.675 . . . . 61.44 112.08 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -121.14 127.38 51.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.794 1.638 . . . . 74.21 107.593 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.0 -28.03 64.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.059 0.944 . . . . 73.21 109.938 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.19 121.06 28.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.604 1.961 . . . . 65.01 106.147 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -117.06 11.03 14.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.598 1.159 . . . . 71.23 111.909 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 116.488 -2.284 . . . . 73.13 110.666 -179.47 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 109.123 -1.591 . . . . 72.34 109.123 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -56.64 164.84 1.32 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.389 1.076 . . . . 72.4 111.107 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 35.0 mtm -108.32 70.49 0.76 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.459 1.103 . . . . 52.43 108.525 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.07 49.9 1.08 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.107 1.763 . . . . 75.23 109.754 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 47.5 pt -67.79 164.66 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 120.56 -1.338 . . . . 55.34 111.705 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.15 -6.07 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.181 0.592 . . . . 64.21 111.972 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -113.1 50.24 0.9 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.779 1.631 . . . . 73.21 109.791 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -82.95 108.67 16.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.143 -1.799 . . . . 71.42 106.143 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.43 -29.15 30.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.547 0.689 . . . . 72.34 111.572 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -75.77 124.28 27.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.91 1.684 . . . . 70.53 109.939 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -92.45 -63.41 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.296 0.953 . . . . 52.31 112.221 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.489 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 50.8 m95 51.85 66.48 1.19 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.85 1.205 . . . . 75.14 112.956 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.69 145.0 21.59 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.027 -1.629 . . . . 30.12 109.027 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.0 134.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.418 1.609 . . . . 72.2 110.003 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -138.61 126.2 22.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.938 0.895 . . . . 65.31 110.579 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.81 118.51 29.46 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.386 -1.709 . . . . 70.14 106.386 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 14.7 t -122.35 113.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.279 0.474 . . . . 43.43 112.279 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 65.8 p -155.13 154.14 31.88 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.796 -1.187 . . . . 73.02 107.796 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.243 0.732 0 C-N-CA 126.936 2.095 . . . . 72.55 106.228 -179.728 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.055 -0.498 . . . . 53.14 110.108 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.83 64.6 4.21 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.282 0.944 . . . . 73.35 112.921 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -76.1 113.58 13.79 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -62.63 -42.74 99.76 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.394 -0.224 . . . . 74.32 110.394 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -56.77 -52.14 66.19 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.507 -0.553 . . . . 75.12 109.507 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -64.94 -34.11 77.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.063 1.345 . . . . 74.32 112.44 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -60.74 -48.89 79.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.441 -0.948 . . . . 70.25 108.441 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.49 -69.24 0.42 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.858 0.724 . . . . 70.33 110.147 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.01 143.66 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.962 1.305 . . . . 72.31 111.474 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 t -130.57 -65.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 117.322 -1.323 . . . . 75.31 112.566 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.2 mt -43.08 -60.69 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 116.477 2.028 . . . . 73.14 116.477 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.27 -48.01 68.98 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 120.719 -1.238 . . . . 73.14 110.418 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -51.91 -46.39 64.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.647 1.179 . . . . 71.44 111.052 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -43.69 91.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.683 -1.627 . . . . 64.13 108.439 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -64.38 -40.11 95.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.61 1.095 . . . . 64.45 110.46 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.15 -48.05 79.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 120.083 -1.635 . . . . 60.23 108.066 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -38.26 90.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.526 -0.749 . . . . 64.53 110.749 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -59.82 -48.05 83.27 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.448 -1.316 . . . . 61.44 107.448 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -50.56 71.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.821 0.448 . . . . 73.5 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -61.77 -52.03 65.91 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.843 0.857 . . . . 61.24 112.399 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.48 -41.79 72.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 116.689 -1.624 . . . . 74.33 111.037 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -64.5 -31.22 72.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.811 2.096 . . . . 70.11 109.263 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.03 -46.67 56.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.094 0.406 . . . . 54.23 110.84 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -77.81 -47.77 18.12 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.774 1.398 . . . . 73.21 114.774 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -126.22 80.59 68.32 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 126.273 1.829 . . . . 74.03 108.107 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.35 -35.3 51.23 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.556 2.171 . . . . 52.13 109.353 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.86 20.76 3.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.733 1.213 . . . . 71.42 114.272 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -125.84 155.77 40.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 120.214 -1.553 . . . . 63.41 108.01 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 m -126.91 138.73 33.26 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.019 0.928 . . . . 74.51 110.25 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HG2' ' HA ' ' A' ' 104' ' ' PHE . 68.5 Cg_endo -77.89 120.03 4.93 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 125.279 3.986 . . . . 63.31 113.307 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.5 135.61 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.003 1.321 . . . . 74.15 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.94 118.36 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.962 -2.236 . . . . 72.35 104.962 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.65 124.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.063 1.745 . . . . 75.15 106.895 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.97 139.17 54.06 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.54 -1.281 . . . . 72.21 107.54 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tmmt? -72.66 140.4 47.9 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.637 0.775 . . . . 75.11 110.414 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.84 126.17 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 125.008 1.323 . . . . 74.23 107.57 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.2 p -55.47 122.18 10.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.877 0.871 . . . . 62.13 109.359 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.73 9.42 66.34 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.618 -1.101 . . . . 75.41 114.723 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 t -86.06 146.44 26.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.364 1.582 . . . . 74.53 110.653 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -65.25 -24.86 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.411 1.084 . . . . 75.24 111.383 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -66.11 162.79 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.426 -1.422 . . . . 75.42 113.475 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.3 141.47 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 125.15 1.38 . . . . 51.12 108.359 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 2.6 p30 -81.78 170.21 15.99 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.588 0.755 . . . . 74.32 110.312 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 tt -126.65 149.56 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.222 1.409 . . . . 74.03 107.803 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -76.57 166.01 23.99 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.347 1.059 . . . . 73.11 109.164 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -73.71 95.77 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 72.22 106.402 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -134.94 159.07 42.62 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.239 1.416 . . . . 75.24 107.336 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -113.56 104.28 12.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.733 -1.21 . . . . 63.42 107.733 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' B' ' 346' ' ' VAL . 5.1 m-30 -84.17 145.67 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.337 0.971 . . . . 71.51 110.381 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.44 112.1 18.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.594 1.558 . . . . 72.1 108.631 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.69 142.19 25.26 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.096 -0.954 . . . . 62.3 110.676 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 76.8 Cg_endo -74.94 141.39 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.572 2.848 . . . . 72.54 112.72 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.29 -21.7 60.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.373 1.469 . . . . 74.31 114.562 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -78.54 -32.87 48.11 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 114.961 1.467 . . . . 63.4 114.961 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -73.52 166.07 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.707 1.14 . . . . 71.01 110.709 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -102.43 161.24 13.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.38 1.072 . . . . 71.54 109.934 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.16 -35.9 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.569 1.148 . . . . 73.41 110.396 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.3 93.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.909 0.777 . . . . 54.5 109.977 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -63.43 -46.32 86.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.619 -0.882 . . . . 73.23 108.619 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.49 -45.75 90.79 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.53 -0.545 . . . . 72.52 109.53 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.21 -40.18 84.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.992 0.917 . . . . 64.41 109.78 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -68.11 -39.18 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.647 0.658 . . . . 75.14 110.321 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.31 -44.49 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.888 -1.153 . . . . 74.31 107.888 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.76 -51.12 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.742 1.155 . . . . 61.34 111.147 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -59.93 -39.03 84.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.034 0.834 . . . . 74.21 110.834 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -70.06 -43.34 71.41 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.778 0.717 . . . . 75.0 109.967 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.84 -49.55 72.98 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.115 1.366 . . . . 74.34 110.936 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.69 -0.47 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.062 0.851 . . . . 64.14 112.181 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 58.3 55.74 4.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.328 1.451 . . . . 75.11 111.571 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' HD2' ' A' ' 71' ' ' PRO . 1.1 tm? -68.79 109.22 3.86 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 106.623 -1.621 . . . . 45.54 106.623 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD2' HD22 ' A' ' 70' ' ' LEU . 88.3 Cg_endo -73.06 164.65 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.986 3.124 . . . . 71.52 111.683 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 m -60.09 -27.39 66.96 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.516 0.326 . . . . 70.32 111.114 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.48 -38.46 89.92 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.253 -0.879 . . . . 64.41 113.367 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 165.35 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.113 1.324 . . . . 65.41 112.115 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.03 177.36 4.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.968 1.707 . . . . 71.32 107.921 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tp -145.98 138.85 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.349 1.06 . . . . 65.25 110.353 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.39 139.49 26.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.351 1.86 . . . . 61.03 109.642 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.04 147.39 40.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.988 2.115 . . . . 64.31 107.598 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.46 123.18 17.49 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.741 -1.577 . . . . 63.21 106.741 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.94 123.36 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 108.52 -0.919 . . . . 32.21 108.52 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.88 35.34 1.08 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.053 1.741 . . . . 63.32 112.601 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 66.04 38.07 5.0 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.158 1.783 . . . . 74.41 113.484 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.0 p -135.1 157.59 46.54 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.942 2.097 . . . . 74.15 107.501 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.99 110.81 63.23 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 105.446 -2.057 . . . . 65.21 105.446 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.39 123.48 10.89 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.763 1.642 . . . . 40.1 109.545 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -67.23 124.41 23.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.47 0.708 . . . . 55.3 109.409 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.42 -33.26 65.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.668 1.187 . . . . 73.32 112.317 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -4.65 51.17 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.947 -1.095 . . . . 72.25 112.551 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.17 146.44 37.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.324 1.42 . . . . 74.33 108.936 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.21 149.07 26.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.977 0.911 . . . . 72.05 108.906 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.3 mmt -55.43 -49.41 72.49 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.721 -1.133 . . . . 73.22 110.109 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.91 -41.74 94.38 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.838 0.745 . . . . 73.43 112.295 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.49 -49.58 70.82 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.279 1.039 . . . . 74.03 109.247 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -44.43 96.0 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 124.661 1.184 . . . . 75.13 111.147 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.71 -50.68 72.51 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.154 1.381 . . . . 75.43 108.172 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -65.18 -28.51 69.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.184 -0.912 . . . . 73.51 112.357 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -28.56 17.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.309 -1.329 . . . . 50.43 113.644 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -105.17 -2.88 23.66 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.882 1.438 . . . . 74.42 114.882 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -37.92 121.42 0.93 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.351 2.261 . . . . 71.23 113.799 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.91 162.99 26.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.012 -1.107 . . . . 74.33 108.012 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.86 -31.76 67.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.901 0.88 . . . . 73.02 110.423 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -85.97 -35.36 20.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.898 -1.149 . . . . 64.0 107.898 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.21 3.84 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 117.626 1.81 . . . . 72.42 117.626 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 7.3 p90 -82.86 179.18 7.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.747 0.773 . . . . 73.32 111.246 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tp -122.51 124.49 43.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.365 -0.976 . . . . 72.05 108.365 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -108.19 113.27 26.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.148 1.379 . . . . 71.23 109.782 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.07 147.07 32.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.255 1.026 . . . . 75.43 109.991 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.81 148.52 36.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.744 -1.206 . . . . 73.13 107.744 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -137.27 153.94 50.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.382 0.61 . . . . 63.02 111.621 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -147.43 168.86 20.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.572 1.149 . . . . 54.5 108.204 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.38 18.28 15.76 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-O 118.761 -1.022 . . . . 74.32 112.049 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -137.47 134.21 35.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.448 1.624 . . . . 71.03 108.001 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -69.08 -6.44 28.33 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.946 2.202 . . . . 64.23 116.946 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.98 108.88 10.12 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.687 -1.597 . . . . 72.43 106.687 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -106.74 22.51 15.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.317 1.847 . . . . 74.45 112.816 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 127.126 2.298 . . . . 42.2 115.013 -179.627 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.56 0 N-CA-C 109.308 -1.517 . . . . 62.23 109.308 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -170.26 85.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.469 1.908 . . . . 24.42 106.102 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 43.1 mtt -82.56 28.82 0.46 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.44 -1.412 . . . . 73.42 112.188 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -67.98 47.72 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 130.245 3.418 . . . . 62.44 112.808 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 2.0 pp -69.37 162.43 3.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.05 -1.093 . . . . 75.01 108.05 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 35.9 mt -118.14 -58.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.095 -1.076 . . . . 75.33 108.095 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -74.62 83.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.4 1.08 . . . . 73.14 109.056 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -70.75 109.82 5.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 104.186 -2.524 . . . . 73.5 104.186 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -50.43 -33.43 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.867 1.667 . . . . 74.25 113.753 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -109.61 164.28 12.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.002 1.321 . . . . 74.31 111.405 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.9 -57.57 3.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.534 -0.543 . . . . 63.22 109.534 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 17.6 m95 48.97 55.62 9.01 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 126.072 1.749 . . . . 65.21 111.974 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.82 126.82 7.61 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.588 -1.005 . . . . 71.21 110.588 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 59.5 mt -68.77 138.13 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.132 0.966 . . . . 52.31 109.657 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.93 139.93 36.28 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.638 0.775 . . . . 75.54 112.836 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 77.6 mt -88.41 111.1 21.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.75 -1.574 . . . . 74.24 106.75 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 49' ' ' TYR . 41.1 t -121.8 112.69 36.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.904 0.881 . . . . 71.54 110.645 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 347' ' ' SER . . . . . 0.41 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.4 p -161.24 160.83 30.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.184 0.994 . . . . 73.44 112.528 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 129.32 3.048 . . . . 63.51 113.7 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 109.373 -0.603 . . . . 74.34 109.373 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.38 159.93 18.7 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.54 2.019 . . . . 74.21 109.178 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -106.05 114.62 28.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.479 1.14 . . . . 74.1 111.206 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.974 0.51 . . . . 75.55 110.139 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -59.65 -46.82 87.86 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.067 -0.396 . . . . 75.44 111.523 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.93 -36.57 84.81 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.474 -0.774 . . . . 74.23 112.641 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -71.82 -41.01 68.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.859 0.754 . . . . 71.45 111.662 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.02 -76.22 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.647 1.179 . . . . 73.12 110.854 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -160.96 119.68 2.52 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.79 1.636 . . . . 71.13 107.417 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -106.89 -65.92 1.05 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.75 -0.594 . . . . 74.22 112.519 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -44.24 -59.24 2.46 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.986 2.115 . . . . 63.23 116.61 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 72.5 mt-10 -66.32 -36.55 83.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.667 1.121 . . . . 64.23 110.33 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.08 -54.73 37.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.202 -0.666 . . . . 75.43 109.202 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.11 89.54 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.835 1.654 . . . . 70.4 111.467 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -54.9 -53.28 57.5 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.814 0.734 . . . . 61.45 110.375 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.66 -46.73 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 122.795 0.438 . . . . 72.33 110.752 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.01 62.97 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.543 1.137 . . . . 62.13 112.462 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 m -65.03 -44.26 89.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.22 -0.895 . . . . 75.43 109.676 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.99 66.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.755 1.161 . . . . 71.22 110.602 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -47.95 83.71 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.939 1.295 . . . . 52.34 110.472 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.3 mt -64.16 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 117.472 -1.251 . . . . 65.32 110.046 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -62.68 -36.64 83.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 121.051 1.75 . . . . 73.42 109.386 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.55 59.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.125 -0.63 . . . . 72.05 111.805 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -79.03 -46.5 18.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.0 2.593 . . . . 71.4 118.0 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.38 81.62 54.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.786 2.035 . . . . 64.32 109.025 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.69 -23.9 55.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.044 2.496 . . . . 75.55 112.922 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.63 14.02 26.29 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.614 0.365 . . . . 74.43 110.365 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -121.57 154.05 37.22 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.913 -1.143 . . . . 73.0 107.913 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.86 142.75 46.09 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 123.753 0.821 . . . . 65.24 111.092 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.03 125.43 9.29 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.623 3.549 . . . . 55.24 111.438 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.02 140.87 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.989 -1.115 . . . . 71.42 107.989 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.89 117.86 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 103.034 -2.95 . . . . 74.52 103.034 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -105.78 120.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.911 -1.885 . . . . 64.01 105.911 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -124.67 146.21 49.24 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.602 0.761 . . . . 72.13 109.611 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -93.3 135.65 34.32 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.049 0.94 . . . . 74.53 109.735 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.21 130.65 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.377 -0.827 . . . . 71.52 109.193 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -63.72 156.59 26.6 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.45 -0.574 . . . . 71.34 109.45 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.86 -20.33 39.94 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.94 1.257 . . . . 63.12 112.996 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.3 t -84.56 142.95 29.63 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.15 -1.796 . . . . 74.05 106.15 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.44 -11.64 60.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.485 1.114 . . . . 53.44 112.484 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.486 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 2.1 tt -62.69 157.43 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.012 1.325 . . . . 71.43 111.498 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -66.11 156.19 6.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.12 1.368 . . . . 75.15 110.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -101.53 173.21 6.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.188 2.195 . . . . 63.14 114.652 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -125.22 136.44 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.612 1.565 . . . . 74.13 108.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.72 165.0 25.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.389 1.076 . . . . 72.4 108.203 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.06 94.81 2.44 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.259 -0.901 . . . . 75.33 111.393 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -129.56 162.42 28.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 125.205 1.402 . . . . 73.22 108.891 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 33.3 mtmt -108.81 101.74 10.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 104.385 -2.45 . . . . 72.23 104.385 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -93.46 120.73 34.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.223 0.465 . . . . 75.0 111.546 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.91 121.19 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.654 -0.869 . . . . 74.41 108.654 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.73 142.42 26.61 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.139 0.975 . . . . 70.24 109.257 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 138.69 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.954 1.769 . . . . 72.25 111.073 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -60.75 -16.77 43.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.27 2.628 . . . . 50.52 111.206 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.46 -34.66 58.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.914 1.45 . . . . 72.23 114.914 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.25 170.28 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.962 0.801 . . . . 74.51 112.199 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -100.26 166.32 11.04 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.909 0.883 . . . . 53.21 111.651 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.0 t -56.65 -34.73 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 O-C-N 121.597 -0.69 . . . . 73.02 109.244 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.89 92.46 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.363 1.065 . . . . 54.42 110.353 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -65.88 -45.25 82.76 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.875 0.87 . . . . 71.4 109.123 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.79 -48.22 82.01 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.719 -0.845 . . . . 74.31 108.719 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.8 ttp -59.51 -45.01 92.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.837 0.855 . . . . 74.11 110.856 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -60.18 -39.72 87.46 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.875 0.47 . . . . 65.25 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.34 -47.29 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 117.368 -1.301 . . . . 55.45 109.521 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.4 -50.89 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 120.374 1.443 . . . . 71.12 109.509 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -61.72 -36.97 82.49 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.346 -0.846 . . . . 62.43 112.183 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -67.4 -43.68 80.71 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-O 118.062 -0.971 . . . . 71.1 110.434 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -63.22 -47.56 81.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.744 1.618 . . . . 75.45 111.01 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -79.39 1.65 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.351 0.596 . . . . 74.55 110.977 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 50.56 59.44 4.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.795 2.438 . . . . 73.34 111.141 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.56 111.26 6.98 Favored Pre-proline 0 C--O 1.24 0.593 0 C-N-CA 125.66 1.584 . . . . 72.15 109.662 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.05 165.58 29.68 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.851 3.701 . . . . 72.41 113.329 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 p -60.91 -23.32 65.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.635 1.574 . . . . 73.14 113.7 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.6 pt-20 -72.27 -54.13 10.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.675 1.59 . . . . 73.43 112.826 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.52 163.47 23.71 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 113.284 0.846 . . . . 75.12 113.284 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.06 166.66 10.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.416 1.886 . . . . 73.44 107.62 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tt -154.4 130.5 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 125.218 1.407 . . . . 74.53 107.744 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -139.16 149.54 44.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.845 1.658 . . . . 72.42 107.713 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.1 mt -112.83 156.57 22.68 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.896 1.278 . . . . 61.14 109.5 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -147.41 140.24 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.286 1.435 . . . . 73.44 109.288 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.459 HG12 ' HD3' ' A' ' 85' ' ' PRO . 12.0 p -134.14 120.78 35.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 125.345 1.458 . . . . 63.42 107.211 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 t0 43.22 52.46 5.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 73.41 111.837 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 62.43 18.87 10.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.78 1.632 . . . . 75.04 113.766 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.4 p -125.9 160.12 30.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.788 1.631 . . . . 73.23 111.31 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.8 104.16 37.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.52 1.928 . . . . 74.31 106.542 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' HG12 ' A' ' 80' ' ' VAL . 38.7 Cg_endo -68.43 155.41 69.24 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.528 2.152 . . . . 51.44 110.639 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -79.86 121.63 25.65 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.018 -0.734 . . . . 64.22 109.018 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.2 m -53.68 -31.4 47.63 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.243 1.201 . . . . 62.41 114.243 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 t -83.7 -8.29 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.706 1.002 . . . . 70.22 113.706 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.82 152.39 44.63 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.309 1.413 . . . . 64.31 109.625 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -88.88 150.01 23.08 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.037 -0.727 . . . . 61.11 109.037 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.8 mmt -58.15 -47.53 83.05 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 117.337 -1.316 . . . . 73.35 110.23 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.07 -48.52 46.08 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 121.227 1.83 . . . . 53.01 113.298 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -64.32 -50.0 69.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.281 1.032 . . . . 74.5 109.533 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.31 -47.86 80.42 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.699 0.8 . . . . 73.22 110.187 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -58.84 -55.17 38.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.912 1.285 . . . . 74.01 108.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -54.71 -43.55 72.66 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.401 0.889 . . . . 65.23 113.401 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -24.81 28.25 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 117.593 -1.194 . . . . 74.1 114.222 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.6 2.74 36.48 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.115 1.325 . . . . 71.33 112.72 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -53.77 126.4 21.94 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.604 1.562 . . . . 62.31 112.258 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.71 165.38 25.32 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.988 -1.116 . . . . 64.34 107.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.75 62.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.696 -1.253 . . . . 71.55 111.023 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.92 17.05 12.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.439 2.295 . . . . 62.02 111.014 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.43 15.33 38.52 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.663 3.03 . . . . 62.03 119.513 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -122.04 179.48 4.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.49 2.145 . . . . 72.03 111.124 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.14 124.47 45.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.796 . . . . 74.42 111.023 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -105.14 118.52 36.74 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.74 -1.207 . . . . 71.42 107.74 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.0 140.22 49.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.524 -0.735 . . . . 73.23 109.026 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 156.89 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.977 -1.077 . . . . 72.35 108.51 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -145.23 156.39 43.81 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.407 0.622 . . . . 74.2 110.083 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.35 170.43 17.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.513 -0.921 . . . . 44.21 108.513 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.84 30.28 7.25 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.522 1.535 . . . . 71.51 109.963 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.56 116.43 23.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.09 1.356 . . . . 72.23 110.449 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -62.22 -14.01 33.67 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.905 1.446 . . . . 72.35 114.905 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.81 141.73 33.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.281 1.401 . . . . 61.42 108.861 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -88.74 51.03 2.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.16 0.984 . . . . 74.51 111.756 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.636 0 CA-C-O 117.35 -1.806 . . . . 53.04 109.483 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.505 0 N-CA-C 109.135 -1.586 . . . . 54.23 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -153.4 -7.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 73.31 111.327 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 24.2 ttp -77.36 29.93 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.195 1.398 . . . . 73.4 112.555 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -74.65 51.09 0.46 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.064 2.146 . . . . 64.43 108.733 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 38.8 pt -76.92 165.24 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.957 1.703 . . . . 51.21 111.695 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 29.1 mt -99.31 -34.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.51 1.524 . . . . 74.3 109.199 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 44.28 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 73.55 112.975 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.8 152.96 43.98 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.796 -1.557 . . . . 64.15 106.796 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -74.99 -46.27 36.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.255 -1.017 . . . . 61.12 108.255 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.58 109.87 21.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.582 1.553 . . . . 64.42 110.544 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -58.61 -51.68 68.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.281 1.215 . . . . 73.51 114.281 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.598 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 28.0 m95 55.12 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.567 1.147 . . . . 72.0 109.552 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -87.12 130.08 9.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.439 -1.413 . . . . 64.41 112.693 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 39.6 mt -68.78 128.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.3 1.55 . . . . 73.34 110.123 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -134.44 161.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.893 1.677 . . . . 65.31 111.282 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.5 116.51 31.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.119 -2.549 . . . . 74.14 104.119 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.13 104.3 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.959 -1.126 . . . . 74.31 107.959 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.7 p -147.56 160.6 42.45 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.217 1.407 . . . . 74.31 108.391 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 131.284 3.834 . . . . 73.42 116.148 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tmm? . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 117.697 -1.144 . . . . 73.52 108.164 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.28 90.65 0.08 OUTLIER Glycine 0 C--N 1.338 0.693 0 CA-C-N 119.97 1.259 . . . . 61.34 113.393 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -91.97 105.72 17.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.382 -2.081 . . . . 73.11 105.382 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -52.48 -38.74 60.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.638 0.775 . . . . 73.22 110.372 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -60.14 -41.08 91.95 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.099 -0.375 . . . . 73.25 111.874 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -67.16 -40.46 86.65 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.627 1.171 . . . . 63.35 109.354 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.57 -40.86 93.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.204 0.601 . . . . 74.5 110.352 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.78 -75.79 0.3 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.117 0.967 . . . . 72.43 112.102 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.78 119.9 2.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.056 1.342 . . . . 65.51 108.852 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -119.65 -65.83 1.12 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 117.243 -1.36 . . . . 73.42 113.358 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.2 tp -47.23 -59.67 3.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 115.97 1.841 . . . . 62.33 115.97 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.44 -50.69 62.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.719 0.771 . . . . 72.5 111.122 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -53.88 -49.83 67.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.735 1.214 . . . . 74.51 111.123 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -67.22 -39.34 86.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 116.587 -1.673 . . . . 74.3 109.93 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.25 -55.52 33.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.252 1.387 . . . . 72.54 110.917 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.73 -48.0 81.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.053 1.341 . . . . 63.12 109.925 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.32 -42.79 87.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 118.182 -0.913 . . . . 72.23 112.151 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.6 p -61.56 -43.04 99.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.81 1.186 . . . . 63.32 108.82 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.6 -50.42 73.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.902 0.773 . . . . 60.23 109.938 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.05 -48.18 77.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.889 -0.507 . . . . 74.01 111.771 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.91 -42.34 94.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 118.004 -0.998 . . . . 63.44 109.97 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -65.73 -34.38 78.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.992 1.269 . . . . 65.44 110.068 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.54 -45.86 51.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.244 -0.408 . . . . 72.35 111.042 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -77.1 -46.46 23.52 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.059 0.845 . . . . 62.43 113.096 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -122.22 79.35 44.05 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.953 2.101 . . . . 74.01 109.977 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.49 -13.46 30.26 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.534 2.823 . . . . 72.23 112.95 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 18.28 20.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.682 1.593 . . . . 74.32 110.569 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 54.4 mtt85 -125.11 147.75 48.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.478 1.111 . . . . 51.32 108.511 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.16 133.14 23.18 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.621 1.168 . . . . 74.2 109.781 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.07 117.5 3.55 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.533 3.488 . . . . 74.52 112.13 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.56 151.19 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.852 1.261 . . . . 53.23 110.129 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.36 120.88 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 104.467 -2.42 . . . . 54.35 104.467 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.75 115.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.147 1.779 . . . . 72.32 108.684 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.38 151.3 51.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 72.41 110.184 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -94.06 158.49 15.59 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.108 -0.995 . . . . 72.34 113.372 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.61 129.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.005 -2.591 . . . . 53.33 104.005 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.1 p -53.0 153.19 3.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.654 0.74 . . . . 65.23 112.142 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.89 -17.69 1.23 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.064 1.793 . . . . 52.23 113.136 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -62.16 124.49 20.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 119.272 1.536 . . . . 53.32 108.69 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -64.4 -12.89 47.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.961 1.304 . . . . 73.12 112.9 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.45 151.54 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.475 -1.306 . . . . 64.44 107.475 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -46.97 141.89 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.733 1.213 . . . . 72.1 112.576 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.15 150.74 41.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.799 -1.546 . . . . 73.44 110.616 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.27 123.46 63.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.724 -1.584 . . . . 71.11 106.724 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.51 165.86 24.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.526 -0.916 . . . . 65.14 108.526 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.82 95.18 1.89 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.272 0.558 . . . . 73.4 111.365 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -132.12 161.86 32.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.562 1.945 . . . . 70.4 109.009 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -112.3 142.27 45.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.69 1.196 . . . . 63.02 108.624 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -122.94 132.63 54.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.792 0.437 . . . . 64.35 109.848 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.66 113.17 21.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.888 1.675 . . . . 70.51 108.282 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.11 142.87 26.83 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-O 118.218 -0.896 . . . . 74.13 110.224 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 51.8 Cg_endo -66.34 139.73 55.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.697 1.598 . . . . 73.43 111.274 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -12.29 30.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.708 1.203 . . . . 61.21 112.6 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.54 -35.07 58.47 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.155 1.782 . . . . 62.33 112.94 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.24 169.46 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 122.018 0.913 . . . . 74.01 110.69 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -107.16 168.47 9.19 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.282 -0.886 . . . . 64.32 112.086 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.19 -35.26 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.86 -1.533 . . . . 64.24 106.86 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 87' ' ' SER . . . -60.61 -47.18 87.35 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 121.381 -0.824 . . . . 75.52 110.654 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.17 -45.69 76.22 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 118.33 -0.843 . . . . 74.03 110.923 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.25 -44.14 88.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.663 0.665 . . . . 73.44 109.602 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 34.5 ttp -65.11 -43.98 90.22 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 117.772 -1.109 . . . . 72.43 111.733 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -59.67 -46.77 88.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.545 1.066 . . . . 75.33 109.182 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG21 ' CG1' ' B' ' 346' ' ' VAL . 40.3 mt -60.35 -48.08 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 117.862 -1.066 . . . . 74.44 108.63 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 ' CE2' ' A' ' 60' ' ' PHE . 55.1 mt -56.35 -50.27 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.874 1.215 . . . . 65.33 110.121 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -61.19 -33.17 73.02 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.864 -1.147 . . . . 74.41 111.74 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.15 -38.34 60.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.085 0.857 . . . . 73.14 110.209 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -60.28 -46.02 91.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.334 1.454 . . . . 71.13 110.291 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.6 pt -79.25 -6.47 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 109.969 -0.382 . . . . 72.34 109.969 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 54.93 59.78 3.86 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 126.55 1.94 . . . . 74.31 109.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.04 108.85 3.09 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.443 1.897 . . . . 72.53 111.098 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.48 151.09 70.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.451 2.101 . . . . 64.24 108.586 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 p -60.28 -25.05 65.42 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.257 -0.902 . . . . 74.15 112.431 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.87 -38.44 78.82 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.719 0.807 . . . . 73.42 110.402 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -96.14 164.7 12.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.513 1.125 . . . . 72.34 108.775 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.88 174.89 5.67 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.145 1.378 . . . . 43.13 108.257 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tp -153.15 136.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.696 -1.224 . . . . 62.55 107.696 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.98 141.12 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.106 1.362 . . . . 72.44 108.149 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.18 151.3 32.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.595 -1.261 . . . . 54.32 107.595 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -141.21 123.59 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.182 0.993 . . . . 73.3 108.575 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.68 140.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.226 -1.398 . . . . 71.32 107.226 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t0 52.11 31.93 9.68 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 122.114 0.959 . . . . 73.02 112.197 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.6 mttm 65.83 25.17 11.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.399 1.88 . . . . 74.04 111.821 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -152.08 163.03 40.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.404 1.082 . . . . 73.31 110.816 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 121.01 74.62 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.038 -2.208 . . . . 70.54 105.038 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.31 140.0 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.057 2.505 . . . . 71.44 109.695 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -67.69 124.76 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.505 1.122 . . . . 73.42 109.841 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 29.9 m -53.17 -27.8 23.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.849 1.66 . . . . 72.14 113.693 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.6 m -75.18 -17.93 60.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.256 1.022 . . . . 61.34 112.214 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.69 153.08 44.51 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.631 1.172 . . . . 64.4 108.812 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -101.03 153.74 19.29 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.109 -0.7 . . . . 61.4 109.109 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.33 -49.61 76.59 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 119.132 -0.461 . . . . 74.25 111.682 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.96 -44.97 92.57 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.237 -0.745 . . . . 51.2 111.237 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.44 -53.33 59.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.733 1.213 . . . . 51.12 110.977 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.74 -51.48 69.58 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.238 1.015 . . . . 72.04 109.718 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.29 -44.6 79.97 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.159 1.383 . . . . 61.02 110.085 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.58 -38.53 91.34 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.839 0.745 . . . . 61.42 111.939 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.05 -24.28 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.484 -1.246 . . . . 55.43 113.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.76 -4.18 22.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.001 1.273 . . . . 75.4 114.301 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.73 120.66 2.72 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.301 1.041 . . . . 71.32 113.647 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.74 175.29 10.57 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.654 -1.98 . . . . 73.34 105.654 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.41 -12.44 14.43 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.762 -1.837 . . . . 70.24 112.873 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.71 6.04 43.85 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.958 1.703 . . . . 74.35 113.651 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.39 68.56 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.706 -0.622 . . . . 71.34 111.815 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.27 164.6 21.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.538 1.535 . . . . 75.25 108.863 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.04 139.67 53.72 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 124.57 1.169 . . . . 74.03 108.667 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -121.48 122.92 40.81 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.284 -1.006 . . . . 72.1 108.284 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.32 133.06 67.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 120.776 -1.202 . . . . 64.41 108.979 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.81 160.27 14.75 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.683 -0.636 . . . . 60.32 110.009 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 35' ' ' LYS . 21.3 p90 -142.13 157.07 45.31 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.446 0.699 . . . . 71.03 111.924 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.9 p -149.22 158.54 44.26 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.988 -0.745 . . . . 54.12 108.988 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.43 29.98 7.26 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.218 1.39 . . . . 74.32 111.542 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.0 142.51 25.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.475 1.51 . . . . 70.15 107.549 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.81 -44.4 73.6 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.095 0.958 . . . . 73.21 111.007 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.73 141.59 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.083 1.753 . . . . 65.13 109.162 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.48 14.87 24.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.92 1.688 . . . . 54.22 109.75 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 N-CA-C 106.565 -2.614 . . . . 33.51 106.565 -179.457 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.891 0 N-CA-C 109.391 -1.483 . . . . 54.24 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -142.58 77.59 1.58 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.381 -2.081 . . . . 71.11 105.381 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 90.1 mmm -112.47 15.44 20.19 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.041 1.337 . . . . 72.12 112.696 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -101.31 45.0 0.98 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.564 -0.902 . . . . 71.34 108.564 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 15.7 mm -82.57 158.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.186 -2.894 . . . . 61.05 103.186 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 35.2 pt -62.41 -6.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 114.156 1.169 . . . . 64.33 114.156 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -111.92 65.24 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.001 1.32 . . . . 72.42 110.326 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -68.71 127.65 33.83 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.395 -0.965 . . . . 74.54 108.395 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.81 -59.1 4.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.273 -1.381 . . . . 73.23 107.273 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -83.91 116.86 22.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.839 -1.541 . . . . 75.1 106.839 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.67 -40.57 69.52 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.354 1.613 . . . . 72.14 115.354 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 30.4 m95 50.07 60.45 3.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.023 1.729 . . . . 73.31 115.307 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.53 137.17 17.12 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.746 -1.341 . . . . 60.21 109.746 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 26.0 mt -77.63 137.1 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.658 1.583 . . . . 73.12 113.154 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.06 142.83 50.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.299 2.24 . . . . 75.22 108.141 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.02 111.17 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.022 1.729 . . . . 74.21 110.931 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.4 t -122.91 125.82 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 113.523 0.934 . . . . 60.24 113.523 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -143.15 110.51 5.76 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.522 1.529 . . . . 73.25 108.198 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.022 1.729 . . . . 71.43 111.661 179.784 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.53 0.681 . . . . 63.14 111.992 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.6 -145.18 17.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 107.094 -2.402 . . . . 45.11 107.094 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -74.23 125.37 28.27 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.131 0.972 . . . . 74.42 109.076 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.64 -48.41 81.89 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.714 -0.847 . . . . 72.21 108.714 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.83 -34.37 74.45 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 118.863 -0.589 . . . . 63.54 111.282 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -64.74 -42.09 95.45 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 120.038 1.29 . . . . 55.13 109.643 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.88 -47.16 86.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.645 -0.872 . . . . 65.23 108.645 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.52 -75.45 0.1 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.212 1.805 . . . . 73.21 113.021 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.23 130.94 5.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.703 2.801 . . . . 73.43 109.505 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.3 p -114.73 -66.63 1.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.215 -1.553 . . . . 74.43 114.266 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -52.84 -57.36 10.48 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 124.83 1.252 . . . . 73.35 113.943 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.22 -56.13 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.172 0.442 . . . . 74.21 111.398 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -52.26 -49.95 63.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.529 1.132 . . . . 73.12 110.836 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.86 76.05 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 117.882 -1.056 . . . . 71.23 112.183 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.6 m -60.35 -51.74 68.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 120.379 1.445 . . . . 61.54 109.264 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.57 -47.34 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.353 -0.61 . . . . 71.02 109.353 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 21' ' ' ILE . 56.5 tt0 -55.64 -49.98 71.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.434 1.094 . . . . 73.31 109.982 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.1 m -60.51 -48.56 81.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.944 0.897 . . . . 64.14 110.198 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.43 90.58 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.694 1.134 . . . . 64.33 111.562 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -47.64 77.32 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.226 1.411 . . . . 72.43 109.475 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 17' ' ' GLU . 62.5 mt -70.05 -42.38 79.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-O 117.784 -1.103 . . . . 73.14 111.807 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -65.16 -39.1 92.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 119.572 1.078 . . . . 62.25 109.7 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.2 -46.91 66.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.07 -0.652 . . . . 70.54 110.921 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -78.16 -38.31 43.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.276 1.954 . . . . 74.34 116.276 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -136.55 74.14 53.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.352 1.861 . . . . 72.31 109.777 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.78 -24.09 54.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.421 2.747 . . . . 75.3 110.726 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.99 12.17 18.38 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.6 -0.687 . . . . 74.55 112.726 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -119.89 154.08 34.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.572 -1.27 . . . . 74.32 107.572 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.82 139.98 27.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.166 -0.679 . . . . 74.54 109.166 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.075 3.85 . . . . 74.1 112.169 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.2 131.93 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.909 -0.775 . . . . 74.21 108.909 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.75 133.59 55.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.367 -2.457 . . . . 75.24 104.367 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.57 137.45 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.777 1.399 . . . . 72.04 114.777 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.84 152.61 43.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.115 0.966 . . . . 70.42 109.913 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -93.39 155.74 17.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.256 -1.016 . . . . 72.12 108.256 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.15 135.08 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.088 -1.819 . . . . 63.22 106.088 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.09 133.13 38.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.107 0.563 . . . . 73.22 111.975 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.57 3.95 43.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.645 -1.086 . . . . 64.13 114.144 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 t -62.5 146.02 52.74 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.685 1.742 . . . . 75.34 111.048 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -65.86 -14.89 62.32 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.825 2.05 . . . . 64.04 112.856 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.409 ' CD1' HD23 ' A' ' 70' ' ' LEU . 9.6 tp -77.66 159.08 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.398 -0.814 . . . . 61.54 109.965 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.25 150.06 11.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.789 -0.819 . . . . 72.14 108.789 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.6 164.58 25.79 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.522 0.729 . . . . 63.32 112.105 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.82 148.57 20.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.161 1.785 . . . . 71.21 106.317 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -87.14 157.44 19.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.452 -0.944 . . . . 65.54 108.452 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.87 100.72 3.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.5 -1.296 . . . . 52.01 107.5 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 87.2 mmt-85 -136.41 161.99 34.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.118 1.767 . . . . 75.44 110.198 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -108.81 95.48 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.178 2.591 . . . . 64.35 104.018 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -89.29 120.02 30.28 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.16 -0.963 . . . . 71.53 112.383 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.71 115.16 28.83 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.96 1.704 . . . . 74.23 109.625 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 141.47 25.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 117.82 -1.085 . . . . 53.22 111.361 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.43 140.7 48.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.281 2.654 . . . . 44.01 110.893 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 m -63.87 -16.33 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.489 1.516 . . . . 75.14 113.34 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.82 -30.43 28.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.295 1.438 . . . . 72.11 113.743 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -71.03 165.59 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 119.018 -1.073 . . . . 73.32 109.257 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -107.02 165.39 11.38 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.587 0.755 . . . . 75.23 110.25 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 t -53.99 -34.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.942 -1.132 . . . . 75.45 107.942 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.38 90.48 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.16 1.384 . . . . 74.52 111.135 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -69.21 -44.62 71.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.838 -0.801 . . . . 75.31 108.838 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.06 -48.6 81.03 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.429 -0.582 . . . . 75.5 109.429 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ttt -54.05 -48.07 70.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.626 1.17 . . . . 71.42 109.553 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.007 -0.521 . . . . 73.22 111.767 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.4 mt -57.32 -44.18 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.067 -0.716 . . . . 55.44 109.067 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mt -59.53 -50.63 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.427 0.558 . . . . 62.42 110.725 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -65.33 -37.27 86.59 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.08 -1.012 . . . . 70.41 111.949 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -64.94 -47.09 78.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.063 0.945 . . . . 72.31 110.29 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.89 -42.29 97.5 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.816 1.246 . . . . 70.31 113.011 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.65 -8.64 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 119.818 -0.753 . . . . 64.44 109.747 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.68 60.52 1.6 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.797 2.039 . . . . 73.35 108.841 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.1 tm? -73.32 110.44 8.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.664 1.186 . . . . 65.3 110.015 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.84 164.47 29.41 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.715 2.943 . . . . 72.14 112.389 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 p -64.28 -21.05 66.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.99 0.916 . . . . 72.25 111.498 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.47 -50.54 25.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.406 0.683 . . . . 73.42 112.794 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.12 164.24 15.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.777 -0.824 . . . . 64.11 108.777 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.23 -178.45 3.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.971 -1.122 . . . . 74.1 107.971 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -150.74 141.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.648 1.579 . . . . 73.12 107.171 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -145.27 139.41 27.1 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 127.288 2.235 . . . . 74.4 107.965 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.9 150.49 35.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.877 0.871 . . . . 42.51 111.135 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -145.25 133.83 22.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.549 1.14 . . . . 73.44 109.75 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 p -132.91 127.93 56.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 105.043 -2.206 . . . . 71.43 105.043 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.32 30.55 10.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.178 1.354 . . . . 74.01 110.863 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt 61.13 25.27 15.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 72.15 110.928 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -119.37 161.57 20.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.623 1.569 . . . . 60.25 109.72 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.2 103.62 21.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.356 -2.09 . . . . 75.15 105.356 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.15 142.7 38.47 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.31 2.007 . . . . 74.33 111.569 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -75.41 121.91 23.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.071 -0.715 . . . . 65.42 109.071 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -49.06 -42.21 37.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.854 2.062 . . . . 43.5 112.665 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -72.92 -11.37 60.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.769 1.228 . . . . 74.2 113.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.69 157.34 36.72 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.579 1.536 . . . . 71.51 109.733 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.03 152.45 18.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.192 1.397 . . . . 64.12 110.085 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.3 mmm -60.7 -43.56 97.62 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.034 -0.53 . . . . 73.01 111.613 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.51 99.71 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.479 -0.623 . . . . 52.43 111.782 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -66.15 -50.18 64.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.017 0.909 . . . . 63.54 109.412 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.23 -35.17 76.5 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.204 -0.295 . . . . 74.2 110.204 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.72 -48.96 67.59 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 120.063 -1.648 . . . . 60.35 109.619 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.92 -28.68 68.5 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.496 -0.752 . . . . 71.24 112.087 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -24.36 19.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 116.6 -1.667 . . . . 53.24 113.86 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.13 -2.97 13.3 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.704 1.742 . . . . 74.51 115.704 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 124.29 6.39 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.259 1.39 . . . . 74.3 113.967 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -77.62 175.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.937 -1.505 . . . . 73.32 106.937 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -58.91 -27.39 65.21 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 119.838 -1.789 . . . . 71.43 113.896 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -79.11 7.76 6.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 75.4 111.131 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.49 69.3 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.616 1.579 . . . . 72.23 114.94 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.77 172.65 10.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.447 1.899 . . . . 73.32 110.789 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.63 141.56 52.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.616 -0.513 . . . . 71.14 109.616 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -113.23 123.67 50.72 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.766 1.226 . . . . 75.11 111.795 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.2 136.81 57.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 122.801 1.286 . . . . 65.33 111.117 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.19 142.74 46.42 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.628 -1.619 . . . . 52.32 106.628 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -133.21 155.54 49.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.457 0.646 . . . . 74.25 110.758 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.3 p -150.97 155.9 40.06 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.567 -0.901 . . . . 55.23 108.567 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.36 9.21 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 119.39 -0.672 . . . . 71.43 112.769 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.28 135.86 41.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.219 1.01 . . . . 71.12 109.169 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -78.12 -15.76 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.216 1.406 . . . . 74.11 112.243 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -131.78 126.76 35.2 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.087 1.355 . . . . 71.3 109.655 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.62 9.72 13.21 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.614 1.966 . . . . 64.44 114.892 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 C-N-CA 128.1 2.762 . . . . 50.22 114.483 -178.823 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.585 0 N-CA-C 108.734 -1.746 . . . . 74.44 108.734 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -144.02 156.23 44.31 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.842 0.857 . . . . 74.14 111.529 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 20.6 ttt -117.15 46.73 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.734 2.014 . . . . 63.23 110.564 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.68 51.58 0.61 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.596 1.558 . . . . 64.25 108.323 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 pt -69.31 165.69 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.951 1.7 . . . . 74.41 110.534 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.12 -34.16 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.723 1.209 . . . . 64.24 109.415 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -82.25 81.51 8.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.428 0.691 . . . . 73.12 109.98 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -127.27 139.6 52.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.755 1.622 . . . . 63.44 106.738 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.88 -27.14 62.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 65.1 113.634 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -109.33 147.33 32.88 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.737 -1.208 . . . . 65.41 107.737 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -81.96 -53.62 5.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 115.572 1.693 . . . . 64.04 115.572 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.3 m95 53.74 58.52 5.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.398 1.079 . . . . 75.32 109.758 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 342' ' ' GLY . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -81.15 139.86 20.86 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 108.252 -1.939 . . . . 63.13 108.252 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 133.83 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 118.871 1.335 . . . . 60.4 109.698 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.09 138.36 48.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.747 1.219 . . . . 72.13 109.444 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.72 118.97 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 103.152 -2.907 . . . . 71.44 103.152 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.45 119.24 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.898 0.879 . . . . 71.53 109.522 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -161.47 123.99 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.42 0.688 . . . . 72.24 109.748 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 128.234 2.614 . . . . 64.43 112.902 -179.213 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.211 0.529 . . . . 74.23 111.673 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.73 -84.08 1.77 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 107.806 -2.118 . . . . 43.31 107.806 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -105.91 116.68 32.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.244 1.818 . . . . 74.23 107.933 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -58.7 -41.99 87.57 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 124.024 0.828 . . . . 72.03 109.531 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -58.82 -42.34 88.96 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.693 -0.629 . . . . 62.11 110.992 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 11.3 ttmm -68.37 -38.06 81.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.312 0.96 . . . . 71.34 111.376 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.62 -46.77 74.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.96 -1.019 . . . . 72.32 108.829 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.92 -77.53 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.561 1.145 . . . . 73.14 110.266 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 119.21 2.13 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.254 1.821 . . . . 74.24 108.223 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 28.7 t -106.88 -65.82 1.06 Allowed 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 106.706 -1.59 . . . . 62.32 106.706 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -41.13 -58.07 1.88 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.512 1.525 . . . . 63.14 115.101 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.35 -51.66 54.94 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.918 -0.488 . . . . 54.43 112.0 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.66 -44.35 73.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.146 0.979 . . . . 74.22 110.325 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.27 70.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.73 1.612 . . . . 63.22 108.782 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.69 -47.71 79.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.359 0.527 . . . . 70.32 111.63 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.79 -48.3 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 C-N-CA 123.035 0.534 . . . . 71.32 109.953 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -64.06 -49.46 72.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.673 -1.156 . . . . 44.34 111.274 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.4 m -55.27 -46.57 76.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.08 1.309 . . . . 61.02 109.733 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.68 70.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.154 0.888 . . . . 62.13 111.576 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -62.47 -39.51 93.66 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.604 -1.31 . . . . 72.22 111.725 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.5 -42.77 56.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 116.008 -1.948 . . . . 62.55 109.285 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.79 -34.67 78.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 121.182 1.81 . . . . 74.44 108.967 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.27 82.21 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.922 -0.486 . . . . 43.45 110.895 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -76.95 -47.23 21.5 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.785 1.032 . . . . 75.11 113.785 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -138.06 89.13 14.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.061 1.744 . . . . 73.35 108.494 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.85 -22.27 36.78 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.626 2.217 . . . . 74.13 112.403 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.29 14.14 25.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.034 2.134 . . . . 62.03 113.588 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -120.02 156.8 30.19 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.158 -1.423 . . . . 72.0 107.158 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.519 HG11 ' CG ' ' A' ' 95' ' ' TYR . 15.7 m -121.92 138.2 28.37 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.353 1.061 . . . . 62.5 111.2 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.48 116.85 3.91 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.216 3.944 . . . . 75.12 112.347 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.21 146.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.745 1.218 . . . . 64.25 108.974 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.9 mt -122.31 128.26 75.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.165 -2.532 . . . . 74.43 104.165 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 120.81 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.643 1.577 . . . . 54.22 107.274 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -131.94 147.09 52.44 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.38 -0.971 . . . . 71.52 108.38 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.11 155.15 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.635 1.107 . . . . 64.12 111.078 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.55 130.89 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.453 -1.314 . . . . 55.51 107.453 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -62.3 130.24 44.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.266 -1.753 . . . . 73.31 106.266 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.9 -2.77 80.25 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 118.031 -1.427 . . . . 63.24 112.289 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -77.42 139.78 39.75 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.053 -2.203 . . . . 74.31 105.053 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.01 -28.2 68.05 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.4 1.48 . . . . 74.44 112.578 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -55.84 152.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.047 1.339 . . . . 74.44 111.431 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.14 134.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.46 1.104 . . . . 53.02 111.421 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.33 158.75 34.49 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.617 -1.253 . . . . 54.12 107.617 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.47 141.13 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.836 -1.172 . . . . 73.21 107.836 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.77 164.44 17.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.405 -0.961 . . . . 72.0 108.405 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 99.37 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.534 -2.765 . . . . 73.33 103.534 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -130.48 155.1 47.02 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.771 0.796 . . . . 70.21 109.499 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 38.1 mtmt -106.46 100.26 9.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.671 -1.233 . . . . 53.44 107.671 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.82 124.47 30.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.996 -1.113 . . . . 73.43 107.996 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.13 112.92 26.05 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.513 -0.921 . . . . 44.14 108.513 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -111.44 141.18 23.97 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 54.22 113.426 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.06 141.71 33.27 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 124.158 3.239 . . . . 55.3 112.216 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -18.43 60.94 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.831 1.049 . . . . 42.23 113.831 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.56 -34.48 70.02 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.906 1.379 . . . . 74.02 114.136 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -78.84 163.52 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.5 0.667 . . . . 73.44 110.219 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 p -104.65 167.78 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.357 1.063 . . . . 71.5 109.795 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.27 -35.31 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.021 -0.733 . . . . 74.33 109.021 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.1 -45.93 82.99 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.246 0.93 . . . . 64.21 109.911 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -68.0 -45.95 72.63 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.19 -0.67 . . . . 72.05 109.19 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.19 -52.0 67.58 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 119.067 -0.492 . . . . 75.24 111.038 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.8 ttp -57.69 -46.9 83.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.434 1.094 . . . . 74.03 110.347 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -59.25 -43.63 92.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.194 0.452 . . . . 74.02 110.785 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.48 -40.04 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 117.851 -1.071 . . . . 70.34 109.561 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.34 -50.22 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 120.611 1.55 . . . . 73.4 108.902 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -59.86 -39.15 84.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.025 -0.988 . . . . 72.4 111.402 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.79 -39.38 69.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 119.588 1.085 . . . . 61.42 110.828 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -62.96 -42.99 99.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.723 1.147 . . . . 73.43 110.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -79.22 -2.63 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.297 0.499 . . . . 74.43 109.7 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 55.47 61.02 3.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.01 2.124 . . . . 63.35 109.734 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.42 107.2 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.602 1.561 . . . . 73.05 109.935 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.97 156.1 66.41 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.485 2.124 . . . . 74.15 109.171 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -65.27 -20.79 66.58 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.183 -0.948 . . . . 71.52 112.703 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.6 -30.63 71.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.483 0.713 . . . . 73.14 110.453 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -103.72 164.9 11.38 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.009 1.324 . . . . 72.13 111.376 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.38 177.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.74 1.616 . . . . 71.3 108.093 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 tp -145.72 135.81 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.559 -1.645 . . . . 43.43 106.559 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -143.1 141.95 31.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.055 -1.461 . . . . 70.11 107.055 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.75 142.34 46.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.403 1.081 . . . . 54.32 108.109 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -144.3 123.66 13.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.294 -1.373 . . . . 72.52 107.294 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -130.21 131.3 65.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 117.046 -1.454 . . . . 65.33 107.255 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 47.89 30.82 2.07 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.519 1.508 . . . . 75.42 113.365 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mttp 64.74 29.11 12.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.235 -1.541 . . . . 71.34 110.61 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.9 p -132.7 161.8 33.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.104 2.562 . . . . 65.22 110.779 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.76 110.9 63.22 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.261 1.424 . . . . 73.33 109.118 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.09 124.81 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.361 2.04 . . . . 64.2 107.417 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -69.31 133.88 48.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.54 1.136 . . . . 72.34 109.655 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -62.72 -40.38 97.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 114.253 1.205 . . . . 51.15 114.253 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -21.62 59.08 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.97 -1.014 . . . . 54.21 113.093 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.95 142.8 58.31 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.268 1.395 . . . . 72.11 111.137 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 p -78.22 153.68 31.72 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.944 . . . . 73.43 110.004 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.1 mmt -59.36 -41.6 89.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.304 -0.855 . . . . 72.41 108.811 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.9 92.3 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.146 0.884 . . . . 73.53 112.964 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -49.76 52.77 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.064 0.932 . . . . 53.41 111.13 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.29 -48.01 81.83 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 123.527 0.731 . . . . 70.51 109.796 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.519 ' CG ' HG11 ' A' ' 29' ' ' VAL . 45.8 t80 -56.87 -52.99 62.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.13 1.372 . . . . 72.12 109.461 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.04 -47.38 84.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 118.971 -0.538 . . . . 74.4 111.964 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -32.74 67.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.373 0.988 . . . . 74.23 112.768 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -93.86 -5.84 47.12 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.683 1.129 . . . . 71.41 113.887 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -38.79 125.14 1.44 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.587 1.955 . . . . 65.21 113.727 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.91 163.47 16.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.927 0.891 . . . . 71.45 110.024 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.82 -29.26 26.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.465 1.106 . . . . 74.42 111.277 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -95.32 -33.88 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.481 1.112 . . . . 75.1 112.541 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.03 4.04 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 117.742 1.857 . . . . 75.21 117.742 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -96.27 178.99 5.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.366 2.083 . . . . 60.24 112.024 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tp -125.74 138.2 53.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.584 -0.722 . . . . 72.41 111.302 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -123.13 108.32 12.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.043 1.337 . . . . 64.34 109.561 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.98 145.11 20.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 122.332 1.063 . . . . 73.43 110.382 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.96 145.54 38.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.169 -0.923 . . . . 71.13 108.509 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -130.96 157.62 42.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.364 0.602 . . . . 65.33 109.863 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.1 p -148.28 161.82 40.75 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.408 -0.96 . . . . 75.52 108.408 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.14 17.85 16.65 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 117.959 -1.467 . . . . 65.33 114.136 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -132.03 141.05 49.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.285 -1.376 . . . . 72.43 107.285 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -80.62 -18.88 46.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.867 0.867 . . . . 72.21 109.645 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.77 138.29 45.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.449 1.1 . . . . 74.54 108.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -117.66 71.13 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.091 1.757 . . . . 74.52 106.959 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 N-CA-C 110.509 -1.036 . . . . 75.04 110.509 -179.306 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.328 0 N-CA-C 109.186 -1.566 . . . . 73.44 109.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -139.49 77.57 1.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.186 1.794 . . . . 52.44 106.474 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 71.7 mtm -115.84 68.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.026 -1.102 . . . . 75.21 108.026 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.18 40.74 2.77 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.903 1.281 . . . . 72.33 107.674 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 11.3 pt -65.97 155.79 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.452 0.644 . . . . 74.3 110.985 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 95.6 mt -101.68 -55.79 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 126.872 2.069 . . . . 70.04 109.755 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -77.44 83.06 3.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.498 0.59 . . . . 71.22 111.006 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -69.1 153.05 44.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.955 -1.498 . . . . 71.25 106.955 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.03 -54.52 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.312 1.045 . . . . 72.11 112.959 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -77.11 161.7 28.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.754 0.822 . . . . 62.41 111.823 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 -62.29 1.58 Allowed 'General case' 0 CA--C 1.557 1.248 1 N-CA-C 122.043 4.09 . . . . 71.24 122.043 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.433 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 10.4 m95 50.67 66.14 1.25 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.479 3.112 . . . . 74.3 112.081 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -99.8 124.89 8.38 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.421 -1.872 . . . . 61.33 108.421 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 343' ' ' ILE . . . . . 0.432 HG12 ' HE3' ' A' ' 48' ' ' LYS . 61.5 mt -68.37 139.9 19.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.585 1.192 . . . . 74.3 108.212 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -141.72 112.21 7.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.071 1.748 . . . . 63.34 106.584 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.48 120.71 22.08 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.374 -2.084 . . . . 74.42 105.374 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.48 110.86 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.458 0.703 . . . . 73.41 111.934 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.1 p -144.48 127.5 16.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.338 1.055 . . . . 62.5 108.958 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 128.94 2.896 . . . . 74.4 114.56 179.549 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 108.88 -0.785 . . . . 75.33 108.88 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.28 110.67 3.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 105.227 -3.149 . . . . 65.31 105.227 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -79.92 113.46 18.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.026 0.93 . . . . 61.23 108.714 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 mmt -60.17 -34.14 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.398 -0.921 . . . . 61.22 110.749 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -60.23 -47.66 85.02 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.232 -0.917 . . . . 74.44 109.982 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -64.43 -32.67 74.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.827 -0.606 . . . . 65.01 110.227 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -60.21 -47.35 86.35 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.87 -1.159 . . . . 54.21 107.87 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.17 -76.26 0.16 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.648 0.779 . . . . 73.33 111.284 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.4 143.08 11.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 127.339 2.256 . . . . 54.12 109.615 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 t -122.89 -59.7 1.57 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.099 -0.953 . . . . 74.21 109.377 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.4 mt -45.42 -58.22 3.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.075 1.35 . . . . 74.52 114.235 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -64.86 -49.99 68.36 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.426 -0.796 . . . . 73.34 110.916 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -52.5 -55.43 22.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.319 1.012 . . . . 74.11 110.377 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -44.71 91.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.637 1.575 . . . . 63.45 111.041 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.51 -50.85 72.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.088 1.313 . . . . 72.41 111.702 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.458 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 74.6 t -69.1 -47.34 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.826 0.85 . . . . 61.42 111.772 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.4 -51.18 70.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.843 1.257 . . . . 62.11 109.443 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -63.63 -40.77 97.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.117 -0.944 . . . . 75.41 110.038 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -49.83 76.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.52 1.509 . . . . 53.41 110.175 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' CG1' ' A' ' 16' ' ' VAL . 50.6 mttm -61.45 -48.42 81.23 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.431 -0.793 . . . . 73.23 110.989 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.68 -41.77 85.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-O 117.564 -1.208 . . . . 75.45 110.403 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -63.51 -33.79 76.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.526 1.966 . . . . 73.12 109.138 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.18 51.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.496 0.589 . . . . 61.44 110.153 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -75.44 -46.34 33.2 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.165 1.172 . . . . 64.45 114.165 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -124.08 74.74 58.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.938 2.895 . . . . 75.44 112.022 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.59 -9.17 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.132 3.221 . . . . 64.14 110.96 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.66 12.53 27.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.171 2.188 . . . . 63.22 111.894 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -127.41 160.08 32.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.87 -1.144 . . . . 74.32 109.791 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.5 142.62 37.72 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.604 1.161 . . . . 61.11 108.909 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.64 119.02 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.669 1 C-N-CA 125.372 4.048 . . . . 75.34 112.185 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.1 t -126.46 148.87 31.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.184 0.994 . . . . 74.13 109.764 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.24 133.41 68.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.52 -2.4 . . . . 72.22 104.52 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.73 118.5 52.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.559 1.544 . . . . 74.24 108.888 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -130.56 153.91 48.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.864 -0.791 . . . . 74.42 108.864 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -93.06 158.38 15.81 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.143 -0.973 . . . . 74.3 110.503 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.06 119.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.545 -2.02 . . . . 74.54 105.545 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 p -54.68 110.8 0.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.968 1.707 . . . . 41.24 111.946 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.4 30.99 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.846 1.688 . . . . 72.45 113.422 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 p -63.95 146.38 54.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.136 1.468 . . . . 63.13 109.816 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -69.59 -0.62 7.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.797 1.639 . . . . 74.41 114.502 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -86.75 169.2 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 119.386 0.994 . . . . 75.13 109.738 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.9 155.72 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.526 1.13 . . . . 63.54 111.358 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.16 163.13 18.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.94 0.896 . . . . 72.05 111.032 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.42 124.5 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.745 1.618 . . . . 62.24 106.675 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.12 164.62 15.15 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.893 0.877 . . . . 55.43 110.175 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 101.51 4.28 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.981 -1.489 . . . . 75.35 106.981 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -134.44 161.79 34.03 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.934 1.294 . . . . 72.23 108.765 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 17.1 mttt -111.26 105.84 14.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.745 -1.946 . . . . 64.12 105.745 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -88.01 118.39 27.54 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.325 0.861 . . . . 73.53 113.325 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.57 108.29 20.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.32 2.248 . . . . 62.15 108.783 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.62 141.35 24.46 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.049 -0.977 . . . . 51.44 110.062 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.19 141.43 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.13 1.887 . . . . 62.51 111.582 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -62.51 -16.15 54.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.098 0.777 . . . . 72.41 113.098 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.72 -34.21 64.69 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.308 1.225 . . . . 71.13 114.308 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.8 168.94 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.206 0.912 . . . . 72.12 111.58 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.1 p -107.88 169.4 8.63 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.082 0.953 . . . . 45.2 111.605 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 60.2 t -55.86 -36.1 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.002 0.921 . . . . 62.4 109.193 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.25 93.81 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.411 1.005 . . . . 71.43 110.541 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -60.91 -46.49 90.44 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 108.15 -1.056 . . . . 73.52 108.15 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -59.65 -49.3 78.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.961 0.504 . . . . 74.44 110.464 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ttt -58.49 -44.15 89.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.329 1.452 . . . . 72.23 109.467 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -63.64 -39.5 94.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.318 0.508 . . . . 74.04 110.212 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.757 HG21 HG13 ' B' ' 346' ' ' VAL . 5.9 mt -67.05 -47.65 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 107.832 -1.173 . . . . 74.22 107.832 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.86 -50.83 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.66 1.118 . . . . 73.33 110.987 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.31 -41.92 97.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.558 -0.734 . . . . 75.54 110.894 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -69.21 -41.92 76.43 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.185 0.902 . . . . 71.21 111.165 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -58.88 -47.65 84.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.462 1.505 . . . . 72.12 110.825 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 pt -83.96 -0.87 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.069 0.395 . . . . 73.3 111.266 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 54.36 71.23 0.54 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 126.521 1.928 . . . . 75.11 108.095 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -82.6 104.96 4.02 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.271 -2.122 . . . . 73.01 105.271 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -66.31 165.53 24.34 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 124.232 3.288 . . . . 72.24 113.816 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -57.86 -37.91 74.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.418 1.087 . . . . 74.3 110.202 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -59.92 -38.64 82.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 116.859 -1.543 . . . . 74.35 113.906 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.51 162.4 13.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.306 1.412 . . . . 70.13 110.673 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.87 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.13 1.372 . . . . 44.34 108.807 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.0 tp -132.58 139.59 49.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.486 1.114 . . . . 61.13 108.225 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -137.7 120.15 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.619 -1.623 . . . . 74.41 106.619 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.79 140.18 49.12 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.931 1.692 . . . . 65.43 109.126 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -145.09 141.51 28.89 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.232 -1.025 . . . . 72.25 108.232 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.68 122.57 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 125.162 1.385 . . . . 74.32 107.681 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 t0 43.49 45.79 5.61 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.338 1.236 . . . . 73.34 114.338 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tptm 71.44 18.79 5.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.22 1.808 . . . . 65.44 114.37 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.4 p -129.18 162.38 27.93 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 120.081 1.31 . . . . 74.2 111.043 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.26 109.55 50.29 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 106.43 -1.693 . . . . 72.01 106.43 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 123.86 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 N-CA-C 107.573 -1.741 . . . . 64.52 107.573 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -69.96 121.5 17.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.685 -0.635 . . . . 63.41 110.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 76.6 p -47.65 -37.59 13.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.972 2.109 . . . . 72.44 114.045 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 m -75.92 -19.19 58.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.529 1.132 . . . . 73.31 113.968 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.06 144.64 53.93 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.174 0.897 . . . . 74.21 109.879 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.7 p -83.09 154.55 24.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.449 0.642 . . . . 72.32 109.677 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.84 -42.27 97.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.702 -0.666 . . . . 72.12 111.384 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.31 -43.13 98.88 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.193 -0.782 . . . . 62.04 111.744 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -68.49 -48.46 64.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.247 1.024 . . . . 72.01 109.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -57.43 -44.43 84.65 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.472 0.709 . . . . 64.53 110.308 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -61.07 -49.74 76.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.17 0.988 . . . . 75.22 108.546 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.09 -32.25 72.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.647 0.98 . . . . 74.14 113.647 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -25.84 18.93 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.971 1.471 . . . . 52.43 114.971 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.22 0.35 23.2 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.711 1.004 . . . . 60.1 113.711 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -48.21 135.17 13.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.355 0.979 . . . . 74.21 112.965 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.77 161.23 29.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.564 -0.902 . . . . 75.44 108.564 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -54.64 -29.94 53.66 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.403 1.481 . . . . 55.24 112.01 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -79.77 -33.1 40.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.145 0.578 . . . . 63.33 111.684 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.45 -6.86 4.97 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 117.434 1.734 . . . . 73.31 117.434 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.77 -179.61 3.7 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.805 2.042 . . . . 73.02 111.957 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.5 tp -123.68 143.63 50.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.395 0.543 . . . . 63.43 111.937 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -122.69 134.52 54.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 41.24 110.602 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.84 140.64 48.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 124.498 1.119 . . . . 53.24 108.264 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.01 149.04 40.93 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.575 -0.898 . . . . 42.33 108.575 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -139.73 159.9 41.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.929 0.871 . . . . 75.24 112.793 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.2 p -149.59 155.94 41.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.014 -1.847 . . . . 50.43 106.014 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 26.16 12.64 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.156 -0.778 . . . . 65.25 111.156 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -134.74 128.75 33.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.417 1.487 . . . . 75.14 107.026 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.07 -45.06 90.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.161 0.505 . . . . 64.33 109.78 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.85 110.78 22.21 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.805 2.042 . . . . 63.43 107.791 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.36 71.35 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.235 2.614 . . . . 72.42 110.293 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 N-CA-C 108.99 -1.644 . . . . 65.21 108.99 179.632 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.569 0 N-CA-C 110.46 -1.056 . . . . 62.33 110.46 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -140.71 -3.88 1.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.193 1.797 . . . . 62.32 113.484 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -55.27 -9.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.595 1.958 . . . . 62.51 116.17 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.81 51.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.558 2.743 . . . . 74.22 111.596 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 31.7 pt -116.32 160.44 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 119.897 -1.752 . . . . 75.12 109.123 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 19.2 pt -110.7 6.84 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.69 1.196 . . . . 75.24 109.885 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -113.33 46.74 1.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.828 1.651 . . . . 75.2 111.381 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -73.06 115.7 12.7 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.432 -2.062 . . . . 74.25 105.432 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.45 -26.63 68.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.598 1.703 . . . . 75.54 115.598 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -109.92 155.53 21.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.741 1.216 . . . . 75.42 110.282 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -83.41 -55.59 4.23 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.349 0.977 . . . . 73.43 112.499 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 341' ' ' TRP . . . . . 0.5 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 52.5 m95 54.02 63.91 2.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.754 1.622 . . . . 73.32 111.792 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.78 126.34 7.34 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.009 -2.436 . . . . 62.34 107.009 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.6 132.08 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.792 1.296 . . . . 73.53 108.016 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -129.9 149.5 51.61 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.227 1.011 . . . . 65.01 109.553 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.8 tt -111.39 114.35 27.43 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.679 1.592 . . . . 71.25 109.159 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.757 HG13 HG21 ' A' ' 63' ' ' ILE . 37.8 t -121.77 136.11 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.1 0.96 . . . . 43.31 111.401 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 160.41 28.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.152 1.781 . . . . 74.33 109.331 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 127.33 2.252 . . . . 71.31 107.32 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 121.249 0.547 . . . . 54.12 109.9 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.58 -109.2 0.3 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.797 -2.121 . . . . 33.24 107.797 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -82.62 132.26 35.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 118.543 1.172 . . . . 73.24 108.814 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.476 ' HG2' ' HE2' ' A' ' 46' ' ' LYS . 16.3 tpt -62.01 -47.11 86.23 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.422 -0.955 . . . . 70.15 108.422 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -60.26 -41.04 92.42 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 119.116 -0.469 . . . . 64.32 111.369 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -64.38 -33.27 75.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.879 0.763 . . . . 74.11 109.476 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.18 -48.31 62.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.506 0.594 . . . . 74.45 110.15 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -75.0 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.178 0.991 . . . . 73.41 112.621 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 130.63 10.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.968 1.307 . . . . 72.31 107.989 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -124.22 -65.93 1.02 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.472 0.916 . . . . 61.13 113.472 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mt -48.49 -58.88 4.01 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.444 1.497 . . . . 62.54 114.539 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.49 -44.37 87.3 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.61 -0.681 . . . . 73.35 112.06 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -59.62 -40.02 86.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.055 0.942 . . . . 74.32 108.688 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -43.12 84.7 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-O 117.437 -1.268 . . . . 73.31 110.054 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.6 m -63.85 -47.01 82.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.182 1.356 . . . . 71.53 112.752 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.39 -47.13 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 O-C-N 121.736 -0.603 . . . . 75.35 109.637 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.04 -40.01 95.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 117.416 -1.278 . . . . 72.31 110.967 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -61.76 -47.45 85.12 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 121.15 1.795 . . . . 61.12 108.767 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.83 72.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.874 0.694 . . . . 74.02 112.874 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.0 -44.94 75.43 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.637 -0.664 . . . . 65.43 112.661 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.2 -41.89 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.296 -0.859 . . . . 73.31 110.237 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -66.15 -38.0 87.05 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.468 1.031 . . . . 70.22 109.484 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.63 78.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.094 -0.642 . . . . 64.22 110.601 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.39 -46.43 22.77 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.138 1.533 . . . . 62.23 115.138 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.15 72.12 55.37 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 127.064 2.146 . . . . 74.31 110.533 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.5 -19.31 48.91 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.778 2.318 . . . . 73.53 112.523 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -97.76 13.02 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.441 0.564 . . . . 63.51 110.871 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -118.54 155.4 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.989 -1.115 . . . . 63.14 107.989 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 27.12 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.879 -1.156 . . . . 72.51 107.879 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.59 122.15 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.98 3.787 . . . . 63.35 112.392 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.55 140.77 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.274 1.83 . . . . 74.52 111.82 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.68 136.76 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 105.764 -1.939 . . . . 75.32 105.764 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.87 110.58 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.99 0.813 . . . . 72.14 110.432 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -112.88 146.81 38.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.118 -1.067 . . . . 72.33 108.118 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 141.94 31.88 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.067 -1.021 . . . . 50.34 109.652 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.34 127.94 23.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.558 -1.275 . . . . 71.41 107.558 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.07 128.77 22.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.115 1.366 . . . . 63.33 109.636 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.1 42.28 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.58 -1.122 . . . . 72.22 113.934 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.19 109.23 2.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.319 -2.104 . . . . 44.11 105.319 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.73 -0.98 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.602 1.561 . . . . 72.05 114.792 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -68.39 163.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.139 -0.975 . . . . 72.12 109.043 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.83 129.68 14.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.219 1.407 . . . . 71.13 110.364 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -84.37 163.94 19.23 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.633 1.573 . . . . 64.2 108.444 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -125.41 135.57 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.871 -1.529 . . . . 63.42 106.871 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.83 165.15 8.97 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.304 0.573 . . . . 74.01 110.609 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE2' ' HG2' ' A' ' 4' ' ' MET . 10.2 mptt -73.88 103.19 4.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.089 -1.448 . . . . 70.0 107.089 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -136.62 158.28 44.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.953 2.101 . . . . 73.23 107.846 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.51 102.11 11.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 104.033 -2.58 . . . . 71.15 104.033 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -83.97 142.14 30.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.576 -1.268 . . . . 74.43 107.576 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD11 HG23 ' B' ' 343' ' ' ILE . 5.0 mp -129.97 123.35 30.43 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 117.921 -1.038 . . . . 74.12 108.844 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.57 143.01 28.11 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 117.787 -1.101 . . . . 73.33 112.785 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.81 141.28 48.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.268 1.978 . . . . 73.23 108.481 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 t -59.25 -12.68 5.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.936 2.494 . . . . 45.35 113.303 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.71 -27.16 17.42 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 115.528 1.677 . . . . 75.32 115.528 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.55 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.031 1.287 . . . . 74.31 110.184 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.9 p -107.28 160.17 15.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.987 0.915 . . . . 53.45 111.053 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.12 -38.13 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.458 1.503 . . . . 64.15 111.465 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.05 91.93 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.556 0.743 . . . . 72.23 110.778 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.62 -42.37 95.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.017 0.927 . . . . 73.44 109.742 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.45 -46.2 89.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.833 -0.803 . . . . 73.44 108.833 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.5 ttp -60.51 -42.36 96.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.574 0.75 . . . . 64.45 110.581 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -61.25 -40.31 93.61 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.49 0.716 . . . . 73.23 109.915 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.433 HG21 ' CG1' ' B' ' 346' ' ' VAL . 34.9 mt -66.18 -51.01 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 118.511 -0.757 . . . . 74.14 109.326 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.7 mt -55.15 -49.98 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.142 0.883 . . . . 72.22 110.339 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.54 -38.71 88.42 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.017 -1.052 . . . . 74.42 111.328 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.712 0.687 . . . . 65.13 110.063 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -61.83 -51.33 68.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.507 1.123 . . . . 72.33 109.888 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.11 5.86 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.002 0.371 . . . . 74.02 112.002 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 46.21 63.4 1.87 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 127.634 2.374 . . . . 70.43 110.651 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 108.58 3.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.97 1.308 . . . . 71.4 110.877 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.31 158.65 36.98 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.116 3.21 . . . . 62.21 110.955 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -26.78 55.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.801 0.84 . . . . 54.44 112.757 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.91 -34.48 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.153 0.981 . . . . 64.31 111.501 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 164.29 11.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.912 1.233 . . . . 53.15 108.106 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.65 175.27 5.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.628 1.171 . . . . 73.23 107.98 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -148.34 130.12 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.512 0.725 . . . . 75.24 111.617 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -141.53 148.28 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.454 1.101 . . . . 74.12 110.213 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.9 152.18 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.569 1.948 . . . . 64.31 108.098 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -144.42 126.87 15.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.444 1.498 . . . . 71.11 108.347 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 85' ' ' PRO . 14.6 p -126.66 124.55 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.326 1.05 . . . . 70.33 108.457 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 43.83 38.44 2.1 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.162 1.385 . . . . 73.42 113.898 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttm 65.05 39.94 5.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.83 2.052 . . . . 74.14 111.063 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 p -141.25 156.61 45.87 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.163 0.985 . . . . 72.12 110.048 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.07 104.0 33.49 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 102.837 -3.023 . . . . 63.2 102.837 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.423 ' HD3' HG12 ' A' ' 80' ' ' VAL . 55.1 Cg_endo -68.59 147.18 69.71 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.554 2.17 . . . . 75.34 110.722 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -70.69 120.89 16.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.799 -1.185 . . . . 62.31 107.799 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 p -51.84 -34.92 42.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.374 1.469 . . . . 52.13 113.813 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -83.68 -6.42 59.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.36 0.874 . . . . 53.3 113.36 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.73 144.58 54.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.678 1.126 . . . . 75.11 108.141 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.17 149.88 25.87 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.888 -0.782 . . . . 64.41 108.888 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.57 -50.75 64.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.264 1.025 . . . . 54.4 112.249 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.67 96.97 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 118.854 0.752 . . . . 75.34 112.378 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -62.07 -53.39 56.14 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.833 0.853 . . . . 74.42 109.261 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.02 -44.92 87.57 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.993 0.917 . . . . 71.54 110.231 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -60.31 -51.97 67.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.611 1.164 . . . . 73.42 108.994 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -35.91 74.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.205 -0.902 . . . . 62.53 112.747 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -24.41 20.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.735 -1.126 . . . . 74.43 113.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -107.21 5.3 27.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.566 1.076 . . . . 74.5 112.993 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -48.82 127.65 14.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.22 1.808 . . . . 72.45 113.513 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.46 175.22 10.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.49 0.716 . . . . 73.42 109.121 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -60.53 -30.47 69.77 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.225 -1.547 . . . . 75.15 110.886 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.28 16.78 12.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.502 1.121 . . . . 61.35 112.283 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.06 28.59 69.14 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.198 -1.335 . . . . 64.44 114.946 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -126.42 177.05 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.647 1.724 . . . . 73.1 111.472 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -123.43 135.32 54.04 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.491 1.116 . . . . 74.23 109.986 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -122.66 127.64 49.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.189 1.396 . . . . 70.11 107.698 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.3 t -129.2 149.02 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 120.505 -1.372 . . . . 70.42 109.457 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.68 150.97 37.29 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.753 -1.573 . . . . 64.15 106.753 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.27 151.92 46.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.097 0.862 . . . . 64.24 111.324 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.2 p -142.88 171.83 13.52 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.451 0.643 . . . . 72.23 111.262 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.62 9.18 21.89 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.597 1.57 . . . . 72.44 112.308 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.16 142.26 28.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.343 1.857 . . . . 73.32 107.968 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.53 -16.33 54.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.518 0.727 . . . . 75.55 111.683 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 p -89.04 119.81 29.89 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.527 1.931 . . . . 65.22 106.081 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -117.36 11.66 14.03 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.908 0.707 . . . . 71.13 112.908 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 CA-C-O 116.83 -2.094 . . . . 45.34 112.29 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 109.201 -1.56 . . . . 71.4 109.201 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -134.43 42.44 2.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.532 0.733 . . . . 63.32 110.122 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 52.7 mtm -79.75 13.36 2.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.695 1.598 . . . . 74.4 112.909 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.51 20.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.254 2.622 . . . . 73.03 115.506 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 24.2 mm -76.68 162.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 125.467 1.507 . . . . 74.31 109.421 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.04 -9.3 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.333 1.453 . . . . 72.03 112.432 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -83.15 14.69 3.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.942 1.297 . . . . 74.42 111.681 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.32 140.07 46.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.192 1.797 . . . . 73.2 110.903 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.73 -40.74 24.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.449 -0.945 . . . . 75.21 108.449 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.51 109.14 10.0 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.03 0.932 . . . . 53.24 110.287 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -74.9 -37.78 62.02 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.011 -0.431 . . . . 64.42 110.761 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 18.3 m95 52.93 55.93 8.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.0 0.92 . . . . 74.34 110.316 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.49 128.35 8.44 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.308 -1.517 . . . . 62.42 109.308 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 343' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 50' ' ' LEU . 93.8 mt -61.94 133.62 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 126.903 2.081 . . . . 74.11 106.914 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.84 104.82 5.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.074 -1.454 . . . . 74.44 107.074 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.5 114.76 19.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.632 1.173 . . . . 73.24 107.882 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 63' ' ' ILE . 53.5 t -122.04 150.42 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.426 1.091 . . . . 72.11 110.723 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -162.89 161.72 25.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.904 2.482 . . . . 62.34 107.04 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.657 -1.609 . . . . 74.31 106.657 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 108.744 -0.836 . . . . 75.14 108.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.53 -73.19 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.054 -2.418 . . . . 41.31 107.054 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -92.71 104.66 16.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.399 -2.074 . . . . 71.13 105.399 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 46' ' ' LYS . 9.5 mtp -56.38 -46.29 80.16 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.966 -0.754 . . . . 72.03 108.966 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -57.18 -43.56 82.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.458 0.703 . . . . 71.02 112.401 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -37.73 87.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.469 0.577 . . . . 72.4 110.689 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -67.37 -48.2 68.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.487 -0.931 . . . . 75.22 108.487 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.84 -76.9 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.118 1.767 . . . . 53.54 113.092 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.75 120.13 2.32 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.207 2.203 . . . . 73.55 108.692 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -131.48 -35.17 1.33 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 116.979 -1.486 . . . . 74.01 114.119 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.67 -60.4 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 121.872 2.124 . . . . 71.32 112.214 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.86 -32.58 73.95 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.519 -0.738 . . . . 73.33 110.721 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -57.09 -59.23 5.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.033 -1.099 . . . . 73.54 108.033 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -39.65 95.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.589 1.156 . . . . 73.22 109.691 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -56.05 -58.03 9.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.758 1.163 . . . . 65.35 111.658 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.95 -42.99 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.83 0.852 . . . . 74.03 110.106 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.21 -47.64 84.6 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.523 -0.751 . . . . 75.41 109.96 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.7 t -58.53 -49.6 76.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.139 -1.06 . . . . 73.34 108.139 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.49 73.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.98 0.809 . . . . 73.02 112.771 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.74 -39.25 84.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 O-C-N 120.535 -1.353 . . . . 74.21 112.17 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.8 -42.13 82.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 O-C-N 120.762 -1.211 . . . . 73.05 108.897 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -67.07 -32.36 73.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.7 1.136 . . . . 74.55 110.96 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.0 -47.49 24.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.238 -0.411 . . . . 60.43 110.529 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -78.49 -44.03 25.49 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.591 1.701 . . . . 75.11 115.591 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.73 72.86 81.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.598 1.959 . . . . 73.44 109.789 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.41 -26.09 76.51 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.433 2.089 . . . . 64.2 111.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.37 12.07 17.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.161 -0.447 . . . . 64.44 111.564 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -123.46 139.07 54.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.737 1.153 . . . . 73.42 108.213 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -107.18 143.83 27.92 Favored Pre-proline 0 C--O 1.249 1.026 0 C-N-CA 123.703 0.801 . . . . 64.12 110.374 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.52 117.37 3.38 Favored 'Trans proline' 0 C--N 1.355 0.903 1 C-N-CA 125.888 4.392 . . . . 50.43 112.885 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 146.91 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.397 1.079 . . . . 73.44 110.611 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.16 135.41 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 104.459 -2.423 . . . . 72.0 104.459 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -123.13 111.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.443 -1.688 . . . . 51.0 106.443 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -128.13 150.42 49.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.195 0.452 . . . . 74.34 110.788 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.76 132.91 34.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.019 -0.734 . . . . 74.11 109.019 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.83 116.86 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.72 -1.585 . . . . 75.24 106.72 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 m -53.76 125.34 18.08 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.8 0.727 . . . . 43.24 109.683 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.97 -3.18 35.58 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.285 1.421 . . . . 72.15 112.642 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.8 m -89.92 127.69 36.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.9 1.35 . . . . 71.35 108.288 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.57 -18.87 62.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 118.453 -0.784 . . . . 61.42 111.708 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.46 156.51 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.065 0.848 . . . . 74.31 111.158 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.0 m -52.28 125.76 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.656 0.782 . . . . 63.34 109.996 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.38 172.47 9.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.603 1.161 . . . . 74.44 108.876 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -125.85 150.88 31.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 123.766 0.826 . . . . 75.4 110.415 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.34 165.37 24.63 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.788 -1.56 . . . . 52.45 106.788 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 4' ' ' MET . 1.0 OUTLIER -74.76 105.75 5.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.03 -1.841 . . . . 74.3 106.03 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -134.11 163.74 28.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.873 0.844 . . . . 72.14 112.508 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -105.55 106.95 17.69 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 103.001 -2.962 . . . . 75.33 103.001 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.04 127.05 37.37 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.604 -1.628 . . . . 74.31 106.604 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.45 112.55 21.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.897 1.679 . . . . 62.55 108.092 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 142.83 27.7 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-N 119.565 1.075 . . . . 62.15 110.525 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.91 132.32 21.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.317 2.012 . . . . 75.12 108.698 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -58.73 -12.61 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.441 1.897 . . . . 63.14 113.123 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.99 -34.46 50.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 60.22 114.141 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 170.49 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.734 1.012 . . . . 62.41 113.734 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -102.63 167.35 9.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.998 1.719 . . . . 73.32 112.529 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.23 -35.87 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.965 0.906 . . . . 72.14 109.247 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.25 91.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.901 0.773 . . . . 64.44 110.362 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -63.85 -45.76 88.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.746 -0.835 . . . . 75.5 108.746 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD2' HG11 ' A' ' 51' ' ' VAL . 6.2 t80 -59.64 -48.91 79.79 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.8 -0.444 . . . . 73.54 109.8 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.9 ttt -55.89 -51.98 65.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.365 1.466 . . . . 74.41 110.114 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -58.27 -41.64 84.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.727 0.811 . . . . 73.5 109.042 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.583 HG21 HG13 ' B' ' 346' ' ' VAL . 21.1 mt -66.87 -45.2 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 120.828 1.649 . . . . 75.32 109.323 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.59 -50.81 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 120.588 1.54 . . . . 61.24 110.554 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -31.91 73.12 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.161 -0.962 . . . . 74.33 111.531 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -68.95 -48.51 63.03 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.537 -0.542 . . . . 74.42 109.537 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -59.98 -51.38 69.89 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 126.926 2.091 . . . . 75.42 111.51 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.23 3.65 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 122.379 -0.2 . . . . 74.5 110.961 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 44.24 63.34 1.67 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 126.849 2.06 . . . . 71.31 109.503 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.22 111.19 5.98 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.993 -1.114 . . . . 71.11 107.993 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.71 165.43 27.67 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 125.177 3.918 . . . . 75.51 114.309 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -26.67 67.66 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.356 0.662 . . . . 54.34 111.411 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.64 -47.07 79.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.347 0.869 . . . . 70.31 113.347 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -100.3 165.35 11.51 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.169 0.895 . . . . 72.14 113.158 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.05 -178.63 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.596 1.958 . . . . 43.14 107.148 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 tp -137.47 135.55 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.664 -1.606 . . . . 70.43 106.664 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.79 130.25 33.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.705 -1.591 . . . . 74.21 106.705 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.43 146.32 40.77 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.084 1.754 . . . . 72.41 107.821 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.62 128.28 19.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.893 1.277 . . . . 64.4 108.501 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.23 123.83 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 107.632 -1.248 . . . . 63.25 107.632 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 47.92 38.27 8.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.11 0.964 . . . . 73.2 111.813 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 23.05 11.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.272 1.429 . . . . 72.15 112.947 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 162.8 21.32 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.978 1.711 . . . . 54.54 112.352 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.14 103.46 12.07 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.823 2.449 . . . . 75.32 106.901 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.37 123.68 7.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.75 2.3 . . . . 74.4 111.887 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 88' ' ' SER . 8.4 tt0 -63.81 127.62 32.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.569 -1.271 . . . . 64.32 107.569 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.4 p -57.23 -28.44 62.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.246 1.419 . . . . 74.13 112.881 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.468 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 25.1 t -85.24 -4.79 59.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.387 1.475 . . . . 53.24 112.064 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.5 tp -76.51 143.93 40.11 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.439 -1.413 . . . . 74.04 107.632 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 m -84.85 152.42 23.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.456 -0.572 . . . . 52.45 109.456 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.64 -51.89 67.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.149 0.98 . . . . 74.14 110.198 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.63 -45.02 60.23 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.528 0.604 . . . . 51.43 111.655 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -66.97 -49.11 66.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.63 0.772 . . . . 72.11 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.91 -42.39 97.96 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.641 -0.662 . . . . 73.01 110.476 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.07 -57.89 8.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.949 1.699 . . . . 75.0 109.455 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.07 -27.69 69.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 118.56 -0.733 . . . . 73.01 112.868 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -38.85 12.75 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.863 -1.065 . . . . 74.03 113.118 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -88.02 -8.78 55.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 117.838 -1.077 . . . . 41.4 113.123 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -33.32 120.83 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.399 1.629 . . . . 63.22 115.399 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.84 177.21 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.057 1.743 . . . . 72.42 109.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -35.1 56.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.025 -1.672 . . . . 73.4 112.056 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -95.62 10.9 35.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.747 1.219 . . . . 74.42 111.786 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.73 60.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.462 1.506 . . . . 61.34 115.151 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -105.07 163.67 12.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.031 1.415 . . . . 64.42 109.133 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.9 tp -120.67 134.81 55.25 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.352 0.661 . . . . 63.04 109.709 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.71 121.91 37.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.889 0.876 . . . . 74.44 108.982 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.07 137.9 54.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 107.826 -1.176 . . . . 71.11 107.826 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.06 152.1 29.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.224 1.01 . . . . 64.42 108.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -140.24 161.19 38.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.556 0.947 . . . . 64.41 113.556 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.4 t -159.05 173.35 16.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.956 1.702 . . . . 72.43 108.947 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.24 17.26 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.65 2.548 . . . . 63.31 112.493 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.8 135.58 51.23 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.326 1.85 . . . . 75.23 109.196 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -66.89 -29.75 69.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.728 1.211 . . . . 63.42 112.716 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.36 131.0 57.07 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.503 1.121 . . . . 64.4 109.119 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -116.13 9.23 14.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.234 1.014 . . . . 63.34 112.657 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 CA-C-O 118.266 -1.297 . . . . 61.2 110.44 179.674 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.773 0 N-CA-C 110.939 -0.864 . . . . 63.02 110.939 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 52.51 10.72 0.15 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.343 2.257 . . . . 52.25 116.023 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 25.5 ttt -85.2 68.01 10.37 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 106.164 -1.791 . . . . 75.12 106.164 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -116.45 49.37 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.971 -1.863 . . . . 72.44 105.971 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 15.0 pt -65.95 142.26 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.855 -0.528 . . . . 74.24 110.525 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.1 4.64 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.701 0.63 . . . . 63.45 112.701 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.35 71.45 0.75 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.014 1.726 . . . . 75.23 109.04 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.31 168.35 15.64 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.911 1.284 . . . . 72.54 109.267 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.03 -12.69 43.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.476 0.71 . . . . 74.12 109.228 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.58 106.94 18.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.021 -1.474 . . . . 75.2 107.021 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -92.63 -62.09 1.47 Allowed 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.056 -0.402 . . . . 71.43 111.545 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 62.9 m95 58.15 66.03 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.209 1.404 . . . . 72.34 110.362 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -83.98 136.12 14.49 Favored Glycine 0 C--N 1.344 0.996 0 O-C-N 121.535 -0.728 . . . . 73.32 111.387 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.35 125.28 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.46 1.904 . . . . 72.12 107.722 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -139.88 130.03 25.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.283 1.033 . . . . 75.34 108.249 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.14 127.11 52.75 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.201 -0.937 . . . . 73.05 110.579 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 63' ' ' ILE . 1.9 t -121.48 117.52 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 125.05 1.34 . . . . 63.44 107.812 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 22.8 p -162.15 126.39 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 104.943 -2.243 . . . . 51.44 104.943 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.135 2.174 . . . . 52.15 111.899 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 121.894 0.854 . . . . 64.019999999999996 109.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tpt -55.97 -46.74 78.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 113.941 -1.481 . . . . 75.239999999999995 109.35 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -59.01 -50.32 74.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.046 0.938 . . . . 75.310000000000002 111.747 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -65.05 -27.31 68.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.549 1.539 . . . . 71.120000000000005 111.672 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.67 -47.94 28.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.536 -0.913 . . . . 64.219999999999999 108.536 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -74.95 0.15 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.58 1.152 . . . . 72.549999999999997 113.086 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -158.98 122.26 3.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 105.815 -1.92 . . . . 63.140000000000001 105.815 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -130.73 -65.14 0.8 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.66 -1.162 . . . . 73.340000000000003 112.686 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.5 mt -39.85 -57.12 1.64 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.562 1.689 . . . . 74.439999999999998 115.562 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.38 -52.71 51.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.254 -0.904 . . . . 64.230000000000004 110.073 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.553 ' CD2' HH21 ' A' ' 14' ' ' ARG . 6.6 t60 -54.37 -55.22 30.8 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.315 1.446 . . . . 74.219999999999999 111.39 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.553 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.0 mmp_? -58.53 -39.88 81.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 116.495 -1.717 . . . . 71.010000000000005 109.031 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -60.64 -55.38 33.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.246 1.384 . . . . 65.430000000000007 111.26 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.67 -47.88 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 117.974 0.352 . . . . 74.25 111.267 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -62.08 -39.88 93.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.626 -0.702 . . . . 72.209999999999994 110.805 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 t -59.73 -46.78 88.09 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.56 -1.274 . . . . 74.239999999999995 107.56 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.63 86.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.487 1.039 . . . . 55.399999999999999 112.251 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.23 -47.71 83.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.321 0.51 . . . . 71.200000000000003 110.747 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.13 -42.36 96.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 C-N-CA 123.923 0.889 . . . . 71.030000000000001 110.322 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -67.6 -40.26 84.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.955 1.252 . . . . 72.109999999999999 109.29 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.07 68.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.771 -0.58 . . . . 62.340000000000003 111.053 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -77.55 -46.72 21.44 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.599 0.963 . . . . 74.140000000000001 113.599 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -119.94 71.95 16.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.305 1.842 . . . . 72.340000000000003 111.024 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.28 -25.4 49.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.139 1.893 . . . . 71.0 112.644 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.21 11.92 21.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.488 0.715 . . . . 61.240000000000002 111.265 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -115.92 158.76 22.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.318 1.417 . . . . 74.040000000000006 109.539 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 m -119.68 129.92 25.11 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.621 1.568 . . . . 72.409999999999997 108.171 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.76 111.66 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.18 3.92 . . . . 74.319999999999993 112.694 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.12 151.45 20.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.306 1.442 . . . . 74.219999999999999 111.206 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.58 133.39 68.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 103.166 -2.901 . . . . 74.129999999999995 103.166 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.31 121.77 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.362 -0.828 . . . . 74.25 110.516 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.6 151.09 46.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.191 0.905 . . . . 61.340000000000003 111.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 123.46 31.75 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.764 1.626 . . . . 73.519999999999996 108.931 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.58 128.55 33.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.81 -1.552 . . . . 71.120000000000005 106.81 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 p -61.95 147.63 46.32 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.905 0.859 . . . . 72.030000000000001 112.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.91 -20.68 45.93 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 116.375 -2.347 . . . . 74.319999999999993 116.415 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 160.9 25.06 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 122.041 2.921 . . . . 72.129999999999995 110.668 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -72.86 -13.0 61.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.953 2.205 . . . . 62.420000000000002 116.953 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.07 162.59 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 120.595 1.543 . . . . 64.340000000000003 114.548 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.2 152.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.173 1.389 . . . . 73.120000000000005 109.578 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -81.1 169.15 17.79 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.016 0.526 . . . . 74.420000000000002 111.417 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -125.61 142.0 43.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.961 1.305 . . . . 73.140000000000001 111.485 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.12 161.49 30.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.889 2.076 . . . . 71.439999999999998 107.986 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -84.2 98.26 9.84 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.768 -2.308 . . . . 75.310000000000002 104.768 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 13.5 mmm180 -136.02 159.13 42.64 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.763 0.71 . . . . 73.230000000000004 111.459 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HE3' HG12 ' B' ' 343' ' ' ILE . 2.4 mtmp? -106.25 99.01 8.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.583 1.553 . . . . 71.420000000000002 107.064 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.43 120.76 26.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.922 0.889 . . . . 70.439999999999998 110.337 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.79 105.46 14.69 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.972 1.309 . . . . 71.530000000000001 108.021 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.51 143.16 27.23 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-O 118.227 -0.892 . . . . 72.530000000000001 112.143 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.16 138.82 57.92 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.369 2.046 . . . . 64.430000000000007 110.329 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.0 p -63.61 -15.75 59.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.803 1.641 . . . . 62.100000000000001 112.431 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -75.07 -35.59 61.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.027 1.731 . . . . 74.109999999999999 113.712 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.06 165.54 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.866 0.841 . . . . 73.409999999999997 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -99.87 165.35 11.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.783 0.833 . . . . 62.5 110.905 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.25 -35.6 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.676 1.19 . . . . 75.230000000000004 108.143 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.77 88.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.966 1.306 . . . . 74.340000000000003 110.447 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.97 -45.63 66.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.373 -0.822 . . . . 64.430000000000007 110.006 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 6.4 t80 -59.07 -48.54 81.21 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.858 0.754 . . . . 70.409999999999997 109.483 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.2 ttp -55.19 -51.37 66.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.766 0.826 . . . . 75.019999999999996 109.949 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.96 -38.94 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.432 -0.318 . . . . 72.140000000000001 110.436 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' B' ' 346' ' ' VAL . 38.0 mt -66.38 -43.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 116.997 -1.477 . . . . 73.450000000000003 110.367 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 83.8 mt -58.86 -50.81 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.636 1.562 . . . . 65.120000000000005 108.417 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -61.93 -39.62 92.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.91 -0.716 . . . . 74.519999999999996 112.616 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -66.93 -40.39 87.58 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.246 0.93 . . . . 74.140000000000001 110.392 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.43 -47.24 86.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 121.348 -0.845 . . . . 71.420000000000002 110.054 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -81.48 -1.24 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.837 0.68 . . . . 74.510000000000005 112.837 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 57.5 58.04 4.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.346 2.258 . . . . 73.230000000000004 112.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.27 108.13 2.55 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.073 0.949 . . . . 75.230000000000004 111.644 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.08 156.67 64.4 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 51.140000000000001 111.296 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.1 m -63.29 -13.97 44.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.696 -0.668 . . . . 74.439999999999998 112.463 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -37.37 76.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.863 1.21 . . . . 71.549999999999997 109.686 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -103.25 164.25 11.75 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.508 1.049 . . . . 70.519999999999996 111.059 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.18 170.79 7.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.044 1.738 . . . . 64.409999999999997 106.843 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 tt -151.62 129.78 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.915 -1.143 . . . . 75.219999999999999 107.915 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.26 147.76 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.889 1.275 . . . . 62.109999999999999 109.145 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.9 mt -114.16 154.59 27.57 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.152 1.381 . . . . 71.129999999999995 109.435 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -145.15 139.83 27.54 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.797 1.239 . . . . 70.439999999999998 108.533 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.37 128.81 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 106.035 -1.839 . . . . 73.420000000000002 106.035 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 45.96 37.13 3.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.447 1.022 . . . . 75.219999999999999 112.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.0 tptt 68.02 22.1 8.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.571 0.952 . . . . 74.209999999999994 113.571 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 p -127.28 162.16 26.89 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.985 1.714 . . . . 52.200000000000003 111.191 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.56 108.01 53.78 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 104.096 -2.557 . . . . 73.299999999999997 104.096 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.09 148.72 51.08 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.877 1.718 . . . . 74.400000000000006 111.881 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.41 117.97 16.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.94 1.296 . . . . 73.109999999999999 108.329 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 p -51.28 -38.79 54.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.134 1.373 . . . . 64.140000000000001 112.953 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -74.36 -12.36 60.5 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.755 1.02 . . . . 72.099999999999994 113.755 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.61 150.62 47.77 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.552 -1.343 . . . . 73.120000000000005 109.631 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.92 26.57 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.162 0.985 . . . . 60.43 110.798 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.8 mmt -57.2 -47.33 81.55 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.841 0.856 . . . . 74.329999999999998 111.063 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.58 96.59 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.526 -0.597 . . . . 61.310000000000002 113.138 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -67.76 -51.0 54.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.948 0.874 . . . . 75.310000000000002 110.508 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.47 -35.84 80.61 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.068 -0.716 . . . . 71.150000000000006 109.068 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -66.26 -57.19 8.09 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.428 -0.796 . . . . 72.530000000000001 108.906 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.7 -41.97 87.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.43 1.013 . . . . 74.319999999999993 112.734 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -32.9 65.48 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 118.398 -0.811 . . . . 73.030000000000001 111.73 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.59 7.09 44.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.071 0.85 . . . . 73.409999999999997 112.584 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.29 119.54 3.04 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 126.783 2.033 . . . . 61.100000000000001 109.13 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.54 175.69 9.59 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.725 0.639 . . . . 72.129999999999995 112.725 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.15 -25.41 61.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.172 1.389 . . . . 75.340000000000003 110.498 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.42 4.98 39.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.215 1.806 . . . . 73.230000000000004 111.248 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.23 28.93 69.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.511 -1.16 . . . . 72.409999999999997 114.78 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -123.78 168.62 12.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.352 1.576 . . . . 64.340000000000003 109.125 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tp -122.02 139.97 53.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.511 1.124 . . . . 74.319999999999993 110.58 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -113.84 115.72 28.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.305 1.442 . . . . 74.340000000000003 109.489 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.54 131.53 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 O-C-N 120.746 -1.221 . . . . 54.100000000000001 108.592 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.59 151.83 31.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.983 -1.117 . . . . 74.340000000000003 107.983 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -131.04 154.42 48.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.607 0.363 . . . . 74.549999999999997 110.588 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.8 m -140.39 155.1 46.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.489 -0.93 . . . . 61.020000000000003 108.489 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.28 27.07 13.2 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.69 1.138 . . . . 43.149999999999999 111.509 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 128.341 2.656 . . . . 72.329999999999998 106.473 -179.629 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 116.24 1.941 . . . . 70.120000000000005 116.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 73.2 m95 67.43 65.0 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.539 1.518 . . . . 73.439999999999998 112.106 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.23 139.08 19.4 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.91 -1.276 . . . . 54.240000000000002 109.91 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . 0.439 HG12 ' HE3' ' A' ' 48' ' ' LYS . 24.3 mt -75.43 134.7 28.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 118.444 1.122 . . . . 73.140000000000001 111.317 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -140.7 114.4 8.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.313 0.645 . . . . 74.349999999999994 111.582 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.56 120.03 24.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 105.544 -2.021 . . . . 63.200000000000003 105.544 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 63' ' ' ILE . 92.5 t -122.4 142.38 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.404 0.682 . . . . 75.400000000000006 109.621 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.7 p -161.95 149.0 14.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.646 1.578 . . . . 24.329999999999998 107.777 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.356 2.262 . . . . 65.409999999999997 105.379 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.5 m95 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 118.764 -0.636 . . . . 65.340000000000003 109.437 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -45.68 75.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.423 0.63 . . . . 74.109999999999999 110.845 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -60.07 -42.35 94.37 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.53 -0.731 . . . . 75.420000000000002 112.208 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -70.3 -32.02 69.61 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.043 0.537 . . . . 72.230000000000004 109.909 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.14 -47.94 69.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.279 -1.008 . . . . 72.519999999999996 108.279 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -71.1 -76.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.422 1.889 . . . . 72.219999999999999 111.485 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.94 126.24 3.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.695 1.198 . . . . 64.019999999999996 108.101 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -124.02 -65.6 1.05 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 116.562 -1.685 . . . . 63.210000000000001 112.664 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 tp -42.46 -58.33 2.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.457 1.481 . . . . 65.019999999999996 114.159 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -60.16 -52.05 66.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.562 0.696 . . . . 72.340000000000003 110.632 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.1 -49.1 69.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.318 1.847 . . . . 74.140000000000001 111.599 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -39.82 91.61 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.018 1.727 . . . . 64.340000000000003 109.458 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.3 m -61.42 -47.18 86.93 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.656 1.116 . . . . 61.420000000000002 110.753 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.21 -47.29 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.04 -1.038 . . . . 72.040000000000006 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 21' ' ' ILE . 37.4 tt0 -58.29 -52.0 67.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.76 1.224 . . . . 70.530000000000001 111.615 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 t -61.04 -48.4 81.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.873 0.869 . . . . 73.299999999999997 109.926 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.87 -47.74 73.85 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.147 0.885 . . . . 62.229999999999997 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.04 -41.61 77.44 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.53 -0.731 . . . . 60.530000000000001 111.552 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 17' ' ' GLU . 68.8 mt -64.47 -41.33 92.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.008 -0.996 . . . . 70.140000000000001 108.947 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -63.45 -41.44 98.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 120.284 1.402 . . . . 62.310000000000002 108.473 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.22 72.74 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.452 0.538 . . . . 62.350000000000001 112.452 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -76.82 -46.21 25.72 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 114.191 1.182 . . . . 64.230000000000004 114.191 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -133.79 79.22 58.85 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 125.02 1.328 . . . . 64.25 111.101 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 -20.38 47.96 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.525 1.484 . . . . 41.020000000000003 109.675 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.47 12.33 16.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.971 1.308 . . . . 62.439999999999998 112.4 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -127.75 141.41 51.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 119.196 0.907 . . . . 63.420000000000002 108.672 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.32 137.29 19.88 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 54.210000000000001 108.01 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.76 111.93 2.59 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.671 3.581 . . . . 74.239999999999995 113.843 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.89 135.6 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.458 1.103 . . . . 51.030000000000001 110.65 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.86 115.14 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 104.454 -2.424 . . . . 71.549999999999997 104.454 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.56 126.79 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.629 1.172 . . . . 73.439999999999998 109.284 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.82 149.13 48.86 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.378 1.071 . . . . 74.319999999999993 109.651 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -83.73 141.15 31.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.234 -1.025 . . . . 71.400000000000006 108.234 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.23 124.55 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 103.093 -2.929 . . . . 45.299999999999997 103.093 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.0 141.24 54.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.646 -0.659 . . . . 64.409999999999997 110.283 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.0 -1.84 78.44 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 116.13 -2.483 . . . . 61.340000000000003 113.655 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -83.95 145.07 28.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 121.575 2.688 . . . . 65.340000000000003 109.283 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.03 -20.16 64.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.976 1.71 . . . . 70.319999999999993 112.108 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.59 158.23 3.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.321 1.057 . . . . 70.219999999999999 113.441 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.52 134.54 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.129 -1.804 . . . . 74.340000000000003 106.129 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.24 171.98 14.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.859 1.664 . . . . 74.239999999999995 109.058 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 tt -126.64 152.02 33.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 123.742 0.817 . . . . 64.239999999999995 110.431 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.43 161.53 27.91 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.022 1.329 . . . . 73.049999999999997 109.141 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -77.89 91.05 4.13 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.209 -0.663 . . . . 74.310000000000002 109.209 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 14.3 mmm180 -131.34 151.92 51.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 106.548 -1.649 . . . . 72.409999999999997 106.548 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -99.98 106.35 18.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.729 -1.211 . . . . 64.329999999999998 107.729 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -87.98 121.07 29.95 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 122.401 1.096 . . . . 64.140000000000001 113.072 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.92 112.52 24.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.762 2.025 . . . . 73.099999999999994 108.246 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 m -111.34 142.03 25.62 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.074 -0.965 . . . . 75.230000000000004 110.704 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.02 139.25 38.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 120.86 1.343 . . . . 61.039999999999999 110.889 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 p -65.57 -12.77 56.04 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.85 1.26 . . . . 62.140000000000001 112.145 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.88 -35.37 43.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.166 1.786 . . . . 70.120000000000005 113.965 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -74.53 170.24 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.957 0.884 . . . . 73.430000000000007 111.444 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 p -97.8 162.84 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.896 1.278 . . . . 65.25 111.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.21 -35.28 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.368 1.067 . . . . 64.030000000000001 108.129 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.31 90.25 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.82 0.848 . . . . 50.43 109.682 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -62.95 -46.06 89.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.182 -0.673 . . . . 75.030000000000001 109.182 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.38 -51.08 71.46 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.983 -0.377 . . . . 65.430000000000007 109.983 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.42 -47.99 72.15 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.596 1.158 . . . . 62.409999999999997 109.619 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -59.79 -44.67 93.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.594 -0.521 . . . . 75.340000000000003 109.594 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.6 mt -62.95 -40.28 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.63 -1.176 . . . . 74.140000000000001 109.453 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.17 -50.15 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.955 1.707 . . . . 74.239999999999995 108.906 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -63.66 -35.25 79.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.787 0.722 . . . . 54.549999999999997 111.16 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -66.89 -43.61 82.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.794 0.724 . . . . 64.340000000000003 109.198 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.59 -49.16 78.64 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.866 1.266 . . . . 71.329999999999998 111.341 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -80.39 0.65 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.026 0.204 . . . . 71.319999999999993 110.781 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 49.46 64.4 1.76 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.618 1.967 . . . . 73.430000000000007 110.016 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.14 111.39 7.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.296 1.438 . . . . 54.229999999999997 111.01 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.66 152.9 69.91 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.998 2.465 . . . . 73.109999999999999 109.94 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 m -62.2 -15.38 46.12 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.809 1.04 . . . . 60.539999999999999 113.809 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.16 -32.07 66.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.516 0.726 . . . . 73.25 110.431 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.37 164.33 11.71 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 122.073 0.94 . . . . 72.140000000000001 109.861 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.28 4.79 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.934 1.694 . . . . 74.200000000000003 107.49 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 tp -139.63 138.23 39.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.99 -1.855 . . . . 41.32 105.99 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -144.08 133.14 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.371 1.469 . . . . 75.109999999999999 107.17 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.5 mt -114.61 151.42 33.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.407 1.083 . . . . 52.020000000000003 108.172 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.0 142.49 29.83 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.709 1.204 . . . . 75.439999999999998 109.565 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.66 124.8 20.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 117.148 -1.406 . . . . 64.030000000000001 107.347 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 46.35 38.45 5.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 120.358 1.435 . . . . 72.030000000000001 110.882 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt 64.57 18.68 11.5 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.286 -1.509 . . . . 71.150000000000006 113.588 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 p -119.48 162.76 18.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.435 2.294 . . . . 65.030000000000001 111.234 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 t -101.39 107.84 52.61 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.97 1.308 . . . . 63.240000000000002 107.966 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.17 140.49 45.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.158 2.572 . . . . 74.299999999999997 109.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -77.63 121.81 24.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.506 0.722 . . . . 73.239999999999995 110.945 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.1 p -52.58 -35.45 54.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.758 1.223 . . . . 73.109999999999999 114.159 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -77.84 -17.3 57.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.624 0.972 . . . . 54.229999999999997 113.624 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.14 149.81 49.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.803 1.183 . . . . 54.100000000000001 109.787 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.6 p -85.98 152.38 22.98 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.767 0.794 . . . . 71.540000000000006 109.722 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.4 mmt -56.12 -43.43 78.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.181 0.992 . . . . 73.400000000000006 112.032 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.62 -36.8 83.95 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.563 -1.132 . . . . 75.439999999999998 113.288 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -66.49 -49.14 67.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.213 1.506 . . . . 74.430000000000007 107.739 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.07 -43.1 95.68 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.859 0.864 . . . . 72.310000000000002 110.102 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -59.55 -54.46 46.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.313 1.845 . . . . 71.420000000000002 108.991 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.14 -43.35 99.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.098 -0.641 . . . . 73.450000000000003 112.69 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.43 -32.38 60.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.895 1.072 . . . . 71.219999999999999 113.895 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -100.44 0.89 40.62 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.23 1.196 . . . . 74.239999999999995 114.23 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.49 121.54 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.635 1.574 . . . . 74.349999999999994 112.384 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.15 175.51 7.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.712 0.405 . . . . 73.540000000000006 109.978 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.64 -34.03 66.9 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.888 -1.133 . . . . 75.319999999999993 110.827 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.23 10.39 29.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.457 1.903 . . . . 45.340000000000003 112.186 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.97 -1.2 1.39 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.848 2.642 . . . . 54.020000000000003 114.264 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.42 170.83 15.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.023 1.411 . . . . 72.230000000000004 111.073 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.68 136.75 54.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.78 0.832 . . . . 74.25 111.075 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -122.18 122.91 40.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.889 1.676 . . . . 71.129999999999995 109.898 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.17 137.51 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.693 -1.254 . . . . 71.319999999999993 109.461 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.16 147.62 32.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.746 -1.205 . . . . 75.329999999999998 107.746 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.85 152.44 48.51 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.315 0.646 . . . . 61.420000000000002 110.641 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 t -147.29 163.55 36.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.495 0.718 . . . . 35.399999999999999 109.895 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.86 17.22 22.84 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.896 1.712 . . . . 55.219999999999999 113.654 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 . . . . . 0 C--O 1.237 0.411 0 C-N-CA 126.076 1.75 . . . . 73.540000000000006 109.201 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 115.902 1.815 . . . . 50.340000000000003 115.902 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 59.4 m95 51.96 52.21 14.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.883 1.673 . . . . 75.109999999999999 111.984 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . 0.448 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -84.48 130.49 9.82 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.789 -1.194 . . . . 41.25 111.498 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.78 132.39 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.956 1.702 . . . . 72.439999999999998 110.992 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.96 141.48 36.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.959 2.104 . . . . 52.119999999999997 110.961 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.15 124.02 37.9 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.061 -1.089 . . . . 62.299999999999997 108.061 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.97 109.97 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.678 1.191 . . . . 74.540000000000006 109.129 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 160.1 40.96 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.659 1.184 . . . . 74.319999999999993 110.694 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.277 1.031 . . . . 71.319999999999993 108.564 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.3 m95 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 112.099 0.407 . . . . 63.219999999999999 112.099 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -35.19 77.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.22 -0.289 . . . . 72.209999999999994 110.22 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.68 -45.77 91.09 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.915 -1.116 . . . . 64.129999999999995 109.992 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -65.22 -33.98 77.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.842 0.857 . . . . 75.430000000000007 110.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.75 -45.29 92.68 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.023 0.929 . . . . 60.25 108.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.09 -75.48 0.3 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.146 0.978 . . . . 72.109999999999999 112.87 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 133.35 6.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.467 1.507 . . . . 74.319999999999993 109.504 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.4 t -130.65 -53.29 1.08 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.787 -1.101 . . . . 24.440000000000001 109.551 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 tp -49.59 -59.94 3.32 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.232 1.567 . . . . 73.409999999999997 115.232 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.63 -58.87 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.249 0.931 . . . . 63.329999999999998 110.847 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CD2' HH21 ' A' ' 14' ' ' ARG . 2.0 t-160 -50.6 -50.33 54.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.885 1.674 . . . . 71.150000000000006 111.892 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.455 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.8 mmp_? -70.27 -42.04 72.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.721 -1.862 . . . . 73.409999999999997 110.734 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.14 -54.45 39.41 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.22 1.373 . . . . 74.109999999999999 110.015 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -47.64 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.027 1.331 . . . . 72.329999999999998 111.476 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.0 -42.59 99.89 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.85 -0.595 . . . . 62.439999999999998 109.837 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -55.34 -48.18 74.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.277 1.031 . . . . 74.140000000000001 108.681 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.62 72.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 0.598 . . . . 72.239999999999995 111.864 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.67 -45.61 91.99 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.971 -0.456 . . . . 72.239999999999995 110.887 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.4 -41.44 89.89 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 108.52 -0.919 . . . . 65.239999999999995 108.52 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -67.57 -29.82 69.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.39 1.45 . . . . 64.239999999999995 110.648 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.36 -47.44 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.681 -0.637 . . . . 71.319999999999993 110.076 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.99 -46.51 29.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.935 0.717 . . . . 63.420000000000002 112.935 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.91 73.65 70.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.773 2.029 . . . . 75.140000000000001 110.492 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -18.37 47.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.162 2.575 . . . . 55.329999999999998 111.831 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.52 14.03 31.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.712 1.205 . . . . 52.340000000000003 111.839 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -123.53 152.37 41.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.77 0.828 . . . . 62.310000000000002 109.458 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 m -114.51 129.39 24.97 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.577 1.551 . . . . 71.310000000000002 108.525 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.66 116.99 3.89 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.22 3.947 . . . . 60.549999999999997 112.601 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.72 146.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.759 0.79 . . . . 43.350000000000001 109.455 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.36 112.77 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.486 -2.783 . . . . 73.129999999999995 103.486 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.33 127.71 61.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.198 -1.408 . . . . 63.229999999999997 107.198 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -128.08 143.61 51.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.226 0.611 . . . . 73.310000000000002 109.841 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.49 136.5 32.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.643 -0.873 . . . . 72.329999999999998 108.643 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -68.48 112.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.345 -1.354 . . . . 73.319999999999993 107.345 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.05 148.64 2.25 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.366 1.466 . . . . 63.450000000000003 111.345 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.23 -20.49 13.3 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 118.471 -1.183 . . . . 60.439999999999998 111.93 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -65.16 144.93 56.88 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.96 1.88 . . . . 44.020000000000003 110.346 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -70.67 -28.76 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.638 1.575 . . . . 65.140000000000001 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 42' ' ' VAL . 5.6 tp -59.79 157.34 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.369 0.668 . . . . 63.210000000000001 111.198 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' H ' HD12 ' A' ' 41' ' ' ILE . 33.7 m -63.46 138.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.178 -1.045 . . . . 42.240000000000002 108.178 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.82 177.58 6.05 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.927 1.691 . . . . 64.439999999999998 110.082 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.97 158.79 35.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.659 1.184 . . . . 73.319999999999993 109.936 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -78.92 166.19 22.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 128.278 2.631 . . . . 75.219999999999999 109.228 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -80.88 80.85 7.28 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 104.009 -2.589 . . . . 71.530000000000001 104.009 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -135.04 145.11 47.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.023 -1.843 . . . . 73.150000000000006 106.023 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -92.02 144.29 25.6 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.558 1.143 . . . . 75.540000000000006 111.745 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.03 116.96 30.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.322 1.449 . . . . 61.130000000000003 107.518 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -108.12 110.32 21.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.981 1.313 . . . . 73.420000000000002 109.379 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -108.0 143.55 27.59 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 119.6 1.091 . . . . 71.239999999999995 112.808 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HG2' HG23 ' A' ' 55' ' ' ILE . 58.4 Cg_endo -64.87 138.83 59.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.911 2.407 . . . . 73.150000000000006 110.603 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.77 -16.47 58.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.656 -0.652 . . . . 74.530000000000001 112.301 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -26.21 59.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.459 1.904 . . . . 60.509999999999998 113.7 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.444 HG23 ' HG2' ' A' ' 52' ' ' PRO . 1.1 pp -80.91 170.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 122.11 0.957 . . . . 72.439999999999998 111.523 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -107.38 162.15 14.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.491 1.116 . . . . 62.409999999999997 109.6 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.3 t -52.36 -37.29 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.083 . . . . 71.540000000000006 108.077 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.36 -46.68 73.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.313 1.445 . . . . 74.219999999999999 112.225 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -70.47 -44.4 67.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 51' ' ' VAL . 2.3 t80 -58.44 -49.91 75.6 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.962 0.41 . . . . 71.239999999999995 109.896 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.6 ttp -62.56 -49.19 76.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.554 -0.736 . . . . 73.230000000000004 110.177 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -57.59 -44.49 85.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.455 1.025 . . . . 71.439999999999998 111.077 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.9 mt -64.79 -42.96 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.534 -0.913 . . . . 72.140000000000001 108.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.426 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.6 mt -57.67 -50.08 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.274 1.397 . . . . 75.510000000000005 110.07 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.54 -35.2 77.08 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.328 -1.483 . . . . 54.350000000000001 111.016 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -70.35 -35.47 73.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.407 0.548 . . . . 74.129999999999995 109.717 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -67.02 -45.3 77.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.608 1.563 . . . . 71.140000000000001 111.682 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 pt -79.6 -3.39 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 123.667 0.604 . . . . 73.120000000000005 110.887 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.72 46.57 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.394 1.077 . . . . 61.119999999999997 109.802 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.92 109.28 3.64 Favored Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.369 1.468 . . . . 52.229999999999997 110.223 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.58 149.91 56.29 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.975 1.783 . . . . 75.140000000000001 108.811 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -61.5 -18.15 57.8 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.507 -0.746 . . . . 44.210000000000001 113.007 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -66.33 -26.17 67.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.241 0.928 . . . . 65.310000000000002 110.449 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.99 164.89 11.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.062 0.945 . . . . 73.109999999999999 109.593 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 166.3 10.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.281 1.433 . . . . 74.409999999999997 109.52 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 tt -149.75 113.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 121.254 -0.904 . . . . 72.239999999999995 109.698 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -123.42 138.03 54.68 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.449 -1.315 . . . . 73.530000000000001 107.449 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.97 149.85 36.7 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.233 1.813 . . . . 74.319999999999993 107.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -141.74 133.36 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.41 1.084 . . . . 75.349999999999994 109.436 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.44 144.2 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 106.743 -1.577 . . . . 72.230000000000004 106.743 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.72 36.45 1.28 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.924 1.29 . . . . 74.420000000000002 112.651 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.51 38.21 29.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.235 1.414 . . . . 73.209999999999994 110.662 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -147.67 162.22 39.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.8 -1.185 . . . . 64.310000000000002 107.8 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.76 114.05 60.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 103.388 -2.819 . . . . 64.420000000000002 103.388 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.77 123.95 10.97 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 N-CA-C 107.427 -1.797 . . . . 72.329999999999998 107.427 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.96 126.56 27.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.461 -0.57 . . . . 52.530000000000001 109.461 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.0 m -45.88 -46.78 16.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 63.109999999999999 113.471 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.7 m -77.04 -3.18 37.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.389 1.45 . . . . 72.129999999999995 114.692 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.0 tp -67.47 141.17 57.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.691 1.587 . . . . 32.329999999999998 106.809 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.1 p -85.52 151.98 23.53 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.705 -0.622 . . . . 64.409999999999997 109.544 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 mmt -62.27 -42.13 99.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 118.206 -0.902 . . . . 72.409999999999997 113.153 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.33 -47.03 92.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.401 -1.079 . . . . 25.510000000000002 110.401 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -61.83 -49.15 77.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.774 0.83 . . . . 75.120000000000005 110.181 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.47 -49.31 75.92 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.384 0.674 . . . . 71.310000000000002 111.216 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -62.72 -45.53 92.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.629 -1.295 . . . . 73.450000000000003 108.915 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.05 -26.06 67.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 120.297 1.408 . . . . 74.129999999999995 111.736 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -24.35 20.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 116.911 -1.519 . . . . 71.430000000000007 112.335 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -112.36 1.1 15.88 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.877 1.436 . . . . 74.209999999999994 114.877 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -46.94 121.5 3.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.936 1.695 . . . . 60.149999999999999 112.148 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -80.85 171.51 14.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.544 -1.28 . . . . 73.120000000000005 107.544 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.1 -20.6 18.03 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.281 1.832 . . . . 55.009999999999998 113.795 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -102.03 13.71 33.98 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.901 1.68 . . . . 75.409999999999997 112.222 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.9 31.76 77.31 Favored Glycine 0 CA--C 1.524 0.623 0 O-C-N 120.547 -1.346 . . . . 62.32 114.092 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -129.16 172.94 10.94 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.361 -1.082 . . . . 75.129999999999995 108.44 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.12 125.36 45.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.946 -1.131 . . . . 72.340000000000003 107.946 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -102.96 120.04 39.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.903 1.281 . . . . 74.25 108.775 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.239 -1.023 . . . . 73.349999999999994 108.239 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.31 148.65 40.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.375 1.47 . . . . 40.450000000000003 107.628 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -138.12 145.81 42.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.433 0.56 . . . . 75.230000000000004 110.443 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 p -143.47 161.5 38.26 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 122.107 0.956 . . . . 74.319999999999993 110.228 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.32 13.31 21.26 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.993 -1.643 . . . . 73.319999999999993 108.993 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 125.76 1.624 . . . . 64.340000000000003 108.509 -178.892 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 115.754 1.761 . . . . 74.319999999999993 115.754 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 77.0 m95 60.7 59.2 2.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 74.329999999999998 113.045 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.78 129.21 9.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.644 -1.382 . . . . 25.329999999999998 109.644 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 55.2 mt -77.31 132.99 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.276 1.538 . . . . 62.43 112.184 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.02 139.81 39.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 71.129999999999995 109.183 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.4 tt -98.68 118.78 36.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.869 2.068 . . . . 74.549999999999997 107.638 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.41 125.66 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 122.917 0.487 . . . . 74.140000000000001 110.636 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.0 p -161.49 149.71 15.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.904 -1.887 . . . . 73.439999999999998 105.904 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.489 0.716 . . . . 55.229999999999997 110.112 -179.685 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.7 m95 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 mmt -58.76 -46.8 86.63 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.729 -1.212 . . . . 51.109999999999999 107.729 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -59.86 -43.33 94.72 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.497 -0.763 . . . . 73.230000000000004 112.307 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -69.33 -35.91 76.39 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.287 0.949 . . . . 63.32 110.924 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.05 -41.26 91.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.511 -0.552 . . . . 73.420000000000002 109.511 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.64 -75.45 0.31 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.745 0.818 . . . . 73.010000000000005 111.393 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 119.38 3.23 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.548 -1.649 . . . . 74.129999999999995 106.548 177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -104.68 -65.48 1.03 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.51 1.124 . . . . 61.549999999999997 112.361 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.61 -58.47 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.072 1.349 . . . . 70.430000000000007 112.922 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.76 -58.79 6.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.717 0.636 . . . . 73.540000000000006 112.717 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -55.63 -54.97 37.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.0 0.429 . . . . 75.420000000000002 111.808 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.33 82.53 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.526 -1.226 . . . . 74.120000000000005 110.982 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -61.8 -56.31 20.8 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.621 1.168 . . . . 73.129999999999995 112.919 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 -44.79 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 120.669 -1.269 . . . . 60.340000000000003 110.124 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 48.4 mm-40 -61.63 -42.76 99.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 117.661 -1.161 . . . . 71.040000000000006 110.405 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.5 p -60.49 -45.1 95.0 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.632 1.56 . . . . 32.219999999999999 109.423 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.22 74.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.983 0.81 . . . . 74.019999999999996 111.95 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.88 -39.84 95.12 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.632 -0.667 . . . . 72.109999999999999 111.132 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.47 -41.2 88.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-O 117.584 -1.198 . . . . 63.229999999999997 108.539 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -65.83 -39.2 90.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.869 1.668 . . . . 75.340000000000003 109.556 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.01 74.76 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.842 -0.743 . . . . 52.140000000000001 110.909 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -78.51 -47.05 18.14 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.855 1.798 . . . . 62.340000000000003 115.855 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -126.24 70.53 69.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 126.585 1.954 . . . . 63.310000000000002 110.647 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.12 -19.47 51.06 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.502 2.134 . . . . 52.439999999999998 110.231 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.46 12.92 17.07 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.44 1.096 . . . . 64.099999999999994 112.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -129.65 160.7 32.52 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.734 1.614 . . . . 54.520000000000003 111.393 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.21 136.97 28.9 Favored Pre-proline 0 C--O 1.247 0.948 0 C-N-CA 124.422 1.089 . . . . 73.209999999999994 108.471 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.98 113.7 3.48 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 126.078 4.519 . . . . 51.109999999999999 111.683 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.1 144.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.666 0.786 . . . . 73.450000000000003 110.477 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -122.6 128.88 75.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 103.861 -2.644 . . . . 75.310000000000002 103.861 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.93 119.69 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 127.124 2.169 . . . . 73.530000000000001 106.692 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -124.4 146.96 48.57 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.614 1.097 . . . . 75.439999999999998 109.051 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -89.35 139.41 30.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.242 0.474 . . . . 71.420000000000002 109.905 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.0 130.24 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.568 -1.271 . . . . 74.409999999999997 107.568 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 p -61.04 122.04 13.97 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.214 -1.402 . . . . 70.519999999999996 107.214 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.93 -13.8 29.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.902 -1.499 . . . . 44.210000000000001 112.87 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.641 ' HB3' HG22 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -79.54 131.08 35.93 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.503 2.151 . . . . 73.030000000000001 106.318 177.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -63.48 -19.66 64.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.813 0.845 . . . . 73.439999999999998 113.012 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 39' ' ' SER . 9.4 tp -51.74 155.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.817 1.647 . . . . 73.409999999999997 112.71 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.16 145.27 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.437 1.095 . . . . 74.299999999999997 111.78 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.79 164.24 25.39 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.036 0.534 . . . . 41.340000000000003 109.798 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.68 132.72 70.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.455 1.102 . . . . 72.329999999999998 112.082 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -67.54 153.6 43.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.996 1.719 . . . . 75.129999999999995 107.821 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.69 99.13 3.6 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.327 -1.731 . . . . 71.409999999999997 106.327 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -134.41 160.96 36.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.429 -0.952 . . . . 74.230000000000004 108.429 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.9 mtpp -109.81 103.01 11.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.018 1.727 . . . . 75.140000000000001 108.372 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -84.38 125.84 32.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.735 -1.209 . . . . 74.209999999999994 107.735 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.74 107.57 18.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.322 -2.103 . . . . 71.239999999999995 105.322 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -109.61 143.01 26.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 117.011 -1.471 . . . . 63.520000000000003 110.492 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.12 134.73 25.75 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.452 2.768 . . . . 45.340000000000003 111.995 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 p -59.63 -17.2 31.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.885 1.274 . . . . 64.420000000000002 113.993 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.6 -34.26 60.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.434 1.894 . . . . 75.519999999999996 113.213 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.39 167.22 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 119.969 1.259 . . . . 71.219999999999999 111.095 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.417 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 57.4 p -107.38 166.66 10.48 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.38 1.072 . . . . 62.509999999999998 110.712 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.12 -37.94 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.378 1.071 . . . . 74.409999999999997 110.085 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.56 93.28 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.238 0.926 . . . . 71.329999999999998 111.311 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.417 ' NE2' ' H ' ' A' ' 56' ' ' THR . 58.3 mt-30 -65.79 -46.2 79.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 108.572 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.95 -50.66 72.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.697 1.199 . . . . 75.319999999999993 110.46 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttp -55.06 -49.07 72.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.61 1.164 . . . . 63.43 110.35 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -57.51 -42.17 82.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.491 -0.559 . . . . 75.319999999999993 109.491 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.21 -48.66 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.822 -1.085 . . . . 74.430000000000007 110.374 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.28 -50.39 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.794 1.179 . . . . 61.25 110.071 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.0 -36.86 82.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.022 -0.99 . . . . 73.230000000000004 111.51 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -71.19 -37.1 72.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.072 1.305 . . . . 71.519999999999996 110.673 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.66 -49.53 74.79 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.491 1.516 . . . . 75.0 109.658 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 pt -79.53 0.7 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 119.605 -0.236 . . . . 73.230000000000004 111.006 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 50.29 58.41 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.498 1.919 . . . . 65.439999999999998 110.039 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 110.14 4.44 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.736 -1.209 . . . . 55.219999999999999 107.736 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.07 162.52 39.65 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.112 2.541 . . . . 74.109999999999999 112.434 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 m -67.35 -22.33 65.59 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.745 -0.597 . . . . 53.340000000000003 110.969 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.66 -34.06 77.01 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.11 0.868 . . . . 63.219999999999999 111.697 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -104.15 164.63 11.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.987 1.315 . . . . 71.329999999999998 111.726 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 175.13 5.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.413 1.885 . . . . 73.530000000000001 106.558 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -144.55 143.1 23.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 64.510000000000005 107.542 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -145.49 134.63 22.78 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.78 1.632 . . . . 74.319999999999993 108.129 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -114.7 142.26 46.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.988 1.315 . . . . 74.450000000000003 109.803 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.59 136.94 36.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.023 1.329 . . . . 74.230000000000004 108.766 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.67 125.7 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 104.305 -2.48 . . . . 45.109999999999999 104.305 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t70 43.72 42.7 4.46 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.252 1.204 . . . . 72.129999999999995 114.252 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? 69.51 18.58 7.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.712 1.605 . . . . 73.0 114.291 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.1 p -124.03 162.57 23.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 120.48 1.491 . . . . 75.219999999999999 112.165 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.24 105.12 11.47 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 105.737 -1.949 . . . . 51.140000000000001 105.737 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.45 133.75 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.065 1.844 . . . . 71.239999999999995 109.844 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -67.57 118.59 11.07 Favored 'General case' 0 C--O 1.227 -0.113 0 O-C-N 121.439 -0.788 . . . . 73.310000000000002 109.366 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m -50.56 -39.32 49.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.224 1.01 . . . . 62.310000000000002 113.563 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.69 -8.07 59.66 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.052 1.501 . . . . 72.329999999999998 115.052 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.47 141.69 50.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.156 1.798 . . . . 63.409999999999997 110.307 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.52 143.39 34.92 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.631 -1.248 . . . . 75.349999999999994 107.631 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.19 -43.39 70.69 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.208 -0.901 . . . . 63.340000000000003 111.09 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.45 -38.0 92.88 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.868 1.213 . . . . 33.130000000000003 112.904 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.65 -53.83 16.79 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.513 -0.993 . . . . 63.020000000000003 108.808 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.26 -38.32 83.13 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.194 -0.912 . . . . 55.219999999999999 110.319 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -61.44 -54.43 43.58 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 117.082 -1.437 . . . . 72.150000000000006 107.461 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -55.12 -53.62 53.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.75 1.159 . . . . 62.32 111.925 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -24.93 64.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 117.963 -1.018 . . . . 75.219999999999999 113.659 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -105.95 4.32 29.37 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.233 1.379 . . . . 65.120000000000005 112.861 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -55.37 120.25 6.82 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.126 1.77 . . . . 64.430000000000007 110.041 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.43 172.37 13.05 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.133 -1.062 . . . . 65.310000000000002 108.133 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.51 -33.96 68.6 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.774 -1.204 . . . . 73.109999999999999 109.926 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -88.35 16.35 6.49 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.734 1.214 . . . . 73.319999999999993 112.193 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.2 28.38 66.64 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.361 1.458 . . . . 71.420000000000002 116.294 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -119.51 175.74 5.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.445 1.622 . . . . 74.239999999999995 111.013 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.68 137.89 54.63 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.161 0.985 . . . . 52.509999999999998 110.502 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.84 101.76 8.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.081 1.353 . . . . 73.109999999999999 109.97 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.72 122.84 69.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.559 0.695 . . . . 72.109999999999999 111.149 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.78 145.86 25.44 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.595 -1.261 . . . . 71.109999999999999 107.595 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -128.67 147.42 50.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.459 -0.941 . . . . 64.230000000000004 108.459 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 p -144.8 154.8 43.06 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.508 -0.923 . . . . 72.209999999999994 108.508 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.74 20.97 14.53 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.983 1.277 . . . . 53.399999999999999 110.064 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 C--O 1.239 0.548 0 C-N-CA 125.694 1.598 . . . . 53.200000000000003 107.828 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 113.006 0.743 . . . . 74.230000000000004 113.006 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 44.5 m95 51.91 59.38 4.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.25 1.82 . . . . 74.219999999999999 112.506 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.24 135.54 14.71 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.982 -1.247 . . . . 75.420000000000002 109.982 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 82.7 mt -80.61 134.47 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.712 1.756 . . . . 74.120000000000005 112.446 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -140.03 133.64 30.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.085 0.954 . . . . 72.409999999999997 111.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 73.6 mt -88.27 116.66 26.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.322 -2.103 . . . . 63.43 105.322 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.68 121.81 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.743 -0.836 . . . . 71.329999999999998 108.743 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -157.3 128.09 6.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.023 -1.103 . . . . 73.549999999999997 108.023 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 105.728 -1.952 . . . . 64.109999999999999 105.728 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.6 m95 . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 106.959 -1.497 . . . . 61.149999999999999 106.959 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 mtt -49.64 -46.83 49.96 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.61 0.764 . . . . 63.240000000000002 109.749 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -56.65 -44.14 81.01 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.038 -0.982 . . . . 74.329999999999998 113.108 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -74.52 -27.72 60.66 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.353 1.061 . . . . 73.230000000000004 113.332 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -72.42 -48.16 43.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.515 -0.92 . . . . 64.099999999999994 108.515 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -74.73 -77.29 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 124.271 0.982 . . . . 61.25 109.085 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.66 117.85 2.11 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 119.773 -1.83 . . . . 73.519999999999996 108.228 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p -112.86 -66.4 1.09 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.839 -1.553 . . . . 72.209999999999994 109.428 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 pp -44.14 -58.13 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.387 1.875 . . . . 62.130000000000003 115.299 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.59 -58.93 6.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.452 1.901 . . . . 73.299999999999997 111.237 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -63.15 -50.73 69.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.913 1.285 . . . . 54.530000000000001 111.141 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -40.92 85.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 116.996 -1.478 . . . . 73.430000000000007 109.824 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.11 -55.6 20.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.821 1.191 . . . . 71.409999999999997 110.117 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.03 -47.71 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.454 0.57 . . . . 74.219999999999999 111.031 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 48' ' ' LYS . 53.9 mm-40 -65.27 -38.59 90.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.412 -0.804 . . . . 65.109999999999999 109.74 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -58.77 -48.44 81.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 120.315 1.416 . . . . 62.399999999999999 108.419 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.42 69.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.88 0.764 . . . . 71.310000000000002 110.485 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.84 -49.92 70.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.479 -0.296 . . . . 64.129999999999995 111.677 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -59.13 -42.02 85.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 124.085 0.954 . . . . 61.310000000000002 110.621 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -69.12 -38.89 79.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.686 1.13 . . . . 71.549999999999997 109.379 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.49 70.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.591 -0.693 . . . . 51.329999999999998 110.468 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -73.2 -46.38 50.8 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 113.153 0.797 . . . . 64.400000000000006 113.153 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -129.0 77.75 77.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.857 1.263 . . . . 75.510000000000005 109.887 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.42 -28.03 71.03 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.731 2.287 . . . . 74.340000000000003 113.581 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.6 13.8 13.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.288 0.949 . . . . 71.140000000000001 110.653 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -118.1 152.44 35.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.584 -0.895 . . . . 72.349999999999994 108.584 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.61 135.2 24.94 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.52 -1.289 . . . . 70.120000000000005 107.52 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.47 114.44 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.293 3.329 . . . . 73.349999999999994 114.108 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.84 149.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 O-C-N 120.938 -1.101 . . . . 72.329999999999998 109.926 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.6 mm -123.1 115.19 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 103.056 -2.942 . . . . 75.310000000000002 103.056 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.08 119.38 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.054 -1.091 . . . . 75.010000000000005 108.054 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.48 159.67 37.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.709 1.14 . . . . 63.32 111.616 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.31 153.59 22.47 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.586 -0.696 . . . . 74.150000000000006 112.052 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.47 135.32 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.55 -2.389 . . . . 60.140000000000001 104.55 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.66 120.97 9.89 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.668 -1.234 . . . . 44.130000000000003 107.668 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.32 -11.82 54.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.538 -1.146 . . . . 31.309999999999999 112.443 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -69.5 113.27 6.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 103.635 -2.728 . . . . 62.340000000000003 103.635 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -72.07 -13.36 61.57 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.411 0.893 . . . . 73.530000000000001 113.411 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 tp -62.54 166.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.547 1.139 . . . . 74.209999999999994 111.723 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 m -55.68 123.49 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.437 1.095 . . . . 72.510000000000005 109.181 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.62 178.16 5.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.795 1.638 . . . . 74.430000000000007 110.05 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.11 149.7 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.453 1.101 . . . . 72.140000000000001 110.867 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.16 166.07 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.475 1.51 . . . . 64.310000000000002 107.26 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.45 103.02 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.562 -1.336 . . . . 73.109999999999999 109.448 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 67.9 mmt-85 -141.44 154.52 45.63 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.136 1.774 . . . . 73.0 109.865 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mtpp -98.97 104.27 16.3 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.964 1.706 . . . . 74.5 108.766 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -84.22 118.23 24.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.766 -1.568 . . . . 72.319999999999993 106.766 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.27 116.83 32.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.885 -1.524 . . . . 53.119999999999997 106.885 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -111.59 141.25 24.24 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.888 -1.053 . . . . 74.239999999999995 110.399 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 71.2 Cg_endo -72.27 141.1 35.04 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.333 2.022 . . . . 75.310000000000002 108.229 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -65.9 -13.03 58.94 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 114.616 1.339 . . . . 75.219999999999999 114.616 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.54 -32.07 24.06 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.417 1.265 . . . . 62.149999999999999 114.417 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.37 164.8 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.305 0.957 . . . . 70.230000000000004 109.319 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -103.21 165.32 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.443 0.697 . . . . 65.010000000000005 110.74 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.81 -35.63 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.037 1.335 . . . . 63.200000000000003 109.259 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.89 -46.12 85.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.244 0.929 . . . . 72.25 109.933 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -67.57 -46.41 72.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.573 -0.727 . . . . 73.140000000000001 109.919 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.38 -46.97 87.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.513 0.597 . . . . 73.329999999999998 110.097 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.4 ttt -55.73 -52.19 64.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.243 1.017 . . . . 74.409999999999997 108.982 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -57.29 -40.35 77.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.581 -0.723 . . . . 75.310000000000002 110.663 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.73 -44.03 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.127 . . . . 71.109999999999999 109.282 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.89 -51.1 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.731 1.605 . . . . 62.229999999999997 110.393 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -36.16 82.85 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.672 -0.68 . . . . 73.219999999999999 110.904 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -68.07 -43.69 77.99 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.173 0.589 . . . . 70.409999999999997 110.689 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -60.23 -51.33 70.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.857 1.663 . . . . 74.120000000000005 110.033 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.53 -2.97 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.125 -0.464 . . . . 75.200000000000003 111.57 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 50.05 65.4 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.756 2.022 . . . . 73.200000000000003 109.532 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.82 115.16 22.05 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.56 0.744 . . . . 74.230000000000004 109.252 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.26 164.47 17.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.668 3.579 . . . . 74.409999999999997 113.817 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -67.92 -29.52 68.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.368 0.667 . . . . 73.109999999999999 111.509 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -62.09 -38.52 89.15 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.061 -0.495 . . . . 75.340000000000003 112.237 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.42 164.44 11.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.7 0.762 . . . . 74.430000000000007 111.756 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 -178.2 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.976 1.711 . . . . 60.130000000000003 107.506 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.2 140.59 22.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.411 1.084 . . . . 74.420000000000002 108.26 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -145.34 140.7 27.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.006 -1.479 . . . . 63.240000000000002 107.006 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.72 153.14 30.82 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.845 1.658 . . . . 72.439999999999998 109.637 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -147.03 132.85 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.525 1.13 . . . . 74.349999999999994 108.946 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -126.61 119.6 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 103.121 -2.918 . . . . 64.430000000000007 103.121 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 46.77 45.8 14.89 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 124.71 2.195 . . . . 73.519999999999996 111.603 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt 56.59 30.38 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.452 -1.405 . . . . 55.450000000000003 112.224 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 p -118.64 159.87 22.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.547 -1.649 . . . . 72.340000000000003 106.547 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.36 109.58 41.25 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.674 -1.973 . . . . 70.430000000000007 105.674 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.38 124.0 13.07 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.093 1.862 . . . . 70.140000000000001 110.51 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -73.93 116.03 14.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.641 1.176 . . . . 44.119999999999997 109.954 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 83.6 p -49.13 -34.2 13.59 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.083 1.512 . . . . 65.439999999999998 115.083 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -82.6 -9.53 59.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.583 0.957 . . . . 63.530000000000001 113.583 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -75.19 144.5 42.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.609 1.095 . . . . 72.400000000000006 109.732 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.69 150.04 26.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.623 0.769 . . . . 44.409999999999997 109.739 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.2 mmt -54.64 -45.42 73.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.473 1.109 . . . . 61.210000000000001 111.785 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.15 91.04 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.456 -0.636 . . . . 55.439999999999998 113.259 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.5 -52.94 40.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.342 1.071 . . . . 73.209999999999994 108.812 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.38 -45.4 76.57 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 124.732 1.213 . . . . 74.329999999999998 108.82 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.28 -56.06 26.9 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.02 1.728 . . . . 61.119999999999997 109.28 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.31 -43.19 88.05 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.193 0.906 . . . . 73.319999999999993 113.298 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -30.71 39.31 Favored 'General case' 0 N--CA 1.46 0.055 0 CA-C-O 117.324 -1.322 . . . . 73.230000000000004 112.844 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -97.58 -7.77 30.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.205 1.366 . . . . 74.120000000000005 114.266 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -33.38 120.16 0.37 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.968 2.907 . . . . 73.109999999999999 114.94 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.01 169.98 17.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.38 -1.341 . . . . 74.120000000000005 107.38 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -54.49 -28.75 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.252 1.421 . . . . 72.230000000000004 112.674 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -99.52 17.59 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.273 1.029 . . . . 75.239999999999995 112.703 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 30.43 74.63 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.325 -0.859 . . . . 62.520000000000003 114.632 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -126.28 174.17 8.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.693 1.246 . . . . 73.230000000000004 110.35 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 tp -124.62 142.95 50.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.127 -0.94 . . . . 74.239999999999995 110.778 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -117.93 116.1 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.473 1.509 . . . . 73.530000000000001 107.761 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.21 131.67 72.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 O-C-N 120.469 -1.394 . . . . 73.329999999999998 108.243 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.62 24.36 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.951 0.9 . . . . 72.219999999999999 109.798 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -139.96 154.49 47.2 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 124.191 0.932 . . . . 74.109999999999999 111.301 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -153.77 169.04 24.31 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.931 1.292 . . . . 72.439999999999998 108.829 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.34 24.9 10.19 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.397 0.999 . . . . 71.319999999999993 113.821 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.532 0.288 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 109.247 -179.026 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 119.619 -0.229 . . . . 72.099999999999994 111.161 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.1 m95 52.36 47.43 24.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.99 0.916 . . . . 74.25 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . 0.415 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -79.28 146.31 28.94 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 108.584 -1.806 . . . . 52.119999999999997 108.584 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.57 143.98 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 118.661 1.23 . . . . 72.450000000000003 111.527 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -148.62 120.81 8.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.524 1.53 . . . . 73.430000000000007 109.781 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.45 119.61 22.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.442 -1.318 . . . . 72.519999999999996 107.442 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.47 108.61 22.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.661 1.184 . . . . 73.530000000000001 108.639 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 p -146.24 162.35 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.247 1.819 . . . . 54.210000000000001 109.913 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 123.571 0.748 . . . . 54.229999999999997 109.752 -179.656 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 109.02 -0.733 . . . . 71.200000000000003 109.02 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -46.75 68.91 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 124.206 0.942 . . . . 73.340000000000003 109.357 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -57.56 -49.25 76.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.743 0.817 . . . . 75.109999999999999 112.524 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.06 -43.99 90.44 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.697 0.799 . . . . 73.219999999999999 112.521 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -67.13 -44.35 80.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 123.572 0.545 . . . . 73.530000000000001 110.608 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -73.25 0.28 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 123.635 0.585 . . . . 71.129999999999995 111.448 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.604 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 1.5 p-80 -157.58 119.44 3.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.409 1.004 . . . . 71.340000000000003 109.948 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.01 -64.97 0.93 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.653 -1.641 . . . . 75.230000000000004 113.588 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.36 -57.82 1.68 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 121.597 1.999 . . . . 54.450000000000003 115.374 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -64.5 -52.62 56.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.768 0.794 . . . . 63.210000000000001 110.439 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.604 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 2.9 t60 -50.98 -58.99 4.63 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.075 1.75 . . . . 45.409999999999997 111.9 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -61.62 -49.43 76.61 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.363 2.665 . . . . 74.200000000000003 111.924 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.8 t -57.64 -49.05 77.75 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 118.724 0.693 . . . . 74.340000000000003 110.833 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.14 -42.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.331 0.652 . . . . 61.039999999999999 110.234 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 18.5 tt0 -60.44 -52.35 65.6 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.52 1.528 . . . . 70.430000000000007 110.436 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 t -58.21 -48.03 81.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.189 0.996 . . . . 73.319999999999993 108.937 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.42 76.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.25 0.477 . . . . 74.549999999999997 111.339 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -60.09 -39.56 86.54 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.35 -0.844 . . . . 72.209999999999994 110.332 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.34 -42.18 87.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-O 118.096 -0.954 . . . . 74.439999999999998 108.892 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -64.29 -32.52 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 120.515 1.507 . . . . 71.129999999999995 109.603 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.71 -47.81 20.77 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.254 0.549 . . . . 73.239999999999995 111.45 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -76.85 -46.87 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.859 1.429 . . . . 73.150000000000006 114.859 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.79 72.68 78.64 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 127.663 2.385 . . . . 74.430000000000007 108.128 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.79 -30.98 93.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.783 2.322 . . . . 75.219999999999999 111.326 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -90.92 14.79 12.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.766 0.826 . . . . 72.25 111.928 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -126.43 142.85 51.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.492 -1.38 . . . . 71.530000000000001 109.611 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.53 142.82 27.28 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.191 0.996 . . . . 73.099999999999994 111.779 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.79 118.66 3.84 Favored 'Trans proline' 0 C--N 1.353 0.78 1 C-N-CA 125.496 4.13 . . . . 72.319999999999993 114.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 t -125.48 143.85 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.248 1.023 . . . . 72.310000000000002 110.09 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mm -119.94 121.19 65.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 100.831 -3.766 . . . . 41.5 100.831 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.58 123.55 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.488 -0.93 . . . . 71.530000000000001 108.488 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -134.13 158.71 42.94 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.313 0.578 . . . . 63.020000000000003 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -79.12 145.75 33.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.01 0.524 . . . . 72.519999999999996 109.798 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.15 113.69 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 101.409 -3.552 . . . . 74.329999999999998 101.409 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.0 p -48.51 134.55 15.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.529 0.566 . . . . 72.329999999999998 112.529 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.29 -19.38 54.46 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 117.318 -1.823 . . . . 63.130000000000003 112.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 t -67.68 146.43 53.81 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.223 2.011 . . . . 61.210000000000001 109.937 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -73.7 -19.59 60.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.251 1.421 . . . . 71.450000000000003 112.791 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.3 tp -60.91 158.14 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.767 -0.457 . . . . 65.049999999999997 109.767 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.84 145.48 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 113.738 1.014 . . . . 41.109999999999999 113.738 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.99 160.99 17.65 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.637 1.975 . . . . 42.240000000000002 111.485 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.53 139.95 50.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.496 1.519 . . . . 75.530000000000001 109.545 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.77 159.36 30.38 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.869 -1.16 . . . . 64.239999999999995 107.869 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.84 95.05 2.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.586 -1.264 . . . . 73.140000000000001 107.586 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -133.09 151.29 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.05 -1.463 . . . . 73.109999999999999 107.05 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.5 mttp -99.79 108.25 20.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.472 -1.307 . . . . 75.329999999999998 107.472 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.88 119.9 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.448 0.642 . . . . 72.030000000000001 111.229 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.85 117.16 32.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.495 -2.039 . . . . 70.420000000000002 105.495 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 m -112.91 142.43 27.24 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.266 -1.013 . . . . 42.119999999999997 108.266 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 55.3 Cg_endo -66.78 138.62 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.324 1.509 . . . . 70.439999999999998 110.304 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -15.82 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.622 0.769 . . . . 64.510000000000005 111.667 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.73 -34.79 72.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.791 2.436 . . . . 64.400000000000006 113.321 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.31 166.5 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.004 -1.06 . . . . 53.32 111.982 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 p -99.87 168.74 9.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.728 0.811 . . . . 55.530000000000001 111.815 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.86 -41.24 56.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 125.078 1.351 . . . . 64.329999999999998 108.973 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.16 86.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.78 0.718 . . . . 72.010000000000005 111.074 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.57 -46.69 81.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.268 -0.642 . . . . 63.5 109.268 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.78 -47.71 84.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.533 0.606 . . . . 73.239999999999995 109.745 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.9 ttt -58.41 -46.17 86.98 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.629 1.571 . . . . 73.420000000000002 110.775 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -63.13 -44.49 95.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.865 -0.791 . . . . 72.439999999999998 108.865 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.53 HG21 ' CG1' ' B' ' 346' ' ' VAL . 29.8 mt -63.24 -40.01 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 117.48 -1.248 . . . . 74.25 108.706 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.12 -50.58 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 120.92 1.691 . . . . 44.409999999999997 109.209 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -63.48 -40.48 97.21 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.608 1.094 . . . . 75.109999999999999 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -63.49 -46.61 85.35 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.143 0.977 . . . . 73.340000000000003 110.593 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -59.97 -49.06 79.15 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.261 1.424 . . . . 73.219999999999999 111.473 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -79.93 -0.76 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 123.431 0.457 . . . . 72.019999999999996 111.261 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 50.11 68.25 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.688 2.395 . . . . 71.329999999999998 109.71 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 111.99 8.97 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.97 1.708 . . . . 64.430000000000007 111.098 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.13 157.92 49.91 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.335 2.69 . . . . 73.409999999999997 112.313 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.314 0.487 . . . . 71.239999999999995 112.314 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.01 -35.98 82.94 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.384 -0.823 . . . . 72.200000000000003 109.688 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.66 164.27 11.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.802 1.287 . . . . 74.540000000000006 112.33 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.1 177.3 4.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.866 2.467 . . . . 44.420000000000002 106.992 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tp -147.06 140.75 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.504 -1.295 . . . . 75.530000000000001 107.504 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.31 141.55 28.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.356 1.862 . . . . 73.239999999999995 108.833 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.0 mt -114.91 147.45 39.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 73.430000000000007 109.348 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -143.82 123.79 13.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.089 -1.449 . . . . 65.019999999999996 107.089 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.48 117.4 49.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.235 -1.394 . . . . 74.409999999999997 107.235 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t0 43.66 51.13 6.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.097 1.759 . . . . 44.310000000000002 111.711 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 63.54 17.9 10.69 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.322 1.449 . . . . 72.450000000000003 114.101 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.2 p -121.79 161.52 22.51 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 120.13 1.332 . . . . 71.510000000000005 111.02 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.26 110.04 60.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.113 -2.551 . . . . 64.129999999999995 104.113 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.65 135.54 33.49 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.446 1.43 . . . . 33.219999999999999 111.473 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.92 120.38 18.48 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 107.768 -1.197 . . . . 72.230000000000004 107.768 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -53.89 -25.81 21.93 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.123 2.169 . . . . 74.209999999999994 114.842 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -92.18 -12.14 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.643 0.777 . . . . 54.229999999999997 112.426 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.42 149.61 49.73 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.514 -0.921 . . . . 74.530000000000001 108.514 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.04 152.53 21.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.697 0.799 . . . . 74.319999999999993 109.489 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.39 -46.36 88.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.582 -0.723 . . . . 72.219999999999999 109.867 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.92 96.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.724 0.678 . . . . 44.140000000000001 111.793 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -65.19 -51.07 63.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 108.937 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.94 -38.53 88.81 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.946 -0.471 . . . . 43.130000000000003 110.855 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -61.89 -52.99 61.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.699 2.0 . . . . 75.530000000000001 109.659 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.38 -33.75 73.52 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.686 0.624 . . . . 73.510000000000005 112.686 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -26.55 33.82 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 117.555 -1.212 . . . . 63.32 111.724 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -103.95 -2.38 26.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.591 1.087 . . . . 71.129999999999995 112.647 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -33.23 121.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 116.324 1.972 . . . . 74.120000000000005 116.324 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.14 175.32 6.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.001 0.921 . . . . 63.229999999999997 109.688 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -51.76 -39.33 58.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.858 1.663 . . . . 72.540000000000006 112.269 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.72 0.35 57.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.603 1.561 . . . . 73.310000000000002 112.516 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.93 66.35 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.137 1.351 . . . . 51.43 112.627 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 161.05 16.21 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.546 1.938 . . . . 63.539999999999999 108.89 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.2 139.27 54.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.385 0.993 . . . . 71.120000000000005 109.937 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.78 132.94 54.45 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.561 1.545 . . . . 73.230000000000004 107.619 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.26 146.54 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.302 -0.999 . . . . 73.299999999999997 108.302 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.45 144.35 44.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.836 -1.172 . . . . 75.120000000000005 107.836 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -128.7 149.77 50.54 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 109.032 -0.729 . . . . 73.310000000000002 109.032 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.7 t -144.86 163.37 34.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.876 -1.157 . . . . 52.219999999999999 107.876 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.3 5.83 55.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.828 -1.709 . . . . 74.140000000000001 108.828 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-N 118.529 1.165 . . . . 74.239999999999995 109.921 -178.604 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 CA--C 1.539 0.519 0 N-CA-C 111.819 0.303 . . . . 51.210000000000001 111.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 27.8 m95 49.48 52.34 14.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.322 1.449 . . . . 74.430000000000007 112.71 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.38 131.87 10.85 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.13 -1.606 . . . . 72.430000000000007 110.257 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.5 141.63 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.205 1.502 . . . . 70.400000000000006 107.315 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -137.44 151.0 48.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.69 1.996 . . . . 55.100000000000001 110.687 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 19.3 tp -113.55 112.23 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.975 1.31 . . . . 74.519999999999996 109.525 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.53 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.1 t -123.95 137.0 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.233 1.413 . . . . 75.349999999999994 111.718 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.2 p -162.46 161.0 26.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.707 0.803 . . . . 52.020000000000003 111.602 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 102.851 -3.018 . . . . 75.140000000000001 102.851 176.498 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m95 . . . . . 0 C--O 1.236 0.384 0 N-CA-C 108.796 -0.816 . . . . 73.349999999999994 108.796 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.8 mmt -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.869 0.366 . . . . 75.420000000000002 110.465 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -58.29 -46.1 86.7 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 112.732 0.641 . . . . 55.329999999999998 112.732 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -63.98 -39.3 93.82 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.114 0.965 . . . . 73.129999999999995 111.363 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.08 -42.69 80.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.497 0.498 . . . . 55.140000000000001 111.497 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.18 -70.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.272 0.841 . . . . 65.329999999999998 113.272 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -158.36 119.98 3.53 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.486 -1.302 . . . . 74.120000000000005 107.486 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -128.83 -66.15 0.84 Allowed 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 117.113 -1.422 . . . . 42.409999999999997 111.883 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 tp -44.74 -50.34 10.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.092 1.357 . . . . 74.420000000000002 114.4 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -66.27 -59.44 3.72 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.939 -1.101 . . . . 61.43 112.235 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.576 ' CD2' HH21 ' A' ' 14' ' ' ARG . 3.0 t-160 -53.94 -51.85 62.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.488 1.115 . . . . 75.129999999999995 109.929 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.576 HH21 ' CD2' ' A' ' 13' ' ' HIS . 11.9 mmp_? -58.39 -46.2 86.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 115.599 -2.143 . . . . 71.140000000000001 109.867 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.17 -43.33 99.05 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.283 1.856 . . . . 71.319999999999993 112.449 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.66 -47.72 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 118.297 0.499 . . . . 74.010000000000005 110.008 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' HD11 ' B' ' 343' ' ' ILE . 0.5 OUTLIER -67.16 -39.9 86.55 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.603 -1.189 . . . . 64.420000000000002 110.371 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 m -56.1 -47.78 77.41 Favored 'General case' 0 CA--C 1.523 -0.059 0 CA-C-N 120.722 1.601 . . . . 74.040000000000006 107.386 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.83 72.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.967 0.358 . . . . 61.109999999999999 111.967 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.52 -51.47 65.34 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.801 -0.562 . . . . 74.319999999999993 111.317 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.46 -42.21 87.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 117.513 -1.232 . . . . 71.430000000000007 109.908 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -72.58 -29.66 63.73 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 120.556 1.526 . . . . 71.209999999999994 111.643 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.23 -46.48 41.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.995 0.816 . . . . 72.030000000000001 109.586 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -73.47 -45.93 51.19 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.669 -0.645 . . . . 71.430000000000007 110.689 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -122.76 79.76 48.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 125.324 1.45 . . . . 71.140000000000001 110.202 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.66 -20.66 52.88 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.877 1.718 . . . . 73.209999999999994 110.897 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.06 16.92 25.32 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.306 1.042 . . . . 64.129999999999995 112.946 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -120.89 153.45 37.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.867 -1.531 . . . . 72.040000000000006 106.867 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 135.11 24.08 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 124.022 0.929 . . . . 54.420000000000002 108.788 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.76 111.92 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 125.31 4.007 . . . . 63.100000000000001 112.884 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.82 149.73 16.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.873 0.869 . . . . 53.350000000000001 109.697 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.63 120.88 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 103.634 -2.728 . . . . 73.219999999999999 103.634 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.58 130.72 64.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.075 -1.454 . . . . 60.350000000000001 107.075 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.99 148.04 52.7 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.656 1.182 . . . . 63.219999999999999 110.3 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.83 132.86 36.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.283 -1.006 . . . . 73.409999999999997 108.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.16 111.96 2.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.375 -1.713 . . . . 75.519999999999996 106.375 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -57.73 123.83 17.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.457 -1.312 . . . . 74.230000000000004 107.457 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.49 -17.99 27.93 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.689 1.137 . . . . 62.409999999999997 110.665 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 t -71.93 168.49 17.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.973 1.386 . . . . 61.420000000000002 108.398 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.23 -11.82 17.73 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.171 0.988 . . . . 74.109999999999999 113.391 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tp -69.72 159.64 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.816 -0.553 . . . . 73.239999999999995 109.981 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.09 148.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.186 1.394 . . . . 63.32 110.385 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -77.67 167.65 21.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.069 1.348 . . . . 61.109999999999999 111.713 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.63 135.86 62.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.795 0.838 . . . . 61.32 111.166 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.36 152.32 38.37 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.693 1.197 . . . . 72.129999999999995 108.395 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -74.75 92.99 2.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.786 -1.19 . . . . 71.420000000000002 107.786 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -132.81 162.63 31.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.67 1.988 . . . . 75.209999999999994 109.838 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -113.32 108.42 17.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.239 -2.134 . . . . 70.030000000000001 105.239 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -84.37 122.95 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.278 -1.008 . . . . 74.040000000000006 108.278 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.87 110.75 23.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.197 -1.779 . . . . 72.140000000000001 106.197 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.29 142.29 26.11 Favored Pre-proline 0 N--CA 1.453 -0.296 0 O-C-N 124.033 0.833 . . . . 75.510000000000005 109.02 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 135.43 39.42 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.986 . . . . 73.420000000000002 111.147 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -14.91 32.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.513 0.725 . . . . 72.129999999999995 111.698 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.23 -31.2 43.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.752 1.221 . . . . 72.319999999999993 114.154 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pt -73.39 170.32 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.392 0.996 . . . . 73.319999999999993 110.708 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -105.33 166.98 10.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.032 0.933 . . . . 62.009999999999998 110.359 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.91 -39.48 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.615 1.166 . . . . 53.219999999999999 109.382 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.02 95.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.877 0.762 . . . . 50.210000000000001 111.447 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -61.62 -47.39 85.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.933 -0.766 . . . . 75.299999999999997 108.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 64' ' ' ILE . 2.3 t80 -60.05 -51.64 68.76 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.592 -0.521 . . . . 73.409999999999997 109.592 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.02 -47.91 71.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.857 1.663 . . . . 74.099999999999994 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -62.47 -41.22 98.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.795 0.271 . . . . 74.200000000000003 110.512 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.3 -39.73 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 118.091 -0.957 . . . . 62.450000000000003 108.432 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 ' CE2' ' A' ' 60' ' ' PHE . 22.1 mt -59.14 -50.47 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.523 1.511 . . . . 63.229999999999997 109.541 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -60.21 -35.06 74.58 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.119 -0.988 . . . . 64.099999999999994 110.37 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.3 -43.17 74.34 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.162 0.892 . . . . 74.010000000000005 109.822 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -60.7 -32.48 71.71 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 52.530000000000001 112.823 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.77 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.373 0.533 . . . . 35.219999999999999 111.46 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 54.56 57.65 5.58 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.161 -1.051 . . . . 65.329999999999998 108.161 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.43 108.82 2.87 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 107.105 -1.443 . . . . 74.310000000000002 107.105 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.03 147.42 67.53 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.346 -1.828 . . . . 62.049999999999997 107.346 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 m -62.72 -14.98 50.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.3 -0.875 . . . . 72.349999999999994 112.861 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -67.5 -28.61 67.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.131 0.878 . . . . 75.340000000000003 110.176 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -103.41 165.29 11.12 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.875 1.27 . . . . 72.430000000000007 108.525 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.69 176.03 5.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.043 1.337 . . . . 65.230000000000004 107.896 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.38 141.39 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.593 1.157 . . . . 55.229999999999997 108.265 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.26 135.96 24.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.808 2.043 . . . . 73.450000000000003 108.293 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.2 mt -114.94 156.14 25.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.75 1.62 . . . . 62.32 110.389 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -147.14 142.5 27.4 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.201 0.938 . . . . 74.019999999999996 109.878 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.96 119.91 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.424 -2.065 . . . . 73.299999999999997 105.424 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.1 t0 44.06 52.15 6.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.023 1.329 . . . . 75.219999999999999 111.347 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 60.19 19.11 8.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.471 1.509 . . . . 65.25 113.998 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 p -122.59 161.5 23.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 120.748 1.613 . . . . 74.019999999999996 110.606 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.42 113.8 64.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 102.181 -3.266 . . . . 73.439999999999998 102.181 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 138.84 35.15 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.327 1.152 . . . . 75.219999999999999 111.119 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -68.08 120.37 14.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.538 -1.282 . . . . 71.109999999999999 107.538 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 p -54.98 -18.67 5.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.967 1.707 . . . . 40.43 113.863 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -97.59 -0.83 45.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.909 1.684 . . . . 63.219999999999999 112.321 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 tp -80.96 151.55 28.45 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.381 1.446 . . . . 74.209999999999994 108.722 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -87.65 151.44 22.95 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 71.129999999999995 108.525 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.2 mmt -60.1 -39.28 85.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.761 -0.637 . . . . 73.319999999999993 110.386 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.89 -43.27 99.16 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.321 -0.712 . . . . 52.229999999999997 111.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -52.5 51.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.671 -0.863 . . . . 74.010000000000005 108.671 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.89 -36.71 72.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.946 0.499 . . . . 62.450000000000003 111.247 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -65.56 -55.16 19.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.151 -1.426 . . . . 74.430000000000007 107.151 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.85 -42.37 75.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.462 1.105 . . . . 71.540000000000006 112.479 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -26.71 29.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 117.466 -1.254 . . . . 74.230000000000004 114.229 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -109.89 9.11 24.57 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.89 1.223 . . . . 75.409999999999997 112.47 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -52.21 121.39 6.77 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.358 1.863 . . . . 73.010000000000005 111.251 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.43 169.29 17.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.511 -1.292 . . . . 74.140000000000001 107.511 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.99 -28.05 55.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.475 1.034 . . . . 71.439999999999998 111.42 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.57 7.33 20.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.982 1.313 . . . . 64.349999999999994 112.58 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.58 29.35 71.65 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 120.744 -1.223 . . . . 75.230000000000004 113.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -126.93 178.31 6.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.099 1.36 . . . . 62.200000000000003 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.82 129.92 51.79 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.211 1.004 . . . . 64.439999999999998 110.281 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -108.23 121.68 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.255 -1.387 . . . . 75.219999999999999 107.255 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.35 141.15 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.043 0.937 . . . . 72.209999999999994 109.529 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.27 151.26 37.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.164 -1.05 . . . . 72.319999999999993 108.164 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -135.67 152.79 51.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.573 0.624 . . . . 73.420000000000002 110.703 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -144.02 157.05 44.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.782 -1.192 . . . . 62.399999999999999 107.782 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 13.53 21.69 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.779 -1.328 . . . . 55.329999999999998 109.779 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 . . . . . 0 N--CA 1.441 -0.89 0 C-N-CA 125.761 1.625 . . . . 72.409999999999997 107.549 -179.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 113.221 0.822 . . . . 61.210000000000001 113.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 80.4 m95 55.16 59.45 3.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.819 1.248 . . . . 74.099999999999994 111.306 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -74.9 133.88 16.12 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.066 -1.214 . . . . 63.130000000000003 110.066 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 17' ' ' GLU . 56.0 mt -74.13 119.24 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.59 1.556 . . . . 64.510000000000005 107.526 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -124.07 145.85 48.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.979 1.312 . . . . 73.530000000000001 110.325 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 20.5 tp -99.81 115.54 29.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.235 1.414 . . . . 75.099999999999994 108.439 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.93 120.43 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.866 1.266 . . . . 63.340000000000003 109.965 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 8.6 p -161.11 159.2 28.8 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.511 1.051 . . . . 64.120000000000005 112.595 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--O 1.249 1.036 0 C-N-CA 127.576 2.35 . . . . 73.299999999999997 108.559 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.7 m95 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 108.479 -0.934 . . . . 73.549999999999997 108.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 mtt -64.51 -43.0 95.44 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.438 1.087 . . . . 75.230000000000004 108.818 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -59.77 -51.72 68.54 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.558 -0.734 . . . . 72.299999999999997 110.668 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.17 -31.71 73.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 117.879 -1.058 . . . . 70.439999999999998 111.672 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -59.76 -45.31 92.65 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.29 -1.374 . . . . 72.230000000000004 107.29 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.57 -74.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.549 0.531 . . . . 64.420000000000002 110.325 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 143.03 13.27 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.74 2.816 . . . . 72.099999999999994 108.914 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 p -120.68 -66.39 1.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 117.268 -1.349 . . . . 72.530000000000001 111.311 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -45.71 -59.0 3.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.355 1.862 . . . . 73.099999999999994 113.915 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.97 -48.02 72.66 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.356 -0.84 . . . . 71.409999999999997 111.754 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.419 ' HE2' ' HZ3' ' A' ' 48' ' ' LYS . 6.1 t60 -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.599 0.36 . . . . 73.540000000000006 110.228 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -47.24 85.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.165 1.386 . . . . 73.420000000000002 108.559 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 t -61.75 -51.93 66.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 120.036 1.289 . . . . 51.539999999999999 111.481 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.42 -47.99 86.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.383 -0.823 . . . . 74.5 110.503 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.83 -52.03 65.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.837 0.855 . . . . 75.409999999999997 110.741 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 p -59.13 -48.13 82.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.293 -0.86 . . . . 63.0 110.456 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.27 78.14 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.668 1.122 . . . . 74.450000000000003 111.536 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -67.61 -40.25 84.71 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.517 -0.739 . . . . 71.109999999999999 110.628 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.1 -41.94 79.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 118.157 -0.925 . . . . 63.039999999999999 110.017 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -62.63 -38.25 89.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 120.208 1.367 . . . . 73.540000000000006 108.509 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.31 69.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.559 -0.856 . . . . 24.149999999999999 110.895 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -78.08 -46.8 19.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 118.448 2.758 . . . . 73.510000000000005 118.448 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -131.59 76.92 74.17 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.397 2.279 . . . . 75.140000000000001 108.789 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.69 -23.5 36.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.756 2.304 . . . . 71.310000000000002 112.364 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.62 12.85 17.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 73.430000000000007 112.426 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -122.0 153.81 38.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.493 -1.669 . . . . 75.109999999999999 106.493 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.32 138.41 24.28 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.483 -0.932 . . . . 62.219999999999999 108.483 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.6 122.27 5.45 Favored 'Trans proline' 0 C--N 1.353 0.792 1 C-N-CA 125.879 4.386 . . . . 54.219999999999999 111.449 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -131.93 143.27 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.121 0.968 . . . . 72.150000000000006 111.56 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.1 mm -117.38 120.48 65.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 103.695 -2.705 . . . . 52.509999999999998 103.695 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -108.16 110.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.978 1.711 . . . . 71.200000000000003 108.65 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -123.02 153.09 40.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.208 0.913 . . . . 74.230000000000004 110.911 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -93.54 146.22 23.95 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.345 0.521 . . . . 72.299999999999997 110.501 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.23 136.55 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.328 1.451 . . . . 63.219999999999999 107.816 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 m -49.19 142.19 7.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.961 0.904 . . . . 61.399999999999999 111.572 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.82 1.57 1.44 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.781 2.134 . . . . 44.43 116.543 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t -58.85 147.3 34.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 119.241 1.52 . . . . 74.109999999999999 111.699 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 -0.79 31.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.906 1.282 . . . . 44.299999999999997 112.449 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -82.92 156.79 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.556 1.071 . . . . 63.310000000000002 109.118 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 151.9 9.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.684 0.754 . . . . 72.150000000000006 109.267 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.02 165.23 23.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.35 1.241 . . . . 72.109999999999999 114.35 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.62 139.5 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 127.572 2.349 . . . . 71.430000000000007 108.177 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.47 161.29 26.17 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.793 -1.558 . . . . 63.43 106.793 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.5 104.92 3.98 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.234 -1.395 . . . . 65.150000000000006 107.234 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -136.61 160.12 39.76 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.755 1.622 . . . . 74.209999999999994 110.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 11.2 mttt -107.96 116.29 31.69 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.296 1.839 . . . . 72.099999999999994 106.51 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -98.26 138.82 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.762 1.165 . . . . 75.099999999999994 111.91 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.6 mt -120.75 110.9 16.92 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.299 1.44 . . . . 74.530000000000001 108.626 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.45 142.11 25.83 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 118.137 -0.935 . . . . 75.540000000000006 111.099 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.55 137.54 27.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.196 2.597 . . . . 72.319999999999993 110.863 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -61.52 -12.5 15.48 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.914 1.45 . . . . 34.229999999999997 114.914 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.95 -34.88 29.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.831 1.196 . . . . 74.310000000000002 113.639 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.64 168.1 2.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.145 0.497 . . . . 51.340000000000003 112.004 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 p -107.54 163.37 13.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.305 0.483 . . . . 62.409999999999997 112.305 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.6 t -50.06 -34.67 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.583 1.153 . . . . 64.209999999999994 109.758 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.66 88.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.635 1.174 . . . . 64.25 111.237 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -69.63 -42.6 74.1 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 124.073 0.949 . . . . 62.109999999999999 110.206 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -59.54 -46.94 87.42 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.586 -0.894 . . . . 72.510000000000005 108.586 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.6 ttt -58.69 -43.7 90.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.706 1.203 . . . . 75.019999999999996 109.553 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -58.55 -46.8 86.09 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.851 0.751 . . . . 70.450000000000003 110.297 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.432 HG21 HG13 ' B' ' 346' ' ' VAL . 12.0 mt -61.78 -42.67 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 118.585 -0.721 . . . . 75.109999999999999 109.804 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.2 mt -58.15 -50.36 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.634 1.107 . . . . 72.409999999999997 109.7 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -64.73 -31.71 73.06 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.961 -1.087 . . . . 71.310000000000002 112.655 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -70.76 -48.4 54.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.523 0.729 . . . . 72.25 109.746 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -59.45 -49.26 78.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.05 1.74 . . . . 74.340000000000003 111.682 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 pt -78.87 -5.87 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.793 -0.363 . . . . 71.150000000000006 111.152 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 56.29 62.32 2.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.565 1.546 . . . . 74.349999999999994 108.289 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 108.53 2.96 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.069 0.948 . . . . 74.019999999999996 108.847 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.8 164.51 35.44 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.137 2.558 . . . . 62.329999999999998 111.059 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -67.01 -17.03 64.73 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.216 -0.928 . . . . 73.400000000000006 112.142 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.76 -42.83 97.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.354 0.979 . . . . 64.25 109.189 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -102.53 164.74 11.48 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 122.6 1.191 . . . . 64.439999999999998 110.802 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.2 -176.78 3.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.336 -1.727 . . . . 75.519999999999996 106.336 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 tp -144.52 139.25 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.145 -1.428 . . . . 63.439999999999998 107.145 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -145.3 134.46 22.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.143 1.377 . . . . 72.430000000000007 108.665 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.28 135.14 54.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.661 1.584 . . . . 65.25 107.907 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.49 124.29 29.83 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.407 1.083 . . . . 74.019999999999996 109.237 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.28 129.67 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.478 1.111 . . . . 44.039999999999999 108.255 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.42 33.24 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.929 1.692 . . . . 71.540000000000006 112.145 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 66.31 23.31 10.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.066 1.347 . . . . 62.25 111.278 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -123.15 162.25 22.87 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.372 1.869 . . . . 51.520000000000003 110.561 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.2 103.34 13.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 105.591 -2.003 . . . . 74.120000000000005 105.591 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.11 139.33 42.18 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.869 1.713 . . . . 71.120000000000005 111.734 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -74.06 120.26 19.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.601 -0.888 . . . . 63.119999999999997 108.601 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 13.0 p -46.75 -37.82 9.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.441 1.896 . . . . 75.340000000000003 114.753 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 p -86.38 -6.1 59.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 115.156 1.539 . . . . 61.140000000000001 115.156 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.41 141.54 57.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.555 -1.646 . . . . 53.039999999999999 106.555 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.3 p -80.61 154.74 27.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.391 -0.818 . . . . 72.540000000000006 109.087 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.2 mmt -59.24 -40.88 87.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.123 0.969 . . . . 72.310000000000002 108.978 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 -44.47 97.45 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.196 -1.336 . . . . 62.439999999999998 110.802 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.74 -48.35 54.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.005 1.403 . . . . 74.319999999999993 111.053 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -45.98 76.5 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.121 -0.696 . . . . 75.409999999999997 109.121 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -63.14 -52.4 62.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.731 0.696 . . . . 64.299999999999997 109.374 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -54.54 -40.42 68.66 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.237 0.828 . . . . 74.340000000000003 113.237 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -23.73 22.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.167 -1.397 . . . . 74.5 113.518 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -103.98 9.55 36.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.058 1.299 . . . . 63.329999999999998 110.842 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -52.42 121.33 6.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.384 2.273 . . . . 75.040000000000006 111.322 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -89.18 175.61 7.3 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.658 0.783 . . . . 74.540000000000006 108.942 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.85 -37.9 60.81 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.199 1.4 . . . . 74.140000000000001 111.571 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.39 -2.78 50.65 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.238 1.815 . . . . 52.420000000000002 111.966 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.62 29.33 71.65 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.911 1.243 . . . . 72.099999999999994 112.724 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 166.67 13.31 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.336 1.454 . . . . 75.519999999999996 109.377 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.3 tp -122.41 131.21 53.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.916 -1.142 . . . . 72.140000000000001 107.916 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -122.5 116.35 23.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.347 1.859 . . . . 75.319999999999993 107.432 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.69 150.15 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 O-C-N 121.227 -0.921 . . . . 62.409999999999997 110.058 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.2 152.51 33.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.089 -0.708 . . . . 73.099999999999994 109.089 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -135.24 154.2 51.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.861 0.839 . . . . 55.439999999999998 110.703 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.9 p -149.22 155.79 41.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.662 1.185 . . . . 71.530000000000001 108.137 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.18 21.86 12.8 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 111.383 -0.687 . . . . 45.340000000000003 111.383 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 126.46 1.904 . . . . 73.209999999999994 108.417 -178.399 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.746 0.647 . . . . 71.310000000000002 112.746 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.494 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 48.8 m95 54.71 64.71 1.72 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.212 1.405 . . . . 64.0 110.863 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.88 138.78 17.15 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 107.517 -2.233 . . . . 62.520000000000003 107.517 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.68 142.94 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.446 1.623 . . . . 73.049999999999997 110.636 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.05 156.49 46.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.358 1.463 . . . . 73.430000000000007 110.489 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.29 119.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.104 2.162 . . . . 74.519999999999996 106.43 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 63' ' ' ILE . 2.7 t -120.97 119.16 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 122.511 1.148 . . . . 65.340000000000003 109.808 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.9 p -161.76 152.76 18.08 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.688 -1.142 . . . . 61.119999999999997 110.248 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 129.466 3.106 . . . . 61.340000000000003 113.506 179.252 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.8 m95 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 106.622 -1.622 . . . . 74.109999999999999 106.622 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.21 -38.93 88.34 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.198 -0.667 . . . . 74.430000000000007 109.198 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -59.97 -39.63 86.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.412 1.005 . . . . 75.120000000000005 110.198 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.564 0.62 . . . . 72.129999999999995 109.431 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.0 -44.87 91.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.355 -0.98 . . . . 73.230000000000004 108.355 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.83 -75.97 0.18 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.746 1.017 . . . . 64.310000000000002 113.746 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -158.56 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.536 1.934 . . . . 70.5 108.229 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 p -102.36 -67.25 0.88 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.409 0.892 . . . . 74.530000000000001 113.409 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 -55.07 22.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 117.176 2.287 . . . . 75.310000000000002 117.176 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.0 -54.92 26.71 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.061 0.846 . . . . 72.530000000000001 111.23 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.75 -43.59 65.86 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.629 1.571 . . . . 74.420000000000002 111.078 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -47.06 63.34 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.891 -1.131 . . . . 75.5 109.626 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.91 -58.46 7.52 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.589 0.756 . . . . 72.319999999999993 111.065 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.39 -46.19 92.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.048 0.539 . . . . 73.099999999999994 110.916 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 48' ' ' LYS . 29.8 mm-40 -64.98 -40.04 94.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.847 -1.073 . . . . 71.439999999999998 110.997 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 t -57.66 -46.92 83.61 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.273 1.397 . . . . 52.020000000000003 108.541 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.43 72.33 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.017 0.371 . . . . 40.310000000000002 111.325 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -59.0 -49.13 79.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.855 1.262 . . . . 71.319999999999993 110.328 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.33 -42.89 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 117.393 -1.289 . . . . 65.400000000000006 111.403 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -71.05 -29.81 65.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.527 1.512 . . . . 73.120000000000005 110.242 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.29 -47.29 57.76 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.676 -0.861 . . . . 73.230000000000004 108.676 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.53 -47.96 18.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.429 1.27 . . . . 74.450000000000003 114.429 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.73 73.43 69.55 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 127.869 2.468 . . . . 74.239999999999995 111.222 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.97 -29.36 89.17 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.063 1.842 . . . . 72.420000000000002 112.457 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.67 11.81 16.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.518 0.599 . . . . 75.409999999999997 111.086 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -112.42 143.33 43.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.61 1.55 . . . . 52.130000000000003 109.414 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -107.06 133.49 20.27 Favored Pre-proline 0 C--O 1.246 0.883 0 C-N-CA 124.323 1.049 . . . . 71.450000000000003 108.295 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.19 119.81 5.45 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.89 3.727 . . . . 74.319999999999993 112.606 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.23 149.67 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 74.510000000000005 111.115 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -122.13 134.4 65.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 102.669 -3.086 . . . . 72.319999999999993 102.669 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.77 119.57 53.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.379 1.471 . . . . 61.109999999999999 109.326 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.7 157.41 46.83 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.453 1.024 . . . . 74.420000000000002 113.279 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.7 150.98 23.28 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.872 0.368 . . . . 71.25 110.602 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.88 135.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.999 -1.482 . . . . 72.200000000000003 106.999 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -64.11 115.74 5.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.118 -1.068 . . . . 54.530000000000001 108.118 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.85 30.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.39 1.471 . . . . 44.409999999999997 112.374 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.9 m -85.23 112.58 20.87 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.623 1.711 . . . . 52.149999999999999 107.727 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.78 -20.98 60.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.267 1.827 . . . . 73.430000000000007 114.548 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.1 tp -53.42 158.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.449 1.5 . . . . 61.520000000000003 114.809 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.6 m -49.07 114.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.785 1.634 . . . . 73.010000000000005 109.64 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -82.1 167.76 18.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.453 1.501 . . . . 74.409999999999997 108.727 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -126.15 139.14 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.724 -1.213 . . . . 71.010000000000005 107.724 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.72 166.15 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.77 0.795 . . . . 64.409999999999997 109.47 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.35 105.81 4.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.267 -2.123 . . . . 64.230000000000004 105.267 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 12.1 mmm180 -139.92 152.41 46.37 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 124.243 1.017 . . . . 74.530000000000001 111.087 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 21.5 mttp -93.95 94.75 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.577 -2.009 . . . . 65.430000000000007 105.577 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -85.08 117.07 23.82 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.197 -1.038 . . . . 71.349999999999994 108.197 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.53 115.48 30.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.145 1.378 . . . . 45.420000000000002 110.471 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.01 142.92 27.7 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 119.966 1.257 . . . . 73.310000000000002 111.945 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 141.67 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.08 2.52 . . . . 54.409999999999997 110.691 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -62.5 -13.62 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.7 2.0 . . . . 63.119999999999997 113.28 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -30.03 25.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.636 0.976 . . . . 75.540000000000006 113.636 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.66 166.68 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 119.391 0.996 . . . . 74.099999999999994 110.403 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 p -107.51 163.01 13.42 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.373 -0.829 . . . . 75.329999999999998 112.989 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.79 -35.98 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.11 0.964 . . . . 73.150000000000006 109.201 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.72 78.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.484 0.714 . . . . 65.109999999999999 110.717 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -71.92 -43.22 65.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 109.942 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.79 -41.97 87.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.123 0.874 . . . . 75.209999999999994 109.474 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 42.3 ttp -63.31 -48.8 76.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.041 -0.725 . . . . 74.310000000000002 109.041 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -58.89 -44.94 91.27 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.398 0.544 . . . . 62.229999999999997 111.092 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.91 -50.91 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.329 1.052 . . . . 73.340000000000003 108.307 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.79 -49.96 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.055 0.843 . . . . 73.129999999999995 111.009 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -64.05 -32.93 74.66 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.937 -1.102 . . . . 74.409999999999997 112.183 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -71.89 -46.47 57.66 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.77 -0.826 . . . . 62.509999999999998 108.77 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.3 -51.41 64.73 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.26 1.824 . . . . 74.25 111.942 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -3.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.142 0.423 . . . . 60.439999999999998 112.142 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 55.29 63.71 2.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.26 1.824 . . . . 73.319999999999993 107.776 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.67 114.28 18.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.229 -1.026 . . . . 74.230000000000004 108.229 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.98 164.37 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.781 2.987 . . . . 71.129999999999995 113.054 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.5 p -66.8 -32.32 73.53 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.929 -1.107 . . . . 53.439999999999998 112.659 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -59.44 -36.0 75.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.034 1.734 . . . . 72.340000000000003 112.337 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.83 165.04 11.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.471 1.108 . . . . 74.519999999999996 111.01 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.27 -179.4 3.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.963 2.105 . . . . 73.409999999999997 108.895 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.3 136.37 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.087 1.355 . . . . 71.010000000000005 107.886 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.34 136.67 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.424 -1.324 . . . . 75.209999999999994 107.424 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.28 148.85 31.09 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.469 1.108 . . . . 72.519999999999996 108.728 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -137.01 123.26 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.071 1.749 . . . . 73.239999999999995 108.417 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.06 144.49 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.582 1.153 . . . . 64.510000000000005 108.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 48.92 35.77 7.22 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.149 1.341 . . . . 70.200000000000003 111.853 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tttt 55.02 31.44 16.11 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.112 0.965 . . . . 55.140000000000001 111.476 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -152.19 163.96 38.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.642 1.177 . . . . 61.210000000000001 109.9 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 115.12 61.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 104.912 -2.255 . . . . 74.340000000000003 104.912 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.74 141.29 40.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.105 1.87 . . . . 71.420000000000002 110.606 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -72.09 127.28 32.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.736 -0.838 . . . . 73.099999999999994 108.736 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 p -53.81 -35.47 61.43 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.012 2.125 . . . . 61.439999999999998 112.218 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 t -70.02 -14.96 62.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.779 1.632 . . . . 63.329999999999998 112.39 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.73 147.78 48.67 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.45 -0.945 . . . . 72.430000000000007 108.45 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 m -98.88 149.09 23.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.871 -1.159 . . . . 65.239999999999995 107.871 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.7 mmt -55.04 -46.19 75.29 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.066 0.547 . . . . 74.439999999999998 111.745 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.91 -46.63 83.37 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.919 -0.873 . . . . 55.039999999999999 110.919 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -65.08 -52.92 52.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.48 0.712 . . . . 73.219999999999999 109.818 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.03 -50.28 64.58 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.045 0.938 . . . . 70.540000000000006 110.814 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.9 -49.14 75.97 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.067 -1.021 . . . . 73.519999999999996 109.838 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -68.22 -24.51 64.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.98 0.809 . . . . 74.099999999999994 112.797 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -37.4 13.87 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 119.687 1.13 . . . . 75.209999999999994 111.179 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.17 -3.77 50.32 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.318 1.229 . . . . 71.140000000000001 114.318 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -36.26 121.78 0.71 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.451 2.389 . . . . 52.329999999999998 117.451 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.31 165.92 23.85 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.206 -1.405 . . . . 61.100000000000001 107.206 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.18 -34.64 57.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.529 1.132 . . . . 54.130000000000003 111.871 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -96.77 14.08 26.33 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.552 1.141 . . . . 75.340000000000003 113.579 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.2 70.59 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 120.688 -1.258 . . . . 60.240000000000002 113.853 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.39 154.48 29.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.526 1.163 . . . . 71.299999999999997 108.382 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.49 133.89 55.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.826 -1.176 . . . . 73.120000000000005 107.826 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.81 124.3 42.99 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.257 1.423 . . . . 72.209999999999994 109.121 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 143.64 40.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-O 122.091 0.948 . . . . 63.009999999999998 108.59 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.85 155.96 22.79 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.551 -0.718 . . . . 75.340000000000003 109.132 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -140.99 161.34 38.07 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.531 0.732 . . . . 61.509999999999998 111.525 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -151.61 156.95 41.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.811 -1.181 . . . . 63.43 107.811 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.0 26.26 9.43 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 126.54 2.019 . . . . 70.099999999999994 109.918 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.445 -0.676 0 C-N-CA 127.376 2.271 . . . . 72.030000000000001 106.72 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 119.385 -0.34 . . . . 72.109999999999999 111.846 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.433 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 75.4 m95 58.68 58.93 3.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 74.040000000000006 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . 0.421 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.85 145.29 28.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.967 -1.653 . . . . 65.530000000000001 108.967 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 33.0 mt -77.51 141.16 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.821 1.31 . . . . 64.109999999999999 111.138 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.66 122.91 16.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.672 0.789 . . . . 74.439999999999998 108.972 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.31 108.54 20.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.666 -2.346 . . . . 62.200000000000003 104.666 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.62 134.78 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.181 0.808 . . . . 70.319999999999993 113.181 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 12.8 p -161.47 158.64 26.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.642 1.577 . . . . 64.209999999999994 107.388 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 127.999 2.519 . . . . 72.340000000000003 112.504 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m95 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.599 -0.889 . . . . 72.129999999999995 108.599 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.5 mmm -57.66 -46.89 83.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.133 -0.692 . . . . 73.099999999999994 109.133 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -58.16 -45.05 88.12 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 119.721 -0.181 . . . . 74.5 111.082 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -64.79 -35.03 79.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.279 -0.391 . . . . 64.349999999999994 111.622 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.76 -48.09 78.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.24 -1.022 . . . . 73.019999999999996 108.24 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -71.34 0.22 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 115.081 1.511 . . . . 75.099999999999994 115.081 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -156.22 128.19 7.42 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.785 2.034 . . . . 74.239999999999995 108.203 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -124.9 -66.15 0.98 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 116.529 -1.701 . . . . 61.329999999999998 114.069 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -56.55 13.7 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.265 1.393 . . . . 71.319999999999993 114.471 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.7 -36.13 82.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.054 0.843 . . . . 72.329999999999998 111.58 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -64.75 -55.09 21.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.702 0.801 . . . . 73.120000000000005 110.831 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -49.24 75.32 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.303 1.441 . . . . 65.420000000000002 109.294 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.2 t -54.15 -61.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.926 0.784 . . . . 72.239999999999995 112.033 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.91 -47.61 90.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 123.874 0.734 . . . . 73.340000000000003 112.279 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -47.08 70.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.151 -1.02 . . . . 65.400000000000006 111.642 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -55.03 -45.41 75.18 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 120.046 1.294 . . . . 73.109999999999999 109.493 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.77 72.09 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.261 0.553 . . . . 72.420000000000002 112.253 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.69 -40.0 88.35 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.331 0.652 . . . . 65.010000000000005 110.276 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.15 -42.09 93.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 117.78 -1.105 . . . . 75.329999999999998 108.624 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -63.86 -39.18 93.59 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 120.092 1.314 . . . . 65.040000000000006 109.423 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.94 67.07 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.935 0.398 . . . . 64.299999999999997 111.633 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -72.23 -44.99 62.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.415 -0.803 . . . . 74.109999999999999 112.783 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -128.75 78.72 75.64 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.121 1.368 . . . . 73.129999999999995 109.694 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.45 -17.65 49.05 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.659 2.239 . . . . 72.450000000000003 112.044 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -99.87 13.17 34.75 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.415 0.686 . . . . 72.040000000000006 110.061 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -123.21 155.64 36.71 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.842 1.201 . . . . 74.319999999999993 108.728 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.76 136.85 27.83 Favored Pre-proline 0 C--O 1.241 0.656 0 C-N-CA 124.126 0.97 . . . . 74.109999999999999 109.846 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.78 114.73 3.7 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 125.251 3.967 . . . . 72.230000000000004 111.769 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.52 143.99 34.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.555 1.142 . . . . 42.140000000000001 109.358 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 mm -120.73 127.05 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 102.375 -3.194 . . . . 73.239999999999995 102.375 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.67 124.55 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.319 1.447 . . . . 70.340000000000003 108.896 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -136.59 154.26 50.73 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.25 1.386 . . . . 74.5 110.513 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -91.78 152.71 20.02 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.944 -0.473 . . . . 73.340000000000003 111.685 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.8 t -66.83 126.1 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.681 1.593 . . . . 74.140000000000001 107.212 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 p -58.72 121.85 12.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.729 0.695 . . . . 74.310000000000002 110.296 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.51 -18.8 49.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.626 2.06 . . . . 73.310000000000002 111.847 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -55.65 136.94 50.18 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.896 1.348 . . . . 63.539999999999999 111.289 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -64.49 -28.73 69.86 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.859 1.264 . . . . 75.129999999999995 114.096 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.11 154.33 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.471 0.708 . . . . 62.310000000000002 112.124 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.78 140.11 20.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.172 -1.418 . . . . 73.120000000000005 107.172 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -84.36 167.6 16.37 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.515 -0.92 . . . . 62.310000000000002 108.515 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.81 144.17 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.745 -1.576 . . . . 65.510000000000005 106.745 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 165.61 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.549 0.69 . . . . 70.409999999999997 110.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.3 95.29 2.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.767 -1.197 . . . . 52.039999999999999 107.767 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -136.25 151.74 49.99 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.153 0.981 . . . . 74.099999999999994 109.562 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 29.8 mttp -95.7 102.09 13.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.058 -2.201 . . . . 74.409999999999997 105.058 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -84.58 136.73 33.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.158 0.89 . . . . 74.420000000000002 109.162 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 mt -120.19 108.56 14.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.975 -1.491 . . . . 70.450000000000003 106.975 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.17 141.99 25.42 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 117.946 -1.026 . . . . 63.420000000000002 110.408 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 141.29 38.87 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.141 1.894 . . . . 72.310000000000002 113.568 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 m -62.58 -17.32 59.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.874 1.67 . . . . 52.130000000000003 110.877 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -68.37 -35.34 77.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.733 2.413 . . . . 73.510000000000005 112.751 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -86.26 171.0 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 122.014 0.911 . . . . 62.340000000000003 112.648 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.6 p -107.23 166.12 10.87 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.492 1.517 . . . . 71.409999999999997 110.541 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.75 -34.32 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 62.409999999999997 108.559 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -47.86 83.55 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 121.495 -0.753 . . . . 54.340000000000003 112.69 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.54 -37.5 71.12 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 123.162 0.585 . . . . 71.5 110.095 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.9 -45.1 91.07 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.934 -0.765 . . . . 74.530000000000001 108.934 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 ttt -63.57 -44.96 92.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.069 -0.967 . . . . 61.340000000000003 110.105 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -57.04 -41.29 78.37 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.996 0.816 . . . . 74.540000000000006 111.09 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.01 -51.12 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.533 -0.914 . . . . 75.099999999999994 108.533 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 60' ' ' PHE . 29.9 mt -52.46 -50.36 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.262 0.937 . . . . 64.140000000000001 111.049 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -62.31 -39.42 92.96 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.062 -1.024 . . . . 74.540000000000006 112.064 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -74.34 -33.75 63.23 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.77 1.168 . . . . 75.120000000000005 111.305 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.47 -48.73 78.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.998 0.817 . . . . 62.200000000000003 109.552 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -79.98 -3.18 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.013 0.196 . . . . 41.25 110.88 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 53.1 57.93 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.203 1.801 . . . . 62.420000000000002 109.532 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.11 109.98 4.87 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 124.979 1.312 . . . . 70.230000000000004 108.735 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.73 159.46 52.61 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.442 2.761 . . . . 74.420000000000002 111.205 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 m -67.3 -14.47 62.95 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.091 -1.005 . . . . 74.120000000000005 112.706 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.46 -34.11 67.51 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.112 -0.47 . . . . 71.040000000000006 110.157 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.55 164.41 11.68 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.355 1.062 . . . . 73.019999999999996 108.942 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 175.72 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.97 1.308 . . . . 72.019999999999996 109.21 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.76 140.63 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 125.278 1.431 . . . . 62.020000000000003 107.722 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -145.06 129.84 18.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.429 1.892 . . . . 65.430000000000007 106.916 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.99 146.57 41.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.004 1.322 . . . . 75.519999999999996 109.244 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -142.66 132.89 24.67 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.707 1.203 . . . . 71.200000000000003 110.303 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.63 121.89 64.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 C-N-CA 124.712 1.205 . . . . 62.140000000000001 107.99 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 43.05 51.83 5.39 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.361 1.465 . . . . 72.349999999999994 113.119 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.51 25.3 15.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.066 1.346 . . . . 74.450000000000003 113.392 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 p -132.66 161.47 33.86 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.479 1.036 . . . . 72.340000000000003 111.049 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.35 105.53 36.93 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 103.184 -2.895 . . . . 73.329999999999998 103.184 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.2 130.57 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.766 2.311 . . . . 74.409999999999997 111.967 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.32 125.84 27.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.166 -1.42 . . . . 74.340000000000003 107.166 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -55.75 -22.48 24.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 63.030000000000001 113.904 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -79.31 -18.41 52.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.466 1.107 . . . . 62.32 111.652 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.66 141.67 56.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.41 -0.806 . . . . 64.5 110.09 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.47 152.0 24.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.029 -1.1 . . . . 73.209999999999994 108.029 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 45.3 mmm -62.93 -42.46 99.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.175 -0.917 . . . . 50.43 110.278 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.42 97.6 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.798 0.727 . . . . 43.229999999999997 111.566 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -46.89 71.33 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.322 0.649 . . . . 72.420000000000002 109.4 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.43 -46.26 86.86 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.727 -0.472 . . . . 75.400000000000006 109.727 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.81 -45.3 94.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.245 1.418 . . . . 74.319999999999993 109.765 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.55 -33.35 75.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.968 0.907 . . . . 71.239999999999995 111.597 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -90.54 -23.5 20.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.264 -1.35 . . . . 75.400000000000006 113.488 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -110.35 -2.1 16.85 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.921 1.452 . . . . 71.109999999999999 114.921 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -45.23 121.85 3.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.969 1.259 . . . . 65.230000000000004 114.377 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -71.45 176.09 4.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.811 1.244 . . . . 64.109999999999999 108.36 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.82 -33.14 55.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.83 2.052 . . . . 74.239999999999995 111.81 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 10.34 36.01 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.151 1.78 . . . . 73.120000000000005 111.563 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.92 68.74 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.899 -1.126 . . . . 63.049999999999997 113.255 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.88 168.81 9.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.21 1.505 . . . . 71.040000000000006 109.889 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.53 136.43 54.55 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.685 0.394 . . . . 72.340000000000003 110.273 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -119.75 119.21 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.254 1.822 . . . . 74.439999999999998 109.084 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.18 144.0 38.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 121.11 -0.994 . . . . 74.439999999999998 109.294 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.56 21.02 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.698 0.799 . . . . 71.040000000000006 109.849 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -146.19 160.84 41.42 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.425 0.631 . . . . 61.130000000000003 110.797 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 p -151.62 161.35 42.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.719 1.208 . . . . 75.120000000000005 108.774 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.88 22.89 12.17 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.298 0.952 . . . . 72.239999999999995 111.909 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.448 -0.568 0 C-N-CA 126.308 1.843 . . . . 75.25 106.961 -178.655 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 114.159 1.17 . . . . 74.120000000000005 114.159 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.452 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 51.3 m95 53.33 57.34 6.31 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.473 1.509 . . . . 73.409999999999997 111.823 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -77.7 141.09 25.06 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.789 -1.324 . . . . 63.340000000000003 109.789 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 28.8 mt -74.1 128.84 36.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 119.142 1.471 . . . . 75.439999999999998 109.437 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.22 126.75 30.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.073 0.949 . . . . 72.400000000000006 109.896 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.44 122.35 31.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 104.179 -2.526 . . . . 73.540000000000006 104.179 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 51.6 t -120.58 124.02 71.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.562 1.145 . . . . 41.310000000000002 109.163 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.4 p -161.19 151.65 17.85 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.947 0.34 . . . . 72.420000000000002 111.524 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 126.675 1.99 . . . . 75.129999999999995 111.408 -179.615 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 CA--C 1.511 -0.55 0 CA-C-O 119.576 -0.249 . . . . 74.129999999999995 110.573 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.3 tpt -55.35 -46.27 76.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.433 1.083 . . . . 63.119999999999997 108.327 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -60.53 -42.27 96.16 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 113.241 0.83 . . . . 74.25 113.241 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.13 -37.44 83.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 118.946 0.794 . . . . 73.319999999999993 110.672 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.04 -47.73 76.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.335 1.022 . . . . 64.430000000000007 108.467 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.48 -75.87 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.025 1.33 . . . . 52.539999999999999 113.033 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.38 131.73 5.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.883 1.673 . . . . 74.219999999999999 107.798 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.2 t -130.2 -58.66 1.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 115.724 1.75 . . . . 62.329999999999998 115.724 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.44 -57.29 12.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.728 1.604 . . . . 75.540000000000006 114.927 -176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 13' ' ' HIS . 1.3 pm0 -62.95 -51.02 68.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.083 0.468 . . . . 64.230000000000004 110.229 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.464 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 84.4 t60 -52.07 -44.83 64.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.022 2.129 . . . . 74.420000000000002 110.073 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -49.84 63.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 116.872 -1.537 . . . . 62.439999999999998 110.136 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.4 m -60.54 -48.83 80.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.917 1.08 . . . . 74.099999999999994 113.917 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.97 -47.53 90.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 121.705 -0.622 . . . . 72.030000000000001 109.894 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.35 -42.49 79.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.518 -0.754 . . . . 73.209999999999994 111.848 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -59.83 -45.02 93.7 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.272 -1.01 . . . . 75.120000000000005 108.272 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.85 -49.17 77.59 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.955 0.798 . . . . 60.210000000000001 110.851 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -61.03 -46.09 92.15 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.864 -1.148 . . . . 53.240000000000002 110.883 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.94 -41.65 93.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-O 117.735 -1.126 . . . . 71.200000000000003 109.441 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -66.69 -41.07 88.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.581 1.537 . . . . 72.299999999999997 110.521 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.76 68.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.596 -0.441 . . . . 63.399999999999999 110.852 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -77.71 -33.11 53.2 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.651 0.982 . . . . 53.520000000000003 113.651 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 82.07 25.04 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.429 1.492 . . . . 63.299999999999997 111.009 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.77 -29.1 36.06 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.888 2.392 . . . . 72.140000000000001 112.602 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.81 13.23 13.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.876 0.871 . . . . 72.129999999999995 110.956 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -121.56 152.35 39.32 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.525 -1.359 . . . . 72.030000000000001 109.749 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.24 140.73 31.71 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 124.007 0.923 . . . . 73.019999999999996 108.584 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 117.66 3.57 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 125.141 3.894 . . . . 71.450000000000003 111.931 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.2 t -120.45 140.91 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.047 1.339 . . . . 64.329999999999998 108.675 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.09 135.33 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.585 -2.376 . . . . 72.409999999999997 104.585 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.73 134.85 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.251 0.62 . . . . 63.210000000000001 109.491 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.85 143.66 43.19 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.888 0.875 . . . . 65.510000000000005 108.701 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.62 143.09 31.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.299 -1.371 . . . . 71.109999999999999 107.299 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.82 108.12 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 103.07 -2.937 . . . . 62.219999999999999 103.07 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -53.75 132.67 41.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.785 -0.82 . . . . 52.32 108.785 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.2 40.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.836 1.207 . . . . 40.229999999999997 112.235 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -81.98 137.63 35.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.539 1.67 . . . . 71.010000000000005 108.027 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -66.2 -11.26 48.62 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.524 0.729 . . . . 53.140000000000001 112.803 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.441 ' CD1' HD23 ' A' ' 70' ' ' LEU . 8.8 tp -60.96 154.37 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.602 0.761 . . . . 75.510000000000005 109.323 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.65 144.97 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.405 1.082 . . . . 55.240000000000002 110.186 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.77 167.13 18.44 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.26 2.224 . . . . 72.030000000000001 112.508 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.61 148.33 31.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 125.194 1.398 . . . . 73.310000000000002 110.267 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.5 163.47 20.45 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.923 0.889 . . . . 74.129999999999995 108.954 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.89 95.83 5.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.019 -1.104 . . . . 72.439999999999998 108.019 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.03 168.23 18.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.137 0.975 . . . . 74.519999999999996 109.895 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -116.35 99.26 7.07 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.294 -2.113 . . . . 73.239999999999995 105.294 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -83.89 136.66 34.02 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.609 -0.723 . . . . 74.5 109.053 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.94 119.2 33.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.494 1.118 . . . . 75.310000000000002 110.232 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.439 HG21 ' SD ' ' A' ' 91' ' ' MET . 17.6 m -111.81 142.12 26.07 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 117.577 -1.202 . . . . 72.109999999999999 112.232 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.12 141.33 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.713 2.275 . . . . 71.310000000000002 109.579 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -63.4 -12.84 33.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.585 0.957 . . . . 75.25 113.585 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.89 -34.26 66.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.645 2.778 . . . . 71.439999999999998 113.445 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 pt -85.09 165.87 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.745 1.157 . . . . 70.349999999999994 111.775 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 54.8 p -99.92 168.79 9.65 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.784 0.834 . . . . 75.409999999999997 111.255 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.92 -36.43 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.714 -1.217 . . . . 65.329999999999998 107.714 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.83 90.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.737 0.815 . . . . 74.430000000000007 110.936 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -66.4 -44.96 81.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.614 -0.708 . . . . 65.219999999999999 109.744 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 4.1 t80 -58.8 -54.51 46.23 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.253 -1.017 . . . . 73.510000000000005 108.253 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.4 ttp -52.63 -49.19 65.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.512 1.525 . . . . 53.329999999999998 110.935 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -57.11 -42.28 80.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.464 0.705 . . . . 72.519999999999996 111.693 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.46 -39.63 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 118.086 -0.959 . . . . 71.540000000000006 108.792 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 4.4 mt -62.31 -50.04 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 120.701 1.591 . . . . 75.450000000000003 109.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.15 -39.16 81.58 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 118.186 -0.912 . . . . 75.030000000000001 111.962 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -68.58 -40.59 80.45 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.051 0.841 . . . . 72.420000000000002 109.223 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -59.51 -49.07 79.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.275 1.03 . . . . 73.219999999999999 111.498 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 pt -79.46 -0.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 119.468 -0.301 . . . . 62.450000000000003 111.277 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 57.51 52.32 8.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.741 1.617 . . . . 73.319999999999993 110.984 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.5 tm? -68.18 108.96 3.24 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.416 1.486 . . . . 72.340000000000003 110.553 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.82 152.8 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.122 2.548 . . . . 75.530000000000001 109.968 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 m -58.95 -20.83 55.99 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.403 -0.811 . . . . 75.310000000000002 113.181 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -39.51 90.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.407 1.003 . . . . 52.109999999999999 109.734 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -96.48 163.61 12.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.285 1.034 . . . . 55.030000000000001 108.865 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.92 171.08 7.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.001 1.321 . . . . 73.420000000000002 108.579 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 tp -146.12 133.75 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.554 1.142 . . . . 65.209999999999994 108.158 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -145.46 142.26 29.11 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.179 1.792 . . . . 75.120000000000005 108.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -114.14 155.83 25.32 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.525 1.53 . . . . 64.439999999999998 111.039 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -147.31 126.84 13.24 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 125.115 1.509 . . . . 64.150000000000006 111.18 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.87 126.03 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.474 -2.047 . . . . 74.310000000000002 105.474 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 49.48 34.53 6.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.761 1.164 . . . . 60.140000000000001 112.961 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp 60.88 31.14 20.0 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.063 -1.648 . . . . 54.149999999999999 110.154 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -130.18 161.38 31.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.324 1.85 . . . . 74.409999999999997 109.788 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -102.49 103.68 33.25 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 126.508 1.923 . . . . 74.349999999999994 108.832 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.6 136.99 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.539 1.492 . . . . 72.439999999999998 108.965 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.0 132.17 44.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.76 0.314 . . . . 72.219999999999999 110.311 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 p -51.89 -45.54 64.22 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.282 2.233 . . . . 40.039999999999999 112.703 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -73.74 -11.84 60.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.694 1.197 . . . . 51.439999999999998 114.047 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.42 146.74 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.037 1.289 . . . . 65.439999999999998 108.665 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 30.4 p -86.08 156.57 20.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.694 -0.629 . . . . 63.109999999999999 109.424 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 51' ' ' VAL . 14.4 mmt -61.38 -44.44 97.15 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 118.538 -0.744 . . . . 74.140000000000001 110.641 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.11 -45.49 95.2 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.351 -0.928 . . . . 61.329999999999998 111.396 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.86 -49.46 72.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.799 0.8 . . . . 73.540000000000006 111.2 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.59 -46.69 88.19 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 123.055 0.542 . . . . 44.020000000000003 110.459 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.43 -56.92 14.89 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.252 1.021 . . . . 53.039999999999999 108.943 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.28 -32.0 64.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.623 -0.703 . . . . 72.140000000000001 111.37 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -25.26 20.26 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 116.342 -1.79 . . . . 63.43 113.828 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -103.42 -2.22 27.28 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.298 1.863 . . . . 71.420000000000002 112.604 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.23 121.72 1.18 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.114 2.165 . . . . 74.400000000000006 113.955 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.71 174.64 8.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.454 1.502 . . . . 53.119999999999997 110.132 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.49 -35.58 72.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.877 1.217 . . . . 63.329999999999998 108.525 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.15 12.92 31.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.77 0.828 . . . . 64.340000000000003 112.51 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.38 28.38 67.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.351 -1.249 . . . . 61.219999999999999 114.862 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -109.44 158.71 17.68 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.948 1.874 . . . . 65.319999999999993 107.932 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 138.0 54.13 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.608 -1.256 . . . . 64.549999999999997 107.608 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -122.35 131.5 53.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.657 1.183 . . . . 74.530000000000001 108.287 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.63 138.73 53.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.545 -1.28 . . . . 72.430000000000007 107.545 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.69 142.14 44.4 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.954 -2.239 . . . . 62.219999999999999 104.954 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -133.96 151.63 51.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.345 0.593 . . . . 75.549999999999997 110.432 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.9 t -147.21 165.04 31.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.689 -1.226 . . . . 65.219999999999999 107.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.81 15.61 19.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.079 -2.008 . . . . 74.219999999999999 108.079 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 126.401 1.88 . . . . 50.049999999999997 107.006 -179.392 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 71.0 113.324 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 58.1 m95 57.22 61.16 2.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.91 0.777 . . . . 74.310000000000002 111.62 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.49 135.68 15.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.384 -1.086 . . . . 74.0 110.384 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.9 123.79 32.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 118.756 1.278 . . . . 72.340000000000003 110.006 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -132.37 118.83 19.89 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.534 1.134 . . . . 72.219999999999999 109.14 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.9 tt -83.17 118.57 23.69 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.724 1.61 . . . . 62.25 108.44 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.31 128.63 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.679 1.192 . . . . 62.420000000000002 110.741 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.9 p -159.31 153.46 23.62 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 71.400000000000006 108.639 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.172 1.789 . . . . 73.439999999999998 106.515 178.535 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.3 m95 . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.089 -0.708 . . . . 74.209999999999994 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -51.53 -45.76 63.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.082 0.944 . . . . 74.430000000000007 110.737 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -60.55 -40.62 92.25 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 121.499 -0.75 . . . . 74.310000000000002 112.726 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -67.1 -36.31 81.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.616 0.766 . . . . 74.219999999999999 112.177 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -67.59 -41.01 84.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.626 -0.879 . . . . 73.150000000000006 108.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -75.12 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.738 -0.664 . . . . 65.230000000000004 111.6 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.61 125.13 3.67 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.696 1.998 . . . . 74.25 110.374 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.3 p -117.11 -65.85 1.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 116.305 -1.807 . . . . 73.030000000000001 114.211 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.1 mt -48.0 -58.36 4.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.326 1.875 . . . . 64.209999999999994 114.842 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.5 -37.09 85.95 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.215 -0.928 . . . . 63.229999999999997 111.785 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -62.97 -57.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.303 1.041 . . . . 65.439999999999998 108.403 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -47.48 85.01 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.72 1.608 . . . . 62.530000000000001 110.987 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -56.57 -53.97 51.35 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.445 1.021 . . . . 72.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.598 HG12 ' HE2' ' A' ' 20' ' ' LYS . 43.6 t -63.07 -47.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 122.398 -0.189 . . . . 74.040000000000006 111.262 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' HD12 ' A' ' 21' ' ' ILE . 65.0 tt0 -57.0 -52.11 66.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.947 1.299 . . . . 75.140000000000001 110.335 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -60.19 -48.28 82.39 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.985 1.314 . . . . 73.0 110.455 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -49.39 76.74 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.42 0.555 . . . . 54.329999999999998 110.943 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HE2' HG12 ' A' ' 16' ' ' VAL . 55.3 mtmt -65.39 -44.31 87.89 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.631 0.372 . . . . 52.119999999999997 110.55 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 17' ' ' GLU . 49.8 mt -61.72 -42.64 95.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.365 -1.303 . . . . 72.519999999999996 110.402 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.08 -33.76 72.31 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 120.325 1.421 . . . . 73.340000000000003 110.263 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -47.12 74.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 119.465 -0.894 . . . . 75.109999999999999 109.986 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -77.75 -47.27 19.46 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.346 1.239 . . . . 73.109999999999999 114.346 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -129.25 77.27 77.88 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.562 1.945 . . . . 61.200000000000003 109.755 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.63 -28.71 44.38 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.159 2.572 . . . . 75.340000000000003 112.487 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -89.66 14.02 12.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.905 0.482 . . . . 72.219999999999999 111.948 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -120.48 146.24 46.46 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.849 -1.537 . . . . 71.040000000000006 106.849 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.57 143.49 28.27 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.191 -1.04 . . . . 54.530000000000001 108.191 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.03 127.2 8.35 Favored 'Trans proline' 0 C--N 1.352 0.752 1 C-N-CA 125.725 4.283 . . . . 65.420000000000002 113.095 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.59 145.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.863 0.865 . . . . 64.329999999999998 111.16 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.4 mm -122.09 135.44 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 103.8 -2.667 . . . . 61.219999999999999 103.8 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -122.68 114.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.854 1.262 . . . . 74.450000000000003 108.511 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.86 153.92 46.98 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 71.099999999999994 108.893 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -93.48 153.4 18.49 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.147 -0.971 . . . . 72.340000000000003 113.036 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.66 126.07 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.616 -1.994 . . . . 75.349999999999994 105.616 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.0 t -58.79 141.09 54.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.75 -0.463 . . . . 51.219999999999999 109.75 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.52 23.95 77.05 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.233 -1.315 . . . . 74.010000000000005 113.964 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 t -97.58 142.3 29.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.527 1.663 . . . . 71.239999999999995 108.211 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -65.81 -9.74 31.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.227 1.195 . . . . 70.120000000000005 114.227 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.37 160.82 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.277 0.944 . . . . 74.019999999999996 111.138 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -64.2 142.24 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.272 -1.01 . . . . 74.209999999999994 108.272 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.32 161.27 28.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.635 1.174 . . . . 73.120000000000005 107.852 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 tt -120.68 135.48 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.677 -1.231 . . . . 74.340000000000003 107.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.49 159.7 32.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.885 -1.524 . . . . 74.239999999999995 106.885 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -73.9 108.17 6.56 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.495 -1.378 . . . . 73.400000000000006 110.285 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -136.04 159.07 42.82 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.823 1.249 . . . . 72.540000000000006 112.021 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 14.8 mttt -104.68 99.26 8.92 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 105.42 -2.067 . . . . 64.450000000000003 105.42 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.73 116.76 23.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.706 1.602 . . . . 73.430000000000007 110.016 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.6 120.0 40.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 117.43 -1.271 . . . . 62.140000000000001 109.394 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -113.07 142.97 28.26 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 120.281 1.401 . . . . 74.129999999999995 111.527 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.18 141.17 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.767 1.645 . . . . 65.219999999999999 108.576 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -62.98 -18.25 63.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.206 2.202 . . . . 73.230000000000004 113.227 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -82.67 -30.69 29.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.213 1.19 . . . . 64.120000000000005 114.213 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.89 170.52 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.715 0.769 . . . . 73.420000000000002 111.393 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -107.13 156.92 18.28 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.124 0.97 . . . . 74.120000000000005 111.688 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.28 -35.91 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.858 1.663 . . . . 74.439999999999998 109.631 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.39 93.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.768 1.227 . . . . 75.319999999999993 111.539 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.33 -42.15 93.24 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.925 -0.768 . . . . 73.340000000000003 108.925 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.46 -44.04 93.07 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.165 -1.05 . . . . 53.130000000000003 108.165 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.5 ttp -59.65 -48.39 81.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.43 -0.795 . . . . 64.109999999999999 110.927 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -58.89 -42.0 88.5 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.342 0.974 . . . . 75.040000000000006 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -66.42 -43.27 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.015 -0.993 . . . . 74.319999999999993 109.699 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.48 -50.7 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 120.212 1.369 . . . . 74.430000000000007 110.1 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -59.67 -39.19 83.65 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.996 -1.065 . . . . 63.409999999999997 111.513 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -70.81 -39.07 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.018 0.826 . . . . 45.229999999999997 110.615 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -60.15 -49.3 78.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.529 1.132 . . . . 75.219999999999999 109.708 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.4 pt -79.23 -0.95 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.949 0.34 . . . . 73.299999999999997 111.476 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 55.65 52.86 10.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.386 1.474 . . . . 75.299999999999997 108.696 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.49 106.63 1.62 Allowed Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 126.856 2.062 . . . . 73.239999999999995 108.452 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.32 157.69 56.26 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.327 2.018 . . . . 55.119999999999997 109.653 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -58.48 -28.08 65.03 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.485 -0.76 . . . . 60.310000000000002 112.713 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.65 -33.04 71.02 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.335 1.054 . . . . 75.040000000000006 112.214 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.33 164.26 11.78 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.36 -1.348 . . . . 65.140000000000001 107.36 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.4 172.31 6.93 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.876 1.271 . . . . 54.420000000000002 108.789 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -143.98 117.22 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.44 1.096 . . . . 74.430000000000007 108.587 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.59 137.55 54.38 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.67 -1.604 . . . . 71.400000000000006 106.67 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.9 148.92 33.94 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.008 1.323 . . . . 75.019999999999996 109.532 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -143.55 128.26 18.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.692 1.197 . . . . 75.140000000000001 109.962 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.95 122.12 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.204 -1.406 . . . . 72.420000000000002 107.204 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.06 34.46 14.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.34 1.456 . . . . 71.239999999999995 111.251 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 63.9 26.62 14.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.721 1.208 . . . . 73.530000000000001 110.322 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -119.58 161.88 19.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.456 1.102 . . . . 61.439999999999998 109.326 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.7 103.34 27.61 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 104.524 -2.399 . . . . 64.319999999999993 104.524 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.56 142.83 45.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.047 1.831 . . . . 73.310000000000002 110.374 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -77.47 114.22 16.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.825 -1.546 . . . . 61.299999999999997 106.825 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.0 m -54.39 -26.84 32.73 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.129 1.772 . . . . 71.349999999999994 112.818 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -86.89 -6.61 58.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.399 -0.813 . . . . 52.219999999999999 113.056 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 tp -75.15 158.58 32.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.569 1.077 . . . . 75.340000000000003 108.933 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.3 p -93.24 161.81 14.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.465 0.575 . . . . 35.219999999999999 109.72 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.9 mmm -64.27 -46.68 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.906 -1.045 . . . . 75.299999999999997 111.653 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.04 74.72 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.333 0.97 . . . . 54.130000000000003 111.172 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.72 -51.96 62.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.751 0.82 . . . . 71.420000000000002 110.628 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 tt -59.04 -44.14 91.75 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.511 -0.28 . . . . 75.439999999999998 110.58 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -65.69 -54.71 23.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.876 0.762 . . . . 71.510000000000005 109.544 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -58.67 -30.7 67.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.043 0.838 . . . . 72.510000000000005 111.638 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -40.85 16.76 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.367 -1.301 . . . . 73.209999999999994 110.36 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.53 6.51 43.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.042 1.292 . . . . 70.239999999999995 113.306 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.51 121.26 6.11 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.429 1.468 . . . . 71.120000000000005 111.731 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.14 174.89 4.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.047 2.139 . . . . 73.0 110.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.15 -30.76 68.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.654 -1.279 . . . . 73.519999999999996 108.939 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.31 6.82 40.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.184 2.194 . . . . 64.010000000000005 112.768 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.73 28.41 65.51 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.482 -1.176 . . . . 71.510000000000005 116.007 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.06 134.96 54.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.08 1.94 . . . . 73.450000000000003 107.453 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.38 133.45 39.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.509 1.05 . . . . 45.450000000000003 109.408 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -123.14 123.72 41.44 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.843 1.657 . . . . 74.5 107.726 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.04 136.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 124.729 1.212 . . . . 73.120000000000005 109.543 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.39 148.86 32.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.446 0.698 . . . . 73.129999999999995 110.815 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -132.96 155.16 49.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.51 0.929 . . . . 75.340000000000003 113.51 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.8 p -146.61 159.47 43.4 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.506 0.67 . . . . 51.149999999999999 110.881 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.21 22.31 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.818 1.675 . . . . 61.439999999999998 112.08 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 . . . . . 0 C--O 1.236 0.345 0 C-N-CA 125.794 1.638 . . . . 74.209999999999994 107.593 -179.529 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 118.469 -0.777 . . . . 52.310000000000002 112.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.489 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 50.8 m95 51.85 66.48 1.19 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.85 1.205 . . . . 75.140000000000001 112.956 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.69 145.0 21.59 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.027 -1.629 . . . . 30.120000000000001 109.027 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.0 134.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.418 1.609 . . . . 72.200000000000003 110.003 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -138.61 126.2 22.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.938 0.895 . . . . 65.310000000000002 110.579 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.81 118.51 29.46 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.386 -1.709 . . . . 70.140000000000001 106.386 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 14.7 t -122.35 113.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.279 0.474 . . . . 43.43 112.279 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 65.8 p -155.13 154.14 31.88 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.796 -1.187 . . . . 73.019999999999996 107.796 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.243 0.732 0 C-N-CA 126.936 2.095 . . . . 72.549999999999997 106.228 -179.728 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.7 m95 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 109.595 -0.521 . . . . 73.329999999999998 109.595 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -62.63 -42.74 99.76 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.394 -0.224 . . . . 74.319999999999993 110.394 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -56.77 -52.14 66.19 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.507 -0.553 . . . . 75.120000000000005 109.507 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -64.94 -34.11 77.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.063 1.345 . . . . 74.319999999999993 112.44 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -60.74 -48.89 79.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.441 -0.948 . . . . 70.25 108.441 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.49 -69.24 0.42 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.858 0.724 . . . . 70.329999999999998 110.147 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.01 143.66 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.962 1.305 . . . . 72.310000000000002 111.474 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 t -130.57 -65.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 117.322 -1.323 . . . . 75.310000000000002 112.566 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.2 mt -43.08 -60.69 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 116.477 2.028 . . . . 73.140000000000001 116.477 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.27 -48.01 68.98 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 120.719 -1.238 . . . . 73.140000000000001 110.418 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -51.91 -46.39 64.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.647 1.179 . . . . 71.439999999999998 111.052 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -43.69 91.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.683 -1.627 . . . . 64.129999999999995 108.439 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -64.38 -40.11 95.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.61 1.095 . . . . 64.450000000000003 110.46 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.15 -48.05 79.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 120.083 -1.635 . . . . 60.229999999999997 108.066 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -38.26 90.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.526 -0.749 . . . . 64.530000000000001 110.749 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -59.82 -48.05 83.27 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.448 -1.316 . . . . 61.439999999999998 107.448 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -50.56 71.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.821 0.448 . . . . 73.5 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -61.77 -52.03 65.91 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.843 0.857 . . . . 61.240000000000002 112.399 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.48 -41.79 72.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 116.689 -1.624 . . . . 74.329999999999998 111.037 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -64.5 -31.22 72.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.811 2.096 . . . . 70.109999999999999 109.263 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.03 -46.67 56.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.094 0.406 . . . . 54.229999999999997 110.84 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -77.81 -47.77 18.12 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.774 1.398 . . . . 73.209999999999994 114.774 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -126.22 80.59 68.32 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 126.273 1.829 . . . . 74.030000000000001 108.107 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.35 -35.3 51.23 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.556 2.171 . . . . 52.130000000000003 109.353 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.86 20.76 3.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.733 1.213 . . . . 71.420000000000002 114.272 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -125.84 155.77 40.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 120.214 -1.553 . . . . 63.409999999999997 108.01 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 m -126.91 138.73 33.26 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.019 0.928 . . . . 74.510000000000005 110.25 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HG2' ' HA ' ' A' ' 104' ' ' PHE . 68.5 Cg_endo -77.89 120.03 4.93 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 125.279 3.986 . . . . 63.310000000000002 113.307 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.5 135.61 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.003 1.321 . . . . 74.150000000000006 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.94 118.36 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.962 -2.236 . . . . 72.349999999999994 104.962 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.65 124.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.063 1.745 . . . . 75.150000000000006 106.895 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.97 139.17 54.06 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.54 -1.281 . . . . 72.209999999999994 107.54 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tmmt? -72.66 140.4 47.9 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.637 0.775 . . . . 75.109999999999999 110.414 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.84 126.17 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 125.008 1.323 . . . . 74.230000000000004 107.57 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.2 p -55.47 122.18 10.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.877 0.871 . . . . 62.130000000000003 109.359 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.73 9.42 66.34 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.618 -1.101 . . . . 75.409999999999997 114.723 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 t -86.06 146.44 26.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.364 1.582 . . . . 74.530000000000001 110.653 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -65.25 -24.86 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.411 1.084 . . . . 75.239999999999995 111.383 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -66.11 162.79 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.426 -1.422 . . . . 75.420000000000002 113.475 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.3 141.47 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 125.15 1.38 . . . . 51.119999999999997 108.359 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 2.6 p30 -81.78 170.21 15.99 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.588 0.755 . . . . 74.319999999999993 110.312 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 tt -126.65 149.56 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.222 1.409 . . . . 74.030000000000001 107.803 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -76.57 166.01 23.99 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.347 1.059 . . . . 73.109999999999999 109.164 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -73.71 95.77 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 72.219999999999999 106.402 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -134.94 159.07 42.62 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.239 1.416 . . . . 75.239999999999995 107.336 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -113.56 104.28 12.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.733 -1.21 . . . . 63.420000000000002 107.733 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' B' ' 346' ' ' VAL . 5.1 m-30 -84.17 145.67 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.337 0.971 . . . . 71.510000000000005 110.381 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.44 112.1 18.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.594 1.558 . . . . 72.099999999999994 108.631 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.69 142.19 25.26 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.096 -0.954 . . . . 62.299999999999997 110.676 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 76.8 Cg_endo -74.94 141.39 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.572 2.848 . . . . 72.540000000000006 112.72 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.29 -21.7 60.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.373 1.469 . . . . 74.310000000000002 114.562 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -78.54 -32.87 48.11 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 114.961 1.467 . . . . 63.399999999999999 114.961 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -73.52 166.07 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.707 1.14 . . . . 71.010000000000005 110.709 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -102.43 161.24 13.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.38 1.072 . . . . 71.540000000000006 109.934 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.16 -35.9 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.569 1.148 . . . . 73.409999999999997 110.396 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.3 93.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.909 0.777 . . . . 54.5 109.977 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -63.43 -46.32 86.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.619 -0.882 . . . . 73.230000000000004 108.619 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.49 -45.75 90.79 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.53 -0.545 . . . . 72.519999999999996 109.53 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.21 -40.18 84.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.992 0.917 . . . . 64.409999999999997 109.78 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -68.11 -39.18 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.647 0.658 . . . . 75.140000000000001 110.321 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.31 -44.49 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.888 -1.153 . . . . 74.310000000000002 107.888 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.76 -51.12 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.742 1.155 . . . . 61.340000000000003 111.147 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -59.93 -39.03 84.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.034 0.834 . . . . 74.209999999999994 110.834 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -70.06 -43.34 71.41 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.778 0.717 . . . . 75.0 109.967 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.84 -49.55 72.98 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.115 1.366 . . . . 74.340000000000003 110.936 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.69 -0.47 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.062 0.851 . . . . 64.140000000000001 112.181 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 58.3 55.74 4.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.328 1.451 . . . . 75.109999999999999 111.571 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' HD2' ' A' ' 71' ' ' PRO . 1.1 tm? -68.79 109.22 3.86 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 106.623 -1.621 . . . . 45.539999999999999 106.623 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD2' HD22 ' A' ' 70' ' ' LEU . 88.3 Cg_endo -73.06 164.65 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.986 3.124 . . . . 71.519999999999996 111.683 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 m -60.09 -27.39 66.96 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.516 0.326 . . . . 70.319999999999993 111.114 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.48 -38.46 89.92 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.253 -0.879 . . . . 64.409999999999997 113.367 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 165.35 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.113 1.324 . . . . 65.409999999999997 112.115 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.03 177.36 4.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.968 1.707 . . . . 71.319999999999993 107.921 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tp -145.98 138.85 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.349 1.06 . . . . 65.25 110.353 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.39 139.49 26.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.351 1.86 . . . . 61.030000000000001 109.642 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.04 147.39 40.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.988 2.115 . . . . 64.310000000000002 107.598 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.46 123.18 17.49 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.741 -1.577 . . . . 63.210000000000001 106.741 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.94 123.36 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 108.52 -0.919 . . . . 32.210000000000001 108.52 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.88 35.34 1.08 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.053 1.741 . . . . 63.32 112.601 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 66.04 38.07 5.0 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.158 1.783 . . . . 74.409999999999997 113.484 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.0 p -135.1 157.59 46.54 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.942 2.097 . . . . 74.150000000000006 107.501 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.99 110.81 63.23 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 105.446 -2.057 . . . . 65.209999999999994 105.446 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.39 123.48 10.89 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.763 1.642 . . . . 40.100000000000001 109.545 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -67.23 124.41 23.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.47 0.708 . . . . 55.299999999999997 109.409 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.42 -33.26 65.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.668 1.187 . . . . 73.319999999999993 112.317 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -4.65 51.17 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.947 -1.095 . . . . 72.25 112.551 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.17 146.44 37.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.324 1.42 . . . . 74.329999999999998 108.936 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.21 149.07 26.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.977 0.911 . . . . 72.049999999999997 108.906 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.3 mmt -55.43 -49.41 72.49 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.721 -1.133 . . . . 73.219999999999999 110.109 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.91 -41.74 94.38 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.838 0.745 . . . . 73.430000000000007 112.295 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.49 -49.58 70.82 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.279 1.039 . . . . 74.030000000000001 109.247 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -44.43 96.0 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 124.661 1.184 . . . . 75.129999999999995 111.147 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.71 -50.68 72.51 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.154 1.381 . . . . 75.430000000000007 108.172 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -65.18 -28.51 69.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.184 -0.912 . . . . 73.510000000000005 112.357 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -28.56 17.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.309 -1.329 . . . . 50.43 113.644 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -105.17 -2.88 23.66 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.882 1.438 . . . . 74.420000000000002 114.882 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -37.92 121.42 0.93 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.351 2.261 . . . . 71.230000000000004 113.799 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.91 162.99 26.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.012 -1.107 . . . . 74.329999999999998 108.012 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.86 -31.76 67.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.901 0.88 . . . . 73.019999999999996 110.423 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -85.97 -35.36 20.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.898 -1.149 . . . . 64.0 107.898 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.21 3.84 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 117.626 1.81 . . . . 72.420000000000002 117.626 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 7.3 p90 -82.86 179.18 7.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.747 0.773 . . . . 73.319999999999993 111.246 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tp -122.51 124.49 43.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.365 -0.976 . . . . 72.049999999999997 108.365 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -108.19 113.27 26.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.148 1.379 . . . . 71.230000000000004 109.782 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.07 147.07 32.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.255 1.026 . . . . 75.430000000000007 109.991 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.81 148.52 36.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.744 -1.206 . . . . 73.129999999999995 107.744 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -137.27 153.94 50.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.382 0.61 . . . . 63.020000000000003 111.621 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -147.43 168.86 20.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.572 1.149 . . . . 54.5 108.204 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.38 18.28 15.76 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-O 118.761 -1.022 . . . . 74.319999999999993 112.049 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-N 119.448 1.624 . . . . 71.030000000000001 108.001 -177.129 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 109.534 -0.543 . . . . 63.219999999999999 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 17.6 m95 48.97 55.62 9.01 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 126.072 1.749 . . . . 65.209999999999994 111.974 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.82 126.82 7.61 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.588 -1.005 . . . . 71.209999999999994 110.588 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 59.5 mt -68.77 138.13 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.132 0.966 . . . . 52.310000000000002 109.657 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.93 139.93 36.28 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.638 0.775 . . . . 75.540000000000006 112.836 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 77.6 mt -88.41 111.1 21.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.75 -1.574 . . . . 74.239999999999995 106.75 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 49' ' ' TYR . 41.1 t -121.8 112.69 36.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.904 0.881 . . . . 71.540000000000006 110.645 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . 0.41 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.4 p -161.24 160.83 30.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.184 0.994 . . . . 73.439999999999998 112.528 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 129.32 3.048 . . . . 63.509999999999998 113.7 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.6 m95 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 119.756 -0.164 . . . . 74.099999999999994 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.974 0.51 . . . . 75.549999999999997 110.139 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -59.65 -46.82 87.86 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.067 -0.396 . . . . 75.439999999999998 111.523 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.93 -36.57 84.81 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.474 -0.774 . . . . 74.230000000000004 112.641 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -71.82 -41.01 68.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.859 0.754 . . . . 71.450000000000003 111.662 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.02 -76.22 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.647 1.179 . . . . 73.120000000000005 110.854 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -160.96 119.68 2.52 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.79 1.636 . . . . 71.129999999999995 107.417 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -106.89 -65.92 1.05 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.75 -0.594 . . . . 74.219999999999999 112.519 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -44.24 -59.24 2.46 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.986 2.115 . . . . 63.229999999999997 116.61 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 72.5 mt-10 -66.32 -36.55 83.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.667 1.121 . . . . 64.230000000000004 110.33 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.08 -54.73 37.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.202 -0.666 . . . . 75.430000000000007 109.202 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.11 89.54 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.835 1.654 . . . . 70.400000000000006 111.467 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -54.9 -53.28 57.5 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.814 0.734 . . . . 61.450000000000003 110.375 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.66 -46.73 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 122.795 0.438 . . . . 72.329999999999998 110.752 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.01 62.97 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.543 1.137 . . . . 62.130000000000003 112.462 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 m -65.03 -44.26 89.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.22 -0.895 . . . . 75.430000000000007 109.676 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.99 66.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.755 1.161 . . . . 71.219999999999999 110.602 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -47.95 83.71 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.939 1.295 . . . . 52.340000000000003 110.472 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.3 mt -64.16 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 117.472 -1.251 . . . . 65.319999999999993 110.046 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -62.68 -36.64 83.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 121.051 1.75 . . . . 73.420000000000002 109.386 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.55 59.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.125 -0.63 . . . . 72.049999999999997 111.805 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -79.03 -46.5 18.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.0 2.593 . . . . 71.400000000000006 118.0 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.38 81.62 54.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.786 2.035 . . . . 64.319999999999993 109.025 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.69 -23.9 55.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.044 2.496 . . . . 75.549999999999997 112.922 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.63 14.02 26.29 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.614 0.365 . . . . 74.430000000000007 110.365 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -121.57 154.05 37.22 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.913 -1.143 . . . . 73.0 107.913 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.86 142.75 46.09 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 123.753 0.821 . . . . 65.239999999999995 111.092 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.03 125.43 9.29 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.623 3.549 . . . . 55.240000000000002 111.438 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.02 140.87 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.989 -1.115 . . . . 71.420000000000002 107.989 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.89 117.86 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 103.034 -2.95 . . . . 74.519999999999996 103.034 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -105.78 120.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.911 -1.885 . . . . 64.010000000000005 105.911 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -124.67 146.21 49.24 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.602 0.761 . . . . 72.129999999999995 109.611 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -93.3 135.65 34.32 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.049 0.94 . . . . 74.530000000000001 109.735 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.21 130.65 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.377 -0.827 . . . . 71.519999999999996 109.193 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -63.72 156.59 26.6 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.45 -0.574 . . . . 71.340000000000003 109.45 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.86 -20.33 39.94 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.94 1.257 . . . . 63.119999999999997 112.996 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.3 t -84.56 142.95 29.63 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.15 -1.796 . . . . 74.049999999999997 106.15 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.44 -11.64 60.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.485 1.114 . . . . 53.439999999999998 112.484 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.486 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 2.1 tt -62.69 157.43 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.012 1.325 . . . . 71.430000000000007 111.498 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -66.11 156.19 6.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.12 1.368 . . . . 75.150000000000006 110.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -101.53 173.21 6.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.188 2.195 . . . . 63.140000000000001 114.652 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -125.22 136.44 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.612 1.565 . . . . 74.129999999999995 108.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.72 165.0 25.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.389 1.076 . . . . 72.400000000000006 108.203 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.06 94.81 2.44 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.259 -0.901 . . . . 75.329999999999998 111.393 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -129.56 162.42 28.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 125.205 1.402 . . . . 73.219999999999999 108.891 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 33.3 mtmt -108.81 101.74 10.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 104.385 -2.45 . . . . 72.230000000000004 104.385 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -93.46 120.73 34.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.223 0.465 . . . . 75.0 111.546 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.91 121.19 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.73 142.42 26.61 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.139 0.975 . . . . 70.239999999999995 109.257 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 138.69 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.954 1.769 . . . . 72.25 111.073 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -60.75 -16.77 43.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.27 2.628 . . . . 50.520000000000003 111.206 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.46 -34.66 58.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.914 1.45 . . . . 72.230000000000004 114.914 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.25 170.28 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.962 0.801 . . . . 74.510000000000005 112.199 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -100.26 166.32 11.04 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.909 0.883 . . . . 53.210000000000001 111.651 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.0 t -56.65 -34.73 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 O-C-N 121.597 -0.69 . . . . 73.019999999999996 109.244 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.89 92.46 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.363 1.065 . . . . 54.420000000000002 110.353 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -65.88 -45.25 82.76 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.875 0.87 . . . . 71.400000000000006 109.123 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.79 -48.22 82.01 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.719 -0.845 . . . . 74.310000000000002 108.719 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.8 ttp -59.51 -45.01 92.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.837 0.855 . . . . 74.109999999999999 110.856 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -60.18 -39.72 87.46 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.875 0.47 . . . . 65.25 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.34 -47.29 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 117.368 -1.301 . . . . 55.450000000000003 109.521 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.4 -50.89 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 120.374 1.443 . . . . 71.120000000000005 109.509 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -61.72 -36.97 82.49 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.346 -0.846 . . . . 62.43 112.183 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -67.4 -43.68 80.71 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-O 118.062 -0.971 . . . . 71.099999999999994 110.434 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -63.22 -47.56 81.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.744 1.618 . . . . 75.450000000000003 111.01 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -79.39 1.65 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.351 0.596 . . . . 74.549999999999997 110.977 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 50.56 59.44 4.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.795 2.438 . . . . 73.340000000000003 111.141 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.56 111.26 6.98 Favored Pre-proline 0 C--O 1.24 0.593 0 C-N-CA 125.66 1.584 . . . . 72.150000000000006 109.662 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.05 165.58 29.68 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.851 3.701 . . . . 72.409999999999997 113.329 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 p -60.91 -23.32 65.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.635 1.574 . . . . 73.140000000000001 113.7 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.6 pt-20 -72.27 -54.13 10.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.675 1.59 . . . . 73.430000000000007 112.826 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.52 163.47 23.71 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 113.284 0.846 . . . . 75.120000000000005 113.284 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.06 166.66 10.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.416 1.886 . . . . 73.439999999999998 107.62 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tt -154.4 130.5 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 125.218 1.407 . . . . 74.530000000000001 107.744 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -139.16 149.54 44.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.845 1.658 . . . . 72.420000000000002 107.713 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.1 mt -112.83 156.57 22.68 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.896 1.278 . . . . 61.140000000000001 109.5 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -147.41 140.24 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.286 1.435 . . . . 73.439999999999998 109.288 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.459 HG12 ' HD3' ' A' ' 85' ' ' PRO . 12.0 p -134.14 120.78 35.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 125.345 1.458 . . . . 63.420000000000002 107.211 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 t0 43.22 52.46 5.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 73.409999999999997 111.837 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 62.43 18.87 10.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.78 1.632 . . . . 75.040000000000006 113.766 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.4 p -125.9 160.12 30.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.788 1.631 . . . . 73.230000000000004 111.31 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.8 104.16 37.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.52 1.928 . . . . 74.310000000000002 106.542 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' HG12 ' A' ' 80' ' ' VAL . 38.7 Cg_endo -68.43 155.41 69.24 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.528 2.152 . . . . 51.439999999999998 110.639 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -79.86 121.63 25.65 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.018 -0.734 . . . . 64.219999999999999 109.018 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.2 m -53.68 -31.4 47.63 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.243 1.201 . . . . 62.409999999999997 114.243 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 t -83.7 -8.29 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.706 1.002 . . . . 70.219999999999999 113.706 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.82 152.39 44.63 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.309 1.413 . . . . 64.310000000000002 109.625 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -88.88 150.01 23.08 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.037 -0.727 . . . . 61.109999999999999 109.037 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.8 mmt -58.15 -47.53 83.05 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 117.337 -1.316 . . . . 73.349999999999994 110.23 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.07 -48.52 46.08 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 121.227 1.83 . . . . 53.009999999999998 113.298 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -64.32 -50.0 69.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.281 1.032 . . . . 74.5 109.533 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.31 -47.86 80.42 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.699 0.8 . . . . 73.219999999999999 110.187 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -58.84 -55.17 38.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.912 1.285 . . . . 74.010000000000005 108.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -54.71 -43.55 72.66 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.401 0.889 . . . . 65.230000000000004 113.401 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -24.81 28.25 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 117.593 -1.194 . . . . 74.099999999999994 114.222 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.6 2.74 36.48 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.115 1.325 . . . . 71.329999999999998 112.72 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -53.77 126.4 21.94 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.604 1.562 . . . . 62.310000000000002 112.258 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.71 165.38 25.32 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.988 -1.116 . . . . 64.340000000000003 107.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.75 62.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.696 -1.253 . . . . 71.549999999999997 111.023 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.92 17.05 12.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.439 2.295 . . . . 62.020000000000003 111.014 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.43 15.33 38.52 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.663 3.03 . . . . 62.030000000000001 119.513 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -122.04 179.48 4.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.49 2.145 . . . . 72.030000000000001 111.124 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.14 124.47 45.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.796 . . . . 74.420000000000002 111.023 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -105.14 118.52 36.74 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.74 -1.207 . . . . 71.420000000000002 107.74 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.0 140.22 49.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.524 -0.735 . . . . 73.230000000000004 109.026 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 156.89 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.977 -1.077 . . . . 72.349999999999994 108.51 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -145.23 156.39 43.81 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.407 0.622 . . . . 74.200000000000003 110.083 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.35 170.43 17.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.513 -0.921 . . . . 44.210000000000001 108.513 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.84 30.28 7.25 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.522 1.535 . . . . 71.510000000000005 109.963 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 C--O 1.236 0.368 0 C-N-CA 125.09 1.356 . . . . 72.230000000000004 110.449 -179.245 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 C--O 1.235 0.33 0 N-CA-C 114.281 1.215 . . . . 73.510000000000005 114.281 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.598 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 28.0 m95 55.12 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.567 1.147 . . . . 72.0 109.552 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -87.12 130.08 9.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.439 -1.413 . . . . 64.409999999999997 112.693 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 39.6 mt -68.78 128.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.3 1.55 . . . . 73.340000000000003 110.123 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -134.44 161.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.893 1.677 . . . . 65.310000000000002 111.282 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.5 116.51 31.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.119 -2.549 . . . . 74.140000000000001 104.119 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.13 104.3 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.959 -1.126 . . . . 74.310000000000002 107.959 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.7 p -147.56 160.6 42.45 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.217 1.407 . . . . 74.310000000000002 108.391 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 131.284 3.834 . . . . 73.420000000000002 116.148 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 105.382 -2.081 . . . . 73.109999999999999 105.382 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -52.48 -38.74 60.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.638 0.775 . . . . 73.219999999999999 110.372 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -60.14 -41.08 91.95 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.099 -0.375 . . . . 73.25 111.874 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -67.16 -40.46 86.65 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.627 1.171 . . . . 63.350000000000001 109.354 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.57 -40.86 93.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.204 0.601 . . . . 74.5 110.352 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.78 -75.79 0.3 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.117 0.967 . . . . 72.430000000000007 112.102 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.78 119.9 2.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.056 1.342 . . . . 65.510000000000005 108.852 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -119.65 -65.83 1.12 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 117.243 -1.36 . . . . 73.420000000000002 113.358 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.2 tp -47.23 -59.67 3.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 115.97 1.841 . . . . 62.329999999999998 115.97 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.44 -50.69 62.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.719 0.771 . . . . 72.5 111.122 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -53.88 -49.83 67.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.735 1.214 . . . . 74.510000000000005 111.123 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -67.22 -39.34 86.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 116.587 -1.673 . . . . 74.299999999999997 109.93 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.25 -55.52 33.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.252 1.387 . . . . 72.540000000000006 110.917 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.73 -48.0 81.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.053 1.341 . . . . 63.119999999999997 109.925 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.32 -42.79 87.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 118.182 -0.913 . . . . 72.230000000000004 112.151 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.6 p -61.56 -43.04 99.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.81 1.186 . . . . 63.32 108.82 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.6 -50.42 73.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.902 0.773 . . . . 60.229999999999997 109.938 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.05 -48.18 77.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.889 -0.507 . . . . 74.010000000000005 111.771 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.91 -42.34 94.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 118.004 -0.998 . . . . 63.439999999999998 109.97 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -65.73 -34.38 78.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.992 1.269 . . . . 65.439999999999998 110.068 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.54 -45.86 51.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.244 -0.408 . . . . 72.349999999999994 111.042 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -77.1 -46.46 23.52 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.059 0.845 . . . . 62.43 113.096 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -122.22 79.35 44.05 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.953 2.101 . . . . 74.010000000000005 109.977 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.49 -13.46 30.26 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.534 2.823 . . . . 72.230000000000004 112.95 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 18.28 20.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.682 1.593 . . . . 74.319999999999993 110.569 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 54.4 mtt85 -125.11 147.75 48.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.478 1.111 . . . . 51.32 108.511 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.16 133.14 23.18 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.621 1.168 . . . . 74.200000000000003 109.781 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.07 117.5 3.55 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.533 3.488 . . . . 74.519999999999996 112.13 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.56 151.19 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.852 1.261 . . . . 53.229999999999997 110.129 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.36 120.88 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 104.467 -2.42 . . . . 54.350000000000001 104.467 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.75 115.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.147 1.779 . . . . 72.319999999999993 108.684 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.38 151.3 51.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 72.409999999999997 110.184 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -94.06 158.49 15.59 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.108 -0.995 . . . . 72.340000000000003 113.372 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.61 129.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.005 -2.591 . . . . 53.329999999999998 104.005 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.1 p -53.0 153.19 3.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.654 0.74 . . . . 65.230000000000004 112.142 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.89 -17.69 1.23 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.064 1.793 . . . . 52.229999999999997 113.136 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -62.16 124.49 20.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 119.272 1.536 . . . . 53.32 108.69 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -64.4 -12.89 47.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.961 1.304 . . . . 73.120000000000005 112.9 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.45 151.54 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.475 -1.306 . . . . 64.439999999999998 107.475 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -46.97 141.89 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.733 1.213 . . . . 72.099999999999994 112.576 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.15 150.74 41.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.799 -1.546 . . . . 73.439999999999998 110.616 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.27 123.46 63.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.724 -1.584 . . . . 71.109999999999999 106.724 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.51 165.86 24.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.526 -0.916 . . . . 65.140000000000001 108.526 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.82 95.18 1.89 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.272 0.558 . . . . 73.400000000000006 111.365 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -132.12 161.86 32.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.562 1.945 . . . . 70.400000000000006 109.009 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -112.3 142.27 45.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.69 1.196 . . . . 63.020000000000003 108.624 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -122.94 132.63 54.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.792 0.437 . . . . 64.349999999999994 109.848 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.66 113.17 21.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.888 1.675 . . . . 70.510000000000005 108.282 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.11 142.87 26.83 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-O 118.218 -0.896 . . . . 74.129999999999995 110.224 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 51.8 Cg_endo -66.34 139.73 55.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.697 1.598 . . . . 73.430000000000007 111.274 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -12.29 30.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.708 1.203 . . . . 61.210000000000001 112.6 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.54 -35.07 58.47 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.155 1.782 . . . . 62.329999999999998 112.94 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.24 169.46 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 122.018 0.913 . . . . 74.010000000000005 110.69 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -107.16 168.47 9.19 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.282 -0.886 . . . . 64.319999999999993 112.086 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.19 -35.26 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.86 -1.533 . . . . 64.239999999999995 106.86 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 87' ' ' SER . . . -60.61 -47.18 87.35 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 121.381 -0.824 . . . . 75.519999999999996 110.654 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.17 -45.69 76.22 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 118.33 -0.843 . . . . 74.030000000000001 110.923 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.25 -44.14 88.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.663 0.665 . . . . 73.439999999999998 109.602 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 34.5 ttp -65.11 -43.98 90.22 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 117.772 -1.109 . . . . 72.430000000000007 111.733 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -59.67 -46.77 88.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.545 1.066 . . . . 75.329999999999998 109.182 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.455 HG21 ' CG1' ' B' ' 346' ' ' VAL . 40.3 mt -60.35 -48.08 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 117.862 -1.066 . . . . 74.439999999999998 108.63 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 ' CE2' ' A' ' 60' ' ' PHE . 55.1 mt -56.35 -50.27 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.874 1.215 . . . . 65.329999999999998 110.121 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -61.19 -33.17 73.02 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.864 -1.147 . . . . 74.409999999999997 111.74 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.15 -38.34 60.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.085 0.857 . . . . 73.140000000000001 110.209 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -60.28 -46.02 91.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.334 1.454 . . . . 71.129999999999995 110.291 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.6 pt -79.25 -6.47 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 109.969 -0.382 . . . . 72.340000000000003 109.969 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 54.93 59.78 3.86 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 126.55 1.94 . . . . 74.310000000000002 109.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.04 108.85 3.09 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.443 1.897 . . . . 72.530000000000001 111.098 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.48 151.09 70.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.451 2.101 . . . . 64.239999999999995 108.586 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 p -60.28 -25.05 65.42 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.257 -0.902 . . . . 74.150000000000006 112.431 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.87 -38.44 78.82 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.719 0.807 . . . . 73.420000000000002 110.402 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -96.14 164.7 12.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.513 1.125 . . . . 72.340000000000003 108.775 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.88 174.89 5.67 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.145 1.378 . . . . 43.130000000000003 108.257 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tp -153.15 136.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.696 -1.224 . . . . 62.549999999999997 107.696 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.98 141.12 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.106 1.362 . . . . 72.439999999999998 108.149 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.18 151.3 32.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.595 -1.261 . . . . 54.32 107.595 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -141.21 123.59 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.182 0.993 . . . . 73.299999999999997 108.575 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.68 140.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.226 -1.398 . . . . 71.319999999999993 107.226 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t0 52.11 31.93 9.68 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 122.114 0.959 . . . . 73.019999999999996 112.197 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.6 mttm 65.83 25.17 11.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.399 1.88 . . . . 74.040000000000006 111.821 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -152.08 163.03 40.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.404 1.082 . . . . 73.310000000000002 110.816 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 121.01 74.62 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.038 -2.208 . . . . 70.540000000000006 105.038 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.31 140.0 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.057 2.505 . . . . 71.439999999999998 109.695 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -67.69 124.76 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.505 1.122 . . . . 73.420000000000002 109.841 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 29.9 m -53.17 -27.8 23.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.849 1.66 . . . . 72.140000000000001 113.693 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.6 m -75.18 -17.93 60.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.256 1.022 . . . . 61.340000000000003 112.214 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.69 153.08 44.51 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.631 1.172 . . . . 64.400000000000006 108.812 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -101.03 153.74 19.29 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.109 -0.7 . . . . 61.399999999999999 109.109 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.33 -49.61 76.59 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 119.132 -0.461 . . . . 74.25 111.682 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.96 -44.97 92.57 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.237 -0.745 . . . . 51.200000000000003 111.237 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.44 -53.33 59.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.733 1.213 . . . . 51.119999999999997 110.977 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.74 -51.48 69.58 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.238 1.015 . . . . 72.040000000000006 109.718 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.29 -44.6 79.97 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.159 1.383 . . . . 61.020000000000003 110.085 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.58 -38.53 91.34 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.839 0.745 . . . . 61.420000000000002 111.939 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.05 -24.28 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.484 -1.246 . . . . 55.43 113.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.76 -4.18 22.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.001 1.273 . . . . 75.400000000000006 114.301 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.73 120.66 2.72 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.301 1.041 . . . . 71.319999999999993 113.647 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.74 175.29 10.57 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.654 -1.98 . . . . 73.340000000000003 105.654 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.41 -12.44 14.43 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.762 -1.837 . . . . 70.239999999999995 112.873 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.71 6.04 43.85 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.958 1.703 . . . . 74.349999999999994 113.651 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.39 68.56 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.706 -0.622 . . . . 71.340000000000003 111.815 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.27 164.6 21.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.538 1.535 . . . . 75.25 108.863 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.04 139.67 53.72 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 124.57 1.169 . . . . 74.030000000000001 108.667 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -121.48 122.92 40.81 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.284 -1.006 . . . . 72.099999999999994 108.284 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.32 133.06 67.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 120.776 -1.202 . . . . 64.409999999999997 108.979 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.81 160.27 14.75 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.683 -0.636 . . . . 60.32 110.009 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 35' ' ' LYS . 21.3 p90 -142.13 157.07 45.31 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.446 0.699 . . . . 71.030000000000001 111.924 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.9 p -149.22 158.54 44.26 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.988 -0.745 . . . . 54.119999999999997 108.988 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.43 29.98 7.26 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.218 1.39 . . . . 74.319999999999993 111.542 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.234 0.254 0 C-N-CA 125.475 1.51 . . . . 70.150000000000006 107.549 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 115.354 1.613 . . . . 72.140000000000001 115.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 30.4 m95 50.07 60.45 3.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.023 1.729 . . . . 73.310000000000002 115.307 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.53 137.17 17.12 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.746 -1.341 . . . . 60.210000000000001 109.746 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 26.0 mt -77.63 137.1 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.658 1.583 . . . . 73.120000000000005 113.154 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.06 142.83 50.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.299 2.24 . . . . 75.219999999999999 108.141 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.02 111.17 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.022 1.729 . . . . 74.209999999999994 110.931 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.4 t -122.91 125.82 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 113.523 0.934 . . . . 60.240000000000002 113.523 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -143.15 110.51 5.76 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.522 1.529 . . . . 73.25 108.198 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.022 1.729 . . . . 71.430000000000007 111.661 179.784 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 C--O 1.244 0.793 0 N-CA-C 109.076 -0.713 . . . . 74.420000000000002 109.076 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.64 -48.41 81.89 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.714 -0.847 . . . . 72.209999999999994 108.714 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.83 -34.37 74.45 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 118.863 -0.589 . . . . 63.539999999999999 111.282 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -64.74 -42.09 95.45 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 120.038 1.29 . . . . 55.130000000000003 109.643 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.88 -47.16 86.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.645 -0.872 . . . . 65.230000000000004 108.645 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.52 -75.45 0.1 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.212 1.805 . . . . 73.209999999999994 113.021 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.23 130.94 5.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.703 2.801 . . . . 73.430000000000007 109.505 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.3 p -114.73 -66.63 1.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.215 -1.553 . . . . 74.430000000000007 114.266 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -52.84 -57.36 10.48 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 124.83 1.252 . . . . 73.349999999999994 113.943 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.22 -56.13 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.172 0.442 . . . . 74.209999999999994 111.398 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -52.26 -49.95 63.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.529 1.132 . . . . 73.120000000000005 110.836 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.86 76.05 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 117.882 -1.056 . . . . 71.230000000000004 112.183 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.6 m -60.35 -51.74 68.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 120.379 1.445 . . . . 61.539999999999999 109.264 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.57 -47.34 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.353 -0.61 . . . . 71.019999999999996 109.353 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 21' ' ' ILE . 56.5 tt0 -55.64 -49.98 71.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.434 1.094 . . . . 73.310000000000002 109.982 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.1 m -60.51 -48.56 81.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.944 0.897 . . . . 64.140000000000001 110.198 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.43 90.58 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.694 1.134 . . . . 64.329999999999998 111.562 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -47.64 77.32 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.226 1.411 . . . . 72.430000000000007 109.475 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 17' ' ' GLU . 62.5 mt -70.05 -42.38 79.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-O 117.784 -1.103 . . . . 73.140000000000001 111.807 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -65.16 -39.1 92.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 119.572 1.078 . . . . 62.25 109.7 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.2 -46.91 66.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.07 -0.652 . . . . 70.540000000000006 110.921 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -78.16 -38.31 43.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.276 1.954 . . . . 74.340000000000003 116.276 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -136.55 74.14 53.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.352 1.861 . . . . 72.310000000000002 109.777 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.78 -24.09 54.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.421 2.747 . . . . 75.299999999999997 110.726 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.99 12.17 18.38 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.6 -0.687 . . . . 74.549999999999997 112.726 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -119.89 154.08 34.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.572 -1.27 . . . . 74.319999999999993 107.572 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.82 139.98 27.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.166 -0.679 . . . . 74.540000000000006 109.166 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.075 3.85 . . . . 74.099999999999994 112.169 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.2 131.93 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.909 -0.775 . . . . 74.209999999999994 108.909 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.75 133.59 55.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.367 -2.457 . . . . 75.239999999999995 104.367 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.57 137.45 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.777 1.399 . . . . 72.040000000000006 114.777 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.84 152.61 43.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.115 0.966 . . . . 70.420000000000002 109.913 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -93.39 155.74 17.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.256 -1.016 . . . . 72.120000000000005 108.256 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.15 135.08 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.088 -1.819 . . . . 63.219999999999999 106.088 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.09 133.13 38.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.107 0.563 . . . . 73.219999999999999 111.975 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.57 3.95 43.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.645 -1.086 . . . . 64.129999999999995 114.144 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 t -62.5 146.02 52.74 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.685 1.742 . . . . 75.340000000000003 111.048 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -65.86 -14.89 62.32 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.825 2.05 . . . . 64.040000000000006 112.856 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.409 ' CD1' HD23 ' A' ' 70' ' ' LEU . 9.6 tp -77.66 159.08 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.398 -0.814 . . . . 61.539999999999999 109.965 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.25 150.06 11.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.789 -0.819 . . . . 72.140000000000001 108.789 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.6 164.58 25.79 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.522 0.729 . . . . 63.32 112.105 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.82 148.57 20.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.161 1.785 . . . . 71.209999999999994 106.317 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -87.14 157.44 19.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.452 -0.944 . . . . 65.540000000000006 108.452 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.87 100.72 3.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.5 -1.296 . . . . 52.009999999999998 107.5 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 87.2 mmt-85 -136.41 161.99 34.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.118 1.767 . . . . 75.439999999999998 110.198 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -108.81 95.48 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.178 2.591 . . . . 64.349999999999994 104.018 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -89.29 120.02 30.28 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.16 -0.963 . . . . 71.530000000000001 112.383 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.71 115.16 28.83 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.96 1.704 . . . . 74.230000000000004 109.625 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 141.47 25.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 117.82 -1.085 . . . . 53.219999999999999 111.361 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.43 140.7 48.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.281 2.654 . . . . 44.009999999999998 110.893 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 m -63.87 -16.33 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.489 1.516 . . . . 75.140000000000001 113.34 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.82 -30.43 28.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.295 1.438 . . . . 72.109999999999999 113.743 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -71.03 165.59 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 119.018 -1.073 . . . . 73.319999999999993 109.257 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -107.02 165.39 11.38 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.587 0.755 . . . . 75.230000000000004 110.25 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 t -53.99 -34.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.942 -1.132 . . . . 75.450000000000003 107.942 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.38 90.48 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.16 1.384 . . . . 74.519999999999996 111.135 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -69.21 -44.62 71.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.838 -0.801 . . . . 75.310000000000002 108.838 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.06 -48.6 81.03 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.429 -0.582 . . . . 75.5 109.429 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ttt -54.05 -48.07 70.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.626 1.17 . . . . 71.420000000000002 109.553 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.007 -0.521 . . . . 73.219999999999999 111.767 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.4 mt -57.32 -44.18 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.067 -0.716 . . . . 55.439999999999998 109.067 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mt -59.53 -50.63 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.427 0.558 . . . . 62.420000000000002 110.725 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -65.33 -37.27 86.59 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.08 -1.012 . . . . 70.409999999999997 111.949 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -64.94 -47.09 78.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.063 0.945 . . . . 72.310000000000002 110.29 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.89 -42.29 97.5 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.816 1.246 . . . . 70.310000000000002 113.011 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.65 -8.64 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 119.818 -0.753 . . . . 64.439999999999998 109.747 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.68 60.52 1.6 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.797 2.039 . . . . 73.349999999999994 108.841 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.1 tm? -73.32 110.44 8.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.664 1.186 . . . . 65.299999999999997 110.015 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.84 164.47 29.41 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.715 2.943 . . . . 72.140000000000001 112.389 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 p -64.28 -21.05 66.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.99 0.916 . . . . 72.25 111.498 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.47 -50.54 25.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.406 0.683 . . . . 73.420000000000002 112.794 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.12 164.24 15.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.777 -0.824 . . . . 64.109999999999999 108.777 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.23 -178.45 3.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.971 -1.122 . . . . 74.099999999999994 107.971 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -150.74 141.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.648 1.579 . . . . 73.120000000000005 107.171 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -145.27 139.41 27.1 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 127.288 2.235 . . . . 74.400000000000006 107.965 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.9 150.49 35.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.877 0.871 . . . . 42.509999999999998 111.135 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -145.25 133.83 22.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.549 1.14 . . . . 73.439999999999998 109.75 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 p -132.91 127.93 56.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 105.043 -2.206 . . . . 71.430000000000007 105.043 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.32 30.55 10.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.178 1.354 . . . . 74.010000000000005 110.863 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt 61.13 25.27 15.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 72.150000000000006 110.928 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -119.37 161.57 20.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.623 1.569 . . . . 60.25 109.72 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.2 103.62 21.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.356 -2.09 . . . . 75.150000000000006 105.356 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.15 142.7 38.47 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.31 2.007 . . . . 74.329999999999998 111.569 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -75.41 121.91 23.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.071 -0.715 . . . . 65.420000000000002 109.071 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -49.06 -42.21 37.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.854 2.062 . . . . 43.5 112.665 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -72.92 -11.37 60.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.769 1.228 . . . . 74.200000000000003 113.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.69 157.34 36.72 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.579 1.536 . . . . 71.510000000000005 109.733 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.03 152.45 18.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.192 1.397 . . . . 64.120000000000005 110.085 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.3 mmm -60.7 -43.56 97.62 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.034 -0.53 . . . . 73.010000000000005 111.613 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.51 99.71 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.479 -0.623 . . . . 52.43 111.782 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -66.15 -50.18 64.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.017 0.909 . . . . 63.539999999999999 109.412 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.23 -35.17 76.5 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.204 -0.295 . . . . 74.200000000000003 110.204 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.72 -48.96 67.59 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 120.063 -1.648 . . . . 60.350000000000001 109.619 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.92 -28.68 68.5 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.496 -0.752 . . . . 71.239999999999995 112.087 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -24.36 19.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 116.6 -1.667 . . . . 53.240000000000002 113.86 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.13 -2.97 13.3 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.704 1.742 . . . . 74.510000000000005 115.704 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 124.29 6.39 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.259 1.39 . . . . 74.299999999999997 113.967 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -77.62 175.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.937 -1.505 . . . . 73.319999999999993 106.937 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -58.91 -27.39 65.21 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 119.838 -1.789 . . . . 71.430000000000007 113.896 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -79.11 7.76 6.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 75.400000000000006 111.131 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.49 69.3 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.616 1.579 . . . . 72.230000000000004 114.94 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.77 172.65 10.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.447 1.899 . . . . 73.319999999999993 110.789 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.63 141.56 52.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.616 -0.513 . . . . 71.140000000000001 109.616 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -113.23 123.67 50.72 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.766 1.226 . . . . 75.109999999999999 111.795 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.2 136.81 57.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 122.801 1.286 . . . . 65.329999999999998 111.117 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.19 142.74 46.42 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.628 -1.619 . . . . 52.32 106.628 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -133.21 155.54 49.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.457 0.646 . . . . 74.25 110.758 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.3 p -150.97 155.9 40.06 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.567 -0.901 . . . . 55.229999999999997 108.567 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.36 9.21 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 119.39 -0.672 . . . . 71.430000000000007 112.769 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 118.219 1.01 . . . . 71.120000000000005 109.169 -177.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 115.572 1.693 . . . . 64.040000000000006 115.572 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.3 m95 53.74 58.52 5.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.398 1.079 . . . . 75.319999999999993 109.758 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -81.15 139.86 20.86 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 108.252 -1.939 . . . . 63.130000000000003 108.252 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 133.83 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 118.871 1.335 . . . . 60.399999999999999 109.698 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.09 138.36 48.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.747 1.219 . . . . 72.129999999999995 109.444 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.72 118.97 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 103.152 -2.907 . . . . 71.439999999999998 103.152 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.45 119.24 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.898 0.879 . . . . 71.530000000000001 109.522 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -161.47 123.99 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.42 0.688 . . . . 72.239999999999995 109.748 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 128.234 2.614 . . . . 64.430000000000007 112.902 -179.213 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 107.933 -1.136 . . . . 74.230000000000004 107.933 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -58.7 -41.99 87.57 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 124.024 0.828 . . . . 72.030000000000001 109.531 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -58.82 -42.34 88.96 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.693 -0.629 . . . . 62.109999999999999 110.992 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 11.3 ttmm -68.37 -38.06 81.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.312 0.96 . . . . 71.340000000000003 111.376 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.62 -46.77 74.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.96 -1.019 . . . . 72.319999999999993 108.829 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.92 -77.53 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.561 1.145 . . . . 73.140000000000001 110.266 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 119.21 2.13 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.254 1.821 . . . . 74.239999999999995 108.223 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 28.7 t -106.88 -65.82 1.06 Allowed 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 106.706 -1.59 . . . . 62.32 106.706 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -41.13 -58.07 1.88 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.512 1.525 . . . . 63.140000000000001 115.101 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.35 -51.66 54.94 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.918 -0.488 . . . . 54.43 112.0 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.66 -44.35 73.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.146 0.979 . . . . 74.219999999999999 110.325 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.27 70.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.73 1.612 . . . . 63.219999999999999 108.782 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.69 -47.71 79.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.359 0.527 . . . . 70.319999999999993 111.63 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.79 -48.3 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 C-N-CA 123.035 0.534 . . . . 71.319999999999993 109.953 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -64.06 -49.46 72.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.673 -1.156 . . . . 44.340000000000003 111.274 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.4 m -55.27 -46.57 76.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.08 1.309 . . . . 61.020000000000003 109.733 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.68 70.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.154 0.888 . . . . 62.130000000000003 111.576 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -62.47 -39.51 93.66 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.604 -1.31 . . . . 72.219999999999999 111.725 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.5 -42.77 56.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 116.008 -1.948 . . . . 62.549999999999997 109.285 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.79 -34.67 78.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 121.182 1.81 . . . . 74.439999999999998 108.967 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.27 82.21 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.922 -0.486 . . . . 43.450000000000003 110.895 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -76.95 -47.23 21.5 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.785 1.032 . . . . 75.109999999999999 113.785 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -138.06 89.13 14.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.061 1.744 . . . . 73.349999999999994 108.494 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.85 -22.27 36.78 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.626 2.217 . . . . 74.129999999999995 112.403 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.29 14.14 25.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.034 2.134 . . . . 62.030000000000001 113.588 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -120.02 156.8 30.19 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.158 -1.423 . . . . 72.0 107.158 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.519 HG11 ' CG ' ' A' ' 95' ' ' TYR . 15.7 m -121.92 138.2 28.37 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.353 1.061 . . . . 62.5 111.2 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.48 116.85 3.91 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.216 3.944 . . . . 75.120000000000005 112.347 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.21 146.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.745 1.218 . . . . 64.25 108.974 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.9 mt -122.31 128.26 75.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.165 -2.532 . . . . 74.430000000000007 104.165 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 120.81 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.643 1.577 . . . . 54.219999999999999 107.274 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -131.94 147.09 52.44 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.38 -0.971 . . . . 71.519999999999996 108.38 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.11 155.15 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.635 1.107 . . . . 64.120000000000005 111.078 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.55 130.89 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.453 -1.314 . . . . 55.509999999999998 107.453 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -62.3 130.24 44.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.266 -1.753 . . . . 73.310000000000002 106.266 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.9 -2.77 80.25 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 118.031 -1.427 . . . . 63.240000000000002 112.289 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -77.42 139.78 39.75 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.053 -2.203 . . . . 74.310000000000002 105.053 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.01 -28.2 68.05 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.4 1.48 . . . . 74.439999999999998 112.578 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -55.84 152.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.047 1.339 . . . . 74.439999999999998 111.431 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.14 134.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.46 1.104 . . . . 53.020000000000003 111.421 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.33 158.75 34.49 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.617 -1.253 . . . . 54.119999999999997 107.617 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.47 141.13 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.836 -1.172 . . . . 73.209999999999994 107.836 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.77 164.44 17.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.405 -0.961 . . . . 72.0 108.405 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 99.37 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.534 -2.765 . . . . 73.329999999999998 103.534 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -130.48 155.1 47.02 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.771 0.796 . . . . 70.209999999999994 109.499 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 38.1 mtmt -106.46 100.26 9.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.671 -1.233 . . . . 53.439999999999998 107.671 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.82 124.47 30.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.996 -1.113 . . . . 73.430000000000007 107.996 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.13 112.92 26.05 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.513 -0.921 . . . . 44.140000000000001 108.513 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -111.44 141.18 23.97 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 54.219999999999999 113.426 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.06 141.71 33.27 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 124.158 3.239 . . . . 55.299999999999997 112.216 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -18.43 60.94 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.831 1.049 . . . . 42.229999999999997 113.831 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.56 -34.48 70.02 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.906 1.379 . . . . 74.019999999999996 114.136 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -78.84 163.52 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.5 0.667 . . . . 73.439999999999998 110.219 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 p -104.65 167.78 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.357 1.063 . . . . 71.5 109.795 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.27 -35.31 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.021 -0.733 . . . . 74.329999999999998 109.021 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.1 -45.93 82.99 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.246 0.93 . . . . 64.209999999999994 109.911 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -68.0 -45.95 72.63 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.19 -0.67 . . . . 72.049999999999997 109.19 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.19 -52.0 67.58 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 119.067 -0.492 . . . . 75.239999999999995 111.038 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.8 ttp -57.69 -46.9 83.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.434 1.094 . . . . 74.030000000000001 110.347 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -59.25 -43.63 92.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.194 0.452 . . . . 74.019999999999996 110.785 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.48 -40.04 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 117.851 -1.071 . . . . 70.340000000000003 109.561 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.34 -50.22 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 120.611 1.55 . . . . 73.400000000000006 108.902 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -59.86 -39.15 84.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.025 -0.988 . . . . 72.400000000000006 111.402 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.79 -39.38 69.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 119.588 1.085 . . . . 61.420000000000002 110.828 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -62.96 -42.99 99.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.723 1.147 . . . . 73.430000000000007 110.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -79.22 -2.63 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.297 0.499 . . . . 74.430000000000007 109.7 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 55.47 61.02 3.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.01 2.124 . . . . 63.350000000000001 109.734 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.42 107.2 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.602 1.561 . . . . 73.049999999999997 109.935 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.97 156.1 66.41 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.485 2.124 . . . . 74.150000000000006 109.171 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -65.27 -20.79 66.58 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.183 -0.948 . . . . 71.519999999999996 112.703 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.6 -30.63 71.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.483 0.713 . . . . 73.140000000000001 110.453 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -103.72 164.9 11.38 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.009 1.324 . . . . 72.129999999999995 111.376 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.38 177.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.74 1.616 . . . . 71.299999999999997 108.093 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 tp -145.72 135.81 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.559 -1.645 . . . . 43.43 106.559 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -143.1 141.95 31.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.055 -1.461 . . . . 70.109999999999999 107.055 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.75 142.34 46.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.403 1.081 . . . . 54.32 108.109 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -144.3 123.66 13.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.294 -1.373 . . . . 72.519999999999996 107.294 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -130.21 131.3 65.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 117.046 -1.454 . . . . 65.329999999999998 107.255 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 47.89 30.82 2.07 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.519 1.508 . . . . 75.420000000000002 113.365 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mttp 64.74 29.11 12.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.235 -1.541 . . . . 71.340000000000003 110.61 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.9 p -132.7 161.8 33.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.104 2.562 . . . . 65.219999999999999 110.779 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.76 110.9 63.22 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.261 1.424 . . . . 73.329999999999998 109.118 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.09 124.81 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.361 2.04 . . . . 64.200000000000003 107.417 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -69.31 133.88 48.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.54 1.136 . . . . 72.340000000000003 109.655 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -62.72 -40.38 97.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 114.253 1.205 . . . . 51.149999999999999 114.253 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -21.62 59.08 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.97 -1.014 . . . . 54.210000000000001 113.093 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.95 142.8 58.31 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.268 1.395 . . . . 72.109999999999999 111.137 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 p -78.22 153.68 31.72 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.944 . . . . 73.430000000000007 110.004 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.1 mmt -59.36 -41.6 89.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.304 -0.855 . . . . 72.409999999999997 108.811 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.9 92.3 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.146 0.884 . . . . 73.530000000000001 112.964 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -49.76 52.77 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.064 0.932 . . . . 53.409999999999997 111.13 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.29 -48.01 81.83 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 123.527 0.731 . . . . 70.510000000000005 109.796 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.519 ' CG ' HG11 ' A' ' 29' ' ' VAL . 45.8 t80 -56.87 -52.99 62.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.13 1.372 . . . . 72.120000000000005 109.461 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.04 -47.38 84.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 118.971 -0.538 . . . . 74.400000000000006 111.964 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -32.74 67.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.373 0.988 . . . . 74.230000000000004 112.768 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -93.86 -5.84 47.12 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.683 1.129 . . . . 71.409999999999997 113.887 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -38.79 125.14 1.44 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.587 1.955 . . . . 65.209999999999994 113.727 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.91 163.47 16.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.927 0.891 . . . . 71.450000000000003 110.024 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.82 -29.26 26.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.465 1.106 . . . . 74.420000000000002 111.277 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -95.32 -33.88 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.481 1.112 . . . . 75.099999999999994 112.541 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.03 4.04 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 117.742 1.857 . . . . 75.209999999999994 117.742 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -96.27 178.99 5.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.366 2.083 . . . . 60.240000000000002 112.024 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tp -125.74 138.2 53.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.584 -0.722 . . . . 72.409999999999997 111.302 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -123.13 108.32 12.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.043 1.337 . . . . 64.340000000000003 109.561 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.98 145.11 20.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 122.332 1.063 . . . . 73.430000000000007 110.382 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.96 145.54 38.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.169 -0.923 . . . . 71.129999999999995 108.509 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -130.96 157.62 42.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.364 0.602 . . . . 65.329999999999998 109.863 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.1 p -148.28 161.82 40.75 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.408 -0.96 . . . . 75.519999999999996 108.408 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.14 17.85 16.65 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 117.959 -1.467 . . . . 65.329999999999998 114.136 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.285 -1.376 . . . . 72.430000000000007 107.285 -179.733 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.557 1.248 1 N-CA-C 122.043 4.09 . . . . 71.239999999999995 122.043 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.433 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 10.4 m95 50.67 66.14 1.25 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.479 3.112 . . . . 74.299999999999997 112.081 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -99.8 124.89 8.38 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.421 -1.872 . . . . 61.329999999999998 108.421 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . 0.432 HG12 ' HE3' ' A' ' 48' ' ' LYS . 61.5 mt -68.37 139.9 19.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.585 1.192 . . . . 74.299999999999997 108.212 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -141.72 112.21 7.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.071 1.748 . . . . 63.340000000000003 106.584 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.48 120.71 22.08 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.374 -2.084 . . . . 74.420000000000002 105.374 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.48 110.86 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.458 0.703 . . . . 73.409999999999997 111.934 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.1 p -144.48 127.5 16.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.338 1.055 . . . . 62.5 108.958 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 128.94 2.896 . . . . 74.400000000000006 114.56 179.549 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.5 m95 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 108.714 -0.847 . . . . 61.229999999999997 108.714 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 mmt -60.17 -34.14 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.398 -0.921 . . . . 61.219999999999999 110.749 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -60.23 -47.66 85.02 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.232 -0.917 . . . . 74.439999999999998 109.982 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -64.43 -32.67 74.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.827 -0.606 . . . . 65.010000000000005 110.227 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -60.21 -47.35 86.35 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.87 -1.159 . . . . 54.210000000000001 107.87 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.17 -76.26 0.16 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.648 0.779 . . . . 73.329999999999998 111.284 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.4 143.08 11.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 127.339 2.256 . . . . 54.119999999999997 109.615 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 t -122.89 -59.7 1.57 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.099 -0.953 . . . . 74.209999999999994 109.377 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.4 mt -45.42 -58.22 3.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.075 1.35 . . . . 74.519999999999996 114.235 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -64.86 -49.99 68.36 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.426 -0.796 . . . . 73.340000000000003 110.916 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -52.5 -55.43 22.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.319 1.012 . . . . 74.109999999999999 110.377 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -44.71 91.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.637 1.575 . . . . 63.450000000000003 111.041 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.51 -50.85 72.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.088 1.313 . . . . 72.409999999999997 111.702 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.458 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 74.6 t -69.1 -47.34 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.826 0.85 . . . . 61.420000000000002 111.772 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.4 -51.18 70.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.843 1.257 . . . . 62.109999999999999 109.443 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -63.63 -40.77 97.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.117 -0.944 . . . . 75.409999999999997 110.038 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -49.83 76.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.52 1.509 . . . . 53.409999999999997 110.175 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' CG1' ' A' ' 16' ' ' VAL . 50.6 mttm -61.45 -48.42 81.23 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.431 -0.793 . . . . 73.230000000000004 110.989 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.68 -41.77 85.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-O 117.564 -1.208 . . . . 75.450000000000003 110.403 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -63.51 -33.79 76.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.526 1.966 . . . . 73.120000000000005 109.138 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.18 51.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.496 0.589 . . . . 61.439999999999998 110.153 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -75.44 -46.34 33.2 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.165 1.172 . . . . 64.450000000000003 114.165 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -124.08 74.74 58.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.938 2.895 . . . . 75.439999999999998 112.022 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.59 -9.17 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.132 3.221 . . . . 64.140000000000001 110.96 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.66 12.53 27.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.171 2.188 . . . . 63.219999999999999 111.894 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -127.41 160.08 32.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.87 -1.144 . . . . 74.319999999999993 109.791 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.5 142.62 37.72 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.604 1.161 . . . . 61.109999999999999 108.909 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.64 119.02 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.669 1 C-N-CA 125.372 4.048 . . . . 75.340000000000003 112.185 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.1 t -126.46 148.87 31.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.184 0.994 . . . . 74.129999999999995 109.764 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.24 133.41 68.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.52 -2.4 . . . . 72.219999999999999 104.52 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.73 118.5 52.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.559 1.544 . . . . 74.239999999999995 108.888 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -130.56 153.91 48.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.864 -0.791 . . . . 74.420000000000002 108.864 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -93.06 158.38 15.81 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.143 -0.973 . . . . 74.299999999999997 110.503 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.06 119.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.545 -2.02 . . . . 74.540000000000006 105.545 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 p -54.68 110.8 0.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.968 1.707 . . . . 41.240000000000002 111.946 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.4 30.99 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.846 1.688 . . . . 72.450000000000003 113.422 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 p -63.95 146.38 54.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.136 1.468 . . . . 63.130000000000003 109.816 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -69.59 -0.62 7.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.797 1.639 . . . . 74.409999999999997 114.502 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -86.75 169.2 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 119.386 0.994 . . . . 75.129999999999995 109.738 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.9 155.72 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.526 1.13 . . . . 63.539999999999999 111.358 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.16 163.13 18.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.94 0.896 . . . . 72.049999999999997 111.032 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.42 124.5 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.745 1.618 . . . . 62.240000000000002 106.675 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.12 164.62 15.15 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.893 0.877 . . . . 55.43 110.175 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 101.51 4.28 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.981 -1.489 . . . . 75.349999999999994 106.981 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -134.44 161.79 34.03 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.934 1.294 . . . . 72.230000000000004 108.765 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 17.1 mttt -111.26 105.84 14.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.745 -1.946 . . . . 64.120000000000005 105.745 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -88.01 118.39 27.54 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.325 0.861 . . . . 73.530000000000001 113.325 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.57 108.29 20.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.32 2.248 . . . . 62.149999999999999 108.783 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.62 141.35 24.46 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.049 -0.977 . . . . 51.439999999999998 110.062 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.19 141.43 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.13 1.887 . . . . 62.509999999999998 111.582 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -62.51 -16.15 54.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.098 0.777 . . . . 72.409999999999997 113.098 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.72 -34.21 64.69 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.308 1.225 . . . . 71.129999999999995 114.308 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.8 168.94 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.206 0.912 . . . . 72.120000000000005 111.58 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.1 p -107.88 169.4 8.63 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.082 0.953 . . . . 45.200000000000003 111.605 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 60.2 t -55.86 -36.1 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.002 0.921 . . . . 62.399999999999999 109.193 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.25 93.81 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.411 1.005 . . . . 71.430000000000007 110.541 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -60.91 -46.49 90.44 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 108.15 -1.056 . . . . 73.519999999999996 108.15 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -59.65 -49.3 78.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.961 0.504 . . . . 74.439999999999998 110.464 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ttt -58.49 -44.15 89.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.329 1.452 . . . . 72.230000000000004 109.467 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -63.64 -39.5 94.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.318 0.508 . . . . 74.040000000000006 110.212 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.757 HG21 HG13 ' B' ' 346' ' ' VAL . 5.9 mt -67.05 -47.65 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 107.832 -1.173 . . . . 74.219999999999999 107.832 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.86 -50.83 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.66 1.118 . . . . 73.329999999999998 110.987 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.31 -41.92 97.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.558 -0.734 . . . . 75.540000000000006 110.894 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -69.21 -41.92 76.43 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.185 0.902 . . . . 71.209999999999994 111.165 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -58.88 -47.65 84.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.462 1.505 . . . . 72.120000000000005 110.825 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 pt -83.96 -0.87 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.069 0.395 . . . . 73.299999999999997 111.266 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 54.36 71.23 0.54 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 126.521 1.928 . . . . 75.109999999999999 108.095 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -82.6 104.96 4.02 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.271 -2.122 . . . . 73.010000000000005 105.271 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -66.31 165.53 24.34 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 124.232 3.288 . . . . 72.239999999999995 113.816 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -57.86 -37.91 74.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.418 1.087 . . . . 74.299999999999997 110.202 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -59.92 -38.64 82.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 116.859 -1.543 . . . . 74.349999999999994 113.906 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.51 162.4 13.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.306 1.412 . . . . 70.129999999999995 110.673 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.87 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.13 1.372 . . . . 44.340000000000003 108.807 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.0 tp -132.58 139.59 49.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.486 1.114 . . . . 61.130000000000003 108.225 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -137.7 120.15 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.619 -1.623 . . . . 74.409999999999997 106.619 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.79 140.18 49.12 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.931 1.692 . . . . 65.430000000000007 109.126 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -145.09 141.51 28.89 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.232 -1.025 . . . . 72.25 108.232 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.68 122.57 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 125.162 1.385 . . . . 74.319999999999993 107.681 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 t0 43.49 45.79 5.61 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.338 1.236 . . . . 73.340000000000003 114.338 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tptm 71.44 18.79 5.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.22 1.808 . . . . 65.439999999999998 114.37 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.4 p -129.18 162.38 27.93 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 120.081 1.31 . . . . 74.200000000000003 111.043 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.26 109.55 50.29 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 106.43 -1.693 . . . . 72.010000000000005 106.43 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 123.86 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 N-CA-C 107.573 -1.741 . . . . 64.519999999999996 107.573 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -69.96 121.5 17.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.685 -0.635 . . . . 63.409999999999997 110.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 76.6 p -47.65 -37.59 13.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.972 2.109 . . . . 72.439999999999998 114.045 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 m -75.92 -19.19 58.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.529 1.132 . . . . 73.310000000000002 113.968 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.06 144.64 53.93 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.174 0.897 . . . . 74.209999999999994 109.879 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.7 p -83.09 154.55 24.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.449 0.642 . . . . 72.319999999999993 109.677 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.84 -42.27 97.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.702 -0.666 . . . . 72.120000000000005 111.384 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.31 -43.13 98.88 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.193 -0.782 . . . . 62.039999999999999 111.744 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -68.49 -48.46 64.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.247 1.024 . . . . 72.010000000000005 109.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -57.43 -44.43 84.65 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.472 0.709 . . . . 64.530000000000001 110.308 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -61.07 -49.74 76.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.17 0.988 . . . . 75.219999999999999 108.546 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.09 -32.25 72.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.647 0.98 . . . . 74.140000000000001 113.647 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -25.84 18.93 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.971 1.471 . . . . 52.43 114.971 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.22 0.35 23.2 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.711 1.004 . . . . 60.100000000000001 113.711 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -48.21 135.17 13.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.355 0.979 . . . . 74.209999999999994 112.965 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.77 161.23 29.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.564 -0.902 . . . . 75.439999999999998 108.564 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -54.64 -29.94 53.66 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.403 1.481 . . . . 55.240000000000002 112.01 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -79.77 -33.1 40.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.145 0.578 . . . . 63.329999999999998 111.684 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.45 -6.86 4.97 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 117.434 1.734 . . . . 73.310000000000002 117.434 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.77 -179.61 3.7 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.805 2.042 . . . . 73.019999999999996 111.957 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.5 tp -123.68 143.63 50.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.395 0.543 . . . . 63.43 111.937 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -122.69 134.52 54.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 41.240000000000002 110.602 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.84 140.64 48.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 124.498 1.119 . . . . 53.240000000000002 108.264 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.01 149.04 40.93 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.575 -0.898 . . . . 42.329999999999998 108.575 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -139.73 159.9 41.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.929 0.871 . . . . 75.239999999999995 112.793 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.2 p -149.59 155.94 41.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.014 -1.847 . . . . 50.43 106.014 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 26.16 12.64 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.156 -0.778 . . . . 65.25 111.156 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 125.417 1.487 . . . . 75.140000000000001 107.026 -178.874 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 112.499 0.555 . . . . 73.430000000000007 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . 0.5 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 52.5 m95 54.02 63.91 2.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.754 1.622 . . . . 73.319999999999993 111.792 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.78 126.34 7.34 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.009 -2.436 . . . . 62.340000000000003 107.009 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.6 132.08 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.792 1.296 . . . . 73.530000000000001 108.016 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -129.9 149.5 51.61 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.227 1.011 . . . . 65.010000000000005 109.553 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.8 tt -111.39 114.35 27.43 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.679 1.592 . . . . 71.25 109.159 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.757 HG13 HG21 ' A' ' 63' ' ' ILE . 37.8 t -121.77 136.11 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.1 0.96 . . . . 43.310000000000002 111.401 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 160.41 28.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.152 1.781 . . . . 74.329999999999998 109.331 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 127.33 2.252 . . . . 71.310000000000002 107.32 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.6 m95 . . . . . 0 C--O 1.239 0.551 0 N-CA-C 108.814 -0.81 . . . . 73.239999999999995 108.814 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.476 ' HG2' ' HE2' ' A' ' 46' ' ' LYS . 16.3 tpt -62.01 -47.11 86.23 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.422 -0.955 . . . . 70.150000000000006 108.422 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -60.26 -41.04 92.42 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 119.116 -0.469 . . . . 64.319999999999993 111.369 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -64.38 -33.27 75.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.879 0.763 . . . . 74.109999999999999 109.476 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.18 -48.31 62.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.506 0.594 . . . . 74.450000000000003 110.15 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -75.0 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.178 0.991 . . . . 73.409999999999997 112.621 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 130.63 10.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.968 1.307 . . . . 72.310000000000002 107.989 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -124.22 -65.93 1.02 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.472 0.916 . . . . 61.130000000000003 113.472 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mt -48.49 -58.88 4.01 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.444 1.497 . . . . 62.539999999999999 114.539 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.49 -44.37 87.3 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.61 -0.681 . . . . 73.349999999999994 112.06 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -59.62 -40.02 86.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.055 0.942 . . . . 74.319999999999993 108.688 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -43.12 84.7 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-O 117.437 -1.268 . . . . 73.310000000000002 110.054 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.6 m -63.85 -47.01 82.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.182 1.356 . . . . 71.530000000000001 112.752 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.39 -47.13 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 O-C-N 121.736 -0.603 . . . . 75.349999999999994 109.637 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.04 -40.01 95.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 117.416 -1.278 . . . . 72.310000000000002 110.967 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -61.76 -47.45 85.12 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 121.15 1.795 . . . . 61.119999999999997 108.767 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.83 72.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.874 0.694 . . . . 74.019999999999996 112.874 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.0 -44.94 75.43 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.637 -0.664 . . . . 65.430000000000007 112.661 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.2 -41.89 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.296 -0.859 . . . . 73.310000000000002 110.237 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -66.15 -38.0 87.05 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.468 1.031 . . . . 70.219999999999999 109.484 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.63 78.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.094 -0.642 . . . . 64.219999999999999 110.601 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.39 -46.43 22.77 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.138 1.533 . . . . 62.229999999999997 115.138 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.15 72.12 55.37 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 127.064 2.146 . . . . 74.310000000000002 110.533 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.5 -19.31 48.91 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.778 2.318 . . . . 73.530000000000001 112.523 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -97.76 13.02 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.441 0.564 . . . . 63.509999999999998 110.871 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -118.54 155.4 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.989 -1.115 . . . . 63.140000000000001 107.989 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 27.12 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.879 -1.156 . . . . 72.510000000000005 107.879 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.59 122.15 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.98 3.787 . . . . 63.350000000000001 112.392 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.55 140.77 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.274 1.83 . . . . 74.519999999999996 111.82 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.68 136.76 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 105.764 -1.939 . . . . 75.319999999999993 105.764 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.87 110.58 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.99 0.813 . . . . 72.140000000000001 110.432 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -112.88 146.81 38.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.118 -1.067 . . . . 72.329999999999998 108.118 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 141.94 31.88 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.067 -1.021 . . . . 50.340000000000003 109.652 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.34 127.94 23.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.558 -1.275 . . . . 71.409999999999997 107.558 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.07 128.77 22.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.115 1.366 . . . . 63.329999999999998 109.636 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.1 42.28 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.58 -1.122 . . . . 72.219999999999999 113.934 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.19 109.23 2.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.319 -2.104 . . . . 44.109999999999999 105.319 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.73 -0.98 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.602 1.561 . . . . 72.049999999999997 114.792 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -68.39 163.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.139 -0.975 . . . . 72.120000000000005 109.043 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.83 129.68 14.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.219 1.407 . . . . 71.129999999999995 110.364 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -84.37 163.94 19.23 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.633 1.573 . . . . 64.200000000000003 108.444 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -125.41 135.57 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.871 -1.529 . . . . 63.420000000000002 106.871 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.83 165.15 8.97 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.304 0.573 . . . . 74.010000000000005 110.609 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE2' ' HG2' ' A' ' 4' ' ' MET . 10.2 mptt -73.88 103.19 4.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.089 -1.448 . . . . 70.0 107.089 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -136.62 158.28 44.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.953 2.101 . . . . 73.230000000000004 107.846 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.51 102.11 11.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 104.033 -2.58 . . . . 71.150000000000006 104.033 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -83.97 142.14 30.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.576 -1.268 . . . . 74.430000000000007 107.576 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD11 HG23 ' B' ' 343' ' ' ILE . 5.0 mp -129.97 123.35 30.43 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 117.921 -1.038 . . . . 74.120000000000005 108.844 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.57 143.01 28.11 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 117.787 -1.101 . . . . 73.329999999999998 112.785 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.81 141.28 48.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.268 1.978 . . . . 73.230000000000004 108.481 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 t -59.25 -12.68 5.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.936 2.494 . . . . 45.350000000000001 113.303 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.71 -27.16 17.42 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 115.528 1.677 . . . . 75.319999999999993 115.528 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.55 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.031 1.287 . . . . 74.310000000000002 110.184 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.9 p -107.28 160.17 15.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.987 0.915 . . . . 53.450000000000003 111.053 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.12 -38.13 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.458 1.503 . . . . 64.150000000000006 111.465 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.05 91.93 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.556 0.743 . . . . 72.230000000000004 110.778 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.62 -42.37 95.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.017 0.927 . . . . 73.439999999999998 109.742 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.45 -46.2 89.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.833 -0.803 . . . . 73.439999999999998 108.833 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.5 ttp -60.51 -42.36 96.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.574 0.75 . . . . 64.450000000000003 110.581 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -61.25 -40.31 93.61 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.49 0.716 . . . . 73.230000000000004 109.915 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.433 HG21 ' CG1' ' B' ' 346' ' ' VAL . 34.9 mt -66.18 -51.01 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 118.511 -0.757 . . . . 74.140000000000001 109.326 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.7 mt -55.15 -49.98 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.142 0.883 . . . . 72.219999999999999 110.339 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.54 -38.71 88.42 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.017 -1.052 . . . . 74.420000000000002 111.328 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.712 0.687 . . . . 65.129999999999995 110.063 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -61.83 -51.33 68.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.507 1.123 . . . . 72.329999999999998 109.888 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.11 5.86 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.002 0.371 . . . . 74.019999999999996 112.002 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 46.21 63.4 1.87 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 127.634 2.374 . . . . 70.430000000000007 110.651 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 108.58 3.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.97 1.308 . . . . 71.400000000000006 110.877 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.31 158.65 36.98 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.116 3.21 . . . . 62.210000000000001 110.955 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -26.78 55.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.801 0.84 . . . . 54.439999999999998 112.757 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.91 -34.48 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.153 0.981 . . . . 64.310000000000002 111.501 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 164.29 11.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.912 1.233 . . . . 53.149999999999999 108.106 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.65 175.27 5.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.628 1.171 . . . . 73.230000000000004 107.98 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -148.34 130.12 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.512 0.725 . . . . 75.239999999999995 111.617 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -141.53 148.28 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.454 1.101 . . . . 74.120000000000005 110.213 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.9 152.18 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.569 1.948 . . . . 64.310000000000002 108.098 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -144.42 126.87 15.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.444 1.498 . . . . 71.109999999999999 108.347 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 85' ' ' PRO . 14.6 p -126.66 124.55 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.326 1.05 . . . . 70.329999999999998 108.457 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 43.83 38.44 2.1 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.162 1.385 . . . . 73.420000000000002 113.898 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttm 65.05 39.94 5.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.83 2.052 . . . . 74.140000000000001 111.063 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 p -141.25 156.61 45.87 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.163 0.985 . . . . 72.120000000000005 110.048 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.07 104.0 33.49 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 102.837 -3.023 . . . . 63.200000000000003 102.837 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.423 ' HD3' HG12 ' A' ' 80' ' ' VAL . 55.1 Cg_endo -68.59 147.18 69.71 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.554 2.17 . . . . 75.340000000000003 110.722 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -70.69 120.89 16.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.799 -1.185 . . . . 62.310000000000002 107.799 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 p -51.84 -34.92 42.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.374 1.469 . . . . 52.130000000000003 113.813 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -83.68 -6.42 59.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.36 0.874 . . . . 53.299999999999997 113.36 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.73 144.58 54.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.678 1.126 . . . . 75.109999999999999 108.141 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.17 149.88 25.87 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.888 -0.782 . . . . 64.409999999999997 108.888 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.57 -50.75 64.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.264 1.025 . . . . 54.399999999999999 112.249 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.67 96.97 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 118.854 0.752 . . . . 75.340000000000003 112.378 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -62.07 -53.39 56.14 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.833 0.853 . . . . 74.420000000000002 109.261 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.02 -44.92 87.57 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.993 0.917 . . . . 71.540000000000006 110.231 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -60.31 -51.97 67.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.611 1.164 . . . . 73.420000000000002 108.994 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -35.91 74.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.205 -0.902 . . . . 62.530000000000001 112.747 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -24.41 20.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.735 -1.126 . . . . 74.430000000000007 113.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -107.21 5.3 27.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.566 1.076 . . . . 74.5 112.993 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -48.82 127.65 14.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.22 1.808 . . . . 72.450000000000003 113.513 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.46 175.22 10.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.49 0.716 . . . . 73.420000000000002 109.121 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -60.53 -30.47 69.77 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.225 -1.547 . . . . 75.150000000000006 110.886 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.28 16.78 12.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.502 1.121 . . . . 61.350000000000001 112.283 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.06 28.59 69.14 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.198 -1.335 . . . . 64.439999999999998 114.946 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -126.42 177.05 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.647 1.724 . . . . 73.099999999999994 111.472 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -123.43 135.32 54.04 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.491 1.116 . . . . 74.230000000000004 109.986 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -122.66 127.64 49.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.189 1.396 . . . . 70.109999999999999 107.698 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.3 t -129.2 149.02 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 120.505 -1.372 . . . . 70.420000000000002 109.457 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.68 150.97 37.29 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.753 -1.573 . . . . 64.150000000000006 106.753 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.27 151.92 46.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.097 0.862 . . . . 64.239999999999995 111.324 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.2 p -142.88 171.83 13.52 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.451 0.643 . . . . 72.230000000000004 111.262 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.62 9.18 21.89 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.597 1.57 . . . . 72.439999999999998 112.308 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.45 -0.443 0 C-N-CA 126.343 1.857 . . . . 73.319999999999993 107.968 -178.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 119.542 -0.266 . . . . 64.420000000000002 110.761 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 18.3 m95 52.93 55.93 8.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.0 0.92 . . . . 74.340000000000003 110.316 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.49 128.35 8.44 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.308 -1.517 . . . . 62.420000000000002 109.308 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 50' ' ' LEU . 93.8 mt -61.94 133.62 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 126.903 2.081 . . . . 74.109999999999999 106.914 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.84 104.82 5.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.074 -1.454 . . . . 74.439999999999998 107.074 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.5 114.76 19.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.632 1.173 . . . . 73.239999999999995 107.882 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 63' ' ' ILE . 53.5 t -122.04 150.42 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.426 1.091 . . . . 72.109999999999999 110.723 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -162.89 161.72 25.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.904 2.482 . . . . 62.340000000000003 107.04 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.657 -1.609 . . . . 74.310000000000002 106.657 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 105.399 -2.074 . . . . 71.129999999999995 105.399 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 46' ' ' LYS . 9.5 mtp -56.38 -46.29 80.16 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.966 -0.754 . . . . 72.030000000000001 108.966 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -57.18 -43.56 82.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.458 0.703 . . . . 71.019999999999996 112.401 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -37.73 87.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.469 0.577 . . . . 72.400000000000006 110.689 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -67.37 -48.2 68.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.487 -0.931 . . . . 75.219999999999999 108.487 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.84 -76.9 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.118 1.767 . . . . 53.539999999999999 113.092 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.75 120.13 2.32 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.207 2.203 . . . . 73.549999999999997 108.692 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -131.48 -35.17 1.33 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 116.979 -1.486 . . . . 74.010000000000005 114.119 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.67 -60.4 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 121.872 2.124 . . . . 71.319999999999993 112.214 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.86 -32.58 73.95 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.519 -0.738 . . . . 73.329999999999998 110.721 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -57.09 -59.23 5.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.033 -1.099 . . . . 73.540000000000006 108.033 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -39.65 95.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.589 1.156 . . . . 73.219999999999999 109.691 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -56.05 -58.03 9.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.758 1.163 . . . . 65.349999999999994 111.658 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.95 -42.99 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.83 0.852 . . . . 74.030000000000001 110.106 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.21 -47.64 84.6 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.523 -0.751 . . . . 75.409999999999997 109.96 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.7 t -58.53 -49.6 76.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.139 -1.06 . . . . 73.340000000000003 108.139 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.49 73.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.98 0.809 . . . . 73.019999999999996 112.771 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.74 -39.25 84.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 O-C-N 120.535 -1.353 . . . . 74.209999999999994 112.17 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.8 -42.13 82.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 O-C-N 120.762 -1.211 . . . . 73.049999999999997 108.897 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -67.07 -32.36 73.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.7 1.136 . . . . 74.549999999999997 110.96 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.0 -47.49 24.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.238 -0.411 . . . . 60.43 110.529 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -78.49 -44.03 25.49 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.591 1.701 . . . . 75.109999999999999 115.591 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.73 72.86 81.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.598 1.959 . . . . 73.439999999999998 109.789 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.41 -26.09 76.51 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.433 2.089 . . . . 64.200000000000003 111.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.37 12.07 17.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.161 -0.447 . . . . 64.439999999999998 111.564 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -123.46 139.07 54.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.737 1.153 . . . . 73.420000000000002 108.213 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -107.18 143.83 27.92 Favored Pre-proline 0 C--O 1.249 1.026 0 C-N-CA 123.703 0.801 . . . . 64.120000000000005 110.374 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.52 117.37 3.38 Favored 'Trans proline' 0 C--N 1.355 0.903 1 C-N-CA 125.888 4.392 . . . . 50.43 112.885 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 146.91 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.397 1.079 . . . . 73.439999999999998 110.611 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.16 135.41 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 104.459 -2.423 . . . . 72.0 104.459 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -123.13 111.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.443 -1.688 . . . . 51.0 106.443 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -128.13 150.42 49.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.195 0.452 . . . . 74.340000000000003 110.788 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.76 132.91 34.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.019 -0.734 . . . . 74.109999999999999 109.019 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.83 116.86 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.72 -1.585 . . . . 75.239999999999995 106.72 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 m -53.76 125.34 18.08 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.8 0.727 . . . . 43.240000000000002 109.683 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.97 -3.18 35.58 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.285 1.421 . . . . 72.150000000000006 112.642 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.8 m -89.92 127.69 36.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.9 1.35 . . . . 71.349999999999994 108.288 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.57 -18.87 62.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 118.453 -0.784 . . . . 61.420000000000002 111.708 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.46 156.51 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.065 0.848 . . . . 74.310000000000002 111.158 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.0 m -52.28 125.76 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.656 0.782 . . . . 63.340000000000003 109.996 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.38 172.47 9.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.603 1.161 . . . . 74.439999999999998 108.876 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -125.85 150.88 31.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 123.766 0.826 . . . . 75.400000000000006 110.415 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.34 165.37 24.63 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.788 -1.56 . . . . 52.450000000000003 106.788 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 4' ' ' MET . 1.0 OUTLIER -74.76 105.75 5.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.03 -1.841 . . . . 74.299999999999997 106.03 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -134.11 163.74 28.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.873 0.844 . . . . 72.140000000000001 112.508 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -105.55 106.95 17.69 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 103.001 -2.962 . . . . 75.329999999999998 103.001 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.04 127.05 37.37 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.604 -1.628 . . . . 74.310000000000002 106.604 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.45 112.55 21.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.897 1.679 . . . . 62.549999999999997 108.092 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 142.83 27.7 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-N 119.565 1.075 . . . . 62.149999999999999 110.525 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.91 132.32 21.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.317 2.012 . . . . 75.120000000000005 108.698 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -58.73 -12.61 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.441 1.897 . . . . 63.140000000000001 113.123 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.99 -34.46 50.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 60.219999999999999 114.141 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 170.49 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.734 1.012 . . . . 62.409999999999997 113.734 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -102.63 167.35 9.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.998 1.719 . . . . 73.319999999999993 112.529 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.23 -35.87 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.965 0.906 . . . . 72.140000000000001 109.247 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.25 91.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.901 0.773 . . . . 64.439999999999998 110.362 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -63.85 -45.76 88.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.746 -0.835 . . . . 75.5 108.746 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD2' HG11 ' A' ' 51' ' ' VAL . 6.2 t80 -59.64 -48.91 79.79 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.8 -0.444 . . . . 73.540000000000006 109.8 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.9 ttt -55.89 -51.98 65.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.365 1.466 . . . . 74.409999999999997 110.114 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -58.27 -41.64 84.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.727 0.811 . . . . 73.5 109.042 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.583 HG21 HG13 ' B' ' 346' ' ' VAL . 21.1 mt -66.87 -45.2 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 120.828 1.649 . . . . 75.319999999999993 109.323 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.59 -50.81 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 120.588 1.54 . . . . 61.240000000000002 110.554 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -31.91 73.12 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.161 -0.962 . . . . 74.329999999999998 111.531 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -68.95 -48.51 63.03 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.537 -0.542 . . . . 74.420000000000002 109.537 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -59.98 -51.38 69.89 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 126.926 2.091 . . . . 75.420000000000002 111.51 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.23 3.65 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 122.379 -0.2 . . . . 74.5 110.961 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 44.24 63.34 1.67 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 126.849 2.06 . . . . 71.310000000000002 109.503 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.22 111.19 5.98 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.993 -1.114 . . . . 71.109999999999999 107.993 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.71 165.43 27.67 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 125.177 3.918 . . . . 75.510000000000005 114.309 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -26.67 67.66 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.356 0.662 . . . . 54.340000000000003 111.411 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.64 -47.07 79.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.347 0.869 . . . . 70.310000000000002 113.347 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -100.3 165.35 11.51 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.169 0.895 . . . . 72.140000000000001 113.158 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.05 -178.63 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.596 1.958 . . . . 43.140000000000001 107.148 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 tp -137.47 135.55 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.664 -1.606 . . . . 70.430000000000007 106.664 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.79 130.25 33.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.705 -1.591 . . . . 74.209999999999994 106.705 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.43 146.32 40.77 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.084 1.754 . . . . 72.409999999999997 107.821 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.62 128.28 19.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.893 1.277 . . . . 64.400000000000006 108.501 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.23 123.83 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 107.632 -1.248 . . . . 63.25 107.632 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 47.92 38.27 8.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.11 0.964 . . . . 73.200000000000003 111.813 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 23.05 11.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.272 1.429 . . . . 72.150000000000006 112.947 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 162.8 21.32 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.978 1.711 . . . . 54.539999999999999 112.352 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.14 103.46 12.07 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.823 2.449 . . . . 75.319999999999993 106.901 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.37 123.68 7.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.75 2.3 . . . . 74.400000000000006 111.887 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 88' ' ' SER . 8.4 tt0 -63.81 127.62 32.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.569 -1.271 . . . . 64.319999999999993 107.569 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.4 p -57.23 -28.44 62.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.246 1.419 . . . . 74.129999999999995 112.881 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.468 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 25.1 t -85.24 -4.79 59.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.387 1.475 . . . . 53.240000000000002 112.064 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.5 tp -76.51 143.93 40.11 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.439 -1.413 . . . . 74.040000000000006 107.632 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 m -84.85 152.42 23.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.456 -0.572 . . . . 52.450000000000003 109.456 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.64 -51.89 67.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.149 0.98 . . . . 74.140000000000001 110.198 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.63 -45.02 60.23 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.528 0.604 . . . . 51.43 111.655 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -66.97 -49.11 66.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.63 0.772 . . . . 72.109999999999999 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.91 -42.39 97.96 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.641 -0.662 . . . . 73.010000000000005 110.476 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.07 -57.89 8.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.949 1.699 . . . . 75.0 109.455 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.07 -27.69 69.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 118.56 -0.733 . . . . 73.010000000000005 112.868 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -38.85 12.75 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.863 -1.065 . . . . 74.030000000000001 113.118 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -88.02 -8.78 55.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 117.838 -1.077 . . . . 41.399999999999999 113.123 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -33.32 120.83 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.399 1.629 . . . . 63.219999999999999 115.399 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.84 177.21 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.057 1.743 . . . . 72.420000000000002 109.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -35.1 56.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.025 -1.672 . . . . 73.400000000000006 112.056 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -95.62 10.9 35.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.747 1.219 . . . . 74.420000000000002 111.786 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.73 60.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.462 1.506 . . . . 61.340000000000003 115.151 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -105.07 163.67 12.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.031 1.415 . . . . 64.420000000000002 109.133 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.9 tp -120.67 134.81 55.25 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.352 0.661 . . . . 63.039999999999999 109.709 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.71 121.91 37.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.889 0.876 . . . . 74.439999999999998 108.982 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.07 137.9 54.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 107.826 -1.176 . . . . 71.109999999999999 107.826 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.06 152.1 29.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.224 1.01 . . . . 64.420000000000002 108.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -140.24 161.19 38.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.556 0.947 . . . . 64.409999999999997 113.556 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.4 t -159.05 173.35 16.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.956 1.702 . . . . 72.430000000000007 108.947 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.24 17.26 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.65 2.548 . . . . 63.310000000000002 112.493 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 C--O 1.235 0.329 0 C-N-CA 126.326 1.85 . . . . 75.230000000000004 109.196 -178.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 119.308 -0.377 . . . . 71.430000000000007 111.545 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 62.9 m95 58.15 66.03 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.209 1.404 . . . . 72.340000000000003 110.362 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -83.98 136.12 14.49 Favored Glycine 0 C--N 1.344 0.996 0 O-C-N 121.535 -0.728 . . . . 73.319999999999993 111.387 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.35 125.28 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.46 1.904 . . . . 72.120000000000005 107.722 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -139.88 130.03 25.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.283 1.033 . . . . 75.340000000000003 108.249 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.14 127.11 52.75 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.201 -0.937 . . . . 73.049999999999997 110.579 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 63' ' ' ILE . 1.9 t -121.48 117.52 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 125.05 1.34 . . . . 63.439999999999998 107.812 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 22.8 p -162.15 126.39 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 104.943 -2.243 . . . . 51.439999999999998 104.943 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.135 2.174 . . . . 52.149999999999999 111.899 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 17.1 ptt? . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.787 -0.82 . . . . 65.239999999999995 108.787 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . 164.63 169.19 27.89 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.031 -2.028 . . . . 71.400000000000006 108.031 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -103.21 105.51 15.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.894 0.854 . . . . 64.019999999999996 109.143 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tpt -55.97 -46.74 78.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 113.941 -1.481 . . . . 75.239999999999995 109.35 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -59.01 -50.32 74.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.046 0.938 . . . . 75.310000000000002 111.747 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -65.05 -27.31 68.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 125.549 1.539 . . . . 71.120000000000005 111.672 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -74.67 -47.94 28.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.536 -0.913 . . . . 64.219999999999999 108.536 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -74.95 0.15 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.58 1.152 . . . . 72.549999999999997 113.086 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -158.98 122.26 3.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 105.815 -1.92 . . . . 63.140000000000001 105.815 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -130.73 -65.14 0.8 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.66 -1.162 . . . . 73.340000000000003 112.686 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.5 mt -39.85 -57.12 1.64 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.562 1.689 . . . . 74.439999999999998 115.562 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.38 -52.71 51.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.254 -0.904 . . . . 64.230000000000004 110.073 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.553 ' CD2' HH21 ' A' ' 14' ' ' ARG . 6.6 t60 -54.37 -55.22 30.8 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.315 1.446 . . . . 74.219999999999999 111.39 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.553 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.0 mmp_? -58.53 -39.88 81.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 116.495 -1.717 . . . . 71.010000000000005 109.031 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 t -60.64 -55.38 33.98 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.246 1.384 . . . . 65.430000000000007 111.26 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.67 -47.88 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 117.974 0.352 . . . . 74.25 111.267 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -62.08 -39.88 93.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.626 -0.702 . . . . 72.209999999999994 110.805 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 t -59.73 -46.78 88.09 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.56 -1.274 . . . . 74.239999999999995 107.56 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -46.63 86.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.487 1.039 . . . . 55.399999999999999 112.251 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.23 -47.71 83.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.321 0.51 . . . . 71.200000000000003 110.747 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.13 -42.36 96.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 C-N-CA 123.923 0.889 . . . . 71.030000000000001 110.322 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -67.6 -40.26 84.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.955 1.252 . . . . 72.109999999999999 109.29 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.07 68.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.771 -0.58 . . . . 62.340000000000003 111.053 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -77.55 -46.72 21.44 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.599 0.963 . . . . 74.140000000000001 113.599 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -119.94 71.95 16.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.305 1.842 . . . . 72.340000000000003 111.024 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.28 -25.4 49.74 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.139 1.893 . . . . 71.0 112.644 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.21 11.92 21.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.488 0.715 . . . . 61.240000000000002 111.265 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -115.92 158.76 22.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.318 1.417 . . . . 74.040000000000006 109.539 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 m -119.68 129.92 25.11 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.621 1.568 . . . . 72.409999999999997 108.171 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.76 111.66 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.18 3.92 . . . . 74.319999999999993 112.694 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.12 151.45 20.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.306 1.442 . . . . 74.219999999999999 111.206 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.58 133.39 68.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 103.166 -2.901 . . . . 74.129999999999995 103.166 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.31 121.77 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.362 -0.828 . . . . 74.25 110.516 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.6 151.09 46.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.191 0.905 . . . . 61.340000000000003 111.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 123.46 31.75 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.764 1.626 . . . . 73.519999999999996 108.931 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.58 128.55 33.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 106.81 -1.552 . . . . 71.120000000000005 106.81 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 p -61.95 147.63 46.32 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.905 0.859 . . . . 72.030000000000001 112.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.91 -20.68 45.93 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 116.375 -2.347 . . . . 74.319999999999993 116.415 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 160.9 25.06 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 122.041 2.921 . . . . 72.129999999999995 110.668 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -72.86 -13.0 61.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.953 2.205 . . . . 62.420000000000002 116.953 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.07 162.59 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 120.595 1.543 . . . . 64.340000000000003 114.548 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.2 152.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.173 1.389 . . . . 73.120000000000005 109.578 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -81.1 169.15 17.79 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.016 0.526 . . . . 74.420000000000002 111.417 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -125.61 142.0 43.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.961 1.305 . . . . 73.140000000000001 111.485 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.12 161.49 30.55 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.889 2.076 . . . . 71.439999999999998 107.986 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -84.2 98.26 9.84 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.768 -2.308 . . . . 75.310000000000002 104.768 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 13.5 mmm180 -136.02 159.13 42.64 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.763 0.71 . . . . 73.230000000000004 111.459 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HE3' HG12 ' B' ' 343' ' ' ILE . 2.4 mtmp? -106.25 99.01 8.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.583 1.553 . . . . 71.420000000000002 107.064 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.43 120.76 26.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.922 0.889 . . . . 70.439999999999998 110.337 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.79 105.46 14.69 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.972 1.309 . . . . 71.530000000000001 108.021 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.51 143.16 27.23 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-O 118.227 -0.892 . . . . 72.530000000000001 112.143 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.16 138.82 57.92 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.369 2.046 . . . . 64.430000000000007 110.329 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.0 p -63.61 -15.75 59.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.803 1.641 . . . . 62.100000000000001 112.431 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -75.07 -35.59 61.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.027 1.731 . . . . 74.109999999999999 113.712 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.06 165.54 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.866 0.841 . . . . 73.409999999999997 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -99.87 165.35 11.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.783 0.833 . . . . 62.5 110.905 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.25 -35.6 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.676 1.19 . . . . 75.230000000000004 108.143 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.77 88.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.966 1.306 . . . . 74.340000000000003 110.447 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.97 -45.63 66.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.373 -0.822 . . . . 64.430000000000007 110.006 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 6.4 t80 -59.07 -48.54 81.21 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.858 0.754 . . . . 70.409999999999997 109.483 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.2 ttp -55.19 -51.37 66.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.766 0.826 . . . . 75.019999999999996 109.949 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.96 -38.94 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.432 -0.318 . . . . 72.140000000000001 110.436 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' B' ' 346' ' ' VAL . 38.0 mt -66.38 -43.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 116.997 -1.477 . . . . 73.450000000000003 110.367 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 83.8 mt -58.86 -50.81 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 120.636 1.562 . . . . 65.120000000000005 108.417 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -61.93 -39.62 92.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 119.91 -0.716 . . . . 74.519999999999996 112.616 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -66.93 -40.39 87.58 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.246 0.93 . . . . 74.140000000000001 110.392 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.43 -47.24 86.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 121.348 -0.845 . . . . 71.420000000000002 110.054 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -81.48 -1.24 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.837 0.68 . . . . 74.510000000000005 112.837 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 57.5 58.04 4.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.346 2.258 . . . . 73.230000000000004 112.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.27 108.13 2.55 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.073 0.949 . . . . 75.230000000000004 111.644 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.08 156.67 64.4 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 51.140000000000001 111.296 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.1 m -63.29 -13.97 44.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.696 -0.668 . . . . 74.439999999999998 112.463 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -37.37 76.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.863 1.21 . . . . 71.549999999999997 109.686 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -103.25 164.25 11.75 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.508 1.049 . . . . 70.519999999999996 111.059 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.18 170.79 7.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.044 1.738 . . . . 64.409999999999997 106.843 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 tt -151.62 129.78 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.915 -1.143 . . . . 75.219999999999999 107.915 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.26 147.76 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.889 1.275 . . . . 62.109999999999999 109.145 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.9 mt -114.16 154.59 27.57 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.152 1.381 . . . . 71.129999999999995 109.435 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -145.15 139.83 27.54 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.797 1.239 . . . . 70.439999999999998 108.533 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.37 128.81 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 106.035 -1.839 . . . . 73.420000000000002 106.035 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 45.96 37.13 3.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.447 1.022 . . . . 75.219999999999999 112.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.0 tptt 68.02 22.1 8.6 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.571 0.952 . . . . 74.209999999999994 113.571 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 p -127.28 162.16 26.89 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.985 1.714 . . . . 52.200000000000003 111.191 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.56 108.01 53.78 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 104.096 -2.557 . . . . 73.299999999999997 104.096 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.09 148.72 51.08 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.877 1.718 . . . . 74.400000000000006 111.881 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.41 117.97 16.83 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.94 1.296 . . . . 73.109999999999999 108.329 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 p -51.28 -38.79 54.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.134 1.373 . . . . 64.140000000000001 112.953 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -74.36 -12.36 60.5 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.755 1.02 . . . . 72.099999999999994 113.755 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.61 150.62 47.77 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.552 -1.343 . . . . 73.120000000000005 109.631 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.92 26.57 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.162 0.985 . . . . 60.43 110.798 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.8 mmt -57.2 -47.33 81.55 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.841 0.856 . . . . 74.329999999999998 111.063 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.58 96.59 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.526 -0.597 . . . . 61.310000000000002 113.138 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -67.76 -51.0 54.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.948 0.874 . . . . 75.310000000000002 110.508 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.47 -35.84 80.61 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.068 -0.716 . . . . 71.150000000000006 109.068 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -66.26 -57.19 8.09 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.428 -0.796 . . . . 72.530000000000001 108.906 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.7 -41.97 87.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.43 1.013 . . . . 74.319999999999993 112.734 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -32.9 65.48 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 118.398 -0.811 . . . . 73.030000000000001 111.73 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.59 7.09 44.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.071 0.85 . . . . 73.409999999999997 112.584 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.29 119.54 3.04 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 126.783 2.033 . . . . 61.100000000000001 109.13 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.54 175.69 9.59 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.725 0.639 . . . . 72.129999999999995 112.725 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.15 -25.41 61.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.172 1.389 . . . . 75.340000000000003 110.498 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -102.42 4.98 39.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.215 1.806 . . . . 73.230000000000004 111.248 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.23 28.93 69.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.511 -1.16 . . . . 72.409999999999997 114.78 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -123.78 168.62 12.49 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.352 1.576 . . . . 64.340000000000003 109.125 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tp -122.02 139.97 53.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.511 1.124 . . . . 74.319999999999993 110.58 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -113.84 115.72 28.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.305 1.442 . . . . 74.340000000000003 109.489 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.9 t -123.54 131.53 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 O-C-N 120.746 -1.221 . . . . 54.100000000000001 108.592 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.59 151.83 31.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.983 -1.117 . . . . 74.340000000000003 107.983 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -131.04 154.42 48.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 122.607 0.363 . . . . 74.549999999999997 110.588 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.8 m -140.39 155.1 46.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.489 -0.93 . . . . 61.020000000000003 108.489 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.28 27.07 13.2 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.69 1.138 . . . . 43.149999999999999 111.509 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -143.8 152.32 41.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.341 2.656 . . . . 72.329999999999998 106.473 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -89.3 -28.21 20.02 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.114 0.566 . . . . 62.439999999999998 111.837 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.92 108.59 14.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.987 -1.486 . . . . 74.409999999999997 106.987 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -79.74 7.85 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.324 1.45 . . . . 72.120000000000005 111.888 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 104.417 -3.473 . . . . 63.329999999999998 104.417 -178.296 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.027 -1.229 . . . . 42.119999999999997 110.027 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 40.72 60.73 1.85 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.399 1.88 . . . . 72.219999999999999 112.065 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 70.8 mtm -82.73 48.17 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.759 0.824 . . . . 64.209999999999994 109.147 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.16 52.54 0.13 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 130.21 3.404 . . . . 72.420000000000002 110.082 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 37.0 pt -49.66 144.33 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 C-N-CA 125.453 1.501 . . . . 45.439999999999998 111.266 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 1.4 pp -73.39 -0.43 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.046 0.539 . . . . 71.430000000000007 111.646 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -102.16 26.55 7.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.328 2.251 . . . . 60.25 113.463 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -54.28 124.01 14.59 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.529 1.058 . . . . 70.340000000000003 109.183 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.53 -59.42 2.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.289 0.95 . . . . 74.310000000000002 108.562 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.75 122.29 28.91 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 105.483 -2.043 . . . . 73.230000000000004 105.483 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.58 -61.92 1.67 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.24 1.941 . . . . 70.120000000000005 116.24 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 73.2 m95 67.43 65.0 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.539 1.518 . . . . 73.439999999999998 112.106 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -82.23 139.08 19.4 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.91 -1.276 . . . . 54.240000000000002 109.91 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . 0.439 HG12 ' HE3' ' A' ' 48' ' ' LYS . 24.3 mt -75.43 134.7 28.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 118.444 1.122 . . . . 73.140000000000001 111.317 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -140.7 114.4 8.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.313 0.645 . . . . 74.349999999999994 111.582 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.56 120.03 24.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 105.544 -2.021 . . . . 63.200000000000003 105.544 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 63' ' ' ILE . 92.5 t -122.4 142.38 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.404 0.682 . . . . 75.400000000000006 109.621 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.7 p -161.95 149.0 14.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.646 1.578 . . . . 24.329999999999998 107.777 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.356 2.262 . . . . 65.409999999999997 105.379 178.594 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tpt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.248 -0.649 . . . . 74.349999999999994 109.248 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.65 136.16 0.31 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.788 1.185 . . . . 65.0 114.197 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -106.92 105.77 15.97 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.176 0.99 . . . . 65.340000000000003 109.437 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -45.68 75.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.423 0.63 . . . . 74.109999999999999 110.845 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -60.07 -42.35 94.37 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.53 -0.731 . . . . 75.420000000000002 112.208 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -70.3 -32.02 69.61 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.043 0.537 . . . . 72.230000000000004 109.909 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.14 -47.94 69.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.279 -1.008 . . . . 72.519999999999996 108.279 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -71.1 -76.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.422 1.889 . . . . 72.219999999999999 111.485 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.94 126.24 3.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.695 1.198 . . . . 64.019999999999996 108.101 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.2 p -124.02 -65.6 1.05 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 116.562 -1.685 . . . . 63.210000000000001 112.664 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 tp -42.46 -58.33 2.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.457 1.481 . . . . 65.019999999999996 114.159 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -60.16 -52.05 66.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.562 0.696 . . . . 72.340000000000003 110.632 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -54.1 -49.1 69.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.318 1.847 . . . . 74.140000000000001 111.599 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -39.82 91.61 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.018 1.727 . . . . 64.340000000000003 109.458 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.3 m -61.42 -47.18 86.93 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.656 1.116 . . . . 61.420000000000002 110.753 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.21 -47.29 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.04 -1.038 . . . . 72.040000000000006 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 21' ' ' ILE . 37.4 tt0 -58.29 -52.0 67.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.76 1.224 . . . . 70.530000000000001 111.615 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 t -61.04 -48.4 81.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.873 0.869 . . . . 73.299999999999997 109.926 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.87 -47.74 73.85 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.147 0.885 . . . . 62.229999999999997 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.04 -41.61 77.44 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.53 -0.731 . . . . 60.530000000000001 111.552 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 17' ' ' GLU . 68.8 mt -64.47 -41.33 92.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.008 -0.996 . . . . 70.140000000000001 108.947 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mmm-85 -63.45 -41.44 98.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 120.284 1.402 . . . . 62.310000000000002 108.473 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.22 72.74 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.452 0.538 . . . . 62.350000000000001 112.452 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -76.82 -46.21 25.72 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 114.191 1.182 . . . . 64.230000000000004 114.191 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -133.79 79.22 58.85 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 125.02 1.328 . . . . 64.25 111.101 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 -20.38 47.96 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.525 1.484 . . . . 41.020000000000003 109.675 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.47 12.33 16.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.971 1.308 . . . . 62.439999999999998 112.4 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -127.75 141.41 51.6 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 119.196 0.907 . . . . 63.420000000000002 108.672 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.32 137.29 19.88 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 54.210000000000001 108.01 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.76 111.93 2.59 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.671 3.581 . . . . 74.239999999999995 113.843 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.89 135.6 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.458 1.103 . . . . 51.030000000000001 110.65 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.86 115.14 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 104.454 -2.424 . . . . 71.549999999999997 104.454 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.56 126.79 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.629 1.172 . . . . 73.439999999999998 109.284 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.82 149.13 48.86 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.378 1.071 . . . . 74.319999999999993 109.651 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -83.73 141.15 31.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.234 -1.025 . . . . 71.400000000000006 108.234 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.23 124.55 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 103.093 -2.929 . . . . 45.299999999999997 103.093 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.0 141.24 54.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.646 -0.659 . . . . 64.409999999999997 110.283 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.0 -1.84 78.44 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 116.13 -2.483 . . . . 61.340000000000003 113.655 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 t -83.95 145.07 28.75 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 121.575 2.688 . . . . 65.340000000000003 109.283 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.03 -20.16 64.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.976 1.71 . . . . 70.319999999999993 112.108 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.59 158.23 3.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.321 1.057 . . . . 70.219999999999999 113.441 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.52 134.54 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.129 -1.804 . . . . 74.340000000000003 106.129 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.24 171.98 14.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.859 1.664 . . . . 74.239999999999995 109.058 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 tt -126.64 152.02 33.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 123.742 0.817 . . . . 64.239999999999995 110.431 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.43 161.53 27.91 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.022 1.329 . . . . 73.049999999999997 109.141 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -77.89 91.05 4.13 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.209 -0.663 . . . . 74.310000000000002 109.209 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 14.3 mmm180 -131.34 151.92 51.07 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 106.548 -1.649 . . . . 72.409999999999997 106.548 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -99.98 106.35 18.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.729 -1.211 . . . . 64.329999999999998 107.729 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -87.98 121.07 29.95 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 122.401 1.096 . . . . 64.140000000000001 113.072 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.92 112.52 24.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.762 2.025 . . . . 73.099999999999994 108.246 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 m -111.34 142.03 25.62 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.074 -0.965 . . . . 75.230000000000004 110.704 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.02 139.25 38.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 120.86 1.343 . . . . 61.039999999999999 110.889 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 p -65.57 -12.77 56.04 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.85 1.26 . . . . 62.140000000000001 112.145 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.88 -35.37 43.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.166 1.786 . . . . 70.120000000000005 113.965 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -74.53 170.24 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.957 0.884 . . . . 73.430000000000007 111.444 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 p -97.8 162.84 13.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.896 1.278 . . . . 65.25 111.451 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.21 -35.28 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.368 1.067 . . . . 64.030000000000001 108.129 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.31 90.25 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.82 0.848 . . . . 50.43 109.682 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -62.95 -46.06 89.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.182 -0.673 . . . . 75.030000000000001 109.182 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -59.38 -51.08 71.46 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.983 -0.377 . . . . 65.430000000000007 109.983 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.42 -47.99 72.15 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.596 1.158 . . . . 62.409999999999997 109.619 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -59.79 -44.67 93.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.594 -0.521 . . . . 75.340000000000003 109.594 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.6 mt -62.95 -40.28 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.63 -1.176 . . . . 74.140000000000001 109.453 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.17 -50.15 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.955 1.707 . . . . 74.239999999999995 108.906 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -63.66 -35.25 79.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.787 0.722 . . . . 54.549999999999997 111.16 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -66.89 -43.61 82.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.794 0.724 . . . . 64.340000000000003 109.198 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.59 -49.16 78.64 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.866 1.266 . . . . 71.329999999999998 111.341 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -80.39 0.65 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.026 0.204 . . . . 71.319999999999993 110.781 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 49.46 64.4 1.76 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.618 1.967 . . . . 73.430000000000007 110.016 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.14 111.39 7.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.296 1.438 . . . . 54.229999999999997 111.01 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -69.66 152.9 69.91 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.998 2.465 . . . . 73.109999999999999 109.94 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 m -62.2 -15.38 46.12 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.809 1.04 . . . . 60.539999999999999 113.809 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.16 -32.07 66.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.516 0.726 . . . . 73.25 110.431 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.37 164.33 11.71 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 122.073 0.94 . . . . 72.140000000000001 109.861 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.28 4.79 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.934 1.694 . . . . 74.200000000000003 107.49 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 tp -139.63 138.23 39.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.99 -1.855 . . . . 41.32 105.99 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -144.08 133.14 22.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.371 1.469 . . . . 75.109999999999999 107.17 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.5 mt -114.61 151.42 33.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.407 1.083 . . . . 52.020000000000003 108.172 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.0 142.49 29.83 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.709 1.204 . . . . 75.439999999999998 109.565 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.66 124.8 20.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 117.148 -1.406 . . . . 64.030000000000001 107.347 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t70 46.35 38.45 5.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 120.358 1.435 . . . . 72.030000000000001 110.882 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt 64.57 18.68 11.5 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.286 -1.509 . . . . 71.150000000000006 113.588 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 p -119.48 162.76 18.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.435 2.294 . . . . 65.030000000000001 111.234 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 t -101.39 107.84 52.61 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.97 1.308 . . . . 63.240000000000002 107.966 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.17 140.49 45.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.158 2.572 . . . . 74.299999999999997 109.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -77.63 121.81 24.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.506 0.722 . . . . 73.239999999999995 110.945 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.1 p -52.58 -35.45 54.04 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.758 1.223 . . . . 73.109999999999999 114.159 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -77.84 -17.3 57.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.624 0.972 . . . . 54.229999999999997 113.624 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.14 149.81 49.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.803 1.183 . . . . 54.100000000000001 109.787 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.6 p -85.98 152.38 22.98 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.767 0.794 . . . . 71.540000000000006 109.722 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.4 mmt -56.12 -43.43 78.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.181 0.992 . . . . 73.400000000000006 112.032 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.62 -36.8 83.95 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.563 -1.132 . . . . 75.439999999999998 113.288 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -66.49 -49.14 67.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.213 1.506 . . . . 74.430000000000007 107.739 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.07 -43.1 95.68 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.859 0.864 . . . . 72.310000000000002 110.102 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -59.55 -54.46 46.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.313 1.845 . . . . 71.420000000000002 108.991 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.14 -43.35 99.01 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.098 -0.641 . . . . 73.450000000000003 112.69 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.43 -32.38 60.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.895 1.072 . . . . 71.219999999999999 113.895 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -100.44 0.89 40.62 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.23 1.196 . . . . 74.239999999999995 114.23 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.49 121.54 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.635 1.574 . . . . 74.349999999999994 112.384 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.15 175.51 7.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.712 0.405 . . . . 73.540000000000006 109.978 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.64 -34.03 66.9 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.888 -1.133 . . . . 75.319999999999993 110.827 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.23 10.39 29.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.457 1.903 . . . . 45.340000000000003 112.186 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.97 -1.2 1.39 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.848 2.642 . . . . 54.020000000000003 114.264 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.42 170.83 15.48 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.023 1.411 . . . . 72.230000000000004 111.073 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.68 136.75 54.17 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.78 0.832 . . . . 74.25 111.075 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -122.18 122.91 40.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.889 1.676 . . . . 71.129999999999995 109.898 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.17 137.51 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.693 -1.254 . . . . 71.319999999999993 109.461 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.16 147.62 32.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.746 -1.205 . . . . 75.329999999999998 107.746 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.85 152.44 48.51 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.315 0.646 . . . . 61.420000000000002 110.641 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 t -147.29 163.55 36.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.495 0.718 . . . . 35.399999999999999 109.895 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.86 17.22 22.84 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.896 1.712 . . . . 55.219999999999999 113.654 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.69 150.61 42.08 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.076 1.75 . . . . 73.540000000000006 109.201 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -92.43 -13.63 29.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.731 1.212 . . . . 62.439999999999998 111.484 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 p -129.53 109.57 11.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.983 1.313 . . . . 44.25 111.264 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -97.07 9.55 41.77 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.375 2.27 . . . . 72.109999999999999 111.381 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.922 0 N-CA-C 106.624 -2.59 . . . . 73.239999999999995 106.624 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.43 0 N-CA-C 108.441 -1.864 . . . . 74.209999999999994 108.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -149.06 176.51 10.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.329 1.052 . . . . 42.130000000000003 109.322 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.3 36.77 3.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.761 1.624 . . . . 73.420000000000002 110.848 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.54 51.81 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.455 1.102 . . . . 63.140000000000001 108.379 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 40.6 pt -59.22 157.9 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 120.795 -1.19 . . . . 72.430000000000007 110.122 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . 0.41 HD12 ' H ' ' B' ' 335' ' ' ILE . 5.2 mp -64.45 -51.74 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.734 -1.58 . . . . 42.229999999999997 106.734 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -74.51 54.1 0.57 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.904 2.082 . . . . 73.230000000000004 111.108 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -52.37 129.63 28.98 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.421 -1.326 . . . . 75.200000000000003 107.421 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.45 -73.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.818 1.647 . . . . 75.010000000000005 113.151 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -77.98 136.17 37.93 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 108.208 -1.034 . . . . 64.120000000000005 108.208 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -62.73 1.43 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 128.08 2.552 . . . . 50.340000000000003 115.902 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 59.4 m95 51.96 52.21 14.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.883 1.673 . . . . 75.109999999999999 111.984 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . 0.448 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -84.48 130.49 9.82 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.789 -1.194 . . . . 41.25 111.498 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.78 132.39 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.956 1.702 . . . . 72.439999999999998 110.992 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.96 141.48 36.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.959 2.104 . . . . 52.119999999999997 110.961 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.15 124.02 37.9 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.061 -1.089 . . . . 62.299999999999997 108.061 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.97 109.97 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.678 1.191 . . . . 74.540000000000006 109.129 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 160.1 40.96 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.659 1.184 . . . . 74.319999999999993 110.694 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.277 1.031 . . . . 71.319999999999993 108.564 179.584 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 mtm . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 110.502 -0.184 . . . . 73.230000000000004 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.6 61.67 0.25 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 106.961 -2.456 . . . . 74.439999999999998 106.961 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -74.84 119.26 18.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.985 0.914 . . . . 63.219999999999999 112.099 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -35.19 77.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.22 -0.289 . . . . 72.209999999999994 110.22 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -59.68 -45.77 91.09 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.915 -1.116 . . . . 64.129999999999995 109.992 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -65.22 -33.98 77.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.842 0.857 . . . . 75.430000000000007 110.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.75 -45.29 92.68 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.023 0.929 . . . . 60.25 108.871 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.09 -75.48 0.3 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.146 0.978 . . . . 72.109999999999999 112.87 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 133.35 6.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.467 1.507 . . . . 74.319999999999993 109.504 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.4 t -130.65 -53.29 1.08 Allowed 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.787 -1.101 . . . . 24.440000000000001 109.551 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 tp -49.59 -59.94 3.32 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 115.232 1.567 . . . . 73.409999999999997 115.232 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.63 -58.87 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.249 0.931 . . . . 63.329999999999998 110.847 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CD2' HH21 ' A' ' 14' ' ' ARG . 2.0 t-160 -50.6 -50.33 54.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.885 1.674 . . . . 71.150000000000006 111.892 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.455 HH21 ' CD2' ' A' ' 13' ' ' HIS . 13.8 mmp_? -70.27 -42.04 72.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.721 -1.862 . . . . 73.409999999999997 110.734 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.14 -54.45 39.41 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.22 1.373 . . . . 74.109999999999999 110.015 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -47.64 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.027 1.331 . . . . 72.329999999999998 111.476 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.0 -42.59 99.89 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.85 -0.595 . . . . 62.439999999999998 109.837 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -55.34 -48.18 74.58 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.277 1.031 . . . . 74.140000000000001 108.681 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.62 72.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 0.598 . . . . 72.239999999999995 111.864 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.67 -45.61 91.99 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.971 -0.456 . . . . 72.239999999999995 110.887 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.4 -41.44 89.89 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 108.52 -0.919 . . . . 65.239999999999995 108.52 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -67.57 -29.82 69.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.39 1.45 . . . . 64.239999999999995 110.648 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.36 -47.44 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.681 -0.637 . . . . 71.319999999999993 110.076 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.99 -46.51 29.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.935 0.717 . . . . 63.420000000000002 112.935 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.91 73.65 70.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.773 2.029 . . . . 75.140000000000001 110.492 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.79 -18.37 47.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.162 2.575 . . . . 55.329999999999998 111.831 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.52 14.03 31.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.712 1.205 . . . . 52.340000000000003 111.839 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -123.53 152.37 41.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.77 0.828 . . . . 62.310000000000002 109.458 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 m -114.51 129.39 24.97 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.577 1.551 . . . . 71.310000000000002 108.525 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.66 116.99 3.89 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.22 3.947 . . . . 60.549999999999997 112.601 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.72 146.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.759 0.79 . . . . 43.350000000000001 109.455 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.36 112.77 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.486 -2.783 . . . . 73.129999999999995 103.486 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.33 127.71 61.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.198 -1.408 . . . . 63.229999999999997 107.198 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -128.08 143.61 51.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.226 0.611 . . . . 73.310000000000002 109.841 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.49 136.5 32.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.643 -0.873 . . . . 72.329999999999998 108.643 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -68.48 112.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.345 -1.354 . . . . 73.319999999999993 107.345 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.05 148.64 2.25 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.366 1.466 . . . . 63.450000000000003 111.345 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.23 -20.49 13.3 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 118.471 -1.183 . . . . 60.439999999999998 111.93 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -65.16 144.93 56.88 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.96 1.88 . . . . 44.020000000000003 110.346 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -70.67 -28.76 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.638 1.575 . . . . 65.140000000000001 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 42' ' ' VAL . 5.6 tp -59.79 157.34 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.369 0.668 . . . . 63.210000000000001 111.198 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' H ' HD12 ' A' ' 41' ' ' ILE . 33.7 m -63.46 138.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.178 -1.045 . . . . 42.240000000000002 108.178 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.82 177.58 6.05 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.927 1.691 . . . . 64.439999999999998 110.082 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.97 158.79 35.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.659 1.184 . . . . 73.319999999999993 109.936 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -78.92 166.19 22.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 128.278 2.631 . . . . 75.219999999999999 109.228 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HE2' ' OD1' ' B' ' 339' ' ' ASN . 9.2 mptt -80.88 80.85 7.28 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 104.009 -2.589 . . . . 71.530000000000001 104.009 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -135.04 145.11 47.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.023 -1.843 . . . . 73.150000000000006 106.023 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -92.02 144.29 25.6 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.558 1.143 . . . . 75.540000000000006 111.745 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.03 116.96 30.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.322 1.449 . . . . 61.130000000000003 107.518 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -108.12 110.32 21.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.981 1.313 . . . . 73.420000000000002 109.379 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -108.0 143.55 27.59 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 119.6 1.091 . . . . 71.239999999999995 112.808 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HG2' HG23 ' A' ' 55' ' ' ILE . 58.4 Cg_endo -64.87 138.83 59.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.911 2.407 . . . . 73.150000000000006 110.603 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.77 -16.47 58.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.656 -0.652 . . . . 74.530000000000001 112.301 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -26.21 59.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.459 1.904 . . . . 60.509999999999998 113.7 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.444 HG23 ' HG2' ' A' ' 52' ' ' PRO . 1.1 pp -80.91 170.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 122.11 0.957 . . . . 72.439999999999998 111.523 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -107.38 162.15 14.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.491 1.116 . . . . 62.409999999999997 109.6 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.3 t -52.36 -37.29 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.083 . . . . 71.540000000000006 108.077 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.36 -46.68 73.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.313 1.445 . . . . 74.219999999999999 112.225 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -70.47 -44.4 67.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 51' ' ' VAL . 2.3 t80 -58.44 -49.91 75.6 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.962 0.41 . . . . 71.239999999999995 109.896 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.6 ttp -62.56 -49.19 76.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.554 -0.736 . . . . 73.230000000000004 110.177 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -57.59 -44.49 85.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.455 1.025 . . . . 71.439999999999998 111.077 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.9 mt -64.79 -42.96 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.534 -0.913 . . . . 72.140000000000001 108.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.426 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.6 mt -57.67 -50.08 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.274 1.397 . . . . 75.510000000000005 110.07 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.54 -35.2 77.08 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.328 -1.483 . . . . 54.350000000000001 111.016 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -70.35 -35.47 73.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.407 0.548 . . . . 74.129999999999995 109.717 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -67.02 -45.3 77.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.608 1.563 . . . . 71.140000000000001 111.682 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 pt -79.6 -3.39 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 123.667 0.604 . . . . 73.120000000000005 110.887 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.72 46.57 3.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.394 1.077 . . . . 61.119999999999997 109.802 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.92 109.28 3.64 Favored Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.369 1.468 . . . . 52.229999999999997 110.223 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.58 149.91 56.29 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.975 1.783 . . . . 75.140000000000001 108.811 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -61.5 -18.15 57.8 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.507 -0.746 . . . . 44.210000000000001 113.007 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -66.33 -26.17 67.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.241 0.928 . . . . 65.310000000000002 110.449 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.99 164.89 11.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.062 0.945 . . . . 73.109999999999999 109.593 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 166.3 10.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.281 1.433 . . . . 74.409999999999997 109.52 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 tt -149.75 113.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 121.254 -0.904 . . . . 72.239999999999995 109.698 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -123.42 138.03 54.68 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.449 -1.315 . . . . 73.530000000000001 107.449 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.97 149.85 36.7 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.233 1.813 . . . . 74.319999999999993 107.58 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -141.74 133.36 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.41 1.084 . . . . 75.349999999999994 109.436 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.44 144.2 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 106.743 -1.577 . . . . 72.230000000000004 106.743 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.72 36.45 1.28 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.924 1.29 . . . . 74.420000000000002 112.651 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.51 38.21 29.31 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.235 1.414 . . . . 73.209999999999994 110.662 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -147.67 162.22 39.59 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.8 -1.185 . . . . 64.310000000000002 107.8 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.76 114.05 60.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 103.388 -2.819 . . . . 64.420000000000002 103.388 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.77 123.95 10.97 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 N-CA-C 107.427 -1.797 . . . . 72.329999999999998 107.427 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.96 126.56 27.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.461 -0.57 . . . . 52.530000000000001 109.461 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.0 m -45.88 -46.78 16.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 63.109999999999999 113.471 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.7 m -77.04 -3.18 37.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.389 1.45 . . . . 72.129999999999995 114.692 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.0 tp -67.47 141.17 57.04 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.691 1.587 . . . . 32.329999999999998 106.809 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.1 p -85.52 151.98 23.53 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.705 -0.622 . . . . 64.409999999999997 109.544 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.6 mmt -62.27 -42.13 99.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 118.206 -0.902 . . . . 72.409999999999997 113.153 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.33 -47.03 92.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.401 -1.079 . . . . 25.510000000000002 110.401 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -61.83 -49.15 77.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.774 0.83 . . . . 75.120000000000005 110.181 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.47 -49.31 75.92 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.384 0.674 . . . . 71.310000000000002 111.216 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -62.72 -45.53 92.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.629 -1.295 . . . . 73.450000000000003 108.915 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.05 -26.06 67.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 120.297 1.408 . . . . 74.129999999999995 111.736 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -24.35 20.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 116.911 -1.519 . . . . 71.430000000000007 112.335 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -112.36 1.1 15.88 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.877 1.436 . . . . 74.209999999999994 114.877 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -46.94 121.5 3.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.936 1.695 . . . . 60.149999999999999 112.148 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -80.85 171.51 14.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.544 -1.28 . . . . 73.120000000000005 107.544 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.1 -20.6 18.03 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.281 1.832 . . . . 55.009999999999998 113.795 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -102.03 13.71 33.98 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.901 1.68 . . . . 75.409999999999997 112.222 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.9 31.76 77.31 Favored Glycine 0 CA--C 1.524 0.623 0 O-C-N 120.547 -1.346 . . . . 62.32 114.092 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -129.16 172.94 10.94 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.361 -1.082 . . . . 75.129999999999995 108.44 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.12 125.36 45.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.946 -1.131 . . . . 72.340000000000003 107.946 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -102.96 120.04 39.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.903 1.281 . . . . 74.25 108.775 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.239 -1.023 . . . . 73.349999999999994 108.239 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.31 148.65 40.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.375 1.47 . . . . 40.450000000000003 107.628 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -138.12 145.81 42.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.433 0.56 . . . . 75.230000000000004 110.443 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 p -143.47 161.5 38.26 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 122.107 0.956 . . . . 74.319999999999993 110.228 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.32 13.31 21.26 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.993 -1.643 . . . . 73.319999999999993 108.993 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -123.52 124.59 43.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.76 1.624 . . . . 64.340000000000003 108.509 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -68.59 -18.02 64.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.285 0.634 . . . . 75.409999999999997 111.338 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.9 109.99 10.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.412 1.885 . . . . 73.310000000000002 107.637 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -83.25 9.23 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.813 1.042 . . . . 74.439999999999998 113.813 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 126.033 1.778 . . . . 62.43 109.611 179.339 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 CA-C-O 118.76 -1.022 . . . . 65.239999999999995 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -145.97 90.27 1.96 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.896 1.278 . . . . 63.210000000000001 108.18 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 65.7 mtt -95.62 70.57 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.072 -1.825 . . . . 64.530000000000001 106.072 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -108.15 50.37 0.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.174 1.789 . . . . 75.409999999999997 109.053 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 40.0 pt -87.81 152.21 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.156 -0.965 . . . . 75.219999999999999 111.489 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 18.4 pt -68.23 -33.65 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 114.892 1.442 . . . . 31.23 114.892 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -81.33 82.74 7.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.45 -0.945 . . . . 73.129999999999995 108.45 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.88 135.69 51.47 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.796 -1.187 . . . . 63.409999999999997 107.796 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.75 -48.72 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.856 -1.905 . . . . 54.130000000000003 105.856 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . 0.421 ' OD1' ' HE2' ' A' ' 46' ' ' LYS . 72.7 m-80 -108.68 113.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.45 2.3 . . . . 73.319999999999993 110.416 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -61.21 -51.85 67.28 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.232 2.213 . . . . 74.319999999999993 115.754 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 77.0 m95 60.7 59.2 2.21 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 74.329999999999998 113.045 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.78 129.21 9.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.644 -1.382 . . . . 25.329999999999998 109.644 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 55.2 mt -77.31 132.99 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.276 1.538 . . . . 62.43 112.184 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.02 139.81 39.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 71.129999999999995 109.183 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.4 tt -98.68 118.78 36.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.869 2.068 . . . . 74.549999999999997 107.638 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.41 125.66 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 122.917 0.487 . . . . 74.140000000000001 110.636 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.0 p -161.49 149.71 15.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.904 -1.887 . . . . 73.439999999999998 105.904 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.489 0.716 . . . . 55.229999999999997 110.112 -179.685 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 109.978 -0.378 . . . . 75.340000000000003 109.978 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.02 -134.01 4.43 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 124.09 0.852 . . . . 74.25 111.569 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -82.38 124.24 29.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.701 0.8 . . . . 73.25 109.012 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 mmt -58.76 -46.8 86.63 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.729 -1.212 . . . . 51.109999999999999 107.729 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -59.86 -43.33 94.72 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.497 -0.763 . . . . 73.230000000000004 112.307 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -69.33 -35.91 76.39 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.287 0.949 . . . . 63.32 110.924 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.05 -41.26 91.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.511 -0.552 . . . . 73.420000000000002 109.511 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.64 -75.45 0.31 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.745 0.818 . . . . 73.010000000000005 111.393 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 119.38 3.23 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.548 -1.649 . . . . 74.129999999999995 106.548 177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -104.68 -65.48 1.03 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.51 1.124 . . . . 61.549999999999997 112.361 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.3 mt -49.61 -58.47 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.072 1.349 . . . . 70.430000000000007 112.922 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.76 -58.79 6.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.717 0.636 . . . . 73.540000000000006 112.717 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -55.63 -54.97 37.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.0 0.429 . . . . 75.420000000000002 111.808 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.33 82.53 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.526 -1.226 . . . . 74.120000000000005 110.982 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -61.8 -56.31 20.8 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.621 1.168 . . . . 73.129999999999995 112.919 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.63 -44.79 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 120.669 -1.269 . . . . 60.340000000000003 110.124 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 48.4 mm-40 -61.63 -42.76 99.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 117.661 -1.161 . . . . 71.040000000000006 110.405 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.5 p -60.49 -45.1 95.0 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.632 1.56 . . . . 32.219999999999999 109.423 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.22 74.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.983 0.81 . . . . 74.019999999999996 111.95 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.88 -39.84 95.12 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.632 -0.667 . . . . 72.109999999999999 111.132 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.47 -41.2 88.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-O 117.584 -1.198 . . . . 63.229999999999997 108.539 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -65.83 -39.2 90.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.869 1.668 . . . . 75.340000000000003 109.556 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.01 74.76 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.842 -0.743 . . . . 52.140000000000001 110.909 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -78.51 -47.05 18.14 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.855 1.798 . . . . 62.340000000000003 115.855 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -126.24 70.53 69.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 126.585 1.954 . . . . 63.310000000000002 110.647 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.12 -19.47 51.06 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.502 2.134 . . . . 52.439999999999998 110.231 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.46 12.92 17.07 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.44 1.096 . . . . 64.099999999999994 112.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -129.65 160.7 32.52 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.734 1.614 . . . . 54.520000000000003 111.393 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.21 136.97 28.9 Favored Pre-proline 0 C--O 1.247 0.948 0 C-N-CA 124.422 1.089 . . . . 73.209999999999994 108.471 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.98 113.7 3.48 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 126.078 4.519 . . . . 51.109999999999999 111.683 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.1 144.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.666 0.786 . . . . 73.450000000000003 110.477 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -122.6 128.88 75.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 103.861 -2.644 . . . . 75.310000000000002 103.861 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.93 119.69 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 127.124 2.169 . . . . 73.530000000000001 106.692 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -124.4 146.96 48.57 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.614 1.097 . . . . 75.439999999999998 109.051 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -89.35 139.41 30.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.242 0.474 . . . . 71.420000000000002 109.905 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.0 130.24 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.568 -1.271 . . . . 74.409999999999997 107.568 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 p -61.04 122.04 13.97 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.214 -1.402 . . . . 70.519999999999996 107.214 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.93 -13.8 29.16 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 117.902 -1.499 . . . . 44.210000000000001 112.87 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.641 ' HB3' HG22 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -79.54 131.08 35.93 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.503 2.151 . . . . 73.030000000000001 106.318 177.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -63.48 -19.66 64.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.813 0.845 . . . . 73.439999999999998 113.012 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 39' ' ' SER . 9.4 tp -51.74 155.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.817 1.647 . . . . 73.409999999999997 112.71 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.16 145.27 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.437 1.095 . . . . 74.299999999999997 111.78 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.79 164.24 25.39 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.036 0.534 . . . . 41.340000000000003 109.798 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.68 132.72 70.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.455 1.102 . . . . 72.329999999999998 112.082 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -67.54 153.6 43.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.996 1.719 . . . . 75.129999999999995 107.821 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.69 99.13 3.6 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.327 -1.731 . . . . 71.409999999999997 106.327 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -134.41 160.96 36.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.429 -0.952 . . . . 74.230000000000004 108.429 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.9 mtpp -109.81 103.01 11.75 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.018 1.727 . . . . 75.140000000000001 108.372 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -84.38 125.84 32.68 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.735 -1.209 . . . . 74.209999999999994 107.735 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.74 107.57 18.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.322 -2.103 . . . . 71.239999999999995 105.322 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -109.61 143.01 26.95 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 117.011 -1.471 . . . . 63.520000000000003 110.492 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.12 134.73 25.75 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.452 2.768 . . . . 45.340000000000003 111.995 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 p -59.63 -17.2 31.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.885 1.274 . . . . 64.420000000000002 113.993 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.6 -34.26 60.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.434 1.894 . . . . 75.519999999999996 113.213 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.39 167.22 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 119.969 1.259 . . . . 71.219999999999999 111.095 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.417 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 57.4 p -107.38 166.66 10.48 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.38 1.072 . . . . 62.509999999999998 110.712 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.12 -37.94 36.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.378 1.071 . . . . 74.409999999999997 110.085 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.56 93.28 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.238 0.926 . . . . 71.329999999999998 111.311 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.417 ' NE2' ' H ' ' A' ' 56' ' ' THR . 58.3 mt-30 -65.79 -46.2 79.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 108.572 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.95 -50.66 72.9 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.697 1.199 . . . . 75.319999999999993 110.46 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttp -55.06 -49.07 72.55 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.61 1.164 . . . . 63.43 110.35 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -57.51 -42.17 82.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.491 -0.559 . . . . 75.319999999999993 109.491 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.21 -48.66 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.822 -1.085 . . . . 74.430000000000007 110.374 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.1 mt -56.28 -50.39 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.794 1.179 . . . . 61.25 110.071 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -62.0 -36.86 82.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.022 -0.99 . . . . 73.230000000000004 111.51 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -71.19 -37.1 72.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.072 1.305 . . . . 71.519999999999996 110.673 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.66 -49.53 74.79 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.491 1.516 . . . . 75.0 109.658 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 pt -79.53 0.7 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 119.605 -0.236 . . . . 73.230000000000004 111.006 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 50.29 58.41 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 126.498 1.919 . . . . 65.439999999999998 110.039 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 110.14 4.44 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.736 -1.209 . . . . 55.219999999999999 107.736 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.07 162.52 39.65 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.112 2.541 . . . . 74.109999999999999 112.434 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 m -67.35 -22.33 65.59 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.745 -0.597 . . . . 53.340000000000003 110.969 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.66 -34.06 77.01 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.11 0.868 . . . . 63.219999999999999 111.697 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -104.15 164.63 11.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.987 1.315 . . . . 71.329999999999998 111.726 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 175.13 5.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.413 1.885 . . . . 73.530000000000001 106.558 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -144.55 143.1 23.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 64.510000000000005 107.542 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -145.49 134.63 22.78 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.78 1.632 . . . . 74.319999999999993 108.129 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.8 mt -114.7 142.26 46.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.988 1.315 . . . . 74.450000000000003 109.803 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.59 136.94 36.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.023 1.329 . . . . 74.230000000000004 108.766 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.67 125.7 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 104.305 -2.48 . . . . 45.109999999999999 104.305 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t70 43.72 42.7 4.46 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.252 1.204 . . . . 72.129999999999995 114.252 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? 69.51 18.58 7.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.712 1.605 . . . . 73.0 114.291 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.1 p -124.03 162.57 23.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 120.48 1.491 . . . . 75.219999999999999 112.165 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.24 105.12 11.47 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 105.737 -1.949 . . . . 51.140000000000001 105.737 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.45 133.75 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.065 1.844 . . . . 71.239999999999995 109.844 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -67.57 118.59 11.07 Favored 'General case' 0 C--O 1.227 -0.113 0 O-C-N 121.439 -0.788 . . . . 73.310000000000002 109.366 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m -50.56 -39.32 49.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.224 1.01 . . . . 62.310000000000002 113.563 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.69 -8.07 59.66 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.052 1.501 . . . . 72.329999999999998 115.052 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.5 tp -71.47 141.69 50.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.156 1.798 . . . . 63.409999999999997 110.307 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.52 143.39 34.92 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.631 -1.248 . . . . 75.349999999999994 107.631 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.19 -43.39 70.69 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.208 -0.901 . . . . 63.340000000000003 111.09 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.45 -38.0 92.88 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.868 1.213 . . . . 33.130000000000003 112.904 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.65 -53.83 16.79 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.513 -0.993 . . . . 63.020000000000003 108.808 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.26 -38.32 83.13 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.194 -0.912 . . . . 55.219999999999999 110.319 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -61.44 -54.43 43.58 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 117.082 -1.437 . . . . 72.150000000000006 107.461 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -55.12 -53.62 53.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.75 1.159 . . . . 62.32 111.925 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -24.93 64.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 117.963 -1.018 . . . . 75.219999999999999 113.659 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -105.95 4.32 29.37 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.233 1.379 . . . . 65.120000000000005 112.861 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -55.37 120.25 6.82 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.126 1.77 . . . . 64.430000000000007 110.041 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.43 172.37 13.05 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.133 -1.062 . . . . 65.310000000000002 108.133 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.51 -33.96 68.6 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.774 -1.204 . . . . 73.109999999999999 109.926 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -88.35 16.35 6.49 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.734 1.214 . . . . 73.319999999999993 112.193 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.2 28.38 66.64 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.361 1.458 . . . . 71.420000000000002 116.294 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -119.51 175.74 5.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.445 1.622 . . . . 74.239999999999995 111.013 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.4 tp -123.68 137.89 54.63 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.161 0.985 . . . . 52.509999999999998 110.502 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.84 101.76 8.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.081 1.353 . . . . 73.109999999999999 109.97 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.72 122.84 69.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.559 0.695 . . . . 72.109999999999999 111.149 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.78 145.86 25.44 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.595 -1.261 . . . . 71.109999999999999 107.595 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -128.67 147.42 50.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.459 -0.941 . . . . 64.230000000000004 108.459 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 p -144.8 154.8 43.06 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.508 -0.923 . . . . 72.209999999999994 108.508 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.74 20.97 14.53 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.983 1.277 . . . . 53.399999999999999 110.064 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -135.05 112.71 10.78 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.694 1.598 . . . . 53.200000000000003 107.828 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -66.05 -40.92 91.35 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.915 -0.772 . . . . 42.119999999999997 108.915 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.29 124.24 38.18 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.491 -1.67 . . . . 72.519999999999996 106.491 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -116.62 9.76 14.23 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.738 1.215 . . . . 75.209999999999994 111.702 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.857 0 N-CA-C 107.927 -2.069 . . . . 51.329999999999998 107.927 179.386 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.765 -1.334 . . . . 71.439999999999998 109.765 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -165.19 106.32 0.79 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.706 -1.22 . . . . 61.32 107.706 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 27.5 mmm -116.43 13.23 15.42 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.774 1.23 . . . . 65.040000000000006 110.984 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -67.43 51.46 0.05 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 129.766 3.226 . . . . 75.310000000000002 112.978 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 4.5 mt -101.85 160.6 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.427 1.891 . . . . 63.520000000000003 107.627 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.14 8.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 126.491 1.917 . . . . 64.430000000000007 113.036 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -112.1 7.08 19.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.555 1.542 . . . . 74.5 111.522 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.33 109.21 0.51 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.436 1.494 . . . . 75.439999999999998 107.446 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.41 -16.03 29.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.544 0.572 . . . . 75.230000000000004 112.544 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -109.91 108.91 19.35 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 105.415 -2.069 . . . . 73.030000000000001 105.415 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -77.71 -36.08 51.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.006 0.743 . . . . 74.230000000000004 113.006 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 44.5 m95 51.91 59.38 4.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.25 1.82 . . . . 74.219999999999999 112.506 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.24 135.54 14.71 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.982 -1.247 . . . . 75.420000000000002 109.982 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 82.7 mt -80.61 134.47 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.712 1.756 . . . . 74.120000000000005 112.446 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -140.03 133.64 30.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.085 0.954 . . . . 72.409999999999997 111.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 73.6 mt -88.27 116.66 26.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.322 -2.103 . . . . 63.43 105.322 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 65.0 t -122.68 121.81 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.743 -0.836 . . . . 71.329999999999998 108.743 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -157.3 128.09 6.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.023 -1.103 . . . . 73.549999999999997 108.023 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 105.728 -1.952 . . . . 64.109999999999999 105.728 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mmm . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 109.435 -0.579 . . . . 73.409999999999997 109.435 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.92 55.93 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.382 -1.087 . . . . 73.439999999999998 110.382 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -73.65 114.43 11.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.959 -1.497 . . . . 61.149999999999999 106.959 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 mtt -49.64 -46.83 49.96 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.61 0.764 . . . . 63.240000000000002 109.749 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -56.65 -44.14 81.01 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.038 -0.982 . . . . 74.329999999999998 113.108 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -74.52 -27.72 60.66 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.353 1.061 . . . . 73.230000000000004 113.332 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -72.42 -48.16 43.38 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.515 -0.92 . . . . 64.099999999999994 108.515 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -74.73 -77.29 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 124.271 0.982 . . . . 61.25 109.085 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.66 117.85 2.11 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 119.773 -1.83 . . . . 73.519999999999996 108.228 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p -112.86 -66.4 1.09 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.839 -1.553 . . . . 72.209999999999994 109.428 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 pp -44.14 -58.13 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.387 1.875 . . . . 62.130000000000003 115.299 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.59 -58.93 6.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.452 1.901 . . . . 73.299999999999997 111.237 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -63.15 -50.73 69.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.913 1.285 . . . . 54.530000000000001 111.141 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -40.92 85.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 116.996 -1.478 . . . . 73.430000000000007 109.824 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.11 -55.6 20.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.821 1.191 . . . . 71.409999999999997 110.117 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.03 -47.71 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.454 0.57 . . . . 74.219999999999999 111.031 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 48' ' ' LYS . 53.9 mm-40 -65.27 -38.59 90.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.412 -0.804 . . . . 65.109999999999999 109.74 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 t -58.77 -48.44 81.22 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 120.315 1.416 . . . . 62.399999999999999 108.419 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.42 69.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.88 0.764 . . . . 71.310000000000002 110.485 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.84 -49.92 70.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.479 -0.296 . . . . 64.129999999999995 111.677 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -59.13 -42.02 85.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 124.085 0.954 . . . . 61.310000000000002 110.621 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -69.12 -38.89 79.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.686 1.13 . . . . 71.549999999999997 109.379 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.49 70.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.591 -0.693 . . . . 51.329999999999998 110.468 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -73.2 -46.38 50.8 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 113.153 0.797 . . . . 64.400000000000006 113.153 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -129.0 77.75 77.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.857 1.263 . . . . 75.510000000000005 109.887 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.42 -28.03 71.03 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.731 2.287 . . . . 74.340000000000003 113.581 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.6 13.8 13.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.288 0.949 . . . . 71.140000000000001 110.653 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -118.1 152.44 35.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.584 -0.895 . . . . 72.349999999999994 108.584 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.61 135.2 24.94 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.52 -1.289 . . . . 70.120000000000005 107.52 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.47 114.44 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.293 3.329 . . . . 73.349999999999994 114.108 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.84 149.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 O-C-N 120.938 -1.101 . . . . 72.329999999999998 109.926 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.6 mm -123.1 115.19 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 103.056 -2.942 . . . . 75.310000000000002 103.056 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.08 119.38 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.054 -1.091 . . . . 75.010000000000005 108.054 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.48 159.67 37.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.709 1.14 . . . . 63.32 111.616 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.31 153.59 22.47 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.586 -0.696 . . . . 74.150000000000006 112.052 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.47 135.32 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.55 -2.389 . . . . 60.140000000000001 104.55 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.66 120.97 9.89 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.668 -1.234 . . . . 44.130000000000003 107.668 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.32 -11.82 54.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.538 -1.146 . . . . 31.309999999999999 112.443 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -69.5 113.27 6.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 103.635 -2.728 . . . . 62.340000000000003 103.635 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -72.07 -13.36 61.57 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.411 0.893 . . . . 73.530000000000001 113.411 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 tp -62.54 166.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.547 1.139 . . . . 74.209999999999994 111.723 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 m -55.68 123.49 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.437 1.095 . . . . 72.510000000000005 109.181 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.62 178.16 5.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.795 1.638 . . . . 74.430000000000007 110.05 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.11 149.7 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.453 1.101 . . . . 72.140000000000001 110.867 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.16 166.07 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.475 1.51 . . . . 64.310000000000002 107.26 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.45 103.02 3.96 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.562 -1.336 . . . . 73.109999999999999 109.448 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 67.9 mmt-85 -141.44 154.52 45.63 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.136 1.774 . . . . 73.0 109.865 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mtpp -98.97 104.27 16.3 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.964 1.706 . . . . 74.5 108.766 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -84.22 118.23 24.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.766 -1.568 . . . . 72.319999999999993 106.766 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.27 116.83 32.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.885 -1.524 . . . . 53.119999999999997 106.885 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -111.59 141.25 24.24 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.888 -1.053 . . . . 74.239999999999995 110.399 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 71.2 Cg_endo -72.27 141.1 35.04 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.333 2.022 . . . . 75.310000000000002 108.229 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -65.9 -13.03 58.94 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 114.616 1.339 . . . . 75.219999999999999 114.616 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.54 -32.07 24.06 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.417 1.265 . . . . 62.149999999999999 114.417 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.37 164.8 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.305 0.957 . . . . 70.230000000000004 109.319 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -103.21 165.32 11.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.443 0.697 . . . . 65.010000000000005 110.74 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.81 -35.63 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.037 1.335 . . . . 63.200000000000003 109.259 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.89 -46.12 85.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.244 0.929 . . . . 72.25 109.933 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -67.57 -46.41 72.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.573 -0.727 . . . . 73.140000000000001 109.919 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.38 -46.97 87.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.513 0.597 . . . . 73.329999999999998 110.097 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.4 ttt -55.73 -52.19 64.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.243 1.017 . . . . 74.409999999999997 108.982 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -57.29 -40.35 77.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.581 -0.723 . . . . 75.310000000000002 110.663 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -66.73 -44.03 89.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.127 . . . . 71.109999999999999 109.282 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.89 -51.1 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.731 1.605 . . . . 62.229999999999997 110.393 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -36.16 82.85 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.672 -0.68 . . . . 73.219999999999999 110.904 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -68.07 -43.69 77.99 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.173 0.589 . . . . 70.409999999999997 110.689 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -60.23 -51.33 70.01 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.857 1.663 . . . . 74.120000000000005 110.033 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.53 -2.97 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 119.125 -0.464 . . . . 75.200000000000003 111.57 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 50.05 65.4 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.756 2.022 . . . . 73.200000000000003 109.532 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.82 115.16 22.05 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.56 0.744 . . . . 74.230000000000004 109.252 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.26 164.47 17.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.668 3.579 . . . . 74.409999999999997 113.817 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.2 m -67.92 -29.52 68.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.368 0.667 . . . . 73.109999999999999 111.509 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -62.09 -38.52 89.15 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.061 -0.495 . . . . 75.340000000000003 112.237 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.42 164.44 11.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.7 0.762 . . . . 74.430000000000007 111.756 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.31 -178.2 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.976 1.711 . . . . 60.130000000000003 107.506 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.2 140.59 22.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.411 1.084 . . . . 74.420000000000002 108.26 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -145.34 140.7 27.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.006 -1.479 . . . . 63.240000000000002 107.006 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.72 153.14 30.82 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.845 1.658 . . . . 72.439999999999998 109.637 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -147.03 132.85 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.525 1.13 . . . . 74.349999999999994 108.946 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -126.61 119.6 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 103.121 -2.918 . . . . 64.430000000000007 103.121 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 46.77 45.8 14.89 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 124.71 2.195 . . . . 73.519999999999996 111.603 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt 56.59 30.38 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.452 -1.405 . . . . 55.450000000000003 112.224 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 p -118.64 159.87 22.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.547 -1.649 . . . . 72.340000000000003 106.547 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.36 109.58 41.25 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.674 -1.973 . . . . 70.430000000000007 105.674 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.38 124.0 13.07 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.093 1.862 . . . . 70.140000000000001 110.51 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -73.93 116.03 14.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.641 1.176 . . . . 44.119999999999997 109.954 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 83.6 p -49.13 -34.2 13.59 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 115.083 1.512 . . . . 65.439999999999998 115.083 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -82.6 -9.53 59.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.583 0.957 . . . . 63.530000000000001 113.583 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -75.19 144.5 42.66 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.609 1.095 . . . . 72.400000000000006 109.732 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.69 150.04 26.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.623 0.769 . . . . 44.409999999999997 109.739 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.2 mmt -54.64 -45.42 73.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.473 1.109 . . . . 61.210000000000001 111.785 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.15 91.04 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.456 -0.636 . . . . 55.439999999999998 113.259 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.5 -52.94 40.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.342 1.071 . . . . 73.209999999999994 108.812 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -55.38 -45.4 76.57 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 124.732 1.213 . . . . 74.329999999999998 108.82 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.28 -56.06 26.9 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.02 1.728 . . . . 61.119999999999997 109.28 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.31 -43.19 88.05 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.193 0.906 . . . . 73.319999999999993 113.298 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -30.71 39.31 Favored 'General case' 0 N--CA 1.46 0.055 0 CA-C-O 117.324 -1.322 . . . . 73.230000000000004 112.844 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -97.58 -7.77 30.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.205 1.366 . . . . 74.120000000000005 114.266 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -33.38 120.16 0.37 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.968 2.907 . . . . 73.109999999999999 114.94 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.01 169.98 17.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.38 -1.341 . . . . 74.120000000000005 107.38 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -54.49 -28.75 46.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.252 1.421 . . . . 72.230000000000004 112.674 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -99.52 17.59 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.273 1.029 . . . . 75.239999999999995 112.703 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 30.43 74.63 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.325 -0.859 . . . . 62.520000000000003 114.632 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -126.28 174.17 8.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.693 1.246 . . . . 73.230000000000004 110.35 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 tp -124.62 142.95 50.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.127 -0.94 . . . . 74.239999999999995 110.778 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -117.93 116.1 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.473 1.509 . . . . 73.530000000000001 107.761 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.21 131.67 72.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 O-C-N 120.469 -1.394 . . . . 73.329999999999998 108.243 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.62 24.36 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.951 0.9 . . . . 72.219999999999999 109.798 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -139.96 154.49 47.2 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 124.191 0.932 . . . . 74.109999999999999 111.301 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -153.77 169.04 24.31 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.931 1.292 . . . . 72.439999999999998 108.829 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.34 24.9 10.19 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.397 0.999 . . . . 71.319999999999993 113.821 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.46 117.36 18.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 109.247 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.86 -17.05 47.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.153 1.168 . . . . 63.240000000000002 114.153 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.862 -1.149 . . . . 73.439999999999998 108.749 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -80.9 71.11 7.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 105.335 -2.098 . . . . 74.120000000000005 105.335 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 117.609 -1.662 . . . . 50.140000000000001 109.672 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 110.884 -0.886 . . . . 71.310000000000002 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 48.18 32.0 2.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.409 1.484 . . . . 72.299999999999997 111.87 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.31 17.67 0.47 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.506 1.923 . . . . 73.430000000000007 111.471 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.01 51.23 0.64 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.047 2.539 . . . . 74.230000000000004 110.308 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 46.8 pt -62.74 148.11 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 O-C-N 121.667 -0.645 . . . . 73.209999999999994 109.757 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 10.2 mt -75.06 -28.65 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.861 1.265 . . . . 72.120000000000005 108.689 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -84.66 61.62 6.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.617 1.567 . . . . 72.120000000000005 110.299 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -71.83 130.72 41.76 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.257 -1.016 . . . . 74.340000000000003 108.257 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.02 -29.82 35.06 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.929 -1.107 . . . . 71.299999999999997 110.707 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -108.73 164.51 12.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.705 -1.247 . . . . 63.32 111.67 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.04 -59.37 2.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.505 0.722 . . . . 72.099999999999994 111.161 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.1 m95 52.36 47.43 24.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.99 0.916 . . . . 74.25 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . 0.415 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -79.28 146.31 28.94 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 108.584 -1.806 . . . . 52.119999999999997 108.584 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.57 143.98 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 118.661 1.23 . . . . 72.450000000000003 111.527 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -148.62 120.81 8.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.524 1.53 . . . . 73.430000000000007 109.781 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.45 119.61 22.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.442 -1.318 . . . . 72.519999999999996 107.442 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.47 108.61 22.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 124.661 1.184 . . . . 73.530000000000001 108.639 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.7 p -146.24 162.35 38.26 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.247 1.819 . . . . 54.210000000000001 109.913 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 123.571 0.748 . . . . 54.229999999999997 109.752 -179.656 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ptt? . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.085 -0.007 . . . . 75.030000000000001 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.6 146.51 10.4 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.52 -1.432 . . . . 74.400000000000006 109.52 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -105.56 111.76 24.59 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.966 0.907 . . . . 71.200000000000003 109.02 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -46.75 68.91 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 124.206 0.942 . . . . 73.340000000000003 109.357 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -57.56 -49.25 76.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.743 0.817 . . . . 75.109999999999999 112.524 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.06 -43.99 90.44 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.697 0.799 . . . . 73.219999999999999 112.521 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -67.13 -44.35 80.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 123.572 0.545 . . . . 73.530000000000001 110.608 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -73.25 0.28 Allowed 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 123.635 0.585 . . . . 71.129999999999995 111.448 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.604 ' CD2' ' HD1' ' A' ' 13' ' ' HIS . 1.5 p-80 -157.58 119.44 3.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.409 1.004 . . . . 71.340000000000003 109.948 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.01 -64.97 0.93 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.653 -1.641 . . . . 75.230000000000004 113.588 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.4 mt -40.36 -57.82 1.68 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 121.597 1.999 . . . . 54.450000000000003 115.374 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -64.5 -52.62 56.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.768 0.794 . . . . 63.210000000000001 110.439 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.604 ' HD1' ' CD2' ' A' ' 9' ' ' HIS . 2.9 t60 -50.98 -58.99 4.63 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.075 1.75 . . . . 45.409999999999997 111.9 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -61.62 -49.43 76.61 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.363 2.665 . . . . 74.200000000000003 111.924 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.8 t -57.64 -49.05 77.75 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 118.724 0.693 . . . . 74.340000000000003 110.833 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.14 -42.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.331 0.652 . . . . 61.039999999999999 110.234 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 18.5 tt0 -60.44 -52.35 65.6 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.52 1.528 . . . . 70.430000000000007 110.436 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 t -58.21 -48.03 81.63 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.189 0.996 . . . . 73.319999999999993 108.937 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.42 76.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.25 0.477 . . . . 74.549999999999997 111.339 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -60.09 -39.56 86.54 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.35 -0.844 . . . . 72.209999999999994 110.332 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.34 -42.18 87.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-O 118.096 -0.954 . . . . 74.439999999999998 108.892 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -64.29 -32.52 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 120.515 1.507 . . . . 71.129999999999995 109.603 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.71 -47.81 20.77 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.254 0.549 . . . . 73.239999999999995 111.45 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -76.85 -46.87 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.859 1.429 . . . . 73.150000000000006 114.859 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.79 72.68 78.64 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 127.663 2.385 . . . . 74.430000000000007 108.128 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.79 -30.98 93.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.783 2.322 . . . . 75.219999999999999 111.326 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -90.92 14.79 12.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.766 0.826 . . . . 72.25 111.928 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -126.43 142.85 51.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.492 -1.38 . . . . 71.530000000000001 109.611 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.53 142.82 27.28 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.191 0.996 . . . . 73.099999999999994 111.779 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.79 118.66 3.84 Favored 'Trans proline' 0 C--N 1.353 0.78 1 C-N-CA 125.496 4.13 . . . . 72.319999999999993 114.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.4 t -125.48 143.85 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.248 1.023 . . . . 72.310000000000002 110.09 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mm -119.94 121.19 65.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 100.831 -3.766 . . . . 41.5 100.831 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.58 123.55 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.488 -0.93 . . . . 71.530000000000001 108.488 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -134.13 158.71 42.94 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.313 0.578 . . . . 63.020000000000003 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -79.12 145.75 33.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.01 0.524 . . . . 72.519999999999996 109.798 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.15 113.69 3.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 101.409 -3.552 . . . . 74.329999999999998 101.409 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.0 p -48.51 134.55 15.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.529 0.566 . . . . 72.329999999999998 112.529 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.29 -19.38 54.46 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 117.318 -1.823 . . . . 63.130000000000003 112.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 t -67.68 146.43 53.81 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.223 2.011 . . . . 61.210000000000001 109.937 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -73.7 -19.59 60.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.251 1.421 . . . . 71.450000000000003 112.791 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 41' ' ' ILE . 7.3 tp -60.91 158.14 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.767 -0.457 . . . . 65.049999999999997 109.767 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.84 145.48 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 113.738 1.014 . . . . 41.109999999999999 113.738 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.99 160.99 17.65 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.637 1.975 . . . . 42.240000000000002 111.485 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.53 139.95 50.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.496 1.519 . . . . 75.530000000000001 109.545 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.77 159.36 30.38 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.869 -1.16 . . . . 64.239999999999995 107.869 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -74.84 95.05 2.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.586 -1.264 . . . . 73.140000000000001 107.586 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -133.09 151.29 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.05 -1.463 . . . . 73.109999999999999 107.05 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 17' ' ' GLU . 23.5 mttp -99.79 108.25 20.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.472 -1.307 . . . . 75.329999999999998 107.472 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.88 119.9 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.448 0.642 . . . . 72.030000000000001 111.229 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.85 117.16 32.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.495 -2.039 . . . . 70.420000000000002 105.495 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 m -112.91 142.43 27.24 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.266 -1.013 . . . . 42.119999999999997 108.266 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 55.3 Cg_endo -66.78 138.62 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.324 1.509 . . . . 70.439999999999998 110.304 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -15.82 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.622 0.769 . . . . 64.510000000000005 111.667 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.73 -34.79 72.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.791 2.436 . . . . 64.400000000000006 113.321 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.31 166.5 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.004 -1.06 . . . . 53.32 111.982 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 p -99.87 168.74 9.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.728 0.811 . . . . 55.530000000000001 111.815 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.86 -41.24 56.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 125.078 1.351 . . . . 64.329999999999998 108.973 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.16 86.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.78 0.718 . . . . 72.010000000000005 111.074 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.57 -46.69 81.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.268 -0.642 . . . . 63.5 109.268 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.78 -47.71 84.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.533 0.606 . . . . 73.239999999999995 109.745 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.9 ttt -58.41 -46.17 86.98 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.629 1.571 . . . . 73.420000000000002 110.775 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -63.13 -44.49 95.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.865 -0.791 . . . . 72.439999999999998 108.865 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.53 HG21 ' CG1' ' B' ' 346' ' ' VAL . 29.8 mt -63.24 -40.01 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 117.48 -1.248 . . . . 74.25 108.706 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.12 -50.58 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 120.92 1.691 . . . . 44.409999999999997 109.209 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -63.48 -40.48 97.21 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.608 1.094 . . . . 75.109999999999999 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -63.49 -46.61 85.35 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.143 0.977 . . . . 73.340000000000003 110.593 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -59.97 -49.06 79.15 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.261 1.424 . . . . 73.219999999999999 111.473 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -79.93 -0.76 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 123.431 0.457 . . . . 72.019999999999996 111.261 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 50.11 68.25 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.688 2.395 . . . . 71.329999999999998 109.71 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 111.99 8.97 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.97 1.708 . . . . 64.430000000000007 111.098 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.13 157.92 49.91 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.335 2.69 . . . . 73.409999999999997 112.313 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.314 0.487 . . . . 71.239999999999995 112.314 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -65.01 -35.98 82.94 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.384 -0.823 . . . . 72.200000000000003 109.688 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.66 164.27 11.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.802 1.287 . . . . 74.540000000000006 112.33 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.1 177.3 4.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.866 2.467 . . . . 44.420000000000002 106.992 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tp -147.06 140.75 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.504 -1.295 . . . . 75.530000000000001 107.504 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -145.31 141.55 28.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.356 1.862 . . . . 73.239999999999995 108.833 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.0 mt -114.91 147.45 39.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 73.430000000000007 109.348 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -143.82 123.79 13.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.089 -1.449 . . . . 65.019999999999996 107.089 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.48 117.4 49.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.235 -1.394 . . . . 74.409999999999997 107.235 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t0 43.66 51.13 6.54 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.097 1.759 . . . . 44.310000000000002 111.711 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 63.54 17.9 10.69 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.322 1.449 . . . . 72.450000000000003 114.101 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.2 p -121.79 161.52 22.51 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 120.13 1.332 . . . . 71.510000000000005 111.02 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.5 t -101.26 110.04 60.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.113 -2.551 . . . . 64.129999999999995 104.113 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.65 135.54 33.49 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.446 1.43 . . . . 33.219999999999999 111.473 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.92 120.38 18.48 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 107.768 -1.197 . . . . 72.230000000000004 107.768 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -53.89 -25.81 21.93 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.123 2.169 . . . . 74.209999999999994 114.842 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -92.18 -12.14 33.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.643 0.777 . . . . 54.229999999999997 112.426 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.42 149.61 49.73 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.514 -0.921 . . . . 74.530000000000001 108.514 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.04 152.53 21.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.697 0.799 . . . . 74.319999999999993 109.489 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.39 -46.36 88.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.582 -0.723 . . . . 72.219999999999999 109.867 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.92 96.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.724 0.678 . . . . 44.140000000000001 111.793 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -65.19 -51.07 63.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.995 0.918 . . . . 62.229999999999997 108.937 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.94 -38.53 88.81 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.946 -0.471 . . . . 43.130000000000003 110.855 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -61.89 -52.99 61.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.699 2.0 . . . . 75.530000000000001 109.659 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.38 -33.75 73.52 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.686 0.624 . . . . 73.510000000000005 112.686 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -26.55 33.82 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 117.555 -1.212 . . . . 63.32 111.724 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -103.95 -2.38 26.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.591 1.087 . . . . 71.129999999999995 112.647 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -33.23 121.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 116.324 1.972 . . . . 74.120000000000005 116.324 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.14 175.32 6.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.001 0.921 . . . . 63.229999999999997 109.688 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -51.76 -39.33 58.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.858 1.663 . . . . 72.540000000000006 112.269 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.72 0.35 57.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.603 1.561 . . . . 73.310000000000002 112.516 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.02 26.93 66.35 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.137 1.351 . . . . 51.43 112.627 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 161.05 16.21 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.546 1.938 . . . . 63.539999999999999 108.89 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.2 139.27 54.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.385 0.993 . . . . 71.120000000000005 109.937 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.78 132.94 54.45 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.561 1.545 . . . . 73.230000000000004 107.619 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.26 146.54 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.302 -0.999 . . . . 73.299999999999997 108.302 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.45 144.35 44.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.836 -1.172 . . . . 75.120000000000005 107.836 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -128.7 149.77 50.54 Favored 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 109.032 -0.729 . . . . 73.310000000000002 109.032 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.7 t -144.86 163.37 34.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.876 -1.157 . . . . 52.219999999999999 107.876 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.3 5.83 55.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.828 -1.709 . . . . 74.140000000000001 108.828 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -135.88 150.62 49.43 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 118.529 1.165 . . . . 74.239999999999995 109.921 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -82.09 -23.16 35.9 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.983 2.113 . . . . 73.049999999999997 109.367 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 p -89.66 125.66 35.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.853 2.061 . . . . 74.439999999999998 105.89 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -116.32 9.61 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.928 0.891 . . . . 72.129999999999995 110.942 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 N-CA-C 106.98 -2.448 . . . . 71.319999999999993 106.98 178.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.567 0 N-CA-C 109.883 -1.287 . . . . 41.049999999999997 109.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.33 135.75 47.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.58 0.752 . . . . 71.099999999999994 109.424 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.03 53.31 2.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.573 1.549 . . . . 73.010000000000005 108.826 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.95 50.85 0.91 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.644 1.977 . . . . 63.32 110.686 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 42.5 pt -67.36 157.31 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.963 1.705 . . . . 52.130000000000003 112.938 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 45.7 mt -74.83 -38.55 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.742 -1.207 . . . . 72.049999999999997 107.742 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -82.41 51.13 1.76 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.659 1.184 . . . . 65.299999999999997 110.578 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -60.06 123.71 17.95 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.375 1.47 . . . . 54.549999999999997 107.321 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -45.01 59.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.719 0.69 . . . . 75.239999999999995 111.481 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.87 108.78 19.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.491 1.117 . . . . 74.420000000000002 113.301 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -69.52 -32.51 71.39 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.707 -0.621 . . . . 51.210000000000001 111.819 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 27.8 m95 49.48 52.34 14.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.322 1.449 . . . . 74.430000000000007 112.71 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.38 131.87 10.85 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.13 -1.606 . . . . 72.430000000000007 110.257 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.5 141.63 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.205 1.502 . . . . 70.400000000000006 107.315 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -137.44 151.0 48.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.69 1.996 . . . . 55.100000000000001 110.687 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 19.3 tp -113.55 112.23 23.21 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.975 1.31 . . . . 74.519999999999996 109.525 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.53 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.1 t -123.95 137.0 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.233 1.413 . . . . 75.349999999999994 111.718 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 4.2 p -162.46 161.0 26.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.707 0.803 . . . . 52.020000000000003 111.602 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 102.851 -3.018 . . . . 75.140000000000001 102.851 176.498 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 108.793 -0.817 . . . . 64.319999999999993 108.793 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.04 47.54 4.96 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.383 -0.687 . . . . 73.430000000000007 111.383 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -77.18 116.51 17.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.796 -0.816 . . . . 73.349999999999994 108.796 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.8 mmt -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.869 0.366 . . . . 75.420000000000002 110.465 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -58.29 -46.1 86.7 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 112.732 0.641 . . . . 55.329999999999998 112.732 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -63.98 -39.3 93.82 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.114 0.965 . . . . 73.129999999999995 111.363 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.08 -42.69 80.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 123.497 0.498 . . . . 55.140000000000001 111.497 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.18 -70.64 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.272 0.841 . . . . 65.329999999999998 113.272 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -158.36 119.98 3.53 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.486 -1.302 . . . . 74.120000000000005 107.486 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -128.83 -66.15 0.84 Allowed 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 117.113 -1.422 . . . . 42.409999999999997 111.883 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 tp -44.74 -50.34 10.09 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.092 1.357 . . . . 74.420000000000002 114.4 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -66.27 -59.44 3.72 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.939 -1.101 . . . . 61.43 112.235 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.576 ' CD2' HH21 ' A' ' 14' ' ' ARG . 3.0 t-160 -53.94 -51.85 62.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.488 1.115 . . . . 75.129999999999995 109.929 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.576 HH21 ' CD2' ' A' ' 13' ' ' HIS . 11.9 mmp_? -58.39 -46.2 86.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 115.599 -2.143 . . . . 71.140000000000001 109.867 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.17 -43.33 99.05 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.283 1.856 . . . . 71.319999999999993 112.449 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.66 -47.72 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 118.297 0.499 . . . . 74.010000000000005 110.008 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' HD11 ' B' ' 343' ' ' ILE . 0.5 OUTLIER -67.16 -39.9 86.55 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.603 -1.189 . . . . 64.420000000000002 110.371 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.5 m -56.1 -47.78 77.41 Favored 'General case' 0 CA--C 1.523 -0.059 0 CA-C-N 120.722 1.601 . . . . 74.040000000000006 107.386 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.83 72.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.967 0.358 . . . . 61.109999999999999 111.967 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.52 -51.47 65.34 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.801 -0.562 . . . . 74.319999999999993 111.317 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.46 -42.21 87.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 117.513 -1.232 . . . . 71.430000000000007 109.908 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -72.58 -29.66 63.73 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 120.556 1.526 . . . . 71.209999999999994 111.643 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.23 -46.48 41.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.995 0.816 . . . . 72.030000000000001 109.586 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -73.47 -45.93 51.19 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.669 -0.645 . . . . 71.430000000000007 110.689 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -122.76 79.76 48.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 125.324 1.45 . . . . 71.140000000000001 110.202 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.66 -20.66 52.88 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.877 1.718 . . . . 73.209999999999994 110.897 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.06 16.92 25.32 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.306 1.042 . . . . 64.129999999999995 112.946 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -120.89 153.45 37.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.867 -1.531 . . . . 72.040000000000006 106.867 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 135.11 24.08 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 124.022 0.929 . . . . 54.420000000000002 108.788 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.76 111.92 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 125.31 4.007 . . . . 63.100000000000001 112.884 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.82 149.73 16.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.873 0.869 . . . . 53.350000000000001 109.697 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.63 120.88 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 103.634 -2.728 . . . . 73.219999999999999 103.634 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.58 130.72 64.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.075 -1.454 . . . . 60.350000000000001 107.075 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.99 148.04 52.7 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.656 1.182 . . . . 63.219999999999999 110.3 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.83 132.86 36.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.283 -1.006 . . . . 73.409999999999997 108.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.16 111.96 2.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.375 -1.713 . . . . 75.519999999999996 106.375 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -57.73 123.83 17.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.457 -1.312 . . . . 74.230000000000004 107.457 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.49 -17.99 27.93 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.689 1.137 . . . . 62.409999999999997 110.665 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 t -71.93 168.49 17.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.973 1.386 . . . . 61.420000000000002 108.398 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.23 -11.82 17.73 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.171 0.988 . . . . 74.109999999999999 113.391 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.3 tp -69.72 159.64 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.816 -0.553 . . . . 73.239999999999995 109.981 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.09 148.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.186 1.394 . . . . 63.32 110.385 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -77.67 167.65 21.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.069 1.348 . . . . 61.109999999999999 111.713 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.63 135.86 62.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 123.795 0.838 . . . . 61.32 111.166 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.36 152.32 38.37 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.693 1.197 . . . . 72.129999999999995 108.395 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -74.75 92.99 2.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.786 -1.19 . . . . 71.420000000000002 107.786 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -132.81 162.63 31.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.67 1.988 . . . . 75.209999999999994 109.838 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -113.32 108.42 17.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.239 -2.134 . . . . 70.030000000000001 105.239 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -84.37 122.95 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.278 -1.008 . . . . 74.040000000000006 108.278 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.87 110.75 23.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.197 -1.779 . . . . 72.140000000000001 106.197 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.29 142.29 26.11 Favored Pre-proline 0 N--CA 1.453 -0.296 0 O-C-N 124.033 0.833 . . . . 75.510000000000005 109.02 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 135.43 39.42 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.986 . . . . 73.420000000000002 111.147 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -14.91 32.93 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.513 0.725 . . . . 72.129999999999995 111.698 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.23 -31.2 43.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.752 1.221 . . . . 72.319999999999993 114.154 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pt -73.39 170.32 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.392 0.996 . . . . 73.319999999999993 110.708 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -105.33 166.98 10.04 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.032 0.933 . . . . 62.009999999999998 110.359 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.91 -39.48 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.615 1.166 . . . . 53.219999999999999 109.382 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.02 95.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.877 0.762 . . . . 50.210000000000001 111.447 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -61.62 -47.39 85.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.933 -0.766 . . . . 75.299999999999997 108.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 64' ' ' ILE . 2.3 t80 -60.05 -51.64 68.76 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.592 -0.521 . . . . 73.409999999999997 109.592 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.0 ttt -54.02 -47.91 71.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.857 1.663 . . . . 74.099999999999994 110.809 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -62.47 -41.22 98.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.795 0.271 . . . . 74.200000000000003 110.512 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.3 -39.73 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 118.091 -0.957 . . . . 62.450000000000003 108.432 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 ' CE2' ' A' ' 60' ' ' PHE . 22.1 mt -59.14 -50.47 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.523 1.511 . . . . 63.229999999999997 109.541 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -60.21 -35.06 74.58 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.119 -0.988 . . . . 64.099999999999994 110.37 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.3 -43.17 74.34 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.162 0.892 . . . . 74.010000000000005 109.822 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -60.7 -32.48 71.71 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 52.530000000000001 112.823 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.7 pt -100.77 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.373 0.533 . . . . 35.219999999999999 111.46 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 54.56 57.65 5.58 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.161 -1.051 . . . . 65.329999999999998 108.161 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.43 108.82 2.87 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 107.105 -1.443 . . . . 74.310000000000002 107.105 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.03 147.42 67.53 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.346 -1.828 . . . . 62.049999999999997 107.346 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 m -62.72 -14.98 50.77 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.3 -0.875 . . . . 72.349999999999994 112.861 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -67.5 -28.61 67.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.131 0.878 . . . . 75.340000000000003 110.176 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -103.41 165.29 11.12 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.875 1.27 . . . . 72.430000000000007 108.525 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.69 176.03 5.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.043 1.337 . . . . 65.230000000000004 107.896 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.38 141.39 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.593 1.157 . . . . 55.229999999999997 108.265 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.26 135.96 24.43 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.808 2.043 . . . . 73.450000000000003 108.293 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.2 mt -114.94 156.14 25.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.75 1.62 . . . . 62.32 110.389 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -147.14 142.5 27.4 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.201 0.938 . . . . 74.019999999999996 109.878 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.96 119.91 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.424 -2.065 . . . . 73.299999999999997 105.424 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.1 t0 44.06 52.15 6.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.023 1.329 . . . . 75.219999999999999 111.347 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 60.19 19.11 8.47 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.471 1.509 . . . . 65.25 113.998 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 p -122.59 161.5 23.61 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 120.748 1.613 . . . . 74.019999999999996 110.606 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.42 113.8 64.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 102.181 -3.266 . . . . 73.439999999999998 102.181 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.86 138.84 35.15 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.327 1.152 . . . . 75.219999999999999 111.119 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -68.08 120.37 14.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.538 -1.282 . . . . 71.109999999999999 107.538 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.2 p -54.98 -18.67 5.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.967 1.707 . . . . 40.43 113.863 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -97.59 -0.83 45.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.909 1.684 . . . . 63.219999999999999 112.321 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 tp -80.96 151.55 28.45 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.381 1.446 . . . . 74.209999999999994 108.722 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -87.65 151.44 22.95 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 71.129999999999995 108.525 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.2 mmt -60.1 -39.28 85.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.761 -0.637 . . . . 73.319999999999993 110.386 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.89 -43.27 99.16 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.321 -0.712 . . . . 52.229999999999997 111.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -52.5 51.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.671 -0.863 . . . . 74.010000000000005 108.671 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.89 -36.71 72.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.946 0.499 . . . . 62.450000000000003 111.247 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -65.56 -55.16 19.22 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.151 -1.426 . . . . 74.430000000000007 107.151 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.85 -42.37 75.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.462 1.105 . . . . 71.540000000000006 112.479 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -26.71 29.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 117.466 -1.254 . . . . 74.230000000000004 114.229 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -109.89 9.11 24.57 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.89 1.223 . . . . 75.409999999999997 112.47 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -52.21 121.39 6.77 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.358 1.863 . . . . 73.010000000000005 111.251 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.43 169.29 17.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.511 -1.292 . . . . 74.140000000000001 107.511 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.99 -28.05 55.45 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.475 1.034 . . . . 71.439999999999998 111.42 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.57 7.33 20.46 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.982 1.313 . . . . 64.349999999999994 112.58 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.58 29.35 71.65 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 120.744 -1.223 . . . . 75.230000000000004 113.33 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -126.93 178.31 6.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.099 1.36 . . . . 62.200000000000003 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.5 tp -123.82 129.92 51.79 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.211 1.004 . . . . 64.439999999999998 110.281 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -108.23 121.68 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.255 -1.387 . . . . 75.219999999999999 107.255 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.35 141.15 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.043 0.937 . . . . 72.209999999999994 109.529 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.27 151.26 37.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.164 -1.05 . . . . 72.319999999999993 108.164 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -135.67 152.79 51.54 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.573 0.624 . . . . 73.420000000000002 110.703 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -144.02 157.05 44.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.782 -1.192 . . . . 62.399999999999999 107.782 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 13.53 21.69 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.779 -1.328 . . . . 55.329999999999998 109.779 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -125.88 127.95 46.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.761 1.625 . . . . 72.409999999999997 107.549 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -62.83 -31.92 73.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.87 1.268 . . . . 73.340000000000003 109.534 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.71 122.23 38.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.52 1.528 . . . . 72.049999999999997 108.14 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -110.13 24.79 12.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.282 1.833 . . . . 64.25 109.176 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 116.189 -2.45 . . . . 75.099999999999994 112.45 -179.36 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.304 0 N-CA-C 111.005 -0.838 . . . . 65.099999999999994 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -147.74 22.91 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.474 1.109 . . . . 72.239999999999995 110.901 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 22.8 mmt -83.03 49.3 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.301 1.04 . . . . 74.340000000000003 111.231 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -85.6 50.43 1.96 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.419 -1.697 . . . . 71.400000000000006 106.419 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 22.3 pt -71.3 152.36 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.999 1.72 . . . . 63.149999999999999 112.196 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 5.9 pt -61.74 -41.49 90.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.041 1.336 . . . . 63.43 114.206 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -87.23 53.64 2.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.762 1.164 . . . . 74.450000000000003 108.802 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -66.21 108.76 2.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.284 -2.487 . . . . 74.230000000000004 104.284 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.097 -1.002 . . . . 63.350000000000001 112.168 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.89 107.54 17.51 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.803 1.641 . . . . 74.140000000000001 108.974 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.06 -37.71 28.59 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.395 1.478 . . . . 61.210000000000001 113.221 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 80.4 m95 55.16 59.45 3.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.819 1.248 . . . . 74.099999999999994 111.306 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -74.9 133.88 16.12 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.066 -1.214 . . . . 63.130000000000003 110.066 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 17' ' ' GLU . 56.0 mt -74.13 119.24 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.59 1.556 . . . . 64.510000000000005 107.526 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -124.07 145.85 48.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.979 1.312 . . . . 73.530000000000001 110.325 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 20.5 tp -99.81 115.54 29.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.235 1.414 . . . . 75.099999999999994 108.439 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.93 120.43 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.866 1.266 . . . . 63.340000000000003 109.965 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 8.6 p -161.11 159.2 28.8 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.511 1.051 . . . . 64.120000000000005 112.595 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--O 1.249 1.036 0 C-N-CA 127.576 2.35 . . . . 73.299999999999997 108.559 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tmm? . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 108.243 -1.021 . . . . 62.100000000000001 108.243 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.4 95.5 0.31 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 106.366 -2.694 . . . . 71.439999999999998 106.366 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -102.67 130.32 49.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.316 1.046 . . . . 73.549999999999997 108.479 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 mtt -64.51 -43.0 95.44 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.438 1.087 . . . . 75.230000000000004 108.818 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -59.77 -51.72 68.54 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.558 -0.734 . . . . 72.299999999999997 110.668 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.17 -31.71 73.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 117.879 -1.058 . . . . 70.439999999999998 111.672 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -59.76 -45.31 92.65 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.29 -1.374 . . . . 72.230000000000004 107.29 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.57 -74.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.549 0.531 . . . . 64.420000000000002 110.325 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 143.03 13.27 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.74 2.816 . . . . 72.099999999999994 108.914 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 p -120.68 -66.39 1.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 117.268 -1.349 . . . . 72.530000000000001 111.311 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -45.71 -59.0 3.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.355 1.862 . . . . 73.099999999999994 113.915 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.97 -48.02 72.66 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.356 -0.84 . . . . 71.409999999999997 111.754 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.419 ' HE2' ' HZ3' ' A' ' 48' ' ' LYS . 6.1 t60 -56.68 -47.59 79.52 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.599 0.36 . . . . 73.540000000000006 110.228 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -47.24 85.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.165 1.386 . . . . 73.420000000000002 108.559 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 t -61.75 -51.93 66.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 120.036 1.289 . . . . 51.539999999999999 111.481 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.42 -47.99 86.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.383 -0.823 . . . . 74.5 110.503 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.83 -52.03 65.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.837 0.855 . . . . 75.409999999999997 110.741 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.7 p -59.13 -48.13 82.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.293 -0.86 . . . . 63.0 110.456 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.27 78.14 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.668 1.122 . . . . 74.450000000000003 111.536 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -67.61 -40.25 84.71 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.517 -0.739 . . . . 71.109999999999999 110.628 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.1 -41.94 79.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 118.157 -0.925 . . . . 63.039999999999999 110.017 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -62.63 -38.25 89.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 120.208 1.367 . . . . 73.540000000000006 108.509 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.31 69.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.559 -0.856 . . . . 24.149999999999999 110.895 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -78.08 -46.8 19.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 118.448 2.758 . . . . 73.510000000000005 118.448 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -131.59 76.92 74.17 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.397 2.279 . . . . 75.140000000000001 108.789 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.69 -23.5 36.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.756 2.304 . . . . 71.310000000000002 112.364 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.62 12.85 17.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 73.430000000000007 112.426 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -122.0 153.81 38.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.493 -1.669 . . . . 75.109999999999999 106.493 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.32 138.41 24.28 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.483 -0.932 . . . . 62.219999999999999 108.483 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.6 122.27 5.45 Favored 'Trans proline' 0 C--N 1.353 0.792 1 C-N-CA 125.879 4.386 . . . . 54.219999999999999 111.449 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.7 t -131.93 143.27 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.121 0.968 . . . . 72.150000000000006 111.56 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.1 mm -117.38 120.48 65.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 103.695 -2.705 . . . . 52.509999999999998 103.695 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -108.16 110.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.978 1.711 . . . . 71.200000000000003 108.65 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -123.02 153.09 40.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.208 0.913 . . . . 74.230000000000004 110.911 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -93.54 146.22 23.95 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.345 0.521 . . . . 72.299999999999997 110.501 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.23 136.55 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.328 1.451 . . . . 63.219999999999999 107.816 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.2 m -49.19 142.19 7.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.961 0.904 . . . . 61.399999999999999 111.572 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.82 1.57 1.44 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.781 2.134 . . . . 44.43 116.543 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 t -58.85 147.3 34.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 119.241 1.52 . . . . 74.109999999999999 111.699 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 -0.79 31.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.906 1.282 . . . . 44.299999999999997 112.449 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -82.92 156.79 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.556 1.071 . . . . 63.310000000000002 109.118 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 151.9 9.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.684 0.754 . . . . 72.150000000000006 109.267 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.02 165.23 23.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.35 1.241 . . . . 72.109999999999999 114.35 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.62 139.5 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 127.572 2.349 . . . . 71.430000000000007 108.177 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.47 161.29 26.17 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.793 -1.558 . . . . 63.43 106.793 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.5 104.92 3.98 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.234 -1.395 . . . . 65.150000000000006 107.234 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -136.61 160.12 39.76 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.755 1.622 . . . . 74.209999999999994 110.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 11.2 mttt -107.96 116.29 31.69 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.296 1.839 . . . . 72.099999999999994 106.51 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -98.26 138.82 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.762 1.165 . . . . 75.099999999999994 111.91 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.6 mt -120.75 110.9 16.92 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.299 1.44 . . . . 74.530000000000001 108.626 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.45 142.11 25.83 Favored Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 118.137 -0.935 . . . . 75.540000000000006 111.099 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.55 137.54 27.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.196 2.597 . . . . 72.319999999999993 110.863 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 m -61.52 -12.5 15.48 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.914 1.45 . . . . 34.229999999999997 114.914 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.95 -34.88 29.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.831 1.196 . . . . 74.310000000000002 113.639 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.64 168.1 2.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.145 0.497 . . . . 51.340000000000003 112.004 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.7 p -107.54 163.37 13.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.305 0.483 . . . . 62.409999999999997 112.305 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.6 t -50.06 -34.67 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.583 1.153 . . . . 64.209999999999994 109.758 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.66 88.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.635 1.174 . . . . 64.25 111.237 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -69.63 -42.6 74.1 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 124.073 0.949 . . . . 62.109999999999999 110.206 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -59.54 -46.94 87.42 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.586 -0.894 . . . . 72.510000000000005 108.586 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.6 ttt -58.69 -43.7 90.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.706 1.203 . . . . 75.019999999999996 109.553 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -58.55 -46.8 86.09 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.851 0.751 . . . . 70.450000000000003 110.297 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.432 HG21 HG13 ' B' ' 346' ' ' VAL . 12.0 mt -61.78 -42.67 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 118.585 -0.721 . . . . 75.109999999999999 109.804 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.2 mt -58.15 -50.36 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.634 1.107 . . . . 72.409999999999997 109.7 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -64.73 -31.71 73.06 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.961 -1.087 . . . . 71.310000000000002 112.655 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -70.76 -48.4 54.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.523 0.729 . . . . 72.25 109.746 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -59.45 -49.26 78.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.05 1.74 . . . . 74.340000000000003 111.682 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 pt -78.87 -5.87 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 120.793 -0.363 . . . . 71.150000000000006 111.152 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 56.29 62.32 2.38 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.565 1.546 . . . . 74.349999999999994 108.289 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 108.53 2.96 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.069 0.948 . . . . 74.019999999999996 108.847 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.8 164.51 35.44 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.137 2.558 . . . . 62.329999999999998 111.059 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -67.01 -17.03 64.73 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.216 -0.928 . . . . 73.400000000000006 112.142 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.76 -42.83 97.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.354 0.979 . . . . 64.25 109.189 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -102.53 164.74 11.48 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-O 122.6 1.191 . . . . 64.439999999999998 110.802 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.2 -176.78 3.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.336 -1.727 . . . . 75.519999999999996 106.336 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 tp -144.52 139.25 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.145 -1.428 . . . . 63.439999999999998 107.145 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -145.3 134.46 22.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.143 1.377 . . . . 72.430000000000007 108.665 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.28 135.14 54.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.661 1.584 . . . . 65.25 107.907 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.49 124.29 29.83 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.407 1.083 . . . . 74.019999999999996 109.237 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.28 129.67 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.478 1.111 . . . . 44.039999999999999 108.255 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.42 33.24 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.929 1.692 . . . . 71.540000000000006 112.145 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 66.31 23.31 10.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.066 1.347 . . . . 62.25 111.278 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -123.15 162.25 22.87 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.372 1.869 . . . . 51.520000000000003 110.561 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.2 103.34 13.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 105.591 -2.003 . . . . 74.120000000000005 105.591 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.11 139.33 42.18 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.869 1.713 . . . . 71.120000000000005 111.734 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -74.06 120.26 19.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.601 -0.888 . . . . 63.119999999999997 108.601 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 13.0 p -46.75 -37.82 9.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.441 1.896 . . . . 75.340000000000003 114.753 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 p -86.38 -6.1 59.01 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 115.156 1.539 . . . . 61.140000000000001 115.156 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.41 141.54 57.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.555 -1.646 . . . . 53.039999999999999 106.555 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.3 p -80.61 154.74 27.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.391 -0.818 . . . . 72.540000000000006 109.087 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.2 mmt -59.24 -40.88 87.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.123 0.969 . . . . 72.310000000000002 108.978 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 -44.47 97.45 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.196 -1.336 . . . . 62.439999999999998 110.802 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.74 -48.35 54.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.005 1.403 . . . . 74.319999999999993 111.053 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -45.98 76.5 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.121 -0.696 . . . . 75.409999999999997 109.121 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -63.14 -52.4 62.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.731 0.696 . . . . 64.299999999999997 109.374 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -54.54 -40.42 68.66 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.237 0.828 . . . . 74.340000000000003 113.237 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -23.73 22.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.167 -1.397 . . . . 74.5 113.518 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -103.98 9.55 36.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.058 1.299 . . . . 63.329999999999998 110.842 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -52.42 121.33 6.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.384 2.273 . . . . 75.040000000000006 111.322 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -89.18 175.61 7.3 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.658 0.783 . . . . 74.540000000000006 108.942 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.85 -37.9 60.81 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.199 1.4 . . . . 74.140000000000001 111.571 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.39 -2.78 50.65 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.238 1.815 . . . . 52.420000000000002 111.966 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.62 29.33 71.65 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.911 1.243 . . . . 72.099999999999994 112.724 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 166.67 13.31 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.336 1.454 . . . . 75.519999999999996 109.377 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.3 tp -122.41 131.21 53.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.916 -1.142 . . . . 72.140000000000001 107.916 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -122.5 116.35 23.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.347 1.859 . . . . 75.319999999999993 107.432 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.69 150.15 29.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 O-C-N 121.227 -0.921 . . . . 62.409999999999997 110.058 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.2 152.51 33.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.089 -0.708 . . . . 73.099999999999994 109.089 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -135.24 154.2 51.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.861 0.839 . . . . 55.439999999999998 110.703 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.9 p -149.22 155.79 41.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.662 1.185 . . . . 71.530000000000001 108.137 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.18 21.86 12.8 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 111.383 -0.687 . . . . 45.340000000000003 111.383 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -117.57 125.38 50.7 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.46 1.904 . . . . 73.209999999999994 108.417 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -71.79 -25.01 61.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.488 1.515 . . . . 63.420000000000002 109.819 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -135.65 133.65 38.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.011 2.125 . . . . 73.340000000000003 106.344 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -97.72 70.77 2.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.396 1.078 . . . . 75.510000000000005 110.712 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.039 -1.423 . . . . 70.329999999999998 110.142 179.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 109.841 -1.303 . . . . 53.009999999999998 109.841 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 54.35 31.71 14.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.475 1.51 . . . . 74.409999999999997 112.235 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 7.3 mtp -86.47 70.08 10.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.048 -1.464 . . . . 71.239999999999995 107.048 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -111.52 27.67 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.84 1.256 . . . . 62.539999999999999 109.23 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . 0.451 HD12 ' H ' ' B' ' 334' ' ' ILE . 1.9 mp -60.44 152.95 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.204 1.401 . . . . 54.149999999999999 107.424 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 48.2 mt -119.4 -34.06 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 124.084 0.954 . . . . 74.340000000000003 111.359 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -112.3 61.26 0.63 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.301 1.041 . . . . 75.430000000000007 109.071 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -67.26 160.02 27.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.545 -1.28 . . . . 74.140000000000001 107.545 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.12 -42.01 99.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.461 1.652 . . . . 63.520000000000003 115.461 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -108.48 144.39 36.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.405 1.002 . . . . 65.310000000000002 109.842 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -62.16 1.52 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.746 0.647 . . . . 71.310000000000002 112.746 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.494 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 48.8 m95 54.71 64.71 1.72 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.212 1.405 . . . . 64.0 110.863 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.88 138.78 17.15 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 107.517 -2.233 . . . . 62.520000000000003 107.517 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.68 142.94 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.446 1.623 . . . . 73.049999999999997 110.636 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.05 156.49 46.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.358 1.463 . . . . 73.430000000000007 110.489 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.29 119.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.104 2.162 . . . . 74.519999999999996 106.43 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 63' ' ' ILE . 2.7 t -120.97 119.16 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 122.511 1.148 . . . . 65.340000000000003 109.808 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.9 p -161.76 152.76 18.08 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.688 -1.142 . . . . 61.119999999999997 110.248 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 129.466 3.106 . . . . 61.340000000000003 113.506 179.252 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.89 -1.152 . . . . 64.319999999999993 107.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.93 -163.03 24.0 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 108.401 -1.88 . . . . 54.549999999999997 108.401 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -74.09 125.68 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.622 -1.622 . . . . 74.109999999999999 106.622 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.21 -38.93 88.34 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.198 -0.667 . . . . 74.430000000000007 109.198 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -59.97 -39.63 86.32 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.412 1.005 . . . . 75.120000000000005 110.198 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.564 0.62 . . . . 72.129999999999995 109.431 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.0 -44.87 91.31 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.355 -0.98 . . . . 73.230000000000004 108.355 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.83 -75.97 0.18 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.746 1.017 . . . . 64.310000000000002 113.746 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -158.56 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.536 1.934 . . . . 70.5 108.229 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.2 p -102.36 -67.25 0.88 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.409 0.892 . . . . 74.530000000000001 113.409 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.91 -55.07 22.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 117.176 2.287 . . . . 75.310000000000002 117.176 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.0 -54.92 26.71 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.061 0.846 . . . . 72.530000000000001 111.23 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.75 -43.59 65.86 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.629 1.571 . . . . 74.420000000000002 111.078 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -47.06 63.34 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.891 -1.131 . . . . 75.5 109.626 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -54.91 -58.46 7.52 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.589 0.756 . . . . 72.319999999999993 111.065 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.39 -46.19 92.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.048 0.539 . . . . 73.099999999999994 110.916 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 48' ' ' LYS . 29.8 mm-40 -64.98 -40.04 94.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.847 -1.073 . . . . 71.439999999999998 110.997 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 t -57.66 -46.92 83.61 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.273 1.397 . . . . 52.020000000000003 108.541 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.43 72.33 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.017 0.371 . . . . 40.310000000000002 111.325 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -59.0 -49.13 79.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.855 1.262 . . . . 71.319999999999993 110.328 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.33 -42.89 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-O 117.393 -1.289 . . . . 65.400000000000006 111.403 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -71.05 -29.81 65.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.527 1.512 . . . . 73.120000000000005 110.242 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.29 -47.29 57.76 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.676 -0.861 . . . . 73.230000000000004 108.676 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -77.53 -47.96 18.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.429 1.27 . . . . 74.450000000000003 114.429 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -125.73 73.43 69.55 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 127.869 2.468 . . . . 74.239999999999995 111.222 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.97 -29.36 89.17 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.063 1.842 . . . . 72.420000000000002 112.457 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.67 11.81 16.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.518 0.599 . . . . 75.409999999999997 111.086 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -112.42 143.33 43.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.61 1.55 . . . . 52.130000000000003 109.414 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -107.06 133.49 20.27 Favored Pre-proline 0 C--O 1.246 0.883 0 C-N-CA 124.323 1.049 . . . . 71.450000000000003 108.295 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.19 119.81 5.45 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.89 3.727 . . . . 74.319999999999993 112.606 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 t -128.23 149.67 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.565 -0.709 . . . . 74.510000000000005 111.115 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -122.13 134.4 65.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 102.669 -3.086 . . . . 72.319999999999993 102.669 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.77 119.57 53.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.379 1.471 . . . . 61.109999999999999 109.326 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.7 157.41 46.83 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.453 1.024 . . . . 74.420000000000002 113.279 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.7 150.98 23.28 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.872 0.368 . . . . 71.25 110.602 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.88 135.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.999 -1.482 . . . . 72.200000000000003 106.999 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -64.11 115.74 5.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.118 -1.068 . . . . 54.530000000000001 108.118 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -6.85 30.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.39 1.471 . . . . 44.409999999999997 112.374 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.9 m -85.23 112.58 20.87 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.623 1.711 . . . . 52.149999999999999 107.727 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.78 -20.98 60.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.267 1.827 . . . . 73.430000000000007 114.548 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.1 tp -53.42 158.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.449 1.5 . . . . 61.520000000000003 114.809 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.6 m -49.07 114.35 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.785 1.634 . . . . 73.010000000000005 109.64 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -82.1 167.76 18.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.453 1.501 . . . . 74.409999999999997 108.727 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -126.15 139.14 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.724 -1.213 . . . . 71.010000000000005 107.724 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.72 166.15 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.77 0.795 . . . . 64.409999999999997 109.47 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.35 105.81 4.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.267 -2.123 . . . . 64.230000000000004 105.267 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' B' ' 342' ' ' GLY . 12.1 mmm180 -139.92 152.41 46.37 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 124.243 1.017 . . . . 74.530000000000001 111.087 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 21.5 mttp -93.95 94.75 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 105.577 -2.009 . . . . 65.430000000000007 105.577 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -85.08 117.07 23.82 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.197 -1.038 . . . . 71.349999999999994 108.197 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.53 115.48 30.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.145 1.378 . . . . 45.420000000000002 110.471 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.01 142.92 27.7 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 119.966 1.257 . . . . 73.310000000000002 111.945 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 141.67 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.08 2.52 . . . . 54.409999999999997 110.691 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -62.5 -13.62 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.7 2.0 . . . . 63.119999999999997 113.28 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.32 -30.03 25.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.636 0.976 . . . . 75.540000000000006 113.636 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.66 166.68 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 119.391 0.996 . . . . 74.099999999999994 110.403 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 p -107.51 163.01 13.42 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.373 -0.829 . . . . 75.329999999999998 112.989 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.79 -35.98 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.11 0.964 . . . . 73.150000000000006 109.201 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.72 78.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.484 0.714 . . . . 65.109999999999999 110.717 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -71.92 -43.22 65.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 109.942 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.79 -41.97 87.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.123 0.874 . . . . 75.209999999999994 109.474 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 42.3 ttp -63.31 -48.8 76.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.041 -0.725 . . . . 74.310000000000002 109.041 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -58.89 -44.94 91.27 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.398 0.544 . . . . 62.229999999999997 111.092 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.91 -50.91 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.329 1.052 . . . . 73.340000000000003 108.307 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.79 -49.96 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.055 0.843 . . . . 73.129999999999995 111.009 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -64.05 -32.93 74.66 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.937 -1.102 . . . . 74.409999999999997 112.183 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -71.89 -46.47 57.66 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.77 -0.826 . . . . 62.509999999999998 108.77 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.3 -51.41 64.73 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.26 1.824 . . . . 74.25 111.942 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -3.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.142 0.423 . . . . 60.439999999999998 112.142 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 55.29 63.71 2.01 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.26 1.824 . . . . 73.319999999999993 107.776 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.67 114.28 18.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.229 -1.026 . . . . 74.230000000000004 108.229 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.98 164.37 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.781 2.987 . . . . 71.129999999999995 113.054 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.5 p -66.8 -32.32 73.53 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.929 -1.107 . . . . 53.439999999999998 112.659 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -59.44 -36.0 75.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.034 1.734 . . . . 72.340000000000003 112.337 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.83 165.04 11.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.471 1.108 . . . . 74.519999999999996 111.01 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.27 -179.4 3.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.963 2.105 . . . . 73.409999999999997 108.895 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.3 136.37 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.087 1.355 . . . . 71.010000000000005 107.886 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.34 136.67 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.424 -1.324 . . . . 75.209999999999994 107.424 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.28 148.85 31.09 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.469 1.108 . . . . 72.519999999999996 108.728 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -137.01 123.26 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.071 1.749 . . . . 73.239999999999995 108.417 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.06 144.49 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.582 1.153 . . . . 64.510000000000005 108.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 48.92 35.77 7.22 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.149 1.341 . . . . 70.200000000000003 111.853 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 tttt 55.02 31.44 16.11 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.112 0.965 . . . . 55.140000000000001 111.476 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -152.19 163.96 38.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.642 1.177 . . . . 61.210000000000001 109.9 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -86.83 115.12 61.32 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 104.912 -2.255 . . . . 74.340000000000003 104.912 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.74 141.29 40.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.105 1.87 . . . . 71.420000000000002 110.606 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -72.09 127.28 32.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.736 -0.838 . . . . 73.099999999999994 108.736 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 p -53.81 -35.47 61.43 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.012 2.125 . . . . 61.439999999999998 112.218 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 t -70.02 -14.96 62.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.779 1.632 . . . . 63.329999999999998 112.39 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.73 147.78 48.67 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.45 -0.945 . . . . 72.430000000000007 108.45 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 m -98.88 149.09 23.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.871 -1.159 . . . . 65.239999999999995 107.871 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.7 mmt -55.04 -46.19 75.29 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.066 0.547 . . . . 74.439999999999998 111.745 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.91 -46.63 83.37 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.919 -0.873 . . . . 55.039999999999999 110.919 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -65.08 -52.92 52.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.48 0.712 . . . . 73.219999999999999 109.818 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -53.03 -50.28 64.58 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.045 0.938 . . . . 70.540000000000006 110.814 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -62.9 -49.14 75.97 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.067 -1.021 . . . . 73.519999999999996 109.838 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -68.22 -24.51 64.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.98 0.809 . . . . 74.099999999999994 112.797 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -37.4 13.87 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 119.687 1.13 . . . . 75.209999999999994 111.179 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.17 -3.77 50.32 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.318 1.229 . . . . 71.140000000000001 114.318 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -36.26 121.78 0.71 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.451 2.389 . . . . 52.329999999999998 117.451 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.31 165.92 23.85 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.206 -1.405 . . . . 61.100000000000001 107.206 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.18 -34.64 57.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.529 1.132 . . . . 54.130000000000003 111.871 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -96.77 14.08 26.33 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.552 1.141 . . . . 75.340000000000003 113.579 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.2 70.59 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 120.688 -1.258 . . . . 60.240000000000002 113.853 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.39 154.48 29.14 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.526 1.163 . . . . 71.299999999999997 108.382 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.49 133.89 55.05 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.826 -1.176 . . . . 73.120000000000005 107.826 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.81 124.3 42.99 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.257 1.423 . . . . 72.209999999999994 109.121 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 143.64 40.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-O 122.091 0.948 . . . . 63.009999999999998 108.59 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.85 155.96 22.79 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.551 -0.718 . . . . 75.340000000000003 109.132 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -140.99 161.34 38.07 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.531 0.732 . . . . 61.509999999999998 111.525 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -151.61 156.95 41.47 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.811 -1.181 . . . . 63.43 107.811 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.0 26.26 9.43 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 126.54 2.019 . . . . 70.099999999999994 109.918 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -132.23 141.44 49.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.376 2.271 . . . . 72.030000000000001 106.72 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -81.09 -48.02 12.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.982 -1.008 . . . . 72.439999999999998 108.383 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m -94.46 124.23 38.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.69 0.796 . . . . 63.020000000000003 108.971 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -118.65 12.29 13.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.904 2.081 . . . . 74.129999999999995 111.043 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 C-N-CA 125.255 1.407 . . . . 62.229999999999997 112.144 -179.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 109.769 -1.332 . . . . 72.239999999999995 109.769 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 68.0 96.25 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 128.418 2.687 . . . . 71.230000000000004 110.348 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.9 19.94 14.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.673 1.189 . . . . 72.510000000000005 110.432 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.08 50.75 0.21 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.484 1.914 . . . . 64.230000000000004 112.391 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.67 118.95 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.123 1.369 . . . . 75.439999999999998 107.609 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.48 -15.5 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 119.202 -0.428 . . . . 72.430000000000007 111.196 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -78.89 62.0 3.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.975 1.31 . . . . 62.229999999999997 107.611 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.96 108.96 2.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.31 -2.478 . . . . 53.210000000000001 104.31 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.94 -27.11 63.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.567 1.147 . . . . 64.140000000000001 111.224 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.74 156.8 20.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.946 -1.501 . . . . 73.310000000000002 106.946 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.9 -57.16 2.91 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.557 -0.714 . . . . 72.109999999999999 111.846 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.433 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 75.4 m95 58.68 58.93 3.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.645 1.178 . . . . 74.040000000000006 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . 0.421 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . -78.85 145.29 28.5 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.967 -1.653 . . . . 65.530000000000001 108.967 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 33.0 mt -77.51 141.16 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.821 1.31 . . . . 64.109999999999999 111.138 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.66 122.91 16.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.672 0.789 . . . . 74.439999999999998 108.972 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.6 tp -93.31 108.54 20.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.666 -2.346 . . . . 62.200000000000003 104.666 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.62 134.78 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.181 0.808 . . . . 70.319999999999993 113.181 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 12.8 p -161.47 158.64 26.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.642 1.577 . . . . 64.209999999999994 107.388 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 127.999 2.519 . . . . 72.340000000000003 112.504 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.5 mtp . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.858 -0.423 . . . . 72.519999999999996 109.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.49 -127.73 1.91 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 108.486 -1.846 . . . . 53.329999999999998 108.486 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -73.42 112.9 9.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.599 -0.889 . . . . 72.129999999999995 108.599 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.5 mmm -57.66 -46.89 83.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.133 -0.692 . . . . 73.099999999999994 109.133 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -58.16 -45.05 88.12 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 119.721 -0.181 . . . . 74.5 111.082 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -64.79 -35.03 79.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.279 -0.391 . . . . 64.349999999999994 111.622 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.76 -48.09 78.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.24 -1.022 . . . . 73.019999999999996 108.24 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -71.34 0.22 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 115.081 1.511 . . . . 75.099999999999994 115.081 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -156.22 128.19 7.42 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.785 2.034 . . . . 74.239999999999995 108.203 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -124.9 -66.15 0.98 Allowed 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 116.529 -1.701 . . . . 61.329999999999998 114.069 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.08 -56.55 13.7 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.265 1.393 . . . . 71.319999999999993 114.471 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.7 -36.13 82.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.054 0.843 . . . . 72.329999999999998 111.58 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -64.75 -55.09 21.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.702 0.801 . . . . 73.120000000000005 110.831 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -49.24 75.32 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.303 1.441 . . . . 65.420000000000002 109.294 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.2 t -54.15 -61.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.926 0.784 . . . . 72.239999999999995 112.033 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.91 -47.61 90.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 123.874 0.734 . . . . 73.340000000000003 112.279 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -47.08 70.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.151 -1.02 . . . . 65.400000000000006 111.642 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -55.03 -45.41 75.18 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 120.046 1.294 . . . . 73.109999999999999 109.493 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.77 72.09 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.261 0.553 . . . . 72.420000000000002 112.253 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -66.69 -40.0 88.35 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.331 0.652 . . . . 65.010000000000005 110.276 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.2 mt -65.15 -42.09 93.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 117.78 -1.105 . . . . 75.329999999999998 108.624 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -63.86 -39.18 93.59 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 120.092 1.314 . . . . 65.040000000000006 109.423 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.9 -46.94 67.07 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.935 0.398 . . . . 64.299999999999997 111.633 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -72.23 -44.99 62.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.415 -0.803 . . . . 74.109999999999999 112.783 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -128.75 78.72 75.64 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.121 1.368 . . . . 73.129999999999995 109.694 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.45 -17.65 49.05 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.659 2.239 . . . . 72.450000000000003 112.044 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -99.87 13.17 34.75 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.415 0.686 . . . . 72.040000000000006 110.061 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -123.21 155.64 36.71 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.842 1.201 . . . . 74.319999999999993 108.728 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.76 136.85 27.83 Favored Pre-proline 0 C--O 1.241 0.656 0 C-N-CA 124.126 0.97 . . . . 74.109999999999999 109.846 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.78 114.73 3.7 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 125.251 3.967 . . . . 72.230000000000004 111.769 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.52 143.99 34.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.555 1.142 . . . . 42.140000000000001 109.358 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 mm -120.73 127.05 75.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 102.375 -3.194 . . . . 73.239999999999995 102.375 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.67 124.55 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.319 1.447 . . . . 70.340000000000003 108.896 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -136.59 154.26 50.73 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.25 1.386 . . . . 74.5 110.513 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -91.78 152.71 20.02 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.944 -0.473 . . . . 73.340000000000003 111.685 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.8 t -66.83 126.1 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.681 1.593 . . . . 74.140000000000001 107.212 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 p -58.72 121.85 12.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.729 0.695 . . . . 74.310000000000002 110.296 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 102.51 -18.8 49.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.626 2.06 . . . . 73.310000000000002 111.847 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -55.65 136.94 50.18 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.896 1.348 . . . . 63.539999999999999 111.289 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -64.49 -28.73 69.86 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.859 1.264 . . . . 75.129999999999995 114.096 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.11 154.33 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.471 0.708 . . . . 62.310000000000002 112.124 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.78 140.11 20.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.172 -1.418 . . . . 73.120000000000005 107.172 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -84.36 167.6 16.37 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.515 -0.92 . . . . 62.310000000000002 108.515 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.81 144.17 20.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.745 -1.576 . . . . 65.510000000000005 106.745 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 165.61 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.549 0.69 . . . . 70.409999999999997 110.463 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.3 95.29 2.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.767 -1.197 . . . . 52.039999999999999 107.767 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -136.25 151.74 49.99 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.153 0.981 . . . . 74.099999999999994 109.562 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' B' ' 341' ' ' TRP . 29.8 mttp -95.7 102.09 13.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.058 -2.201 . . . . 74.409999999999997 105.058 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -84.58 136.73 33.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.158 0.89 . . . . 74.420000000000002 109.162 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 mt -120.19 108.56 14.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.975 -1.491 . . . . 70.450000000000003 106.975 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.17 141.99 25.42 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-O 117.946 -1.026 . . . . 63.420000000000002 110.408 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 141.29 38.87 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.141 1.894 . . . . 72.310000000000002 113.568 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.3 m -62.58 -17.32 59.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.874 1.67 . . . . 52.130000000000003 110.877 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -68.37 -35.34 77.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.733 2.413 . . . . 73.510000000000005 112.751 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -86.26 171.0 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 122.014 0.911 . . . . 62.340000000000003 112.648 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.6 p -107.23 166.12 10.87 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.492 1.517 . . . . 71.409999999999997 110.541 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.75 -34.32 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.81 1.244 . . . . 62.409999999999997 108.559 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -47.86 83.55 Favored 'General case' 0 C--O 1.244 0.8 0 O-C-N 121.495 -0.753 . . . . 54.340000000000003 112.69 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.54 -37.5 71.12 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 123.162 0.585 . . . . 71.5 110.095 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.9 -45.1 91.07 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.934 -0.765 . . . . 74.530000000000001 108.934 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 ttt -63.57 -44.96 92.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.069 -0.967 . . . . 61.340000000000003 110.105 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -57.04 -41.29 78.37 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.996 0.816 . . . . 74.540000000000006 111.09 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.01 -51.12 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.533 -0.914 . . . . 75.099999999999994 108.533 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 60' ' ' PHE . 29.9 mt -52.46 -50.36 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.262 0.937 . . . . 64.140000000000001 111.049 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -62.31 -39.42 92.96 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.062 -1.024 . . . . 74.540000000000006 112.064 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -74.34 -33.75 63.23 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.77 1.168 . . . . 75.120000000000005 111.305 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.47 -48.73 78.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.998 0.817 . . . . 62.200000000000003 109.552 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -79.98 -3.18 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.013 0.196 . . . . 41.25 110.88 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 53.1 57.93 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.203 1.801 . . . . 62.420000000000002 109.532 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.11 109.98 4.87 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 124.979 1.312 . . . . 70.230000000000004 108.735 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.73 159.46 52.61 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.442 2.761 . . . . 74.420000000000002 111.205 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 m -67.3 -14.47 62.95 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.091 -1.005 . . . . 74.120000000000005 112.706 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.46 -34.11 67.51 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.112 -0.47 . . . . 71.040000000000006 110.157 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.55 164.41 11.68 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.355 1.062 . . . . 73.019999999999996 108.942 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.16 175.72 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.97 1.308 . . . . 72.019999999999996 109.21 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.76 140.63 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 125.278 1.431 . . . . 62.020000000000003 107.722 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -145.06 129.84 18.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.429 1.892 . . . . 65.430000000000007 106.916 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.99 146.57 41.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.004 1.322 . . . . 75.519999999999996 109.244 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -142.66 132.89 24.67 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.707 1.203 . . . . 71.200000000000003 110.303 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.63 121.89 64.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 C-N-CA 124.712 1.205 . . . . 62.140000000000001 107.99 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 43.05 51.83 5.39 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.361 1.465 . . . . 72.349999999999994 113.119 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.51 25.3 15.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.066 1.346 . . . . 74.450000000000003 113.392 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 p -132.66 161.47 33.86 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.479 1.036 . . . . 72.340000000000003 111.049 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.35 105.53 36.93 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 103.184 -2.895 . . . . 73.329999999999998 103.184 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.2 130.57 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.766 2.311 . . . . 74.409999999999997 111.967 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.32 125.84 27.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.166 -1.42 . . . . 74.340000000000003 107.166 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -55.75 -22.48 24.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 63.030000000000001 113.904 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -79.31 -18.41 52.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.466 1.107 . . . . 62.32 111.652 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.66 141.67 56.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.41 -0.806 . . . . 64.5 110.09 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.47 152.0 24.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.029 -1.1 . . . . 73.209999999999994 108.029 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 45.3 mmm -62.93 -42.46 99.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.175 -0.917 . . . . 50.43 110.278 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.42 97.6 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.798 0.727 . . . . 43.229999999999997 111.566 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -46.89 71.33 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.322 0.649 . . . . 72.420000000000002 109.4 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.43 -46.26 86.86 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.727 -0.472 . . . . 75.400000000000006 109.727 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.81 -45.3 94.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.245 1.418 . . . . 74.319999999999993 109.765 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.55 -33.35 75.48 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.968 0.907 . . . . 71.239999999999995 111.597 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -90.54 -23.5 20.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.264 -1.35 . . . . 75.400000000000006 113.488 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -110.35 -2.1 16.85 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.921 1.452 . . . . 71.109999999999999 114.921 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -45.23 121.85 3.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.969 1.259 . . . . 65.230000000000004 114.377 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -71.45 176.09 4.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.811 1.244 . . . . 64.109999999999999 108.36 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.82 -33.14 55.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.83 2.052 . . . . 74.239999999999995 111.81 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 10.34 36.01 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.151 1.78 . . . . 73.120000000000005 111.563 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.92 68.74 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.899 -1.126 . . . . 63.049999999999997 113.255 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -114.88 168.81 9.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.21 1.505 . . . . 71.040000000000006 109.889 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.53 136.43 54.55 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.685 0.394 . . . . 72.340000000000003 110.273 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -119.75 119.21 32.97 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.254 1.822 . . . . 74.439999999999998 109.084 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.18 144.0 38.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 121.11 -0.994 . . . . 74.439999999999998 109.294 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.56 21.02 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.698 0.799 . . . . 71.040000000000006 109.849 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -146.19 160.84 41.42 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.425 0.631 . . . . 61.130000000000003 110.797 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 p -151.62 161.35 42.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.719 1.208 . . . . 75.120000000000005 108.774 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.88 22.89 12.17 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.298 0.952 . . . . 72.239999999999995 111.909 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 132.2 37.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.308 1.843 . . . . 75.25 106.961 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -77.0 -27.54 54.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.086 0.47 . . . . 73.040000000000006 110.353 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.5 p -100.74 114.65 28.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.059 -1.83 . . . . 75.340000000000003 106.059 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -116.61 9.66 14.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.115 0.966 . . . . 74.540000000000006 111.767 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.695 0 CA-C-O 116.902 -2.054 . . . . 62.450000000000003 110.585 179.15 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 112.074 -0.41 . . . . 75.409999999999997 112.074 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.65 162.12 29.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.258 0.623 . . . . 62.399999999999999 110.826 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 50.2 mtt -76.62 70.6 3.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.408 1.483 . . . . 74.140000000000001 112.009 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -117.17 32.62 6.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.444 1.098 . . . . 63.299999999999997 109.566 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . 0.549 HD12 ' H ' ' B' ' 334' ' ' ILE . 1.1 mp -69.07 148.71 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.264 -1.013 . . . . 74.099999999999994 108.264 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 87.9 mt -72.03 -22.41 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.748 1.219 . . . . 74.450000000000003 109.792 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -89.15 77.2 7.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.986 -1.116 . . . . 74.439999999999998 107.986 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.2 143.66 33.08 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.501 1.92 . . . . 72.099999999999994 106.498 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.97 -33.5 11.18 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.426 0.632 . . . . 60.299999999999997 110.824 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -109.02 137.41 46.97 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.648 1.179 . . . . 71.329999999999998 108.688 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.73 -58.94 4.5 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.159 1.17 . . . . 74.120000000000005 114.159 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.452 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 51.3 m95 53.33 57.34 6.31 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.473 1.509 . . . . 73.409999999999997 111.823 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -77.7 141.09 25.06 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.789 -1.324 . . . . 63.340000000000003 109.789 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 28.8 mt -74.1 128.84 36.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 119.142 1.471 . . . . 75.439999999999998 109.437 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.22 126.75 30.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.073 0.949 . . . . 72.400000000000006 109.896 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.44 122.35 31.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 104.179 -2.526 . . . . 73.540000000000006 104.179 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 51.6 t -120.58 124.02 71.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.562 1.145 . . . . 41.310000000000002 109.163 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.4 p -161.19 151.65 17.85 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.947 0.34 . . . . 72.420000000000002 111.524 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 126.675 1.99 . . . . 75.129999999999995 111.408 -179.615 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 109.834 -0.432 . . . . 63.439999999999998 109.834 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.37 146.76 5.36 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.548 -1.421 . . . . 75.409999999999997 109.548 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -106.46 118.92 37.92 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.262 0.625 . . . . 74.129999999999995 110.573 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.3 tpt -55.35 -46.27 76.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.433 1.083 . . . . 63.119999999999997 108.327 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -60.53 -42.27 96.16 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 113.241 0.83 . . . . 74.25 113.241 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -67.13 -37.44 83.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 118.946 0.794 . . . . 73.319999999999993 110.672 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -65.04 -47.73 76.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.335 1.022 . . . . 64.430000000000007 108.467 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.48 -75.87 0.1 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.025 1.33 . . . . 52.539999999999999 113.033 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.38 131.73 5.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.883 1.673 . . . . 74.219999999999999 107.798 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.2 t -130.2 -58.66 1.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 115.724 1.75 . . . . 62.329999999999998 115.724 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.44 -57.29 12.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.728 1.604 . . . . 75.540000000000006 114.927 -176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 13' ' ' HIS . 1.3 pm0 -62.95 -51.02 68.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.083 0.468 . . . . 64.230000000000004 110.229 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.464 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 84.4 t60 -52.07 -44.83 64.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.022 2.129 . . . . 74.420000000000002 110.073 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -49.84 63.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 116.872 -1.537 . . . . 62.439999999999998 110.136 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.4 m -60.54 -48.83 80.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.917 1.08 . . . . 74.099999999999994 113.917 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.97 -47.53 90.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 121.705 -0.622 . . . . 72.030000000000001 109.894 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.35 -42.49 79.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.518 -0.754 . . . . 73.209999999999994 111.848 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -59.83 -45.02 93.7 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.272 -1.01 . . . . 75.120000000000005 108.272 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.85 -49.17 77.59 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.955 0.798 . . . . 60.210000000000001 110.851 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -61.03 -46.09 92.15 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.864 -1.148 . . . . 53.240000000000002 110.883 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.94 -41.65 93.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-O 117.735 -1.126 . . . . 71.200000000000003 109.441 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -66.69 -41.07 88.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.581 1.537 . . . . 72.299999999999997 110.521 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.76 68.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.596 -0.441 . . . . 63.399999999999999 110.852 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -77.71 -33.11 53.2 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.651 0.982 . . . . 53.520000000000003 113.651 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.17 82.07 25.04 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.429 1.492 . . . . 63.299999999999997 111.009 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.77 -29.1 36.06 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.888 2.392 . . . . 72.140000000000001 112.602 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.81 13.23 13.01 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.876 0.871 . . . . 72.129999999999995 110.956 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -121.56 152.35 39.32 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.525 -1.359 . . . . 72.030000000000001 109.749 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 m -121.24 140.73 31.71 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 124.007 0.923 . . . . 73.019999999999996 108.584 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.08 117.66 3.57 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 125.141 3.894 . . . . 71.450000000000003 111.931 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.2 t -120.45 140.91 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.047 1.339 . . . . 64.329999999999998 108.675 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.09 135.33 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.585 -2.376 . . . . 72.409999999999997 104.585 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.73 134.85 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.251 0.62 . . . . 63.210000000000001 109.491 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.85 143.66 43.19 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.888 0.875 . . . . 65.510000000000005 108.701 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.62 143.09 31.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.299 -1.371 . . . . 71.109999999999999 107.299 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.82 108.12 6.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 103.07 -2.937 . . . . 62.219999999999999 103.07 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -53.75 132.67 41.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.785 -0.82 . . . . 52.32 108.785 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.2 40.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.836 1.207 . . . . 40.229999999999997 112.235 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.9 m -81.98 137.63 35.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.539 1.67 . . . . 71.010000000000005 108.027 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -66.2 -11.26 48.62 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.524 0.729 . . . . 53.140000000000001 112.803 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.441 ' CD1' HD23 ' A' ' 70' ' ' LEU . 8.8 tp -60.96 154.37 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.602 0.761 . . . . 75.510000000000005 109.323 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.65 144.97 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.405 1.082 . . . . 55.240000000000002 110.186 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.77 167.13 18.44 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.26 2.224 . . . . 72.030000000000001 112.508 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.61 148.33 31.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 125.194 1.398 . . . . 73.310000000000002 110.267 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.5 163.47 20.45 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.923 0.889 . . . . 74.129999999999995 108.954 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.89 95.83 5.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.019 -1.104 . . . . 72.439999999999998 108.019 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.03 168.23 18.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.137 0.975 . . . . 74.519999999999996 109.895 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -116.35 99.26 7.07 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.294 -2.113 . . . . 73.239999999999995 105.294 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -83.89 136.66 34.02 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.609 -0.723 . . . . 74.5 109.053 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -118.94 119.2 33.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.494 1.118 . . . . 75.310000000000002 110.232 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.439 HG21 ' SD ' ' A' ' 91' ' ' MET . 17.6 m -111.81 142.12 26.07 Favored Pre-proline 0 N--CA 1.47 0.537 0 CA-C-O 117.577 -1.202 . . . . 72.109999999999999 112.232 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.12 141.33 23.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.713 2.275 . . . . 71.310000000000002 109.579 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -63.4 -12.84 33.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.585 0.957 . . . . 75.25 113.585 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.89 -34.26 66.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.645 2.778 . . . . 71.439999999999998 113.445 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 pt -85.09 165.87 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.745 1.157 . . . . 70.349999999999994 111.775 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 54.8 p -99.92 168.79 9.65 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.784 0.834 . . . . 75.409999999999997 111.255 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.92 -36.43 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.714 -1.217 . . . . 65.329999999999998 107.714 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.83 90.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.737 0.815 . . . . 74.430000000000007 110.936 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -66.4 -44.96 81.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.614 -0.708 . . . . 65.219999999999999 109.744 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 64' ' ' ILE . 4.1 t80 -58.8 -54.51 46.23 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.253 -1.017 . . . . 73.510000000000005 108.253 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.4 ttp -52.63 -49.19 65.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.512 1.525 . . . . 53.329999999999998 110.935 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -57.11 -42.28 80.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.464 0.705 . . . . 72.519999999999996 111.693 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.46 -39.63 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 118.086 -0.959 . . . . 71.540000000000006 108.792 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 4.4 mt -62.31 -50.04 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 120.701 1.591 . . . . 75.450000000000003 109.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.15 -39.16 81.58 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 118.186 -0.912 . . . . 75.030000000000001 111.962 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -68.58 -40.59 80.45 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.051 0.841 . . . . 72.420000000000002 109.223 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -59.51 -49.07 79.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.275 1.03 . . . . 73.219999999999999 111.498 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 pt -79.46 -0.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 119.468 -0.301 . . . . 62.450000000000003 111.277 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 57.51 52.32 8.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.741 1.617 . . . . 73.319999999999993 110.984 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.5 tm? -68.18 108.96 3.24 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.416 1.486 . . . . 72.340000000000003 110.553 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.82 152.8 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.122 2.548 . . . . 75.530000000000001 109.968 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.1 m -58.95 -20.83 55.99 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.403 -0.811 . . . . 75.310000000000002 113.181 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -39.51 90.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.407 1.003 . . . . 52.109999999999999 109.734 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -96.48 163.61 12.97 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.285 1.034 . . . . 55.030000000000001 108.865 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.92 171.08 7.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.001 1.321 . . . . 73.420000000000002 108.579 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 tp -146.12 133.75 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.554 1.142 . . . . 65.209999999999994 108.158 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -145.46 142.26 29.11 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.179 1.792 . . . . 75.120000000000005 108.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -114.14 155.83 25.32 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.525 1.53 . . . . 64.439999999999998 111.039 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -147.31 126.84 13.24 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 125.115 1.509 . . . . 64.150000000000006 111.18 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.87 126.03 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.474 -2.047 . . . . 74.310000000000002 105.474 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 49.48 34.53 6.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.761 1.164 . . . . 60.140000000000001 112.961 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp 60.88 31.14 20.0 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.063 -1.648 . . . . 54.149999999999999 110.154 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -130.18 161.38 31.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.324 1.85 . . . . 74.409999999999997 109.788 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -102.49 103.68 33.25 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 126.508 1.923 . . . . 74.349999999999994 108.832 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.6 136.99 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.539 1.492 . . . . 72.439999999999998 108.965 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.0 132.17 44.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.76 0.314 . . . . 72.219999999999999 110.311 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.4 p -51.89 -45.54 64.22 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.282 2.233 . . . . 40.039999999999999 112.703 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -73.74 -11.84 60.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.694 1.197 . . . . 51.439999999999998 114.047 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.42 146.74 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.037 1.289 . . . . 65.439999999999998 108.665 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 30.4 p -86.08 156.57 20.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.694 -0.629 . . . . 63.109999999999999 109.424 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 51' ' ' VAL . 14.4 mmt -61.38 -44.44 97.15 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 118.538 -0.744 . . . . 74.140000000000001 110.641 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.11 -45.49 95.2 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.351 -0.928 . . . . 61.329999999999998 111.396 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.86 -49.46 72.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.799 0.8 . . . . 73.540000000000006 111.2 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.59 -46.69 88.19 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 123.055 0.542 . . . . 44.020000000000003 110.459 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.43 -56.92 14.89 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.252 1.021 . . . . 53.039999999999999 108.943 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.28 -32.0 64.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.623 -0.703 . . . . 72.140000000000001 111.37 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -25.26 20.26 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 116.342 -1.79 . . . . 63.43 113.828 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -103.42 -2.22 27.28 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.298 1.863 . . . . 71.420000000000002 112.604 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.23 121.72 1.18 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.114 2.165 . . . . 74.400000000000006 113.955 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.71 174.64 8.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.454 1.502 . . . . 53.119999999999997 110.132 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.49 -35.58 72.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.877 1.217 . . . . 63.329999999999998 108.525 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.15 12.92 31.06 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.77 0.828 . . . . 64.340000000000003 112.51 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.38 28.38 67.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.351 -1.249 . . . . 61.219999999999999 114.862 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -109.44 158.71 17.68 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.948 1.874 . . . . 65.319999999999993 107.932 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 138.0 54.13 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.608 -1.256 . . . . 64.549999999999997 107.608 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -122.35 131.5 53.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.657 1.183 . . . . 74.530000000000001 108.287 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.63 138.73 53.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.545 -1.28 . . . . 72.430000000000007 107.545 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.69 142.14 44.4 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.954 -2.239 . . . . 62.219999999999999 104.954 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -133.96 151.63 51.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.345 0.593 . . . . 75.549999999999997 110.432 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.9 t -147.21 165.04 31.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.689 -1.226 . . . . 65.219999999999999 107.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.81 15.61 19.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.079 -2.008 . . . . 74.219999999999999 108.079 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -115.42 115.94 27.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.401 1.88 . . . . 50.049999999999997 107.006 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -5.76 5.56 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.467 1.284 . . . . 74.049999999999997 114.467 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.19 131.66 25.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.502 1.521 . . . . 73.200000000000003 108.894 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -117.22 9.56 13.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.533 1.533 . . . . 71.219999999999999 111.78 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.845 1.688 . . . . 73.409999999999997 110.69 -179.481 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 110.87 -0.892 . . . . 72.040000000000006 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -95.04 68.86 3.2 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.282 1.433 . . . . 73.299999999999997 108.799 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -115.79 13.98 16.22 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.424 1.268 . . . . 51.329999999999998 114.424 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -71.25 51.27 0.16 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.479 2.312 . . . . 71.010000000000005 112.826 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 13.9 pt -64.35 140.4 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 120.707 -1.245 . . . . 65.340000000000003 109.104 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 63.7 mt -108.24 -21.76 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.456 1.502 . . . . 70.140000000000001 110.129 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -83.65 83.54 7.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 120.911 -1.118 . . . . 52.310000000000002 111.939 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.07 109.49 14.57 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 101.864 -3.384 . . . . 75.219999999999999 101.864 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.52 -30.58 59.85 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.154 -0.966 . . . . 75.299999999999997 112.092 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -88.1 155.19 19.92 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.432 1.093 . . . . 54.450000000000003 110.729 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.26 -63.16 1.47 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 71.0 113.324 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 58.1 m95 57.22 61.16 2.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.91 0.777 . . . . 74.310000000000002 111.62 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -79.49 135.68 15.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.384 -1.086 . . . . 74.0 110.384 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.9 123.79 32.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 118.756 1.278 . . . . 72.340000000000003 110.006 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -132.37 118.83 19.89 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.534 1.134 . . . . 72.219999999999999 109.14 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.9 tt -83.17 118.57 23.69 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.724 1.61 . . . . 62.25 108.44 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.31 128.63 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.679 1.192 . . . . 62.420000000000002 110.741 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.9 p -159.31 153.46 23.62 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 71.400000000000006 108.639 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.172 1.789 . . . . 73.439999999999998 106.515 178.535 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.658 -0.497 . . . . 75.129999999999995 109.658 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.88 -168.61 14.18 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.686 1.612 . . . . 52.450000000000003 110.02 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -76.08 111.13 11.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.089 -0.708 . . . . 74.209999999999994 109.089 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -51.53 -45.76 63.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.082 0.944 . . . . 74.430000000000007 110.737 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -60.55 -40.62 92.25 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 121.499 -0.75 . . . . 74.310000000000002 112.726 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -67.1 -36.31 81.66 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.616 0.766 . . . . 74.219999999999999 112.177 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -67.59 -41.01 84.75 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.626 -0.879 . . . . 73.150000000000006 108.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -75.12 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.738 -0.664 . . . . 65.230000000000004 111.6 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.61 125.13 3.67 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.696 1.998 . . . . 74.25 110.374 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.3 p -117.11 -65.85 1.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 116.305 -1.807 . . . . 73.030000000000001 114.211 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.1 mt -48.0 -58.36 4.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.326 1.875 . . . . 64.209999999999994 114.842 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.5 -37.09 85.95 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.215 -0.928 . . . . 63.229999999999997 111.785 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -62.97 -57.04 12.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.303 1.041 . . . . 65.439999999999998 108.403 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -47.48 85.01 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.72 1.608 . . . . 62.530000000000001 110.987 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -56.57 -53.97 51.35 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.445 1.021 . . . . 72.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.598 HG12 ' HE2' ' A' ' 20' ' ' LYS . 43.6 t -63.07 -47.04 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 122.398 -0.189 . . . . 74.040000000000006 111.262 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' HD12 ' A' ' 21' ' ' ILE . 65.0 tt0 -57.0 -52.11 66.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.947 1.299 . . . . 75.140000000000001 110.335 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -60.19 -48.28 82.39 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.985 1.314 . . . . 73.0 110.455 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -49.39 76.74 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.42 0.555 . . . . 54.329999999999998 110.943 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HE2' HG12 ' A' ' 16' ' ' VAL . 55.3 mtmt -65.39 -44.31 87.89 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.631 0.372 . . . . 52.119999999999997 110.55 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 17' ' ' GLU . 49.8 mt -61.72 -42.64 95.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.365 -1.303 . . . . 72.519999999999996 110.402 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.08 -33.76 72.31 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 120.325 1.421 . . . . 73.340000000000003 110.263 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -47.12 74.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 119.465 -0.894 . . . . 75.109999999999999 109.986 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -77.75 -47.27 19.46 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.346 1.239 . . . . 73.109999999999999 114.346 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -129.25 77.27 77.88 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.562 1.945 . . . . 61.200000000000003 109.755 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.63 -28.71 44.38 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.159 2.572 . . . . 75.340000000000003 112.487 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -89.66 14.02 12.72 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.905 0.482 . . . . 72.219999999999999 111.948 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -120.48 146.24 46.46 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.849 -1.537 . . . . 71.040000000000006 106.849 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.57 143.49 28.27 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.191 -1.04 . . . . 54.530000000000001 108.191 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.03 127.2 8.35 Favored 'Trans proline' 0 C--N 1.352 0.752 1 C-N-CA 125.725 4.283 . . . . 65.420000000000002 113.095 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.59 145.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.863 0.865 . . . . 64.329999999999998 111.16 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.4 mm -122.09 135.44 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 103.8 -2.667 . . . . 61.219999999999999 103.8 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -122.68 114.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.854 1.262 . . . . 74.450000000000003 108.511 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.86 153.92 46.98 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 71.099999999999994 108.893 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -93.48 153.4 18.49 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.147 -0.971 . . . . 72.340000000000003 113.036 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.66 126.07 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.616 -1.994 . . . . 75.349999999999994 105.616 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.0 t -58.79 141.09 54.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.75 -0.463 . . . . 51.219999999999999 109.75 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.52 23.95 77.05 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.233 -1.315 . . . . 74.010000000000005 113.964 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 t -97.58 142.3 29.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.527 1.663 . . . . 71.239999999999995 108.211 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -65.81 -9.74 31.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.227 1.195 . . . . 70.120000000000005 114.227 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.37 160.82 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.277 0.944 . . . . 74.019999999999996 111.138 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -64.2 142.24 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.272 -1.01 . . . . 74.209999999999994 108.272 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.32 161.27 28.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.635 1.174 . . . . 73.120000000000005 107.852 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.9 tt -120.68 135.48 60.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.677 -1.231 . . . . 74.340000000000003 107.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.49 159.7 32.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.885 -1.524 . . . . 74.239999999999995 106.885 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -73.9 108.17 6.56 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.495 -1.378 . . . . 73.400000000000006 110.285 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -136.04 159.07 42.82 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.823 1.249 . . . . 72.540000000000006 112.021 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 14.8 mttt -104.68 99.26 8.92 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 105.42 -2.067 . . . . 64.450000000000003 105.42 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.73 116.76 23.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.706 1.602 . . . . 73.430000000000007 110.016 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -104.6 120.0 40.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 117.43 -1.271 . . . . 62.140000000000001 109.394 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -113.07 142.97 28.26 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 120.281 1.401 . . . . 74.129999999999995 111.527 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.18 141.17 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.767 1.645 . . . . 65.219999999999999 108.576 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -62.98 -18.25 63.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.206 2.202 . . . . 73.230000000000004 113.227 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -82.67 -30.69 29.11 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.213 1.19 . . . . 64.120000000000005 114.213 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.89 170.52 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.715 0.769 . . . . 73.420000000000002 111.393 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -107.13 156.92 18.28 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.124 0.97 . . . . 74.120000000000005 111.688 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.28 -35.91 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.858 1.663 . . . . 74.439999999999998 109.631 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.39 93.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.768 1.227 . . . . 75.319999999999993 111.539 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.33 -42.15 93.24 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.925 -0.768 . . . . 73.340000000000003 108.925 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.46 -44.04 93.07 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.165 -1.05 . . . . 53.130000000000003 108.165 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.5 ttp -59.65 -48.39 81.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.43 -0.795 . . . . 64.109999999999999 110.927 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -58.89 -42.0 88.5 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.342 0.974 . . . . 75.040000000000006 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -66.42 -43.27 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.015 -0.993 . . . . 74.319999999999993 109.699 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.48 -50.7 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 120.212 1.369 . . . . 74.430000000000007 110.1 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -59.67 -39.19 83.65 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 120.996 -1.065 . . . . 63.409999999999997 111.513 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -70.81 -39.07 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.018 0.826 . . . . 45.229999999999997 110.615 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -60.15 -49.3 78.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.529 1.132 . . . . 75.219999999999999 109.708 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.4 pt -79.23 -0.95 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.949 0.34 . . . . 73.299999999999997 111.476 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 55.65 52.86 10.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.386 1.474 . . . . 75.299999999999997 108.696 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -69.49 106.63 1.62 Allowed Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 126.856 2.062 . . . . 73.239999999999995 108.452 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.32 157.69 56.26 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.327 2.018 . . . . 55.119999999999997 109.653 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -58.48 -28.08 65.03 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.485 -0.76 . . . . 60.310000000000002 112.713 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.65 -33.04 71.02 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.335 1.054 . . . . 75.040000000000006 112.214 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -102.33 164.26 11.78 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.36 -1.348 . . . . 65.140000000000001 107.36 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.4 172.31 6.93 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.876 1.271 . . . . 54.420000000000002 108.789 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -143.98 117.22 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.44 1.096 . . . . 74.430000000000007 108.587 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -124.59 137.55 54.38 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.67 -1.604 . . . . 71.400000000000006 106.67 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.9 148.92 33.94 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.008 1.323 . . . . 75.019999999999996 109.532 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -143.55 128.26 18.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.692 1.197 . . . . 75.140000000000001 109.962 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.95 122.12 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.204 -1.406 . . . . 72.420000000000002 107.204 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.06 34.46 14.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.34 1.456 . . . . 71.239999999999995 111.251 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 63.9 26.62 14.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.721 1.208 . . . . 73.530000000000001 110.322 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -119.58 161.88 19.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.456 1.102 . . . . 61.439999999999998 109.326 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.7 103.34 27.61 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 104.524 -2.399 . . . . 64.319999999999993 104.524 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.56 142.83 45.36 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.047 1.831 . . . . 73.310000000000002 110.374 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -77.47 114.22 16.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.825 -1.546 . . . . 61.299999999999997 106.825 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.0 m -54.39 -26.84 32.73 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.129 1.772 . . . . 71.349999999999994 112.818 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -86.89 -6.61 58.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.399 -0.813 . . . . 52.219999999999999 113.056 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 tp -75.15 158.58 32.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.569 1.077 . . . . 75.340000000000003 108.933 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.3 p -93.24 161.81 14.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.465 0.575 . . . . 35.219999999999999 109.72 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.9 mmm -64.27 -46.68 82.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.906 -1.045 . . . . 75.299999999999997 111.653 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.04 74.72 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.333 0.97 . . . . 54.130000000000003 111.172 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.72 -51.96 62.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.751 0.82 . . . . 71.420000000000002 110.628 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 tt -59.04 -44.14 91.75 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.511 -0.28 . . . . 75.439999999999998 110.58 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -65.69 -54.71 23.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.876 0.762 . . . . 71.510000000000005 109.544 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -58.67 -30.7 67.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.043 0.838 . . . . 72.510000000000005 111.638 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -40.85 16.76 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.367 -1.301 . . . . 73.209999999999994 110.36 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.53 6.51 43.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.042 1.292 . . . . 70.239999999999995 113.306 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.51 121.26 6.11 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.429 1.468 . . . . 71.120000000000005 111.731 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.14 174.89 4.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.047 2.139 . . . . 73.0 110.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.15 -30.76 68.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.654 -1.279 . . . . 73.519999999999996 108.939 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -102.31 6.82 40.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.184 2.194 . . . . 64.010000000000005 112.768 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.73 28.41 65.51 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.482 -1.176 . . . . 71.510000000000005 116.007 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -114.06 134.96 54.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 120.08 1.94 . . . . 73.450000000000003 107.453 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.38 133.45 39.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.509 1.05 . . . . 45.450000000000003 109.408 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -123.14 123.72 41.44 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.843 1.657 . . . . 74.5 107.726 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.04 136.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 C-N-CA 124.729 1.212 . . . . 73.120000000000005 109.543 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.39 148.86 32.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.446 0.698 . . . . 73.129999999999995 110.815 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -132.96 155.16 49.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.51 0.929 . . . . 75.340000000000003 113.51 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.8 p -146.61 159.47 43.4 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.506 0.67 . . . . 51.149999999999999 110.881 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.21 22.31 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.818 1.675 . . . . 61.439999999999998 112.08 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -121.14 127.38 51.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.794 1.638 . . . . 74.209999999999994 107.593 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.0 -28.03 64.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.059 0.944 . . . . 73.209999999999994 109.938 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.19 121.06 28.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.604 1.961 . . . . 65.010000000000005 106.147 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -117.06 11.03 14.11 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.598 1.159 . . . . 71.230000000000004 111.909 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 116.488 -2.284 . . . . 73.129999999999995 110.666 -179.47 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 109.123 -1.591 . . . . 72.340000000000003 109.123 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -56.64 164.84 1.32 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.389 1.076 . . . . 72.400000000000006 111.107 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 35.0 mtm -108.32 70.49 0.76 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.459 1.103 . . . . 52.43 108.525 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.07 49.9 1.08 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.107 1.763 . . . . 75.230000000000004 109.754 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 47.5 pt -67.79 164.66 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 120.56 -1.338 . . . . 55.340000000000003 111.705 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.15 -6.07 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.181 0.592 . . . . 64.209999999999994 111.972 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -113.1 50.24 0.9 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.779 1.631 . . . . 73.209999999999994 109.791 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -82.95 108.67 16.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.143 -1.799 . . . . 71.420000000000002 106.143 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.43 -29.15 30.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.547 0.689 . . . . 72.340000000000003 111.572 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -75.77 124.28 27.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.91 1.684 . . . . 70.530000000000001 109.939 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -92.45 -63.41 1.23 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.296 0.953 . . . . 52.310000000000002 112.221 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.489 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 50.8 m95 51.85 66.48 1.19 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.85 1.205 . . . . 75.140000000000001 112.956 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -84.69 145.0 21.59 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.027 -1.629 . . . . 30.120000000000001 109.027 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.0 134.76 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 119.418 1.609 . . . . 72.200000000000003 110.003 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -138.61 126.2 22.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.938 0.895 . . . . 65.310000000000002 110.579 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.81 118.51 29.46 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.386 -1.709 . . . . 70.140000000000001 106.386 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 14.7 t -122.35 113.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.279 0.474 . . . . 43.43 112.279 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 65.8 p -155.13 154.14 31.88 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.796 -1.187 . . . . 73.019999999999996 107.796 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.243 0.732 0 C-N-CA 126.936 2.095 . . . . 72.549999999999997 106.228 -179.728 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.055 -0.498 . . . . 53.140000000000001 110.108 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.83 64.6 4.21 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.282 0.944 . . . . 73.349999999999994 112.921 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -76.1 113.58 13.79 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.595 -0.521 . . . . 73.329999999999998 109.595 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -62.63 -42.74 99.76 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.394 -0.224 . . . . 74.319999999999993 110.394 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -56.77 -52.14 66.19 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.507 -0.553 . . . . 75.120000000000005 109.507 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -64.94 -34.11 77.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.063 1.345 . . . . 74.319999999999993 112.44 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -60.74 -48.89 79.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.441 -0.948 . . . . 70.25 108.441 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.49 -69.24 0.42 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.858 0.724 . . . . 70.329999999999998 110.147 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.01 143.66 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.962 1.305 . . . . 72.310000000000002 111.474 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 t -130.57 -65.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 117.322 -1.323 . . . . 75.310000000000002 112.566 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.2 mt -43.08 -60.69 1.55 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 116.477 2.028 . . . . 73.140000000000001 116.477 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.27 -48.01 68.98 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 120.719 -1.238 . . . . 73.140000000000001 110.418 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -51.91 -46.39 64.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.647 1.179 . . . . 71.439999999999998 111.052 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -43.69 91.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 116.683 -1.627 . . . . 64.129999999999995 108.439 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.3 t -64.38 -40.11 95.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.61 1.095 . . . . 64.450000000000003 110.46 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.15 -48.05 79.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 120.083 -1.635 . . . . 60.229999999999997 108.066 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -38.26 90.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.526 -0.749 . . . . 64.530000000000001 110.749 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.9 p -59.82 -48.05 83.27 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.448 -1.316 . . . . 61.439999999999998 107.448 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.35 -50.56 71.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.821 0.448 . . . . 73.5 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -61.77 -52.03 65.91 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.843 0.857 . . . . 61.240000000000002 112.399 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.48 -41.79 72.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 116.689 -1.624 . . . . 74.329999999999998 111.037 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -64.5 -31.22 72.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.811 2.096 . . . . 70.109999999999999 109.263 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.03 -46.67 56.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 118.094 0.406 . . . . 54.229999999999997 110.84 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -77.81 -47.77 18.12 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.774 1.398 . . . . 73.209999999999994 114.774 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -126.22 80.59 68.32 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 126.273 1.829 . . . . 74.030000000000001 108.107 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.35 -35.3 51.23 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.556 2.171 . . . . 52.130000000000003 109.353 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.86 20.76 3.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.733 1.213 . . . . 71.420000000000002 114.272 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -125.84 155.77 40.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 120.214 -1.553 . . . . 63.409999999999997 108.01 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 m -126.91 138.73 33.26 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.019 0.928 . . . . 74.510000000000005 110.25 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HG2' ' HA ' ' A' ' 104' ' ' PHE . 68.5 Cg_endo -77.89 120.03 4.93 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 125.279 3.986 . . . . 63.310000000000002 113.307 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.5 135.61 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.003 1.321 . . . . 74.150000000000006 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.94 118.36 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.962 -2.236 . . . . 72.349999999999994 104.962 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.65 124.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.063 1.745 . . . . 75.150000000000006 106.895 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.97 139.17 54.06 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.54 -1.281 . . . . 72.209999999999994 107.54 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tmmt? -72.66 140.4 47.9 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.637 0.775 . . . . 75.109999999999999 110.414 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.84 126.17 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 125.008 1.323 . . . . 74.230000000000004 107.57 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.2 p -55.47 122.18 10.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.877 0.871 . . . . 62.130000000000003 109.359 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.73 9.42 66.34 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 118.618 -1.101 . . . . 75.409999999999997 114.723 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 t -86.06 146.44 26.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.364 1.582 . . . . 74.530000000000001 110.653 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -65.25 -24.86 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.411 1.084 . . . . 75.239999999999995 111.383 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -66.11 162.79 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.426 -1.422 . . . . 75.420000000000002 113.475 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.3 141.47 16.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 125.15 1.38 . . . . 51.119999999999997 108.359 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 2.6 p30 -81.78 170.21 15.99 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.588 0.755 . . . . 74.319999999999993 110.312 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 tt -126.65 149.56 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.222 1.409 . . . . 74.030000000000001 107.803 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -76.57 166.01 23.99 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.347 1.059 . . . . 73.109999999999999 109.164 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -73.71 95.77 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 72.219999999999999 106.402 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -134.94 159.07 42.62 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.239 1.416 . . . . 75.239999999999995 107.336 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -113.56 104.28 12.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.733 -1.21 . . . . 63.420000000000002 107.733 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' B' ' 346' ' ' VAL . 5.1 m-30 -84.17 145.67 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.337 0.971 . . . . 71.510000000000005 110.381 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.44 112.1 18.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.594 1.558 . . . . 72.099999999999994 108.631 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.69 142.19 25.26 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.096 -0.954 . . . . 62.299999999999997 110.676 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' B' ' 347' ' ' SER . 76.8 Cg_endo -74.94 141.39 26.77 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.572 2.848 . . . . 72.540000000000006 112.72 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.29 -21.7 60.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.373 1.469 . . . . 74.310000000000002 114.562 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -78.54 -32.87 48.11 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 114.961 1.467 . . . . 63.399999999999999 114.961 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -73.52 166.07 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.707 1.14 . . . . 71.010000000000005 110.709 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -102.43 161.24 13.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.38 1.072 . . . . 71.540000000000006 109.934 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.16 -35.9 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.569 1.148 . . . . 73.409999999999997 110.396 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.3 93.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.909 0.777 . . . . 54.5 109.977 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -63.43 -46.32 86.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.619 -0.882 . . . . 73.230000000000004 108.619 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.49 -45.75 90.79 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.53 -0.545 . . . . 72.519999999999996 109.53 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.21 -40.18 84.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.992 0.917 . . . . 64.409999999999997 109.78 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -68.11 -39.18 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.647 0.658 . . . . 75.140000000000001 110.321 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.31 -44.49 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.888 -1.153 . . . . 74.310000000000002 107.888 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.76 -51.12 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.742 1.155 . . . . 61.340000000000003 111.147 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -59.93 -39.03 84.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.034 0.834 . . . . 74.209999999999994 110.834 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -70.06 -43.34 71.41 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.778 0.717 . . . . 75.0 109.967 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.84 -49.55 72.98 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.115 1.366 . . . . 74.340000000000003 110.936 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.69 -0.47 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.062 0.851 . . . . 64.140000000000001 112.181 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 58.3 55.74 4.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.328 1.451 . . . . 75.109999999999999 111.571 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' HD2' ' A' ' 71' ' ' PRO . 1.1 tm? -68.79 109.22 3.86 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 106.623 -1.621 . . . . 45.539999999999999 106.623 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD2' HD22 ' A' ' 70' ' ' LEU . 88.3 Cg_endo -73.06 164.65 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.986 3.124 . . . . 71.519999999999996 111.683 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 m -60.09 -27.39 66.96 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.516 0.326 . . . . 70.319999999999993 111.114 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.48 -38.46 89.92 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.253 -0.879 . . . . 64.409999999999997 113.367 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 165.35 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.113 1.324 . . . . 65.409999999999997 112.115 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.03 177.36 4.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.968 1.707 . . . . 71.319999999999993 107.921 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tp -145.98 138.85 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.349 1.06 . . . . 65.25 110.353 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.39 139.49 26.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.351 1.86 . . . . 61.030000000000001 109.642 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -115.04 147.39 40.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.988 2.115 . . . . 64.310000000000002 107.598 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.46 123.18 17.49 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.741 -1.577 . . . . 63.210000000000001 106.741 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.94 123.36 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 108.52 -0.919 . . . . 32.210000000000001 108.52 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 43.88 35.34 1.08 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.053 1.741 . . . . 63.32 112.601 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 66.04 38.07 5.0 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.158 1.783 . . . . 74.409999999999997 113.484 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.0 p -135.1 157.59 46.54 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.942 2.097 . . . . 74.150000000000006 107.501 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.99 110.81 63.23 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 105.446 -2.057 . . . . 65.209999999999994 105.446 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.39 123.48 10.89 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.763 1.642 . . . . 40.100000000000001 109.545 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -67.23 124.41 23.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.47 0.708 . . . . 55.299999999999997 109.409 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.42 -33.26 65.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.668 1.187 . . . . 73.319999999999993 112.317 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -4.65 51.17 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.947 -1.095 . . . . 72.25 112.551 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.17 146.44 37.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.324 1.42 . . . . 74.329999999999998 108.936 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.21 149.07 26.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.977 0.911 . . . . 72.049999999999997 108.906 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.3 mmt -55.43 -49.41 72.49 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.721 -1.133 . . . . 73.219999999999999 110.109 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.91 -41.74 94.38 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.838 0.745 . . . . 73.430000000000007 112.295 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.49 -49.58 70.82 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.279 1.039 . . . . 74.030000000000001 109.247 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -44.43 96.0 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 124.661 1.184 . . . . 75.129999999999995 111.147 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.71 -50.68 72.51 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.154 1.381 . . . . 75.430000000000007 108.172 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -65.18 -28.51 69.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.184 -0.912 . . . . 73.510000000000005 112.357 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -28.56 17.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.309 -1.329 . . . . 50.43 113.644 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -105.17 -2.88 23.66 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.882 1.438 . . . . 74.420000000000002 114.882 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -37.92 121.42 0.93 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.351 2.261 . . . . 71.230000000000004 113.799 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.91 162.99 26.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.012 -1.107 . . . . 74.329999999999998 108.012 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.86 -31.76 67.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.901 0.88 . . . . 73.019999999999996 110.423 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -85.97 -35.36 20.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.898 -1.149 . . . . 64.0 107.898 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.21 3.84 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 117.626 1.81 . . . . 72.420000000000002 117.626 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 7.3 p90 -82.86 179.18 7.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.747 0.773 . . . . 73.319999999999993 111.246 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tp -122.51 124.49 43.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.365 -0.976 . . . . 72.049999999999997 108.365 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -108.19 113.27 26.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.148 1.379 . . . . 71.230000000000004 109.782 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.07 147.07 32.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.255 1.026 . . . . 75.430000000000007 109.991 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.81 148.52 36.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.744 -1.206 . . . . 73.129999999999995 107.744 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -137.27 153.94 50.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.382 0.61 . . . . 63.020000000000003 111.621 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -147.43 168.86 20.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.572 1.149 . . . . 54.5 108.204 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.38 18.28 15.76 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-O 118.761 -1.022 . . . . 74.319999999999993 112.049 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -137.47 134.21 35.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.448 1.624 . . . . 71.030000000000001 108.001 -177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -69.08 -6.44 28.33 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.946 2.202 . . . . 64.230000000000004 116.946 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.98 108.88 10.12 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.687 -1.597 . . . . 72.430000000000007 106.687 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -106.74 22.51 15.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.317 1.847 . . . . 74.450000000000003 112.816 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 127.126 2.298 . . . . 42.200000000000003 115.013 -179.627 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.56 0 N-CA-C 109.308 -1.517 . . . . 62.229999999999997 109.308 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -170.26 85.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.469 1.908 . . . . 24.420000000000002 106.102 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 43.1 mtt -82.56 28.82 0.46 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.44 -1.412 . . . . 73.420000000000002 112.188 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -67.98 47.72 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 130.245 3.418 . . . . 62.439999999999998 112.808 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 2.0 pp -69.37 162.43 3.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.05 -1.093 . . . . 75.010000000000005 108.05 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 35.9 mt -118.14 -58.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.095 -1.076 . . . . 75.329999999999998 108.095 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -74.62 83.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.4 1.08 . . . . 73.140000000000001 109.056 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -70.75 109.82 5.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 104.186 -2.524 . . . . 73.5 104.186 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -50.43 -33.43 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.867 1.667 . . . . 74.25 113.753 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -109.61 164.28 12.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.002 1.321 . . . . 74.310000000000002 111.405 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.9 -57.57 3.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.534 -0.543 . . . . 63.219999999999999 109.534 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 17.6 m95 48.97 55.62 9.01 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 126.072 1.749 . . . . 65.209999999999994 111.974 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.82 126.82 7.61 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.588 -1.005 . . . . 71.209999999999994 110.588 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 59.5 mt -68.77 138.13 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.132 0.966 . . . . 52.310000000000002 109.657 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.93 139.93 36.28 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.638 0.775 . . . . 75.540000000000006 112.836 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 77.6 mt -88.41 111.1 21.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.75 -1.574 . . . . 74.239999999999995 106.75 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 49' ' ' TYR . 41.1 t -121.8 112.69 36.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 123.904 0.881 . . . . 71.540000000000006 110.645 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . 0.41 ' HB3' ' HD3' ' A' ' 52' ' ' PRO . 1.4 p -161.24 160.83 30.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.184 0.994 . . . . 73.439999999999998 112.528 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--O 1.247 0.928 0 C-N-CA 129.32 3.048 . . . . 63.509999999999998 113.7 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 109.373 -0.603 . . . . 74.340000000000003 109.373 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.38 159.93 18.7 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.54 2.019 . . . . 74.209999999999994 109.178 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -106.05 114.62 28.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.479 1.14 . . . . 74.099999999999994 111.206 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -46.99 85.89 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.974 0.51 . . . . 75.549999999999997 110.139 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -59.65 -46.82 87.86 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.067 -0.396 . . . . 75.439999999999998 111.523 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.93 -36.57 84.81 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.474 -0.774 . . . . 74.230000000000004 112.641 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -71.82 -41.01 68.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.859 0.754 . . . . 71.450000000000003 111.662 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.02 -76.22 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.647 1.179 . . . . 73.120000000000005 110.854 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -160.96 119.68 2.52 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.79 1.636 . . . . 71.129999999999995 107.417 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -106.89 -65.92 1.05 Allowed 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.75 -0.594 . . . . 74.219999999999999 112.519 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -44.24 -59.24 2.46 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.986 2.115 . . . . 63.229999999999997 116.61 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 72.5 mt-10 -66.32 -36.55 83.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.667 1.121 . . . . 64.230000000000004 110.33 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.08 -54.73 37.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.202 -0.666 . . . . 75.430000000000007 109.202 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.11 89.54 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.835 1.654 . . . . 70.400000000000006 111.467 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -54.9 -53.28 57.5 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.814 0.734 . . . . 61.450000000000003 110.375 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.66 -46.73 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 122.795 0.438 . . . . 72.329999999999998 110.752 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.01 62.97 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.543 1.137 . . . . 62.130000000000003 112.462 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 m -65.03 -44.26 89.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.22 -0.895 . . . . 75.430000000000007 109.676 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.99 66.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.755 1.161 . . . . 71.219999999999999 110.602 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -47.95 83.71 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.939 1.295 . . . . 52.340000000000003 110.472 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.3 mt -64.16 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 CA-C-O 117.472 -1.251 . . . . 65.319999999999993 110.046 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -62.68 -36.64 83.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 121.051 1.75 . . . . 73.420000000000002 109.386 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.55 59.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.125 -0.63 . . . . 72.049999999999997 111.805 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -79.03 -46.5 18.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.0 2.593 . . . . 71.400000000000006 118.0 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.38 81.62 54.78 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.786 2.035 . . . . 64.319999999999993 109.025 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.69 -23.9 55.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.044 2.496 . . . . 75.549999999999997 112.922 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -96.63 14.02 26.29 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.614 0.365 . . . . 74.430000000000007 110.365 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -121.57 154.05 37.22 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.913 -1.143 . . . . 73.0 107.913 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.86 142.75 46.09 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 123.753 0.821 . . . . 65.239999999999995 111.092 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.03 125.43 9.29 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.623 3.549 . . . . 55.240000000000002 111.438 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.02 140.87 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.989 -1.115 . . . . 71.420000000000002 107.989 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.89 117.86 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 103.034 -2.95 . . . . 74.519999999999996 103.034 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -105.78 120.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.911 -1.885 . . . . 64.010000000000005 105.911 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -124.67 146.21 49.24 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.602 0.761 . . . . 72.129999999999995 109.611 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -93.3 135.65 34.32 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.049 0.94 . . . . 74.530000000000001 109.735 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -80.21 130.65 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.377 -0.827 . . . . 71.519999999999996 109.193 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -63.72 156.59 26.6 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.45 -0.574 . . . . 71.340000000000003 109.45 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.86 -20.33 39.94 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.94 1.257 . . . . 63.119999999999997 112.996 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.3 t -84.56 142.95 29.63 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.15 -1.796 . . . . 74.049999999999997 106.15 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.44 -11.64 60.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.485 1.114 . . . . 53.439999999999998 112.484 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.486 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 2.1 tt -62.69 157.43 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.012 1.325 . . . . 71.430000000000007 111.498 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 m -66.11 156.19 6.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.12 1.368 . . . . 75.150000000000006 110.358 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -101.53 173.21 6.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.188 2.195 . . . . 63.140000000000001 114.652 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 tt -125.22 136.44 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.612 1.565 . . . . 74.129999999999995 108.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.72 165.0 25.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.389 1.076 . . . . 72.400000000000006 108.203 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.06 94.81 2.44 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.259 -0.901 . . . . 75.329999999999998 111.393 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -129.56 162.42 28.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 125.205 1.402 . . . . 73.219999999999999 108.891 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 33.3 mtmt -108.81 101.74 10.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 104.385 -2.45 . . . . 72.230000000000004 104.385 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -93.46 120.73 34.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.223 0.465 . . . . 75.0 111.546 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.91 121.19 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.73 142.42 26.61 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.139 0.975 . . . . 70.239999999999995 109.257 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 138.69 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.954 1.769 . . . . 72.25 111.073 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -60.75 -16.77 43.65 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.27 2.628 . . . . 50.520000000000003 111.206 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -76.46 -34.66 58.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.914 1.45 . . . . 72.230000000000004 114.914 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.25 170.28 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.962 0.801 . . . . 74.510000000000005 112.199 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -100.26 166.32 11.04 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.909 0.883 . . . . 53.210000000000001 111.651 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 2.0 t -56.65 -34.73 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 O-C-N 121.597 -0.69 . . . . 73.019999999999996 109.244 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.89 92.46 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.363 1.065 . . . . 54.420000000000002 110.353 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -65.88 -45.25 82.76 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.875 0.87 . . . . 71.400000000000006 109.123 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -58.79 -48.22 82.01 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.719 -0.845 . . . . 74.310000000000002 108.719 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.8 ttp -59.51 -45.01 92.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.837 0.855 . . . . 74.109999999999999 110.856 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -60.18 -39.72 87.46 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.875 0.47 . . . . 65.25 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -64.34 -47.29 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 117.368 -1.301 . . . . 55.450000000000003 109.521 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.4 -50.89 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 120.374 1.443 . . . . 71.120000000000005 109.509 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -61.72 -36.97 82.49 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.346 -0.846 . . . . 62.43 112.183 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -67.4 -43.68 80.71 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-O 118.062 -0.971 . . . . 71.099999999999994 110.434 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -63.22 -47.56 81.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.744 1.618 . . . . 75.450000000000003 111.01 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -79.39 1.65 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.351 0.596 . . . . 74.549999999999997 110.977 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 50.56 59.44 4.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.795 2.438 . . . . 73.340000000000003 111.141 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.56 111.26 6.98 Favored Pre-proline 0 C--O 1.24 0.593 0 C-N-CA 125.66 1.584 . . . . 72.150000000000006 109.662 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.05 165.58 29.68 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.851 3.701 . . . . 72.409999999999997 113.329 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 p -60.91 -23.32 65.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.635 1.574 . . . . 73.140000000000001 113.7 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 73' ' ' GLU . 3.6 pt-20 -72.27 -54.13 10.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.675 1.59 . . . . 73.430000000000007 112.826 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.52 163.47 23.71 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 113.284 0.846 . . . . 75.120000000000005 113.284 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.06 166.66 10.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.416 1.886 . . . . 73.439999999999998 107.62 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tt -154.4 130.5 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 125.218 1.407 . . . . 74.530000000000001 107.744 178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -139.16 149.54 44.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.845 1.658 . . . . 72.420000000000002 107.713 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.1 mt -112.83 156.57 22.68 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.896 1.278 . . . . 61.140000000000001 109.5 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -147.41 140.24 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.286 1.435 . . . . 73.439999999999998 109.288 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.459 HG12 ' HD3' ' A' ' 85' ' ' PRO . 12.0 p -134.14 120.78 35.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 125.345 1.458 . . . . 63.420000000000002 107.211 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 t0 43.22 52.46 5.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.405 1.082 . . . . 73.409999999999997 111.837 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 62.43 18.87 10.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.78 1.632 . . . . 75.040000000000006 113.766 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.4 p -125.9 160.12 30.76 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.788 1.631 . . . . 73.230000000000004 111.31 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.8 104.16 37.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.52 1.928 . . . . 74.310000000000002 106.542 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' HG12 ' A' ' 80' ' ' VAL . 38.7 Cg_endo -68.43 155.41 69.24 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.528 2.152 . . . . 51.439999999999998 110.639 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -79.86 121.63 25.65 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.018 -0.734 . . . . 64.219999999999999 109.018 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.2 m -53.68 -31.4 47.63 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.243 1.201 . . . . 62.409999999999997 114.243 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 t -83.7 -8.29 59.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.706 1.002 . . . . 70.219999999999999 113.706 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.82 152.39 44.63 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.309 1.413 . . . . 64.310000000000002 109.625 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -88.88 150.01 23.08 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.037 -0.727 . . . . 61.109999999999999 109.037 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.8 mmt -58.15 -47.53 83.05 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 117.337 -1.316 . . . . 73.349999999999994 110.23 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.07 -48.52 46.08 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 121.227 1.83 . . . . 53.009999999999998 113.298 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -64.32 -50.0 69.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.281 1.032 . . . . 74.5 109.533 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.31 -47.86 80.42 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.699 0.8 . . . . 73.219999999999999 110.187 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -58.84 -55.17 38.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 124.912 1.285 . . . . 74.010000000000005 108.086 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -54.71 -43.55 72.66 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.401 0.889 . . . . 65.230000000000004 113.401 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -24.81 28.25 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 117.593 -1.194 . . . . 74.099999999999994 114.222 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.6 2.74 36.48 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.115 1.325 . . . . 71.329999999999998 112.72 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -53.77 126.4 21.94 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.604 1.562 . . . . 62.310000000000002 112.258 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.71 165.38 25.32 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.988 -1.116 . . . . 64.340000000000003 107.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.75 62.44 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.696 -1.253 . . . . 71.549999999999997 111.023 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.92 17.05 12.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.439 2.295 . . . . 62.020000000000003 111.014 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.43 15.33 38.52 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.663 3.03 . . . . 62.030000000000001 119.513 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -122.04 179.48 4.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.49 2.145 . . . . 72.030000000000001 111.124 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.14 124.47 45.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.796 . . . . 74.420000000000002 111.023 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -105.14 118.52 36.74 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.74 -1.207 . . . . 71.420000000000002 107.74 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -128.0 140.22 49.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.524 -0.735 . . . . 73.230000000000004 109.026 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 156.89 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.977 -1.077 . . . . 72.349999999999994 108.51 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -145.23 156.39 43.81 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.407 0.622 . . . . 74.200000000000003 110.083 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.35 170.43 17.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.513 -0.921 . . . . 44.210000000000001 108.513 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.84 30.28 7.25 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.522 1.535 . . . . 71.510000000000005 109.963 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.56 116.43 23.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.09 1.356 . . . . 72.230000000000004 110.449 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -62.22 -14.01 33.67 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.905 1.446 . . . . 72.349999999999994 114.905 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.81 141.73 33.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.281 1.401 . . . . 61.420000000000002 108.861 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -88.74 51.03 2.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.16 0.984 . . . . 74.510000000000005 111.756 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.636 0 CA-C-O 117.35 -1.806 . . . . 53.039999999999999 109.483 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.505 0 N-CA-C 109.135 -1.586 . . . . 54.229999999999997 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -153.4 -7.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 73.310000000000002 111.327 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 24.2 ttp -77.36 29.93 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.195 1.398 . . . . 73.400000000000006 112.555 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -74.65 51.09 0.46 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.064 2.146 . . . . 64.430000000000007 108.733 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 38.8 pt -76.92 165.24 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.957 1.703 . . . . 51.210000000000001 111.695 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 29.1 mt -99.31 -34.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.51 1.524 . . . . 74.299999999999997 109.199 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 44.28 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 73.549999999999997 112.975 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.8 152.96 43.98 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.796 -1.557 . . . . 64.150000000000006 106.796 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -74.99 -46.27 36.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.255 -1.017 . . . . 61.119999999999997 108.255 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.58 109.87 21.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.582 1.553 . . . . 64.420000000000002 110.544 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -58.61 -51.68 68.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.281 1.215 . . . . 73.510000000000005 114.281 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.598 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 28.0 m95 55.12 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.567 1.147 . . . . 72.0 109.552 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -87.12 130.08 9.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.439 -1.413 . . . . 64.409999999999997 112.693 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 39.6 mt -68.78 128.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.3 1.55 . . . . 73.340000000000003 110.123 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -134.44 161.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.893 1.677 . . . . 65.310000000000002 111.282 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.5 116.51 31.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 104.119 -2.549 . . . . 74.140000000000001 104.119 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.13 104.3 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.959 -1.126 . . . . 74.310000000000002 107.959 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.7 p -147.56 160.6 42.45 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.217 1.407 . . . . 74.310000000000002 108.391 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 131.284 3.834 . . . . 73.420000000000002 116.148 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tmm? . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 117.697 -1.144 . . . . 73.519999999999996 108.164 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.28 90.65 0.08 OUTLIER Glycine 0 C--N 1.338 0.693 0 CA-C-N 119.97 1.259 . . . . 61.340000000000003 113.393 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -91.97 105.72 17.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.382 -2.081 . . . . 73.109999999999999 105.382 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -52.48 -38.74 60.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.638 0.775 . . . . 73.219999999999999 110.372 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -60.14 -41.08 91.95 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.099 -0.375 . . . . 73.25 111.874 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -67.16 -40.46 86.65 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.627 1.171 . . . . 63.350000000000001 109.354 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.57 -40.86 93.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.204 0.601 . . . . 74.5 110.352 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.78 -75.79 0.3 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.117 0.967 . . . . 72.430000000000007 112.102 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.78 119.9 2.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.056 1.342 . . . . 65.510000000000005 108.852 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -119.65 -65.83 1.12 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 117.243 -1.36 . . . . 73.420000000000002 113.358 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.2 tp -47.23 -59.67 3.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 115.97 1.841 . . . . 62.329999999999998 115.97 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.44 -50.69 62.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.719 0.771 . . . . 72.5 111.122 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -53.88 -49.83 67.67 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.735 1.214 . . . . 74.510000000000005 111.123 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -67.22 -39.34 86.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 116.587 -1.673 . . . . 74.299999999999997 109.93 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.25 -55.52 33.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.252 1.387 . . . . 72.540000000000006 110.917 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.73 -48.0 81.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.053 1.341 . . . . 63.119999999999997 109.925 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.32 -42.79 87.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 118.182 -0.913 . . . . 72.230000000000004 112.151 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.6 p -61.56 -43.04 99.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.81 1.186 . . . . 63.32 108.82 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.6 -50.42 73.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.902 0.773 . . . . 60.229999999999997 109.938 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.05 -48.18 77.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.889 -0.507 . . . . 74.010000000000005 111.771 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.91 -42.34 94.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 118.004 -0.998 . . . . 63.439999999999998 109.97 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -65.73 -34.38 78.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.992 1.269 . . . . 65.439999999999998 110.068 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.54 -45.86 51.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.244 -0.408 . . . . 72.349999999999994 111.042 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -77.1 -46.46 23.52 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.059 0.845 . . . . 62.43 113.096 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -122.22 79.35 44.05 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.953 2.101 . . . . 74.010000000000005 109.977 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.49 -13.46 30.26 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.534 2.823 . . . . 72.230000000000004 112.95 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 18.28 20.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.682 1.593 . . . . 74.319999999999993 110.569 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 54.4 mtt85 -125.11 147.75 48.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.478 1.111 . . . . 51.32 108.511 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.16 133.14 23.18 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.621 1.168 . . . . 74.200000000000003 109.781 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.07 117.5 3.55 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.533 3.488 . . . . 74.519999999999996 112.13 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.56 151.19 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.852 1.261 . . . . 53.229999999999997 110.129 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.36 120.88 62.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 104.467 -2.42 . . . . 54.350000000000001 104.467 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.75 115.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.147 1.779 . . . . 72.319999999999993 108.684 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.38 151.3 51.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 72.409999999999997 110.184 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -94.06 158.49 15.59 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.108 -0.995 . . . . 72.340000000000003 113.372 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.61 129.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.005 -2.591 . . . . 53.329999999999998 104.005 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.1 p -53.0 153.19 3.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.654 0.74 . . . . 65.230000000000004 112.142 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.89 -17.69 1.23 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.064 1.793 . . . . 52.229999999999997 113.136 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t -62.16 124.49 20.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 119.272 1.536 . . . . 53.32 108.69 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -64.4 -12.89 47.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.961 1.304 . . . . 73.120000000000005 112.9 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.45 151.54 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.475 -1.306 . . . . 64.439999999999998 107.475 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -46.97 141.89 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.733 1.213 . . . . 72.099999999999994 112.576 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.15 150.74 41.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.799 -1.546 . . . . 73.439999999999998 110.616 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -126.27 123.46 63.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.724 -1.584 . . . . 71.109999999999999 106.724 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.51 165.86 24.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.526 -0.916 . . . . 65.140000000000001 108.526 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.82 95.18 1.89 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.272 0.558 . . . . 73.400000000000006 111.365 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -132.12 161.86 32.27 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.562 1.945 . . . . 70.400000000000006 109.009 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -112.3 142.27 45.0 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.69 1.196 . . . . 63.020000000000003 108.624 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -122.94 132.63 54.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 122.792 0.437 . . . . 64.349999999999994 109.848 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -117.66 113.17 21.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.888 1.675 . . . . 70.510000000000005 108.282 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.11 142.87 26.83 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-O 118.218 -0.896 . . . . 74.129999999999995 110.224 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 51.8 Cg_endo -66.34 139.73 55.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.697 1.598 . . . . 73.430000000000007 111.274 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -12.29 30.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.708 1.203 . . . . 61.210000000000001 112.6 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.54 -35.07 58.47 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.155 1.782 . . . . 62.329999999999998 112.94 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -72.24 169.46 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 122.018 0.913 . . . . 74.010000000000005 110.69 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -107.16 168.47 9.19 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.282 -0.886 . . . . 64.319999999999993 112.086 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.19 -35.26 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.86 -1.533 . . . . 64.239999999999995 106.86 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 87' ' ' SER . . . -60.61 -47.18 87.35 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 121.381 -0.824 . . . . 75.519999999999996 110.654 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.17 -45.69 76.22 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 118.33 -0.843 . . . . 74.030000000000001 110.923 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.503 ' CE2' HD11 ' A' ' 64' ' ' ILE . 3.9 t80 -58.25 -44.14 88.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.663 0.665 . . . . 73.439999999999998 109.602 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 34.5 ttp -65.11 -43.98 90.22 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 117.772 -1.109 . . . . 72.430000000000007 111.733 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -59.67 -46.77 88.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.545 1.066 . . . . 75.329999999999998 109.182 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG21 ' CG1' ' B' ' 346' ' ' VAL . 40.3 mt -60.35 -48.08 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 117.862 -1.066 . . . . 74.439999999999998 108.63 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 ' CE2' ' A' ' 60' ' ' PHE . 55.1 mt -56.35 -50.27 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.874 1.215 . . . . 65.329999999999998 110.121 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -61.19 -33.17 73.02 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.864 -1.147 . . . . 74.409999999999997 111.74 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.15 -38.34 60.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.085 0.857 . . . . 73.140000000000001 110.209 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -60.28 -46.02 91.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.334 1.454 . . . . 71.129999999999995 110.291 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.6 pt -79.25 -6.47 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 109.969 -0.382 . . . . 72.340000000000003 109.969 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 54.93 59.78 3.86 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 126.55 1.94 . . . . 74.310000000000002 109.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.04 108.85 3.09 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.443 1.897 . . . . 72.530000000000001 111.098 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.48 151.09 70.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.451 2.101 . . . . 64.239999999999995 108.586 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.1 p -60.28 -25.05 65.42 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.257 -0.902 . . . . 74.150000000000006 112.431 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.87 -38.44 78.82 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.719 0.807 . . . . 73.420000000000002 110.402 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -96.14 164.7 12.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.513 1.125 . . . . 72.340000000000003 108.775 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.88 174.89 5.67 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.145 1.378 . . . . 43.130000000000003 108.257 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tp -153.15 136.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.696 -1.224 . . . . 62.549999999999997 107.696 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.98 141.12 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.106 1.362 . . . . 72.439999999999998 108.149 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.18 151.3 32.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.595 -1.261 . . . . 54.32 107.595 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -141.21 123.59 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.182 0.993 . . . . 73.299999999999997 108.575 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.68 140.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.226 -1.398 . . . . 71.319999999999993 107.226 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t0 52.11 31.93 9.68 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 122.114 0.959 . . . . 73.019999999999996 112.197 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.6 mttm 65.83 25.17 11.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.399 1.88 . . . . 74.040000000000006 111.821 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -152.08 163.03 40.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.404 1.082 . . . . 73.310000000000002 110.816 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 121.01 74.62 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.038 -2.208 . . . . 70.540000000000006 105.038 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.31 140.0 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.057 2.505 . . . . 71.439999999999998 109.695 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -67.69 124.76 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.505 1.122 . . . . 73.420000000000002 109.841 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 29.9 m -53.17 -27.8 23.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.849 1.66 . . . . 72.140000000000001 113.693 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.6 m -75.18 -17.93 60.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.256 1.022 . . . . 61.340000000000003 112.214 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.69 153.08 44.51 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.631 1.172 . . . . 64.400000000000006 108.812 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -101.03 153.74 19.29 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.109 -0.7 . . . . 61.399999999999999 109.109 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.33 -49.61 76.59 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 119.132 -0.461 . . . . 74.25 111.682 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.96 -44.97 92.57 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.237 -0.745 . . . . 51.200000000000003 111.237 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.44 -53.33 59.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.733 1.213 . . . . 51.119999999999997 110.977 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.74 -51.48 69.58 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.238 1.015 . . . . 72.040000000000006 109.718 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.29 -44.6 79.97 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.159 1.383 . . . . 61.020000000000003 110.085 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.58 -38.53 91.34 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.839 0.745 . . . . 61.420000000000002 111.939 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.05 -24.28 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.484 -1.246 . . . . 55.43 113.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.76 -4.18 22.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.001 1.273 . . . . 75.400000000000006 114.301 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.73 120.66 2.72 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.301 1.041 . . . . 71.319999999999993 113.647 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.74 175.29 10.57 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.654 -1.98 . . . . 73.340000000000003 105.654 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.41 -12.44 14.43 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.762 -1.837 . . . . 70.239999999999995 112.873 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.71 6.04 43.85 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.958 1.703 . . . . 74.349999999999994 113.651 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.39 68.56 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.706 -0.622 . . . . 71.340000000000003 111.815 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.27 164.6 21.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.538 1.535 . . . . 75.25 108.863 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.04 139.67 53.72 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 124.57 1.169 . . . . 74.030000000000001 108.667 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -121.48 122.92 40.81 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.284 -1.006 . . . . 72.099999999999994 108.284 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.32 133.06 67.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 O-C-N 120.776 -1.202 . . . . 64.409999999999997 108.979 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.81 160.27 14.75 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.683 -0.636 . . . . 60.32 110.009 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 35' ' ' LYS . 21.3 p90 -142.13 157.07 45.31 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.446 0.699 . . . . 71.030000000000001 111.924 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.9 p -149.22 158.54 44.26 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.988 -0.745 . . . . 54.119999999999997 108.988 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.43 29.98 7.26 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.218 1.39 . . . . 74.319999999999993 111.542 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.0 142.51 25.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.475 1.51 . . . . 70.150000000000006 107.549 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.81 -44.4 73.6 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.095 0.958 . . . . 73.209999999999994 111.007 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.73 141.59 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.083 1.753 . . . . 65.129999999999995 109.162 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.48 14.87 24.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.92 1.688 . . . . 54.219999999999999 109.75 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 N-CA-C 106.565 -2.614 . . . . 33.509999999999998 106.565 -179.457 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.891 0 N-CA-C 109.391 -1.483 . . . . 54.240000000000002 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -142.58 77.59 1.58 Allowed 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 105.381 -2.081 . . . . 71.109999999999999 105.381 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 90.1 mmm -112.47 15.44 20.19 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.041 1.337 . . . . 72.120000000000005 112.696 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -101.31 45.0 0.98 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.564 -0.902 . . . . 71.340000000000003 108.564 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 15.7 mm -82.57 158.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.186 -2.894 . . . . 61.049999999999997 103.186 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 35.2 pt -62.41 -6.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 114.156 1.169 . . . . 64.329999999999998 114.156 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -111.92 65.24 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.001 1.32 . . . . 72.420000000000002 110.326 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -68.71 127.65 33.83 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.395 -0.965 . . . . 74.540000000000006 108.395 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.81 -59.1 4.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.273 -1.381 . . . . 73.230000000000004 107.273 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -83.91 116.86 22.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.839 -1.541 . . . . 75.099999999999994 106.839 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.67 -40.57 69.52 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.354 1.613 . . . . 72.140000000000001 115.354 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 30.4 m95 50.07 60.45 3.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.023 1.729 . . . . 73.310000000000002 115.307 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -81.53 137.17 17.12 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.746 -1.341 . . . . 60.210000000000001 109.746 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 26.0 mt -77.63 137.1 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.658 1.583 . . . . 73.120000000000005 113.154 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -131.06 142.83 50.33 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.299 2.24 . . . . 75.219999999999999 108.141 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.02 111.17 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.022 1.729 . . . . 74.209999999999994 110.931 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 63' ' ' ILE . 70.4 t -122.91 125.82 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 113.523 0.934 . . . . 60.240000000000002 113.523 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -143.15 110.51 5.76 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.522 1.529 . . . . 73.25 108.198 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 126.022 1.729 . . . . 71.430000000000007 111.661 179.784 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.53 0.681 . . . . 63.140000000000001 111.992 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.6 -145.18 17.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 107.094 -2.402 . . . . 45.109999999999999 107.094 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -74.23 125.37 28.27 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.131 0.972 . . . . 74.420000000000002 109.076 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.64 -48.41 81.89 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.714 -0.847 . . . . 72.209999999999994 108.714 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.83 -34.37 74.45 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 118.863 -0.589 . . . . 63.539999999999999 111.282 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -64.74 -42.09 95.45 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 120.038 1.29 . . . . 55.130000000000003 109.643 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.88 -47.16 86.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.645 -0.872 . . . . 65.230000000000004 108.645 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.52 -75.45 0.1 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.212 1.805 . . . . 73.209999999999994 113.021 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.23 130.94 5.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.703 2.801 . . . . 73.430000000000007 109.505 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.3 p -114.73 -66.63 1.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.215 -1.553 . . . . 74.430000000000007 114.266 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -52.84 -57.36 10.48 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 124.83 1.252 . . . . 73.349999999999994 113.943 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.22 -56.13 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.172 0.442 . . . . 74.209999999999994 111.398 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -52.26 -49.95 63.06 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.529 1.132 . . . . 73.120000000000005 110.836 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.86 76.05 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 117.882 -1.056 . . . . 71.230000000000004 112.183 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.6 m -60.35 -51.74 68.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 120.379 1.445 . . . . 61.539999999999999 109.264 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.57 -47.34 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.353 -0.61 . . . . 71.019999999999996 109.353 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 21' ' ' ILE . 56.5 tt0 -55.64 -49.98 71.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.434 1.094 . . . . 73.310000000000002 109.982 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.1 m -60.51 -48.56 81.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.944 0.897 . . . . 64.140000000000001 110.198 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.66 -41.43 90.58 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.694 1.134 . . . . 64.329999999999998 111.562 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -47.64 77.32 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.226 1.411 . . . . 72.430000000000007 109.475 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 17' ' ' GLU . 62.5 mt -70.05 -42.38 79.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-O 117.784 -1.103 . . . . 73.140000000000001 111.807 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -65.16 -39.1 92.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 119.572 1.078 . . . . 62.25 109.7 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.2 -46.91 66.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.07 -0.652 . . . . 70.540000000000006 110.921 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -78.16 -38.31 43.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.276 1.954 . . . . 74.340000000000003 116.276 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -136.55 74.14 53.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.352 1.861 . . . . 72.310000000000002 109.777 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.78 -24.09 54.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.421 2.747 . . . . 75.299999999999997 110.726 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.99 12.17 18.38 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.6 -0.687 . . . . 74.549999999999997 112.726 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -119.89 154.08 34.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.572 -1.27 . . . . 74.319999999999993 107.572 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.82 139.98 27.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.166 -0.679 . . . . 74.540000000000006 109.166 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 125.075 3.85 . . . . 74.099999999999994 112.169 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.2 131.93 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.909 -0.775 . . . . 74.209999999999994 108.909 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.75 133.59 55.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.367 -2.457 . . . . 75.239999999999995 104.367 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.57 137.45 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 114.777 1.399 . . . . 72.040000000000006 114.777 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.84 152.61 43.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.115 0.966 . . . . 70.420000000000002 109.913 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -93.39 155.74 17.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.256 -1.016 . . . . 72.120000000000005 108.256 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.15 135.08 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.088 -1.819 . . . . 63.219999999999999 106.088 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.09 133.13 38.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.107 0.563 . . . . 73.219999999999999 111.975 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.57 3.95 43.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.645 -1.086 . . . . 64.129999999999995 114.144 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.2 t -62.5 146.02 52.74 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.685 1.742 . . . . 75.340000000000003 111.048 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -65.86 -14.89 62.32 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.825 2.05 . . . . 64.040000000000006 112.856 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.409 ' CD1' HD23 ' A' ' 70' ' ' LEU . 9.6 tp -77.66 159.08 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.398 -0.814 . . . . 61.539999999999999 109.965 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.25 150.06 11.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.789 -0.819 . . . . 72.140000000000001 108.789 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.6 164.58 25.79 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.522 0.729 . . . . 63.32 112.105 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.82 148.57 20.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.161 1.785 . . . . 71.209999999999994 106.317 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -87.14 157.44 19.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.452 -0.944 . . . . 65.540000000000006 108.452 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.87 100.72 3.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.5 -1.296 . . . . 52.009999999999998 107.5 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' H ' ' B' ' 342' ' ' GLY . 87.2 mmt-85 -136.41 161.99 34.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.118 1.767 . . . . 75.439999999999998 110.198 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -108.81 95.48 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.178 2.591 . . . . 64.349999999999994 104.018 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -89.29 120.02 30.28 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.16 -0.963 . . . . 71.530000000000001 112.383 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mt -99.71 115.16 28.83 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.96 1.704 . . . . 74.230000000000004 109.625 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 141.47 25.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 117.82 -1.085 . . . . 53.219999999999999 111.361 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.43 140.7 48.82 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.281 2.654 . . . . 44.009999999999998 110.893 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 m -63.87 -16.33 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.489 1.516 . . . . 75.140000000000001 113.34 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.82 -30.43 28.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.295 1.438 . . . . 72.109999999999999 113.743 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -71.03 165.59 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 119.018 -1.073 . . . . 73.319999999999993 109.257 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -107.02 165.39 11.38 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.587 0.755 . . . . 75.230000000000004 110.25 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 t -53.99 -34.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.942 -1.132 . . . . 75.450000000000003 107.942 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.38 90.48 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.16 1.384 . . . . 74.519999999999996 111.135 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -69.21 -44.62 71.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.838 -0.801 . . . . 75.310000000000002 108.838 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.06 -48.6 81.03 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.429 -0.582 . . . . 75.5 109.429 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ttt -54.05 -48.07 70.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.626 1.17 . . . . 71.420000000000002 109.553 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.007 -0.521 . . . . 73.219999999999999 111.767 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.4 mt -57.32 -44.18 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.067 -0.716 . . . . 55.439999999999998 109.067 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mt -59.53 -50.63 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.427 0.558 . . . . 62.420000000000002 110.725 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -65.33 -37.27 86.59 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.08 -1.012 . . . . 70.409999999999997 111.949 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -64.94 -47.09 78.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.063 0.945 . . . . 72.310000000000002 110.29 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.89 -42.29 97.5 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.816 1.246 . . . . 70.310000000000002 113.011 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.65 -8.64 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 119.818 -0.753 . . . . 64.439999999999998 109.747 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.68 60.52 1.6 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.797 2.039 . . . . 73.349999999999994 108.841 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' A' ' 41' ' ' ILE . 1.1 tm? -73.32 110.44 8.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.664 1.186 . . . . 65.299999999999997 110.015 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.84 164.47 29.41 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.715 2.943 . . . . 72.140000000000001 112.389 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 p -64.28 -21.05 66.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.99 0.916 . . . . 72.25 111.498 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.47 -50.54 25.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.406 0.683 . . . . 73.420000000000002 112.794 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.12 164.24 15.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.777 -0.824 . . . . 64.109999999999999 108.777 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.23 -178.45 3.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.971 -1.122 . . . . 74.099999999999994 107.971 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -150.74 141.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.648 1.579 . . . . 73.120000000000005 107.171 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -145.27 139.41 27.1 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 127.288 2.235 . . . . 74.400000000000006 107.965 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.9 150.49 35.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.877 0.871 . . . . 42.509999999999998 111.135 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -145.25 133.83 22.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.549 1.14 . . . . 73.439999999999998 109.75 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 p -132.91 127.93 56.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 105.043 -2.206 . . . . 71.430000000000007 105.043 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.32 30.55 10.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.178 1.354 . . . . 74.010000000000005 110.863 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt 61.13 25.27 15.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 72.150000000000006 110.928 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -119.37 161.57 20.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.623 1.569 . . . . 60.25 109.72 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.2 103.62 21.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.356 -2.09 . . . . 75.150000000000006 105.356 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.15 142.7 38.47 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.31 2.007 . . . . 74.329999999999998 111.569 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -75.41 121.91 23.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.071 -0.715 . . . . 65.420000000000002 109.071 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -49.06 -42.21 37.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.854 2.062 . . . . 43.5 112.665 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -72.92 -11.37 60.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.769 1.228 . . . . 74.200000000000003 113.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.69 157.34 36.72 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.579 1.536 . . . . 71.510000000000005 109.733 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.03 152.45 18.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.192 1.397 . . . . 64.120000000000005 110.085 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.3 mmm -60.7 -43.56 97.62 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.034 -0.53 . . . . 73.010000000000005 111.613 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.51 99.71 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.479 -0.623 . . . . 52.43 111.782 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -66.15 -50.18 64.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.017 0.909 . . . . 63.539999999999999 109.412 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.23 -35.17 76.5 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.204 -0.295 . . . . 74.200000000000003 110.204 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.72 -48.96 67.59 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 120.063 -1.648 . . . . 60.350000000000001 109.619 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.92 -28.68 68.5 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.496 -0.752 . . . . 71.239999999999995 112.087 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 -24.36 19.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 116.6 -1.667 . . . . 53.240000000000002 113.86 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.13 -2.97 13.3 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.704 1.742 . . . . 74.510000000000005 115.704 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 124.29 6.39 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.259 1.39 . . . . 74.299999999999997 113.967 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -77.62 175.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.937 -1.505 . . . . 73.319999999999993 106.937 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -58.91 -27.39 65.21 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 119.838 -1.789 . . . . 71.430000000000007 113.896 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -79.11 7.76 6.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 75.400000000000006 111.131 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.49 69.3 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.616 1.579 . . . . 72.230000000000004 114.94 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.77 172.65 10.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.447 1.899 . . . . 73.319999999999993 110.789 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.1 tp -124.63 141.56 52.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.616 -0.513 . . . . 71.140000000000001 109.616 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -113.23 123.67 50.72 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.766 1.226 . . . . 75.109999999999999 111.795 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.2 136.81 57.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 122.801 1.286 . . . . 65.329999999999998 111.117 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.19 142.74 46.42 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.628 -1.619 . . . . 52.32 106.628 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -133.21 155.54 49.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.457 0.646 . . . . 74.25 110.758 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.3 p -150.97 155.9 40.06 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.567 -0.901 . . . . 55.229999999999997 108.567 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.36 9.21 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 119.39 -0.672 . . . . 71.430000000000007 112.769 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.28 135.86 41.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.219 1.01 . . . . 71.120000000000005 109.169 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -78.12 -15.76 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.216 1.406 . . . . 74.109999999999999 112.243 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -131.78 126.76 35.2 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.087 1.355 . . . . 71.299999999999997 109.655 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.62 9.72 13.21 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.614 1.966 . . . . 64.439999999999998 114.892 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 C-N-CA 128.1 2.762 . . . . 50.219999999999999 114.483 -178.823 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.585 0 N-CA-C 108.734 -1.746 . . . . 74.439999999999998 108.734 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -144.02 156.23 44.31 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.842 0.857 . . . . 74.140000000000001 111.529 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 20.6 ttt -117.15 46.73 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.734 2.014 . . . . 63.229999999999997 110.564 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.68 51.58 0.61 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.596 1.558 . . . . 64.25 108.323 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 pt -69.31 165.69 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.951 1.7 . . . . 74.409999999999997 110.534 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.12 -34.16 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.723 1.209 . . . . 64.239999999999995 109.415 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -82.25 81.51 8.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.428 0.691 . . . . 73.120000000000005 109.98 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -127.27 139.6 52.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.755 1.622 . . . . 63.439999999999998 106.738 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.88 -27.14 62.66 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.634 0.976 . . . . 65.099999999999994 113.634 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -109.33 147.33 32.88 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.737 -1.208 . . . . 65.409999999999997 107.737 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -81.96 -53.62 5.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 115.572 1.693 . . . . 64.040000000000006 115.572 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 60.3 m95 53.74 58.52 5.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.398 1.079 . . . . 75.319999999999993 109.758 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' ARG . . . -81.15 139.86 20.86 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 108.252 -1.939 . . . . 63.130000000000003 108.252 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 133.83 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 118.871 1.335 . . . . 60.399999999999999 109.698 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.09 138.36 48.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.747 1.219 . . . . 72.129999999999995 109.444 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.72 118.97 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 103.152 -2.907 . . . . 71.439999999999998 103.152 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.45 119.24 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.898 0.879 . . . . 71.530000000000001 109.522 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 1.6 p -161.47 123.99 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.42 0.688 . . . . 72.239999999999995 109.748 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 128.234 2.614 . . . . 64.430000000000007 112.902 -179.213 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.211 0.529 . . . . 74.230000000000004 111.673 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.73 -84.08 1.77 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 107.806 -2.118 . . . . 43.310000000000002 107.806 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -105.91 116.68 32.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.244 1.818 . . . . 74.230000000000004 107.933 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -58.7 -41.99 87.57 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 124.024 0.828 . . . . 72.030000000000001 109.531 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -58.82 -42.34 88.96 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.693 -0.629 . . . . 62.109999999999999 110.992 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 11.3 ttmm -68.37 -38.06 81.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.312 0.96 . . . . 71.340000000000003 111.376 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.62 -46.77 74.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.96 -1.019 . . . . 72.319999999999993 108.829 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.92 -77.53 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.561 1.145 . . . . 73.140000000000001 110.266 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 119.21 2.13 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.254 1.821 . . . . 74.239999999999995 108.223 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 28.7 t -106.88 -65.82 1.06 Allowed 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 106.706 -1.59 . . . . 62.32 106.706 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -41.13 -58.07 1.88 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.512 1.525 . . . . 63.140000000000001 115.101 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.35 -51.66 54.94 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.918 -0.488 . . . . 54.43 112.0 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.66 -44.35 73.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.146 0.979 . . . . 74.219999999999999 110.325 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -51.27 70.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.73 1.612 . . . . 63.219999999999999 108.782 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.69 -47.71 79.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.359 0.527 . . . . 70.319999999999993 111.63 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.79 -48.3 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 C-N-CA 123.035 0.534 . . . . 71.319999999999993 109.953 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -64.06 -49.46 72.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 117.673 -1.156 . . . . 44.340000000000003 111.274 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.4 m -55.27 -46.57 76.14 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.08 1.309 . . . . 61.020000000000003 109.733 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.71 -50.68 70.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.154 0.888 . . . . 62.130000000000003 111.576 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -62.47 -39.51 93.66 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 120.604 -1.31 . . . . 72.219999999999999 111.725 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.5 -42.77 56.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 116.008 -1.948 . . . . 62.549999999999997 109.285 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.79 -34.67 78.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 121.182 1.81 . . . . 74.439999999999998 108.967 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.27 82.21 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.922 -0.486 . . . . 43.450000000000003 110.895 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -76.95 -47.23 21.5 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.785 1.032 . . . . 75.109999999999999 113.785 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -138.06 89.13 14.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.061 1.744 . . . . 73.349999999999994 108.494 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.85 -22.27 36.78 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.626 2.217 . . . . 74.129999999999995 112.403 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.29 14.14 25.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.034 2.134 . . . . 62.030000000000001 113.588 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -120.02 156.8 30.19 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.158 -1.423 . . . . 72.0 107.158 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.519 HG11 ' CG ' ' A' ' 95' ' ' TYR . 15.7 m -121.92 138.2 28.37 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.353 1.061 . . . . 62.5 111.2 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.48 116.85 3.91 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 125.216 3.944 . . . . 75.120000000000005 112.347 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.21 146.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.745 1.218 . . . . 64.25 108.974 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.9 mt -122.31 128.26 75.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.165 -2.532 . . . . 74.430000000000007 104.165 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 120.81 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 125.643 1.577 . . . . 54.219999999999999 107.274 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -131.94 147.09 52.44 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.38 -0.971 . . . . 71.519999999999996 108.38 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.11 155.15 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.635 1.107 . . . . 64.120000000000005 111.078 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.55 130.89 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.453 -1.314 . . . . 55.509999999999998 107.453 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -62.3 130.24 44.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.266 -1.753 . . . . 73.310000000000002 106.266 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.9 -2.77 80.25 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 118.031 -1.427 . . . . 63.240000000000002 112.289 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 t -77.42 139.78 39.75 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.053 -2.203 . . . . 74.310000000000002 105.053 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.01 -28.2 68.05 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.4 1.48 . . . . 74.439999999999998 112.578 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -55.84 152.43 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.047 1.339 . . . . 74.439999999999998 111.431 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -53.14 134.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.46 1.104 . . . . 53.020000000000003 111.421 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.33 158.75 34.49 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.617 -1.253 . . . . 54.119999999999997 107.617 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.47 141.13 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.836 -1.172 . . . . 73.209999999999994 107.836 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.77 164.44 17.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.405 -0.961 . . . . 72.0 108.405 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 99.37 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.534 -2.765 . . . . 73.329999999999998 103.534 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -130.48 155.1 47.02 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.771 0.796 . . . . 70.209999999999994 109.499 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' B' ' 341' ' ' TRP . 38.1 mtmt -106.46 100.26 9.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.671 -1.233 . . . . 53.439999999999998 107.671 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.82 124.47 30.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.996 -1.113 . . . . 73.430000000000007 107.996 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.13 112.92 26.05 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.513 -0.921 . . . . 44.140000000000001 108.513 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -111.44 141.18 23.97 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 54.219999999999999 113.426 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.06 141.71 33.27 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 124.158 3.239 . . . . 55.299999999999997 112.216 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -18.43 60.94 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.831 1.049 . . . . 42.229999999999997 113.831 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.56 -34.48 70.02 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.906 1.379 . . . . 74.019999999999996 114.136 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -78.84 163.52 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.5 0.667 . . . . 73.439999999999998 110.219 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 p -104.65 167.78 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.357 1.063 . . . . 71.5 109.795 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.27 -35.31 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.021 -0.733 . . . . 74.329999999999998 109.021 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.1 -45.93 82.99 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.246 0.93 . . . . 64.209999999999994 109.911 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -68.0 -45.95 72.63 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.19 -0.67 . . . . 72.049999999999997 109.19 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.19 -52.0 67.58 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 119.067 -0.492 . . . . 75.239999999999995 111.038 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.8 ttp -57.69 -46.9 83.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.434 1.094 . . . . 74.030000000000001 110.347 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -59.25 -43.63 92.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.194 0.452 . . . . 74.019999999999996 110.785 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.48 -40.04 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 117.851 -1.071 . . . . 70.340000000000003 109.561 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.34 -50.22 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 120.611 1.55 . . . . 73.400000000000006 108.902 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -59.86 -39.15 84.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.025 -0.988 . . . . 72.400000000000006 111.402 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.79 -39.38 69.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 119.588 1.085 . . . . 61.420000000000002 110.828 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -62.96 -42.99 99.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.723 1.147 . . . . 73.430000000000007 110.692 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -79.22 -2.63 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.297 0.499 . . . . 74.430000000000007 109.7 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 55.47 61.02 3.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.01 2.124 . . . . 63.350000000000001 109.734 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -67.42 107.2 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.602 1.561 . . . . 73.049999999999997 109.935 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.97 156.1 66.41 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.485 2.124 . . . . 74.150000000000006 109.171 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -65.27 -20.79 66.58 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.183 -0.948 . . . . 71.519999999999996 112.703 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.6 -30.63 71.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.483 0.713 . . . . 73.140000000000001 110.453 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -103.72 164.9 11.38 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.009 1.324 . . . . 72.129999999999995 111.376 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.38 177.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.74 1.616 . . . . 71.299999999999997 108.093 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 tp -145.72 135.81 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.559 -1.645 . . . . 43.43 106.559 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -143.1 141.95 31.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.055 -1.461 . . . . 70.109999999999999 107.055 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.75 142.34 46.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.403 1.081 . . . . 54.32 108.109 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -144.3 123.66 13.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.294 -1.373 . . . . 72.519999999999996 107.294 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -130.21 131.3 65.78 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 117.046 -1.454 . . . . 65.329999999999998 107.255 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 47.89 30.82 2.07 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.519 1.508 . . . . 75.420000000000002 113.365 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mttp 64.74 29.11 12.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.235 -1.541 . . . . 71.340000000000003 110.61 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.9 p -132.7 161.8 33.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.104 2.562 . . . . 65.219999999999999 110.779 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.0 t -101.76 110.9 63.22 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.261 1.424 . . . . 73.329999999999998 109.118 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.09 124.81 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.361 2.04 . . . . 64.200000000000003 107.417 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -69.31 133.88 48.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.54 1.136 . . . . 72.340000000000003 109.655 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -62.72 -40.38 97.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 114.253 1.205 . . . . 51.149999999999999 114.253 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -21.62 59.08 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.97 -1.014 . . . . 54.210000000000001 113.093 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.95 142.8 58.31 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.268 1.395 . . . . 72.109999999999999 111.137 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 p -78.22 153.68 31.72 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.944 . . . . 73.430000000000007 110.004 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.1 mmt -59.36 -41.6 89.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.304 -0.855 . . . . 72.409999999999997 108.811 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.9 92.3 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.146 0.884 . . . . 73.530000000000001 112.964 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 -49.76 52.77 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.064 0.932 . . . . 53.409999999999997 111.13 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.29 -48.01 81.83 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 123.527 0.731 . . . . 70.510000000000005 109.796 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.519 ' CG ' HG11 ' A' ' 29' ' ' VAL . 45.8 t80 -56.87 -52.99 62.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.13 1.372 . . . . 72.120000000000005 109.461 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.04 -47.38 84.98 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 118.971 -0.538 . . . . 74.400000000000006 111.964 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -32.74 67.66 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.373 0.988 . . . . 74.230000000000004 112.768 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -93.86 -5.84 47.12 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.683 1.129 . . . . 71.409999999999997 113.887 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -38.79 125.14 1.44 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.587 1.955 . . . . 65.209999999999994 113.727 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.91 163.47 16.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.927 0.891 . . . . 71.450000000000003 110.024 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.82 -29.26 26.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.465 1.106 . . . . 74.420000000000002 111.277 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -95.32 -33.88 12.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.481 1.112 . . . . 75.099999999999994 112.541 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.03 4.04 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 117.742 1.857 . . . . 75.209999999999994 117.742 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -96.27 178.99 5.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.366 2.083 . . . . 60.240000000000002 112.024 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tp -125.74 138.2 53.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.584 -0.722 . . . . 72.409999999999997 111.302 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -123.13 108.32 12.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.043 1.337 . . . . 64.340000000000003 109.561 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.98 145.11 20.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-O 122.332 1.063 . . . . 73.430000000000007 110.382 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.96 145.54 38.21 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.169 -0.923 . . . . 71.129999999999995 108.509 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -130.96 157.62 42.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.364 0.602 . . . . 65.329999999999998 109.863 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.1 p -148.28 161.82 40.75 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.408 -0.96 . . . . 75.519999999999996 108.408 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.14 17.85 16.65 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 117.959 -1.467 . . . . 65.329999999999998 114.136 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -132.03 141.05 49.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.285 -1.376 . . . . 72.430000000000007 107.285 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -80.62 -18.88 46.78 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.867 0.867 . . . . 72.209999999999994 109.645 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.77 138.29 45.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.449 1.1 . . . . 74.540000000000006 108.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -117.66 71.13 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.091 1.757 . . . . 74.519999999999996 106.959 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 N-CA-C 110.509 -1.036 . . . . 75.040000000000006 110.509 -179.306 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.328 0 N-CA-C 109.186 -1.566 . . . . 73.439999999999998 109.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -139.49 77.57 1.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.186 1.794 . . . . 52.439999999999998 106.474 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 71.7 mtm -115.84 68.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.026 -1.102 . . . . 75.209999999999994 108.026 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.18 40.74 2.77 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.903 1.281 . . . . 72.329999999999998 107.674 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 11.3 pt -65.97 155.79 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.452 0.644 . . . . 74.299999999999997 110.985 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 95.6 mt -101.68 -55.79 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 126.872 2.069 . . . . 70.040000000000006 109.755 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -77.44 83.06 3.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.498 0.59 . . . . 71.219999999999999 111.006 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -69.1 153.05 44.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.955 -1.498 . . . . 71.25 106.955 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.03 -54.52 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.312 1.045 . . . . 72.109999999999999 112.959 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -77.11 161.7 28.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.754 0.822 . . . . 62.409999999999997 111.823 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 -62.29 1.58 Allowed 'General case' 0 CA--C 1.557 1.248 1 N-CA-C 122.043 4.09 . . . . 71.239999999999995 122.043 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.433 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 10.4 m95 50.67 66.14 1.25 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.479 3.112 . . . . 74.299999999999997 112.081 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -99.8 124.89 8.38 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.421 -1.872 . . . . 61.329999999999998 108.421 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . 0.432 HG12 ' HE3' ' A' ' 48' ' ' LYS . 61.5 mt -68.37 139.9 19.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.585 1.192 . . . . 74.299999999999997 108.212 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -141.72 112.21 7.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.071 1.748 . . . . 63.340000000000003 106.584 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.48 120.71 22.08 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.374 -2.084 . . . . 74.420000000000002 105.374 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.48 110.86 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.458 0.703 . . . . 73.409999999999997 111.934 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 5.1 p -144.48 127.5 16.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.338 1.055 . . . . 62.5 108.958 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 128.94 2.896 . . . . 74.400000000000006 114.56 179.549 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 108.88 -0.785 . . . . 75.329999999999998 108.88 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.28 110.67 3.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 105.227 -3.149 . . . . 65.310000000000002 105.227 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -79.92 113.46 18.1 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.026 0.93 . . . . 61.229999999999997 108.714 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 mmt -60.17 -34.14 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 119.398 -0.921 . . . . 61.219999999999999 110.749 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -60.23 -47.66 85.02 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.232 -0.917 . . . . 74.439999999999998 109.982 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -64.43 -32.67 74.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.827 -0.606 . . . . 65.010000000000005 110.227 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -60.21 -47.35 86.35 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.87 -1.159 . . . . 54.210000000000001 107.87 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.17 -76.26 0.16 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.648 0.779 . . . . 73.329999999999998 111.284 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.4 143.08 11.67 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 127.339 2.256 . . . . 54.119999999999997 109.615 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 t -122.89 -59.7 1.57 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.099 -0.953 . . . . 74.209999999999994 109.377 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.4 mt -45.42 -58.22 3.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.075 1.35 . . . . 74.519999999999996 114.235 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -64.86 -49.99 68.36 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.426 -0.796 . . . . 73.340000000000003 110.916 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -52.5 -55.43 22.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.319 1.012 . . . . 74.109999999999999 110.377 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -44.71 91.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.637 1.575 . . . . 63.450000000000003 111.041 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.51 -50.85 72.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.088 1.313 . . . . 72.409999999999997 111.702 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.458 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 74.6 t -69.1 -47.34 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.826 0.85 . . . . 61.420000000000002 111.772 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.4 -51.18 70.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.843 1.257 . . . . 62.109999999999999 109.443 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t -63.63 -40.77 97.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.117 -0.944 . . . . 75.409999999999997 110.038 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -49.83 76.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.52 1.509 . . . . 53.409999999999997 110.175 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' CG1' ' A' ' 16' ' ' VAL . 50.6 mttm -61.45 -48.42 81.23 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.431 -0.793 . . . . 73.230000000000004 110.989 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.68 -41.77 85.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-O 117.564 -1.208 . . . . 75.450000000000003 110.403 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -63.51 -33.79 76.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.526 1.966 . . . . 73.120000000000005 109.138 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.18 51.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.496 0.589 . . . . 61.439999999999998 110.153 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -75.44 -46.34 33.2 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.165 1.172 . . . . 64.450000000000003 114.165 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -124.08 74.74 58.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.938 2.895 . . . . 75.439999999999998 112.022 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.59 -9.17 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.132 3.221 . . . . 64.140000000000001 110.96 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.66 12.53 27.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.171 2.188 . . . . 63.219999999999999 111.894 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -127.41 160.08 32.52 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.87 -1.144 . . . . 74.319999999999993 109.791 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.5 142.62 37.72 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.604 1.161 . . . . 61.109999999999999 108.909 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.64 119.02 3.25 Favored 'Trans proline' 0 N--CA 1.457 -0.669 1 C-N-CA 125.372 4.048 . . . . 75.340000000000003 112.185 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.1 t -126.46 148.87 31.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.184 0.994 . . . . 74.129999999999995 109.764 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.24 133.41 68.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.52 -2.4 . . . . 72.219999999999999 104.52 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.73 118.5 52.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.559 1.544 . . . . 74.239999999999995 108.888 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -130.56 153.91 48.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.864 -0.791 . . . . 74.420000000000002 108.864 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -93.06 158.38 15.81 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.143 -0.973 . . . . 74.299999999999997 110.503 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.06 119.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.545 -2.02 . . . . 74.540000000000006 105.545 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 p -54.68 110.8 0.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.968 1.707 . . . . 41.240000000000002 111.946 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.4 30.99 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.846 1.688 . . . . 72.450000000000003 113.422 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 p -63.95 146.38 54.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.136 1.468 . . . . 63.130000000000003 109.816 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -69.59 -0.62 7.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.797 1.639 . . . . 74.409999999999997 114.502 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 tt -86.75 169.2 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 119.386 0.994 . . . . 75.129999999999995 109.738 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.9 155.72 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.526 1.13 . . . . 63.539999999999999 111.358 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.16 163.13 18.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.94 0.896 . . . . 72.049999999999997 111.032 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.42 124.5 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 125.745 1.618 . . . . 62.240000000000002 106.675 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.12 164.62 15.15 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.893 0.877 . . . . 55.43 110.175 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.64 101.51 4.28 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.981 -1.489 . . . . 75.349999999999994 106.981 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -134.44 161.79 34.03 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.934 1.294 . . . . 72.230000000000004 108.765 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' B' ' 341' ' ' TRP . 17.1 mttt -111.26 105.84 14.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.745 -1.946 . . . . 64.120000000000005 105.745 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -88.01 118.39 27.54 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.325 0.861 . . . . 73.530000000000001 113.325 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.57 108.29 20.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.32 2.248 . . . . 62.149999999999999 108.783 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.62 141.35 24.46 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.049 -0.977 . . . . 51.439999999999998 110.062 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.19 141.43 32.42 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.13 1.887 . . . . 62.509999999999998 111.582 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -62.51 -16.15 54.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.098 0.777 . . . . 72.409999999999997 113.098 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.72 -34.21 64.69 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.308 1.225 . . . . 71.129999999999995 114.308 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.8 168.94 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.206 0.912 . . . . 72.120000000000005 111.58 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.1 p -107.88 169.4 8.63 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.082 0.953 . . . . 45.200000000000003 111.605 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 87' ' ' SER . 60.2 t -55.86 -36.1 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.002 0.921 . . . . 62.399999999999999 109.193 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.25 93.81 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.411 1.005 . . . . 71.430000000000007 110.541 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -60.91 -46.49 90.44 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 108.15 -1.056 . . . . 73.519999999999996 108.15 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -59.65 -49.3 78.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.961 0.504 . . . . 74.439999999999998 110.464 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ttt -58.49 -44.15 89.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.329 1.452 . . . . 72.230000000000004 109.467 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -63.64 -39.5 94.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.318 0.508 . . . . 74.040000000000006 110.212 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.757 HG21 HG13 ' B' ' 346' ' ' VAL . 5.9 mt -67.05 -47.65 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 107.832 -1.173 . . . . 74.219999999999999 107.832 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.86 -50.83 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.66 1.118 . . . . 73.329999999999998 110.987 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -61.31 -41.92 97.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.558 -0.734 . . . . 75.540000000000006 110.894 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -69.21 -41.92 76.43 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.185 0.902 . . . . 71.209999999999994 111.165 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -58.88 -47.65 84.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.462 1.505 . . . . 72.120000000000005 110.825 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 pt -83.96 -0.87 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.069 0.395 . . . . 73.299999999999997 111.266 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 54.36 71.23 0.54 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 126.521 1.928 . . . . 75.109999999999999 108.095 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -82.6 104.96 4.02 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.271 -2.122 . . . . 73.010000000000005 105.271 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -66.31 165.53 24.34 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 124.232 3.288 . . . . 72.239999999999995 113.816 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -57.86 -37.91 74.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.418 1.087 . . . . 74.299999999999997 110.202 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -59.92 -38.64 82.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 116.859 -1.543 . . . . 74.349999999999994 113.906 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.51 162.4 13.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.306 1.412 . . . . 70.129999999999995 110.673 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.39 177.87 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.13 1.372 . . . . 44.340000000000003 108.807 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.0 tp -132.58 139.59 49.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.486 1.114 . . . . 61.130000000000003 108.225 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -137.7 120.15 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.619 -1.623 . . . . 74.409999999999997 106.619 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.79 140.18 49.12 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.931 1.692 . . . . 65.430000000000007 109.126 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -145.09 141.51 28.89 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.232 -1.025 . . . . 72.25 108.232 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.68 122.57 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 125.162 1.385 . . . . 74.319999999999993 107.681 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 t0 43.49 45.79 5.61 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.338 1.236 . . . . 73.340000000000003 114.338 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tptm 71.44 18.79 5.41 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.22 1.808 . . . . 65.439999999999998 114.37 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.4 p -129.18 162.38 27.93 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 120.081 1.31 . . . . 74.200000000000003 111.043 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.26 109.55 50.29 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 106.43 -1.693 . . . . 72.010000000000005 106.43 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 123.86 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 N-CA-C 107.573 -1.741 . . . . 64.519999999999996 107.573 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -69.96 121.5 17.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.685 -0.635 . . . . 63.409999999999997 110.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 76.6 p -47.65 -37.59 13.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.972 2.109 . . . . 72.439999999999998 114.045 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 m -75.92 -19.19 58.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.529 1.132 . . . . 73.310000000000002 113.968 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.06 144.64 53.93 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.174 0.897 . . . . 74.209999999999994 109.879 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.7 p -83.09 154.55 24.31 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.449 0.642 . . . . 72.319999999999993 109.677 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.84 -42.27 97.43 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.702 -0.666 . . . . 72.120000000000005 111.384 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.31 -43.13 98.88 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.193 -0.782 . . . . 62.039999999999999 111.744 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -68.49 -48.46 64.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.247 1.024 . . . . 72.010000000000005 109.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 tt -57.43 -44.43 84.65 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.472 0.709 . . . . 64.530000000000001 110.308 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -61.07 -49.74 76.11 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.17 0.988 . . . . 75.219999999999999 108.546 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.09 -32.25 72.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.647 0.98 . . . . 74.140000000000001 113.647 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -25.84 18.93 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.971 1.471 . . . . 52.43 114.971 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.22 0.35 23.2 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.711 1.004 . . . . 60.100000000000001 113.711 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -48.21 135.17 13.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.355 0.979 . . . . 74.209999999999994 112.965 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -75.77 161.23 29.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.564 -0.902 . . . . 75.439999999999998 108.564 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -54.64 -29.94 53.66 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.403 1.481 . . . . 55.240000000000002 112.01 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -79.77 -33.1 40.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.145 0.578 . . . . 63.329999999999998 111.684 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.45 -6.86 4.97 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 117.434 1.734 . . . . 73.310000000000002 117.434 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.77 -179.61 3.7 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.805 2.042 . . . . 73.019999999999996 111.957 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.5 tp -123.68 143.63 50.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.395 0.543 . . . . 63.43 111.937 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -122.69 134.52 54.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.798 1.239 . . . . 41.240000000000002 110.602 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.84 140.64 48.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 124.498 1.119 . . . . 53.240000000000002 108.264 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.01 149.04 40.93 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.575 -0.898 . . . . 42.329999999999998 108.575 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -139.73 159.9 41.1 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.929 0.871 . . . . 75.239999999999995 112.793 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.2 p -149.59 155.94 41.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.014 -1.847 . . . . 50.43 106.014 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 26.16 12.64 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.156 -0.778 . . . . 65.25 111.156 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -134.74 128.75 33.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.417 1.487 . . . . 75.140000000000001 107.026 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.07 -45.06 90.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.161 0.505 . . . . 64.329999999999998 109.78 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.85 110.78 22.21 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.805 2.042 . . . . 63.43 107.791 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.36 71.35 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.235 2.614 . . . . 72.420000000000002 110.293 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 N-CA-C 108.99 -1.644 . . . . 65.209999999999994 108.99 179.632 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.569 0 N-CA-C 110.46 -1.056 . . . . 62.329999999999998 110.46 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -140.71 -3.88 1.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.193 1.797 . . . . 62.32 113.484 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -55.27 -9.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.595 1.958 . . . . 62.509999999999998 116.17 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.81 51.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.558 2.743 . . . . 74.219999999999999 111.596 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 31.7 pt -116.32 160.44 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 119.897 -1.752 . . . . 75.120000000000005 109.123 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 19.2 pt -110.7 6.84 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.69 1.196 . . . . 75.239999999999995 109.885 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -113.33 46.74 1.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.828 1.651 . . . . 75.200000000000003 111.381 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -73.06 115.7 12.7 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.432 -2.062 . . . . 74.25 105.432 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.45 -26.63 68.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.598 1.703 . . . . 75.540000000000006 115.598 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -109.92 155.53 21.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.741 1.216 . . . . 75.420000000000002 110.282 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -83.41 -55.59 4.23 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.349 0.977 . . . . 73.430000000000007 112.499 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . 0.5 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 52.5 m95 54.02 63.91 2.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.754 1.622 . . . . 73.319999999999993 111.792 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.78 126.34 7.34 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.009 -2.436 . . . . 62.340000000000003 107.009 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.6 132.08 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.792 1.296 . . . . 73.530000000000001 108.016 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -129.9 149.5 51.61 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.227 1.011 . . . . 65.010000000000005 109.553 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 8.8 tt -111.39 114.35 27.43 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.679 1.592 . . . . 71.25 109.159 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.757 HG13 HG21 ' A' ' 63' ' ' ILE . 37.8 t -121.77 136.11 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.1 0.96 . . . . 43.310000000000002 111.401 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 160.41 28.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.152 1.781 . . . . 74.329999999999998 109.331 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 127.33 2.252 . . . . 71.310000000000002 107.32 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 121.249 0.547 . . . . 54.119999999999997 109.9 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.58 -109.2 0.3 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.797 -2.121 . . . . 33.240000000000002 107.797 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -82.62 132.26 35.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 118.543 1.172 . . . . 73.239999999999995 108.814 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.476 ' HG2' ' HE2' ' A' ' 46' ' ' LYS . 16.3 tpt -62.01 -47.11 86.23 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.422 -0.955 . . . . 70.150000000000006 108.422 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -60.26 -41.04 92.42 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 119.116 -0.469 . . . . 64.319999999999993 111.369 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -64.38 -33.27 75.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.879 0.763 . . . . 74.109999999999999 109.476 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.18 -48.31 62.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.506 0.594 . . . . 74.450000000000003 110.15 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -75.0 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.178 0.991 . . . . 73.409999999999997 112.621 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 130.63 10.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.968 1.307 . . . . 72.310000000000002 107.989 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.1 p -124.22 -65.93 1.02 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.472 0.916 . . . . 61.130000000000003 113.472 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mt -48.49 -58.88 4.01 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.444 1.497 . . . . 62.539999999999999 114.539 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.49 -44.37 87.3 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.61 -0.681 . . . . 73.349999999999994 112.06 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -59.62 -40.02 86.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.055 0.942 . . . . 74.319999999999993 108.688 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -43.12 84.7 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-O 117.437 -1.268 . . . . 73.310000000000002 110.054 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.6 m -63.85 -47.01 82.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.182 1.356 . . . . 71.530000000000001 112.752 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.39 -47.13 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 O-C-N 121.736 -0.603 . . . . 75.349999999999994 109.637 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -64.04 -40.01 95.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 117.416 -1.278 . . . . 72.310000000000002 110.967 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -61.76 -47.45 85.12 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 121.15 1.795 . . . . 61.119999999999997 108.767 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.83 72.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.874 0.694 . . . . 74.019999999999996 112.874 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.0 -44.94 75.43 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.637 -0.664 . . . . 65.430000000000007 112.661 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 95.2 mt -67.2 -41.89 87.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 118.296 -0.859 . . . . 73.310000000000002 110.237 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -66.15 -38.0 87.05 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.468 1.031 . . . . 70.219999999999999 109.484 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.63 78.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.094 -0.642 . . . . 64.219999999999999 110.601 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.39 -46.43 22.77 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.138 1.533 . . . . 62.229999999999997 115.138 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.15 72.12 55.37 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 127.064 2.146 . . . . 74.310000000000002 110.533 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.5 -19.31 48.91 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.778 2.318 . . . . 73.530000000000001 112.523 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -97.76 13.02 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.441 0.564 . . . . 63.509999999999998 110.871 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -118.54 155.4 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.989 -1.115 . . . . 63.140000000000001 107.989 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.26 136.5 27.12 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.879 -1.156 . . . . 72.510000000000005 107.879 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.59 122.15 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.98 3.787 . . . . 63.350000000000001 112.392 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.55 140.77 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.274 1.83 . . . . 74.519999999999996 111.82 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.68 136.76 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 105.764 -1.939 . . . . 75.319999999999993 105.764 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.87 110.58 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.99 0.813 . . . . 72.140000000000001 110.432 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -112.88 146.81 38.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.118 -1.067 . . . . 72.329999999999998 108.118 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 141.94 31.88 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.067 -1.021 . . . . 50.340000000000003 109.652 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.34 127.94 23.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.558 -1.275 . . . . 71.409999999999997 107.558 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.07 128.77 22.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.115 1.366 . . . . 63.329999999999998 109.636 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.1 42.28 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.58 -1.122 . . . . 72.219999999999999 113.934 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.19 109.23 2.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.319 -2.104 . . . . 44.109999999999999 105.319 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.73 -0.98 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.602 1.561 . . . . 72.049999999999997 114.792 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.3 tp -68.39 163.89 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 121.139 -0.975 . . . . 72.120000000000005 109.043 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -53.83 129.68 14.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.219 1.407 . . . . 71.129999999999995 110.364 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -84.37 163.94 19.23 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.633 1.573 . . . . 64.200000000000003 108.444 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -125.41 135.57 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.871 -1.529 . . . . 63.420000000000002 106.871 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.83 165.15 8.97 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.304 0.573 . . . . 74.010000000000005 110.609 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE2' ' HG2' ' A' ' 4' ' ' MET . 10.2 mptt -73.88 103.19 4.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.089 -1.448 . . . . 70.0 107.089 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -136.62 158.28 44.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.953 2.101 . . . . 73.230000000000004 107.846 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.51 102.11 11.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 104.033 -2.58 . . . . 71.150000000000006 104.033 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -83.97 142.14 30.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.576 -1.268 . . . . 74.430000000000007 107.576 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD11 HG23 ' B' ' 343' ' ' ILE . 5.0 mp -129.97 123.35 30.43 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 117.921 -1.038 . . . . 74.120000000000005 108.844 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.57 143.01 28.11 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 117.787 -1.101 . . . . 73.329999999999998 112.785 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.81 141.28 48.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.268 1.978 . . . . 73.230000000000004 108.481 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 t -59.25 -12.68 5.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.936 2.494 . . . . 45.350000000000001 113.303 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.71 -27.16 17.42 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 115.528 1.677 . . . . 75.319999999999993 115.528 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.55 169.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.031 1.287 . . . . 74.310000000000002 110.184 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.9 p -107.28 160.17 15.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.987 0.915 . . . . 53.450000000000003 111.053 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.12 -38.13 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.458 1.503 . . . . 64.150000000000006 111.465 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.05 91.93 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.556 0.743 . . . . 72.230000000000004 110.778 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.62 -42.37 95.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.017 0.927 . . . . 73.439999999999998 109.742 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.45 -46.2 89.44 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.833 -0.803 . . . . 73.439999999999998 108.833 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.5 ttp -60.51 -42.36 96.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.574 0.75 . . . . 64.450000000000003 110.581 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -61.25 -40.31 93.61 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.49 0.716 . . . . 73.230000000000004 109.915 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.433 HG21 ' CG1' ' B' ' 346' ' ' VAL . 34.9 mt -66.18 -51.01 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 118.511 -0.757 . . . . 74.140000000000001 109.326 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.7 mt -55.15 -49.98 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.142 0.883 . . . . 72.219999999999999 110.339 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.54 -38.71 88.42 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.017 -1.052 . . . . 74.420000000000002 111.328 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.712 0.687 . . . . 65.129999999999995 110.063 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -61.83 -51.33 68.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.507 1.123 . . . . 72.329999999999998 109.888 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 pt -84.11 5.86 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.002 0.371 . . . . 74.019999999999996 112.002 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 46.21 63.4 1.87 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 127.634 2.374 . . . . 70.430000000000007 110.651 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 108.58 3.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.97 1.308 . . . . 71.400000000000006 110.877 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.31 158.65 36.98 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.116 3.21 . . . . 62.210000000000001 110.955 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -26.78 55.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.801 0.84 . . . . 54.439999999999998 112.757 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.91 -34.48 77.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.153 0.981 . . . . 64.310000000000002 111.501 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 164.29 11.72 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.912 1.233 . . . . 53.149999999999999 108.106 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.65 175.27 5.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.628 1.171 . . . . 73.230000000000004 107.98 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -148.34 130.12 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.512 0.725 . . . . 75.239999999999995 111.617 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -141.53 148.28 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.454 1.101 . . . . 74.120000000000005 110.213 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.9 152.18 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.569 1.948 . . . . 64.310000000000002 108.098 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -144.42 126.87 15.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.444 1.498 . . . . 71.109999999999999 108.347 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 85' ' ' PRO . 14.6 p -126.66 124.55 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.326 1.05 . . . . 70.329999999999998 108.457 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 43.83 38.44 2.1 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.162 1.385 . . . . 73.420000000000002 113.898 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttm 65.05 39.94 5.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.83 2.052 . . . . 74.140000000000001 111.063 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 p -141.25 156.61 45.87 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.163 0.985 . . . . 72.120000000000005 110.048 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.07 104.0 33.49 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 102.837 -3.023 . . . . 63.200000000000003 102.837 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.423 ' HD3' HG12 ' A' ' 80' ' ' VAL . 55.1 Cg_endo -68.59 147.18 69.71 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.554 2.17 . . . . 75.340000000000003 110.722 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -70.69 120.89 16.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.799 -1.185 . . . . 62.310000000000002 107.799 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 p -51.84 -34.92 42.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.374 1.469 . . . . 52.130000000000003 113.813 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -83.68 -6.42 59.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.36 0.874 . . . . 53.299999999999997 113.36 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.73 144.58 54.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.678 1.126 . . . . 75.109999999999999 108.141 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.17 149.88 25.87 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.888 -0.782 . . . . 64.409999999999997 108.888 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.57 -50.75 64.89 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.264 1.025 . . . . 54.399999999999999 112.249 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.67 96.97 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 118.854 0.752 . . . . 75.340000000000003 112.378 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -62.07 -53.39 56.14 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.833 0.853 . . . . 74.420000000000002 109.261 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.02 -44.92 87.57 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 123.993 0.917 . . . . 71.540000000000006 110.231 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -60.31 -51.97 67.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.611 1.164 . . . . 73.420000000000002 108.994 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -35.91 74.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.205 -0.902 . . . . 62.530000000000001 112.747 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -24.41 20.37 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.735 -1.126 . . . . 74.430000000000007 113.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -107.21 5.3 27.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.566 1.076 . . . . 74.5 112.993 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -48.82 127.65 14.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.22 1.808 . . . . 72.450000000000003 113.513 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.46 175.22 10.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.49 0.716 . . . . 73.420000000000002 109.121 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -60.53 -30.47 69.77 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.225 -1.547 . . . . 75.150000000000006 110.886 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.28 16.78 12.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.502 1.121 . . . . 61.350000000000001 112.283 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.06 28.59 69.14 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.198 -1.335 . . . . 64.439999999999998 114.946 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -126.42 177.05 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.647 1.724 . . . . 73.099999999999994 111.472 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -123.43 135.32 54.04 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.491 1.116 . . . . 74.230000000000004 109.986 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -122.66 127.64 49.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.189 1.396 . . . . 70.109999999999999 107.698 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.3 t -129.2 149.02 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 120.505 -1.372 . . . . 70.420000000000002 109.457 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.68 150.97 37.29 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.753 -1.573 . . . . 64.150000000000006 106.753 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.27 151.92 46.86 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.097 0.862 . . . . 64.239999999999995 111.324 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.2 p -142.88 171.83 13.52 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.451 0.643 . . . . 72.230000000000004 111.262 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.62 9.18 21.89 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.597 1.57 . . . . 72.439999999999998 112.308 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.16 142.26 28.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.343 1.857 . . . . 73.319999999999993 107.968 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.53 -16.33 54.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.518 0.727 . . . . 75.549999999999997 111.683 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.3 p -89.04 119.81 29.89 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.527 1.931 . . . . 65.219999999999999 106.081 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -117.36 11.66 14.03 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.908 0.707 . . . . 71.129999999999995 112.908 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 CA-C-O 116.83 -2.094 . . . . 45.340000000000003 112.29 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 109.201 -1.56 . . . . 71.400000000000006 109.201 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . -134.43 42.44 2.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.532 0.733 . . . . 63.32 110.122 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 52.7 mtm -79.75 13.36 2.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.695 1.598 . . . . 74.400000000000006 112.909 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.51 20.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.254 2.622 . . . . 73.030000000000001 115.506 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 24.2 mm -76.68 162.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 125.467 1.507 . . . . 74.310000000000002 109.421 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.04 -9.3 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.333 1.453 . . . . 72.030000000000001 112.432 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -83.15 14.69 3.27 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.942 1.297 . . . . 74.420000000000002 111.681 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -56.32 140.07 46.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.192 1.797 . . . . 73.200000000000003 110.903 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.73 -40.74 24.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.449 -0.945 . . . . 75.209999999999994 108.449 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.51 109.14 10.0 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.03 0.932 . . . . 53.240000000000002 110.287 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -74.9 -37.78 62.02 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.011 -0.431 . . . . 64.420000000000002 110.761 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 18.3 m95 52.93 55.93 8.27 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.0 0.92 . . . . 74.340000000000003 110.316 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -82.49 128.35 8.44 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.308 -1.517 . . . . 62.420000000000002 109.308 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 50' ' ' LEU . 93.8 mt -61.94 133.62 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 126.903 2.081 . . . . 74.109999999999999 106.914 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.84 104.82 5.17 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.074 -1.454 . . . . 74.439999999999998 107.074 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.5 114.76 19.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.632 1.173 . . . . 73.239999999999995 107.882 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 63' ' ' ILE . 53.5 t -122.04 150.42 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.426 1.091 . . . . 72.109999999999999 110.723 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 3.0 p -162.89 161.72 25.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.904 2.482 . . . . 62.340000000000003 107.04 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.657 -1.609 . . . . 74.310000000000002 106.657 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 108.744 -0.836 . . . . 75.140000000000001 108.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.53 -73.19 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.054 -2.418 . . . . 41.310000000000002 107.054 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -92.71 104.66 16.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.399 -2.074 . . . . 71.129999999999995 105.399 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 46' ' ' LYS . 9.5 mtp -56.38 -46.29 80.16 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.966 -0.754 . . . . 72.030000000000001 108.966 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -57.18 -43.56 82.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.458 0.703 . . . . 71.019999999999996 112.401 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -37.73 87.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.469 0.577 . . . . 72.400000000000006 110.689 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -67.37 -48.2 68.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.487 -0.931 . . . . 75.219999999999999 108.487 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.84 -76.9 0.07 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.118 1.767 . . . . 53.539999999999999 113.092 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.75 120.13 2.32 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.207 2.203 . . . . 73.549999999999997 108.692 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -131.48 -35.17 1.33 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 116.979 -1.486 . . . . 74.010000000000005 114.119 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.67 -60.4 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 121.872 2.124 . . . . 71.319999999999993 112.214 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -66.86 -32.58 73.95 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.519 -0.738 . . . . 73.329999999999998 110.721 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -57.09 -59.23 5.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.033 -1.099 . . . . 73.540000000000006 108.033 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -39.65 95.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.589 1.156 . . . . 73.219999999999999 109.691 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -56.05 -58.03 9.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.758 1.163 . . . . 65.349999999999994 111.658 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.95 -42.99 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.83 0.852 . . . . 74.030000000000001 110.106 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.21 -47.64 84.6 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.523 -0.751 . . . . 75.409999999999997 109.96 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.7 t -58.53 -49.6 76.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.139 -1.06 . . . . 73.340000000000003 108.139 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.49 73.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.98 0.809 . . . . 73.019999999999996 112.771 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.74 -39.25 84.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 O-C-N 120.535 -1.353 . . . . 74.209999999999994 112.17 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.8 -42.13 82.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 O-C-N 120.762 -1.211 . . . . 73.049999999999997 108.897 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -67.07 -32.36 73.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.7 1.136 . . . . 74.549999999999997 110.96 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.0 -47.49 24.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 119.238 -0.411 . . . . 60.43 110.529 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -78.49 -44.03 25.49 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.591 1.701 . . . . 75.109999999999999 115.591 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.73 72.86 81.66 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.598 1.959 . . . . 73.439999999999998 109.789 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.41 -26.09 76.51 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.433 2.089 . . . . 64.200000000000003 111.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.37 12.07 17.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.161 -0.447 . . . . 64.439999999999998 111.564 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -123.46 139.07 54.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.737 1.153 . . . . 73.420000000000002 108.213 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -107.18 143.83 27.92 Favored Pre-proline 0 C--O 1.249 1.026 0 C-N-CA 123.703 0.801 . . . . 64.120000000000005 110.374 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.52 117.37 3.38 Favored 'Trans proline' 0 C--N 1.355 0.903 1 C-N-CA 125.888 4.392 . . . . 50.43 112.885 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 146.91 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.397 1.079 . . . . 73.439999999999998 110.611 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.16 135.41 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 104.459 -2.423 . . . . 72.0 104.459 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -123.13 111.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.443 -1.688 . . . . 51.0 106.443 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -128.13 150.42 49.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.195 0.452 . . . . 74.340000000000003 110.788 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.76 132.91 34.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.019 -0.734 . . . . 74.109999999999999 109.019 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.83 116.86 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.72 -1.585 . . . . 75.239999999999995 106.72 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 m -53.76 125.34 18.08 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.8 0.727 . . . . 43.240000000000002 109.683 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.97 -3.18 35.58 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.285 1.421 . . . . 72.150000000000006 112.642 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.8 m -89.92 127.69 36.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.9 1.35 . . . . 71.349999999999994 108.288 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.57 -18.87 62.22 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 118.453 -0.784 . . . . 61.420000000000002 111.708 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 tp -54.46 156.51 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 119.065 0.848 . . . . 74.310000000000002 111.158 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.0 m -52.28 125.76 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.656 0.782 . . . . 63.340000000000003 109.996 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -87.38 172.47 9.81 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.603 1.161 . . . . 74.439999999999998 108.876 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -125.85 150.88 31.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 123.766 0.826 . . . . 75.400000000000006 110.415 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.34 165.37 24.63 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.788 -1.56 . . . . 52.450000000000003 106.788 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 4' ' ' MET . 1.0 OUTLIER -74.76 105.75 5.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.03 -1.841 . . . . 74.299999999999997 106.03 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -134.11 163.74 28.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.873 0.844 . . . . 72.140000000000001 112.508 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -105.55 106.95 17.69 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 103.001 -2.962 . . . . 75.329999999999998 103.001 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.04 127.05 37.37 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.604 -1.628 . . . . 74.310000000000002 106.604 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.45 112.55 21.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.897 1.679 . . . . 62.549999999999997 108.092 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 142.83 27.7 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-N 119.565 1.075 . . . . 62.149999999999999 110.525 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.91 132.32 21.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.317 2.012 . . . . 75.120000000000005 108.698 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -58.73 -12.61 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.441 1.897 . . . . 63.140000000000001 113.123 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.99 -34.46 50.87 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 60.219999999999999 114.141 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 170.49 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.734 1.012 . . . . 62.409999999999997 113.734 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -102.63 167.35 9.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.998 1.719 . . . . 73.319999999999993 112.529 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.23 -35.87 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.965 0.906 . . . . 72.140000000000001 109.247 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.25 91.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.901 0.773 . . . . 64.439999999999998 110.362 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -63.85 -45.76 88.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.746 -0.835 . . . . 75.5 108.746 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD2' HG11 ' A' ' 51' ' ' VAL . 6.2 t80 -59.64 -48.91 79.79 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.8 -0.444 . . . . 73.540000000000006 109.8 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.9 ttt -55.89 -51.98 65.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.365 1.466 . . . . 74.409999999999997 110.114 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -58.27 -41.64 84.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.727 0.811 . . . . 73.5 109.042 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.583 HG21 HG13 ' B' ' 346' ' ' VAL . 21.1 mt -66.87 -45.2 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 120.828 1.649 . . . . 75.319999999999993 109.323 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.59 -50.81 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 120.588 1.54 . . . . 61.240000000000002 110.554 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -31.91 73.12 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.161 -0.962 . . . . 74.329999999999998 111.531 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -68.95 -48.51 63.03 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.537 -0.542 . . . . 74.420000000000002 109.537 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -59.98 -51.38 69.89 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 126.926 2.091 . . . . 75.420000000000002 111.51 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.23 3.65 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 122.379 -0.2 . . . . 74.5 110.961 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 44.24 63.34 1.67 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 126.849 2.06 . . . . 71.310000000000002 109.503 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.22 111.19 5.98 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.993 -1.114 . . . . 71.109999999999999 107.993 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.71 165.43 27.67 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 125.177 3.918 . . . . 75.510000000000005 114.309 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -26.67 67.66 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.356 0.662 . . . . 54.340000000000003 111.411 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.64 -47.07 79.89 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.347 0.869 . . . . 70.310000000000002 113.347 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -100.3 165.35 11.51 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.169 0.895 . . . . 72.140000000000001 113.158 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.05 -178.63 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.596 1.958 . . . . 43.140000000000001 107.148 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.7 tp -137.47 135.55 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.664 -1.606 . . . . 70.430000000000007 106.664 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.79 130.25 33.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.705 -1.591 . . . . 74.209999999999994 106.705 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.43 146.32 40.77 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.084 1.754 . . . . 72.409999999999997 107.821 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.62 128.28 19.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.893 1.277 . . . . 64.400000000000006 108.501 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.23 123.83 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 107.632 -1.248 . . . . 63.25 107.632 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.5 t0 47.92 38.27 8.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.11 0.964 . . . . 73.200000000000003 111.813 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 23.05 11.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.272 1.429 . . . . 72.150000000000006 112.947 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 162.8 21.32 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.978 1.711 . . . . 54.539999999999999 112.352 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.14 103.46 12.07 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.823 2.449 . . . . 75.319999999999993 106.901 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.37 123.68 7.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.75 2.3 . . . . 74.400000000000006 111.887 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 88' ' ' SER . 8.4 tt0 -63.81 127.62 32.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.569 -1.271 . . . . 64.319999999999993 107.569 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.4 p -57.23 -28.44 62.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.246 1.419 . . . . 74.129999999999995 112.881 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.468 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 25.1 t -85.24 -4.79 59.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.387 1.475 . . . . 53.240000000000002 112.064 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.5 tp -76.51 143.93 40.11 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.439 -1.413 . . . . 74.040000000000006 107.632 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 m -84.85 152.42 23.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.456 -0.572 . . . . 52.450000000000003 109.456 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 19.2 mmt -59.64 -51.89 67.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.149 0.98 . . . . 74.140000000000001 110.198 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.63 -45.02 60.23 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.528 0.604 . . . . 51.43 111.655 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -66.97 -49.11 66.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.63 0.772 . . . . 72.109999999999999 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.91 -42.39 97.96 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.641 -0.662 . . . . 73.010000000000005 110.476 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.07 -57.89 8.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.949 1.699 . . . . 75.0 109.455 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.07 -27.69 69.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 118.56 -0.733 . . . . 73.010000000000005 112.868 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -38.85 12.75 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.863 -1.065 . . . . 74.030000000000001 113.118 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -88.02 -8.78 55.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 117.838 -1.077 . . . . 41.399999999999999 113.123 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -33.32 120.83 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.399 1.629 . . . . 63.219999999999999 115.399 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.84 177.21 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.057 1.743 . . . . 72.420000000000002 109.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -35.1 56.38 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.025 -1.672 . . . . 73.400000000000006 112.056 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -95.62 10.9 35.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.747 1.219 . . . . 74.420000000000002 111.786 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.73 60.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.462 1.506 . . . . 61.340000000000003 115.151 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -105.07 163.67 12.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.031 1.415 . . . . 64.420000000000002 109.133 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.9 tp -120.67 134.81 55.25 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.352 0.661 . . . . 63.039999999999999 109.709 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.71 121.91 37.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.889 0.876 . . . . 74.439999999999998 108.982 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.07 137.9 54.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 N-CA-C 107.826 -1.176 . . . . 71.109999999999999 107.826 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -113.06 152.1 29.93 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.224 1.01 . . . . 64.420000000000002 108.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -140.24 161.19 38.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.556 0.947 . . . . 64.409999999999997 113.556 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.4 t -159.05 173.35 16.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.956 1.702 . . . . 72.430000000000007 108.947 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -115.24 17.26 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.65 2.548 . . . . 63.310000000000002 112.493 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.8 135.58 51.23 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.326 1.85 . . . . 75.230000000000004 109.196 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -66.89 -29.75 69.72 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.728 1.211 . . . . 63.420000000000002 112.716 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.36 131.0 57.07 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.503 1.121 . . . . 64.400000000000006 109.119 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -116.13 9.23 14.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.234 1.014 . . . . 63.340000000000003 112.657 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 CA-C-O 118.266 -1.297 . . . . 61.200000000000003 110.44 179.674 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 330' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.773 0 N-CA-C 110.939 -0.864 . . . . 63.020000000000003 110.939 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 331' ' ' ALA . . . . . . . . . . . . . . . 52.51 10.72 0.15 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.343 2.257 . . . . 52.25 116.023 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 332' ' ' MET . . . . . . . . . . . . . 25.5 ttt -85.2 68.01 10.37 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 106.164 -1.791 . . . . 75.120000000000005 106.164 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 333' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -116.45 49.37 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.971 -1.863 . . . . 72.439999999999998 105.971 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 334' ' ' ILE . . . . . . . . . . . . . 15.0 pt -65.95 142.26 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.855 -0.528 . . . . 74.239999999999995 110.525 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 335' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.1 4.64 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.701 0.63 . . . . 63.450000000000003 112.701 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 336' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -110.35 71.45 0.75 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.014 1.726 . . . . 75.230000000000004 109.04 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 337' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.31 168.35 15.64 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.911 1.284 . . . . 72.540000000000006 109.267 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.03 -12.69 43.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.476 0.71 . . . . 74.120000000000005 109.228 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 339' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.58 106.94 18.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.021 -1.474 . . . . 75.200000000000003 107.021 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -92.63 -62.09 1.47 Allowed 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.056 -0.402 . . . . 71.430000000000007 111.545 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 341' ' ' TRP . . . . . . . . . . . . . 62.9 m95 58.15 66.03 1.18 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.209 1.404 . . . . 72.340000000000003 110.362 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 342' ' ' GLY . . . . . . . . . . . . . . . -83.98 136.12 14.49 Favored Glycine 0 C--N 1.344 0.996 0 O-C-N 121.535 -0.728 . . . . 73.319999999999993 111.387 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 343' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.35 125.28 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.46 1.904 . . . . 72.120000000000005 107.722 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -139.88 130.03 25.1 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.283 1.033 . . . . 75.340000000000003 108.249 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.14 127.11 52.75 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.201 -0.937 . . . . 73.049999999999997 110.579 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 63' ' ' ILE . 1.9 t -121.48 117.52 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 125.05 1.34 . . . . 63.439999999999998 107.812 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 22.8 p -162.15 126.39 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 104.943 -2.243 . . . . 51.439999999999998 104.943 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.135 2.174 . . . . 52.149999999999999 111.899 -179.676 . . . . . . . . 0 0 . 1 stop_ save_